data_5a3g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5a3g _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 111.144 0.053 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -48.2 -38.14 17.57 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -165.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -94.68 -22.24 18.26 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.281 0.946 . . . . 0.0 112.151 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.6 t -72.44 -51.12 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.697 1.599 . . . . 0.0 113.164 -168.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.94 -46.66 94.11 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.27 -35.91 67.98 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.222 1.011 . . . . 0.0 112.584 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -68.43 -47.47 67.11 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.405 1.482 . . . . 0.0 112.534 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.48 -38.31 77.64 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.209 -0.932 . . . . 0.0 111.977 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.58 -39.83 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.505 1.522 . . . . 0.0 110.497 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.2 t -58.97 -48.27 82.16 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.197 0.999 . . . . 0.0 111.51 172.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -60.36 -43.01 96.92 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.66 -0.65 . . . . 0.0 111.156 173.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.9 m -62.75 -45.97 90.21 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.621 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.7 ptt-85 -65.81 -36.65 84.09 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.587 1.54 . . . . 0.0 112.592 174.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -68.66 -42.85 77.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.408 1.883 . . . . 0.0 114.375 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . 0.3 0.8 OUTLIER -88.24 -17.34 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 173.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.13 -5.72 58.64 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 121.022 1.737 . . . . 0.0 112.309 163.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 48.86 41.67 18.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 128.05 2.54 . . . . 0.0 114.468 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 pp -120.48 169.82 9.97 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.458 2.303 . . . . 0.0 110.804 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -92.74 168.41 11.22 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -66.95 -18.24 65.29 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.698 1.599 . . . . 0.0 114.427 -173.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -102.97 12.14 36.46 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.043 1.337 . . . . 0.0 112.314 171.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -127.48 -14.02 5.34 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.101 1.76 . . . . 0.0 110.953 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 35.6 tp -83.93 122.35 28.62 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 155.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.9 ttp-105 -92.19 126.43 37.26 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 118.932 -1.107 . . . . 0.0 110.839 172.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.8 mm -98.99 142.42 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.946 1.699 . . . . 0.0 112.007 173.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.9 m -140.8 143.14 34.68 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.318 0.508 . . . . 0.0 110.116 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -96.85 -142.38 0.29 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.386 1.474 . . . . 0.0 111.656 176.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.9 p -46.92 -38.55 10.71 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.16 2.184 . . . . 0.0 115.706 -156.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.45 -29.61 64.33 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -165.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.39 -15.2 16.6 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 115.961 1.838 . . . . 0.0 115.961 173.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 pt -112.62 -14.0 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 -175.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.5 t -61.53 9.33 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 -166.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -83.79 -15.7 47.4 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 119.657 -1.902 . . . . 0.0 113.075 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.431 ' HB2' ' H ' ' A' ' 92' ' ' PHE . 48.6 t-20 -91.49 113.44 58.56 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 141.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.99 -11.1 11.29 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.125 1.883 . . . . 0.0 115.871 -160.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -121.9 -10.97 8.6 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 120.806 1.639 . . . . 0.0 115.164 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 1.631 ' HD2' ' CD1' ' A' ' 43' ' ' TYR . 37.2 p90 -162.1 160.19 27.04 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.078 1.351 . . . . 0.0 108.325 -169.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.7 p 164.61 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.273 1.829 . . . . 0.0 106.426 -155.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.0 tp -122.33 -78.16 0.6 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 119.16 -1.016 . . . . 0.0 112.42 147.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.414 ' HB3' ' H ' ' A' ' 47' ' ' ASP . 1.5 m -177.34 -160.04 0.05 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.794 2.038 . . . . 0.0 108.004 -165.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.414 ' H ' ' HB3' ' A' ' 46' ' ' CYS . 11.7 t70 -131.78 157.83 42.84 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.921 2.088 . . . . 0.0 107.937 169.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -135.17 130.97 36.19 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 128.815 2.846 . . . . 0.0 108.951 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 35.8 ttp -118.22 131.67 56.36 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.096 -1.003 . . . . 0.0 110.844 -166.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 mt -127.51 149.03 50.31 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.348 2.659 . . . . 0.0 112.711 -151.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.1 p -96.93 159.02 15.15 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.063 2.145 . . . . 0.0 113.176 -169.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.5 t -72.07 158.61 35.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.903 1.281 . . . . 0.0 112.537 173.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.3 t70 57.11 43.69 23.73 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.113 1.765 . . . . 0.0 113.7 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 tp -132.74 139.73 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.546 1.139 . . . . 0.0 111.266 -171.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.2 p -123.37 140.92 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.424 1.49 . . . . 0.0 111.769 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 1.65 ' HD1' ' CD2' ' A' ' 56' ' ' TYR . 9.7 p90 -138.35 153.1 72.57 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 157.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.82 78.09 1.78 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.847 3.032 . . . . 0.0 109.949 167.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -47.73 -36.7 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 127.547 2.339 . . . . 0.0 115.047 -167.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.98 -18.61 60.35 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -59.55 -34.23 72.4 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.268 -0.895 . . . . 0.0 111.011 167.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.6 tp -78.87 -44.57 22.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.523 1.129 . . . . 0.0 112.409 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.7 mp -54.25 -45.93 72.51 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.733 1.151 . . . . 0.0 110.627 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.4 t -57.57 -50.36 73.35 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.924 1.29 . . . . 0.0 111.864 175.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -61.87 -37.69 85.46 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -59.55 -54.92 41.01 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.711 1.604 . . . . 0.0 111.95 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -72.1 -31.38 66.0 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 9.9 t -72.27 -18.26 61.82 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 -69.59 -35.14 75.06 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -168.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.1 m -147.17 8.04 0.92 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.84 71.76 0.79 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.986 1.279 . . . . 0.0 111.784 -170.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -168.0 135.31 2.18 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 128.425 2.69 . . . . 0.0 105.76 172.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -100.79 154.99 18.18 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 127.832 2.453 . . . . 0.0 111.734 -170.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.74 147.27 44.6 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.599 1.16 . . . . 0.0 112.566 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 26.9 p -86.9 142.29 28.13 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.661 0.743 . . . . 0.0 110.517 160.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 1.581 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 13.9 m-30 -92.06 108.61 20.06 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 167.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.3 t -101.48 109.02 24.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -92.36 113.12 25.31 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 120.712 -1.243 . . . . 0.0 107.677 -173.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -107.52 101.68 11.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.383 1.473 . . . . 0.0 108.851 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -79.62 129.02 34.1 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.801 1.64 . . . . 0.0 109.511 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.8 p -145.18 168.71 19.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.075 2.55 . . . . 0.0 104.57 -170.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -12.75 -119.44 0.0 OUTLIER Glycine 0 N--CA 1.487 2.051 0 C-N-CA 129.542 3.449 . . . . 0.0 116.098 -171.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.8 p -95.45 105.84 17.85 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 113.96 -3.096 . . . . 0.0 111.082 153.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -178.75 145.88 0.31 Allowed 'General case' 0 N--CA 1.474 0.728 1 C-N-CA 132.179 4.192 . . . . 0.0 108.477 146.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 t -78.73 142.27 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 119.246 -2.159 . . . . 0.0 110.431 145.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.0 p -125.23 161.95 25.77 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.77 -1.207 . . . . 0.0 112.69 154.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 pp -112.44 116.11 29.77 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 122.11 0.957 . . . . 0.0 109.034 158.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.4 m -80.23 121.26 25.4 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.389 1.476 . . . . 0.0 108.006 169.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 42.4 t -104.91 113.68 27.43 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.028 -1.045 . . . . 0.0 110.98 -172.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 1.667 ' HE1' ' CE2' ' A' ' 89' ' ' TYR . 61.8 m-85 -105.11 108.84 20.57 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.75 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.7 mt -76.67 72.09 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 140.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.77 -179.11 48.43 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 121.445 3.338 . . . . 0.0 121.445 -155.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 1.621 ' HE1' ' CE2' ' A' ' 92' ' ' PHE . 2.3 m-85 -115.57 105.49 51.88 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-N 111.134 -2.533 . . . . 0.0 110.035 -171.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -86.12 152.68 9.58 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.639 2.226 . . . . 0.0 114.636 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -42.93 62.52 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -177.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 ttt85 -88.76 3.63 50.28 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.88 -29.36 8.0 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.339 2.256 . . . . 0.0 113.612 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -53.49 -45.03 69.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.413 1.885 . . . . 0.0 113.543 168.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -122.08 -20.18 6.35 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -166.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 pp -60.93 168.92 2.15 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 121.578 1.99 . . . . 0.0 114.711 165.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -117.25 172.88 7.01 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -160.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.602 ' CZ ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -131.0 155.14 47.33 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.984 1.313 . . . . 0.0 113.992 157.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.602 ' H ' ' CZ ' ' A' ' 101' ' ' ARG . 1.5 p -136.67 137.61 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.327 1.451 . . . . 0.0 113.432 174.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 28.1 p -123.38 112.66 17.83 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.448 133.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 t0 176.49 -167.23 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 128.521 2.729 . . . . 0.0 107.601 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 1.644 ' HD2' ' CD1' ' A' ' 105' ' ' PHE . 42.0 p90 -113.59 138.83 49.62 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.064 1.346 . . . . 0.0 111.396 150.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -158.09 159.66 36.52 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 1.643 ' HD1' ' CD2' ' A' ' 107' ' ' PHE . 7.3 t80 -60.77 142.59 55.81 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.306 1.042 . . . . 0.0 111.034 160.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 20.9 tp -142.4 133.39 25.84 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.848 1.659 . . . . 0.0 110.172 -173.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 m -71.68 156.57 39.21 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -174.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.47 -10.43 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -169.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.99 41.73 3.12 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.052 1.341 . . . . 0.0 112.201 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -105.04 172.42 6.8 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.058 2.143 . . . . 0.0 113.481 -169.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -149.8 139.07 21.31 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 126.579 1.952 . . . . 0.0 106.315 -167.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.54 133.21 9.19 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.263 0.938 . . . . 0.0 113.445 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.6 t -95.88 136.43 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 117.252 -1.356 . . . . 0.0 109.315 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.528 ' HB ' ' CZ ' ' A' ' 101' ' ' ARG . 11.4 p -138.23 115.39 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 120.322 1.419 . . . . 0.0 109.354 164.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.01 171.29 14.63 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.002 1.721 . . . . 0.0 111.282 -175.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 79.4 mt -59.71 -29.99 68.49 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.534 0.734 . . . . 0.0 112.913 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.98 -33.32 65.75 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 119.712 1.142 . . . . 0.0 113.043 173.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -74.39 -45.64 45.46 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.802 1.241 . . . . 0.0 111.862 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 28.4 mm -60.34 -40.98 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.493 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -61.44 -29.99 70.3 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 172.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -70.1 -41.05 74.54 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 121.692 2.042 . . . . 0.0 111.864 172.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.5 pt -96.72 -11.9 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -168.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -154.15 150.67 22.89 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 126.539 1.936 . . . . 0.0 110.748 166.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -61.34 113.2 1.67 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 121.775 1.65 . . . . 0.0 110.926 168.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 19.7 p -83.32 161.64 21.36 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.608 0.718 . . . . 0.0 112.672 -176.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -151.19 147.96 27.66 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.264 1.826 . . . . 0.0 108.233 -171.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.257 0.1 OUTLIER -67.14 54.23 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 127.859 2.464 . . . . 0.0 112.635 170.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 179.6 -0.58 0.02 OUTLIER Glycine 0 CA--C 1.539 1.562 0 C-N-CA 127.516 2.484 . . . . 0.0 114.215 -167.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.1 t -65.42 131.15 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.011 1.405 . . . . 0.0 111.28 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 90.5 mt -118.44 89.21 3.08 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.982 1.713 . . . . 0.0 108.281 159.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.0 m -72.95 148.36 44.35 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 170.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -133.28 134.29 43.71 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.427 1.491 . . . . 0.0 108.661 -165.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 41.9 t -140.89 135.97 31.84 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.525 1.057 . . . . 0.0 112.027 -169.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.5 124.17 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.374 1.869 . . . . 0.0 110.175 -167.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.0 m -121.65 145.86 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.213 -0.93 . . . . 0.0 112.831 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -130.22 138.6 50.65 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.389 1.076 . . . . 0.0 112.12 158.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.475 ' HD2' ' CE1' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -77.58 146.08 36.45 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 129.034 2.934 . . . . 0.0 112.423 152.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.5 t -139.51 143.49 37.47 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.518 1.127 . . . . 0.0 110.217 162.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -101.29 -41.18 6.79 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.453 1.501 . . . . 0.0 110.755 169.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.9 t -54.76 -33.75 61.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.832 0.853 . . . . 0.0 112.808 174.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -102.49 1.2 49.65 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 117.71 -1.605 . . . . 0.0 115.849 172.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.3 mmt 39.44 57.85 2.04 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.837 1.819 . . . . 0.0 113.455 -173.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.0 m -149.46 163.52 37.55 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.002 0.921 . . . . 0.0 113.13 -163.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 1.663 ' HD2' ' CD1' ' A' ' 146' ' ' TYR . 76.7 m-85 -107.29 154.34 21.4 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.098 0.959 . . . . 0.0 111.098 154.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -130.83 106.19 8.28 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.61 139.19 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 123.972 0.909 . . . . 0.0 109.683 -163.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -141.46 134.3 28.82 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.689 0.796 . . . . 0.0 109.45 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.5 p -150.44 132.58 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 122.42 1.105 . . . . 0.0 110.642 164.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.4 m -137.28 145.69 29.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 126.505 1.922 . . . . 0.0 109.013 -162.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -112.36 118.11 34.32 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.689 -0.632 . . . . 0.0 112.392 -169.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 1.654 ' HD1' ' CD2' ' A' ' 153' ' ' PHE . 29.7 m-85 -121.59 157.21 31.28 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.384 1.074 . . . . 0.0 111.338 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -85.6 -146.97 9.25 Favored Glycine 0 CA--C 1.54 1.626 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 159.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -63.39 -3.44 5.22 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.564 2.843 . . . . 0.0 115.973 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -63.76 -18.7 64.32 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.133 1.373 . . . . 0.0 114.01 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -77.37 30.24 0.15 Allowed 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.478 1.111 . . . . 0.0 112.172 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -61.54 -26.79 68.17 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.433 1.893 . . . . 0.0 114.177 -171.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.88 -52.57 12.54 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.404 1.082 . . . . 0.0 112.051 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -61.38 -39.78 91.93 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.375 1.07 . . . . 0.0 112.188 171.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -52.44 -54.68 29.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.611 0.764 . . . . 0.0 110.873 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -59.04 -45.29 91.11 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.565 -0.71 . . . . 0.0 112.852 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.36 -34.81 75.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.319 0.648 . . . . 0.0 112.309 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.43 -45.33 60.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.434 -0.791 . . . . 0.0 111.942 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 88.9 mt -56.85 -34.38 67.74 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.824 0.738 . . . . 0.0 111.683 171.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -79.38 -7.93 58.72 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.229 1.812 . . . . 0.0 114.231 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -99.78 -57.23 2.19 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.987 1.315 . . . . 0.0 113.053 160.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.8 pt -83.8 -32.12 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -160.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 1.65 ' HD1' ' CD2' ' A' ' 169' ' ' TYR . 13.3 t80 -90.69 10.98 23.66 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.017 0.927 . . . . 0.0 109.449 168.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.91 24.87 5.31 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.399 1.48 . . . . 0.0 114.638 174.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 16.7 mmt85 . . . . . 0 C--O 1.252 1.233 0 CA-C-O 117.628 -1.177 . . . . 0.0 111.319 157.46 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.4 t0 . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 121.608 0.718 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -68.5 -23.48 64.56 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 -135.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -112.8 -17.17 12.6 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.039 1.336 . . . . 0.0 113.425 172.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 80.1 t -67.18 -60.64 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.298 1.039 . . . . 0.0 111.532 -173.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.28 -37.35 80.48 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.282 -0.732 . . . . 0.0 113.472 175.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.71 -59.2 5.79 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.245 1.023 . . . . 0.0 110.916 175.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -65.77 -46.95 76.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.616 1.166 . . . . 0.0 111.668 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.0 mp -70.46 -43.7 69.28 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.643 -0.66 . . . . 0.0 111.637 -173.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.29 -34.56 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 119.203 0.91 . . . . 0.0 110.231 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.2 t -59.49 -52.33 66.02 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.41 1.005 . . . . 0.0 111.761 174.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -64.73 -31.51 72.76 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.416 -0.803 . . . . 0.0 111.581 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 m -68.72 -50.09 53.57 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.196 -0.94 . . . . 0.0 111.685 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.1 ptt85 -61.87 -22.06 65.22 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.002 1.274 . . . . 0.0 113.577 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -85.1 -52.56 5.86 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.446 1.099 . . . . 0.0 112.953 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.85 -30.48 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 118.635 0.652 . . . . 0.0 112.201 -175.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -84.38 -7.66 59.23 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.912 1.233 . . . . 0.0 111.633 171.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 65.65 5.13 3.14 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 128.243 2.617 . . . . 0.0 115.249 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 pp -97.37 147.1 24.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.153 1.381 . . . . 0.0 111.497 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -76.01 165.23 25.26 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -168.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -58.77 -39.77 81.97 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.196 -1.565 . . . . 0.0 112.51 -174.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -88.27 6.92 34.64 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.84 0.856 . . . . 0.0 112.784 176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -108.87 -5.59 16.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.321 1.448 . . . . 0.0 111.769 172.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.6 tp -89.06 112.61 23.61 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 166.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.59 93.17 8.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 118.701 -1.199 . . . . 0.0 109.193 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -87.69 146.69 5.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 125.609 1.563 . . . . 0.0 112.541 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 m -145.86 153.3 40.71 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.925 1.29 . . . . 0.0 110.425 -171.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -117.72 -165.69 1.12 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.368 1.467 . . . . 0.0 112.609 -163.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.4 t -41.34 -41.15 1.88 Allowed 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 118.081 2.622 . . . . 0.0 118.081 -147.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.7 -17.24 61.15 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 -160.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.42 -14.25 17.64 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.3 pt -102.85 -6.65 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 126.703 2.001 . . . . 0.0 113.583 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -41.53 8.14 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.055 1 C-N-CA 133.641 4.776 . . . . 0.0 121.397 -169.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -65.48 -21.39 66.63 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 122.468 2.395 . . . . 0.0 113.391 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -92.65 117.51 67.62 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 144.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -73.26 -8.31 21.77 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.052 2.501 . . . . 0.0 114.561 -171.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -108.69 -43.43 4.27 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 120.099 1.318 . . . . 0.0 112.007 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -165.51 126.69 1.93 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.539 1.535 . . . . 0.0 110.062 159.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 t -92.94 -162.03 0.9 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 147.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.96 -82.48 0.17 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -168.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 2.4 t -164.9 175.99 9.08 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 120.803 1.638 . . . . 0.0 113.562 -170.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -147.61 106.88 3.88 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.83 158.54 15.46 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.91 2.884 . . . . 0.0 112.059 -168.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 12.8 tmm? -125.57 137.2 53.9 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.895 1.225 . . . . 0.0 110.944 172.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.1 mt -129.86 128.99 43.38 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 129.204 3.002 . . . . 0.0 111.095 -157.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.7 t -128.95 162.7 26.96 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 128.021 2.528 . . . . 0.0 110.383 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.6 p -39.11 113.03 0.28 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.744 1.618 . . . . 0.0 113.515 -149.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -106.81 159.05 16.53 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.939 172.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.519 HG23 ' H ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -121.78 177.44 3.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 113.69 -1.596 . . . . 0.0 106.721 -173.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.519 ' H ' HG23 ' A' ' 54' ' ' ILE . 11.7 p -77.15 103.38 4.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.912 -155.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -137.72 158.22 72.08 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.433 1.093 . . . . 0.0 111.913 -166.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.53 88.27 0.27 Allowed 'Trans proline' 0 C--N 1.357 0.999 1 C-N-CA 125.741 4.294 . . . . 0.0 112.187 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.64 -40.83 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.451 0.7 . . . . 0.0 112.541 -172.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -12.52 60.39 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -55.39 -27.72 49.43 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.192 0.905 . . . . 0.0 112.687 167.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.3 mp -77.97 -44.32 27.12 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.885 0.874 . . . . 0.0 111.554 171.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mp -56.71 -43.57 80.71 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 118.138 0.426 . . . . 0.0 111.37 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.3 p -72.31 -30.74 65.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.801 0.84 . . . . 0.0 112.515 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 1.617 ' HE1' ' CE2' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -60.07 -37.6 80.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.381 0.991 . . . . 0.0 112.865 171.015 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -50.63 16.2 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.105 0.866 . . . . 0.0 111.866 172.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -61.24 -33.62 73.81 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.775 -1.203 . . . . 0.0 113.325 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 69.5 m -79.17 -20.56 48.15 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 172.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -38.36 79.34 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.641 1.11 . . . . 0.0 113.269 -169.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.6 m -150.81 0.23 0.41 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.97 82.3 0.16 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.19 1.376 . . . . 0.0 110.952 -165.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -153.71 115.91 4.34 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 125.665 1.586 . . . . 0.0 107.841 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 79.4 m -91.89 113.12 25.3 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.942 1.297 . . . . 0.0 109.792 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.47 148.38 40.81 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.056 1.342 . . . . 0.0 113.285 -168.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 74.4 m -89.21 127.14 35.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.702 0.801 . . . . 0.0 109.535 165.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -91.91 103.48 16.01 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 164.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.6 t -105.46 141.62 20.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 C-N-CA 125.07 1.348 . . . . 0.0 109.204 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -124.93 123.28 39.56 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.245 -0.909 . . . . 0.0 110.08 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.1 112.86 25.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.054 1.741 . . . . 0.0 109.262 172.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -86.26 126.68 34.47 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.074 -1.016 . . . . 0.0 111.281 165.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.8 p -143.69 157.11 44.64 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.732 3.213 . . . . 0.0 103.369 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -7.07 -129.85 0.0 OUTLIER Glycine 0 N--CA 1.486 1.993 0 O-C-N 117.707 -3.121 . . . . 0.0 112.83 -116.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 82.4 m -97.58 107.5 20.02 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 113.666 -3.213 . . . . 0.0 108.601 149.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -169.66 125.14 0.83 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 130.754 3.622 . . . . 0.0 106.203 161.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.03 135.45 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 117.978 -1.489 . . . . 0.0 110.938 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.8 m -110.22 146.19 36.02 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.21 0.604 . . . . 0.0 110.477 163.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.1 tp -110.73 108.79 18.78 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 126.208 1.803 . . . . 0.0 107.082 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.6 m -80.12 101.47 8.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 167.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 45.3 t -103.81 108.12 19.29 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 120.73 -1.231 . . . . 0.0 108.23 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.4 151.17 48.26 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -175.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.59 96.1 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 141.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.91 142.75 6.67 Favored Glycine 0 N--CA 1.471 1.015 0 N-CA-C 118.332 2.093 . . . . 0.0 118.332 -167.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -133.28 64.81 71.02 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.626 1.571 . . . . 0.0 112.267 175.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.58 158.12 32.24 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.369 2.713 . . . . 0.0 115.495 -172.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -50.52 -19.89 1.01 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.252 2.621 . . . . 0.0 115.752 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -69.83 -11.62 61.0 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.182 -1.574 . . . . 0.0 113.242 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.71 -4.7 16.76 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 164.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 1.67 32.76 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 120.051 1.296 . . . . 0.0 112.241 160.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -131.16 -34.2 1.45 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.533 1.933 . . . . 0.0 114.154 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 pp -100.49 160.0 14.7 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 120.196 1.362 . . . . 0.0 114.628 -172.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -108.69 -160.97 0.74 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 125.714 1.606 . . . . 0.0 113.069 -166.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.45 166.11 13.08 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.711 1.205 . . . . 0.0 111.833 162.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.1 p -125.13 130.97 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 170.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 10.8 t -147.58 112.1 5.3 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 127.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -176.91 175.29 1.62 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.507 1.923 . . . . 0.0 107.886 -170.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -115.82 121.06 41.27 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.384 1.873 . . . . 0.0 110.667 161.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -159.0 165.95 32.88 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 177.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 1.631 ' HD1' ' CD2' ' A' ' 107' ' ' PHE . 81.4 m-85 -74.09 149.42 41.11 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.517 -0.74 . . . . 0.0 111.71 164.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.8 tp -135.87 143.09 44.86 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.596 1.958 . . . . 0.0 108.87 -171.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.8 p -117.44 173.21 6.83 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -166.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.9 t -67.11 -9.77 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 128.433 2.693 . . . . 0.0 115.422 -163.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -135.21 25.11 3.54 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.996 -1.065 . . . . 0.0 112.803 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -116.2 151.75 35.1 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.141 -0.974 . . . . 0.0 111.803 -163.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.61 166.15 31.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.077 -1.014 . . . . 0.0 112.549 -165.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.69 164.1 37.67 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.276 1.03 . . . . 0.0 113.46 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.8 t -99.76 145.45 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 127.788 2.435 . . . . 0.0 109.275 163.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.6 128.7 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.565 0.698 . . . . 0.0 109.287 151.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.7 p -128.97 159.13 36.87 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.444 1.498 . . . . 0.0 111.001 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -59.44 -38.46 80.73 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.383 0.673 . . . . 0.0 111.672 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.18 -32.53 74.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.046 0.938 . . . . 0.0 112.58 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -71.47 -33.14 69.06 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 117.575 -1.202 . . . . 0.0 111.996 173.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 31.9 mm -66.7 -41.39 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 119.742 1.156 . . . . 0.0 110.786 170.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.54 -27.89 66.6 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 171.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -86.52 -21.84 26.72 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.97 1.708 . . . . 0.0 115.178 171.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 6.3 mt -77.2 -38.54 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.056 1.342 . . . . 0.0 111.007 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 127' ' ' CYS . 61.4 mmtt -145.06 172.31 5.52 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 125.715 1.606 . . . . 0.0 111.858 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -57.43 20.97 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.335 1 C-N-CA 126.262 4.641 . . . . 0.0 117.086 164.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.418 ' H ' ' C ' ' A' ' 125' ' ' LYS . 77.9 m -74.75 160.38 30.81 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.676 1.99 . . . . 0.0 112.097 176.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -125.02 -166.42 1.53 Allowed 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 128.002 2.521 . . . . 0.0 108.7 173.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.26 -24.69 67.75 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -173.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -85.86 15.24 48.92 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 118.155 -1.358 . . . . 0.0 115.98 -175.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.73 158.61 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.219 1.509 . . . . 0.0 113.801 -165.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.7 tt -116.43 126.71 53.8 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 122.352 1.072 . . . . 0.0 110.618 154.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 2.4 p -123.26 148.38 45.96 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 127.496 2.318 . . . . 0.0 109.711 -173.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -130.98 128.47 40.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -164.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 46.3 t -136.38 138.92 42.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.467 0.707 . . . . 0.0 110.728 -165.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.5 t -146.23 114.76 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.892 0.877 . . . . 0.0 110.98 -167.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 m -109.01 129.95 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -115.51 140.92 48.72 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.46 2.304 . . . . 0.0 107.261 168.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.413 ' HB2' ' CD2' ' A' ' 146' ' ' TYR 0.304 0.2 OUTLIER -149.69 152.84 36.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.504 0.722 . . . . 0.0 110.664 169.845 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.7 t -136.8 123.34 20.92 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.846 0.748 . . . . 0.0 109.16 171.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -76.0 -57.08 4.09 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.213 1.405 . . . . 0.0 110.67 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.6 t -61.09 -36.32 79.35 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.04 0.936 . . . . 0.0 112.591 169.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.66 14.16 48.7 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.361 -1.244 . . . . 0.0 114.896 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 28.0 ptm 42.63 49.46 4.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.268 2.227 . . . . 0.0 116.985 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.5 t -157.82 148.74 21.09 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.413 ' CD2' ' HB2' ' A' ' 139' ' ' LYS . 1.4 t80 -108.93 140.08 42.9 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.706 1.202 . . . . 0.0 111.267 163.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -140.79 121.32 14.16 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 122.17 0.986 . . . . 0.0 111.447 -173.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -133.5 134.58 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.097 -1.002 . . . . 0.0 110.828 -151.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -142.66 131.76 23.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.675 1.19 . . . . 0.0 111.064 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.8 p -145.19 139.37 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.545 -0.722 . . . . 0.0 110.588 161.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.9 m -136.04 151.43 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 127.772 2.429 . . . . 0.0 109.821 -165.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.12 128.85 23.12 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -166.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 1.599 ' HE2' ' CE1' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -148.12 133.25 18.3 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 170.445 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.54 -162.21 0.27 Allowed Glycine 0 CA--C 1.549 2.185 0 C-N-CA 127.558 2.504 . . . . 0.0 116.344 166.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.6 -20.77 12.92 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.892 3.728 . . . . 0.0 119.521 -160.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -75.58 -2.39 28.95 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 120.58 1.537 . . . . 0.0 114.03 173.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 45.7 p30 -58.82 13.03 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 129.304 3.042 . . . . 0.0 117.861 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -49.4 -40.02 34.67 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.389 1.876 . . . . 0.0 112.623 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.43 -51.44 65.72 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -74.2 -26.7 60.42 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.086 -1.009 . . . . 0.0 112.427 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 1.665 ' HE2' ' CE1' ' A' ' 161' ' ' TYR . 67.3 t80 -64.98 -48.56 73.56 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.709 0.804 . . . . 0.0 111.74 168.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -62.61 -38.11 88.91 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.332 -0.855 . . . . 0.0 112.087 174.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.55 -30.85 70.03 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.09 -51.72 9.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.724 1.21 . . . . 0.0 110.887 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.5 pp -66.43 -27.55 67.91 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.316 -0.865 . . . . 0.0 110.972 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -77.21 -24.42 51.29 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 117.895 -1.05 . . . . 0.0 112.828 172.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.64 -30.86 64.67 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 167.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.1 mt -76.03 -36.8 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 120.708 -1.245 . . . . 0.0 110.977 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -64.83 -4.9 4.9 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 158.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -108.56 25.17 12.02 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 170.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.171 0 C-N-CA 128.539 2.736 . . . . 0.0 116.52 162.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.6 t0 . . . . . 0 CA--C 1.552 1.05 0 CA-C-O 121.147 0.499 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -57.86 -35.58 71.16 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 -143.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -102.92 -19.73 14.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.211 1.404 . . . . 0.0 112.349 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.27 -52.41 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.986 0.915 . . . . 0.0 112.388 -168.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.73 -49.92 73.33 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 119.179 0.9 . . . . 0.0 111.885 174.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.51 76.84 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.278 1.039 . . . . 0.0 112.156 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.76 -42.41 73.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.334 1.054 . . . . 0.0 113.303 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.4 tp -76.58 -31.44 57.5 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.271 1.029 . . . . 0.0 112.914 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.9 -40.41 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 121.487 -0.758 . . . . 0.0 109.344 168.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.1 m -59.58 -35.24 73.9 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 119.688 1.131 . . . . 0.0 112.495 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -72.0 -40.09 68.75 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.675 1.19 . . . . 0.0 111.452 177.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.7 m -64.87 -42.51 94.78 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.989 -1.069 . . . . 0.0 110.514 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -54.33 -37.21 64.61 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.977 1.711 . . . . 0.0 112.353 171.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -83.84 -49.28 9.2 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.519 1.528 . . . . 0.0 113.473 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.8 -42.49 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 118.989 0.813 . . . . 0.0 111.093 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.01 -2.52 58.38 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.471 0.708 . . . . 0.0 112.785 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . 0.273 32.8 ptt180 51.88 22.99 1.92 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.07 2.548 . . . . 0.0 116.179 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 pp -92.36 153.41 19.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.145 1.778 . . . . 0.0 112.139 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -80.41 160.12 25.45 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.006 0.922 . . . . 0.0 113.454 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -69.76 -24.37 63.52 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 119.903 -1.748 . . . . 0.0 115.586 -168.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -96.14 8.06 44.8 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.673 1.124 . . . . 0.0 112.517 167.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -110.62 -1.35 16.86 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.842 1.657 . . . . 0.0 111.013 172.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -94.8 117.67 30.52 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 127.839 2.456 . . . . 0.0 105.804 165.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -89.09 134.18 34.1 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.537 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 47' ' ' ASP . 0.3 OUTLIER -125.83 142.95 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 124.71 1.204 . . . . 0.0 112.21 173.025 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.4 p -154.3 145.12 22.52 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.974 1.31 . . . . 0.0 110.123 -166.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -166.94 59.89 0.09 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 122.935 1.35 . . . . 0.0 112.329 -170.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 76.1 p -89.89 -58.3 2.56 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.38 -0.825 . . . . 0.0 111.836 153.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.95 -55.95 4.09 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.959 0.885 . . . . 0.0 113.016 -151.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.25 -30.15 70.28 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.801 1.241 . . . . 0.0 112.344 172.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.03 -29.87 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.922 0.889 . . . . 0.0 111.174 175.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.8 m -84.71 4.89 30.54 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.394 1.478 . . . . 0.0 114.612 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -84.47 -14.42 49.22 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.531 1.514 . . . . 0.0 112.346 170.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -120.66 161.96 37.02 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 127.045 2.138 . . . . 0.0 110.389 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -58.83 -38.26 89.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.52 2.147 . . . . 0.0 114.26 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -121.57 -35.78 3.17 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 116.852 2.168 . . . . 0.0 116.852 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 1.628 ' HD1' ' CD2' ' A' ' 43' ' ' TYR . 1.9 p90 -166.31 143.68 5.23 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 120.705 1.593 . . . . 0.0 109.387 -171.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 96.8 p -106.57 -168.09 1.37 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 135.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -75.62 -75.45 0.18 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.768 1.622 . . . . 0.0 112.195 -166.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -178.13 -174.65 0.43 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.926 0.89 . . . . 0.0 109.541 -173.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 11.5 t0 -139.13 136.38 35.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.74 140.87 49.24 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.527 1.531 . . . . 0.0 112.154 -169.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.8 mtt -114.48 130.53 56.74 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 120.56 1.527 . . . . 0.0 111.857 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.0 mt -131.55 161.24 33.08 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 128.536 2.734 . . . . 0.0 112.936 -153.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.5 p -93.93 179.81 5.22 Favored 'General case' 0 N--CA 1.48 1.062 1 C-N-CA 132.876 4.47 . . . . 0.0 114.573 -153.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 t -120.34 109.01 14.85 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.52 -1.362 . . . . 0.0 108.082 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -161.01 -154.97 0.39 Allowed 'General case' 0 CA--C 1.561 1.367 0 O-C-N 120.88 -1.138 . . . . 0.0 112.898 -136.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.35 178.85 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 1 C-N-CA 132.359 4.264 . . . . 0.0 109.09 -157.066 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.7 p -76.22 123.44 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.973 1.309 . . . . 0.0 112.294 -164.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -122.56 148.08 52.06 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.84 1.256 . . . . 0.0 112.315 -173.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.62 72.74 5.92 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 125.234 3.956 . . . . 0.0 111.986 -172.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.3 p -66.12 -24.09 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.075 0.95 . . . . 0.0 113.3 -169.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.61 -40.08 51.79 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.514 1.126 . . . . 0.0 113.765 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -60.82 -38.5 85.62 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.032 0.533 . . . . 0.0 111.784 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.7 -46.7 62.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.294 1.038 . . . . 0.0 111.037 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -58.35 -44.72 88.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.206 1.002 . . . . 0.0 111.673 173.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.5 m -73.59 -48.09 35.42 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.977 0.911 . . . . 0.0 112.307 -172.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 1.611 ' HD1' ' CD2' ' A' ' 64' ' ' TYR . 3.3 m-85 -59.43 -45.2 92.23 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.215 174.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -58.64 -48.42 81.1 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.106 0.866 . . . . 0.0 112.497 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -58.98 -43.67 91.46 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 70.9 m -74.17 -23.46 59.24 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -74.14 -17.16 60.96 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -167.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.7 p -144.2 2.84 1.16 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 175.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.34 71.27 0.86 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 127.062 2.267 . . . . 0.0 110.342 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -165.5 128.85 2.2 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 127.882 2.473 . . . . 0.0 105.677 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.0 m -84.55 141.73 30.5 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 126.412 1.885 . . . . 0.0 110.496 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.93 151.04 31.58 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -170.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 24.9 p -101.06 133.86 44.94 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.819 0.848 . . . . 0.0 111.427 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 1.669 ' HE2' ' CE1' ' A' ' 75' ' ' PHE . 5.5 m-85 -89.35 117.61 28.42 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 168.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.1 t -121.86 113.85 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 123.464 0.706 . . . . 0.0 109.284 -169.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 1.614 ' HD1' ' CD2' ' A' ' 77' ' ' PHE . 93.2 m-85 -89.86 125.12 35.21 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.518 -1.364 . . . . 0.0 107.581 -176.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.8 97.82 6.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 123.293 1.52 . . . . 0.0 107.55 168.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -73.7 116.77 14.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.545 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.0 p -147.41 158.27 43.91 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 128.521 2.728 . . . . 0.0 104.674 -161.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -11.42 -131.09 0.0 OUTLIER Glycine 0 N--CA 1.483 1.783 0 O-C-N 119.304 -2.122 . . . . 0.0 114.442 -127.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 30.3 p -94.03 101.01 13.03 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 115.058 -2.657 . . . . 0.0 108.308 161.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -172.67 165.87 5.43 Favored 'General case' 0 N--CA 1.469 0.516 1 C-N-CA 131.76 4.024 . . . . 0.0 106.835 158.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.4 t -87.98 124.77 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.02 -1.05 . . . . 0.0 110.218 159.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.78 141.55 37.84 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.991 0.814 . . . . 0.0 108.861 164.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 31.4 tp -119.72 106.1 11.81 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.416 1.086 . . . . 0.0 108.617 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.4 m -80.17 125.62 30.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.122 0.569 . . . . 0.0 110.916 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 10.8 m -111.38 107.04 16.15 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 120.893 -1.129 . . . . 0.0 109.751 -173.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 1.673 ' HE2' ' CE1' ' A' ' 89' ' ' TYR . 88.1 m-85 -103.73 97.65 7.63 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.028 0.531 . . . . 0.0 112.32 -176.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.3 mt -75.7 82.81 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 139.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -178.03 179.87 48.29 Favored Glycine 0 N--CA 1.468 0.791 0 N-CA-C 122.413 3.725 . . . . 0.0 122.413 -161.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -108.88 66.73 0.32 Allowed Pre-proline 0 CA--C 1.551 1.002 0 CA-C-N 112.886 -1.657 . . . . 0.0 113.346 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.67 134.78 45.69 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.192 2.594 . . . . 0.0 113.428 -176.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -76.33 -41.74 47.39 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.3 1.04 . . . . 0.0 111.77 171.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -69.84 -11.67 61.03 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -172.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.11 -18.29 5.36 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.478 1.911 . . . . 0.0 114.017 163.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -78.37 -2.22 37.19 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.879 1.272 . . . . 0.0 114.063 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -134.35 -35.7 0.91 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.12 0.873 . . . . 0.0 113.188 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 pp -77.0 166.26 23.56 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -164.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -92.13 -175.17 3.99 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.515 1.126 . . . . 0.0 112.808 -162.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -122.07 168.63 11.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.566 1.546 . . . . 0.0 109.541 159.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.5 p -122.69 124.9 71.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 167.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 47.3 t -125.14 114.39 18.96 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 122.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -178.23 168.16 1.93 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 123.126 1.441 . . . . 0.0 109.126 -165.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -141.99 109.16 5.52 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 127.045 2.138 . . . . 0.0 109.591 164.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -151.04 162.8 40.15 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -168.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 1.662 ' HE1' ' CE2' ' A' ' 107' ' ' PHE . 50.9 m-85 -73.69 149.71 41.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.17 0.988 . . . . 0.0 111.946 164.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.4 tp -142.45 147.54 36.29 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 128.125 2.57 . . . . 0.0 109.696 -157.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.7 p -114.75 176.0 5.25 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.919 2.088 . . . . 0.0 114.013 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.83 -13.19 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 126.166 1.787 . . . . 0.0 114.548 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -115.02 33.07 5.63 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.672 -1.268 . . . . 0.0 112.46 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.07 153.13 19.82 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.733 -1.229 . . . . 0.0 114.114 -172.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -156.92 128.15 6.89 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.491 1.516 . . . . 0.0 108.854 -174.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.4 pp -158.18 152.26 24.1 Favored 'General case' 0 CA--C 1.554 1.096 0 O-C-N 121.062 -1.024 . . . . 0.0 113.194 -168.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 29.8 t -99.91 146.46 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 126.585 1.954 . . . . 0.0 111.981 175.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.41 133.51 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.317 0.579 . . . . 0.0 110.841 145.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.2 t -154.42 153.83 32.23 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.027 1.331 . . . . 0.0 111.839 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -27.67 68.24 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.157 1.383 . . . . 0.0 114.34 -166.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.7 -30.72 46.21 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.524 -1.36 . . . . 0.0 113.307 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.29 -33.65 65.33 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.129 -0.982 . . . . 0.0 111.39 168.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.6 mm -60.95 -38.67 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 118.626 0.648 . . . . 0.0 111.004 166.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -65.79 -23.7 66.76 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 173.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -70.4 -29.69 66.39 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 120.243 -1.535 . . . . 0.0 112.269 167.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 27.4 mt -78.58 -38.31 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.715 0.806 . . . . 0.0 110.717 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.463 ' HE3' ' HA ' ' A' ' 153' ' ' PHE . 54.9 mmtt -136.08 109.78 9.88 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 126.549 1.94 . . . . 0.0 111.82 -174.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -62.33 -12.59 28.05 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 N-CA-C 120.083 3.07 . . . . 0.0 120.083 -166.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 9.5 m -133.95 130.96 38.45 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.824 1.647 . . . . 0.0 112.303 173.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -96.59 12.57 31.2 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 -167.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -77.71 14.16 1.12 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -171.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.49 41.16 0.08 OUTLIER Glycine 0 N--CA 1.47 0.951 0 O-C-N 120.918 -1.113 . . . . 0.0 112.856 -172.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.537 ' CG1' ' HG1' ' A' ' 133' ' ' THR . 53.9 t -69.8 115.65 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.383 0.673 . . . . 0.0 111.65 -172.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.42 88.21 3.6 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 158.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.537 ' HG1' ' CG1' ' A' ' 131' ' ' VAL . 88.7 m -88.3 133.67 34.01 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 163.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -131.78 128.79 39.53 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.655 1.182 . . . . 0.0 108.431 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 51.7 t -136.6 136.04 38.88 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.938 -1.101 . . . . 0.0 111.786 -162.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -142.87 129.83 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.489 1.116 . . . . 0.0 109.855 -167.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 m -131.94 144.6 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 121.454 -0.778 . . . . 0.0 110.68 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -132.51 152.08 51.69 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 125.256 1.423 . . . . 0.0 108.384 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.29 0.9 OUTLIER -148.43 152.68 37.37 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.938 1.295 . . . . 0.0 108.507 167.126 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.0 t -128.33 139.77 52.23 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -93.43 -53.26 4.15 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.989 0.916 . . . . 0.0 109.614 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.3 m -50.3 -41.44 50.85 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.253 1.421 . . . . 0.0 113.18 172.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -100.5 13.32 59.75 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.589 1.566 . . . . 0.0 115.007 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 92.7 mtp 28.96 63.53 0.12 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 127.961 2.504 . . . . 0.0 114.754 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.8 t -159.68 139.76 11.77 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.292 -0.88 . . . . 0.0 110.279 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 1.66 ' HE1' ' CE2' ' A' ' 146' ' ' TYR . 2.4 m-85 -130.92 156.92 44.26 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 122.129 -0.357 . . . . 0.0 110.262 -162.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -149.85 136.93 19.6 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.038 0.835 . . . . 0.0 113.139 -163.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -146.56 115.27 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.184 0.516 . . . . 0.0 110.519 -159.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -142.86 137.42 29.56 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.178 -0.951 . . . . 0.0 112.311 -169.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.1 p -150.43 140.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 120.912 -1.118 . . . . 0.0 110.563 162.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.7 m -118.84 149.29 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 128.281 2.633 . . . . 0.0 109.552 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -134.34 135.25 42.6 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 1.642 ' HE1' ' CE2' ' A' ' 153' ' ' PHE . 64.8 m-85 -135.81 158.54 44.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.901 2.081 . . . . 0.0 110.537 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -104.1 -143.3 12.34 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 164.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -45.41 -35.47 11.94 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.931 3.087 . . . . 0.0 114.653 169.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -62.68 -10.02 11.1 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -172.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -107.77 70.21 0.77 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 123.17 1.462 . . . . 0.0 111.195 167.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.1 -25.25 58.45 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.726 1.611 . . . . 0.0 112.096 165.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.44 -53.89 8.65 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -74.61 -20.44 59.91 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 120.598 1.545 . . . . 0.0 113.107 170.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 1.64 ' HE1' ' CE2' ' A' ' 161' ' ' TYR . 80.4 t80 -60.84 -57.45 12.6 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.488 1.495 . . . . 0.0 110.978 165.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -63.4 -29.64 70.91 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.981 -1.074 . . . . 0.0 112.995 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.16 -33.79 76.84 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.364 0.984 . . . . 0.0 113.088 172.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -75.13 -52.45 10.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.255 -0.903 . . . . 0.0 112.091 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 10.0 mp -50.93 -34.82 30.23 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.627 1.103 . . . . 0.0 113.963 170.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -60.41 -50.97 71.49 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.989 1.716 . . . . 0.0 110.689 171.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -72.88 -18.2 61.45 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.2 mm -83.29 -38.38 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 120.288 1.403 . . . . 0.0 110.707 171.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -62.21 -22.63 66.09 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.512 -1.367 . . . . 0.0 112.558 166.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -101.33 28.68 5.25 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.589 1.556 . . . . 0.0 114.362 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 C-N-CA 126.205 1.802 . . . . 0.0 115.831 170.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.541 0.598 0 CA-C-O 121.564 0.697 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -59.99 -24.34 64.36 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 116.618 2.081 . . . . 0.0 116.618 -155.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -106.08 -27.05 11.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.127 0.971 . . . . 0.0 112.436 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.9 t -74.35 -61.0 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.754 1.221 . . . . 0.0 111.687 -172.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.8 -45.93 92.91 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.471 -0.627 . . . . 0.0 111.829 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.15 -53.04 30.37 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.936 0.894 . . . . 0.0 112.741 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -68.29 -41.08 81.48 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 mp -75.98 -40.08 54.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.987 1.267 . . . . 0.0 111.92 -172.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.56 -46.31 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.424 -0.797 . . . . 0.0 109.863 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.4 m -70.16 -41.29 74.0 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.536 -0.727 . . . . 0.0 111.666 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -69.35 -22.27 63.76 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.685 -1.26 . . . . 0.0 112.833 172.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.3 m -63.83 -48.15 77.93 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.772 1.624 . . . . 0.0 109.804 168.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -43.09 92.04 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.996 0.816 . . . . 0.0 112.105 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.8 ttt85 -71.22 -42.08 69.38 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.228 1.811 . . . . 0.0 113.54 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.7 -40.26 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 119.44 1.018 . . . . 0.0 110.036 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -79.46 -8.12 58.9 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 55.57 37.11 28.45 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.978 1.711 . . . . 0.0 114.247 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 pp -112.46 160.07 18.12 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.821 1.248 . . . . 0.0 110.878 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.9 156.08 39.61 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.239 0.542 . . . . 0.0 112.282 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -60.23 -26.97 66.83 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.308 -1.495 . . . . 0.0 112.033 170.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -91.88 12.48 21.45 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.314 1.845 . . . . 0.0 113.27 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -119.38 -10.41 9.7 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.511 1.124 . . . . 0.0 111.945 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 26.8 tp -88.54 111.32 21.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 171.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -85.46 124.78 32.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.258 175.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.0 mm -89.7 141.33 14.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 125.581 1.553 . . . . 0.0 109.875 172.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 54.6 m -118.68 141.77 48.3 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 164.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.71 -152.62 0.32 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.392 2.277 . . . . 0.0 112.513 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.0 t -51.41 -32.13 25.34 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -158.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.4 -42.3 61.33 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -167.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.99 -8.17 24.2 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.457 ' C ' ' H ' ' A' ' 39' ' ' LYS . 35.0 pt -110.3 -2.85 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 127.186 2.194 . . . . 0.0 115.051 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.3 m -42.08 11.17 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 130.256 3.422 . . . . 0.0 117.468 160.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.457 ' H ' ' C ' ' A' ' 37' ' ' ILE . 57.3 mmtt -67.58 -48.9 65.56 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.106 -1.621 . . . . 0.0 109.282 171.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -69.91 160.15 81.35 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.949 162.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -52.73 -35.03 67.25 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.264 2.643 . . . . 0.0 114.817 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -118.71 -52.9 2.33 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.243 0.929 . . . . 0.0 112.852 161.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -145.51 123.85 12.31 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.312 1.968 . . . . 0.0 116.312 -163.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.4 m -73.89 -159.27 0.07 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.834 1.253 . . . . 0.0 109.83 144.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.4 tp -70.15 -76.43 0.1 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 121.272 1.851 . . . . 0.0 112.528 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 11.8 p -174.96 -161.69 0.1 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.974 0.91 . . . . 0.0 111.735 -167.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -127.25 158.31 37.51 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.635 1.574 . . . . 0.0 108.676 161.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.31 133.69 45.61 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.909 2.884 . . . . 0.0 108.93 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.1 ttp -124.89 132.61 53.28 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.161 -0.962 . . . . 0.0 111.32 -168.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.6 mt -137.22 163.86 29.9 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.37 1.868 . . . . 0.0 114.296 -139.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.2 t -92.76 179.51 5.46 Favored 'General case' 0 N--CA 1.475 0.811 1 C-N-CA 132.596 4.358 . . . . 0.0 114.303 -145.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.2 t -134.15 112.96 11.55 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 170.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.54 -151.89 0.17 Allowed 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -141.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.421 HG23 ' H ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -125.8 -176.03 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 131.391 3.876 . . . . 0.0 109.546 -165.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.421 ' H ' HG23 ' A' ' 54' ' ' ILE . 32.9 m -76.04 133.7 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.499 0.719 . . . . 0.0 111.563 -177.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -132.2 145.3 56.75 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.044 0.938 . . . . 0.0 113.255 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -76.45 71.42 5.91 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 125.175 3.917 . . . . 0.0 111.784 -173.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.8 p -58.88 -29.38 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.307 1.843 . . . . 0.0 113.221 -169.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -52.48 -37.42 57.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.073 1.749 . . . . 0.0 113.817 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 1.668 ' HD2' ' CD1' ' A' ' 60' ' ' TYR . 18.1 m-30 -66.15 -35.2 79.86 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.241 -0.912 . . . . 0.0 110.697 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 37.4 tp -74.97 -42.49 57.51 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.623 0.769 . . . . 0.0 112.207 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 mp -57.62 -32.15 66.95 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.973 0.806 . . . . 0.0 112.122 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.7 m -73.77 -50.95 18.14 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.823 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -58.29 -34.97 71.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.258 0.935 . . . . 0.0 112.894 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 47.8 t-105 -66.64 -58.71 4.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.749 1.22 . . . . 0.0 112.825 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -75.85 -36.96 59.41 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -174.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.5 t -69.08 -13.81 62.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.012 0.925 . . . . 0.0 113.352 -175.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.4 tpt85 -68.45 -16.13 63.79 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 119.537 1.062 . . . . 0.0 113.151 -172.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.2 p -140.46 -28.79 0.71 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.401 1.48 . . . . 0.0 112.259 165.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.18 79.99 0.67 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 125.796 1.665 . . . . 0.0 108.983 -164.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -158.17 119.95 3.6 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 127.871 2.469 . . . . 0.0 107.168 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.0 m -64.89 116.29 6.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 122.111 0.958 . . . . 0.0 111.268 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.52 143.46 31.56 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.189 1.795 . . . . 0.0 111.857 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 79.3 m -96.25 128.86 43.54 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.748 -0.595 . . . . 0.0 111.791 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -80.31 129.31 34.42 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 149.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.8 t -123.81 114.37 41.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -174.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -87.43 110.97 20.66 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -173.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -112.56 102.17 10.27 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -74.33 125.92 29.54 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.394 -0.817 . . . . 0.0 109.92 170.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.3 p -145.48 160.19 41.97 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 128.285 2.634 . . . . 0.0 104.772 -165.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -11.09 -128.39 0.0 OUTLIER Glycine 0 N--CA 1.486 1.967 0 C-N-CA 126.809 2.147 . . . . 0.0 116.267 -146.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 53.5 t -92.95 98.08 11.13 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 116.27 -2.172 . . . . 0.0 108.588 162.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.68 154.91 2.58 Favored 'General case' 0 CA--C 1.538 0.519 1 C-N-CA 132.412 4.285 . . . . 0.0 106.628 159.199 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.07 148.85 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 119.714 -1.866 . . . . 0.0 109.429 149.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.2 p -139.61 163.62 32.09 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 119.597 -1.939 . . . . 0.0 110.764 162.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 pp -128.93 130.14 46.37 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.696 0.76 . . . . 0.0 110.467 164.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.3 m -83.78 133.6 34.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.99 1.316 . . . . 0.0 109.845 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 61.6 m -104.37 108.85 20.45 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 121.099 -1.001 . . . . 0.0 110.029 -172.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 1.669 ' HD2' ' CD1' ' A' ' 89' ' ' TYR . 82.7 m-85 -111.05 94.71 5.13 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.5 mt -74.96 78.32 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 135.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.34 178.6 47.12 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 116.517 1.367 . . . . 0.0 116.517 -169.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 1.648 ' HD1' ' CD2' ' A' ' 92' ' ' PHE . 8.4 p90 -110.25 74.82 0.87 Allowed Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.919 1.288 . . . . 0.0 114.196 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -70.52 105.38 1.6 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.769 2.979 . . . . 0.0 112.27 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.85 -21.67 30.91 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -73.09 -20.23 61.0 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.862 1.665 . . . . 0.0 112.93 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.34 -21.18 22.78 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.14 2.176 . . . . 0.0 114.135 171.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.13 -38.82 54.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.14 0.976 . . . . 0.0 111.515 167.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -125.45 -17.15 5.66 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 118.119 2.637 . . . . 0.0 118.119 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . 0.26 3.9 pp -70.31 167.49 17.93 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 123.174 2.716 . . . . 0.0 112.83 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -89.5 -163.94 1.08 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.811 1.244 . . . . 0.0 113.659 -157.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.27 170.32 8.03 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 126.673 1.989 . . . . 0.0 112.787 163.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.2 m -73.47 151.13 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.423 -0.798 . . . . 0.0 112.721 155.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 27.2 p -152.4 -178.57 6.91 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 128.054 2.542 . . . . 0.0 108.796 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -56.84 -141.88 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.848 1 C-N-CA 133.302 4.641 . . . . 0.0 107.767 161.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -86.49 127.05 34.83 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 118.089 -1.444 . . . . 0.0 114.068 -149.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -154.08 145.33 22.93 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.759 1.224 . . . . 0.0 112.409 -172.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 1.642 ' HE1' ' CE2' ' A' ' 107' ' ' PHE . 5.5 m-85 -105.46 131.56 52.72 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.327 1.451 . . . . 0.0 110.358 169.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.4 pp -141.83 150.32 41.48 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.119 1.368 . . . . 0.0 114.537 -167.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.1 m -96.2 174.19 7.02 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 -166.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.25 -10.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 128.772 2.829 . . . . 0.0 114.8 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -134.84 35.63 3.11 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.212 -0.93 . . . . 0.0 111.412 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -110.07 147.5 33.49 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -175.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -152.75 135.26 15.18 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.255 1.022 . . . . 0.0 108.406 -148.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.01 157.9 38.33 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.067 1.347 . . . . 0.0 112.287 -175.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.8 t -97.35 143.67 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.859 1.264 . . . . 0.0 110.491 169.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.9 p -124.76 106.07 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 122.991 1.377 . . . . 0.0 109.749 157.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.5 p -123.46 163.93 19.91 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.077 1.751 . . . . 0.0 108.773 165.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.416 HD12 ' HG ' ' A' ' 127' ' ' CYS . 1.9 tm? -59.57 -21.32 60.15 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.571 -0.705 . . . . 0.0 112.414 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.17 -32.85 65.09 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.66 1.184 . . . . 0.0 113.566 173.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -69.96 -29.36 66.46 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 120.496 -1.378 . . . . 0.0 111.636 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.3 mp -72.25 -40.8 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.096 0.958 . . . . 0.0 109.924 167.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -55.26 -27.36 45.92 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.694 0.798 . . . . 0.0 112.414 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -79.71 -20.19 47.1 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.368 -1.458 . . . . 0.0 114.918 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 88.7 mt -84.13 -41.63 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 120.001 1.273 . . . . 0.0 110.01 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -153.17 139.89 12.71 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 127.25 2.22 . . . . 0.0 109.444 165.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.12 119.75 7.22 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.409 2.073 . . . . 0.0 112.201 174.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.416 ' HG ' HD12 ' A' ' 118' ' ' LEU . 71.2 m -68.98 162.03 27.65 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.707 0.803 . . . . 0.0 112.421 -172.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.38 149.46 28.64 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.168 2.187 . . . . 0.0 106.509 169.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -50.62 114.51 1.16 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 169.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.91 11.11 13.01 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 117.937 -1.479 . . . . 0.0 116.357 -166.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.8 t -59.63 147.76 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 120.938 2.369 . . . . 0.0 111.045 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.25 86.49 2.37 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.566 1.546 . . . . 0.0 109.345 160.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.8 m -78.32 137.96 38.33 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 168.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -123.12 130.1 52.33 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -174.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 21.7 p -116.8 136.22 53.13 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.029 -0.419 . . . . 0.0 110.771 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.0 t -113.1 130.26 67.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 125.454 1.502 . . . . 0.0 106.972 165.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.8 m -119.98 145.2 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.633 0.73 . . . . 0.0 109.933 160.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 45.5 ttm180 -146.14 154.82 42.23 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.797 1.639 . . . . 0.0 108.092 -169.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.311 0.0 OUTLIER -144.51 148.19 34.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.108 -0.995 . . . . 0.0 110.042 164.234 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.1 t -153.97 -171.28 3.83 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.233 1.013 . . . . 0.0 112.2 -155.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.3 m120 48.73 80.53 0.06 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.07 2.548 . . . . 0.0 111.664 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 63.2 p 53.55 -1.2 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -165.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.15 34.68 8.6 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.653 1.12 . . . . 0.0 113.003 -165.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 36.5 tpp -124.36 5.15 8.4 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.109 1.764 . . . . 0.0 113.203 -175.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.2 t -143.68 155.37 44.2 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.295 1.438 . . . . 0.0 111.05 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -134.57 144.37 47.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.852 1.261 . . . . 0.0 109.085 -164.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -151.45 147.44 26.86 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.658 -1.276 . . . . 0.0 111.333 -151.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.5 tt -145.78 147.01 18.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -170.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -139.82 122.97 16.86 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.757 0.823 . . . . 0.0 109.599 163.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.99 127.23 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 122.816 1.293 . . . . 0.0 112.777 172.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.5 m -132.61 150.51 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.819 2.048 . . . . 0.0 110.394 -164.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -126.77 138.17 53.33 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -173.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -139.92 157.0 46.4 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.236 1.415 . . . . 0.0 110.196 167.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.23 -153.11 29.59 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 124.548 1.071 . . . . 0.0 113.451 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.32 -16.12 16.86 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 124.908 3.738 . . . . 0.0 115.07 177.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -71.79 -12.47 61.31 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.438 2.695 . . . . 0.0 115.965 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -81.87 41.31 0.65 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 122.861 1.315 . . . . 0.0 112.916 -174.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -64.12 -20.58 66.08 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.528 1.531 . . . . 0.0 113.78 -168.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.83 -52.58 12.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.52 1.054 . . . . 0.0 110.921 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -60.19 -41.98 94.09 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.176 0.99 . . . . 0.0 112.121 171.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -61.16 -52.96 62.66 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 122.564 0.345 . . . . 0.0 110.908 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -65.21 -34.51 78.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.452 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.72 -33.07 74.83 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 119.386 0.994 . . . . 0.0 113.135 175.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.54 -50.13 34.17 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.463 0.705 . . . . 0.0 112.36 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.7 mt -55.26 -37.86 67.81 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.643 0.656 . . . . 0.0 111.582 175.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -69.91 -29.69 66.94 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.392 1.877 . . . . 0.0 112.267 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -88.03 -52.26 5.35 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . 0.287 1.3 pp -104.87 -7.15 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 -165.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 1.605 ' HE2' ' CE1' ' A' ' 169' ' ' TYR . 21.4 m-85 -116.82 8.5 13.64 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.88 1.218 . . . . 0.0 111.927 163.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -137.29 27.76 2.83 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.877 1.271 . . . . 0.0 113.825 172.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.261 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 168.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 t70 . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -56.43 -46.08 80.45 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -139.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -92.37 -28.05 17.15 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.152 0.981 . . . . 0.0 111.985 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.1 t -67.33 -55.04 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 124.47 1.108 . . . . 0.0 111.386 -169.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.66 -55.13 31.52 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 168.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.7 -41.65 70.53 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.735 1.268 . . . . 0.0 113.898 -174.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -73.16 -40.99 64.4 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.894 1.278 . . . . 0.0 112.425 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 mp -70.62 -37.63 73.85 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.099 -1.001 . . . . 0.0 112.523 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.62 -43.57 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.087 1.355 . . . . 0.0 109.491 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.2 p -66.19 -40.63 90.55 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.109 0.413 . . . . 0.0 111.643 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -63.6 -41.86 98.3 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 118.838 0.744 . . . . 0.0 112.263 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.3 m -60.44 -49.15 78.7 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.205 -0.935 . . . . 0.0 110.64 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.2 ptt85 -69.35 -32.9 72.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 118.241 -0.885 . . . . 0.0 113.251 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.1 ttt-85 -62.18 -48.4 80.24 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.29 1.436 . . . . 0.0 111.349 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.19 -33.03 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.978 0.911 . . . . 0.0 111.828 -174.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -90.51 -0.6 57.73 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 172.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 58.23 30.8 19.97 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.637 1.975 . . . . 0.0 114.874 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 pp -100.9 162.64 12.76 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.374 0.988 . . . . 0.0 112.311 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.75 155.37 33.25 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.12 0.968 . . . . 0.0 111.302 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.35 -21.24 66.67 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.073 -1.642 . . . . 0.0 113.542 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -96.2 10.5 37.6 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.294 1.438 . . . . 0.0 113.614 168.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -113.28 14.82 19.38 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.477 1.511 . . . . 0.0 110.215 168.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.9 tp -112.42 120.84 43.04 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 165.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -85.33 125.34 32.86 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 118.462 -1.295 . . . . 0.0 107.589 162.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 47' ' ' ASP 0.255 0.7 OUTLIER -117.08 144.24 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.602 1.961 . . . . 0.0 114.463 167.715 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -154.93 144.51 21.38 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.123 1.369 . . . . 0.0 109.346 -160.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -167.72 62.22 0.07 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.429 1.492 . . . . 0.0 112.298 -167.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.3 t -91.78 -58.35 2.44 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.742 -1.224 . . . . 0.0 112.888 154.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.24 -59.15 2.32 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.02 -152.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.454 ' H ' HD21 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -54.42 -38.95 66.84 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.886 1.674 . . . . 0.0 112.979 177.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -55.6 -25.98 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.156 1.382 . . . . 0.0 111.289 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 63.5 m -110.05 3.19 20.09 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.386 2.274 . . . . 0.0 115.38 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -94.49 20.39 8.46 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 120.378 1.444 . . . . 0.0 112.699 169.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -144.46 170.17 8.76 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 128.574 2.75 . . . . 0.0 107.412 173.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -58.74 -45.35 29.8 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.292 1.995 . . . . 0.0 114.861 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -119.44 -52.91 2.25 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 -171.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -170.31 133.47 1.09 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.201 2.2 . . . . 0.0 106.945 -166.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 t -93.07 -156.69 0.49 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 117.695 -1.145 . . . . 0.0 108.146 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -88.84 -81.91 0.26 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 118.046 -1.462 . . . . 0.0 112.04 165.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 t 179.63 -176.41 0.3 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.235 1.016 . . . . 0.0 109.055 -170.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.428 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 17.6 t70 -136.68 115.88 12.54 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.52 132.81 48.32 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.725 1.61 . . . . 0.0 111.099 -158.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.1 ttm -128.73 123.47 33.1 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.705 -1.247 . . . . 0.0 112.785 -156.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.3 mt -120.77 141.73 50.23 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 127.129 2.172 . . . . 0.0 113.351 -144.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.6 p -96.96 160.0 14.59 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.559 1.544 . . . . 0.0 110.334 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 69.2 p -124.98 177.9 5.8 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -153.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.7 t70 59.47 50.77 7.17 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.69 1.996 . . . . 0.0 110.394 -162.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.5 tp -142.75 145.32 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.647 1.579 . . . . 0.0 110.955 -167.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.8 p -109.18 140.56 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.964 1.306 . . . . 0.0 111.772 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 1.648 ' HE1' ' CE2' ' A' ' 56' ' ' TYR . 4.0 p90 -133.72 138.59 31.33 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 119.361 0.982 . . . . 0.0 111.896 170.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.99 71.4 2.15 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 125.142 3.895 . . . . 0.0 109.356 171.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 p -52.32 -38.55 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.326 1.45 . . . . 0.0 114.254 -157.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -70.19 -21.97 62.99 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.552 1.141 . . . . 0.0 112.472 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -66.29 -29.79 70.08 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.379 -0.826 . . . . 0.0 112.204 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 36.6 tp -76.52 -47.01 24.14 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.598 1.09 . . . . 0.0 110.572 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.2 mp -53.68 -49.4 68.08 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.022 0.529 . . . . 0.0 110.99 174.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.2 p -71.67 -29.37 64.52 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 1.67 ' HD1' ' CD2' ' A' ' 64' ' ' TYR . 46.1 t80 -65.76 -33.35 75.66 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.963 0.905 . . . . 0.0 112.086 174.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -75.7 -58.35 3.33 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 160.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.61 -34.46 77.05 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.251 -0.906 . . . . 0.0 112.365 -156.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 71.7 m -78.76 -11.51 59.99 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 ttt85 -69.49 -37.47 77.25 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.011 1.325 . . . . 0.0 114.019 -163.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.9 p -152.39 15.99 0.61 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.349 1.46 . . . . 0.0 112.46 171.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.31 81.8 0.14 Allowed Glycine 0 C--N 1.341 0.835 0 C-N-CA 125.705 1.622 . . . . 0.0 113.237 173.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -151.44 113.64 4.54 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.131 0.967 . . . . 0.0 111.809 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.0 m -66.19 133.59 50.97 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.152 1.381 . . . . 0.0 112.695 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -131.93 159.35 38.93 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.555 1.542 . . . . 0.0 114.439 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 81.8 m -96.76 108.03 20.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.069 2.547 . . . . 0.0 108.543 164.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 1.612 ' HE1' ' CE2' ' A' ' 75' ' ' PHE . 70.2 m-85 -91.13 96.39 10.57 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.216 -0.927 . . . . 0.0 108.784 177.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.53 114.86 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.856 0.862 . . . . 0.0 110.852 -164.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -91.35 117.28 29.53 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 120.323 -1.486 . . . . 0.0 107.704 176.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.06 126.74 54.32 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.685 1.594 . . . . 0.0 111.094 174.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -95.4 128.61 42.4 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.527 1.131 . . . . 0.0 109.147 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.5 p -144.56 165.31 28.37 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 130.512 3.525 . . . . 0.0 105.711 -165.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.35 -121.54 0.0 OUTLIER Glycine 0 N--CA 1.491 2.314 0 C-N-CA 129.868 3.604 . . . . 0.0 115.935 -174.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.9 p -93.51 104.81 16.91 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 114.649 -2.82 . . . . 0.0 109.854 150.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.8 mtt85 -178.54 145.39 0.32 Allowed 'General case' 0 CA--C 1.555 1.138 1 C-N-CA 134.376 5.07 . . . . 0.0 106.753 131.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.14 135.52 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 121.839 2.109 . . . . 0.0 109.731 149.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.5 t -107.05 147.12 30.35 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.427 -1.421 . . . . 0.0 110.77 170.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 18.2 tp -110.98 106.32 15.37 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 159.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.5 m -78.64 111.33 14.61 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.126 164.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.7 t -103.88 110.75 23.0 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 119.613 -1.929 . . . . 0.0 110.733 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -111.13 113.35 25.8 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -173.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.9 mp -77.33 88.73 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 133.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.3 172.38 42.64 Favored Glycine 0 N--CA 1.475 1.299 0 N-CA-C 121.219 3.248 . . . . 0.0 121.219 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 1.645 ' HD1' ' CD2' ' A' ' 92' ' ' PHE . 45.6 m-85 -110.91 49.61 0.27 Allowed Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 127.181 2.193 . . . . 0.0 116.457 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -63.25 166.94 13.65 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 CA-C-N 122.607 1.967 . . . . 0.0 115.514 173.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -77.52 -28.43 52.02 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -84.02 -16.73 42.85 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -172.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -50.74 -28.07 8.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 128.02 2.528 . . . . 0.0 112.908 172.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -61.88 -39.62 92.59 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.788 -0.625 . . . . 0.0 112.302 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -112.19 -17.3 12.82 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -173.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 pp -80.62 157.97 25.82 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 120.675 1.58 . . . . 0.0 111.894 168.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -168.45 138.17 2.42 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -172.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.693 ' CD ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -112.18 -179.14 3.6 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.851 1.66 . . . . 0.0 112.502 177.042 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.693 ' H ' ' CD ' ' A' ' 101' ' ' ARG . 3.1 p -162.6 173.91 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 125.764 1.626 . . . . 0.0 112.732 -142.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 46.3 t -121.56 122.21 39.18 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.716 0.806 . . . . 0.0 108.949 144.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -175.14 170.2 3.19 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.646 1.578 . . . . 0.0 108.823 -172.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -109.78 104.11 13.02 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.597 2.359 . . . . 0.0 110.436 165.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -129.93 165.93 21.08 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -171.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 1.609 ' HE2' ' CE1' ' A' ' 107' ' ' PHE . 13.7 p90 -137.22 137.01 38.64 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.632 1.173 . . . . 0.0 113.31 167.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.6 tt -149.82 144.04 25.74 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.277 1.031 . . . . 0.0 112.192 -135.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 m -71.5 156.0 39.94 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -6.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 129.364 3.065 . . . . 0.0 114.066 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -138.1 60.1 1.63 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.624 2.37 . . . . 0.0 108.587 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -142.36 150.42 40.71 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 121.014 -1.054 . . . . 0.0 113.091 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -150.9 155.27 38.81 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.08 -1.637 . . . . 0.0 112.976 -155.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.68 145.76 26.04 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.166 1.386 . . . . 0.0 111.038 -165.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.99 134.9 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 120.987 1.722 . . . . 0.0 112.885 162.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.83 157.68 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.47 1.108 . . . . 0.0 109.811 171.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.9 t -157.82 161.97 38.4 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.608 1.963 . . . . 0.0 108.288 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.43 -25.38 24.58 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.37 -37.33 28.41 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 120.302 1.41 . . . . 0.0 113.552 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.41 -31.62 63.97 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.67 -1.269 . . . . 0.0 111.319 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.1 tp -70.97 -32.92 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 121.645 -0.66 . . . . 0.0 111.764 167.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -65.51 -12.99 57.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.274 1.03 . . . . 0.0 112.882 171.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.33 -30.38 68.41 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.421 -1.425 . . . . 0.0 113.656 163.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 14.3 mt -87.2 -40.73 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.711 1.204 . . . . 0.0 111.223 -169.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -155.49 155.44 29.75 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 128.382 2.673 . . . . 0.0 107.597 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -53.8 130.22 38.0 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 121.915 1.744 . . . . 0.0 112.32 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 25.7 t -99.54 153.16 19.26 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.9 1.68 . . . . 0.0 111.046 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -156.8 162.71 39.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.502 1.521 . . . . 0.0 109.476 -170.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -58.44 126.9 29.51 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 127.055 2.142 . . . . 0.0 109.999 170.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.77 15.22 65.98 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-O 118.419 -1.212 . . . . 0.0 115.032 -173.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.77 138.94 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.253 1.526 . . . . 0.0 110.34 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 tp -132.7 82.48 2.01 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 123.781 1.753 . . . . 0.0 109.458 173.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 16.8 m -77.31 142.44 39.41 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 155.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -131.63 133.44 44.95 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 121.408 -0.808 . . . . 0.0 109.506 -167.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 46.1 t -127.04 130.54 50.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.215 0.461 . . . . 0.0 110.602 -166.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.78 113.4 40.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.584 1.554 . . . . 0.0 107.735 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.1 m -111.12 135.59 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 122.189 0.995 . . . . 0.0 111.152 173.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -131.12 160.45 34.68 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.23 2.612 . . . . 0.0 106.901 170.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.274 0.0 OUTLIER -143.6 147.67 34.73 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.364 -0.835 . . . . 0.0 109.29 167.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.5 m -97.99 137.34 36.94 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.62 0.645 . . . . 0.0 109.548 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -61.09 168.54 2.44 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -169.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.7 m 53.08 28.26 6.64 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.613 1.165 . . . . 0.0 114.062 -170.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 69.48 25.37 75.56 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.416 1.008 . . . . 0.0 114.706 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 86.1 mtp -83.2 -22.1 33.27 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -166.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 t -165.99 156.32 12.74 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 174.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 1.637 ' HE1' ' CE2' ' A' ' 146' ' ' TYR . 27.4 m-85 -104.66 137.27 42.74 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.075 0.95 . . . . 0.0 111.14 149.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -126.07 108.29 11.22 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -175.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.3 tp -140.64 103.14 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 122.659 1.219 . . . . 0.0 108.895 -142.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -136.48 141.54 43.51 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.67 -158.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 p -154.15 146.02 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.717 0.807 . . . . 0.0 111.083 177.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.2 m -132.14 134.39 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 127.189 2.196 . . . . 0.0 110.464 -174.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.85 116.18 31.56 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -168.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 1.604 ' HD2' ' CD1' ' A' ' 153' ' ' PHE . 80.9 m-85 -137.61 158.15 44.99 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.876 0.845 . . . . 0.0 112.201 172.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -86.32 -160.6 34.43 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 125.568 1.556 . . . . 0.0 113.31 172.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.23 -16.27 27.27 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.67 2.913 . . . . 0.0 115.787 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -90.19 16.97 7.6 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.905 1.682 . . . . 0.0 114.273 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -70.43 56.24 0.16 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.565 1.546 . . . . 0.0 111.309 165.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.81 -26.15 65.54 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.304 1.042 . . . . 0.0 112.347 -173.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.51 -53.69 13.04 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -76.64 -26.34 54.77 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.662 0.665 . . . . 0.0 112.518 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 1.62 ' HD1' ' CD2' ' A' ' 161' ' ' TYR . 13.6 t80 -63.24 -56.25 18.16 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.268 0.94 . . . . 0.0 109.871 172.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -55.83 -33.48 64.51 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.115 -0.991 . . . . 0.0 112.949 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.86 -34.11 76.04 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.78 -48.13 64.46 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 120.687 -1.258 . . . . 0.0 112.537 171.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -59.49 -25.96 64.87 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 121.423 1.919 . . . . 0.0 114.484 172.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.0 ttp85 -68.49 -39.62 81.26 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.715 1.206 . . . . 0.0 111.975 169.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -72.21 -29.98 64.48 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.402 1.081 . . . . 0.0 113.486 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.69 -47.34 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.156 1.382 . . . . 0.0 109.589 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -62.6 -3.46 1.49 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 166.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -124.72 26.91 7.01 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 . . . . . 0 C--O 1.254 1.317 0 O-C-N 121.112 -0.993 . . . . 0.0 111.561 168.229 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.3 t70 . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 120.546 0.212 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -52.95 -28.27 22.85 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -78.71 -25.53 44.67 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.497 -0.752 . . . . 0.0 111.564 -174.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.4 t -70.5 -46.25 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.613 1.165 . . . . 0.0 110.243 173.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.32 -52.58 52.37 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 169.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.6 -28.71 70.08 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.37 -1.076 . . . . 0.0 113.428 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -75.08 -43.71 51.61 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.232 1.378 . . . . 0.0 114.097 169.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.95 -40.14 83.28 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.321 0.964 . . . . 0.0 111.378 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -66.63 -41.9 88.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 O-C-N 121.256 -0.902 . . . . 0.0 110.238 172.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.3 t -57.7 -47.43 82.4 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.248 0.931 . . . . 0.0 112.506 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -72.38 -29.06 63.42 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.602 -0.686 . . . . 0.0 111.666 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.9 m -63.42 -47.66 81.02 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.701 1.137 . . . . 0.0 110.456 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -51.55 -50.54 59.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.61 1.164 . . . . 0.0 111.283 171.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -77.05 -38.71 52.14 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -168.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -78.97 -42.87 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.191 0.905 . . . . 0.0 110.755 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.04 -8.2 59.72 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 118.815 0.734 . . . . 0.0 112.695 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.4 mmt85 56.57 41.21 28.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.432 1.893 . . . . 0.0 113.034 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 pp -114.59 150.44 35.03 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.454 1.502 . . . . 0.0 110.255 168.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -66.85 153.3 43.78 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.807 -0.558 . . . . 0.0 111.151 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.53 -19.04 63.71 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.518 -1.364 . . . . 0.0 113.2 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -92.17 7.43 42.59 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.305 1.442 . . . . 0.0 113.258 166.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -119.33 10.55 11.98 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.948 1.699 . . . . 0.0 111.7 168.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.8 tp -99.63 130.58 45.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.225 2.21 . . . . 0.0 105.311 161.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -95.48 112.59 24.28 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.168 170.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -108.16 143.74 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 126.073 1.749 . . . . 0.0 112.411 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 m -155.55 131.0 9.65 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -139.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -171.27 57.73 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.774 0.797 . . . . 0.0 111.695 -161.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.5 p -87.55 -54.97 4.0 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.937 -1.102 . . . . 0.0 110.249 153.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.17 -45.37 16.47 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -158.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.458 ' H ' ' CD1' ' A' ' 36' ' ' LEU . 3.0 mp -60.02 -41.64 92.63 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.379 1.072 . . . . 0.0 109.557 176.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mp -75.92 -20.99 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 127.626 2.37 . . . . 0.0 111.107 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 15.4 t -74.09 -39.44 63.41 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.561 -1.337 . . . . 0.0 111.82 172.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.9 mmpt? -72.0 -46.27 57.85 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.96 0.8 . . . . 0.0 110.663 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -148.77 95.53 3.93 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 124.709 1.203 . . . . 0.0 109.59 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -66.33 -56.85 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 121.885 1.724 . . . . 0.0 112.596 -173.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -92.77 29.24 1.83 Allowed 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.516 1.126 . . . . 0.0 110.548 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 1.603 ' HE1' ' CE2' ' A' ' 43' ' ' TYR . 29.0 t80 -160.42 99.53 1.31 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 155.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.5 p -178.66 -178.55 0.58 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.778 1.631 . . . . 0.0 110.0 -173.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.5 tp -127.35 -87.03 0.58 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 168.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 p -178.67 176.04 1.02 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.815 1.293 . . . . 0.0 112.451 -159.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -148.91 120.16 7.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.334 1.454 . . . . 0.0 107.989 -177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.5 144.05 45.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.199 2.2 . . . . 0.0 110.05 -157.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.5 mtt -132.83 131.68 41.3 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.369 1.44 . . . . 0.0 112.532 -162.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.3 mt -128.96 145.42 51.24 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 127.706 3.128 . . . . 0.0 112.15 -144.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.2 p -123.09 163.24 20.9 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 128.062 2.545 . . . . 0.0 111.558 -170.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.6 p -51.98 127.99 22.95 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.59 1.556 . . . . 0.0 113.489 -164.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.37 151.88 32.58 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 118.081 2.623 . . . . 0.0 118.081 -135.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.83 118.37 54.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 165.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 m -79.04 130.49 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.858 -154.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -136.29 148.81 65.79 Favored Pre-proline 0 C--O 1.236 0.367 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -166.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.55 76.67 2.3 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.061 3.174 . . . . 0.0 110.807 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.36 -45.44 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 126.526 1.93 . . . . 0.0 113.261 -167.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -78.26 -13.29 59.91 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -70.91 -35.98 72.52 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.409 -1.432 . . . . 0.0 110.146 162.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.0 tp -61.7 -43.95 97.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.745 0.818 . . . . 0.0 111.099 170.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp -56.29 -43.2 78.63 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.326 0.966 . . . . 0.0 112.6 170.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.1 t -61.83 -45.38 94.05 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.401 0.546 . . . . 0.0 111.575 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 1.63 ' HE1' ' CE2' ' A' ' 64' ' ' TYR . 62.3 t80 -66.5 -38.75 87.94 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.19 0.596 . . . . 0.0 112.511 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -57.49 12.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.406 1.483 . . . . 0.0 110.733 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.9 -35.81 81.3 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.198 0.599 . . . . 0.0 111.687 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.2 t -76.1 -23.45 54.93 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.54 -28.64 60.56 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 120.847 1.658 . . . . 0.0 115.163 -165.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.8 p -139.01 14.48 2.65 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.838 1.255 . . . . 0.0 113.415 157.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.47 79.73 0.2 Allowed Glycine 0 N--CA 1.472 1.051 0 C-N-CA 126.454 1.978 . . . . 0.0 113.305 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 74.5 mtt85 -157.58 115.91 3.16 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.033 1.733 . . . . 0.0 110.877 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.67 145.16 29.78 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -152.39 159.15 43.45 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.786 1.634 . . . . 0.0 113.373 -165.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.6 m -76.39 113.81 14.39 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.756 1.222 . . . . 0.0 109.725 162.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -96.2 98.38 10.27 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 122.559 1.171 . . . . 0.0 108.352 173.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.6 t -101.45 150.63 5.86 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 C-N-CA 127.206 2.202 . . . . 0.0 109.419 -164.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 1.64 ' HD2' ' CD1' ' A' ' 77' ' ' PHE . 47.2 m-85 -121.76 129.71 52.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.073 -1.017 . . . . 0.0 108.837 164.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -123.04 116.32 23.31 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.805 1.642 . . . . 0.0 110.086 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -95.09 115.94 28.07 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.398 1.479 . . . . 0.0 109.13 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.6 t -147.79 159.7 43.54 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 -170.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -6.75 -126.2 0.0 OUTLIER Glycine 0 N--CA 1.48 1.574 0 O-C-N 119.021 -2.3 . . . . 0.0 112.959 -133.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.445 ' HB3' ' HE3' ' A' ' 139' ' ' LYS . 57.3 m -94.45 111.32 23.06 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 113.642 -3.223 . . . . 0.0 110.17 149.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -169.58 146.22 3.3 Favored 'General case' 0 N--CA 1.475 0.824 1 C-N-CA 132.111 4.164 . . . . 0.0 107.581 133.228 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.9 t -72.23 139.5 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.068 -1.645 . . . . 0.0 110.294 165.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.58 148.5 29.2 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.616 0.766 . . . . 0.0 111.636 165.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.3 tp -108.84 110.37 21.7 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 157.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.4 m -97.83 114.26 26.27 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.868 1.667 . . . . 0.0 108.723 -174.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 99.0 m -103.93 108.36 19.66 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.063 -1.648 . . . . 0.0 109.449 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -103.49 94.2 5.35 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.643 0.735 . . . . 0.0 111.74 -172.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.2 mp -72.99 94.67 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 126.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.36 149.73 10.02 Favored Glycine 0 N--CA 1.468 0.79 0 N-CA-C 119.113 2.405 . . . . 0.0 119.113 -169.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -114.46 58.05 0.93 Allowed Pre-proline 0 CA--C 1.556 1.178 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 170.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -67.77 174.09 8.14 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.993 2.462 . . . . 0.0 114.281 166.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -82.66 -39.08 22.56 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -75.31 -13.05 60.39 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -158.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -51.57 -30.56 21.33 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 128.046 2.539 . . . . 0.0 112.994 170.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -52.95 -42.07 65.12 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.705 0.802 . . . . 0.0 111.206 170.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -100.77 -34.39 9.86 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -171.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.2 pp -85.61 155.99 20.91 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -167.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -151.47 122.74 7.76 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -159.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -106.38 179.5 4.25 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 126.992 2.117 . . . . 0.0 110.104 171.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 p -165.07 173.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -149.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 97.7 m -128.32 120.63 27.44 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.723 1.147 . . . . 0.0 111.258 137.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -176.49 179.52 1.16 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 129.507 3.123 . . . . 0.0 105.237 -172.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 1.655 ' HE1' ' CE2' ' A' ' 105' ' ' PHE . 36.8 p90 -111.42 127.58 55.72 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.456 1.502 . . . . 0.0 110.875 162.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -148.45 159.36 44.12 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.455 1.102 . . . . 0.0 113.658 -161.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -109.13 151.47 26.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.447 2.299 . . . . 0.0 111.162 174.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 mt -142.48 146.8 35.13 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.836 1.255 . . . . 0.0 111.925 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.9 m -106.69 178.49 4.55 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.747 1.219 . . . . 0.0 114.001 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.82 -5.13 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 128.809 2.844 . . . . 0.0 116.113 -161.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -138.3 47.9 1.97 Allowed 'General case' 0 CA--C 1.551 1.015 0 O-C-N 120.608 -1.308 . . . . 0.0 112.794 168.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -111.18 146.76 36.32 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.911 1.284 . . . . 0.0 112.064 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -150.02 147.06 27.38 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 119.687 -1.883 . . . . 0.0 111.296 -154.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.17 147.5 36.72 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.999 1.32 . . . . 0.0 112.73 -169.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.47 141.75 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-N 121.396 1.907 . . . . 0.0 114.065 162.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.91 148.86 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.179 1.392 . . . . 0.0 109.831 173.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.9 t -140.42 159.83 41.33 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.738 2.015 . . . . 0.0 106.542 161.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -49.74 -30.66 9.82 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -171.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.36 -33.35 75.04 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 121.145 1.793 . . . . 0.0 113.734 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.49 -26.36 63.58 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.225 -0.922 . . . . 0.0 112.027 172.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 37.0 mm -77.95 -30.18 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.755 0.822 . . . . 0.0 111.48 167.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.96 -13.98 62.6 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.252 -0.905 . . . . 0.0 113.196 170.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -70.0 -36.25 74.99 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 120.107 -1.621 . . . . 0.0 113.3 158.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.83 -37.67 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.852 1.261 . . . . 0.0 110.593 -176.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.5 135.37 15.82 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 125.112 1.365 . . . . 0.0 111.323 169.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.54 -24.73 63.02 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.893 3.062 . . . . 0.0 116.39 -157.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.7 t -147.65 130.1 15.79 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.393 1.077 . . . . 0.0 110.436 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -168.5 158.5 9.58 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.951 2.1 . . . . 0.0 108.206 169.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -136.07 -31.95 0.89 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.903 1.681 . . . . 0.0 113.64 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -101.76 21.73 41.16 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.949 1.738 . . . . 0.0 114.982 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.87 146.25 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.017 1.408 . . . . 0.0 113.527 -159.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.7 mp -113.63 81.58 1.54 Allowed 'General case' 0 C--O 1.24 0.554 0 CA-C-O 123.431 1.586 . . . . 0.0 108.531 169.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.0 m -75.44 146.27 40.83 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 162.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -124.07 132.56 53.68 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 44.5 t -124.34 133.64 53.39 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.005 0.82 . . . . 0.0 111.168 -169.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.1 t -144.79 108.89 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.398 0.679 . . . . 0.0 111.027 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.1 m -99.59 141.4 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.996 1.319 . . . . 0.0 113.33 173.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -122.98 162.0 23.16 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.63 1.172 . . . . 0.0 109.456 155.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.445 ' HE3' ' HB3' ' A' ' 82' ' ' CYS 0.273 0.1 OUTLIER -147.61 154.49 40.73 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.006 1.722 . . . . 0.0 108.019 169.589 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.8 t -132.88 121.03 22.29 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -73.14 -43.52 61.45 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 118.068 0.394 . . . . 0.0 110.337 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.9 m -45.76 -46.19 15.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.782 1.633 . . . . 0.0 112.762 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -91.18 5.44 81.32 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.449 1.499 . . . . 0.0 115.692 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 43.9 tpp 41.89 50.11 4.09 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.201 1.8 . . . . 0.0 113.63 -173.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.3 t -138.69 140.18 38.69 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.309 -0.869 . . . . 0.0 111.652 -162.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 1.623 ' HD1' ' CD2' ' A' ' 146' ' ' TYR . 56.8 m-85 -109.08 139.49 43.89 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.265 1.026 . . . . 0.0 109.603 162.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -143.15 106.44 4.57 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.9 pt -136.32 152.22 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.577 0.751 . . . . 0.0 112.936 -160.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -136.77 149.15 47.64 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.311 0.577 . . . . 0.0 112.245 165.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.18 132.9 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.137 0.975 . . . . 0.0 109.169 169.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.9 m -138.17 122.98 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.33 1.052 . . . . 0.0 111.668 -156.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -103.95 122.78 45.91 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -164.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -141.24 148.19 39.48 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.256 1.423 . . . . 0.0 110.186 165.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -74.61 -162.43 9.17 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.322 1.439 . . . . 0.0 115.164 169.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -56.15 -13.49 9.64 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 124.401 3.401 . . . . 0.0 117.04 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -63.33 -4.87 2.89 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.746 1.618 . . . . 0.0 113.882 166.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -73.55 43.59 0.15 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 126.075 1.75 . . . . 0.0 112.86 172.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -50.32 -30.44 12.07 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.617 2.767 . . . . 0.0 113.673 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.75 -42.89 57.38 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.377 1.471 . . . . 0.0 114.415 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -71.21 -32.44 68.81 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.404 -1.435 . . . . 0.0 111.629 170.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -58.16 -54.0 51.96 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.478 1.035 . . . . 0.0 111.364 169.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -54.63 -49.31 70.82 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.493 0.588 . . . . 0.0 111.527 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -57.24 -44.45 83.82 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.032 0.833 . . . . 0.0 112.837 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.01 -60.95 2.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.1 mp -53.15 -35.86 60.2 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.269 1.427 . . . . 0.0 112.924 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -68.07 -35.74 78.7 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.148 1.379 . . . . 0.0 111.852 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.65 -26.1 24.52 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.8 pt -104.74 -44.85 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -171.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -90.2 -32.62 16.52 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.247 1.385 . . . . 0.0 109.93 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -97.45 24.11 6.93 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.084 0.954 . . . . 0.0 112.982 171.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.492 -1.242 . . . . 0.0 112.637 163.009 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 CA--C 1.543 0.692 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -65.09 -4.23 4.59 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -155.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -93.7 -22.33 18.8 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.482 1.113 . . . . 0.0 113.511 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.73 -42.82 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.664 1.186 . . . . 0.0 113.539 -168.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.88 -47.33 89.75 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 168.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.77 -37.29 70.89 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.966 1.383 . . . . 0.0 112.493 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.43 -35.19 63.38 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.591 1.556 . . . . 0.0 114.129 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.4 tp -75.39 -37.07 60.75 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.136 1.374 . . . . 0.0 112.22 176.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -67.76 -44.32 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.604 1.562 . . . . 0.0 109.368 170.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.5 t -53.87 -44.85 70.74 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.234 1.014 . . . . 0.0 111.742 168.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -60.41 -37.05 79.6 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.495 -0.753 . . . . 0.0 111.451 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.5 m -67.01 -49.04 66.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.834 0.854 . . . . 0.0 111.501 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -64.79 -38.75 92.04 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 119.926 1.239 . . . . 0.0 112.77 173.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -78.79 -35.59 44.09 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -172.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.91 -23.7 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.965 1.257 . . . . 0.0 111.509 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.0 mp -86.75 -11.96 49.54 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 167.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 53.55 43.29 31.43 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.835 1.654 . . . . 0.0 112.08 -177.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 pp -107.18 162.63 13.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.545 0.738 . . . . 0.0 110.555 171.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.36 148.81 43.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.758 0.423 . . . . 0.0 111.777 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -25.41 67.94 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.447 -1.408 . . . . 0.0 112.881 173.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -79.11 2.38 20.97 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.945 1.698 . . . . 0.0 113.696 168.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -130.18 -5.93 4.36 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.522 1.529 . . . . 0.0 110.772 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 26.0 tp -87.78 138.49 31.42 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.306 1.842 . . . . 0.0 106.774 154.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.73 138.9 51.72 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 164.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.0 mm -98.79 141.11 16.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 O-C-N 125.8 1.938 . . . . 0.0 111.796 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.61 149.22 37.01 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.691 0.397 . . . . 0.0 110.808 174.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -158.26 56.29 0.46 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 166.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.7 p -87.43 -56.78 3.21 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.024 -1.672 . . . . 0.0 112.294 162.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.64 -55.99 3.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.808 0.813 . . . . 0.0 113.041 -158.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.446 ' H ' HD21 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -64.39 -42.11 96.31 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.951 1.701 . . . . 0.0 112.482 -175.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.87 -27.17 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.393 1.077 . . . . 0.0 110.278 174.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.8 m -92.81 4.14 54.38 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.246 1.418 . . . . 0.0 114.272 174.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.24 -41.75 9.3 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.23 1.377 . . . . 0.0 110.737 172.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -100.38 77.64 0.17 Allowed Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 162.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -72.63 -0.09 8.34 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 N-CA-C 118.833 2.59 . . . . 0.0 118.833 -121.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -119.82 3.97 11.04 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 126.072 1.749 . . . . 0.0 113.234 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 1.639 ' HE1' ' CE2' ' A' ' 43' ' ' TYR . 53.6 m-85 -133.02 170.6 15.14 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.735 1.607 . . . . 0.0 113.636 -148.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.5 m -67.58 158.71 31.41 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.162 1.385 . . . . 0.0 113.991 -169.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.78 -77.88 0.57 Allowed 'General case' 0 CA--C 1.541 0.629 0 O-C-N 117.738 -3.101 . . . . 0.0 115.722 14.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.48 -171.84 0.85 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.944 1.247 . . . . 0.0 112.736 -172.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -132.29 149.96 52.26 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -130.81 141.73 50.36 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 129.784 3.234 . . . . 0.0 108.326 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.3 ttp -124.89 128.25 48.35 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.888 -1.132 . . . . 0.0 108.331 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.5 mt -133.79 147.63 51.28 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.468 1.907 . . . . 0.0 114.73 -147.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.5 t -124.22 169.13 12.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.833 2.853 . . . . 0.0 112.999 -169.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.9 p -96.77 176.25 6.06 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.323 2.649 . . . . 0.0 115.419 -159.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 66.66 21.98 10.52 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 116.995 2.22 . . . . 0.0 116.995 166.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.52 161.38 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.86 1.264 . . . . 0.0 111.077 165.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.5 m -101.3 139.73 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.996 1.318 . . . . 0.0 109.235 171.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 1.655 ' HD2' ' CD1' ' A' ' 56' ' ' TYR . 4.1 p90 -133.28 125.25 18.72 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 118.995 0.816 . . . . 0.0 110.022 171.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -63.4 65.53 0.18 Allowed 'Trans proline' 0 C--N 1.357 1.005 1 C-N-CA 125.508 4.138 . . . . 0.0 113.129 170.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.12 -38.67 39.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 127.78 2.432 . . . . 0.0 114.292 -156.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -75.0 -10.47 59.5 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.33 -0.856 . . . . 0.0 113.032 -177.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -59.38 -31.49 69.27 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.616 -1.303 . . . . 0.0 112.058 161.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.8 tp -72.38 -42.98 64.61 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.268 0.94 . . . . 0.0 111.246 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mp -57.83 -43.73 86.01 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 122.128 -0.358 . . . . 0.0 111.062 169.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.9 m -62.63 -38.76 91.51 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.948 0.899 . . . . 0.0 111.52 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 1.619 ' HD1' ' CD2' ' A' ' 64' ' ' TYR . 40.1 t80 -65.73 -36.13 82.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 118.618 -0.706 . . . . 0.0 112.041 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -69.39 -53.66 18.3 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 168.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -63.04 -36.5 83.79 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.315 -0.865 . . . . 0.0 111.865 -172.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 73.6 m -73.57 -9.94 59.2 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.0 tpt85 -75.5 -32.56 60.58 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.395 0.998 . . . . 0.0 112.426 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.9 p -148.61 -36.91 0.18 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.401 1.08 . . . . 0.0 112.749 173.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.35 81.94 1.63 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 126.755 2.121 . . . . 0.0 110.816 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 72.6 mtt85 -148.44 114.15 5.69 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.321 1.848 . . . . 0.0 110.071 170.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.9 m -65.29 140.37 58.69 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.589 1.156 . . . . 0.0 113.099 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.8 147.86 33.39 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -170.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 64.4 m -76.39 108.79 9.59 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.896 2.878 . . . . 0.0 111.694 165.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 1.631 ' HD1' ' CD2' ' A' ' 75' ' ' PHE . 6.9 m-85 -91.62 99.63 12.51 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.555 -1.341 . . . . 0.0 108.323 167.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.7 t -99.7 115.79 41.45 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 C-N-CA 125.906 1.682 . . . . 0.0 109.348 -168.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -96.8 124.97 40.93 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 120.351 -1.468 . . . . 0.0 108.365 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -118.06 122.57 43.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.858 1.263 . . . . 0.0 111.832 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -95.89 114.85 26.61 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.546 1.538 . . . . 0.0 109.692 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 p -144.17 160.16 41.42 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 -173.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -7.92 -130.56 0.0 OUTLIER Glycine 0 N--CA 1.483 1.801 0 O-C-N 118.642 -2.537 . . . . 0.0 113.492 -137.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.2 p -96.41 101.86 13.56 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 121.798 2.799 . . . . 0.0 110.124 158.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 mtt85 -173.84 141.63 0.83 Allowed 'General case' 0 N--CA 1.471 0.607 1 C-N-CA 132.982 4.513 . . . . 0.0 107.92 144.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.6 t -68.35 137.43 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 120.244 1.384 . . . . 0.0 110.405 165.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.9 m -104.49 145.7 29.91 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.101 -0.999 . . . . 0.0 110.374 158.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.8 tp -109.62 109.7 20.53 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 160.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.2 m -88.84 96.64 10.78 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.398 1.079 . . . . 0.0 109.19 170.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 7.9 p -101.9 111.16 23.33 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 119.396 -2.065 . . . . 0.0 109.927 -172.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 1.629 ' HE1' ' CE2' ' A' ' 89' ' ' TYR . 18.8 p90 -146.64 150.5 35.57 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 116.828 2.159 . . . . 0.0 116.828 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.17 109.04 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 168.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.41 139.9 14.74 Favored Glycine 0 CA--C 1.536 1.357 0 N-CA-C 117.864 1.906 . . . . 0.0 117.864 -138.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.3 62.93 46.93 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 152.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.49 106.35 1.6 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.688 2.926 . . . . 0.0 114.604 -170.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.49 -30.74 61.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.687 1.195 . . . . 0.0 113.85 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.3 tpt85 -92.68 3.13 56.17 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.2 tp -70.89 1.0 6.09 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.728 -1.232 . . . . 0.0 114.287 166.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -51.81 -37.8 53.17 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.656 -0.652 . . . . 0.0 111.099 150.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -123.78 -35.3 2.9 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 -169.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 pp -82.81 167.4 18.14 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 121.999 2.181 . . . . 0.0 114.862 -167.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -168.2 126.22 1.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 -165.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.42 ' CD ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -105.21 178.22 4.62 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.547 1.539 . . . . 0.0 110.261 170.147 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.42 ' H ' ' CD ' ' A' ' 101' ' ' ARG . 1.1 p -162.38 169.81 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -147.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 99.4 m -123.82 122.42 37.96 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.029 -1.044 . . . . 0.0 111.125 136.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -176.15 175.17 1.93 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 129.083 2.953 . . . . 0.0 106.838 -174.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 1.635 ' HE2' ' CE1' ' A' ' 105' ' ' PHE . 51.8 p90 -122.36 121.72 37.35 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.296 2.239 . . . . 0.0 111.476 164.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -159.09 171.43 19.98 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -100.14 137.53 38.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.485 2.314 . . . . 0.0 110.376 175.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.8 tp -146.2 142.97 28.93 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.139 1.376 . . . . 0.0 111.039 -158.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 p -92.38 177.16 6.22 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 118.161 2.652 . . . . 0.0 118.161 -172.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.6 t -76.54 -6.87 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 129.486 3.114 . . . . 0.0 114.551 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -122.43 32.65 5.7 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.233 1.413 . . . . 0.0 111.746 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -136.01 159.9 40.27 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.25 -1.531 . . . . 0.0 113.079 -162.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -155.17 148.71 25.21 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.667 -1.271 . . . . 0.0 110.356 -151.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.4 148.0 35.5 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.767 1.227 . . . . 0.0 110.971 -169.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.46 138.42 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 120.639 1.563 . . . . 0.0 113.229 160.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.92 156.37 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.659 1.184 . . . . 0.0 109.5 169.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.6 t -145.01 167.25 23.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.654 1.582 . . . . 0.0 108.27 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.53 -33.53 71.51 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.14 0.882 . . . . 0.0 113.324 -172.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.05 -30.74 70.89 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 172.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -73.19 -35.48 66.39 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.298 -0.876 . . . . 0.0 111.045 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.1 mm -77.53 -33.43 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.359 1.064 . . . . 0.0 111.647 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -57.98 -34.5 70.03 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.059 -1.025 . . . . 0.0 111.015 168.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -70.97 -25.47 62.73 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.618 171.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 54.0 mt -72.61 -44.85 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.394 1.452 . . . . 0.0 110.157 171.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.6 tptp 168.39 -49.62 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 128.291 2.636 . . . . 0.0 110.15 168.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -62.96 112.64 1.72 Allowed 'Trans proline' 0 C--N 1.357 0.985 0 CA-C-N 121.653 1.626 . . . . 0.0 114.604 -167.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 87.8 m -66.36 154.44 40.04 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.328 1.851 . . . . 0.0 112.933 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -80.36 -5.96 57.24 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 117.311 2.337 . . . . 0.0 117.311 -149.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -93.72 9.28 37.66 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.48 1.912 . . . . 0.0 115.413 -176.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -166.49 14.31 0.08 OUTLIER Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.506 1.363 . . . . 0.0 116.506 -166.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 63.9 t -70.1 122.73 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 118.724 1.262 . . . . 0.0 111.683 -171.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.9 mp -127.76 80.05 1.93 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 123.777 1.751 . . . . 0.0 108.344 153.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.6 m -85.09 129.91 34.71 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 160.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -125.86 132.64 52.16 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.146 0.979 . . . . 0.0 110.796 -158.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 49.3 t -124.4 141.45 52.07 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.546 1.138 . . . . 0.0 111.334 -167.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.9 t -137.21 125.33 32.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.547 1.539 . . . . 0.0 108.87 -173.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.23 143.87 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 28.4 mtt-85 -133.12 159.14 41.0 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 128.087 2.555 . . . . 0.0 107.987 164.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.301 0.0 OUTLIER -145.67 100.89 3.49 Favored 'General case' 0 CA--C 1.558 1.258 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 173.085 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.1 t -58.44 125.18 22.22 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.044 -1.66 . . . . 0.0 112.642 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -81.34 -53.85 5.98 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.904 0.882 . . . . 0.0 112.141 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.0 m -57.12 -22.41 39.63 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -119.2 22.39 9.0 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 117.333 -1.815 . . . . 0.0 114.216 174.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 91.7 mmm 22.77 71.49 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 128.454 2.702 . . . . 0.0 114.876 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.7 p -164.35 170.43 16.13 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.373 -0.829 . . . . 0.0 112.312 -169.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 1.66 ' HE2' ' CE1' ' A' ' 146' ' ' TYR . 89.4 m-85 -113.24 149.39 33.85 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.783 1.633 . . . . 0.0 112.055 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -123.85 115.76 21.84 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 166.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.8 tt -122.05 142.5 38.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.703 -170.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -140.03 145.96 38.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.198 0.523 . . . . 0.0 110.628 159.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 4.4 p -145.27 136.68 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 122.394 1.092 . . . . 0.0 111.179 167.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.4 m -130.54 129.67 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 126.38 1.872 . . . . 0.0 110.065 -163.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -100.12 120.68 40.23 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -164.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -140.3 153.21 46.38 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.953 0.883 . . . . 0.0 112.742 171.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -87.28 -143.78 8.39 Favored Glycine 0 CA--C 1.543 1.784 0 C-N-CA 125.267 1.413 . . . . 0.0 111.718 162.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.58 -13.88 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.712 3.608 . . . . 0.0 116.048 174.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -58.81 -14.58 9.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.487 1.915 . . . . 0.0 113.977 171.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -95.67 18.6 12.63 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -54.72 -30.3 55.68 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.22 -36.04 82.01 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.626 -1.296 . . . . 0.0 113.277 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -73.06 -37.6 66.76 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.593 -1.317 . . . . 0.0 111.113 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 1.64 ' HD2' ' CD1' ' A' ' 161' ' ' TYR . 31.0 t80 -56.17 -47.23 78.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.413 0.685 . . . . 0.0 111.048 171.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -60.48 -37.25 80.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.55 1.14 . . . . 0.0 112.461 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.92 -38.2 79.41 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.312 0.96 . . . . 0.0 113.518 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.04 -57.31 12.12 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.979 0.911 . . . . 0.0 113.017 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.7 mp -43.99 -39.88 4.36 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.847 1.659 . . . . 0.0 112.517 166.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 53.3 tpt85 -73.02 -21.5 60.81 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -92.46 -37.38 12.57 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.824 1.193 . . . . 0.0 113.103 171.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.4 pt -81.86 -34.61 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.028 0.931 . . . . 0.0 113.185 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -74.55 6.44 3.8 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.456 -0.778 . . . . 0.0 111.481 161.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -124.85 23.14 7.98 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 167.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 . . . . . 0 C--O 1.254 1.305 0 C-N-CA 126.054 1.742 . . . . 0.0 109.963 162.06 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.8 t70 . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -53.75 -10.5 0.3 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.859 2.064 . . . . 0.0 115.104 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -113.14 -28.97 7.46 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.49 1.516 . . . . 0.0 114.551 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.1 t -72.0 -46.98 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.646 1.112 . . . . 0.0 112.433 -169.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.41 -45.02 95.89 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 171.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.28 -44.35 71.83 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 117.843 0.822 . . . . 0.0 112.539 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -74.89 -41.09 60.43 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.822 1.249 . . . . 0.0 114.25 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.63 -47.87 74.12 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.062 1.301 . . . . 0.0 111.012 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.12 -40.53 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.274 0.63 . . . . 0.0 109.567 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.9 t -56.56 -44.7 81.22 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.741 0.817 . . . . 0.0 112.337 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -64.43 -37.94 89.27 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.284 -0.885 . . . . 0.0 112.303 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.03 -49.25 78.39 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 120.57 1.532 . . . . 0.0 112.427 171.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 ptt85 -64.1 -39.59 94.39 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 120.328 1.422 . . . . 0.0 113.298 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -58.78 -44.17 90.64 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.809 2.044 . . . . 0.0 113.453 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.49 -30.77 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.307 1.043 . . . . 0.0 112.318 -175.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.4 -7.48 57.66 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.001 1.32 . . . . 0.0 112.455 174.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 64.31 9.35 4.8 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.488 2.715 . . . . 0.0 115.61 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . 0.262 4.3 pp -94.1 178.64 5.58 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.726 -1.234 . . . . 0.0 112.8 -173.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -95.96 154.32 17.3 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.275 1.03 . . . . 0.0 111.765 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -64.23 -24.18 67.57 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 119.488 -2.007 . . . . 0.0 112.81 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -78.36 0.26 26.26 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.811 1.644 . . . . 0.0 112.648 169.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -109.86 -18.8 13.32 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.149 1.38 . . . . 0.0 111.202 170.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.9 tp -88.23 111.81 22.07 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.629 1.572 . . . . 0.0 106.9 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.425 ' H ' ' HB3' ' A' ' 49' ' ' MET . 12.3 tpp180 -84.65 97.79 9.83 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 118.424 -1.31 . . . . 0.0 107.777 175.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.255 1.1 pp -92.46 148.63 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 126.646 1.978 . . . . 0.0 111.752 172.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.2 m -147.65 150.03 33.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.863 0.865 . . . . 0.0 108.921 -170.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -123.05 -158.68 0.8 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.829 1.252 . . . . 0.0 112.453 -161.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.8 t -41.49 -42.83 2.47 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 126.185 1.794 . . . . 0.0 115.252 -160.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.01 -30.08 65.82 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -171.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.23 -9.66 20.25 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 pt -110.14 -19.9 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.1 t -60.72 10.99 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 127.187 2.195 . . . . 0.0 116.781 -169.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -72.95 -20.12 61.11 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.714 2.006 . . . . 0.0 112.385 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -60.2 177.27 0.3 Allowed Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 127.433 2.293 . . . . 0.0 112.532 163.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -63.44 -86.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.936 2.424 . . . . 0.0 112.67 163.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -129.69 25.57 5.35 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 117.349 2.352 . . . . 0.0 117.349 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 1.623 ' HD1' ' CD2' ' A' ' 43' ' ' TYR . 8.6 p90 -162.68 142.13 9.14 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 118.811 -2.431 . . . . 0.0 110.717 -153.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m 176.54 -174.66 0.11 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.895 2.078 . . . . 0.0 108.895 -175.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 tp -122.5 -75.41 0.6 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 119.174 -0.441 . . . . 0.0 111.306 150.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 15.0 p -163.35 -170.3 2.22 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.479 1.133 . . . . 0.0 113.223 -163.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 87' ' ' SER . 42.0 t0 -146.3 115.08 6.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.057 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.7 144.14 47.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.941 2.897 . . . . 0.0 109.287 -153.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.425 ' HB3' ' H ' ' A' ' 30' ' ' ARG . 29.5 ttp -122.3 128.1 50.66 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.904 1.684 . . . . 0.0 110.854 -165.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.0 162.09 37.78 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 127.001 2.688 . . . . 0.0 115.439 -159.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.26 148.49 25.06 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 111.887 -2.415 . . . . 0.0 111.887 -142.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 t -66.03 156.37 33.93 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.072 0.949 . . . . 0.0 112.483 166.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 69.62 -0.85 2.47 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.109 2.164 . . . . 0.0 115.525 168.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.5 mp -103.98 147.01 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 126.08 1.752 . . . . 0.0 111.011 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.9 p -87.52 136.66 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.023 1.329 . . . . 0.0 111.714 170.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -107.54 110.25 62.78 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.56 1.144 . . . . 0.0 108.663 172.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -60.43 66.65 0.08 OUTLIER 'Trans proline' 0 CA--C 1.542 0.884 1 C-N-CA 126.521 4.814 . . . . 0.0 113.726 164.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 p -68.75 -27.02 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.098 1.359 . . . . 0.0 114.424 -157.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -46.86 -45.19 20.15 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 126.46 1.904 . . . . 0.0 112.716 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -69.72 -30.67 68.34 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.996 -0.44 . . . . 0.0 112.164 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.1 mt -75.74 -45.26 37.52 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.824 0.85 . . . . 0.0 111.737 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 mp -53.58 -49.47 67.67 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.722 0.692 . . . . 0.0 109.813 171.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.8 m -64.97 -39.42 93.46 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 1.625 ' HE2' ' CE1' ' A' ' 64' ' ' TYR . 12.4 t80 -74.7 -33.75 62.48 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.444 -0.785 . . . . 0.0 112.408 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -63.89 -53.03 56.8 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.91 0.777 . . . . 0.0 111.375 171.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -73.67 -33.49 64.49 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -168.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.6 t -79.78 -19.15 49.28 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.904 1.282 . . . . 0.0 114.316 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -86.22 -26.1 25.24 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -166.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.2 m -138.79 -2.81 1.69 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -174.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.22 80.47 0.17 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.042 1.306 . . . . 0.0 111.384 -174.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.0 mtp85 -162.11 141.77 9.8 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 128.09 2.556 . . . . 0.0 105.642 169.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.2 m -65.61 140.98 58.56 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 125.064 1.346 . . . . 0.0 111.396 170.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.49 117.09 31.42 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 80.8 m -75.4 102.06 5.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.069 1.748 . . . . 0.0 108.333 157.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -85.12 96.15 9.36 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 167.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.9 t -99.75 141.3 17.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 C-N-CA 125.876 1.671 . . . . 0.0 108.165 -170.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -127.91 123.5 35.09 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 120.264 -1.523 . . . . 0.0 107.748 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -113.02 117.0 30.81 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.737 1.615 . . . . 0.0 108.842 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.75 115.79 31.12 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.309 1.844 . . . . 0.0 109.451 -172.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.3 p -143.25 165.09 28.41 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.409 2.684 . . . . 0.0 104.699 -160.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -13.66 -125.08 0.0 OUTLIER Glycine 0 N--CA 1.485 1.958 0 C-N-CA 129.58 3.466 . . . . 0.0 114.827 -152.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.7 p -92.89 99.78 12.37 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 113.862 -3.135 . . . . 0.0 110.151 152.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -170.75 162.49 7.71 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 130.605 3.562 . . . . 0.0 109.729 157.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.3 t -105.91 138.45 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 121.24 1.836 . . . . 0.0 112.443 148.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.7 t -104.42 138.91 40.13 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.932 0.893 . . . . 0.0 109.842 163.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tp -107.82 108.46 19.66 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 168.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 12.1 m -82.5 93.54 7.28 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 172.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.7 p -106.38 104.79 14.56 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 119.995 -1.691 . . . . 0.0 108.43 -169.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 1.657 ' HE1' ' CE2' ' A' ' 89' ' ' TYR . 0.8 OUTLIER -142.9 149.92 39.12 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 117.022 2.231 . . . . 0.0 117.022 -177.026 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.7 pt -78.58 72.49 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 113.026 -1.897 . . . . 0.0 107.856 154.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -174.34 178.13 46.28 Favored Glycine 0 N--CA 1.478 1.471 0 N-CA-C 120.088 2.795 . . . . 0.0 120.088 -160.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 1.646 ' HD2' ' CD1' ' A' ' 92' ' ' PHE . 54.7 m-85 -140.77 136.16 16.13 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.996 1.318 . . . . 0.0 114.499 -172.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -93.56 -166.71 0.15 Allowed 'Trans proline' 0 CA--C 1.549 1.241 1 C-N-CA 125.797 4.332 . . . . 0.0 112.492 172.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -79.26 -36.66 39.5 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 164.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -96.87 0.18 48.75 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 119.339 3.088 . . . . 0.0 119.339 -167.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.1 -27.97 36.36 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 122.395 2.361 . . . . 0.0 114.383 -177.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.6 pttm -57.98 -30.41 66.01 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.275 1.03 . . . . 0.0 113.251 170.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -111.49 -29.97 7.56 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 pp -74.31 165.31 25.39 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 121.753 2.07 . . . . 0.0 112.07 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -155.01 107.33 2.72 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 118.415 2.746 . . . . 0.0 118.415 -156.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.461 ' CD ' ' H ' ' A' ' 102' ' ' VAL . 0.1 OUTLIER -103.11 177.53 4.81 Favored 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 126.437 1.895 . . . . 0.0 111.533 169.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.461 ' H ' ' CD ' ' A' ' 101' ' ' ARG . 0.5 OUTLIER -165.82 170.64 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 -142.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 37.1 t -121.08 124.7 45.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.901 1.28 . . . . 0.0 109.918 141.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -172.86 167.91 5.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.4 1.88 . . . . 0.0 108.807 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -107.81 126.83 53.11 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.402 1.481 . . . . 0.0 109.522 150.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -152.12 165.65 34.11 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -165.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 1.649 ' HD1' ' CD2' ' A' ' 107' ' ' PHE . 48.0 p90 -101.0 145.43 28.71 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.023 1.729 . . . . 0.0 111.245 173.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.7 tp -140.89 143.04 34.43 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.133 0.973 . . . . 0.0 110.897 -158.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.9 p -111.43 -171.69 1.89 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.525 1.93 . . . . 0.0 114.639 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 65.9 t -73.32 -8.46 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 127.24 2.216 . . . . 0.0 113.58 172.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 -99.89 -3.41 32.51 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -165.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -96.98 148.95 22.45 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.503 1.501 . . . . 0.0 113.273 -147.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -144.73 143.76 30.86 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.144 -1.597 . . . . 0.0 109.061 -175.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.94 149.75 34.79 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-O 117.512 -1.232 . . . . 0.0 112.434 -168.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.41 141.94 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-N 121.338 1.881 . . . . 0.0 114.809 157.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.82 149.63 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.714 0.806 . . . . 0.0 111.123 169.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 39.8 m -146.29 154.43 41.68 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.844 2.057 . . . . 0.0 108.376 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -56.65 -36.9 70.05 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -163.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.02 -32.86 69.75 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.594 -1.316 . . . . 0.0 113.028 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -78.18 -29.37 48.49 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.373 1.069 . . . . 0.0 112.222 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.8 tp -76.97 -35.02 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 123.093 0.557 . . . . 0.0 111.889 168.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -61.14 -27.53 68.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.466 0.706 . . . . 0.0 112.27 171.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 22.3 ttm105 -77.44 -3.99 43.14 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.293 1.437 . . . . 0.0 114.622 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.8 mt -78.54 -25.22 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 O-C-N 120.955 -1.091 . . . . 0.0 110.616 168.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -91.09 179.5 1.42 Allowed Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.324 1.45 . . . . 0.0 108.855 153.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.6 -43.07 2.12 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 121.39 1.393 . . . . 0.0 111.435 160.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 38.2 t -158.53 148.72 19.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.925 2.49 . . . . 0.0 107.632 170.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -160.19 91.98 0.97 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.688 1.131 . . . . 0.0 111.732 171.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.7 63.34 0.19 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.56 1.944 . . . . 0.0 110.516 174.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 162.44 28.37 0.02 OUTLIER Glycine 0 CA--C 1.539 1.541 0 C-N-CA 125.195 1.378 . . . . 0.0 115.735 -171.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.7 t -61.58 128.0 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 120.132 1.966 . . . . 0.0 111.539 -174.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.18 89.05 2.98 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.459 1.904 . . . . 0.0 107.848 168.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.0 t -98.83 145.29 27.12 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.763 1.225 . . . . 0.0 111.488 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -138.72 132.78 31.33 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.267 1.027 . . . . 0.0 109.007 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 31.3 t -117.33 136.02 53.43 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.201 1.0 . . . . 0.0 111.038 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.4 t -136.71 138.14 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.457 1.903 . . . . 0.0 109.301 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.81 142.72 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.907 0.883 . . . . 0.0 110.943 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 31.5 mmm-85 -111.21 113.57 26.16 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.02 0.928 . . . . 0.0 108.734 163.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.615 ' HE2' ' CG ' ' A' ' 146' ' ' TYR . 0.0 OUTLIER -89.79 118.08 29.12 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 155.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.7 t -147.98 -167.94 2.94 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.027 0.831 . . . . 0.0 111.987 -169.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.408 ' C ' ' H ' ' A' ' 143' ' ' GLY . 6.2 m120 50.07 72.36 0.33 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.429 2.292 . . . . 0.0 112.321 168.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.9 m 54.01 3.45 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 -173.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 141' ' ' ASN . . . 86.03 38.16 8.75 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.791 0.71 . . . . 0.0 112.288 -168.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 61.6 mtt -133.77 -13.23 2.56 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.73 142.33 24.48 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.875 0.845 . . . . 0.0 112.789 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 1.645 ' HD2' ' CD1' ' A' ' 146' ' ' TYR . 7.3 m-85 -140.82 173.63 11.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.666 -155.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -151.95 151.51 31.31 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.9 tt -141.19 136.5 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.405 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -137.53 125.7 23.05 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.386 1.074 . . . . 0.0 109.493 177.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.8 133.13 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.01 -1.056 . . . . 0.0 111.073 170.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.5 m -116.39 147.81 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.894 1.678 . . . . 0.0 110.966 -166.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.18 100.54 4.43 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.358 1.063 . . . . 0.0 111.609 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 1.649 ' HE2' ' CE1' ' A' ' 153' ' ' PHE . 63.0 m-85 -119.85 161.77 20.25 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.718 1.607 . . . . 0.0 109.843 176.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -78.72 -147.35 3.58 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 118.639 0.654 . . . . 0.0 112.034 166.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.29 -11.99 7.11 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.625 2.883 . . . . 0.0 113.624 164.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -22.54 51.1 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.82 2.048 . . . . 0.0 113.012 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -87.36 57.09 4.25 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.946 1.355 . . . . 0.0 111.344 172.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -31.91 65.47 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.326 1.05 . . . . 0.0 111.531 171.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.78 -53.23 57.46 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -76.85 -25.52 53.23 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.186 0.903 . . . . 0.0 112.494 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 1.636 ' HE2' ' CE1' ' A' ' 161' ' ' TYR . 63.9 t80 -62.35 -54.02 46.57 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.986 1.267 . . . . 0.0 111.844 169.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -64.55 -28.67 69.8 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.458 -1.402 . . . . 0.0 112.352 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.19 -36.13 83.06 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.392 0.677 . . . . 0.0 112.484 168.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -70.59 -47.9 57.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.308 -0.853 . . . . 0.0 113.234 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.6 mp -48.41 -39.56 22.98 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 120.021 1.282 . . . . 0.0 112.858 166.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -71.33 -29.56 65.15 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -77.85 -32.58 52.16 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.637 1.575 . . . . 0.0 112.419 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.7 mt -86.4 -47.65 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.713 1.605 . . . . 0.0 112.149 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 1.635 ' HD2' ' CD1' ' A' ' 169' ' ' TYR . 30.0 m-85 -68.04 1.74 2.54 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.066 0.848 . . . . 0.0 112.015 166.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -124.23 24.35 8.11 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 164.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . 0.277 9.6 mmm180 . . . . . 0 N--CA 1.48 1.025 0 C-N-CA 128.722 2.809 . . . . 0.0 116.344 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.3 t70 . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 121.678 0.751 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -63.51 -23.74 67.52 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -160.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -94.41 -28.91 15.25 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.378 0.99 . . . . 0.0 112.773 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.23 -54.49 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 118.778 0.717 . . . . 0.0 112.23 -171.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.08 -43.08 99.64 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 119.186 0.903 . . . . 0.0 112.16 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.12 74.85 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 117.749 0.775 . . . . 0.0 111.77 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -75.58 -31.76 60.09 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.92 -48.5 53.23 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.244 1.383 . . . . 0.0 111.654 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.18 -36.34 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 119.026 -0.511 . . . . 0.0 109.718 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 m -69.92 -43.53 71.5 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.549 1.068 . . . . 0.0 112.329 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -65.51 -39.08 91.43 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.222 -0.924 . . . . 0.0 111.29 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.73 -34.64 69.72 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.038 1.29 . . . . 0.0 112.297 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -52.88 -43.92 66.48 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 120.589 -1.319 . . . . 0.0 111.611 169.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -76.85 -43.34 36.58 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.597 1.159 . . . . 0.0 113.25 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.75 -31.99 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.035 1.334 . . . . 0.0 112.266 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.1 mt -89.85 -12.12 39.97 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.676 1.191 . . . . 0.0 113.065 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 60.21 25.7 15.1 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.783 2.033 . . . . 0.0 113.808 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 pp -117.91 155.55 29.99 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.87 1.268 . . . . 0.0 111.422 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -80.69 161.04 24.8 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -168.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -69.19 -19.28 63.98 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 119.771 -1.831 . . . . 0.0 115.381 -166.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -94.91 -5.76 44.13 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.609 1.563 . . . . 0.0 113.612 168.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -110.99 2.51 18.06 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.099 2.16 . . . . 0.0 110.801 -176.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 13.6 tp -90.54 124.11 34.74 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 128.692 2.797 . . . . 0.0 105.385 154.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.8 ttt-85 -85.39 119.82 26.18 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 117.951 -1.5 . . . . 0.0 107.766 166.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 47' ' ' ASP 0.276 0.8 OUTLIER -112.26 141.77 26.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.193 0.997 . . . . 0.0 112.393 170.269 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.6 m -157.74 141.24 15.51 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.07 1.348 . . . . 0.0 108.138 -159.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -163.3 60.76 0.18 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.521 1.153 . . . . 0.0 112.702 -172.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.9 t -93.55 -56.62 2.85 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.908 -1.12 . . . . 0.0 113.274 150.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.82 -54.3 4.99 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.308 1.051 . . . . 0.0 113.108 -146.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.43 ' H ' HD21 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -63.9 -9.82 17.41 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.326 1.85 . . . . 0.0 113.188 171.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mm -90.2 6.31 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.105 1.362 . . . . 0.0 110.731 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.4 p -69.01 -17.66 63.95 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -173.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -53.78 49.29 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.917 1.235 . . . . 0.0 110.111 169.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -168.85 155.89 6.9 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 125.675 1.59 . . . . 0.0 109.038 169.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.51 -27.3 18.58 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 122.933 2.422 . . . . 0.0 114.961 166.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -110.15 18.77 19.63 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.147 2.979 . . . . 0.0 113.143 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -153.13 92.06 1.58 Allowed 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t 165.85 -169.19 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 130.073 3.349 . . . . 0.0 107.743 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.264 1.2 tm? -132.08 -79.77 0.51 Allowed 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 151.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 5.7 t -175.9 -178.33 1.03 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.917 1.687 . . . . 0.0 109.96 -168.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 6.1 t70 -143.3 126.65 16.68 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 120.676 -1.265 . . . . 0.0 109.882 -170.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.22 154.46 17.38 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.548 1.939 . . . . 0.0 110.538 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -124.58 129.39 50.5 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.413 1.006 . . . . 0.0 108.786 168.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.59 162.39 38.5 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 126.709 2.506 . . . . 0.0 114.826 -156.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 p -102.5 156.53 17.55 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.736 2.014 . . . . 0.0 114.734 -147.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 t -71.79 149.19 45.55 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.572 1.149 . . . . 0.0 113.565 173.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 t70 68.72 16.67 8.95 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 163.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.61 146.88 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.743 1.617 . . . . 0.0 109.542 168.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.6 p -97.48 139.47 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.559 1.544 . . . . 0.0 111.272 166.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -122.21 128.74 25.38 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.9 1.28 . . . . 0.0 110.472 -169.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.94 70.13 5.32 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 124.598 3.532 . . . . 0.0 110.782 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 p -65.48 -26.47 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.25 1.42 . . . . 0.0 113.956 -161.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -48.22 -45.99 34.71 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.531 1.533 . . . . 0.0 112.62 171.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -62.35 -39.68 93.89 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.591 0.632 . . . . 0.0 111.186 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.5 tp -69.63 -53.51 18.38 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.021 0.528 . . . . 0.0 110.814 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.18 -53.31 58.7 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.441 0.696 . . . . 0.0 111.479 177.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 72.7 m -76.72 -40.46 48.56 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -168.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -69.95 -33.48 72.17 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.596 1.089 . . . . 0.0 112.246 173.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -63.67 -48.22 78.08 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.106 0.866 . . . . 0.0 112.331 172.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -55.71 -41.9 74.47 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.434 0.694 . . . . 0.0 111.343 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.8 t -69.22 -17.92 63.84 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -63.28 -35.84 81.69 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.277 1.031 . . . . 0.0 113.414 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.9 m -115.99 -28.06 6.76 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.139 0.976 . . . . 0.0 112.223 167.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.88 77.35 0.95 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.956 2.217 . . . . 0.0 109.813 -169.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -160.63 117.98 2.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.517 2.327 . . . . 0.0 108.779 -174.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.4 m -61.78 130.15 44.38 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.517 0.727 . . . . 0.0 111.204 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.74 160.43 25.94 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.833 1.653 . . . . 0.0 114.502 -163.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 89.9 m -103.34 116.01 31.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.322 1.449 . . . . 0.0 112.49 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -91.14 114.51 27.05 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.639 1.575 . . . . 0.0 107.632 167.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 50.9 t -129.85 123.92 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 O-C-N 121.514 -0.742 . . . . 0.0 111.055 -162.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 1.661 ' HD1' ' CD2' ' A' ' 77' ' ' PHE . 35.3 m-85 -96.39 129.78 43.67 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 119.963 -1.71 . . . . 0.0 109.609 174.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.66 98.12 8.72 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 162.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -106.95 111.61 24.18 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 125.093 1.357 . . . . 0.0 114.438 -164.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.3 p -144.76 165.61 27.58 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 129.661 3.184 . . . . 0.0 105.206 -149.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.08 -123.2 0.0 OUTLIER Glycine 0 N--CA 1.49 2.289 0 C-N-CA 130.524 3.916 . . . . 0.0 115.6 -163.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.6 p -91.66 104.95 17.37 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 113.182 -3.407 . . . . 0.0 110.443 152.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -169.1 153.29 5.45 Favored 'General case' 0 N--CA 1.474 0.75 1 C-N-CA 134.638 5.175 . . . . 0.0 106.236 159.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.6 t -106.29 136.29 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 119.748 -1.845 . . . . 0.0 109.716 129.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.9 m -106.56 140.79 38.89 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 160.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.0 tp -110.82 107.67 17.24 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.5 1.52 . . . . 0.0 107.234 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.6 m -78.03 128.81 34.43 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.252 1.021 . . . . 0.0 108.904 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 77.3 m -120.49 116.51 25.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 1.638 ' HE1' ' CE2' ' A' ' 89' ' ' TYR . 15.2 p90 -140.33 141.09 35.73 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 173.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.48 99.97 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 149.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 175.32 178.3 45.06 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 118.108 2.003 . . . . 0.0 118.108 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 1.603 ' HD1' ' CD2' ' A' ' 92' ' ' PHE . 35.8 p90 -125.86 56.35 15.19 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.973 1.309 . . . . 0.0 112.802 164.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -59.8 142.28 98.35 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.736 2.291 . . . . 0.0 111.197 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -55.09 -17.11 3.58 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 -158.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -21.18 63.19 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.77 -1.206 . . . . 0.0 113.301 171.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.532 ' CD2' ' HH ' ' A' ' 89' ' ' TYR . 1.5 mm? -52.55 -33.2 44.54 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.297 1.839 . . . . 0.0 113.565 168.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -79.57 4.63 15.3 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.815 1.246 . . . . 0.0 112.648 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -130.09 -35.82 1.58 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.002 1.321 . . . . 0.0 114.142 177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.04 165.86 18.21 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 117.991 2.589 . . . . 0.0 117.991 -168.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -104.21 -172.62 2.14 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 126.784 2.033 . . . . 0.0 115.248 -161.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.65 158.95 16.83 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 126.823 2.049 . . . . 0.0 110.749 170.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.3 p -123.83 125.56 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 159.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 41.5 t -142.27 119.4 11.41 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 142.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -171.2 140.03 1.43 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.259 0.552 . . . . 0.0 110.335 -164.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -114.67 95.74 5.39 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.695 1.198 . . . . 0.0 108.997 141.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -160.96 177.51 10.29 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.983 -1.073 . . . . 0.0 113.636 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 1.632 ' HE1' ' CE2' ' A' ' 107' ' ' PHE . 0.8 OUTLIER -70.19 157.32 37.85 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 121.331 -0.856 . . . . 0.0 111.828 161.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.7 tp -145.13 143.79 30.56 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.865 1.666 . . . . 0.0 108.994 -170.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.9 m -104.04 -174.03 2.45 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.217 1.007 . . . . 0.0 112.881 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.356 89.1 t -66.65 1.92 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 128.371 2.668 . . . . 0.0 115.08 -173.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -50.5 -4.75 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 118.244 2.683 . . . . 0.0 118.244 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.373 4.7 pt-20 54.57 3.54 0.05 Allowed 'General case' 0 N--CA 1.466 0.364 1 N-CA-C 124.319 4.933 . . . . 0.0 124.319 153.705 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -163.13 123.83 2.35 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 123.139 2.7 . . . . 0.0 108.448 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.4 pp -155.88 150.01 25.53 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.595 1.558 . . . . 0.0 111.459 -174.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.6 t -115.3 144.86 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 127.349 2.26 . . . . 0.0 113.062 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.6 138.81 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 123.844 0.857 . . . . 0.0 110.853 146.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.4 p -114.82 167.27 10.93 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.338 1.055 . . . . 0.0 112.403 172.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -35.38 74.65 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 120.721 -1.237 . . . . 0.0 111.667 174.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.91 -36.04 82.63 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.334 0.653 . . . . 0.0 112.518 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -64.36 -47.57 78.81 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 118.693 -0.67 . . . . 0.0 111.256 172.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.93 -50.01 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 119.026 0.83 . . . . 0.0 110.846 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -57.51 -36.11 71.13 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.069 0.947 . . . . 0.0 113.067 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -78.88 -31.6 45.52 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.982 -1.074 . . . . 0.0 112.738 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.4 mt -71.04 -37.62 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.727 1.611 . . . . 0.0 111.238 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -158.75 -54.54 0.02 OUTLIER Pre-proline 0 N--CA 1.48 1.061 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 164.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -120.2 109.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.66 0 CA-C-N 121.349 1.517 . . . . 0.0 112.818 -159.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 82.8 m -73.66 128.18 34.79 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 145.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -179.99 135.33 0.11 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.272 1.829 . . . . 0.0 111.07 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -74.47 56.84 0.69 Allowed 'General case' 0 N--CA 1.482 1.134 0 O-C-N 120.586 -1.321 . . . . 0.0 110.71 159.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.11 19.1 0.04 OUTLIER Glycine 0 CA--C 1.544 1.886 0 C-N-CA 127.253 2.359 . . . . 0.0 114.571 -169.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.0 t -63.97 136.91 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.903 1.281 . . . . 0.0 111.551 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.3 85.04 2.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 122.68 1.228 . . . . 0.0 109.191 160.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.8 m -78.07 144.85 36.22 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 166.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -146.03 132.5 19.72 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -165.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 42.0 t -136.55 140.79 43.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.533 0.606 . . . . 0.0 112.48 -167.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.1 t -136.09 138.99 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 127.199 2.2 . . . . 0.0 108.369 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.2 m -130.84 140.9 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.992 -0.442 . . . . 0.0 109.845 166.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -114.6 143.42 45.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 122.281 1.039 . . . . 0.0 110.686 157.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.96 137.52 49.84 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.732 2.013 . . . . 0.0 107.699 163.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 53.0 m -140.45 131.23 25.82 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 123.711 0.632 . . . . 0.0 110.489 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 17.4 m120 45.82 65.09 1.23 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.847 2.059 . . . . 0.0 114.437 168.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 37.1 m 59.5 12.63 2.85 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 101.71 7.04 48.87 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.494 1.045 . . . . 0.0 114.945 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 23.3 mmt -64.88 -13.88 57.87 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.728 1.264 . . . . 0.0 113.258 171.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.3 t -139.68 141.01 37.0 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.8 1.24 . . . . 0.0 110.242 158.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 1.63 ' HD1' ' CD2' ' A' ' 146' ' ' TYR . 0.6 OUTLIER -115.59 152.24 33.45 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 157.143 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -134.53 146.42 49.68 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.161 -0.962 . . . . 0.0 109.689 170.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.3 tt -143.39 143.76 24.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.547 0.689 . . . . 0.0 112.327 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -134.57 130.94 37.29 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 161.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.22 131.07 35.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 122.907 1.337 . . . . 0.0 109.688 150.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.7 m -137.27 142.99 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 111.365 -2.652 . . . . 0.0 108.35 -162.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -123.47 132.96 54.08 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 1.635 ' HD1' ' CD2' ' A' ' 153' ' ' PHE . 98.5 m-85 -142.91 162.23 36.03 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.431 1.892 . . . . 0.0 110.21 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -70.14 -144.82 0.24 Allowed Glycine 0 CA--C 1.543 1.828 0 O-C-N 120.632 -1.293 . . . . 0.0 110.928 149.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.64 17.36 0.46 Allowed 'Trans proline' 0 CA--C 1.553 1.45 0 C-N-CA 123.126 2.551 . . . . 0.0 114.17 174.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -85.63 -17.37 36.33 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -164.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -77.67 54.48 1.22 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 123.28 1.514 . . . . 0.0 109.802 163.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.88 -21.28 65.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.995 1.718 . . . . 0.0 114.144 -161.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.24 -43.62 66.9 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.925 0.784 . . . . 0.0 111.985 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -73.0 -31.65 64.63 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.579 0.752 . . . . 0.0 111.424 175.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 1.649 ' HE2' ' CE1' ' A' ' 161' ' ' TYR . 24.3 t80 -64.05 -49.99 70.17 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.309 -0.869 . . . . 0.0 110.609 171.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -54.95 -36.54 65.42 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.004 -1.06 . . . . 0.0 113.668 172.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.89 85.62 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.432 0.56 . . . . 0.0 112.185 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -71.81 -48.2 48.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.29 1.036 . . . . 0.0 113.192 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 98.1 mt -54.74 -35.95 64.28 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.621 1.101 . . . . 0.0 112.539 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -70.89 -40.93 71.92 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 125.723 1.609 . . . . 0.0 112.902 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -77.34 -35.56 54.57 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.8 pt -75.07 -38.32 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.142 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -65.6 -10.41 35.34 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 120.259 1.39 . . . . 0.0 112.885 164.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -110.64 28.14 8.97 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.257 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.8 t0 . . . . . 0 CA--C 1.551 1.008 0 CA-C-O 121.232 0.539 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -63.84 -30.55 71.63 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 -139.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.85 -15.56 15.64 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.38 0.991 . . . . 0.0 113.663 172.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.3 t -69.96 -62.26 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.841 1.256 . . . . 0.0 111.662 -173.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.0 -53.46 14.45 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.63 1.109 . . . . 0.0 112.248 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.36 -45.94 72.87 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 118.958 1.379 . . . . 0.0 113.504 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.89 -39.02 76.51 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.085 -1.009 . . . . 0.0 112.805 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -70.39 -42.89 71.12 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.236 0.925 . . . . 0.0 112.219 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.36 -42.71 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.285 1.034 . . . . 0.0 109.851 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.7 p -68.51 -40.36 80.86 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.74 0.7 . . . . 0.0 112.227 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -69.08 -36.89 78.11 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.223 -0.923 . . . . 0.0 112.466 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 87.7 m -66.92 -48.09 69.73 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.193 -0.942 . . . . 0.0 110.715 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.2 ptt-85 -59.32 -41.58 89.4 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.284 0.947 . . . . 0.0 111.26 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -62.24 -56.74 15.64 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.19 1.396 . . . . 0.0 112.286 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.82 -30.18 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 119.369 0.986 . . . . 0.0 112.202 -172.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.75 -8.33 59.18 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.22 0.918 . . . . 0.0 113.249 169.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 52.76 46.36 26.89 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.387 1.875 . . . . 0.0 111.921 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 pp -129.37 159.44 36.2 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.851 1.261 . . . . 0.0 111.051 172.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -73.5 160.54 31.56 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -60.52 -27.89 67.98 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.166 -1.583 . . . . 0.0 111.983 168.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -84.4 6.12 24.5 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 119.775 1.171 . . . . 0.0 113.056 171.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -116.1 -12.95 11.2 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.605 -1.309 . . . . 0.0 110.996 174.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 26.9 tp -89.68 113.16 24.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.494 1.918 . . . . 0.0 109.348 171.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -94.67 130.72 41.05 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 119.584 -0.846 . . . . 0.0 112.849 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' ASP . 37.4 mm -95.87 138.01 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 127.442 2.297 . . . . 0.0 113.308 -176.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 m -147.29 148.44 31.42 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.818 1.19 . . . . 0.0 109.476 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.7 p30 -150.76 56.43 0.91 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 122.886 1.327 . . . . 0.0 114.394 171.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.0 p -91.45 -56.15 3.24 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.112 1.365 . . . . 0.0 114.352 157.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.92 -52.2 5.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 122.744 1.259 . . . . 0.0 114.193 -152.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.511 ' H ' HD21 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -64.88 -27.54 68.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.112 1.765 . . . . 0.0 112.448 173.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.5 mp -71.43 -16.18 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.565 1.946 . . . . 0.0 112.6 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 54.7 m -61.04 -0.14 0.29 Allowed 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 118.069 2.618 . . . . 0.0 118.069 -166.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -90.07 -30.9 17.41 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 121.42 1.918 . . . . 0.0 113.298 169.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -134.41 84.3 41.13 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 165.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -69.98 21.95 0.18 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.535 3.49 . . . . 0.0 114.721 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -113.75 4.27 15.9 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.44 1.896 . . . . 0.0 111.587 169.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -130.14 164.27 24.8 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 120.302 1.41 . . . . 0.0 108.284 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 p -150.16 150.67 31.96 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.242 -0.911 . . . . 0.0 111.49 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.12 -82.77 0.64 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 117.036 -1.459 . . . . 0.0 110.692 147.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 30.5 p -170.88 163.5 7.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 121.681 2.037 . . . . 0.0 114.507 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 16.2 t70 -115.47 152.82 32.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 153.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.23 135.79 55.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 129.129 2.972 . . . . 0.0 108.743 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 55.7 mtm -112.04 134.05 53.83 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.9 1.227 . . . . 0.0 108.145 168.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.269 0.6 OUTLIER -147.79 131.93 17.34 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 118.493 2.775 . . . . 0.0 118.493 -155.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.25 160.22 18.53 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 110.539 -3.028 . . . . 0.0 114.395 -174.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.6 p -96.02 179.75 4.97 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.627 1.971 . . . . 0.0 115.464 -158.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . 0.268 28.9 t70 63.16 46.0 4.84 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.482 2.313 . . . . 0.0 115.349 177.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.36 164.28 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 127.065 2.146 . . . . 0.0 109.22 163.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 m -101.11 141.07 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.228 1.011 . . . . 0.0 108.548 161.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.65 110.52 44.49 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 119.829 1.195 . . . . 0.0 108.219 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -67.67 74.71 0.61 Allowed 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 125.159 3.906 . . . . 0.0 111.072 173.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.6 -24.65 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.644 1.978 . . . . 0.0 114.294 -152.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.11 -26.72 50.97 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.652 0.66 . . . . 0.0 112.26 172.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 1.655 ' HD1' ' CD2' ' A' ' 60' ' ' TYR . 7.3 t80 -57.26 -38.49 73.94 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.641 174.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.7 -43.09 63.49 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.434 1.015 . . . . 0.0 111.257 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -56.09 -48.72 75.58 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.166 0.986 . . . . 0.0 110.325 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.0 m -71.92 -42.89 66.17 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.391 1.476 . . . . 0.0 113.166 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -67.38 -33.96 76.29 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.909 1.231 . . . . 0.0 111.784 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -66.54 -46.99 74.29 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.524 0.602 . . . . 0.0 112.491 165.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -60.6 -30.06 69.59 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.786 -1.196 . . . . 0.0 112.717 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 79.2 m -76.66 -6.31 51.57 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.755 1.622 . . . . 0.0 114.234 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -82.38 -35.17 27.99 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 120.089 1.313 . . . . 0.0 112.971 -175.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.6 p -154.87 -23.98 0.12 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.534 1.134 . . . . 0.0 113.121 167.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.86 82.04 1.35 Allowed Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.761 2.124 . . . . 0.0 112.028 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.9 tpt85 -153.26 118.77 5.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 128.828 2.851 . . . . 0.0 104.957 169.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.6 m -62.03 150.99 36.54 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.705 0.802 . . . . 0.0 111.89 -175.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -141.04 149.91 42.3 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.146 1.378 . . . . 0.0 113.229 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 29.5 p -83.02 138.19 33.84 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.736 1.214 . . . . 0.0 111.484 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 1.664 ' HE2' ' CE1' ' A' ' 75' ' ' PHE . 53.0 m-85 -110.59 115.7 30.07 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 172.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.1 t -130.04 111.26 21.01 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.549 0 C-N-CA 123.76 0.824 . . . . 0.0 109.56 -154.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 1.667 ' HE1' ' CE2' ' A' ' 77' ' ' PHE . 2.3 m-85 -96.07 115.67 27.78 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 120.338 -1.476 . . . . 0.0 107.499 -170.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -108.49 107.87 18.57 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.89 1.276 . . . . 0.0 108.772 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -84.06 137.41 33.6 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.276 -0.89 . . . . 0.0 111.184 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.1 p -144.28 167.87 21.41 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 129.591 3.156 . . . . 0.0 104.626 -167.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -16.42 -123.32 0.0 OUTLIER Glycine 0 N--CA 1.489 2.169 1 C-N-CA 130.831 4.063 . . . . 0.0 116.636 -176.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 55.8 m -97.99 101.96 13.58 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 113.029 -3.468 . . . . 0.0 111.254 152.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.68 164.29 12.16 Favored 'General case' 0 CA--C 1.542 0.671 1 C-N-CA 133.465 4.706 . . . . 0.0 106.419 136.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.6 156.96 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 O-C-N 119.468 -2.02 . . . . 0.0 108.714 147.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -127.74 146.67 50.5 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.621 0.768 . . . . 0.0 110.242 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.0 tp -117.17 109.37 16.82 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.068 0.947 . . . . 0.0 108.657 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.2 m -76.69 132.02 39.13 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.103 1.361 . . . . 0.0 110.139 167.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.1 m -128.69 115.34 17.86 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.624 -1.298 . . . . 0.0 110.011 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 1.66 ' HD2' ' CD1' ' A' ' 89' ' ' TYR . 23.9 t80 -137.15 134.77 36.72 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.29 85.28 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 161.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 174.63 -176.61 46.89 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 117.694 1.837 . . . . 0.0 117.694 -174.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -111.15 79.97 2.23 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.734 1.214 . . . . 0.0 112.407 168.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -53.4 153.62 17.08 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 124.528 3.485 . . . . 0.0 116.479 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -72.56 -32.46 66.06 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -172.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -76.33 -10.02 59.08 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.943 1.247 . . . . 0.0 113.634 172.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.51 -2.71 9.38 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.524 1.93 . . . . 0.0 114.815 167.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 9.8 mmpt? -50.55 -41.02 53.59 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.489 -0.757 . . . . 0.0 110.753 151.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -118.98 -34.5 3.88 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -167.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.7 pp -83.87 160.6 21.11 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 120.69 1.586 . . . . 0.0 113.187 -163.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.3 pttt -164.08 129.08 2.83 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 -165.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.471 ' HG2' ' H ' ' A' ' 102' ' ' VAL 0.339 11.5 ttt180 -108.89 -173.59 2.31 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 125.472 1.509 . . . . 0.0 113.172 167.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.471 ' H ' ' HG2' ' A' ' 101' ' ' ARG . 7.4 p 179.9 166.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 128.105 2.562 . . . . 0.0 109.353 -133.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 57.3 m -118.12 122.3 42.75 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.155 0.889 . . . . 0.0 109.286 151.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -170.97 163.32 7.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.652 2.381 . . . . 0.0 106.756 -171.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 1.626 ' HE1' ' CE2' ' A' ' 105' ' ' PHE . 13.0 p90 -139.27 115.36 10.3 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 126.077 1.751 . . . . 0.0 112.903 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -159.88 -172.92 3.84 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.339 1.456 . . . . 0.0 111.904 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -66.94 160.78 25.58 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.124 0.97 . . . . 0.0 112.58 160.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.6 tp -135.22 145.96 48.18 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 129.142 2.977 . . . . 0.0 108.777 -172.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.7 t -109.27 155.51 21.04 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.932 2.093 . . . . 0.0 110.543 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.01 -15.81 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -157.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -130.35 46.72 2.61 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.34 1.056 . . . . 0.0 110.643 -170.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -104.69 150.66 24.53 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.505 1.522 . . . . 0.0 112.589 -167.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -144.13 136.09 26.28 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.166 -1.584 . . . . 0.0 110.042 -172.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.32 139.25 15.32 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 120.632 -1.292 . . . . 0.0 113.63 -170.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.6 t -108.87 132.77 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 125.745 1.618 . . . . 0.0 111.012 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . 0.254 0.8 OUTLIER -129.79 123.53 57.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 122.64 1.209 . . . . 0.0 110.065 157.086 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.9 t -124.73 158.53 33.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.596 2.358 . . . . 0.0 107.846 173.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -36.12 64.41 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.968 0.803 . . . . 0.0 112.006 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.11 -31.95 68.41 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -76.2 -28.96 57.44 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.611 -1.306 . . . . 0.0 112.258 174.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 41.3 mm -67.81 -40.65 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 121.556 -0.715 . . . . 0.0 110.562 164.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.23 -11.9 52.89 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.26 1.024 . . . . 0.0 113.191 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -79.29 -45.39 19.8 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 119.77 -1.831 . . . . 0.0 112.214 164.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.9 pt -92.04 -12.94 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -170.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -122.87 161.32 44.95 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 125.287 1.435 . . . . 0.0 112.422 174.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -68.32 -31.4 28.5 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.906 1.737 . . . . 0.0 115.694 -168.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.417 ' SG ' ' HE2' ' A' ' 129' ' ' LYS . 5.6 t -153.29 162.39 41.34 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -172.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -99.99 -137.32 0.31 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.148 2.579 . . . . 0.0 111.482 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.417 ' HE2' ' SG ' ' A' ' 127' ' ' CYS . 63.4 pttt 44.84 22.03 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 119.278 3.066 . . . . 0.0 119.278 165.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.46 21.66 0.04 OUTLIER Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.124 1.345 . . . . 0.0 115.946 168.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.1 t -65.89 132.9 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 118.698 1.249 . . . . 0.0 111.946 -169.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 20.7 mt -124.18 108.84 12.72 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 122.4 1.095 . . . . 0.0 109.138 151.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.2 t -101.69 147.25 26.67 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.855 1.662 . . . . 0.0 109.725 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -124.7 133.74 53.09 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.661 1.184 . . . . 0.0 108.394 -174.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 72.3 m -109.67 143.09 39.92 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.625 0.77 . . . . 0.0 111.057 171.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.71 129.33 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.727 1.611 . . . . 0.0 108.863 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.1 m -136.85 147.81 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -132.0 145.9 51.74 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.08 1.752 . . . . 0.0 112.699 172.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.667 ' HE2' ' CD1' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -129.12 93.14 3.52 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.565 2.346 . . . . 0.0 114.211 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 18.1 t -83.79 123.1 29.54 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.679 -0.638 . . . . 0.0 112.211 170.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -96.38 -41.13 8.77 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.591 1.557 . . . . 0.0 110.963 167.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 98.0 p -64.63 -18.38 64.88 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -131.73 23.33 4.22 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 125.824 1.678 . . . . 0.0 114.919 168.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.9 mmt 31.1 59.83 0.25 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 128.352 2.661 . . . . 0.0 116.326 172.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.9 t -164.62 146.55 8.36 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.174 0.99 . . . . 0.0 110.55 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 1.669 ' HD1' ' CD2' ' A' ' 146' ' ' TYR . 4.5 m-85 -129.21 158.11 39.95 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -158.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -144.07 144.98 31.87 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 120.946 -1.096 . . . . 0.0 108.847 -171.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.0 tt -144.94 142.67 22.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.843 -168.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -141.02 136.21 31.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.361 1.465 . . . . 0.0 107.46 174.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.52 136.52 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 122.051 0.929 . . . . 0.0 110.946 155.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.3 m -129.23 149.64 33.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 126.218 1.807 . . . . 0.0 109.734 -172.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.93 127.63 23.35 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -133.47 157.62 45.17 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.457 1.903 . . . . 0.0 110.867 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -90.61 -159.35 35.53 Favored Glycine 0 CA--C 1.541 1.702 0 C-N-CA 124.404 1.002 . . . . 0.0 113.519 174.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.25 -7.75 21.73 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.339 2.693 . . . . 0.0 115.522 -172.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -75.58 -2.91 31.38 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 171.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -76.73 57.27 1.25 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.347 1.859 . . . . 0.0 111.683 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.18 -23.14 61.97 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.334 1.454 . . . . 0.0 113.696 -174.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.57 -51.24 37.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.141 0.882 . . . . 0.0 111.591 178.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -71.21 -34.97 71.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.881 0.872 . . . . 0.0 112.729 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -58.9 -53.71 55.33 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.854 0.752 . . . . 0.0 110.689 171.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -57.02 -39.02 73.95 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.884 0.765 . . . . 0.0 112.07 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.82 -42.99 98.78 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.295 0.952 . . . . 0.0 112.926 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.21 -46.98 72.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.569 -0.707 . . . . 0.0 112.586 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 86.9 mt -57.31 -34.64 68.94 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.837 0.455 . . . . 0.0 111.497 175.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -75.63 -17.59 59.95 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.586 1.955 . . . . 0.0 113.549 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -101.9 -31.17 10.83 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.0 pt -86.54 -36.63 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 120.415 1.461 . . . . 0.0 113.547 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -76.32 12.62 1.15 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.381 1.446 . . . . 0.0 111.508 161.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.85 25.61 4.31 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 170.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 125.224 1.409 . . . . 0.0 112.495 168.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 120.984 0.421 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -55.76 -20.95 16.68 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -162.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -97.17 -31.17 12.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.278 1.031 . . . . 0.0 112.603 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.9 -59.49 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.93 0.892 . . . . 0.0 112.079 -168.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.37 -42.38 97.42 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.534 -0.592 . . . . 0.0 111.845 171.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.61 -51.15 69.75 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.542 1.171 . . . . 0.0 112.757 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -64.45 -43.03 95.57 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.317 1.047 . . . . 0.0 112.445 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.44 -47.36 61.09 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.896 0.878 . . . . 0.0 111.893 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.16 -41.55 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.547 0.739 . . . . 0.0 109.646 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.5 m -59.29 -38.37 80.02 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.769 0.713 . . . . 0.0 112.387 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -76.0 -32.32 59.37 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.645 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -71.99 -43.66 64.74 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 120.454 1.479 . . . . 0.0 111.646 170.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -49.72 -43.64 47.78 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.456 1.502 . . . . 0.0 111.791 172.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -73.46 -59.57 2.65 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.245 1.418 . . . . 0.0 113.651 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.02 -31.81 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 120.699 1.59 . . . . 0.0 112.718 -168.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.0 mp -84.0 -13.43 53.31 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.152 -0.967 . . . . 0.0 112.543 173.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 54.44 60.1 3.76 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.82 1.648 . . . . 0.0 112.514 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 pp -130.89 148.66 52.69 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.89 0.876 . . . . 0.0 109.385 167.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -69.99 159.51 33.65 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.991 0.424 . . . . 0.0 110.585 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -65.42 -27.38 68.49 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.376 -1.452 . . . . 0.0 111.757 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -68.57 -9.01 46.8 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.97 1.308 . . . . 0.0 113.848 166.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -125.49 3.05 7.66 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.471 1.508 . . . . 0.0 111.639 -176.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 24.2 tp -93.34 128.68 39.47 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 156.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 131.91 50.17 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.906 0.775 . . . . 0.0 111.134 167.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.8 mm -93.71 143.44 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 127.236 2.215 . . . . 0.0 110.723 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.5 m -149.77 154.1 37.92 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 121.394 -0.816 . . . . 0.0 110.674 168.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.2 p30 -155.75 58.81 0.61 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.678 1.228 . . . . 0.0 112.999 -176.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 30.1 p -86.93 -60.2 2.05 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.626 -1.296 . . . . 0.0 111.341 169.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.16 -38.09 15.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 113.919 -1.491 . . . . 0.0 112.474 -158.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 pp -99.63 -1.94 36.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.054 2.142 . . . . 0.0 113.718 -171.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.5 5.53 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 126.53 1.932 . . . . 0.0 110.354 166.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.3 t -59.49 -29.71 68.03 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.354 1.462 . . . . 0.0 114.117 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -81.22 26.75 0.43 Allowed 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.059 -1.651 . . . . 0.0 112.913 169.354 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 m120 71.69 165.13 0.14 Allowed Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 128.646 2.779 . . . . 0.0 112.758 -168.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.12 -3.69 3.22 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.749 2.966 . . . . 0.0 114.896 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -97.82 5.71 48.75 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.409 2.284 . . . . 0.0 112.454 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 1.615 ' HE1' ' CE2' ' A' ' 43' ' ' TYR . 53.4 m-85 -157.36 94.54 1.39 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 171.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.4 p -175.24 168.76 3.34 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.501 -159.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -131.61 -81.51 0.52 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 116.78 -1.968 . . . . 0.0 115.345 132.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.38 -176.98 2.31 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.343 1.057 . . . . 0.0 111.408 -174.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -116.72 146.18 42.96 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 168.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.54 130.24 42.05 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.628 2.371 . . . . 0.0 107.682 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 18.4 mtt -123.6 134.16 53.85 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.018 -1.051 . . . . 0.0 110.61 -170.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.5 mt -130.77 142.26 50.4 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 126.154 2.159 . . . . 0.0 112.748 -147.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.6 p -110.7 161.58 15.61 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.058 2.543 . . . . 0.0 111.584 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.4 p -126.77 108.6 11.19 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -163.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -158.92 2.26 0.09 Allowed 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 125.584 1.554 . . . . 0.0 114.84 165.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.65 173.08 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 126.578 1.951 . . . . 0.0 113.196 -162.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 m -96.78 142.54 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.894 1.678 . . . . 0.0 112.178 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -109.2 106.41 58.65 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -73.51 71.53 3.85 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.668 3.579 . . . . 0.0 110.397 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.48 -28.58 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 114.088 -1.414 . . . . 0.0 114.653 -149.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -56.99 -35.01 68.7 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -67.13 -32.94 74.4 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.384 0.538 . . . . 0.0 111.722 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.0 mt -75.01 -45.0 44.82 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.748 0.704 . . . . 0.0 111.458 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 mp -55.27 -44.21 75.4 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.8 0.727 . . . . 0.0 111.261 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -63.62 -45.37 90.62 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.606 0.762 . . . . 0.0 112.501 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -63.69 -32.44 73.93 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.63 0.772 . . . . 0.0 112.593 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -69.1 -45.25 70.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.575 1.15 . . . . 0.0 111.823 171.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.09 -37.79 77.95 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 119.583 1.083 . . . . 0.0 112.095 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.1 t -62.97 -1.48 0.93 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.438 1.895 . . . . 0.0 115.706 -168.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -70.88 -18.22 62.69 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 120.287 -1.508 . . . . 0.0 113.58 172.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.7 p -164.21 -16.4 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.628 1.571 . . . . 0.0 113.813 166.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.5 83.55 1.12 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 126.941 2.21 . . . . 0.0 109.62 -165.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -161.76 114.87 1.84 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.469 2.308 . . . . 0.0 106.555 -168.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.4 m -71.93 126.28 29.34 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -167.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.11 143.52 36.75 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.858 1.663 . . . . 0.0 111.667 172.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 60.3 m -98.4 127.77 44.49 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.143 0.977 . . . . 0.0 109.389 176.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -93.89 104.2 16.27 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.909 1.684 . . . . 0.0 109.311 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.4 t -99.06 117.92 44.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 C-N-CA 124.787 1.235 . . . . 0.0 109.225 -171.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -94.37 109.03 20.91 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HE3' ' HB1' ' A' ' 113' ' ' ALA . 14.2 mmmm -111.14 101.83 10.32 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.727 2.011 . . . . 0.0 108.743 172.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -98.28 135.84 39.32 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.797 -1.19 . . . . 0.0 111.366 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.31 165.05 36.97 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 130.173 3.389 . . . . 0.0 104.407 -161.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -9.68 -123.01 0.0 OUTLIER Glycine 0 N--CA 1.486 1.996 0 C-N-CA 128.7 3.047 . . . . 0.0 115.286 -153.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 9.1 p -95.48 106.61 18.69 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 113.405 -3.318 . . . . 0.0 111.57 150.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.96 139.95 2.42 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 131.529 3.932 . . . . 0.0 107.276 131.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.1 t -63.38 133.41 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 117.104 -1.838 . . . . 0.0 108.482 152.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.68 140.44 39.54 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.7 0.682 . . . . 0.0 109.432 163.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.8 tp -110.64 106.15 15.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 163.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.9 m -86.93 118.64 26.45 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.88 1.672 . . . . 0.0 109.019 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 82.2 m -102.92 110.32 22.19 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.296 -1.502 . . . . 0.0 109.169 -172.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 1.632 ' HE1' ' CE2' ' A' ' 89' ' ' TYR . 8.1 m-30 -99.92 109.8 22.15 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.658 -175.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mp -82.33 98.08 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 129.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.47 178.89 47.44 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 118.621 2.208 . . . . 0.0 118.621 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 1.614 ' HD2' ' CD1' ' A' ' 92' ' ' PHE . 1.9 t80 -126.21 45.79 1.62 Allowed Pre-proline 0 CA--C 1.56 1.331 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 160.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -52.18 155.36 9.23 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.826 3.017 . . . . 0.0 117.689 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -49.86 -33.42 16.93 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.841 2.456 . . . . 0.0 116.249 -162.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -92.99 -17.32 24.06 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.14 -35.61 59.91 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.622 2.769 . . . . 0.0 113.653 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -57.24 -43.03 82.57 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 118.486 -0.768 . . . . 0.0 111.845 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -98.26 -34.34 10.74 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.982 1.264 . . . . 0.0 114.105 -174.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.92 157.8 35.92 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 121.113 1.778 . . . . 0.0 112.166 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -164.12 134.38 4.17 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 -163.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.546 ' HD3' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -120.2 -178.03 3.57 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.638 1.575 . . . . 0.0 114.332 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.546 ' H ' ' HD3' ' A' ' 101' ' ' ARG . 8.9 p -163.37 174.67 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 127.733 2.413 . . . . 0.0 112.278 -140.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 75.0 m -129.72 135.51 48.56 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.081 -1.012 . . . . 0.0 111.333 144.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.3 t0 178.57 166.76 0.85 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 127.865 2.466 . . . . 0.0 107.249 -168.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -128.76 121.39 28.3 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.166 1.386 . . . . 0.0 113.959 162.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -160.38 -176.68 5.75 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 126.027 1.731 . . . . 0.0 110.923 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -80.67 165.67 21.78 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.442 -1.411 . . . . 0.0 111.481 164.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.7 tp -144.67 141.2 29.16 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.555 1.142 . . . . 0.0 111.149 -170.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.3 m -77.98 151.67 33.5 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.09 1.756 . . . . 0.0 115.293 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.65 -8.62 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 127.094 2.158 . . . . 0.0 116.131 -161.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -137.6 38.65 2.43 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.769 1.228 . . . . 0.0 112.787 -170.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -106.05 165.95 10.85 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.257 1.423 . . . . 0.0 113.753 -164.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.416 ' HB1' ' HE3' ' A' ' 78' ' ' LYS . . . -146.95 133.73 20.06 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 125.537 1.535 . . . . 0.0 110.157 -170.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.8 144.28 20.2 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.823 1.249 . . . . 0.0 111.38 -174.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.77 141.76 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 121.472 1.942 . . . . 0.0 113.965 174.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.99 149.87 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.648 1.179 . . . . 0.0 110.784 175.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 t -146.6 172.59 13.34 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.013 0.925 . . . . 0.0 112.091 168.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.37 -34.17 66.4 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.71 -41.92 67.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.712 0.687 . . . . 0.0 112.385 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -75.4 -26.51 58.46 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.884 0.874 . . . . 0.0 112.734 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.2 tp -75.51 -38.96 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.212 1.005 . . . . 0.0 111.452 170.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -55.11 -39.96 69.96 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.23 1.012 . . . . 0.0 111.315 168.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -66.97 -20.22 65.85 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.344 1.058 . . . . 0.0 112.794 -173.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 66.9 mt -69.74 -41.43 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 118.67 0.668 . . . . 0.0 110.463 -177.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -167.39 -47.73 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.765 0 CA-C-O 116.559 -1.686 . . . . 0.0 112.301 175.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -82.58 -132.84 0.01 OUTLIER 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 122.606 2.204 . . . . 0.0 112.949 -170.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 20.9 t -166.7 133.94 2.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.2 1.8 . . . . 0.0 111.209 -164.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . 0.253 25.4 p30 -70.69 3.76 2.94 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 -161.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -104.67 10.4 34.8 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.61 1.964 . . . . 0.0 113.208 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.07 29.17 0.16 Allowed Glycine 0 CA--C 1.534 1.271 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.6 t -83.58 135.61 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 119.139 1.469 . . . . 0.0 112.349 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.49 105.67 11.9 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.992 0.917 . . . . 0.0 108.691 153.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.34 144.62 31.39 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.699 0.8 . . . . 0.0 110.086 166.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -137.05 136.93 38.83 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.692 0.797 . . . . 0.0 109.411 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 43.2 t -128.11 133.81 49.05 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.846 0.859 . . . . 0.0 111.42 -169.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.5 t -132.55 111.35 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.119 0.968 . . . . 0.0 109.483 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.7 m -105.22 151.61 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.573 1.549 . . . . 0.0 110.595 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -124.7 135.63 53.2 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.152 1.381 . . . . 0.0 111.256 157.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.462 ' HE3' ' CE2' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -77.32 144.52 38.0 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.278 1.031 . . . . 0.0 112.166 135.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.0 m -147.31 76.57 1.41 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.735 2.014 . . . . 0.0 109.061 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -65.66 -48.48 71.99 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.539 -1.351 . . . . 0.0 113.617 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.1 m -57.75 -39.66 77.89 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.072 -1.017 . . . . 0.0 111.715 174.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.05 -0.16 68.95 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 126.304 1.907 . . . . 0.0 115.938 173.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 75.9 mtm 43.37 53.14 5.68 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.078 2.551 . . . . 0.0 115.241 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 99.5 p -148.66 163.39 37.42 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 1.605 ' HD1' ' CD2' ' A' ' 146' ' ' TYR . 41.8 m-85 -100.2 151.84 20.97 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.684 147.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -134.95 141.85 46.36 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.04 137.31 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.81 0.814 . . . . 0.0 110.647 -161.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -135.79 139.26 43.38 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.498 1.519 . . . . 0.0 108.587 169.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.2 p -140.9 134.39 32.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 122.363 1.077 . . . . 0.0 109.196 149.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 30.2 m -116.65 143.18 27.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 127.95 2.5 . . . . 0.0 109.033 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.82 129.95 39.19 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -165.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 1.612 ' HD2' ' CD1' ' A' ' 153' ' ' PHE . 64.4 m-85 -134.43 156.05 49.24 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.576 1.551 . . . . 0.0 110.799 177.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.577 ' H ' ' CD ' ' A' ' 155' ' ' PRO . . . -171.78 33.33 0.14 Allowed Glycine 0 CA--C 1.546 1.97 0 CA-C-O 116.364 -2.354 . . . . 0.0 117.28 161.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.577 ' CD ' ' H ' ' A' ' 154' ' ' GLY . 59.5 Cg_endo -105.62 -49.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.037 0 CA-C-N 121.812 2.806 . . . . 0.0 113.353 160.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -117.74 -26.96 6.38 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 53.79 1.28 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 118.289 2.7 . . . . 0.0 118.289 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.97 -45.31 94.23 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -155.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.91 -53.07 29.25 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -169.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -69.04 -31.56 70.43 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.889 0.876 . . . . 0.0 112.241 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -60.63 -55.31 34.79 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.048 0.84 . . . . 0.0 110.84 172.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -64.5 -34.16 77.56 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.385 -0.822 . . . . 0.0 112.721 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.21 -33.19 74.96 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.99 1.268 . . . . 0.0 112.654 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -50.97 51.29 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.425 1.49 . . . . 0.0 108.868 173.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 76.7 mt -60.59 -38.09 83.51 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.231 1.012 . . . . 0.0 111.439 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -70.0 -32.16 70.2 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 127.059 2.143 . . . . 0.0 112.939 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -86.72 -37.96 17.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.31 1.044 . . . . 0.0 113.359 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.6 pt -77.55 -34.2 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 119.33 0.968 . . . . 0.0 111.629 -178.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -63.45 -19.83 65.05 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.826 -0.546 . . . . 0.0 111.256 166.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -117.01 26.49 9.76 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 . . . . . 0 C--O 1.252 1.186 0 C-N-CA 128.42 2.688 . . . . 0.0 114.886 168.874 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 121.16 0.505 . . . . 0.0 111.443 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -64.21 -6.27 6.44 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 118.379 2.733 . . . . 0.0 118.379 -139.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.6 -4.24 15.54 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 120.37 1.441 . . . . 0.0 114.033 172.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 78.6 t -69.51 -56.17 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.825 1.25 . . . . 0.0 111.649 -172.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.34 -43.18 98.88 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.6 -54.31 43.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 117.925 0.862 . . . . 0.0 112.147 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -67.11 -37.85 84.59 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.088 -1.007 . . . . 0.0 113.602 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -69.18 -45.91 68.8 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.848 1.204 . . . . 0.0 111.845 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.85 -43.09 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.299 0.64 . . . . 0.0 109.745 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -68.88 -37.15 78.84 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.588 0.631 . . . . 0.0 112.609 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -76.02 -30.63 58.55 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.061 -1.024 . . . . 0.0 111.695 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.4 m -62.98 -46.52 87.32 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.799 1.636 . . . . 0.0 110.397 169.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.5 ttt-85 -52.84 -34.73 55.48 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.086 1.754 . . . . 0.0 112.396 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -83.03 -49.1 9.9 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.741 -1.224 . . . . 0.0 113.258 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.03 -28.86 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.41 1.084 . . . . 0.0 111.878 -174.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -91.71 -8.71 46.18 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.809 1.243 . . . . 0.0 112.633 171.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.5 mtp-105 58.09 17.98 4.89 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.925 2.09 . . . . 0.0 115.07 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 pp -94.31 159.04 15.3 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.331 1.452 . . . . 0.0 111.734 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -81.89 163.16 22.45 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 119.641 1.109 . . . . 0.0 112.467 176.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -64.8 -34.74 79.06 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 119.512 -1.993 . . . . 0.0 111.393 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -60.42 -16.85 39.96 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.429 2.291 . . . . 0.0 113.382 166.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -105.6 -9.83 17.17 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.958 1.254 . . . . 0.0 111.708 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 26.5 tp -91.47 135.57 33.74 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.265 1.826 . . . . 0.0 108.868 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -106.39 128.36 53.98 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 118.363 0.529 . . . . 0.0 112.395 170.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.4 mm -97.26 142.0 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.919 2.087 . . . . 0.0 112.829 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.2 m -124.92 146.34 49.4 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.371 0.987 . . . . 0.0 108.836 167.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -123.56 -153.42 0.55 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.336 2.254 . . . . 0.0 110.642 -163.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 t -36.8 -36.04 0.1 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 128.306 2.643 . . . . 0.0 116.241 -167.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.1 -43.56 70.5 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 174.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.72 -22.83 25.78 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 121.164 1.802 . . . . 0.0 112.419 175.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.8 mm -58.29 -39.7 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.144 0.977 . . . . 0.0 109.45 173.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 57.0 m -55.65 6.73 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -117.59 13.92 14.4 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 121.518 1.963 . . . . 0.0 112.034 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.9 170.2 5.68 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 126.511 1.924 . . . . 0.0 109.145 146.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -66.92 -51.14 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 121.721 1.614 . . . . 0.0 114.693 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -124.82 -34.32 2.83 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 117.562 2.43 . . . . 0.0 117.562 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 1.583 ' HE1' ' CE2' ' A' ' 43' ' ' TYR . 3.0 t80 -161.12 100.24 1.22 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 122.893 1.33 . . . . 0.0 109.458 -137.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.9 m -140.44 165.62 26.92 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.261 2.224 . . . . 0.0 107.507 173.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.29 1.1 tm? -87.47 -77.2 0.35 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 117.288 -1.339 . . . . 0.0 113.058 -164.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 12.7 m -163.94 -175.56 4.12 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.954 1.706 . . . . 0.0 111.86 -172.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -119.82 156.98 29.62 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.301 1.44 . . . . 0.0 107.398 157.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -137.39 131.62 32.32 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.738 2.815 . . . . 0.0 108.07 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.5 ttp -121.93 134.47 54.85 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.232 1.378 . . . . 0.0 110.661 -169.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 mt -131.7 146.44 52.17 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 128.473 2.709 . . . . 0.0 113.385 -148.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.6 t -98.62 159.12 15.17 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.066 1.346 . . . . 0.0 113.581 -171.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -71.38 170.84 12.34 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.229 1.811 . . . . 0.0 112.66 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.7 t70 57.89 36.23 26.09 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 170.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.58 134.66 60.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.993 1.717 . . . . 0.0 110.079 -176.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.9 p -91.24 139.17 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.966 0.907 . . . . 0.0 109.456 159.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -134.28 136.93 26.88 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 118.862 0.756 . . . . 0.0 111.701 169.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.45 69.75 5.79 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.905 3.737 . . . . 0.0 111.105 177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.4 p -62.29 -43.53 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -152.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.97 -9.31 58.18 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.037 -1.039 . . . . 0.0 113.093 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -65.54 -33.37 75.77 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.775 1.171 . . . . 0.0 111.598 165.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.9 tp -70.18 -37.45 75.15 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.656 0.662 . . . . 0.0 111.32 173.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.92 -49.87 76.01 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.375 0.534 . . . . 0.0 111.911 173.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.3 p -67.45 -31.97 72.5 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 119.175 -0.44 . . . . 0.0 112.119 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 1.614 ' HD1' ' CD2' ' A' ' 64' ' ' TYR . 39.5 t80 -63.6 -39.15 93.63 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.947 0.794 . . . . 0.0 112.512 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -66.26 -51.71 54.85 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.492 1.042 . . . . 0.0 112.299 169.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.26 -41.07 83.45 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.662 0.385 . . . . 0.0 111.514 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 83.1 m -77.43 -2.57 35.96 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.95 -34.66 13.68 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.379 1.472 . . . . 0.0 114.046 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.2 m -137.29 -8.73 1.73 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.32 74.49 0.43 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 126.006 1.765 . . . . 0.0 112.523 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -166.9 136.44 2.94 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.304 1.442 . . . . 0.0 109.775 161.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.4 m -64.47 142.81 58.29 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.031 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.74 151.08 47.82 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 m -75.29 103.94 5.65 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.326 1.851 . . . . 0.0 109.768 167.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 1.595 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 9.4 m-85 -87.74 99.83 12.38 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 166.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.07 147.4 6.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 C-N-CA 126.585 1.954 . . . . 0.0 108.254 -171.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 1.61 ' HD2' ' CD1' ' A' ' 77' ' ' PHE . 82.7 m-85 -130.72 121.42 25.43 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 120.513 -1.367 . . . . 0.0 107.583 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -121.7 121.01 36.35 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.303 1.841 . . . . 0.0 109.412 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -95.84 125.41 40.38 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.895 1.678 . . . . 0.0 108.892 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.4 p -143.71 155.31 44.16 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -174.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.94 80.61 0.1 OUTLIER Glycine 0 N--CA 1.476 1.339 0 C-N-CA 130.39 3.852 . . . . 0.0 112.175 -172.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.3 t 168.95 -128.15 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 -136.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -129.28 178.7 6.25 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 130.379 3.472 . . . . 0.0 109.336 -176.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.8 t -75.96 136.66 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.574 -1.329 . . . . 0.0 109.203 164.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.3 m -114.78 152.62 31.78 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.858 0.754 . . . . 0.0 112.28 170.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 tp -108.81 108.68 19.58 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.084 2.154 . . . . 0.0 105.705 164.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.2 m -80.93 102.63 10.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 167.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 44.1 t -102.49 111.28 23.51 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 119.778 -1.826 . . . . 0.0 108.556 -173.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 1.626 ' HD2' ' CD1' ' A' ' 89' ' ' TYR . 0.8 OUTLIER -150.93 151.0 31.52 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 118.628 2.825 . . . . 0.0 118.628 174.695 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.493 ' H ' HD11 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -70.94 84.17 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 112.632 -2.077 . . . . 0.0 108.503 143.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.22 166.21 38.61 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 118.7 2.24 . . . . 0.0 118.7 -163.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -156.27 49.35 0.4 Allowed Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -170.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -47.4 121.25 5.22 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.241 1.961 . . . . 0.0 113.112 166.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -44.17 -13.69 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 118.615 2.82 . . . . 0.0 118.615 -169.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -59.89 -23.59 63.59 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.283 1.401 . . . . 0.0 113.856 163.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -50.93 -28.58 10.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.831 2.052 . . . . 0.0 112.72 166.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -62.28 -34.8 77.26 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.661 175.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -115.75 -22.39 9.16 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -174.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 pp -75.67 165.59 24.83 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 121.346 1.885 . . . . 0.0 114.1 -176.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -152.16 118.08 5.47 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -163.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.446 ' CD ' ' H ' ' A' ' 102' ' ' VAL . 0.1 OUTLIER -107.43 178.15 4.62 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 120.495 1.498 . . . . 0.0 111.926 161.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.446 ' H ' ' CD ' ' A' ' 101' ' ' ARG . 3.0 p -172.35 173.62 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.587 -140.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 64.8 m -120.86 124.82 45.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.33 0.652 . . . . 0.0 109.501 137.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -172.31 171.41 4.79 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.71 2.404 . . . . 0.0 107.514 -166.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 1.639 ' HD1' ' CD2' ' A' ' 105' ' ' PHE . 13.9 m-85 -122.72 99.85 6.61 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.006 2.522 . . . . 0.0 110.061 172.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -140.51 148.4 41.02 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 -173.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -82.19 142.04 32.52 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.914 1.286 . . . . 0.0 110.578 165.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 37.9 tp -148.23 141.59 25.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.076 0.95 . . . . 0.0 110.087 -150.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 p -93.09 168.9 10.81 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 116.941 2.201 . . . . 0.0 116.941 -169.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.6 t -69.76 -6.92 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 128.145 2.578 . . . . 0.0 113.083 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -134.74 45.84 2.51 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.469 1.108 . . . . 0.0 110.25 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -125.59 152.26 45.35 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 116.064 1.875 . . . . 0.0 116.064 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -149.3 142.46 25.0 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.632 -146.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.38 147.95 34.06 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.183 1.393 . . . . 0.0 111.521 -168.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -136.31 141.64 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 121.404 1.911 . . . . 0.0 113.166 158.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.59 153.28 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.88 0.872 . . . . 0.0 110.538 167.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.0 t -143.01 167.34 22.29 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.696 0.798 . . . . 0.0 109.979 162.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.93 -36.09 76.3 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -160.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.7 73.03 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.791 -1.193 . . . . 0.0 113.791 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -70.7 -30.83 67.51 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.394 -0.816 . . . . 0.0 111.627 175.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.0 mm -73.37 -35.51 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.012 0.925 . . . . 0.0 111.076 169.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -59.9 -25.48 65.14 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.448 -0.783 . . . . 0.0 111.931 170.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -83.2 -7.64 59.59 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 168.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.9 mt -89.21 -40.05 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.803 1.183 . . . . 0.0 109.987 167.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -143.31 124.36 8.16 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.603 1.161 . . . . 0.0 110.413 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -82.5 60.1 7.16 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 123.943 3.095 . . . . 0.0 114.355 -163.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 45.6 t -155.84 134.59 11.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.56 1.544 . . . . 0.0 110.201 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -122.85 -4.01 8.63 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -85.2 12.85 7.16 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.85 50.83 0.06 OUTLIER Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.71 1.148 . . . . 0.0 113.516 -176.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.83 125.12 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 117.947 0.873 . . . . 0.0 110.701 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.83 88.04 2.52 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.518 1.527 . . . . 0.0 108.229 169.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.6 p -83.83 146.39 28.14 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.908 0.883 . . . . 0.0 109.316 164.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.46 125.77 52.15 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 18.8 t -118.43 127.8 54.0 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.39 0.996 . . . . 0.0 109.131 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.4 t -138.43 116.91 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.411 1.084 . . . . 0.0 109.149 -167.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.1 m -112.3 140.59 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.268 -0.895 . . . . 0.0 111.421 -175.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 29.0 ttm105 -129.57 98.23 4.77 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 122.162 0.982 . . . . 0.0 110.343 171.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.251 9.0 tmtt? -120.13 134.98 55.11 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.767 1.227 . . . . 0.0 109.047 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.1 m -161.45 133.33 5.67 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.026 1.33 . . . . 0.0 110.585 -164.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -85.68 -35.55 20.81 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.766 -0.584 . . . . 0.0 112.496 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.1 p -48.45 -50.12 32.65 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.201 1.401 . . . . 0.0 113.398 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -96.29 11.25 67.28 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.258 1.885 . . . . 0.0 115.074 171.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 41.1 ttm 44.61 57.35 4.53 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.114 2.166 . . . . 0.0 115.397 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 97.9 p -147.82 142.86 27.02 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -106.65 144.54 33.17 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 163.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -150.87 147.26 27.01 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.445 -1.409 . . . . 0.0 109.492 -173.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.8 tt -141.62 140.31 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 122.213 1.006 . . . . 0.0 113.4 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -135.31 115.44 13.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.033 1.333 . . . . 0.0 109.941 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . 0.28 7.3 p -139.27 145.14 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 121.129 -0.982 . . . . 0.0 112.981 174.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.3 m -141.31 151.55 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 128.109 2.564 . . . . 0.0 109.643 -167.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.59 125.73 43.65 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -168.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 1.665 ' HD1' ' CD2' ' A' ' 153' ' ' PHE . 87.3 m-85 -142.18 156.88 45.36 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.686 1.194 . . . . 0.0 111.926 175.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -91.51 -148.92 22.87 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 124.519 1.057 . . . . 0.0 112.177 165.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.94 -22.72 10.69 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 124.53 3.487 . . . . 0.0 117.041 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.13 1.46 2.79 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 126.423 1.889 . . . . 0.0 115.595 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -90.86 38.84 0.97 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.192 1.797 . . . . 0.0 112.163 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -62.36 -28.85 70.05 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -167.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.32 -51.49 51.83 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.918 0.781 . . . . 0.0 112.099 -176.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -65.18 -34.21 77.84 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.934 0.894 . . . . 0.0 112.468 170.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -62.02 -49.31 76.53 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.427 1.012 . . . . 0.0 111.457 175.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -65.83 -29.67 70.17 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.81 -1.182 . . . . 0.0 112.701 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.42 83.91 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 119.189 0.904 . . . . 0.0 112.671 171.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.92 -54.29 19.84 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.523 1.129 . . . . 0.0 112.763 174.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.7 mp -46.79 -34.92 5.68 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.752 1.221 . . . . 0.0 113.983 167.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -74.67 -25.78 59.41 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.46 1.504 . . . . 0.0 113.357 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -89.71 -36.63 15.09 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.537 1.062 . . . . 0.0 113.664 170.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.2 pt -88.42 -42.37 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.063 -1.023 . . . . 0.0 112.724 -169.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -71.33 -6.15 37.78 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.622 1.555 . . . . 0.0 111.355 171.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -119.62 23.18 11.3 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 172.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 . . . . . 0 C--O 1.252 1.207 0 C-N-CA 126.472 1.909 . . . . 0.0 112.503 169.967 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -19.03 64.53 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -163.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -85.21 -24.0 28.05 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.798 0.839 . . . . 0.0 112.283 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.4 t -73.38 -53.68 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.682 1.193 . . . . 0.0 112.565 -165.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.12 -52.04 53.78 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 168.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.8 -39.93 59.53 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 118.443 1.121 . . . . 0.0 113.323 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -74.74 -39.24 61.96 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.867 -1.146 . . . . 0.0 113.972 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.12 -40.74 98.5 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.614 1.166 . . . . 0.0 111.7 173.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.52 -43.05 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.053 1.341 . . . . 0.0 109.721 174.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.4 m -66.64 -31.21 71.75 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.296 -0.878 . . . . 0.0 112.918 175.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -67.37 -44.19 79.57 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.318 -0.864 . . . . 0.0 109.345 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.3 m -60.55 -43.61 97.04 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.168 -1.582 . . . . 0.0 111.753 175.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -54.24 -32.09 55.11 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.27 1.828 . . . . 0.0 112.8 171.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.22 -46.79 10.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.053 1.341 . . . . 0.0 113.449 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.6 mm -66.63 -49.21 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 119.691 1.132 . . . . 0.0 110.889 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.66 -2.88 57.11 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.036 1.334 . . . . 0.0 112.528 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 59.33 11.52 2.21 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 127.629 2.372 . . . . 0.0 115.43 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.7 pp -94.45 154.97 17.17 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.112 0.965 . . . . 0.0 111.172 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.81 155.93 38.21 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.441 -0.787 . . . . 0.0 112.917 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.79 -24.13 63.87 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.83 -1.169 . . . . 0.0 112.546 171.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -97.04 8.74 43.85 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.489 1.516 . . . . 0.0 113.316 172.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -118.73 8.52 11.88 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.963 1.705 . . . . 0.0 111.478 167.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 21.3 tp -107.74 127.7 53.92 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.859 2.463 . . . . 0.0 107.521 166.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -94.34 115.39 27.61 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 120.076 1.307 . . . . 0.0 111.305 171.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.8 mm -91.02 143.06 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.292 1.437 . . . . 0.0 112.58 170.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.4 m -126.71 147.75 49.93 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 162.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.57 -148.29 0.26 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.309 1.444 . . . . 0.0 112.265 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.9 t -58.51 -29.17 66.08 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -162.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.77 -33.36 34.9 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -169.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.62 -4.84 27.66 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.45 14.42 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 124.806 1.242 . . . . 0.0 111.974 167.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.4 t -57.89 12.06 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 128.64 2.776 . . . . 0.0 117.985 -163.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -57.4 -40.37 78.12 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 119.798 -1.814 . . . . 0.0 113.033 -172.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -127.02 139.19 34.4 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 132.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -58.54 -31.06 93.61 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 CA-C-N 121.663 1.63 . . . . 0.0 112.571 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -96.46 30.97 2.37 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.237 1.815 . . . . 0.0 110.403 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -147.86 101.12 3.28 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.472 1.487 . . . . 0.0 107.299 159.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 p 179.91 151.24 0.4 Allowed 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.985 -1.072 . . . . 0.0 111.986 -139.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.36 -81.17 0.52 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 164.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.1 p -166.51 -174.48 2.85 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -174.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -122.82 154.98 37.51 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.403 1.881 . . . . 0.0 107.891 163.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.95 122.81 10.64 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.797 1.635 . . . . 0.0 109.094 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.3 ttm -117.94 129.28 55.52 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.748 -1.22 . . . . 0.0 111.564 -160.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.27 0.3 OUTLIER -138.4 156.6 47.44 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 124.677 2.18 . . . . 0.0 115.979 -159.019 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 t -99.24 167.96 10.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 130.446 3.498 . . . . 0.0 108.515 -172.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -50.95 114.0 1.06 Allowed 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.574 1.079 . . . . 0.0 109.334 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -151.69 156.8 41.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.754 1.264 . . . . 0.0 109.865 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.443 HG23 ' H ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -119.51 -176.8 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 113.243 -1.799 . . . . 0.0 109.044 -146.414 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.443 ' H ' HG23 ' A' ' 54' ' ' ILE . 9.5 p -70.16 121.65 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 121.485 -0.759 . . . . 0.0 111.598 -132.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 1.664 ' HD1' ' CD2' ' A' ' 56' ' ' TYR . 29.3 p90 -130.34 151.5 78.63 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -166.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -80.22 80.98 2.88 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 124.425 3.417 . . . . 0.0 111.031 -166.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 p -69.42 -39.17 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -164.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.2 -33.36 75.21 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 119.688 1.131 . . . . 0.0 113.26 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -57.7 -37.86 74.22 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 119.105 -0.474 . . . . 0.0 110.621 167.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.51 -44.88 61.6 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.917 1.287 . . . . 0.0 112.083 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mp -52.5 -46.73 66.77 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 122.147 0.975 . . . . 0.0 110.621 169.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.1 m -72.23 -39.81 68.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.616 0.766 . . . . 0.0 112.168 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 1.66 ' HD1' ' CD2' ' A' ' 64' ' ' TYR . 39.6 t80 -63.94 -41.78 97.51 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.736 0.698 . . . . 0.0 110.837 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.15 -55.65 29.86 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.272 1.029 . . . . 0.0 110.993 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.38 -29.36 68.05 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -176.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.1 t -76.35 -32.09 58.46 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -61.25 -25.68 67.24 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 -161.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.7 t -141.66 4.97 1.76 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.661 1.184 . . . . 0.0 113.289 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.52 78.4 0.2 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.895 1.712 . . . . 0.0 111.34 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -166.64 134.18 2.62 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.007 1.723 . . . . 0.0 107.555 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.3 m -76.64 149.73 36.47 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 128.19 2.596 . . . . 0.0 112.973 -173.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -152.05 165.43 34.74 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.628 1.171 . . . . 0.0 113.839 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 27.4 p -108.81 142.37 39.48 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.432 0.693 . . . . 0.0 111.551 156.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -82.6 132.58 35.19 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.442 1.097 . . . . 0.0 108.887 165.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.47 151.34 35.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 124.734 1.214 . . . . 0.0 109.348 -172.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 1.667 ' HE2' ' CE1' ' A' ' 77' ' ' PHE . 86.9 m-85 -131.05 122.59 27.03 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 176.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -124.62 108.77 12.4 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.906 2.083 . . . . 0.0 108.538 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -90.74 123.37 34.27 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.381 -0.824 . . . . 0.0 109.447 173.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.8 p -148.07 150.52 34.05 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 130.132 3.373 . . . . 0.0 104.147 -166.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -11.5 -133.53 0.0 OUTLIER Glycine 0 N--CA 1.481 1.648 0 O-C-N 117.802 -3.061 . . . . 0.0 114.841 -121.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 13.2 p -90.69 88.22 7.01 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 120.145 1.972 . . . . 0.0 108.434 169.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.0 ttt85 -169.61 144.02 2.85 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 128.605 2.762 . . . . 0.0 109.044 166.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.1 t -83.32 140.02 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 119.995 1.271 . . . . 0.0 109.675 171.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.45 143.8 40.23 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 121.007 -1.058 . . . . 0.0 111.328 157.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tp -107.95 107.0 17.52 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 171.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.412 ' HB3' ' CE1' ' A' ' 89' ' ' TYR . 7.5 m -98.1 130.26 44.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.383 -172.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 76.1 m -117.57 108.38 15.4 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.11 -1.619 . . . . 0.0 109.007 -170.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 1.614 ' HE2' ' CE1' ' A' ' 89' ' ' TYR . 14.4 m-30 -121.92 98.43 5.94 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.414 0.626 . . . . 0.0 110.619 -157.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.3 mt -59.88 -38.36 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.46 -177.54 16.37 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.802 1.668 . . . . 0.0 110.634 166.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 1.64 ' HE2' ' CE1' ' A' ' 92' ' ' PHE . 26.4 p90 -107.46 96.05 15.29 Favored Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -163.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.38 -177.76 3.23 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 124.126 3.217 . . . . 0.0 115.973 -173.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -50.37 -39.58 46.97 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 117.284 2.328 . . . . 0.0 117.284 -160.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.265 17.1 mmt180 -98.85 -3.67 34.86 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 175.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.55 -33.86 47.58 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.556 2.343 . . . . 0.0 114.052 175.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -50.82 -35.9 34.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.398 1.079 . . . . 0.0 111.45 169.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.01 -27.8 8.27 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -169.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.9 pp -87.37 144.54 26.72 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 121.042 1.746 . . . . 0.0 112.231 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -157.07 126.43 6.04 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -153.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -115.57 -172.3 2.13 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 128.369 2.668 . . . . 0.0 112.529 173.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -166.22 168.55 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 129.094 2.957 . . . . 0.0 108.842 -135.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -123.45 122.48 38.34 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.142 0.883 . . . . 0.0 110.695 138.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -176.88 175.53 1.6 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 129.029 2.931 . . . . 0.0 106.144 -165.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -105.93 117.91 35.23 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 128.28 2.632 . . . . 0.0 109.04 171.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -151.18 160.05 44.07 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 1.641 ' HE2' ' CE1' ' A' ' 107' ' ' PHE . 91.4 m-85 -92.55 162.7 14.09 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.892 1.677 . . . . 0.0 112.613 170.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.8 mt -141.06 152.05 44.51 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 129.441 3.096 . . . . 0.0 111.026 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 m -128.12 167.3 16.97 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.822 2.449 . . . . 0.0 110.224 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.283 0.9 OUTLIER -69.92 -4.88 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -173.536 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -122.25 32.9 5.63 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.556 1.143 . . . . 0.0 113.012 167.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -104.01 132.66 50.05 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.095 -1.003 . . . . 0.0 110.303 -173.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -140.25 138.08 34.77 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.122 0.969 . . . . 0.0 112.846 -166.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.22 141.15 29.71 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.974 1.31 . . . . 0.0 112.712 -165.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.0 t -118.42 137.9 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 126.603 1.961 . . . . 0.0 111.919 168.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.1 t -125.66 121.36 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.744 0.783 . . . . 0.0 109.711 157.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 73.3 p -90.02 163.95 14.71 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.075 0.95 . . . . 0.0 110.575 165.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.47 -35.23 73.68 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.332 -0.855 . . . . 0.0 111.08 174.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.38 -34.88 78.2 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -63.12 -33.52 75.63 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.953 1.251 . . . . 0.0 112.175 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.8 mm -77.18 -36.07 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.087 0.955 . . . . 0.0 111.433 172.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -54.88 -38.65 67.8 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.802 0.841 . . . . 0.0 111.294 174.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.3 mmt-85 -74.16 -12.77 60.68 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.422 ' C ' ' HE2' ' A' ' 125' ' ' LYS . 20.3 mt -73.25 -26.54 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 119.973 1.26 . . . . 0.0 110.192 175.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.422 ' HE2' ' C ' ' A' ' 124' ' ' ILE . 0.5 OUTLIER -105.12 161.5 22.56 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 125.127 1.371 . . . . 0.0 111.634 175.211 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -74.35 -39.69 1.45 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.623 2.215 . . . . 0.0 113.131 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 42.2 t -152.41 134.34 14.84 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.58 1.952 . . . . 0.0 108.439 174.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -73.8 -53.29 10.6 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 -154.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? 51.74 10.31 0.1 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 128.66 2.784 . . . . 0.0 116.823 166.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 132.75 67.45 0.08 OUTLIER Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.337 1.446 . . . . 0.0 112.536 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 76.8 t -72.85 130.48 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.216 0.607 . . . . 0.0 111.289 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 50.4 tp -119.37 157.59 27.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 123.147 1.451 . . . . 0.0 109.169 145.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 49.8 m -149.48 146.56 27.47 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 119.392 -2.068 . . . . 0.0 106.426 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -123.99 127.93 48.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -166.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 38.2 t -126.65 138.37 53.41 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.213 0.605 . . . . 0.0 109.945 -171.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.8 t -142.84 139.53 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.31 1.444 . . . . 0.0 108.966 -174.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.5 m -129.5 139.04 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.849 0.833 . . . . 0.0 112.152 174.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 43.2 mtm105 -126.0 150.58 47.97 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 127.985 2.514 . . . . 0.0 108.685 172.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.27 1.9 tmtt? -153.24 151.72 30.38 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.434 1.094 . . . . 0.0 109.07 172.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.6 t -134.22 127.83 32.71 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.787 1.176 . . . . 0.0 107.84 170.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -73.23 -55.61 6.21 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.084 0.402 . . . . 0.0 111.069 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.1 p -65.07 -31.87 73.3 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.176 1.391 . . . . 0.0 113.077 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.05 2.22 76.48 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.874 1.226 . . . . 0.0 115.222 170.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.8 mmt 48.12 40.74 14.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.095 1.758 . . . . 0.0 114.96 173.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.3 m -147.91 137.74 22.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.397 0.679 . . . . 0.0 111.58 -170.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 1.654 ' HE1' ' CE2' ' A' ' 146' ' ' TYR . 1.9 m-85 -125.35 131.42 53.0 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -177.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -152.46 112.27 3.97 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 120.468 1.486 . . . . 0.0 112.89 -147.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 4.8 pt -137.12 151.57 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 O-C-N 120.932 -1.105 . . . . 0.0 113.351 -163.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.34 144.15 36.16 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.938 0.875 . . . . 0.0 111.507 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.8 p -146.18 136.93 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 121.07 -1.019 . . . . 0.0 109.927 169.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.5 m -131.7 125.79 56.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.723 1.609 . . . . 0.0 108.843 -165.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -113.98 135.7 53.71 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.955 0.902 . . . . 0.0 112.409 -167.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -144.38 159.13 43.25 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.175 0.988 . . . . 0.0 113.614 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -89.74 -140.97 8.29 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 160.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.04 83.89 0.26 Allowed 'Trans proline' 0 CA--C 1.548 1.22 0 CA-C-N 119.344 1.572 . . . . 0.0 110.421 153.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -123.02 -25.29 4.57 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 172.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.11 74.91 1.42 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -172.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -51.05 -35.4 34.41 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.136 -1.393 . . . . 0.0 112.396 175.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.54 -35.1 75.18 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.464 1.029 . . . . 0.0 113.311 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.13 -44.04 55.22 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.345 1.058 . . . . 0.0 111.637 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 1.639 ' HE2' ' CE1' ' A' ' 161' ' ' TYR . 46.1 m-85 -54.75 -49.27 71.25 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.51 1.05 . . . . 0.0 111.36 175.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -63.98 -41.02 97.66 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.843 1.657 . . . . 0.0 112.261 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.23 -31.65 72.22 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.473 -0.767 . . . . 0.0 112.554 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.63 -47.24 61.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.226 -0.921 . . . . 0.0 112.982 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 96.6 mt -53.72 -37.69 63.56 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.011 0.525 . . . . 0.0 111.772 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 88.1 mtm-85 -75.54 -32.9 60.61 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -73.93 -39.18 63.97 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.353 1.061 . . . . 0.0 112.646 173.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.9 pt -90.91 -38.62 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.144 -0.972 . . . . 0.0 112.639 -168.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 1.651 ' HE1' ' CE2' ' A' ' 169' ' ' TYR . 13.7 t80 -85.81 4.41 37.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.657 0.662 . . . . 0.0 111.44 173.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.75 29.52 5.0 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 165.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 . . . . . 0 C--O 1.258 1.542 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 -179.512 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -48.18 -32.51 7.15 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.246 2.218 . . . . 0.0 114.746 174.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -93.46 -25.09 17.79 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.084 0.856 . . . . 0.0 112.04 -177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.3 t -62.55 -51.02 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.064 0.946 . . . . 0.0 109.762 170.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.36 -50.49 59.63 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.233 -0.759 . . . . 0.0 112.291 168.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.42 -47.25 79.45 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.805 1.303 . . . . 0.0 113.055 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -74.07 -40.86 62.49 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.092 0.957 . . . . 0.0 112.615 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.51 -33.33 62.77 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.552 1.524 . . . . 0.0 113.074 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.1 mp -68.92 -38.92 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 119.06 0.845 . . . . 0.0 109.555 169.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.6 m -59.9 -45.44 92.51 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.054 -1.029 . . . . 0.0 112.483 171.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -77.55 -28.07 51.74 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -173.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 p -66.79 -53.2 35.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.135 1.334 . . . . 0.0 110.252 168.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -49.16 -46.65 45.66 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.611 1.564 . . . . 0.0 112.786 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -70.22 -49.21 52.5 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.014 1.726 . . . . 0.0 114.463 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.93 -26.49 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.687 1.131 . . . . 0.0 111.198 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.6 mt -82.07 -17.21 47.42 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 171.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 46.32 56.45 6.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.959 1.704 . . . . 0.0 112.343 -167.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 pp -125.99 166.53 16.76 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.886 1.274 . . . . 0.0 111.122 167.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -75.92 158.31 32.18 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.755 1.222 . . . . 0.0 112.503 176.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -61.94 -21.74 65.03 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 119.994 -1.692 . . . . 0.0 114.175 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -95.56 3.05 54.47 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.215 1.006 . . . . 0.0 112.932 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -101.54 -12.62 18.36 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.477 1.111 . . . . 0.0 111.487 169.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 18.2 tp -88.84 137.71 32.07 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.538 1.935 . . . . 0.0 105.863 165.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -102.48 124.77 48.63 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.938 160.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.3 mm -90.42 142.75 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 125.469 1.508 . . . . 0.0 110.815 168.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.3 m -117.62 136.51 53.25 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 149.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -87.0 -151.09 0.16 Allowed 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 t -59.79 -21.21 60.5 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -166.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.37 -32.07 24.55 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.267 0.9 OUTLIER -96.03 -8.67 32.95 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 176.531 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.3 11.52 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.323 1.449 . . . . 0.0 111.732 166.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.9 t -64.15 6.43 0.18 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.627 2.371 . . . . 0.0 115.352 -167.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -61.37 -21.49 64.09 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 121.042 -1.036 . . . . 0.0 111.167 174.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -142.54 124.84 8.95 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 140.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.86 -15.98 53.07 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 121.842 1.695 . . . . 0.0 114.119 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -105.96 23.29 14.22 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.369 2.267 . . . . 0.0 111.97 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 1.624 ' HD1' ' CD2' ' A' ' 43' ' ' TYR . 67.6 t80 -154.92 94.44 1.65 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 170.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.1 p 175.57 154.78 0.17 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.727 -1.579 . . . . 0.0 108.083 -142.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.92 -82.22 0.48 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.367 1.44 . . . . 0.0 114.446 151.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 9.2 m -163.99 177.72 8.28 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.734 1.214 . . . . 0.0 112.966 -172.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -115.95 155.87 27.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.06 1.744 . . . . 0.0 108.59 165.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.9 138.86 48.56 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.208 2.603 . . . . 0.0 107.481 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -126.5 131.64 51.57 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.092 1.315 . . . . 0.0 109.329 -169.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 mt -123.27 142.36 51.02 Favored 'General case' 0 C--O 1.245 0.847 0 O-C-N 127.074 2.734 . . . . 0.0 111.736 -153.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.3 p -97.07 161.62 13.74 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.262 2.225 . . . . 0.0 112.673 -172.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.8 t -67.58 143.37 56.11 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . 0.271 12.7 t70 66.21 33.09 7.54 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.795 2.438 . . . . 0.0 114.646 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 tp -109.83 137.33 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.721 1.209 . . . . 0.0 111.858 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 p -110.4 141.12 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 125.701 1.6 . . . . 0.0 112.655 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -136.48 120.24 12.39 Favored Pre-proline 0 CA--C 1.548 0.9 0 O-C-N 120.803 -1.186 . . . . 0.0 111.64 166.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -65.29 80.23 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 125.03 3.82 . . . . 0.0 112.003 168.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.3 p -67.15 -30.75 50.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -151.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -55.2 -39.28 69.43 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 119.036 0.835 . . . . 0.0 112.538 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 1.59 ' HE2' ' CE1' ' A' ' 60' ' ' TYR . 38.9 t80 -62.38 -27.19 68.91 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.69 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.2 tp -81.3 -48.96 11.31 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.922 1.289 . . . . 0.0 112.511 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 mp -53.65 -49.2 68.45 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.461 0.704 . . . . 0.0 110.189 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.0 m -74.8 -27.54 60.35 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.254 1.022 . . . . 0.0 113.1 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 1.665 ' HD2' ' CD1' ' A' ' 64' ' ' TYR . 51.5 t80 -61.44 -34.69 75.84 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.294 1.406 . . . . 0.0 112.456 169.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 41.6 t-105 -70.63 -57.75 4.39 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.461 0.573 . . . . 0.0 112.05 167.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.54 -36.35 83.48 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -169.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 45.7 t -59.01 -17.49 25.54 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.686 1.594 . . . . 0.0 113.355 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.1 ttt85 -70.21 -43.64 70.26 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.199 -0.938 . . . . 0.0 112.768 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.5 m -159.22 3.35 0.09 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -169.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.93 82.72 0.11 Allowed Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.205 0.907 . . . . 0.0 111.481 -171.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -146.65 124.51 11.96 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 126.862 2.065 . . . . 0.0 106.833 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.3 m -78.42 117.09 19.31 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 126.25 1.82 . . . . 0.0 112.482 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.24 139.26 35.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.889 1.675 . . . . 0.0 110.828 168.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 39.1 m -102.24 145.48 29.36 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.887 0.851 . . . . 0.0 111.256 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.82 105.09 10.85 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.711 1.604 . . . . 0.0 108.923 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.7 t -96.32 154.04 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 126.677 1.991 . . . . 0.0 108.815 176.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -142.11 110.82 6.17 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.874 2.07 . . . . 0.0 106.856 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -111.15 115.35 29.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.021 2.128 . . . . 0.0 110.161 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -93.12 134.85 34.87 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.691 -0.671 . . . . 0.0 112.046 174.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.1 p -153.65 167.44 29.57 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 130.892 3.677 . . . . 0.0 107.088 -156.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -9.81 -124.99 0.0 OUTLIER Glycine 0 N--CA 1.49 2.294 0 C-N-CA 130.063 3.697 . . . . 0.0 116.296 -167.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 17.1 m -96.45 104.39 16.36 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 111.774 -3.97 . . . . 0.0 107.97 146.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.42 139.29 0.44 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 129.753 3.221 . . . . 0.0 109.272 151.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.9 t -74.73 134.77 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.97 1.259 . . . . 0.0 110.05 154.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.46 138.93 45.09 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.59 0.756 . . . . 0.0 110.288 163.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.2 tt -111.16 112.48 24.3 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.089 1.755 . . . . 0.0 106.452 170.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 m -95.87 126.88 41.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.256 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 49.0 t -108.5 111.03 22.68 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 119.976 -1.703 . . . . 0.0 107.9 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -116.44 100.38 7.83 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.971 0.415 . . . . 0.0 111.507 -169.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.9 mt -62.32 115.28 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 130.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -178.83 167.46 37.8 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 122.445 3.738 . . . . 0.0 122.445 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 1.662 ' HD1' ' CD2' ' A' ' 92' ' ' PHE . 49.1 m-85 -126.47 49.66 4.11 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 126.748 2.019 . . . . 0.0 113.895 155.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.04 172.73 14.91 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.595 2.863 . . . . 0.0 114.38 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.1 -40.78 59.7 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -156.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.268 11.7 tpt180 -95.68 -7.33 37.77 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 116.299 1.962 . . . . 0.0 116.299 -177.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -51.09 -42.29 60.52 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 128.774 2.829 . . . . 0.0 113.708 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -64.5 -27.4 68.95 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 117.434 -1.27 . . . . 0.0 112.52 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -106.15 -24.78 12.26 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 pp -75.41 161.06 29.56 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-N 121.358 1.89 . . . . 0.0 113.647 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -168.24 137.02 2.35 Favored 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 117.746 2.499 . . . . 0.0 117.746 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.533 ' CD ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -105.83 179.72 4.19 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 127.639 2.376 . . . . 0.0 111.453 178.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.533 ' H ' ' CD ' ' A' ' 101' ' ' ARG . 2.5 p -165.82 174.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.465 1.906 . . . . 0.0 112.172 -142.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 11.1 t -117.22 121.88 42.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.822 1.249 . . . . 0.0 109.354 151.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -171.55 153.7 3.54 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.369 1.868 . . . . 0.0 108.082 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 1.622 ' HE2' ' CE1' ' A' ' 105' ' ' PHE . 32.8 p90 -120.76 112.16 18.49 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.35 1.86 . . . . 0.0 110.724 172.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -160.06 -172.8 3.76 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.82 1.248 . . . . 0.0 112.04 -157.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -102.43 160.52 14.48 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.094 0.957 . . . . 0.0 111.84 164.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.4 tp -134.59 151.37 51.03 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 128.661 2.784 . . . . 0.0 108.668 -168.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 m -124.21 158.51 32.25 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.004 1.722 . . . . 0.0 111.818 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -5.17 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 126.143 1.777 . . . . 0.0 115.543 -166.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -127.14 55.13 1.59 Allowed 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.946 -1.096 . . . . 0.0 112.186 170.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.25 152.73 23.72 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 177.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -149.34 128.44 12.76 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 126.218 1.807 . . . . 0.0 107.402 -172.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.84 143.95 21.03 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 121.054 -1.029 . . . . 0.0 110.891 -172.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.73 140.69 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 125.285 1.434 . . . . 0.0 114.423 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.2 t -134.79 154.12 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.07 1.748 . . . . 0.0 111.442 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.6 t -143.07 170.34 15.9 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.27 1.828 . . . . 0.0 110.152 171.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.19 -31.47 63.49 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.873 -1.142 . . . . 0.0 113.875 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.14 -32.54 67.01 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 118.623 0.647 . . . . 0.0 112.579 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -67.92 -44.8 76.06 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.641 1.177 . . . . 0.0 110.249 176.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 37.5 mm -67.33 -33.67 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.705 -0.622 . . . . 0.0 111.252 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -62.65 -24.65 67.72 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.245 -0.909 . . . . 0.0 113.285 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -80.85 -15.67 55.74 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 120.741 1.61 . . . . 0.0 113.701 168.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.7 mt -73.81 -44.34 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 120.309 1.413 . . . . 0.0 111.392 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -173.24 -38.55 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.181 0 CA-C-O 116.687 -1.625 . . . . 0.0 112.092 168.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -73.21 -147.04 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.259 0 C-N-CA 123.068 2.512 . . . . 0.0 115.753 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 5.3 t -152.63 138.95 18.45 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 129.967 3.307 . . . . 0.0 108.844 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.04 -0.9 17.82 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 119.816 3.265 . . . . 0.0 119.816 -151.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.34 19.29 20.04 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -173.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.59 12.38 0.76 Allowed Glycine 0 N--CA 1.473 1.144 0 C-N-CA 124.322 0.963 . . . . 0.0 114.735 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.44 125.5 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 118.15 0.975 . . . . 0.0 111.907 -167.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.81 85.81 2.45 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.644 1.212 . . . . 0.0 108.097 162.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.1 t -90.83 148.35 22.57 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.978 0.911 . . . . 0.0 109.914 166.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -141.58 137.61 32.05 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.966 0.906 . . . . 0.0 110.203 -169.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 35.9 t -135.05 130.32 35.44 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.188 0.449 . . . . 0.0 110.11 -160.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.1 t -135.54 126.91 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.076 1.351 . . . . 0.0 109.655 -169.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.7 m -121.9 143.5 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.691 0.757 . . . . 0.0 111.907 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -127.56 159.86 33.34 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.136 2.174 . . . . 0.0 109.05 165.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.305 0.1 OUTLIER -148.44 155.51 41.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.104 1.361 . . . . 0.0 110.099 166.769 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.6 t -134.65 115.38 13.74 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.31 0.959 . . . . 0.0 109.437 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -71.03 -52.69 18.1 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.999 0.818 . . . . 0.0 110.886 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.1 p -56.8 -36.26 69.68 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.68 -4.3 90.26 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.648 1.118 . . . . 0.0 115.542 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 58.5 mtm 47.67 38.87 9.03 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.21 1.804 . . . . 0.0 114.986 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.8 t -149.55 166.04 30.4 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -130.27 137.26 49.91 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.61 1.564 . . . . 0.0 107.901 -173.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -130.47 132.25 45.58 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.596 0.634 . . . . 0.0 109.969 -166.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.15 132.69 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -153.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -140.03 132.31 28.28 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.304 1.842 . . . . 0.0 109.257 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.5 139.12 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 120.684 -1.26 . . . . 0.0 109.275 159.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.68 147.38 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.77 2.028 . . . . 0.0 109.542 -172.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.56 112.41 9.54 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.378 -0.826 . . . . 0.0 113.212 -170.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 1.653 ' HE2' ' CE1' ' A' ' 153' ' ' PHE . 32.4 m-85 -126.37 161.0 28.86 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.042 2.137 . . . . 0.0 110.661 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -75.94 -146.05 1.68 Allowed Glycine 0 CA--C 1.546 2.029 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 154.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.81 0.08 8.2 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.553 2.835 . . . . 0.0 114.728 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.01 -20.51 65.96 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.107 -1.621 . . . . 0.0 114.107 -177.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -83.37 61.58 6.25 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.842 1.306 . . . . 0.0 112.04 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -52.7 -32.87 44.92 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.489 1.515 . . . . 0.0 111.846 171.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.74 -51.71 66.1 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.908 0.883 . . . . 0.0 113.099 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.94 -36.12 79.59 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.791 1.178 . . . . 0.0 113.077 171.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 1.627 ' HE2' ' CE1' ' A' ' 161' ' ' TYR . 14.7 t80 -64.51 -52.86 55.65 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.95 1.25 . . . . 0.0 110.792 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -63.08 -32.38 73.75 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.836 -1.165 . . . . 0.0 113.192 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.89 -38.22 84.93 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.219 0.918 . . . . 0.0 112.277 171.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -76.02 -43.03 46.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.119 0.968 . . . . 0.0 113.547 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 93.8 mt -56.0 -36.03 67.46 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.212 0.914 . . . . 0.0 112.254 172.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -66.89 -51.08 59.67 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.467 1.107 . . . . 0.0 110.83 172.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.53 -26.81 64.69 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.2 pt -85.22 -34.95 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.681 0.793 . . . . 0.0 112.028 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -67.64 -0.96 4.43 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.684 1.129 . . . . 0.0 112.819 158.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -127.77 25.56 5.98 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 125.629 1.572 . . . . 0.0 112.293 179.852 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.3 t70 . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -55.14 -17.8 4.75 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -75.08 -21.96 58.61 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.865 -1.147 . . . . 0.0 112.111 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 t -72.05 -44.0 66.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.483 1.513 . . . . 0.0 110.093 171.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.88 -51.83 56.57 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 169.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.07 -45.12 64.63 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.295 1.047 . . . . 0.0 112.709 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -74.54 -35.13 63.1 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.47 -33.67 60.84 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.572 -1.33 . . . . 0.0 112.668 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -70.41 -41.25 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.839 0.745 . . . . 0.0 109.78 170.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.0 m -55.54 -46.78 77.04 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.207 -0.933 . . . . 0.0 111.858 171.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -64.41 -43.91 92.91 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.513 -0.742 . . . . 0.0 112.453 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -71.5 -24.65 62.01 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . 0.274 22.9 ptt-85 -74.8 -55.78 5.47 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 120.606 1.548 . . . . 0.0 113.88 158.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.0 -42.28 15.03 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -158.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.41 -25.89 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-N 119.654 1.115 . . . . 0.0 110.871 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.06 -12.1 60.25 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.699 1.6 . . . . 0.0 112.58 169.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 52.23 46.32 26.85 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 128.057 2.543 . . . . 0.0 115.199 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 pp -121.12 161.03 22.5 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.995 1.718 . . . . 0.0 112.703 174.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.31 149.48 26.04 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.659 -0.651 . . . . 0.0 111.49 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -64.96 -25.17 67.76 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.614 -1.304 . . . . 0.0 113.295 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -69.24 -21.46 63.92 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.995 -1.066 . . . . 0.0 112.417 168.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -104.25 -3.96 23.63 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.425 1.89 . . . . 0.0 112.297 -172.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.2 tp -94.61 133.49 38.19 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.528 2.731 . . . . 0.0 108.462 163.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.89 122.66 44.43 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.573 0.624 . . . . 0.0 109.724 166.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.2 mm -94.62 138.61 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.388 1.075 . . . . 0.0 110.746 170.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 m -139.21 144.66 38.6 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -117.02 -146.13 0.4 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.632 1.573 . . . . 0.0 110.608 -161.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 t -42.53 -32.31 0.54 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 128.122 2.569 . . . . 0.0 115.884 -171.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.52 -26.99 67.27 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 120.201 1.364 . . . . 0.0 113.989 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.8 mt -76.79 -43.69 35.74 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.817 1.19 . . . . 0.0 112.824 174.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -96.61 16.09 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.505 1.922 . . . . 0.0 111.415 -170.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.2 t -57.37 5.6 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.93 2.892 . . . . 0.0 116.845 -165.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.57 -39.04 11.06 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.851 1.26 . . . . 0.0 110.99 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -121.96 67.62 24.01 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.215 1.406 . . . . 0.0 107.393 160.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.89 -44.42 49.38 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 123.323 2.682 . . . . 0.0 113.241 -165.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -93.3 6.57 47.64 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.617 -1.182 . . . . 0.0 110.784 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -128.58 100.2 5.66 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 121.172 1.805 . . . . 0.0 107.516 171.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.1 p 176.67 170.51 0.48 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.447 -0.783 . . . . 0.0 111.147 -141.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.7 tp -128.05 -83.93 0.59 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 118.576 -1.25 . . . . 0.0 112.967 145.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 77.3 m -170.58 -161.98 0.26 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.348 1.459 . . . . 0.0 109.175 -160.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -148.0 157.37 43.48 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.348 2.259 . . . . 0.0 107.838 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.68 134.49 46.0 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.075 2.55 . . . . 0.0 107.571 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.8 ttm -122.51 130.94 53.57 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.428 -1.42 . . . . 0.0 111.273 -166.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.0 147.86 52.48 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.368 1.467 . . . . 0.0 114.685 -158.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.9 t -99.95 154.93 17.98 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.411 1.884 . . . . 0.0 109.315 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.2 t -46.89 113.15 0.61 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.538 1.535 . . . . 0.0 110.992 -153.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.78 157.86 26.71 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.356 1.074 . . . . 0.0 113.21 -143.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.447 HG23 ' H ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -110.71 178.5 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 113.499 -1.682 . . . . 0.0 109.575 -160.197 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.447 ' H ' HG23 ' A' ' 54' ' ' ILE . 7.6 p -80.15 116.87 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.854 -168.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 1.62 ' HD2' ' CD1' ' A' ' 56' ' ' TYR . 66.4 m-85 -125.58 139.3 33.69 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 118.612 -0.708 . . . . 0.0 109.736 175.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -66.38 78.19 0.34 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.148 3.232 . . . . 0.0 113.688 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.2 p -56.39 -30.28 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 127.554 2.341 . . . . 0.0 113.745 -170.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.46 ' HB2' ' H ' ' A' ' 133' ' ' THR . 22.7 tp10 -62.52 -22.49 66.33 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -177.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 1.631 ' HD1' ' CD2' ' A' ' 60' ' ' TYR . 21.1 m-85 -55.59 -44.32 76.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.119 0.872 . . . . 0.0 111.117 169.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.1 mp -74.25 -44.5 52.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.941 1.296 . . . . 0.0 111.884 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mp -54.0 -50.04 67.48 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 172.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.1 m -63.72 -50.39 69.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.126 0.97 . . . . 0.0 112.056 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -60.02 -29.56 68.58 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 118.264 -0.874 . . . . 0.0 113.008 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -76.29 -57.63 3.75 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.107 1.321 . . . . 0.0 114.204 169.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -76.53 -40.43 50.01 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -167.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 6.5 p -75.95 -1.81 27.38 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.85 -1.156 . . . . 0.0 113.625 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -60.83 -37.0 80.52 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.173 1.789 . . . . 0.0 113.333 -172.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.7 p -165.76 27.1 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.576 1.55 . . . . 0.0 113.483 169.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.03 86.08 0.16 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.686 1.612 . . . . 0.0 113.936 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -150.08 118.88 6.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 128.85 2.86 . . . . 0.0 104.656 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.6 m -65.6 117.93 8.78 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 122.909 0.484 . . . . 0.0 110.02 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.12 144.91 50.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.476 1.51 . . . . 0.0 111.372 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 26.8 p -115.73 141.0 48.67 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.663 1.185 . . . . 0.0 111.43 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -90.11 151.45 21.6 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 157.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 t -137.67 156.37 32.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 126.534 1.933 . . . . 0.0 108.284 -173.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -123.85 138.52 54.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.044 0.926 . . . . 0.0 109.865 159.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -116.92 103.12 9.96 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.997 2.119 . . . . 0.0 108.246 172.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -87.84 127.36 35.34 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.036 1.334 . . . . 0.0 110.166 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.6 t -148.41 166.76 27.13 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 130.318 3.447 . . . . 0.0 105.405 -151.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -18.02 -122.81 0.0 OUTLIER Glycine 0 N--CA 1.486 1.986 1 C-N-CA 131.241 4.258 . . . . 0.0 116.327 -176.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 45.9 t -96.23 101.03 12.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 113.897 -3.121 . . . . 0.0 109.651 150.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.7 mtt180 -171.64 -177.16 1.95 Allowed 'General case' 0 CA--C 1.549 0.934 1 C-N-CA 133.496 4.718 . . . . 0.0 107.05 123.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.5 t -95.26 146.34 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 120.265 -1.522 . . . . 0.0 111.5 145.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.11 136.91 43.73 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.09 1.356 . . . . 0.0 110.359 162.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -110.94 109.35 19.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.032 2.133 . . . . 0.0 106.175 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 m -104.3 144.78 31.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.332 1.053 . . . . 0.0 110.82 -164.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 74.1 m -127.53 114.32 17.28 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 120.908 -1.12 . . . . 0.0 110.79 -171.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -128.31 117.02 20.73 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.7 pt -88.45 62.54 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 122.792 1.282 . . . . 0.0 109.082 144.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.36 -179.38 43.99 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 121.618 3.407 . . . . 0.0 121.618 -145.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 1.665 ' HD1' ' CD2' ' A' ' 92' ' ' PHE . 95.4 m-85 -144.46 116.22 5.43 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 126.162 1.785 . . . . 0.0 111.702 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -82.97 163.65 15.65 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.556 2.837 . . . . 0.0 111.706 153.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.72 -18.73 56.11 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.546 1.138 . . . . 0.0 114.061 175.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 -25.64 36.21 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.42 1.488 . . . . 0.0 114.966 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.4 -44.08 65.16 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.45 2.7 . . . . 0.0 114.289 -169.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -36.84 76.29 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.001 0.52 . . . . 0.0 110.907 175.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -98.04 -23.63 15.69 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -170.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 pp -76.68 175.42 9.36 Favored 'General case' 0 CA--C 1.556 1.173 0 CA-C-N 119.926 1.239 . . . . 0.0 112.375 172.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -119.62 -162.51 0.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.878 -1.139 . . . . 0.0 113.917 -162.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -121.88 149.07 43.91 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.451 1.501 . . . . 0.0 111.693 172.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.4 p -127.89 136.7 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.155 0.982 . . . . 0.0 111.607 164.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.96 123.81 8.0 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 123.131 1.443 . . . . 0.0 108.793 116.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 170.89 -179.47 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 130.088 3.355 . . . . 0.0 105.156 -153.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 1.607 ' HD1' ' CD2' ' A' ' 105' ' ' PHE . 11.2 p90 -124.96 133.25 53.09 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.244 1.018 . . . . 0.0 112.331 159.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -150.85 149.89 30.25 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.63 1.172 . . . . 0.0 112.666 -164.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -73.29 132.62 43.33 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.131 0.972 . . . . 0.0 110.801 170.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.1 tp -119.13 148.7 42.78 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.049 1.739 . . . . 0.0 111.233 -163.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.7 t -117.26 168.56 10.21 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.07 2.148 . . . . 0.0 110.979 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -77.24 -8.9 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.331 1.452 . . . . 0.0 113.931 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -130.57 70.51 1.45 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.488 1.915 . . . . 0.0 109.175 172.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -133.44 142.06 48.12 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.295 -0.878 . . . . 0.0 111.115 173.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -149.79 129.26 13.02 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.183 1.393 . . . . 0.0 108.077 -163.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.4 pp -157.94 156.14 30.75 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -159.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.4 t -105.03 145.37 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 127.33 2.252 . . . . 0.0 111.644 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.41 123.39 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 122.489 1.138 . . . . 0.0 111.156 152.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.0 t -146.65 153.55 40.43 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.043 1.337 . . . . 0.0 111.191 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.87 -27.22 67.96 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.469 1.107 . . . . 0.0 113.393 -173.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.19 83.2 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 120.805 1.639 . . . . 0.0 112.628 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.18 -33.97 59.32 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.742 0.817 . . . . 0.0 112.672 172.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.52 -37.09 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.851 1.205 . . . . 0.0 110.714 168.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.33 -19.52 65.46 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.937 1.695 . . . . 0.0 112.761 171.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.2 mtm-85 -80.07 -30.33 39.3 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 121.935 2.152 . . . . 0.0 113.365 161.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 73.1 mt -82.63 -34.51 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.417 1.487 . . . . 0.0 113.461 -172.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -120.5 150.95 53.18 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 125.254 1.422 . . . . 0.0 110.845 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.31 -7.87 21.71 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.149 2.566 . . . . 0.0 113.522 173.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 35.3 m -121.31 131.17 54.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.74 1.616 . . . . 0.0 109.569 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -103.61 -137.43 0.35 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.143 1.377 . . . . 0.0 111.124 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -36.57 125.62 0.84 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.721 1.608 . . . . 0.0 111.701 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 116.69 -30.28 6.48 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.243 1.402 . . . . 0.0 112.293 -149.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 t -60.52 147.84 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.943 1.297 . . . . 0.0 113.153 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 26.4 tp -122.28 92.64 3.77 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.548 1.539 . . . . 0.0 109.481 159.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.46 ' H ' ' HB2' ' A' ' 59' ' ' GLU . 17.9 m -75.29 154.78 37.22 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.201 2.201 . . . . 0.0 109.933 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -142.11 134.57 28.03 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.773 1.229 . . . . 0.0 108.208 -168.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 34.7 t -139.28 142.04 37.76 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.252 0.933 . . . . 0.0 112.136 -163.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.7 t -147.2 141.44 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.976 2.11 . . . . 0.0 109.888 -168.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.91 138.21 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 O-C-N 121.208 -0.933 . . . . 0.0 111.068 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.02 113.2 26.57 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.472 1.109 . . . . 0.0 108.981 166.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.677 ' HE2' ' CD1' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -88.79 128.83 35.65 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 143.573 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.8 m -149.74 175.31 11.7 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -167.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 69.89 160.39 0.2 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 128.244 2.618 . . . . 0.0 115.154 167.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 84.4 p -89.82 -47.71 7.72 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.568 1.547 . . . . 0.0 110.526 171.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -65.88 -1.28 8.71 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 125.629 1.585 . . . . 0.0 115.082 165.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.4 mmt 64.78 128.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 129.032 2.933 . . . . 0.0 114.754 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.4 p -172.31 155.67 3.61 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.877 2.071 . . . . 0.0 108.476 169.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.677 ' CD1' ' HE2' ' A' ' 139' ' ' LYS . 2.5 m-85 -136.08 163.95 29.14 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -166.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -151.46 155.7 39.11 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.35 -1.469 . . . . 0.0 107.55 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.1 tt -136.59 138.94 45.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.092 -0.38 . . . . 0.0 110.516 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -141.69 123.61 15.34 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.321 0.648 . . . . 0.0 110.389 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.1 p -140.61 133.07 31.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-O 122.356 1.074 . . . . 0.0 110.201 168.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.4 m -135.6 130.88 50.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 127.102 2.161 . . . . 0.0 110.735 -163.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -107.65 111.13 23.2 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.094 0.957 . . . . 0.0 111.62 -171.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 1.647 ' HE2' ' CE1' ' A' ' 153' ' ' PHE . 21.2 m-85 -109.95 159.47 17.23 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.25 1.42 . . . . 0.0 110.719 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -74.79 -170.79 26.32 Favored Glycine 0 CA--C 1.542 1.735 0 O-C-N 121.314 -0.866 . . . . 0.0 113.728 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.27 -25.8 64.4 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.37 2.047 . . . . 0.0 112.085 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.52 9.0 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 129.349 3.06 . . . . 0.0 114.963 171.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -82.51 46.86 1.1 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.085 2.154 . . . . 0.0 108.605 169.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -58.2 -39.6 79.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.289 2.236 . . . . 0.0 111.824 -165.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.57 -44.42 78.27 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.832 -0.604 . . . . 0.0 112.585 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.91 -40.87 75.34 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.657 0.783 . . . . 0.0 111.783 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 1.636 ' HE1' ' CE2' ' A' ' 161' ' ' TYR . 80.9 t80 -53.69 -59.08 5.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.224 1.01 . . . . 0.0 110.433 175.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -60.55 -43.11 97.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.962 0.905 . . . . 0.0 112.91 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.43 -38.01 88.07 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.293 0.951 . . . . 0.0 113.058 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.7 -42.7 70.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.314 -0.866 . . . . 0.0 111.962 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.05 -35.12 74.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.33 0.513 . . . . 0.0 111.7 173.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -63.06 -31.66 72.85 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.597 1.559 . . . . 0.0 111.803 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -88.37 -45.11 10.27 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -106.7 -24.82 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 118.013 2.597 . . . . 0.0 118.013 -167.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -103.47 -11.49 17.78 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.707 1.203 . . . . 0.0 110.05 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -125.21 25.8 7.08 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.482 1.513 . . . . 0.0 114.134 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 160.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 120.691 0.282 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.44 -142.27 5.64 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.739 0.685 . . . . 0.0 114.342 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -89.86 0.6 56.95 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.63 151.27 26.37 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.668 1.187 . . . . 0.0 110.182 156.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -138.24 109.46 6.86 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.468 -0.77 . . . . 0.0 111.586 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 tp -126.81 143.72 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 C-N-CA 130.113 3.365 . . . . 0.0 108.509 163.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -74.31 148.39 41.42 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 126.356 1.862 . . . . 0.0 111.144 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -48.2 -38.14 17.57 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -165.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -94.68 -22.24 18.26 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.281 0.946 . . . . 0.0 112.151 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.6 t -72.44 -51.12 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.697 1.599 . . . . 0.0 113.164 -168.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.94 -46.66 94.11 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.27 -35.91 67.98 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.222 1.011 . . . . 0.0 112.584 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -68.43 -47.47 67.11 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.405 1.482 . . . . 0.0 112.534 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.48 -38.31 77.64 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.209 -0.932 . . . . 0.0 111.977 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.58 -39.83 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.505 1.522 . . . . 0.0 110.497 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.2 t -58.97 -48.27 82.16 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.197 0.999 . . . . 0.0 111.51 172.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -60.36 -43.01 96.92 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.66 -0.65 . . . . 0.0 111.156 173.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.9 m -62.75 -45.97 90.21 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.621 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.7 ptt-85 -65.81 -36.65 84.09 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.587 1.54 . . . . 0.0 112.592 174.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -68.66 -42.85 77.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.408 1.883 . . . . 0.0 114.375 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . 0.3 0.8 OUTLIER -88.24 -17.34 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 173.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.13 -5.72 58.64 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 121.022 1.737 . . . . 0.0 112.309 163.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 48.86 41.67 18.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 128.05 2.54 . . . . 0.0 114.468 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 pp -120.48 169.82 9.97 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.458 2.303 . . . . 0.0 110.804 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -92.74 168.41 11.22 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -66.95 -18.24 65.29 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.698 1.599 . . . . 0.0 114.427 -173.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -102.97 12.14 36.46 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.043 1.337 . . . . 0.0 112.314 171.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -127.48 -14.02 5.34 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.101 1.76 . . . . 0.0 110.953 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 35.6 tp -83.93 122.35 28.62 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 155.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.9 ttp-105 -92.19 126.43 37.26 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 118.932 -1.107 . . . . 0.0 110.839 172.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.8 mm -98.99 142.42 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.946 1.699 . . . . 0.0 112.007 173.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.9 m -140.8 143.14 34.68 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.318 0.508 . . . . 0.0 110.116 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -96.85 -142.38 0.29 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.386 1.474 . . . . 0.0 111.656 176.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.9 p -46.92 -38.55 10.71 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.16 2.184 . . . . 0.0 115.706 -156.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.45 -29.61 64.33 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -165.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.39 -15.2 16.6 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 115.961 1.838 . . . . 0.0 115.961 173.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 pt -112.62 -14.0 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 -175.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.5 t -61.53 9.33 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 -166.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -83.79 -15.7 47.4 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 119.657 -1.902 . . . . 0.0 113.075 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.431 ' HB2' ' H ' ' A' ' 92' ' ' PHE . 48.6 t-20 -91.49 113.44 58.56 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 141.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.99 -11.1 11.29 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.125 1.883 . . . . 0.0 115.871 -160.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -121.9 -10.97 8.6 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 120.806 1.639 . . . . 0.0 115.164 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 1.631 ' HD2' ' CD1' ' A' ' 43' ' ' TYR . 37.2 p90 -162.1 160.19 27.04 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.078 1.351 . . . . 0.0 108.325 -169.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.7 p 164.61 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.273 1.829 . . . . 0.0 106.426 -155.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.0 tp -122.33 -78.16 0.6 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 119.16 -1.016 . . . . 0.0 112.42 147.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.414 ' HB3' ' H ' ' A' ' 47' ' ' ASP . 1.5 m -177.34 -160.04 0.05 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.794 2.038 . . . . 0.0 108.004 -165.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.414 ' H ' ' HB3' ' A' ' 46' ' ' CYS . 11.7 t70 -131.78 157.83 42.84 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.921 2.088 . . . . 0.0 107.937 169.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -135.17 130.97 36.19 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 128.815 2.846 . . . . 0.0 108.951 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 35.8 ttp -118.22 131.67 56.36 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.096 -1.003 . . . . 0.0 110.844 -166.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 mt -127.51 149.03 50.31 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.348 2.659 . . . . 0.0 112.711 -151.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.1 p -96.93 159.02 15.15 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.063 2.145 . . . . 0.0 113.176 -169.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.5 t -72.07 158.61 35.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.903 1.281 . . . . 0.0 112.537 173.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.3 t70 57.11 43.69 23.73 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.113 1.765 . . . . 0.0 113.7 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 tp -132.74 139.73 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.546 1.139 . . . . 0.0 111.266 -171.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.2 p -123.37 140.92 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.424 1.49 . . . . 0.0 111.769 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 1.65 ' HD1' ' CD2' ' A' ' 56' ' ' TYR . 9.7 p90 -138.35 153.1 72.57 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 157.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.82 78.09 1.78 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.847 3.032 . . . . 0.0 109.949 167.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -47.73 -36.7 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 127.547 2.339 . . . . 0.0 115.047 -167.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.98 -18.61 60.35 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -59.55 -34.23 72.4 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.268 -0.895 . . . . 0.0 111.011 167.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.6 tp -78.87 -44.57 22.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.523 1.129 . . . . 0.0 112.409 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.7 mp -54.25 -45.93 72.51 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.733 1.151 . . . . 0.0 110.627 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.4 t -57.57 -50.36 73.35 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.924 1.29 . . . . 0.0 111.864 175.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -61.87 -37.69 85.46 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -59.55 -54.92 41.01 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.711 1.604 . . . . 0.0 111.95 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -72.1 -31.38 66.0 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 9.9 t -72.27 -18.26 61.82 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 -69.59 -35.14 75.06 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -168.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.1 m -147.17 8.04 0.92 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.84 71.76 0.79 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.986 1.279 . . . . 0.0 111.784 -170.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -168.0 135.31 2.18 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 128.425 2.69 . . . . 0.0 105.76 172.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -100.79 154.99 18.18 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 127.832 2.453 . . . . 0.0 111.734 -170.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.74 147.27 44.6 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.599 1.16 . . . . 0.0 112.566 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 26.9 p -86.9 142.29 28.13 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.661 0.743 . . . . 0.0 110.517 160.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 1.581 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 13.9 m-30 -92.06 108.61 20.06 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 167.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.3 t -101.48 109.02 24.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -92.36 113.12 25.31 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 120.712 -1.243 . . . . 0.0 107.677 -173.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -107.52 101.68 11.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.383 1.473 . . . . 0.0 108.851 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -79.62 129.02 34.1 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.801 1.64 . . . . 0.0 109.511 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.8 p -145.18 168.71 19.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.075 2.55 . . . . 0.0 104.57 -170.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -12.75 -119.44 0.0 OUTLIER Glycine 0 N--CA 1.487 2.051 0 C-N-CA 129.542 3.449 . . . . 0.0 116.098 -171.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.8 p -95.45 105.84 17.85 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 113.96 -3.096 . . . . 0.0 111.082 153.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -178.75 145.88 0.31 Allowed 'General case' 0 N--CA 1.474 0.728 1 C-N-CA 132.179 4.192 . . . . 0.0 108.477 146.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 t -78.73 142.27 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 119.246 -2.159 . . . . 0.0 110.431 145.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.0 p -125.23 161.95 25.77 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.77 -1.207 . . . . 0.0 112.69 154.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 pp -112.44 116.11 29.77 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 122.11 0.957 . . . . 0.0 109.034 158.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.4 m -80.23 121.26 25.4 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.389 1.476 . . . . 0.0 108.006 169.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 42.4 t -104.91 113.68 27.43 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.028 -1.045 . . . . 0.0 110.98 -172.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 1.667 ' HE1' ' CE2' ' A' ' 89' ' ' TYR . 61.8 m-85 -105.11 108.84 20.57 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.75 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.7 mt -76.67 72.09 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 140.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.77 -179.11 48.43 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 121.445 3.338 . . . . 0.0 121.445 -155.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 1.621 ' HE1' ' CE2' ' A' ' 92' ' ' PHE . 2.3 m-85 -115.57 105.49 51.88 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-N 111.134 -2.533 . . . . 0.0 110.035 -171.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -86.12 152.68 9.58 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.639 2.226 . . . . 0.0 114.636 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -42.93 62.52 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -177.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 ttt85 -88.76 3.63 50.28 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.88 -29.36 8.0 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.339 2.256 . . . . 0.0 113.612 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -53.49 -45.03 69.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.413 1.885 . . . . 0.0 113.543 168.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -122.08 -20.18 6.35 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -166.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 pp -60.93 168.92 2.15 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 121.578 1.99 . . . . 0.0 114.711 165.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -117.25 172.88 7.01 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -160.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.602 ' CZ ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -131.0 155.14 47.33 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.984 1.313 . . . . 0.0 113.992 157.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.602 ' H ' ' CZ ' ' A' ' 101' ' ' ARG . 1.5 p -136.67 137.61 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.327 1.451 . . . . 0.0 113.432 174.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 28.1 p -123.38 112.66 17.83 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.448 133.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 t0 176.49 -167.23 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 128.521 2.729 . . . . 0.0 107.601 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 1.644 ' HD2' ' CD1' ' A' ' 105' ' ' PHE . 42.0 p90 -113.59 138.83 49.62 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.064 1.346 . . . . 0.0 111.396 150.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -158.09 159.66 36.52 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 1.643 ' HD1' ' CD2' ' A' ' 107' ' ' PHE . 7.3 t80 -60.77 142.59 55.81 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.306 1.042 . . . . 0.0 111.034 160.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 20.9 tp -142.4 133.39 25.84 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.848 1.659 . . . . 0.0 110.172 -173.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 m -71.68 156.57 39.21 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -174.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.47 -10.43 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -169.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.99 41.73 3.12 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.052 1.341 . . . . 0.0 112.201 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -105.04 172.42 6.8 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.058 2.143 . . . . 0.0 113.481 -169.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -149.8 139.07 21.31 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 126.579 1.952 . . . . 0.0 106.315 -167.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.54 133.21 9.19 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.263 0.938 . . . . 0.0 113.445 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.6 t -95.88 136.43 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 117.252 -1.356 . . . . 0.0 109.315 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.528 ' HB ' ' CZ ' ' A' ' 101' ' ' ARG . 11.4 p -138.23 115.39 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 120.322 1.419 . . . . 0.0 109.354 164.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.01 171.29 14.63 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.002 1.721 . . . . 0.0 111.282 -175.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 79.4 mt -59.71 -29.99 68.49 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.534 0.734 . . . . 0.0 112.913 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.98 -33.32 65.75 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 119.712 1.142 . . . . 0.0 113.043 173.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -74.39 -45.64 45.46 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.802 1.241 . . . . 0.0 111.862 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 28.4 mm -60.34 -40.98 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.493 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -61.44 -29.99 70.3 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 172.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -70.1 -41.05 74.54 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 121.692 2.042 . . . . 0.0 111.864 172.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.5 pt -96.72 -11.9 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -168.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -154.15 150.67 22.89 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 126.539 1.936 . . . . 0.0 110.748 166.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -61.34 113.2 1.67 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 121.775 1.65 . . . . 0.0 110.926 168.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 19.7 p -83.32 161.64 21.36 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.608 0.718 . . . . 0.0 112.672 -176.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -151.19 147.96 27.66 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.264 1.826 . . . . 0.0 108.233 -171.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.257 0.1 OUTLIER -67.14 54.23 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 127.859 2.464 . . . . 0.0 112.635 170.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 179.6 -0.58 0.02 OUTLIER Glycine 0 CA--C 1.539 1.562 0 C-N-CA 127.516 2.484 . . . . 0.0 114.215 -167.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.1 t -65.42 131.15 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.011 1.405 . . . . 0.0 111.28 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 90.5 mt -118.44 89.21 3.08 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.982 1.713 . . . . 0.0 108.281 159.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.0 m -72.95 148.36 44.35 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 170.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -133.28 134.29 43.71 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.427 1.491 . . . . 0.0 108.661 -165.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 41.9 t -140.89 135.97 31.84 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.525 1.057 . . . . 0.0 112.027 -169.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.5 124.17 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.374 1.869 . . . . 0.0 110.175 -167.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.0 m -121.65 145.86 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.213 -0.93 . . . . 0.0 112.831 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -130.22 138.6 50.65 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.389 1.076 . . . . 0.0 112.12 158.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.475 ' HD2' ' CE1' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -77.58 146.08 36.45 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 129.034 2.934 . . . . 0.0 112.423 152.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.5 t -139.51 143.49 37.47 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.518 1.127 . . . . 0.0 110.217 162.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -101.29 -41.18 6.79 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.453 1.501 . . . . 0.0 110.755 169.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.9 t -54.76 -33.75 61.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.832 0.853 . . . . 0.0 112.808 174.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -102.49 1.2 49.65 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 117.71 -1.605 . . . . 0.0 115.849 172.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.3 mmt 39.44 57.85 2.04 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.837 1.819 . . . . 0.0 113.455 -173.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.0 m -149.46 163.52 37.55 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.002 0.921 . . . . 0.0 113.13 -163.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 1.663 ' HD2' ' CD1' ' A' ' 146' ' ' TYR . 76.7 m-85 -107.29 154.34 21.4 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.098 0.959 . . . . 0.0 111.098 154.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -130.83 106.19 8.28 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.61 139.19 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 123.972 0.909 . . . . 0.0 109.683 -163.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -141.46 134.3 28.82 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.689 0.796 . . . . 0.0 109.45 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.5 p -150.44 132.58 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 122.42 1.105 . . . . 0.0 110.642 164.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.4 m -137.28 145.69 29.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 126.505 1.922 . . . . 0.0 109.013 -162.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -112.36 118.11 34.32 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.689 -0.632 . . . . 0.0 112.392 -169.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 1.654 ' HD1' ' CD2' ' A' ' 153' ' ' PHE . 29.7 m-85 -121.59 157.21 31.28 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.384 1.074 . . . . 0.0 111.338 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -85.6 -146.97 9.25 Favored Glycine 0 CA--C 1.54 1.626 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 159.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -63.39 -3.44 5.22 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.564 2.843 . . . . 0.0 115.973 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -63.76 -18.7 64.32 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.133 1.373 . . . . 0.0 114.01 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -77.37 30.24 0.15 Allowed 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.478 1.111 . . . . 0.0 112.172 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -61.54 -26.79 68.17 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.433 1.893 . . . . 0.0 114.177 -171.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.88 -52.57 12.54 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.404 1.082 . . . . 0.0 112.051 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -61.38 -39.78 91.93 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.375 1.07 . . . . 0.0 112.188 171.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -52.44 -54.68 29.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.611 0.764 . . . . 0.0 110.873 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -59.04 -45.29 91.11 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.565 -0.71 . . . . 0.0 112.852 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.36 -34.81 75.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.319 0.648 . . . . 0.0 112.309 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.43 -45.33 60.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.434 -0.791 . . . . 0.0 111.942 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 88.9 mt -56.85 -34.38 67.74 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.824 0.738 . . . . 0.0 111.683 171.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -79.38 -7.93 58.72 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.229 1.812 . . . . 0.0 114.231 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -99.78 -57.23 2.19 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.987 1.315 . . . . 0.0 113.053 160.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.8 pt -83.8 -32.12 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -160.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 1.65 ' HD1' ' CD2' ' A' ' 169' ' ' TYR . 13.3 t80 -90.69 10.98 23.66 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.017 0.927 . . . . 0.0 109.449 168.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.91 24.87 5.31 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.399 1.48 . . . . 0.0 114.638 174.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 16.7 mmt85 . . . . . 0 C--O 1.252 1.233 0 CA-C-O 117.628 -1.177 . . . . 0.0 111.319 157.46 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.04 -175.24 47.15 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.822 0.725 . . . . 0.0 113.311 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -82.9 -33.7 26.83 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.847 0.859 . . . . 0.0 111.029 173.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -125.78 131.01 52.57 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.286 1.434 . . . . 0.0 110.235 169.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -136.63 152.51 50.51 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.449 1.499 . . . . 0.0 110.357 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.5 tp -140.04 145.7 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 128.899 2.88 . . . . 0.0 111.617 -169.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -44.12 131.09 6.07 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.46 1.504 . . . . 0.0 111.673 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -68.5 -23.48 64.56 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 -135.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -112.8 -17.17 12.6 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.039 1.336 . . . . 0.0 113.425 172.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 80.1 t -67.18 -60.64 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.298 1.039 . . . . 0.0 111.532 -173.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.28 -37.35 80.48 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.282 -0.732 . . . . 0.0 113.472 175.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.71 -59.2 5.79 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.245 1.023 . . . . 0.0 110.916 175.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -65.77 -46.95 76.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.616 1.166 . . . . 0.0 111.668 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.0 mp -70.46 -43.7 69.28 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.643 -0.66 . . . . 0.0 111.637 -173.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.29 -34.56 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 119.203 0.91 . . . . 0.0 110.231 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.2 t -59.49 -52.33 66.02 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.41 1.005 . . . . 0.0 111.761 174.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -64.73 -31.51 72.76 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.416 -0.803 . . . . 0.0 111.581 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 m -68.72 -50.09 53.57 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.196 -0.94 . . . . 0.0 111.685 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.1 ptt85 -61.87 -22.06 65.22 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.002 1.274 . . . . 0.0 113.577 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -85.1 -52.56 5.86 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.446 1.099 . . . . 0.0 112.953 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.85 -30.48 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 118.635 0.652 . . . . 0.0 112.201 -175.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -84.38 -7.66 59.23 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.912 1.233 . . . . 0.0 111.633 171.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 65.65 5.13 3.14 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 128.243 2.617 . . . . 0.0 115.249 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 pp -97.37 147.1 24.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.153 1.381 . . . . 0.0 111.497 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -76.01 165.23 25.26 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -168.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -58.77 -39.77 81.97 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.196 -1.565 . . . . 0.0 112.51 -174.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -88.27 6.92 34.64 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.84 0.856 . . . . 0.0 112.784 176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -108.87 -5.59 16.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.321 1.448 . . . . 0.0 111.769 172.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.6 tp -89.06 112.61 23.61 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 166.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.59 93.17 8.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 118.701 -1.199 . . . . 0.0 109.193 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -87.69 146.69 5.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 125.609 1.563 . . . . 0.0 112.541 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 m -145.86 153.3 40.71 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.925 1.29 . . . . 0.0 110.425 -171.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -117.72 -165.69 1.12 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.368 1.467 . . . . 0.0 112.609 -163.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.4 t -41.34 -41.15 1.88 Allowed 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 118.081 2.622 . . . . 0.0 118.081 -147.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.7 -17.24 61.15 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 -160.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.42 -14.25 17.64 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.3 pt -102.85 -6.65 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 126.703 2.001 . . . . 0.0 113.583 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -41.53 8.14 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.055 1 C-N-CA 133.641 4.776 . . . . 0.0 121.397 -169.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -65.48 -21.39 66.63 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 122.468 2.395 . . . . 0.0 113.391 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -92.65 117.51 67.62 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 144.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -73.26 -8.31 21.77 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.052 2.501 . . . . 0.0 114.561 -171.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -108.69 -43.43 4.27 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 120.099 1.318 . . . . 0.0 112.007 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -165.51 126.69 1.93 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.539 1.535 . . . . 0.0 110.062 159.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 t -92.94 -162.03 0.9 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 147.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.96 -82.48 0.17 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -168.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 2.4 t -164.9 175.99 9.08 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 120.803 1.638 . . . . 0.0 113.562 -170.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -147.61 106.88 3.88 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.83 158.54 15.46 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.91 2.884 . . . . 0.0 112.059 -168.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 12.8 tmm? -125.57 137.2 53.9 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.895 1.225 . . . . 0.0 110.944 172.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.1 mt -129.86 128.99 43.38 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 129.204 3.002 . . . . 0.0 111.095 -157.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.7 t -128.95 162.7 26.96 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 128.021 2.528 . . . . 0.0 110.383 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.6 p -39.11 113.03 0.28 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.744 1.618 . . . . 0.0 113.515 -149.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -106.81 159.05 16.53 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.939 172.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.519 HG23 ' H ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -121.78 177.44 3.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 113.69 -1.596 . . . . 0.0 106.721 -173.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.519 ' H ' HG23 ' A' ' 54' ' ' ILE . 11.7 p -77.15 103.38 4.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.912 -155.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -137.72 158.22 72.08 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.433 1.093 . . . . 0.0 111.913 -166.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.53 88.27 0.27 Allowed 'Trans proline' 0 C--N 1.357 0.999 1 C-N-CA 125.741 4.294 . . . . 0.0 112.187 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.64 -40.83 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.451 0.7 . . . . 0.0 112.541 -172.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -12.52 60.39 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -55.39 -27.72 49.43 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.192 0.905 . . . . 0.0 112.687 167.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.3 mp -77.97 -44.32 27.12 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.885 0.874 . . . . 0.0 111.554 171.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mp -56.71 -43.57 80.71 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 118.138 0.426 . . . . 0.0 111.37 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.3 p -72.31 -30.74 65.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.801 0.84 . . . . 0.0 112.515 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 1.617 ' HE1' ' CE2' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -60.07 -37.6 80.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.381 0.991 . . . . 0.0 112.865 171.015 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -50.63 16.2 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.105 0.866 . . . . 0.0 111.866 172.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -61.24 -33.62 73.81 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.775 -1.203 . . . . 0.0 113.325 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 69.5 m -79.17 -20.56 48.15 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 172.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -38.36 79.34 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.641 1.11 . . . . 0.0 113.269 -169.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.6 m -150.81 0.23 0.41 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.97 82.3 0.16 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.19 1.376 . . . . 0.0 110.952 -165.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -153.71 115.91 4.34 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 125.665 1.586 . . . . 0.0 107.841 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 79.4 m -91.89 113.12 25.3 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.942 1.297 . . . . 0.0 109.792 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.47 148.38 40.81 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.056 1.342 . . . . 0.0 113.285 -168.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 74.4 m -89.21 127.14 35.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.702 0.801 . . . . 0.0 109.535 165.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -91.91 103.48 16.01 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 164.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.6 t -105.46 141.62 20.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 C-N-CA 125.07 1.348 . . . . 0.0 109.204 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -124.93 123.28 39.56 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.245 -0.909 . . . . 0.0 110.08 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.1 112.86 25.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.054 1.741 . . . . 0.0 109.262 172.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -86.26 126.68 34.47 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.074 -1.016 . . . . 0.0 111.281 165.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.8 p -143.69 157.11 44.64 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.732 3.213 . . . . 0.0 103.369 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -7.07 -129.85 0.0 OUTLIER Glycine 0 N--CA 1.486 1.993 0 O-C-N 117.707 -3.121 . . . . 0.0 112.83 -116.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 82.4 m -97.58 107.5 20.02 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 113.666 -3.213 . . . . 0.0 108.601 149.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -169.66 125.14 0.83 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 130.754 3.622 . . . . 0.0 106.203 161.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.6 t -78.03 135.45 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 117.978 -1.489 . . . . 0.0 110.938 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.8 m -110.22 146.19 36.02 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.21 0.604 . . . . 0.0 110.477 163.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.1 tp -110.73 108.79 18.78 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 126.208 1.803 . . . . 0.0 107.082 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.6 m -80.12 101.47 8.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 167.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 45.3 t -103.81 108.12 19.29 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 120.73 -1.231 . . . . 0.0 108.23 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.4 151.17 48.26 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -175.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.59 96.1 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 141.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.91 142.75 6.67 Favored Glycine 0 N--CA 1.471 1.015 0 N-CA-C 118.332 2.093 . . . . 0.0 118.332 -167.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -133.28 64.81 71.02 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.626 1.571 . . . . 0.0 112.267 175.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.58 158.12 32.24 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.369 2.713 . . . . 0.0 115.495 -172.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -50.52 -19.89 1.01 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.252 2.621 . . . . 0.0 115.752 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -69.83 -11.62 61.0 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.182 -1.574 . . . . 0.0 113.242 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.71 -4.7 16.76 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 164.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 1.67 32.76 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 120.051 1.296 . . . . 0.0 112.241 160.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -131.16 -34.2 1.45 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.533 1.933 . . . . 0.0 114.154 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 pp -100.49 160.0 14.7 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 120.196 1.362 . . . . 0.0 114.628 -172.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -108.69 -160.97 0.74 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 125.714 1.606 . . . . 0.0 113.069 -166.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.45 166.11 13.08 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.711 1.205 . . . . 0.0 111.833 162.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.1 p -125.13 130.97 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 170.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 10.8 t -147.58 112.1 5.3 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 127.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -176.91 175.29 1.62 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.507 1.923 . . . . 0.0 107.886 -170.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -115.82 121.06 41.27 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.384 1.873 . . . . 0.0 110.667 161.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -159.0 165.95 32.88 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 177.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 1.631 ' HD1' ' CD2' ' A' ' 107' ' ' PHE . 81.4 m-85 -74.09 149.42 41.11 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.517 -0.74 . . . . 0.0 111.71 164.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.8 tp -135.87 143.09 44.86 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.596 1.958 . . . . 0.0 108.87 -171.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.8 p -117.44 173.21 6.83 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -166.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.9 t -67.11 -9.77 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 128.433 2.693 . . . . 0.0 115.422 -163.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -135.21 25.11 3.54 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.996 -1.065 . . . . 0.0 112.803 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -116.2 151.75 35.1 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.141 -0.974 . . . . 0.0 111.803 -163.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.61 166.15 31.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.077 -1.014 . . . . 0.0 112.549 -165.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.69 164.1 37.67 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.276 1.03 . . . . 0.0 113.46 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.8 t -99.76 145.45 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 127.788 2.435 . . . . 0.0 109.275 163.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.6 128.7 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.565 0.698 . . . . 0.0 109.287 151.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 4.7 p -128.97 159.13 36.87 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.444 1.498 . . . . 0.0 111.001 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -59.44 -38.46 80.73 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.383 0.673 . . . . 0.0 111.672 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.18 -32.53 74.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.046 0.938 . . . . 0.0 112.58 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -71.47 -33.14 69.06 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 117.575 -1.202 . . . . 0.0 111.996 173.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 31.9 mm -66.7 -41.39 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 119.742 1.156 . . . . 0.0 110.786 170.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.54 -27.89 66.6 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 171.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -86.52 -21.84 26.72 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.97 1.708 . . . . 0.0 115.178 171.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 6.3 mt -77.2 -38.54 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.056 1.342 . . . . 0.0 111.007 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 127' ' ' CYS . 61.4 mmtt -145.06 172.31 5.52 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 125.715 1.606 . . . . 0.0 111.858 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -57.43 20.97 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.335 1 C-N-CA 126.262 4.641 . . . . 0.0 117.086 164.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.418 ' H ' ' C ' ' A' ' 125' ' ' LYS . 77.9 m -74.75 160.38 30.81 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.676 1.99 . . . . 0.0 112.097 176.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -125.02 -166.42 1.53 Allowed 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 128.002 2.521 . . . . 0.0 108.7 173.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.26 -24.69 67.75 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -173.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -85.86 15.24 48.92 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 118.155 -1.358 . . . . 0.0 115.98 -175.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.73 158.61 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.219 1.509 . . . . 0.0 113.801 -165.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.7 tt -116.43 126.71 53.8 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 122.352 1.072 . . . . 0.0 110.618 154.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 2.4 p -123.26 148.38 45.96 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 127.496 2.318 . . . . 0.0 109.711 -173.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -130.98 128.47 40.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -164.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 46.3 t -136.38 138.92 42.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.467 0.707 . . . . 0.0 110.728 -165.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.5 t -146.23 114.76 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.892 0.877 . . . . 0.0 110.98 -167.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 m -109.01 129.95 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -115.51 140.92 48.72 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.46 2.304 . . . . 0.0 107.261 168.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.413 ' HB2' ' CD2' ' A' ' 146' ' ' TYR 0.304 0.2 OUTLIER -149.69 152.84 36.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.504 0.722 . . . . 0.0 110.664 169.845 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.7 t -136.8 123.34 20.92 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.846 0.748 . . . . 0.0 109.16 171.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -76.0 -57.08 4.09 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.213 1.405 . . . . 0.0 110.67 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.6 t -61.09 -36.32 79.35 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.04 0.936 . . . . 0.0 112.591 169.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.66 14.16 48.7 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.361 -1.244 . . . . 0.0 114.896 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 28.0 ptm 42.63 49.46 4.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.268 2.227 . . . . 0.0 116.985 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.5 t -157.82 148.74 21.09 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.413 ' CD2' ' HB2' ' A' ' 139' ' ' LYS . 1.4 t80 -108.93 140.08 42.9 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.706 1.202 . . . . 0.0 111.267 163.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -140.79 121.32 14.16 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 122.17 0.986 . . . . 0.0 111.447 -173.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -133.5 134.58 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.097 -1.002 . . . . 0.0 110.828 -151.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -142.66 131.76 23.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.675 1.19 . . . . 0.0 111.064 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.8 p -145.19 139.37 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.545 -0.722 . . . . 0.0 110.588 161.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.9 m -136.04 151.43 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 127.772 2.429 . . . . 0.0 109.821 -165.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.12 128.85 23.12 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -166.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 1.599 ' HE2' ' CE1' ' A' ' 153' ' ' PHE . 0.5 OUTLIER -148.12 133.25 18.3 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 170.445 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.54 -162.21 0.27 Allowed Glycine 0 CA--C 1.549 2.185 0 C-N-CA 127.558 2.504 . . . . 0.0 116.344 166.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.6 -20.77 12.92 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.892 3.728 . . . . 0.0 119.521 -160.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -75.58 -2.39 28.95 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 120.58 1.537 . . . . 0.0 114.03 173.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 45.7 p30 -58.82 13.03 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 129.304 3.042 . . . . 0.0 117.861 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -49.4 -40.02 34.67 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.389 1.876 . . . . 0.0 112.623 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.43 -51.44 65.72 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -74.2 -26.7 60.42 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.086 -1.009 . . . . 0.0 112.427 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 1.665 ' HE2' ' CE1' ' A' ' 161' ' ' TYR . 67.3 t80 -64.98 -48.56 73.56 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.709 0.804 . . . . 0.0 111.74 168.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -62.61 -38.11 88.91 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.332 -0.855 . . . . 0.0 112.087 174.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.55 -30.85 70.03 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.09 -51.72 9.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.724 1.21 . . . . 0.0 110.887 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.5 pp -66.43 -27.55 67.91 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.316 -0.865 . . . . 0.0 110.972 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -77.21 -24.42 51.29 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 117.895 -1.05 . . . . 0.0 112.828 172.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.64 -30.86 64.67 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 167.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.1 mt -76.03 -36.8 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 120.708 -1.245 . . . . 0.0 110.977 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -64.83 -4.9 4.9 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 158.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -108.56 25.17 12.02 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 170.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.171 0 C-N-CA 128.539 2.736 . . . . 0.0 116.52 162.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.675 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.23 -17.6 9.66 Favored Glycine 0 CA--C 1.542 1.752 0 N-CA-C 116.548 1.379 . . . . 0.0 116.548 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -132.31 -157.01 0.79 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.173 1.789 . . . . 0.0 112.144 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.46 159.41 15.64 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 119.873 -1.767 . . . . 0.0 113.175 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -126.82 97.97 5.18 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.355 -0.841 . . . . 0.0 112.497 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.6 tp -76.32 106.07 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 123.1 1.428 . . . . 0.0 112.442 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -45.19 123.85 4.26 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 111.831 -2.441 . . . . 0.0 110.613 -173.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -57.86 -35.58 71.16 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 -143.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -102.92 -19.73 14.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.211 1.404 . . . . 0.0 112.349 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.27 -52.41 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.986 0.915 . . . . 0.0 112.388 -168.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.73 -49.92 73.33 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 119.179 0.9 . . . . 0.0 111.885 174.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.51 76.84 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.278 1.039 . . . . 0.0 112.156 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.76 -42.41 73.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.334 1.054 . . . . 0.0 113.303 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.4 tp -76.58 -31.44 57.5 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.271 1.029 . . . . 0.0 112.914 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.9 -40.41 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 121.487 -0.758 . . . . 0.0 109.344 168.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.1 m -59.58 -35.24 73.9 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 119.688 1.131 . . . . 0.0 112.495 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -72.0 -40.09 68.75 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.675 1.19 . . . . 0.0 111.452 177.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.7 m -64.87 -42.51 94.78 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.989 -1.069 . . . . 0.0 110.514 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -54.33 -37.21 64.61 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.977 1.711 . . . . 0.0 112.353 171.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -83.84 -49.28 9.2 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.519 1.528 . . . . 0.0 113.473 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.8 -42.49 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 118.989 0.813 . . . . 0.0 111.093 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.01 -2.52 58.38 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.471 0.708 . . . . 0.0 112.785 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . 0.273 32.8 ptt180 51.88 22.99 1.92 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.07 2.548 . . . . 0.0 116.179 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 pp -92.36 153.41 19.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.145 1.778 . . . . 0.0 112.139 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -80.41 160.12 25.45 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.006 0.922 . . . . 0.0 113.454 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -69.76 -24.37 63.52 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 119.903 -1.748 . . . . 0.0 115.586 -168.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -96.14 8.06 44.8 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.673 1.124 . . . . 0.0 112.517 167.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -110.62 -1.35 16.86 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.842 1.657 . . . . 0.0 111.013 172.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -94.8 117.67 30.52 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 127.839 2.456 . . . . 0.0 105.804 165.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -89.09 134.18 34.1 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.537 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 47' ' ' ASP . 0.3 OUTLIER -125.83 142.95 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 124.71 1.204 . . . . 0.0 112.21 173.025 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.4 p -154.3 145.12 22.52 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.974 1.31 . . . . 0.0 110.123 -166.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -166.94 59.89 0.09 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 122.935 1.35 . . . . 0.0 112.329 -170.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 76.1 p -89.89 -58.3 2.56 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.38 -0.825 . . . . 0.0 111.836 153.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.95 -55.95 4.09 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.959 0.885 . . . . 0.0 113.016 -151.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.25 -30.15 70.28 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.801 1.241 . . . . 0.0 112.344 172.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.03 -29.87 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.922 0.889 . . . . 0.0 111.174 175.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.8 m -84.71 4.89 30.54 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.394 1.478 . . . . 0.0 114.612 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -84.47 -14.42 49.22 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.531 1.514 . . . . 0.0 112.346 170.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -120.66 161.96 37.02 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 127.045 2.138 . . . . 0.0 110.389 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -58.83 -38.26 89.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.52 2.147 . . . . 0.0 114.26 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -121.57 -35.78 3.17 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 116.852 2.168 . . . . 0.0 116.852 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 1.628 ' HD1' ' CD2' ' A' ' 43' ' ' TYR . 1.9 p90 -166.31 143.68 5.23 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 120.705 1.593 . . . . 0.0 109.387 -171.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 96.8 p -106.57 -168.09 1.37 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 135.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -75.62 -75.45 0.18 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.768 1.622 . . . . 0.0 112.195 -166.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -178.13 -174.65 0.43 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.926 0.89 . . . . 0.0 109.541 -173.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 11.5 t0 -139.13 136.38 35.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.74 140.87 49.24 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.527 1.531 . . . . 0.0 112.154 -169.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.8 mtt -114.48 130.53 56.74 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 120.56 1.527 . . . . 0.0 111.857 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.0 mt -131.55 161.24 33.08 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 128.536 2.734 . . . . 0.0 112.936 -153.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.5 p -93.93 179.81 5.22 Favored 'General case' 0 N--CA 1.48 1.062 1 C-N-CA 132.876 4.47 . . . . 0.0 114.573 -153.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 t -120.34 109.01 14.85 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.52 -1.362 . . . . 0.0 108.082 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -161.01 -154.97 0.39 Allowed 'General case' 0 CA--C 1.561 1.367 0 O-C-N 120.88 -1.138 . . . . 0.0 112.898 -136.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.35 178.85 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 1 C-N-CA 132.359 4.264 . . . . 0.0 109.09 -157.066 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.7 p -76.22 123.44 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.973 1.309 . . . . 0.0 112.294 -164.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -122.56 148.08 52.06 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.84 1.256 . . . . 0.0 112.315 -173.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.62 72.74 5.92 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 125.234 3.956 . . . . 0.0 111.986 -172.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.3 p -66.12 -24.09 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.075 0.95 . . . . 0.0 113.3 -169.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.61 -40.08 51.79 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.514 1.126 . . . . 0.0 113.765 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -60.82 -38.5 85.62 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.032 0.533 . . . . 0.0 111.784 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.7 -46.7 62.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.294 1.038 . . . . 0.0 111.037 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -58.35 -44.72 88.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.206 1.002 . . . . 0.0 111.673 173.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.5 m -73.59 -48.09 35.42 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.977 0.911 . . . . 0.0 112.307 -172.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 1.611 ' HD1' ' CD2' ' A' ' 64' ' ' TYR . 3.3 m-85 -59.43 -45.2 92.23 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.215 174.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -58.64 -48.42 81.1 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.106 0.866 . . . . 0.0 112.497 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -58.98 -43.67 91.46 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 70.9 m -74.17 -23.46 59.24 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -74.14 -17.16 60.96 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -167.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.7 p -144.2 2.84 1.16 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 175.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.34 71.27 0.86 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 127.062 2.267 . . . . 0.0 110.342 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -165.5 128.85 2.2 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 127.882 2.473 . . . . 0.0 105.677 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.0 m -84.55 141.73 30.5 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 126.412 1.885 . . . . 0.0 110.496 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.93 151.04 31.58 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -170.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 24.9 p -101.06 133.86 44.94 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.819 0.848 . . . . 0.0 111.427 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 1.669 ' HE2' ' CE1' ' A' ' 75' ' ' PHE . 5.5 m-85 -89.35 117.61 28.42 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 168.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.1 t -121.86 113.85 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 123.464 0.706 . . . . 0.0 109.284 -169.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 1.614 ' HD1' ' CD2' ' A' ' 77' ' ' PHE . 93.2 m-85 -89.86 125.12 35.21 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.518 -1.364 . . . . 0.0 107.581 -176.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.8 97.82 6.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 123.293 1.52 . . . . 0.0 107.55 168.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -73.7 116.77 14.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.545 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.0 p -147.41 158.27 43.91 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 128.521 2.728 . . . . 0.0 104.674 -161.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -11.42 -131.09 0.0 OUTLIER Glycine 0 N--CA 1.483 1.783 0 O-C-N 119.304 -2.122 . . . . 0.0 114.442 -127.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 30.3 p -94.03 101.01 13.03 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 115.058 -2.657 . . . . 0.0 108.308 161.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -172.67 165.87 5.43 Favored 'General case' 0 N--CA 1.469 0.516 1 C-N-CA 131.76 4.024 . . . . 0.0 106.835 158.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.4 t -87.98 124.77 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.02 -1.05 . . . . 0.0 110.218 159.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.78 141.55 37.84 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.991 0.814 . . . . 0.0 108.861 164.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 31.4 tp -119.72 106.1 11.81 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.416 1.086 . . . . 0.0 108.617 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.4 m -80.17 125.62 30.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.122 0.569 . . . . 0.0 110.916 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 10.8 m -111.38 107.04 16.15 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 120.893 -1.129 . . . . 0.0 109.751 -173.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 1.673 ' HE2' ' CE1' ' A' ' 89' ' ' TYR . 88.1 m-85 -103.73 97.65 7.63 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.028 0.531 . . . . 0.0 112.32 -176.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.3 mt -75.7 82.81 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 139.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -178.03 179.87 48.29 Favored Glycine 0 N--CA 1.468 0.791 0 N-CA-C 122.413 3.725 . . . . 0.0 122.413 -161.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -108.88 66.73 0.32 Allowed Pre-proline 0 CA--C 1.551 1.002 0 CA-C-N 112.886 -1.657 . . . . 0.0 113.346 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.67 134.78 45.69 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.192 2.594 . . . . 0.0 113.428 -176.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -76.33 -41.74 47.39 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.3 1.04 . . . . 0.0 111.77 171.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -69.84 -11.67 61.03 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -172.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.11 -18.29 5.36 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.478 1.911 . . . . 0.0 114.017 163.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -78.37 -2.22 37.19 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.879 1.272 . . . . 0.0 114.063 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -134.35 -35.7 0.91 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.12 0.873 . . . . 0.0 113.188 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 pp -77.0 166.26 23.56 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -164.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -92.13 -175.17 3.99 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.515 1.126 . . . . 0.0 112.808 -162.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -122.07 168.63 11.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.566 1.546 . . . . 0.0 109.541 159.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.5 p -122.69 124.9 71.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 167.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 47.3 t -125.14 114.39 18.96 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 122.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -178.23 168.16 1.93 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 123.126 1.441 . . . . 0.0 109.126 -165.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -141.99 109.16 5.52 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 127.045 2.138 . . . . 0.0 109.591 164.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -151.04 162.8 40.15 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -168.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 1.662 ' HE1' ' CE2' ' A' ' 107' ' ' PHE . 50.9 m-85 -73.69 149.71 41.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.17 0.988 . . . . 0.0 111.946 164.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.4 tp -142.45 147.54 36.29 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 128.125 2.57 . . . . 0.0 109.696 -157.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.7 p -114.75 176.0 5.25 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.919 2.088 . . . . 0.0 114.013 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.83 -13.19 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 126.166 1.787 . . . . 0.0 114.548 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -115.02 33.07 5.63 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.672 -1.268 . . . . 0.0 112.46 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.07 153.13 19.82 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.733 -1.229 . . . . 0.0 114.114 -172.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -156.92 128.15 6.89 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.491 1.516 . . . . 0.0 108.854 -174.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.4 pp -158.18 152.26 24.1 Favored 'General case' 0 CA--C 1.554 1.096 0 O-C-N 121.062 -1.024 . . . . 0.0 113.194 -168.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 29.8 t -99.91 146.46 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 126.585 1.954 . . . . 0.0 111.981 175.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.41 133.51 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.317 0.579 . . . . 0.0 110.841 145.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.2 t -154.42 153.83 32.23 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.027 1.331 . . . . 0.0 111.839 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -27.67 68.24 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.157 1.383 . . . . 0.0 114.34 -166.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.7 -30.72 46.21 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.524 -1.36 . . . . 0.0 113.307 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.29 -33.65 65.33 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.129 -0.982 . . . . 0.0 111.39 168.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.6 mm -60.95 -38.67 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 118.626 0.648 . . . . 0.0 111.004 166.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -65.79 -23.7 66.76 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 173.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -70.4 -29.69 66.39 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 120.243 -1.535 . . . . 0.0 112.269 167.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 27.4 mt -78.58 -38.31 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.715 0.806 . . . . 0.0 110.717 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.463 ' HE3' ' HA ' ' A' ' 153' ' ' PHE . 54.9 mmtt -136.08 109.78 9.88 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 126.549 1.94 . . . . 0.0 111.82 -174.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -62.33 -12.59 28.05 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 N-CA-C 120.083 3.07 . . . . 0.0 120.083 -166.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 9.5 m -133.95 130.96 38.45 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.824 1.647 . . . . 0.0 112.303 173.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -96.59 12.57 31.2 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 -167.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -77.71 14.16 1.12 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -171.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.49 41.16 0.08 OUTLIER Glycine 0 N--CA 1.47 0.951 0 O-C-N 120.918 -1.113 . . . . 0.0 112.856 -172.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.537 ' CG1' ' HG1' ' A' ' 133' ' ' THR . 53.9 t -69.8 115.65 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.383 0.673 . . . . 0.0 111.65 -172.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.42 88.21 3.6 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 158.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.537 ' HG1' ' CG1' ' A' ' 131' ' ' VAL . 88.7 m -88.3 133.67 34.01 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 163.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -131.78 128.79 39.53 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.655 1.182 . . . . 0.0 108.431 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 51.7 t -136.6 136.04 38.88 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.938 -1.101 . . . . 0.0 111.786 -162.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -142.87 129.83 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.489 1.116 . . . . 0.0 109.855 -167.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.0 m -131.94 144.6 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 121.454 -0.778 . . . . 0.0 110.68 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -132.51 152.08 51.69 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 125.256 1.423 . . . . 0.0 108.384 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.29 0.9 OUTLIER -148.43 152.68 37.37 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.938 1.295 . . . . 0.0 108.507 167.126 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.0 t -128.33 139.77 52.23 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -93.43 -53.26 4.15 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.989 0.916 . . . . 0.0 109.614 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.3 m -50.3 -41.44 50.85 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.253 1.421 . . . . 0.0 113.18 172.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -100.5 13.32 59.75 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.589 1.566 . . . . 0.0 115.007 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 92.7 mtp 28.96 63.53 0.12 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 127.961 2.504 . . . . 0.0 114.754 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.8 t -159.68 139.76 11.77 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.292 -0.88 . . . . 0.0 110.279 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 1.66 ' HE1' ' CE2' ' A' ' 146' ' ' TYR . 2.4 m-85 -130.92 156.92 44.26 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 122.129 -0.357 . . . . 0.0 110.262 -162.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -149.85 136.93 19.6 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.038 0.835 . . . . 0.0 113.139 -163.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -146.56 115.27 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.184 0.516 . . . . 0.0 110.519 -159.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -142.86 137.42 29.56 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.178 -0.951 . . . . 0.0 112.311 -169.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.1 p -150.43 140.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 120.912 -1.118 . . . . 0.0 110.563 162.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.7 m -118.84 149.29 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 128.281 2.633 . . . . 0.0 109.552 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -134.34 135.25 42.6 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 1.642 ' HE1' ' CE2' ' A' ' 153' ' ' PHE . 64.8 m-85 -135.81 158.54 44.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.901 2.081 . . . . 0.0 110.537 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -104.1 -143.3 12.34 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 164.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -45.41 -35.47 11.94 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.931 3.087 . . . . 0.0 114.653 169.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -62.68 -10.02 11.1 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -172.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -107.77 70.21 0.77 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 123.17 1.462 . . . . 0.0 111.195 167.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.1 -25.25 58.45 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.726 1.611 . . . . 0.0 112.096 165.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.44 -53.89 8.65 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -74.61 -20.44 59.91 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 120.598 1.545 . . . . 0.0 113.107 170.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 1.64 ' HE1' ' CE2' ' A' ' 161' ' ' TYR . 80.4 t80 -60.84 -57.45 12.6 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.488 1.495 . . . . 0.0 110.978 165.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -63.4 -29.64 70.91 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.981 -1.074 . . . . 0.0 112.995 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.16 -33.79 76.84 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.364 0.984 . . . . 0.0 113.088 172.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -75.13 -52.45 10.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.255 -0.903 . . . . 0.0 112.091 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 10.0 mp -50.93 -34.82 30.23 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.627 1.103 . . . . 0.0 113.963 170.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -60.41 -50.97 71.49 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.989 1.716 . . . . 0.0 110.689 171.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -72.88 -18.2 61.45 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.2 mm -83.29 -38.38 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 120.288 1.403 . . . . 0.0 110.707 171.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -62.21 -22.63 66.09 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.512 -1.367 . . . . 0.0 112.558 166.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -101.33 28.68 5.25 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.589 1.556 . . . . 0.0 114.362 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 C-N-CA 126.205 1.802 . . . . 0.0 115.831 170.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 120.773 0.321 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.69 -0.73 85.4 Favored Glycine 0 CA--C 1.537 1.446 0 N-CA-C 117.252 1.661 . . . . 0.0 117.252 168.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -56.8 143.72 35.83 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 120.157 1.979 . . . . 0.0 111.821 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 94.0 mtp -72.05 96.54 1.76 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.727 1.211 . . . . 0.0 112.599 -171.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -83.78 92.85 7.83 Favored 'General case' 0 C--O 1.24 0.579 0 O-C-N 121.478 -0.764 . . . . 0.0 109.377 177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 tp -80.67 104.93 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 123.137 1.446 . . . . 0.0 113.073 -172.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.2 125.92 10.14 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 111.786 -2.461 . . . . 0.0 111.309 -173.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -59.99 -24.34 64.36 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 116.618 2.081 . . . . 0.0 116.618 -155.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -106.08 -27.05 11.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.127 0.971 . . . . 0.0 112.436 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.9 t -74.35 -61.0 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.754 1.221 . . . . 0.0 111.687 -172.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.8 -45.93 92.91 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.471 -0.627 . . . . 0.0 111.829 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.15 -53.04 30.37 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.936 0.894 . . . . 0.0 112.741 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -68.29 -41.08 81.48 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 mp -75.98 -40.08 54.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.987 1.267 . . . . 0.0 111.92 -172.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.56 -46.31 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.424 -0.797 . . . . 0.0 109.863 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.4 m -70.16 -41.29 74.0 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.536 -0.727 . . . . 0.0 111.666 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -69.35 -22.27 63.76 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.685 -1.26 . . . . 0.0 112.833 172.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.3 m -63.83 -48.15 77.93 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.772 1.624 . . . . 0.0 109.804 168.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -43.09 92.04 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.996 0.816 . . . . 0.0 112.105 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.8 ttt85 -71.22 -42.08 69.38 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.228 1.811 . . . . 0.0 113.54 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.7 -40.26 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 119.44 1.018 . . . . 0.0 110.036 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -79.46 -8.12 58.9 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 55.57 37.11 28.45 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.978 1.711 . . . . 0.0 114.247 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 pp -112.46 160.07 18.12 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.821 1.248 . . . . 0.0 110.878 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.9 156.08 39.61 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.239 0.542 . . . . 0.0 112.282 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -60.23 -26.97 66.83 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.308 -1.495 . . . . 0.0 112.033 170.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -91.88 12.48 21.45 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.314 1.845 . . . . 0.0 113.27 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -119.38 -10.41 9.7 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.511 1.124 . . . . 0.0 111.945 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 26.8 tp -88.54 111.32 21.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 171.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -85.46 124.78 32.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.258 175.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.0 mm -89.7 141.33 14.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 125.581 1.553 . . . . 0.0 109.875 172.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 54.6 m -118.68 141.77 48.3 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 164.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.71 -152.62 0.32 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.392 2.277 . . . . 0.0 112.513 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.0 t -51.41 -32.13 25.34 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -158.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.4 -42.3 61.33 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -167.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.99 -8.17 24.2 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.457 ' C ' ' H ' ' A' ' 39' ' ' LYS . 35.0 pt -110.3 -2.85 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 127.186 2.194 . . . . 0.0 115.051 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.3 m -42.08 11.17 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 130.256 3.422 . . . . 0.0 117.468 160.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.457 ' H ' ' C ' ' A' ' 37' ' ' ILE . 57.3 mmtt -67.58 -48.9 65.56 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.106 -1.621 . . . . 0.0 109.282 171.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -69.91 160.15 81.35 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.949 162.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -52.73 -35.03 67.25 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.264 2.643 . . . . 0.0 114.817 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -118.71 -52.9 2.33 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.243 0.929 . . . . 0.0 112.852 161.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -145.51 123.85 12.31 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.312 1.968 . . . . 0.0 116.312 -163.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.4 m -73.89 -159.27 0.07 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.834 1.253 . . . . 0.0 109.83 144.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.4 tp -70.15 -76.43 0.1 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 121.272 1.851 . . . . 0.0 112.528 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 11.8 p -174.96 -161.69 0.1 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.974 0.91 . . . . 0.0 111.735 -167.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -127.25 158.31 37.51 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.635 1.574 . . . . 0.0 108.676 161.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.31 133.69 45.61 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.909 2.884 . . . . 0.0 108.93 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.1 ttp -124.89 132.61 53.28 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.161 -0.962 . . . . 0.0 111.32 -168.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.6 mt -137.22 163.86 29.9 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.37 1.868 . . . . 0.0 114.296 -139.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.2 t -92.76 179.51 5.46 Favored 'General case' 0 N--CA 1.475 0.811 1 C-N-CA 132.596 4.358 . . . . 0.0 114.303 -145.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.2 t -134.15 112.96 11.55 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 170.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -164.54 -151.89 0.17 Allowed 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -141.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.421 HG23 ' H ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -125.8 -176.03 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 131.391 3.876 . . . . 0.0 109.546 -165.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.421 ' H ' HG23 ' A' ' 54' ' ' ILE . 32.9 m -76.04 133.7 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.499 0.719 . . . . 0.0 111.563 -177.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -132.2 145.3 56.75 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.044 0.938 . . . . 0.0 113.255 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -76.45 71.42 5.91 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 125.175 3.917 . . . . 0.0 111.784 -173.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.8 p -58.88 -29.38 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.307 1.843 . . . . 0.0 113.221 -169.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -52.48 -37.42 57.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.073 1.749 . . . . 0.0 113.817 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 1.668 ' HD2' ' CD1' ' A' ' 60' ' ' TYR . 18.1 m-30 -66.15 -35.2 79.86 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.241 -0.912 . . . . 0.0 110.697 178.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 37.4 tp -74.97 -42.49 57.51 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.623 0.769 . . . . 0.0 112.207 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 mp -57.62 -32.15 66.95 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.973 0.806 . . . . 0.0 112.122 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.7 m -73.77 -50.95 18.14 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.823 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -58.29 -34.97 71.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.258 0.935 . . . . 0.0 112.894 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 47.8 t-105 -66.64 -58.71 4.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.749 1.22 . . . . 0.0 112.825 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -75.85 -36.96 59.41 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -174.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.5 t -69.08 -13.81 62.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.012 0.925 . . . . 0.0 113.352 -175.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.4 tpt85 -68.45 -16.13 63.79 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 119.537 1.062 . . . . 0.0 113.151 -172.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.2 p -140.46 -28.79 0.71 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.401 1.48 . . . . 0.0 112.259 165.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.18 79.99 0.67 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 125.796 1.665 . . . . 0.0 108.983 -164.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -158.17 119.95 3.6 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 127.871 2.469 . . . . 0.0 107.168 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.0 m -64.89 116.29 6.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 122.111 0.958 . . . . 0.0 111.268 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.52 143.46 31.56 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.189 1.795 . . . . 0.0 111.857 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 79.3 m -96.25 128.86 43.54 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.748 -0.595 . . . . 0.0 111.791 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -80.31 129.31 34.42 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 149.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.8 t -123.81 114.37 41.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -174.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -87.43 110.97 20.66 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -173.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -112.56 102.17 10.27 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -74.33 125.92 29.54 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.394 -0.817 . . . . 0.0 109.92 170.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.3 p -145.48 160.19 41.97 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 128.285 2.634 . . . . 0.0 104.772 -165.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -11.09 -128.39 0.0 OUTLIER Glycine 0 N--CA 1.486 1.967 0 C-N-CA 126.809 2.147 . . . . 0.0 116.267 -146.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 53.5 t -92.95 98.08 11.13 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 116.27 -2.172 . . . . 0.0 108.588 162.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.68 154.91 2.58 Favored 'General case' 0 CA--C 1.538 0.519 1 C-N-CA 132.412 4.285 . . . . 0.0 106.628 159.199 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.07 148.85 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 119.714 -1.866 . . . . 0.0 109.429 149.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.2 p -139.61 163.62 32.09 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 119.597 -1.939 . . . . 0.0 110.764 162.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 pp -128.93 130.14 46.37 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.696 0.76 . . . . 0.0 110.467 164.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.3 m -83.78 133.6 34.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.99 1.316 . . . . 0.0 109.845 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 61.6 m -104.37 108.85 20.45 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 121.099 -1.001 . . . . 0.0 110.029 -172.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 1.669 ' HD2' ' CD1' ' A' ' 89' ' ' TYR . 82.7 m-85 -111.05 94.71 5.13 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.5 mt -74.96 78.32 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 135.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.34 178.6 47.12 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 116.517 1.367 . . . . 0.0 116.517 -169.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 1.648 ' HD1' ' CD2' ' A' ' 92' ' ' PHE . 8.4 p90 -110.25 74.82 0.87 Allowed Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.919 1.288 . . . . 0.0 114.196 178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -70.52 105.38 1.6 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.769 2.979 . . . . 0.0 112.27 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.85 -21.67 30.91 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -73.09 -20.23 61.0 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.862 1.665 . . . . 0.0 112.93 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.34 -21.18 22.78 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.14 2.176 . . . . 0.0 114.135 171.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.13 -38.82 54.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.14 0.976 . . . . 0.0 111.515 167.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -125.45 -17.15 5.66 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 118.119 2.637 . . . . 0.0 118.119 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . 0.26 3.9 pp -70.31 167.49 17.93 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 123.174 2.716 . . . . 0.0 112.83 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -89.5 -163.94 1.08 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.811 1.244 . . . . 0.0 113.659 -157.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.27 170.32 8.03 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 126.673 1.989 . . . . 0.0 112.787 163.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.2 m -73.47 151.13 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.423 -0.798 . . . . 0.0 112.721 155.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 27.2 p -152.4 -178.57 6.91 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 128.054 2.542 . . . . 0.0 108.796 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -56.84 -141.88 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.848 1 C-N-CA 133.302 4.641 . . . . 0.0 107.767 161.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -86.49 127.05 34.83 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 118.089 -1.444 . . . . 0.0 114.068 -149.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -154.08 145.33 22.93 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.759 1.224 . . . . 0.0 112.409 -172.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 1.642 ' HE1' ' CE2' ' A' ' 107' ' ' PHE . 5.5 m-85 -105.46 131.56 52.72 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.327 1.451 . . . . 0.0 110.358 169.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.4 pp -141.83 150.32 41.48 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.119 1.368 . . . . 0.0 114.537 -167.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.1 m -96.2 174.19 7.02 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 -166.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.25 -10.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 128.772 2.829 . . . . 0.0 114.8 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -134.84 35.63 3.11 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.212 -0.93 . . . . 0.0 111.412 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -110.07 147.5 33.49 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -175.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -152.75 135.26 15.18 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.255 1.022 . . . . 0.0 108.406 -148.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.01 157.9 38.33 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.067 1.347 . . . . 0.0 112.287 -175.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.8 t -97.35 143.67 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.859 1.264 . . . . 0.0 110.491 169.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.9 p -124.76 106.07 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 122.991 1.377 . . . . 0.0 109.749 157.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.5 p -123.46 163.93 19.91 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.077 1.751 . . . . 0.0 108.773 165.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.416 HD12 ' HG ' ' A' ' 127' ' ' CYS . 1.9 tm? -59.57 -21.32 60.15 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.571 -0.705 . . . . 0.0 112.414 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.17 -32.85 65.09 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.66 1.184 . . . . 0.0 113.566 173.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -69.96 -29.36 66.46 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 120.496 -1.378 . . . . 0.0 111.636 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.3 mp -72.25 -40.8 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.096 0.958 . . . . 0.0 109.924 167.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -55.26 -27.36 45.92 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.694 0.798 . . . . 0.0 112.414 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -79.71 -20.19 47.1 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.368 -1.458 . . . . 0.0 114.918 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 88.7 mt -84.13 -41.63 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 120.001 1.273 . . . . 0.0 110.01 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -153.17 139.89 12.71 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 127.25 2.22 . . . . 0.0 109.444 165.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.12 119.75 7.22 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.409 2.073 . . . . 0.0 112.201 174.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.416 ' HG ' HD12 ' A' ' 118' ' ' LEU . 71.2 m -68.98 162.03 27.65 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.707 0.803 . . . . 0.0 112.421 -172.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.38 149.46 28.64 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.168 2.187 . . . . 0.0 106.509 169.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -50.62 114.51 1.16 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 169.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.91 11.11 13.01 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 117.937 -1.479 . . . . 0.0 116.357 -166.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.8 t -59.63 147.76 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 120.938 2.369 . . . . 0.0 111.045 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.25 86.49 2.37 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.566 1.546 . . . . 0.0 109.345 160.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.8 m -78.32 137.96 38.33 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 168.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -123.12 130.1 52.33 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -174.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 21.7 p -116.8 136.22 53.13 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.029 -0.419 . . . . 0.0 110.771 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.0 t -113.1 130.26 67.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 125.454 1.502 . . . . 0.0 106.972 165.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.8 m -119.98 145.2 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.633 0.73 . . . . 0.0 109.933 160.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 45.5 ttm180 -146.14 154.82 42.23 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.797 1.639 . . . . 0.0 108.092 -169.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.311 0.0 OUTLIER -144.51 148.19 34.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.108 -0.995 . . . . 0.0 110.042 164.234 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.1 t -153.97 -171.28 3.83 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.233 1.013 . . . . 0.0 112.2 -155.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.3 m120 48.73 80.53 0.06 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.07 2.548 . . . . 0.0 111.664 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 63.2 p 53.55 -1.2 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -165.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.15 34.68 8.6 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.653 1.12 . . . . 0.0 113.003 -165.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 36.5 tpp -124.36 5.15 8.4 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.109 1.764 . . . . 0.0 113.203 -175.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.2 t -143.68 155.37 44.2 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.295 1.438 . . . . 0.0 111.05 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -134.57 144.37 47.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.852 1.261 . . . . 0.0 109.085 -164.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -151.45 147.44 26.86 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.658 -1.276 . . . . 0.0 111.333 -151.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.5 tt -145.78 147.01 18.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -170.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -139.82 122.97 16.86 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.757 0.823 . . . . 0.0 109.599 163.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.99 127.23 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 122.816 1.293 . . . . 0.0 112.777 172.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.5 m -132.61 150.51 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.819 2.048 . . . . 0.0 110.394 -164.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -126.77 138.17 53.33 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -173.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -139.92 157.0 46.4 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.236 1.415 . . . . 0.0 110.196 167.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.23 -153.11 29.59 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 124.548 1.071 . . . . 0.0 113.451 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.32 -16.12 16.86 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 124.908 3.738 . . . . 0.0 115.07 177.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -71.79 -12.47 61.31 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.438 2.695 . . . . 0.0 115.965 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -81.87 41.31 0.65 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 122.861 1.315 . . . . 0.0 112.916 -174.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -64.12 -20.58 66.08 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.528 1.531 . . . . 0.0 113.78 -168.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.83 -52.58 12.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.52 1.054 . . . . 0.0 110.921 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -60.19 -41.98 94.09 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.176 0.99 . . . . 0.0 112.121 171.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -61.16 -52.96 62.66 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 122.564 0.345 . . . . 0.0 110.908 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -65.21 -34.51 78.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.452 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.72 -33.07 74.83 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 119.386 0.994 . . . . 0.0 113.135 175.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.54 -50.13 34.17 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.463 0.705 . . . . 0.0 112.36 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.7 mt -55.26 -37.86 67.81 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.643 0.656 . . . . 0.0 111.582 175.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -69.91 -29.69 66.94 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.392 1.877 . . . . 0.0 112.267 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -88.03 -52.26 5.35 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . 0.287 1.3 pp -104.87 -7.15 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 -165.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 1.605 ' HE2' ' CE1' ' A' ' 169' ' ' TYR . 21.4 m-85 -116.82 8.5 13.64 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.88 1.218 . . . . 0.0 111.927 163.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -137.29 27.76 2.83 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.877 1.271 . . . . 0.0 113.825 172.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.261 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 168.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 121.214 0.53 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.99 -4.53 24.18 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 125.12 1.343 . . . . 0.0 114.381 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -127.41 160.74 30.52 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.094 1.758 . . . . 0.0 112.015 -172.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -89.12 129.18 35.77 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 154.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -136.95 111.95 8.96 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.848 0.749 . . . . 0.0 112.08 -165.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.9 tp -76.66 99.22 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 122.929 1.347 . . . . 0.0 111.423 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -47.6 129.05 13.42 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 111.432 -2.622 . . . . 0.0 112.776 -162.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -56.43 -46.08 80.45 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -139.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -92.37 -28.05 17.15 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.152 0.981 . . . . 0.0 111.985 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.1 t -67.33 -55.04 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 124.47 1.108 . . . . 0.0 111.386 -169.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.66 -55.13 31.52 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 168.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.7 -41.65 70.53 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.735 1.268 . . . . 0.0 113.898 -174.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -73.16 -40.99 64.4 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.894 1.278 . . . . 0.0 112.425 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 mp -70.62 -37.63 73.85 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.099 -1.001 . . . . 0.0 112.523 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.62 -43.57 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.087 1.355 . . . . 0.0 109.491 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.2 p -66.19 -40.63 90.55 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.109 0.413 . . . . 0.0 111.643 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -63.6 -41.86 98.3 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 118.838 0.744 . . . . 0.0 112.263 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.3 m -60.44 -49.15 78.7 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.205 -0.935 . . . . 0.0 110.64 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.2 ptt85 -69.35 -32.9 72.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 118.241 -0.885 . . . . 0.0 113.251 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.1 ttt-85 -62.18 -48.4 80.24 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.29 1.436 . . . . 0.0 111.349 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.19 -33.03 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.978 0.911 . . . . 0.0 111.828 -174.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -90.51 -0.6 57.73 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 172.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 58.23 30.8 19.97 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.637 1.975 . . . . 0.0 114.874 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 pp -100.9 162.64 12.76 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.374 0.988 . . . . 0.0 112.311 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.75 155.37 33.25 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.12 0.968 . . . . 0.0 111.302 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.35 -21.24 66.67 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.073 -1.642 . . . . 0.0 113.542 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -96.2 10.5 37.6 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.294 1.438 . . . . 0.0 113.614 168.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -113.28 14.82 19.38 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.477 1.511 . . . . 0.0 110.215 168.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.9 tp -112.42 120.84 43.04 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 165.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -85.33 125.34 32.86 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 118.462 -1.295 . . . . 0.0 107.589 162.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 47' ' ' ASP 0.255 0.7 OUTLIER -117.08 144.24 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.602 1.961 . . . . 0.0 114.463 167.715 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -154.93 144.51 21.38 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.123 1.369 . . . . 0.0 109.346 -160.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -167.72 62.22 0.07 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.429 1.492 . . . . 0.0 112.298 -167.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.3 t -91.78 -58.35 2.44 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.742 -1.224 . . . . 0.0 112.888 154.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.24 -59.15 2.32 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.02 -152.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.454 ' H ' HD21 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -54.42 -38.95 66.84 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.886 1.674 . . . . 0.0 112.979 177.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -55.6 -25.98 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.156 1.382 . . . . 0.0 111.289 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 63.5 m -110.05 3.19 20.09 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.386 2.274 . . . . 0.0 115.38 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -94.49 20.39 8.46 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 120.378 1.444 . . . . 0.0 112.699 169.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -144.46 170.17 8.76 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 128.574 2.75 . . . . 0.0 107.412 173.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -58.74 -45.35 29.8 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.292 1.995 . . . . 0.0 114.861 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -119.44 -52.91 2.25 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 -171.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -170.31 133.47 1.09 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.201 2.2 . . . . 0.0 106.945 -166.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 t -93.07 -156.69 0.49 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 117.695 -1.145 . . . . 0.0 108.146 173.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -88.84 -81.91 0.26 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 118.046 -1.462 . . . . 0.0 112.04 165.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 t 179.63 -176.41 0.3 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.235 1.016 . . . . 0.0 109.055 -170.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.428 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 17.6 t70 -136.68 115.88 12.54 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.52 132.81 48.32 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.725 1.61 . . . . 0.0 111.099 -158.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.1 ttm -128.73 123.47 33.1 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.705 -1.247 . . . . 0.0 112.785 -156.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.3 mt -120.77 141.73 50.23 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 127.129 2.172 . . . . 0.0 113.351 -144.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.6 p -96.96 160.0 14.59 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.559 1.544 . . . . 0.0 110.334 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 69.2 p -124.98 177.9 5.8 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -153.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.7 t70 59.47 50.77 7.17 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.69 1.996 . . . . 0.0 110.394 -162.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.5 tp -142.75 145.32 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.647 1.579 . . . . 0.0 110.955 -167.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.8 p -109.18 140.56 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.964 1.306 . . . . 0.0 111.772 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 1.648 ' HE1' ' CE2' ' A' ' 56' ' ' TYR . 4.0 p90 -133.72 138.59 31.33 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 119.361 0.982 . . . . 0.0 111.896 170.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.99 71.4 2.15 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 125.142 3.895 . . . . 0.0 109.356 171.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 p -52.32 -38.55 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.326 1.45 . . . . 0.0 114.254 -157.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -70.19 -21.97 62.99 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.552 1.141 . . . . 0.0 112.472 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -66.29 -29.79 70.08 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.379 -0.826 . . . . 0.0 112.204 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 36.6 tp -76.52 -47.01 24.14 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.598 1.09 . . . . 0.0 110.572 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.2 mp -53.68 -49.4 68.08 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.022 0.529 . . . . 0.0 110.99 174.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.2 p -71.67 -29.37 64.52 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 1.67 ' HD1' ' CD2' ' A' ' 64' ' ' TYR . 46.1 t80 -65.76 -33.35 75.66 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.963 0.905 . . . . 0.0 112.086 174.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -75.7 -58.35 3.33 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 160.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.61 -34.46 77.05 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.251 -0.906 . . . . 0.0 112.365 -156.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 71.7 m -78.76 -11.51 59.99 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 ttt85 -69.49 -37.47 77.25 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.011 1.325 . . . . 0.0 114.019 -163.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.9 p -152.39 15.99 0.61 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.349 1.46 . . . . 0.0 112.46 171.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.31 81.8 0.14 Allowed Glycine 0 C--N 1.341 0.835 0 C-N-CA 125.705 1.622 . . . . 0.0 113.237 173.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -151.44 113.64 4.54 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.131 0.967 . . . . 0.0 111.809 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.0 m -66.19 133.59 50.97 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.152 1.381 . . . . 0.0 112.695 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -131.93 159.35 38.93 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.555 1.542 . . . . 0.0 114.439 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 81.8 m -96.76 108.03 20.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.069 2.547 . . . . 0.0 108.543 164.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 1.612 ' HE1' ' CE2' ' A' ' 75' ' ' PHE . 70.2 m-85 -91.13 96.39 10.57 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.216 -0.927 . . . . 0.0 108.784 177.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.53 114.86 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.856 0.862 . . . . 0.0 110.852 -164.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -91.35 117.28 29.53 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 120.323 -1.486 . . . . 0.0 107.704 176.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.06 126.74 54.32 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.685 1.594 . . . . 0.0 111.094 174.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -95.4 128.61 42.4 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.527 1.131 . . . . 0.0 109.147 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.5 p -144.56 165.31 28.37 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 130.512 3.525 . . . . 0.0 105.711 -165.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.35 -121.54 0.0 OUTLIER Glycine 0 N--CA 1.491 2.314 0 C-N-CA 129.868 3.604 . . . . 0.0 115.935 -174.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.9 p -93.51 104.81 16.91 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 114.649 -2.82 . . . . 0.0 109.854 150.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.8 mtt85 -178.54 145.39 0.32 Allowed 'General case' 0 CA--C 1.555 1.138 1 C-N-CA 134.376 5.07 . . . . 0.0 106.753 131.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.14 135.52 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 121.839 2.109 . . . . 0.0 109.731 149.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.5 t -107.05 147.12 30.35 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.427 -1.421 . . . . 0.0 110.77 170.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 18.2 tp -110.98 106.32 15.37 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 159.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.5 m -78.64 111.33 14.61 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.126 164.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.7 t -103.88 110.75 23.0 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 119.613 -1.929 . . . . 0.0 110.733 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -111.13 113.35 25.8 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -173.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.9 mp -77.33 88.73 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 133.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.3 172.38 42.64 Favored Glycine 0 N--CA 1.475 1.299 0 N-CA-C 121.219 3.248 . . . . 0.0 121.219 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 1.645 ' HD1' ' CD2' ' A' ' 92' ' ' PHE . 45.6 m-85 -110.91 49.61 0.27 Allowed Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 127.181 2.193 . . . . 0.0 116.457 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -63.25 166.94 13.65 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 CA-C-N 122.607 1.967 . . . . 0.0 115.514 173.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -77.52 -28.43 52.02 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -84.02 -16.73 42.85 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -172.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -50.74 -28.07 8.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 128.02 2.528 . . . . 0.0 112.908 172.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -61.88 -39.62 92.59 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.788 -0.625 . . . . 0.0 112.302 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -112.19 -17.3 12.82 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -173.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 pp -80.62 157.97 25.82 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 120.675 1.58 . . . . 0.0 111.894 168.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -168.45 138.17 2.42 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -172.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.693 ' CD ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -112.18 -179.14 3.6 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.851 1.66 . . . . 0.0 112.502 177.042 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.693 ' H ' ' CD ' ' A' ' 101' ' ' ARG . 3.1 p -162.6 173.91 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 125.764 1.626 . . . . 0.0 112.732 -142.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 46.3 t -121.56 122.21 39.18 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.716 0.806 . . . . 0.0 108.949 144.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -175.14 170.2 3.19 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.646 1.578 . . . . 0.0 108.823 -172.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -109.78 104.11 13.02 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.597 2.359 . . . . 0.0 110.436 165.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -129.93 165.93 21.08 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -171.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 1.609 ' HE2' ' CE1' ' A' ' 107' ' ' PHE . 13.7 p90 -137.22 137.01 38.64 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.632 1.173 . . . . 0.0 113.31 167.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.6 tt -149.82 144.04 25.74 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.277 1.031 . . . . 0.0 112.192 -135.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 m -71.5 156.0 39.94 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -6.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 129.364 3.065 . . . . 0.0 114.066 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -138.1 60.1 1.63 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.624 2.37 . . . . 0.0 108.587 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -142.36 150.42 40.71 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 121.014 -1.054 . . . . 0.0 113.091 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -150.9 155.27 38.81 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.08 -1.637 . . . . 0.0 112.976 -155.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.68 145.76 26.04 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.166 1.386 . . . . 0.0 111.038 -165.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.99 134.9 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 120.987 1.722 . . . . 0.0 112.885 162.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.83 157.68 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.47 1.108 . . . . 0.0 109.811 171.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.9 t -157.82 161.97 38.4 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.608 1.963 . . . . 0.0 108.288 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.43 -25.38 24.58 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.37 -37.33 28.41 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 120.302 1.41 . . . . 0.0 113.552 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.41 -31.62 63.97 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.67 -1.269 . . . . 0.0 111.319 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.1 tp -70.97 -32.92 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 121.645 -0.66 . . . . 0.0 111.764 167.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -65.51 -12.99 57.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.274 1.03 . . . . 0.0 112.882 171.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.33 -30.38 68.41 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.421 -1.425 . . . . 0.0 113.656 163.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 14.3 mt -87.2 -40.73 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.711 1.204 . . . . 0.0 111.223 -169.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -155.49 155.44 29.75 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 128.382 2.673 . . . . 0.0 107.597 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -53.8 130.22 38.0 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 121.915 1.744 . . . . 0.0 112.32 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 25.7 t -99.54 153.16 19.26 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.9 1.68 . . . . 0.0 111.046 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -156.8 162.71 39.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.502 1.521 . . . . 0.0 109.476 -170.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -58.44 126.9 29.51 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 127.055 2.142 . . . . 0.0 109.999 170.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.77 15.22 65.98 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-O 118.419 -1.212 . . . . 0.0 115.032 -173.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.77 138.94 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.253 1.526 . . . . 0.0 110.34 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 tp -132.7 82.48 2.01 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 123.781 1.753 . . . . 0.0 109.458 173.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 16.8 m -77.31 142.44 39.41 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 155.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -131.63 133.44 44.95 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 121.408 -0.808 . . . . 0.0 109.506 -167.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 46.1 t -127.04 130.54 50.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.215 0.461 . . . . 0.0 110.602 -166.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.78 113.4 40.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.584 1.554 . . . . 0.0 107.735 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.1 m -111.12 135.59 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 122.189 0.995 . . . . 0.0 111.152 173.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -131.12 160.45 34.68 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.23 2.612 . . . . 0.0 106.901 170.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.274 0.0 OUTLIER -143.6 147.67 34.73 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.364 -0.835 . . . . 0.0 109.29 167.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.5 m -97.99 137.34 36.94 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.62 0.645 . . . . 0.0 109.548 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -61.09 168.54 2.44 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -169.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.7 m 53.08 28.26 6.64 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.613 1.165 . . . . 0.0 114.062 -170.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 69.48 25.37 75.56 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.416 1.008 . . . . 0.0 114.706 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 86.1 mtp -83.2 -22.1 33.27 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -166.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 t -165.99 156.32 12.74 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 174.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 1.637 ' HE1' ' CE2' ' A' ' 146' ' ' TYR . 27.4 m-85 -104.66 137.27 42.74 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.075 0.95 . . . . 0.0 111.14 149.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -126.07 108.29 11.22 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -175.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.3 tp -140.64 103.14 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 122.659 1.219 . . . . 0.0 108.895 -142.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -136.48 141.54 43.51 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.67 -158.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 p -154.15 146.02 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.717 0.807 . . . . 0.0 111.083 177.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.2 m -132.14 134.39 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 127.189 2.196 . . . . 0.0 110.464 -174.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.85 116.18 31.56 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -168.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 1.604 ' HD2' ' CD1' ' A' ' 153' ' ' PHE . 80.9 m-85 -137.61 158.15 44.99 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.876 0.845 . . . . 0.0 112.201 172.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -86.32 -160.6 34.43 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 125.568 1.556 . . . . 0.0 113.31 172.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.23 -16.27 27.27 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.67 2.913 . . . . 0.0 115.787 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -90.19 16.97 7.6 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.905 1.682 . . . . 0.0 114.273 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -70.43 56.24 0.16 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.565 1.546 . . . . 0.0 111.309 165.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.81 -26.15 65.54 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.304 1.042 . . . . 0.0 112.347 -173.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.51 -53.69 13.04 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -76.64 -26.34 54.77 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.662 0.665 . . . . 0.0 112.518 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 1.62 ' HD1' ' CD2' ' A' ' 161' ' ' TYR . 13.6 t80 -63.24 -56.25 18.16 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.268 0.94 . . . . 0.0 109.871 172.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -55.83 -33.48 64.51 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.115 -0.991 . . . . 0.0 112.949 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.86 -34.11 76.04 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.78 -48.13 64.46 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 120.687 -1.258 . . . . 0.0 112.537 171.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -59.49 -25.96 64.87 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 121.423 1.919 . . . . 0.0 114.484 172.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.0 ttp85 -68.49 -39.62 81.26 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.715 1.206 . . . . 0.0 111.975 169.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -72.21 -29.98 64.48 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.402 1.081 . . . . 0.0 113.486 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.69 -47.34 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.156 1.382 . . . . 0.0 109.589 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -62.6 -3.46 1.49 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 166.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -124.72 26.91 7.01 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 . . . . . 0 C--O 1.254 1.317 0 O-C-N 121.112 -0.993 . . . . 0.0 111.561 168.229 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.56 -150.78 45.48 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 118.913 0.779 . . . . 0.0 113.618 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -80.03 38.74 0.41 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -168.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.3 mtt -67.57 96.58 0.54 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.68 -1.263 . . . . 0.0 112.251 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -140.85 121.71 14.46 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.054 0.942 . . . . 0.0 112.787 169.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.4 mm -103.59 118.98 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 122.697 1.236 . . . . 0.0 107.79 145.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -85.3 149.48 25.43 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.421 -1.718 . . . . 0.0 111.051 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -52.95 -28.27 22.85 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -78.71 -25.53 44.67 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.497 -0.752 . . . . 0.0 111.564 -174.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.4 t -70.5 -46.25 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.613 1.165 . . . . 0.0 110.243 173.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.32 -52.58 52.37 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 169.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.6 -28.71 70.08 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.37 -1.076 . . . . 0.0 113.428 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -75.08 -43.71 51.61 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.232 1.378 . . . . 0.0 114.097 169.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.95 -40.14 83.28 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.321 0.964 . . . . 0.0 111.378 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -66.63 -41.9 88.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 O-C-N 121.256 -0.902 . . . . 0.0 110.238 172.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.3 t -57.7 -47.43 82.4 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.248 0.931 . . . . 0.0 112.506 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -72.38 -29.06 63.42 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.602 -0.686 . . . . 0.0 111.666 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.9 m -63.42 -47.66 81.02 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.701 1.137 . . . . 0.0 110.456 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -51.55 -50.54 59.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.61 1.164 . . . . 0.0 111.283 171.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -77.05 -38.71 52.14 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -168.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -78.97 -42.87 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.191 0.905 . . . . 0.0 110.755 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.04 -8.2 59.72 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 118.815 0.734 . . . . 0.0 112.695 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.4 mmt85 56.57 41.21 28.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.432 1.893 . . . . 0.0 113.034 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 pp -114.59 150.44 35.03 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.454 1.502 . . . . 0.0 110.255 168.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -66.85 153.3 43.78 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.807 -0.558 . . . . 0.0 111.151 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.53 -19.04 63.71 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.518 -1.364 . . . . 0.0 113.2 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -92.17 7.43 42.59 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.305 1.442 . . . . 0.0 113.258 166.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -119.33 10.55 11.98 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.948 1.699 . . . . 0.0 111.7 168.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.8 tp -99.63 130.58 45.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.225 2.21 . . . . 0.0 105.311 161.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -95.48 112.59 24.28 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.168 170.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -108.16 143.74 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 126.073 1.749 . . . . 0.0 112.411 173.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 m -155.55 131.0 9.65 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -139.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -171.27 57.73 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.774 0.797 . . . . 0.0 111.695 -161.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.5 p -87.55 -54.97 4.0 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.937 -1.102 . . . . 0.0 110.249 153.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.17 -45.37 16.47 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -158.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.458 ' H ' ' CD1' ' A' ' 36' ' ' LEU . 3.0 mp -60.02 -41.64 92.63 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.379 1.072 . . . . 0.0 109.557 176.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mp -75.92 -20.99 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 127.626 2.37 . . . . 0.0 111.107 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 15.4 t -74.09 -39.44 63.41 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.561 -1.337 . . . . 0.0 111.82 172.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.9 mmpt? -72.0 -46.27 57.85 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.96 0.8 . . . . 0.0 110.663 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -148.77 95.53 3.93 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 124.709 1.203 . . . . 0.0 109.59 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -66.33 -56.85 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 121.885 1.724 . . . . 0.0 112.596 -173.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -92.77 29.24 1.83 Allowed 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.516 1.126 . . . . 0.0 110.548 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 1.603 ' HE1' ' CE2' ' A' ' 43' ' ' TYR . 29.0 t80 -160.42 99.53 1.31 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 155.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.5 p -178.66 -178.55 0.58 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.778 1.631 . . . . 0.0 110.0 -173.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.5 tp -127.35 -87.03 0.58 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 168.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 p -178.67 176.04 1.02 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.815 1.293 . . . . 0.0 112.451 -159.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -148.91 120.16 7.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.334 1.454 . . . . 0.0 107.989 -177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.5 144.05 45.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.199 2.2 . . . . 0.0 110.05 -157.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.5 mtt -132.83 131.68 41.3 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.369 1.44 . . . . 0.0 112.532 -162.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.3 mt -128.96 145.42 51.24 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 127.706 3.128 . . . . 0.0 112.15 -144.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.2 p -123.09 163.24 20.9 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 128.062 2.545 . . . . 0.0 111.558 -170.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.6 p -51.98 127.99 22.95 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.59 1.556 . . . . 0.0 113.489 -164.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.37 151.88 32.58 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 118.081 2.623 . . . . 0.0 118.081 -135.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.83 118.37 54.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 165.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 m -79.04 130.49 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.858 -154.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -136.29 148.81 65.79 Favored Pre-proline 0 C--O 1.236 0.367 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -166.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.55 76.67 2.3 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.061 3.174 . . . . 0.0 110.807 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.36 -45.44 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 126.526 1.93 . . . . 0.0 113.261 -167.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -78.26 -13.29 59.91 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -70.91 -35.98 72.52 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.409 -1.432 . . . . 0.0 110.146 162.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.0 tp -61.7 -43.95 97.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.745 0.818 . . . . 0.0 111.099 170.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp -56.29 -43.2 78.63 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.326 0.966 . . . . 0.0 112.6 170.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.1 t -61.83 -45.38 94.05 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.401 0.546 . . . . 0.0 111.575 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 1.63 ' HE1' ' CE2' ' A' ' 64' ' ' TYR . 62.3 t80 -66.5 -38.75 87.94 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.19 0.596 . . . . 0.0 112.511 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -57.49 12.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.406 1.483 . . . . 0.0 110.733 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.9 -35.81 81.3 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.198 0.599 . . . . 0.0 111.687 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.2 t -76.1 -23.45 54.93 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.54 -28.64 60.56 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 120.847 1.658 . . . . 0.0 115.163 -165.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.8 p -139.01 14.48 2.65 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.838 1.255 . . . . 0.0 113.415 157.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.47 79.73 0.2 Allowed Glycine 0 N--CA 1.472 1.051 0 C-N-CA 126.454 1.978 . . . . 0.0 113.305 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 74.5 mtt85 -157.58 115.91 3.16 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.033 1.733 . . . . 0.0 110.877 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.67 145.16 29.78 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -152.39 159.15 43.45 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.786 1.634 . . . . 0.0 113.373 -165.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.6 m -76.39 113.81 14.39 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.756 1.222 . . . . 0.0 109.725 162.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -96.2 98.38 10.27 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 122.559 1.171 . . . . 0.0 108.352 173.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.6 t -101.45 150.63 5.86 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 C-N-CA 127.206 2.202 . . . . 0.0 109.419 -164.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 1.64 ' HD2' ' CD1' ' A' ' 77' ' ' PHE . 47.2 m-85 -121.76 129.71 52.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.073 -1.017 . . . . 0.0 108.837 164.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -123.04 116.32 23.31 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.805 1.642 . . . . 0.0 110.086 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -95.09 115.94 28.07 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.398 1.479 . . . . 0.0 109.13 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.6 t -147.79 159.7 43.54 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 -170.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -6.75 -126.2 0.0 OUTLIER Glycine 0 N--CA 1.48 1.574 0 O-C-N 119.021 -2.3 . . . . 0.0 112.959 -133.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.445 ' HB3' ' HE3' ' A' ' 139' ' ' LYS . 57.3 m -94.45 111.32 23.06 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 113.642 -3.223 . . . . 0.0 110.17 149.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -169.58 146.22 3.3 Favored 'General case' 0 N--CA 1.475 0.824 1 C-N-CA 132.111 4.164 . . . . 0.0 107.581 133.228 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.9 t -72.23 139.5 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.068 -1.645 . . . . 0.0 110.294 165.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.58 148.5 29.2 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.616 0.766 . . . . 0.0 111.636 165.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.3 tp -108.84 110.37 21.7 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 157.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.4 m -97.83 114.26 26.27 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.868 1.667 . . . . 0.0 108.723 -174.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 99.0 m -103.93 108.36 19.66 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.063 -1.648 . . . . 0.0 109.449 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -103.49 94.2 5.35 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.643 0.735 . . . . 0.0 111.74 -172.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.2 mp -72.99 94.67 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 126.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.36 149.73 10.02 Favored Glycine 0 N--CA 1.468 0.79 0 N-CA-C 119.113 2.405 . . . . 0.0 119.113 -169.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -114.46 58.05 0.93 Allowed Pre-proline 0 CA--C 1.556 1.178 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 170.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -67.77 174.09 8.14 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.993 2.462 . . . . 0.0 114.281 166.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -82.66 -39.08 22.56 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -75.31 -13.05 60.39 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -158.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -51.57 -30.56 21.33 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 128.046 2.539 . . . . 0.0 112.994 170.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -52.95 -42.07 65.12 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.705 0.802 . . . . 0.0 111.206 170.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -100.77 -34.39 9.86 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -171.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.2 pp -85.61 155.99 20.91 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -167.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -151.47 122.74 7.76 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -159.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -106.38 179.5 4.25 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 126.992 2.117 . . . . 0.0 110.104 171.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 p -165.07 173.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -149.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 97.7 m -128.32 120.63 27.44 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.723 1.147 . . . . 0.0 111.258 137.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -176.49 179.52 1.16 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 129.507 3.123 . . . . 0.0 105.237 -172.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 1.655 ' HE1' ' CE2' ' A' ' 105' ' ' PHE . 36.8 p90 -111.42 127.58 55.72 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.456 1.502 . . . . 0.0 110.875 162.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -148.45 159.36 44.12 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.455 1.102 . . . . 0.0 113.658 -161.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -109.13 151.47 26.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.447 2.299 . . . . 0.0 111.162 174.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 mt -142.48 146.8 35.13 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.836 1.255 . . . . 0.0 111.925 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.9 m -106.69 178.49 4.55 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.747 1.219 . . . . 0.0 114.001 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.82 -5.13 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 128.809 2.844 . . . . 0.0 116.113 -161.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -138.3 47.9 1.97 Allowed 'General case' 0 CA--C 1.551 1.015 0 O-C-N 120.608 -1.308 . . . . 0.0 112.794 168.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -111.18 146.76 36.32 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.911 1.284 . . . . 0.0 112.064 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -150.02 147.06 27.38 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 119.687 -1.883 . . . . 0.0 111.296 -154.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.17 147.5 36.72 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.999 1.32 . . . . 0.0 112.73 -169.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.47 141.75 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-N 121.396 1.907 . . . . 0.0 114.065 162.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.91 148.86 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.179 1.392 . . . . 0.0 109.831 173.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.9 t -140.42 159.83 41.33 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.738 2.015 . . . . 0.0 106.542 161.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -49.74 -30.66 9.82 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -171.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.36 -33.35 75.04 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 121.145 1.793 . . . . 0.0 113.734 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.49 -26.36 63.58 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.225 -0.922 . . . . 0.0 112.027 172.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 37.0 mm -77.95 -30.18 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.755 0.822 . . . . 0.0 111.48 167.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.96 -13.98 62.6 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.252 -0.905 . . . . 0.0 113.196 170.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -70.0 -36.25 74.99 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 120.107 -1.621 . . . . 0.0 113.3 158.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.83 -37.67 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.852 1.261 . . . . 0.0 110.593 -176.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.5 135.37 15.82 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 125.112 1.365 . . . . 0.0 111.323 169.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.54 -24.73 63.02 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.893 3.062 . . . . 0.0 116.39 -157.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.7 t -147.65 130.1 15.79 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.393 1.077 . . . . 0.0 110.436 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -168.5 158.5 9.58 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.951 2.1 . . . . 0.0 108.206 169.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -136.07 -31.95 0.89 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.903 1.681 . . . . 0.0 113.64 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -101.76 21.73 41.16 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.949 1.738 . . . . 0.0 114.982 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.87 146.25 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.017 1.408 . . . . 0.0 113.527 -159.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.7 mp -113.63 81.58 1.54 Allowed 'General case' 0 C--O 1.24 0.554 0 CA-C-O 123.431 1.586 . . . . 0.0 108.531 169.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.0 m -75.44 146.27 40.83 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 162.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -124.07 132.56 53.68 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 44.5 t -124.34 133.64 53.39 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.005 0.82 . . . . 0.0 111.168 -169.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.1 t -144.79 108.89 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.398 0.679 . . . . 0.0 111.027 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.1 m -99.59 141.4 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.996 1.319 . . . . 0.0 113.33 173.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -122.98 162.0 23.16 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.63 1.172 . . . . 0.0 109.456 155.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.445 ' HE3' ' HB3' ' A' ' 82' ' ' CYS 0.273 0.1 OUTLIER -147.61 154.49 40.73 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.006 1.722 . . . . 0.0 108.019 169.589 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.8 t -132.88 121.03 22.29 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -73.14 -43.52 61.45 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 118.068 0.394 . . . . 0.0 110.337 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.9 m -45.76 -46.19 15.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.782 1.633 . . . . 0.0 112.762 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -91.18 5.44 81.32 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.449 1.499 . . . . 0.0 115.692 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 43.9 tpp 41.89 50.11 4.09 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.201 1.8 . . . . 0.0 113.63 -173.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.3 t -138.69 140.18 38.69 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.309 -0.869 . . . . 0.0 111.652 -162.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 1.623 ' HD1' ' CD2' ' A' ' 146' ' ' TYR . 56.8 m-85 -109.08 139.49 43.89 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.265 1.026 . . . . 0.0 109.603 162.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -143.15 106.44 4.57 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.9 pt -136.32 152.22 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.577 0.751 . . . . 0.0 112.936 -160.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -136.77 149.15 47.64 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.311 0.577 . . . . 0.0 112.245 165.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.18 132.9 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.137 0.975 . . . . 0.0 109.169 169.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.9 m -138.17 122.98 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.33 1.052 . . . . 0.0 111.668 -156.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -103.95 122.78 45.91 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -164.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -141.24 148.19 39.48 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.256 1.423 . . . . 0.0 110.186 165.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -74.61 -162.43 9.17 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.322 1.439 . . . . 0.0 115.164 169.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -56.15 -13.49 9.64 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 124.401 3.401 . . . . 0.0 117.04 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -63.33 -4.87 2.89 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.746 1.618 . . . . 0.0 113.882 166.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -73.55 43.59 0.15 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 126.075 1.75 . . . . 0.0 112.86 172.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -50.32 -30.44 12.07 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.617 2.767 . . . . 0.0 113.673 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.75 -42.89 57.38 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.377 1.471 . . . . 0.0 114.415 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -71.21 -32.44 68.81 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.404 -1.435 . . . . 0.0 111.629 170.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -58.16 -54.0 51.96 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.478 1.035 . . . . 0.0 111.364 169.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -54.63 -49.31 70.82 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.493 0.588 . . . . 0.0 111.527 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -57.24 -44.45 83.82 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.032 0.833 . . . . 0.0 112.837 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.01 -60.95 2.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.1 mp -53.15 -35.86 60.2 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.269 1.427 . . . . 0.0 112.924 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -68.07 -35.74 78.7 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.148 1.379 . . . . 0.0 111.852 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.65 -26.1 24.52 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.8 pt -104.74 -44.85 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -171.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -90.2 -32.62 16.52 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.247 1.385 . . . . 0.0 109.93 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -97.45 24.11 6.93 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.084 0.954 . . . . 0.0 112.982 171.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.492 -1.242 . . . . 0.0 112.637 163.009 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.66 -36.02 67.25 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 119.575 1.08 . . . . 0.0 112.91 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -102.69 164.22 11.77 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.651 1.18 . . . . 0.0 110.589 158.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.26 132.79 54.76 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 122.829 0.452 . . . . 0.0 111.367 -170.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -72.77 97.21 2.17 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 123.112 1.434 . . . . 0.0 111.656 -164.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 tp -145.85 145.82 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 1 C-N-CA 134.554 5.141 . . . . 0.0 106.483 172.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -75.56 129.6 37.48 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.603 163.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -65.09 -4.23 4.59 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -155.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -93.7 -22.33 18.8 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.482 1.113 . . . . 0.0 113.511 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.73 -42.82 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.664 1.186 . . . . 0.0 113.539 -168.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.88 -47.33 89.75 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 168.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.77 -37.29 70.89 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.966 1.383 . . . . 0.0 112.493 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.43 -35.19 63.38 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.591 1.556 . . . . 0.0 114.129 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.4 tp -75.39 -37.07 60.75 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.136 1.374 . . . . 0.0 112.22 176.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -67.76 -44.32 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.604 1.562 . . . . 0.0 109.368 170.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.5 t -53.87 -44.85 70.74 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.234 1.014 . . . . 0.0 111.742 168.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -60.41 -37.05 79.6 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.495 -0.753 . . . . 0.0 111.451 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.5 m -67.01 -49.04 66.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.834 0.854 . . . . 0.0 111.501 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -64.79 -38.75 92.04 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 119.926 1.239 . . . . 0.0 112.77 173.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -78.79 -35.59 44.09 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -172.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.91 -23.7 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.965 1.257 . . . . 0.0 111.509 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.0 mp -86.75 -11.96 49.54 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 167.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 53.55 43.29 31.43 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.835 1.654 . . . . 0.0 112.08 -177.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 pp -107.18 162.63 13.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.545 0.738 . . . . 0.0 110.555 171.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.36 148.81 43.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.758 0.423 . . . . 0.0 111.777 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -25.41 67.94 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.447 -1.408 . . . . 0.0 112.881 173.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -79.11 2.38 20.97 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.945 1.698 . . . . 0.0 113.696 168.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -130.18 -5.93 4.36 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.522 1.529 . . . . 0.0 110.772 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 26.0 tp -87.78 138.49 31.42 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.306 1.842 . . . . 0.0 106.774 154.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.73 138.9 51.72 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 164.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.0 mm -98.79 141.11 16.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 O-C-N 125.8 1.938 . . . . 0.0 111.796 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.61 149.22 37.01 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.691 0.397 . . . . 0.0 110.808 174.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -158.26 56.29 0.46 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 166.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.7 p -87.43 -56.78 3.21 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.024 -1.672 . . . . 0.0 112.294 162.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.64 -55.99 3.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.808 0.813 . . . . 0.0 113.041 -158.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.446 ' H ' HD21 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -64.39 -42.11 96.31 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.951 1.701 . . . . 0.0 112.482 -175.114 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.87 -27.17 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.393 1.077 . . . . 0.0 110.278 174.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.8 m -92.81 4.14 54.38 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.246 1.418 . . . . 0.0 114.272 174.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.24 -41.75 9.3 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.23 1.377 . . . . 0.0 110.737 172.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -100.38 77.64 0.17 Allowed Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 162.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -72.63 -0.09 8.34 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 N-CA-C 118.833 2.59 . . . . 0.0 118.833 -121.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -119.82 3.97 11.04 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 126.072 1.749 . . . . 0.0 113.234 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 1.639 ' HE1' ' CE2' ' A' ' 43' ' ' TYR . 53.6 m-85 -133.02 170.6 15.14 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.735 1.607 . . . . 0.0 113.636 -148.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.5 m -67.58 158.71 31.41 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.162 1.385 . . . . 0.0 113.991 -169.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.78 -77.88 0.57 Allowed 'General case' 0 CA--C 1.541 0.629 0 O-C-N 117.738 -3.101 . . . . 0.0 115.722 14.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.48 -171.84 0.85 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.944 1.247 . . . . 0.0 112.736 -172.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -132.29 149.96 52.26 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -130.81 141.73 50.36 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 129.784 3.234 . . . . 0.0 108.326 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.3 ttp -124.89 128.25 48.35 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.888 -1.132 . . . . 0.0 108.331 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.5 mt -133.79 147.63 51.28 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.468 1.907 . . . . 0.0 114.73 -147.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.5 t -124.22 169.13 12.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.833 2.853 . . . . 0.0 112.999 -169.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.9 p -96.77 176.25 6.06 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.323 2.649 . . . . 0.0 115.419 -159.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 66.66 21.98 10.52 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 116.995 2.22 . . . . 0.0 116.995 166.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.52 161.38 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.86 1.264 . . . . 0.0 111.077 165.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.5 m -101.3 139.73 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.996 1.318 . . . . 0.0 109.235 171.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 1.655 ' HD2' ' CD1' ' A' ' 56' ' ' TYR . 4.1 p90 -133.28 125.25 18.72 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 118.995 0.816 . . . . 0.0 110.022 171.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -63.4 65.53 0.18 Allowed 'Trans proline' 0 C--N 1.357 1.005 1 C-N-CA 125.508 4.138 . . . . 0.0 113.129 170.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.12 -38.67 39.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 127.78 2.432 . . . . 0.0 114.292 -156.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -75.0 -10.47 59.5 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.33 -0.856 . . . . 0.0 113.032 -177.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -59.38 -31.49 69.27 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.616 -1.303 . . . . 0.0 112.058 161.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.8 tp -72.38 -42.98 64.61 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.268 0.94 . . . . 0.0 111.246 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mp -57.83 -43.73 86.01 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 122.128 -0.358 . . . . 0.0 111.062 169.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.9 m -62.63 -38.76 91.51 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.948 0.899 . . . . 0.0 111.52 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 1.619 ' HD1' ' CD2' ' A' ' 64' ' ' TYR . 40.1 t80 -65.73 -36.13 82.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 118.618 -0.706 . . . . 0.0 112.041 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -69.39 -53.66 18.3 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 168.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -63.04 -36.5 83.79 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.315 -0.865 . . . . 0.0 111.865 -172.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 73.6 m -73.57 -9.94 59.2 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.0 tpt85 -75.5 -32.56 60.58 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.395 0.998 . . . . 0.0 112.426 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.9 p -148.61 -36.91 0.18 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.401 1.08 . . . . 0.0 112.749 173.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.35 81.94 1.63 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 126.755 2.121 . . . . 0.0 110.816 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 72.6 mtt85 -148.44 114.15 5.69 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.321 1.848 . . . . 0.0 110.071 170.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.9 m -65.29 140.37 58.69 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.589 1.156 . . . . 0.0 113.099 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.8 147.86 33.39 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -170.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 64.4 m -76.39 108.79 9.59 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.896 2.878 . . . . 0.0 111.694 165.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 1.631 ' HD1' ' CD2' ' A' ' 75' ' ' PHE . 6.9 m-85 -91.62 99.63 12.51 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.555 -1.341 . . . . 0.0 108.323 167.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.7 t -99.7 115.79 41.45 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 C-N-CA 125.906 1.682 . . . . 0.0 109.348 -168.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -96.8 124.97 40.93 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 120.351 -1.468 . . . . 0.0 108.365 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -118.06 122.57 43.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.858 1.263 . . . . 0.0 111.832 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -95.89 114.85 26.61 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.546 1.538 . . . . 0.0 109.692 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 p -144.17 160.16 41.42 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 -173.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -7.92 -130.56 0.0 OUTLIER Glycine 0 N--CA 1.483 1.801 0 O-C-N 118.642 -2.537 . . . . 0.0 113.492 -137.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.2 p -96.41 101.86 13.56 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 121.798 2.799 . . . . 0.0 110.124 158.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 mtt85 -173.84 141.63 0.83 Allowed 'General case' 0 N--CA 1.471 0.607 1 C-N-CA 132.982 4.513 . . . . 0.0 107.92 144.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.6 t -68.35 137.43 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 120.244 1.384 . . . . 0.0 110.405 165.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.9 m -104.49 145.7 29.91 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.101 -0.999 . . . . 0.0 110.374 158.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.8 tp -109.62 109.7 20.53 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 160.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.2 m -88.84 96.64 10.78 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.398 1.079 . . . . 0.0 109.19 170.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 7.9 p -101.9 111.16 23.33 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 119.396 -2.065 . . . . 0.0 109.927 -172.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 1.629 ' HE1' ' CE2' ' A' ' 89' ' ' TYR . 18.8 p90 -146.64 150.5 35.57 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 116.828 2.159 . . . . 0.0 116.828 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.17 109.04 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 168.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.41 139.9 14.74 Favored Glycine 0 CA--C 1.536 1.357 0 N-CA-C 117.864 1.906 . . . . 0.0 117.864 -138.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.3 62.93 46.93 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 152.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.49 106.35 1.6 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.688 2.926 . . . . 0.0 114.604 -170.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.49 -30.74 61.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.687 1.195 . . . . 0.0 113.85 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.3 tpt85 -92.68 3.13 56.17 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.2 tp -70.89 1.0 6.09 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.728 -1.232 . . . . 0.0 114.287 166.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -51.81 -37.8 53.17 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.656 -0.652 . . . . 0.0 111.099 150.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -123.78 -35.3 2.9 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 -169.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 pp -82.81 167.4 18.14 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 121.999 2.181 . . . . 0.0 114.862 -167.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -168.2 126.22 1.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 -165.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.42 ' CD ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -105.21 178.22 4.62 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.547 1.539 . . . . 0.0 110.261 170.147 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.42 ' H ' ' CD ' ' A' ' 101' ' ' ARG . 1.1 p -162.38 169.81 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -147.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 99.4 m -123.82 122.42 37.96 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.029 -1.044 . . . . 0.0 111.125 136.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -176.15 175.17 1.93 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 129.083 2.953 . . . . 0.0 106.838 -174.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 1.635 ' HE2' ' CE1' ' A' ' 105' ' ' PHE . 51.8 p90 -122.36 121.72 37.35 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.296 2.239 . . . . 0.0 111.476 164.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -159.09 171.43 19.98 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -100.14 137.53 38.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.485 2.314 . . . . 0.0 110.376 175.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.8 tp -146.2 142.97 28.93 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.139 1.376 . . . . 0.0 111.039 -158.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 p -92.38 177.16 6.22 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 118.161 2.652 . . . . 0.0 118.161 -172.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.6 t -76.54 -6.87 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 129.486 3.114 . . . . 0.0 114.551 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -122.43 32.65 5.7 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.233 1.413 . . . . 0.0 111.746 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -136.01 159.9 40.27 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.25 -1.531 . . . . 0.0 113.079 -162.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -155.17 148.71 25.21 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.667 -1.271 . . . . 0.0 110.356 -151.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.4 148.0 35.5 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.767 1.227 . . . . 0.0 110.971 -169.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.46 138.42 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 120.639 1.563 . . . . 0.0 113.229 160.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.92 156.37 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.659 1.184 . . . . 0.0 109.5 169.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.6 t -145.01 167.25 23.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.654 1.582 . . . . 0.0 108.27 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.53 -33.53 71.51 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.14 0.882 . . . . 0.0 113.324 -172.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.05 -30.74 70.89 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 172.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -73.19 -35.48 66.39 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.298 -0.876 . . . . 0.0 111.045 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.1 mm -77.53 -33.43 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.359 1.064 . . . . 0.0 111.647 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -57.98 -34.5 70.03 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.059 -1.025 . . . . 0.0 111.015 168.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -70.97 -25.47 62.73 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.618 171.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 54.0 mt -72.61 -44.85 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.394 1.452 . . . . 0.0 110.157 171.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.6 tptp 168.39 -49.62 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 128.291 2.636 . . . . 0.0 110.15 168.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -62.96 112.64 1.72 Allowed 'Trans proline' 0 C--N 1.357 0.985 0 CA-C-N 121.653 1.626 . . . . 0.0 114.604 -167.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 87.8 m -66.36 154.44 40.04 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.328 1.851 . . . . 0.0 112.933 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -80.36 -5.96 57.24 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 117.311 2.337 . . . . 0.0 117.311 -149.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -93.72 9.28 37.66 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.48 1.912 . . . . 0.0 115.413 -176.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -166.49 14.31 0.08 OUTLIER Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.506 1.363 . . . . 0.0 116.506 -166.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 63.9 t -70.1 122.73 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 118.724 1.262 . . . . 0.0 111.683 -171.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.9 mp -127.76 80.05 1.93 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 123.777 1.751 . . . . 0.0 108.344 153.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.6 m -85.09 129.91 34.71 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 160.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -125.86 132.64 52.16 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.146 0.979 . . . . 0.0 110.796 -158.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 49.3 t -124.4 141.45 52.07 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.546 1.138 . . . . 0.0 111.334 -167.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.9 t -137.21 125.33 32.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.547 1.539 . . . . 0.0 108.87 -173.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.23 143.87 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 28.4 mtt-85 -133.12 159.14 41.0 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 128.087 2.555 . . . . 0.0 107.987 164.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.301 0.0 OUTLIER -145.67 100.89 3.49 Favored 'General case' 0 CA--C 1.558 1.258 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 173.085 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.1 t -58.44 125.18 22.22 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.044 -1.66 . . . . 0.0 112.642 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -81.34 -53.85 5.98 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.904 0.882 . . . . 0.0 112.141 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.0 m -57.12 -22.41 39.63 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -119.2 22.39 9.0 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 117.333 -1.815 . . . . 0.0 114.216 174.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 91.7 mmm 22.77 71.49 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 128.454 2.702 . . . . 0.0 114.876 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.7 p -164.35 170.43 16.13 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.373 -0.829 . . . . 0.0 112.312 -169.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 1.66 ' HE2' ' CE1' ' A' ' 146' ' ' TYR . 89.4 m-85 -113.24 149.39 33.85 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.783 1.633 . . . . 0.0 112.055 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -123.85 115.76 21.84 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 166.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.8 tt -122.05 142.5 38.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.703 -170.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -140.03 145.96 38.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.198 0.523 . . . . 0.0 110.628 159.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 4.4 p -145.27 136.68 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 122.394 1.092 . . . . 0.0 111.179 167.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.4 m -130.54 129.67 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 126.38 1.872 . . . . 0.0 110.065 -163.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -100.12 120.68 40.23 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -164.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -140.3 153.21 46.38 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.953 0.883 . . . . 0.0 112.742 171.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -87.28 -143.78 8.39 Favored Glycine 0 CA--C 1.543 1.784 0 C-N-CA 125.267 1.413 . . . . 0.0 111.718 162.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.58 -13.88 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.712 3.608 . . . . 0.0 116.048 174.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -58.81 -14.58 9.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.487 1.915 . . . . 0.0 113.977 171.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -95.67 18.6 12.63 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -54.72 -30.3 55.68 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.22 -36.04 82.01 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.626 -1.296 . . . . 0.0 113.277 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -73.06 -37.6 66.76 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.593 -1.317 . . . . 0.0 111.113 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 1.64 ' HD2' ' CD1' ' A' ' 161' ' ' TYR . 31.0 t80 -56.17 -47.23 78.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.413 0.685 . . . . 0.0 111.048 171.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -60.48 -37.25 80.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.55 1.14 . . . . 0.0 112.461 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.92 -38.2 79.41 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.312 0.96 . . . . 0.0 113.518 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.04 -57.31 12.12 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.979 0.911 . . . . 0.0 113.017 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.7 mp -43.99 -39.88 4.36 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.847 1.659 . . . . 0.0 112.517 166.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 53.3 tpt85 -73.02 -21.5 60.81 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -92.46 -37.38 12.57 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.824 1.193 . . . . 0.0 113.103 171.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.4 pt -81.86 -34.61 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.028 0.931 . . . . 0.0 113.185 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -74.55 6.44 3.8 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.456 -0.778 . . . . 0.0 111.481 161.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -124.85 23.14 7.98 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 167.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 . . . . . 0 C--O 1.254 1.305 0 C-N-CA 126.054 1.742 . . . . 0.0 109.963 162.06 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.3 -10.52 59.96 Favored Glycine 0 CA--C 1.543 1.815 0 N-CA-C 117.61 1.804 . . . . 0.0 117.61 -171.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -137.4 174.99 10.01 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.088 2.155 . . . . 0.0 110.455 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.2 ptm -65.14 144.74 57.01 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.62 -1.3 . . . . 0.0 113.177 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -127.42 104.14 7.75 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.298 1.039 . . . . 0.0 111.995 -172.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 51.0 mm -114.62 117.23 54.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 127.676 2.391 . . . . 0.0 107.23 166.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.37 154.98 22.62 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 126.918 2.087 . . . . 0.0 112.188 176.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -53.75 -10.5 0.3 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.859 2.064 . . . . 0.0 115.104 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -113.14 -28.97 7.46 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.49 1.516 . . . . 0.0 114.551 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.1 t -72.0 -46.98 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.646 1.112 . . . . 0.0 112.433 -169.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.41 -45.02 95.89 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 171.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.28 -44.35 71.83 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 117.843 0.822 . . . . 0.0 112.539 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -74.89 -41.09 60.43 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.822 1.249 . . . . 0.0 114.25 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.63 -47.87 74.12 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.062 1.301 . . . . 0.0 111.012 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.12 -40.53 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.274 0.63 . . . . 0.0 109.567 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.9 t -56.56 -44.7 81.22 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.741 0.817 . . . . 0.0 112.337 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -64.43 -37.94 89.27 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.284 -0.885 . . . . 0.0 112.303 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.03 -49.25 78.39 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 120.57 1.532 . . . . 0.0 112.427 171.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 ptt85 -64.1 -39.59 94.39 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 120.328 1.422 . . . . 0.0 113.298 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -58.78 -44.17 90.64 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.809 2.044 . . . . 0.0 113.453 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.49 -30.77 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.307 1.043 . . . . 0.0 112.318 -175.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.4 -7.48 57.66 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.001 1.32 . . . . 0.0 112.455 174.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 64.31 9.35 4.8 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.488 2.715 . . . . 0.0 115.61 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . 0.262 4.3 pp -94.1 178.64 5.58 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.726 -1.234 . . . . 0.0 112.8 -173.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -95.96 154.32 17.3 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.275 1.03 . . . . 0.0 111.765 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -64.23 -24.18 67.57 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 119.488 -2.007 . . . . 0.0 112.81 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -78.36 0.26 26.26 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.811 1.644 . . . . 0.0 112.648 169.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -109.86 -18.8 13.32 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.149 1.38 . . . . 0.0 111.202 170.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.9 tp -88.23 111.81 22.07 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.629 1.572 . . . . 0.0 106.9 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.425 ' H ' ' HB3' ' A' ' 49' ' ' MET . 12.3 tpp180 -84.65 97.79 9.83 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 118.424 -1.31 . . . . 0.0 107.777 175.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.255 1.1 pp -92.46 148.63 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 126.646 1.978 . . . . 0.0 111.752 172.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.2 m -147.65 150.03 33.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.863 0.865 . . . . 0.0 108.921 -170.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -123.05 -158.68 0.8 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.829 1.252 . . . . 0.0 112.453 -161.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.8 t -41.49 -42.83 2.47 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 126.185 1.794 . . . . 0.0 115.252 -160.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.01 -30.08 65.82 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -171.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.23 -9.66 20.25 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 pt -110.14 -19.9 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.1 t -60.72 10.99 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 127.187 2.195 . . . . 0.0 116.781 -169.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -72.95 -20.12 61.11 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.714 2.006 . . . . 0.0 112.385 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -60.2 177.27 0.3 Allowed Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 127.433 2.293 . . . . 0.0 112.532 163.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -63.44 -86.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.936 2.424 . . . . 0.0 112.67 163.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -129.69 25.57 5.35 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 117.349 2.352 . . . . 0.0 117.349 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 1.623 ' HD1' ' CD2' ' A' ' 43' ' ' TYR . 8.6 p90 -162.68 142.13 9.14 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 118.811 -2.431 . . . . 0.0 110.717 -153.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m 176.54 -174.66 0.11 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.895 2.078 . . . . 0.0 108.895 -175.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 tp -122.5 -75.41 0.6 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 119.174 -0.441 . . . . 0.0 111.306 150.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 15.0 p -163.35 -170.3 2.22 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.479 1.133 . . . . 0.0 113.223 -163.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 87' ' ' SER . 42.0 t0 -146.3 115.08 6.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.057 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.7 144.14 47.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.941 2.897 . . . . 0.0 109.287 -153.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.425 ' HB3' ' H ' ' A' ' 30' ' ' ARG . 29.5 ttp -122.3 128.1 50.66 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.904 1.684 . . . . 0.0 110.854 -165.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.0 162.09 37.78 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 127.001 2.688 . . . . 0.0 115.439 -159.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.26 148.49 25.06 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 111.887 -2.415 . . . . 0.0 111.887 -142.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 t -66.03 156.37 33.93 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.072 0.949 . . . . 0.0 112.483 166.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 69.62 -0.85 2.47 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.109 2.164 . . . . 0.0 115.525 168.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.5 mp -103.98 147.01 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 126.08 1.752 . . . . 0.0 111.011 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.9 p -87.52 136.66 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.023 1.329 . . . . 0.0 111.714 170.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -107.54 110.25 62.78 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.56 1.144 . . . . 0.0 108.663 172.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -60.43 66.65 0.08 OUTLIER 'Trans proline' 0 CA--C 1.542 0.884 1 C-N-CA 126.521 4.814 . . . . 0.0 113.726 164.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 p -68.75 -27.02 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.098 1.359 . . . . 0.0 114.424 -157.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -46.86 -45.19 20.15 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 126.46 1.904 . . . . 0.0 112.716 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -69.72 -30.67 68.34 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.996 -0.44 . . . . 0.0 112.164 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.1 mt -75.74 -45.26 37.52 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.824 0.85 . . . . 0.0 111.737 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 mp -53.58 -49.47 67.67 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.722 0.692 . . . . 0.0 109.813 171.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.8 m -64.97 -39.42 93.46 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 1.625 ' HE2' ' CE1' ' A' ' 64' ' ' TYR . 12.4 t80 -74.7 -33.75 62.48 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.444 -0.785 . . . . 0.0 112.408 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -63.89 -53.03 56.8 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.91 0.777 . . . . 0.0 111.375 171.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -73.67 -33.49 64.49 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -168.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.6 t -79.78 -19.15 49.28 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.904 1.282 . . . . 0.0 114.316 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -86.22 -26.1 25.24 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -166.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.2 m -138.79 -2.81 1.69 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -174.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.22 80.47 0.17 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.042 1.306 . . . . 0.0 111.384 -174.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.0 mtp85 -162.11 141.77 9.8 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 128.09 2.556 . . . . 0.0 105.642 169.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.2 m -65.61 140.98 58.56 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 125.064 1.346 . . . . 0.0 111.396 170.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.49 117.09 31.42 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 80.8 m -75.4 102.06 5.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.069 1.748 . . . . 0.0 108.333 157.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -85.12 96.15 9.36 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 167.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.9 t -99.75 141.3 17.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 C-N-CA 125.876 1.671 . . . . 0.0 108.165 -170.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -127.91 123.5 35.09 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 120.264 -1.523 . . . . 0.0 107.748 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -113.02 117.0 30.81 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.737 1.615 . . . . 0.0 108.842 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.75 115.79 31.12 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.309 1.844 . . . . 0.0 109.451 -172.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.3 p -143.25 165.09 28.41 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.409 2.684 . . . . 0.0 104.699 -160.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -13.66 -125.08 0.0 OUTLIER Glycine 0 N--CA 1.485 1.958 0 C-N-CA 129.58 3.466 . . . . 0.0 114.827 -152.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.7 p -92.89 99.78 12.37 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 113.862 -3.135 . . . . 0.0 110.151 152.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -170.75 162.49 7.71 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 130.605 3.562 . . . . 0.0 109.729 157.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.3 t -105.91 138.45 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 121.24 1.836 . . . . 0.0 112.443 148.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.7 t -104.42 138.91 40.13 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.932 0.893 . . . . 0.0 109.842 163.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tp -107.82 108.46 19.66 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 168.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 12.1 m -82.5 93.54 7.28 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 172.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.7 p -106.38 104.79 14.56 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 119.995 -1.691 . . . . 0.0 108.43 -169.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 1.657 ' HE1' ' CE2' ' A' ' 89' ' ' TYR . 0.8 OUTLIER -142.9 149.92 39.12 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 117.022 2.231 . . . . 0.0 117.022 -177.026 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.7 pt -78.58 72.49 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 113.026 -1.897 . . . . 0.0 107.856 154.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -174.34 178.13 46.28 Favored Glycine 0 N--CA 1.478 1.471 0 N-CA-C 120.088 2.795 . . . . 0.0 120.088 -160.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 1.646 ' HD2' ' CD1' ' A' ' 92' ' ' PHE . 54.7 m-85 -140.77 136.16 16.13 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.996 1.318 . . . . 0.0 114.499 -172.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -93.56 -166.71 0.15 Allowed 'Trans proline' 0 CA--C 1.549 1.241 1 C-N-CA 125.797 4.332 . . . . 0.0 112.492 172.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -79.26 -36.66 39.5 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 164.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -96.87 0.18 48.75 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 119.339 3.088 . . . . 0.0 119.339 -167.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.1 -27.97 36.36 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 122.395 2.361 . . . . 0.0 114.383 -177.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.6 pttm -57.98 -30.41 66.01 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.275 1.03 . . . . 0.0 113.251 170.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -111.49 -29.97 7.56 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 pp -74.31 165.31 25.39 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 121.753 2.07 . . . . 0.0 112.07 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -155.01 107.33 2.72 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 118.415 2.746 . . . . 0.0 118.415 -156.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.461 ' CD ' ' H ' ' A' ' 102' ' ' VAL . 0.1 OUTLIER -103.11 177.53 4.81 Favored 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 126.437 1.895 . . . . 0.0 111.533 169.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.461 ' H ' ' CD ' ' A' ' 101' ' ' ARG . 0.5 OUTLIER -165.82 170.64 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 -142.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 37.1 t -121.08 124.7 45.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.901 1.28 . . . . 0.0 109.918 141.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -172.86 167.91 5.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.4 1.88 . . . . 0.0 108.807 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -107.81 126.83 53.11 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.402 1.481 . . . . 0.0 109.522 150.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -152.12 165.65 34.11 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -165.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 1.649 ' HD1' ' CD2' ' A' ' 107' ' ' PHE . 48.0 p90 -101.0 145.43 28.71 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.023 1.729 . . . . 0.0 111.245 173.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.7 tp -140.89 143.04 34.43 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.133 0.973 . . . . 0.0 110.897 -158.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.9 p -111.43 -171.69 1.89 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.525 1.93 . . . . 0.0 114.639 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 65.9 t -73.32 -8.46 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 127.24 2.216 . . . . 0.0 113.58 172.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 -99.89 -3.41 32.51 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -165.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -96.98 148.95 22.45 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.503 1.501 . . . . 0.0 113.273 -147.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -144.73 143.76 30.86 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.144 -1.597 . . . . 0.0 109.061 -175.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.94 149.75 34.79 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-O 117.512 -1.232 . . . . 0.0 112.434 -168.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.41 141.94 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-N 121.338 1.881 . . . . 0.0 114.809 157.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.82 149.63 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.714 0.806 . . . . 0.0 111.123 169.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 39.8 m -146.29 154.43 41.68 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.844 2.057 . . . . 0.0 108.376 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -56.65 -36.9 70.05 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -163.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.02 -32.86 69.75 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.594 -1.316 . . . . 0.0 113.028 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -78.18 -29.37 48.49 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.373 1.069 . . . . 0.0 112.222 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.8 tp -76.97 -35.02 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 123.093 0.557 . . . . 0.0 111.889 168.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -61.14 -27.53 68.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.466 0.706 . . . . 0.0 112.27 171.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 22.3 ttm105 -77.44 -3.99 43.14 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.293 1.437 . . . . 0.0 114.622 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.8 mt -78.54 -25.22 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 O-C-N 120.955 -1.091 . . . . 0.0 110.616 168.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -91.09 179.5 1.42 Allowed Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.324 1.45 . . . . 0.0 108.855 153.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.6 -43.07 2.12 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 121.39 1.393 . . . . 0.0 111.435 160.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 38.2 t -158.53 148.72 19.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.925 2.49 . . . . 0.0 107.632 170.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -160.19 91.98 0.97 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.688 1.131 . . . . 0.0 111.732 171.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.7 63.34 0.19 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.56 1.944 . . . . 0.0 110.516 174.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 162.44 28.37 0.02 OUTLIER Glycine 0 CA--C 1.539 1.541 0 C-N-CA 125.195 1.378 . . . . 0.0 115.735 -171.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.7 t -61.58 128.0 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 120.132 1.966 . . . . 0.0 111.539 -174.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.18 89.05 2.98 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.459 1.904 . . . . 0.0 107.848 168.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.0 t -98.83 145.29 27.12 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.763 1.225 . . . . 0.0 111.488 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -138.72 132.78 31.33 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.267 1.027 . . . . 0.0 109.007 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 31.3 t -117.33 136.02 53.43 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.201 1.0 . . . . 0.0 111.038 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.4 t -136.71 138.14 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.457 1.903 . . . . 0.0 109.301 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.81 142.72 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.907 0.883 . . . . 0.0 110.943 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 31.5 mmm-85 -111.21 113.57 26.16 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.02 0.928 . . . . 0.0 108.734 163.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.615 ' HE2' ' CG ' ' A' ' 146' ' ' TYR . 0.0 OUTLIER -89.79 118.08 29.12 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 155.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.7 t -147.98 -167.94 2.94 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.027 0.831 . . . . 0.0 111.987 -169.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.408 ' C ' ' H ' ' A' ' 143' ' ' GLY . 6.2 m120 50.07 72.36 0.33 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.429 2.292 . . . . 0.0 112.321 168.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.9 m 54.01 3.45 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 -173.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 141' ' ' ASN . . . 86.03 38.16 8.75 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.791 0.71 . . . . 0.0 112.288 -168.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 61.6 mtt -133.77 -13.23 2.56 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.73 142.33 24.48 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.875 0.845 . . . . 0.0 112.789 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 1.645 ' HD2' ' CD1' ' A' ' 146' ' ' TYR . 7.3 m-85 -140.82 173.63 11.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.666 -155.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -151.95 151.51 31.31 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.9 tt -141.19 136.5 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.405 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -137.53 125.7 23.05 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.386 1.074 . . . . 0.0 109.493 177.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.8 133.13 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.01 -1.056 . . . . 0.0 111.073 170.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.5 m -116.39 147.81 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.894 1.678 . . . . 0.0 110.966 -166.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.18 100.54 4.43 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.358 1.063 . . . . 0.0 111.609 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 1.649 ' HE2' ' CE1' ' A' ' 153' ' ' PHE . 63.0 m-85 -119.85 161.77 20.25 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.718 1.607 . . . . 0.0 109.843 176.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -78.72 -147.35 3.58 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 118.639 0.654 . . . . 0.0 112.034 166.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.29 -11.99 7.11 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.625 2.883 . . . . 0.0 113.624 164.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -22.54 51.1 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.82 2.048 . . . . 0.0 113.012 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -87.36 57.09 4.25 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.946 1.355 . . . . 0.0 111.344 172.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -31.91 65.47 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.326 1.05 . . . . 0.0 111.531 171.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.78 -53.23 57.46 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -76.85 -25.52 53.23 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.186 0.903 . . . . 0.0 112.494 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 1.636 ' HE2' ' CE1' ' A' ' 161' ' ' TYR . 63.9 t80 -62.35 -54.02 46.57 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.986 1.267 . . . . 0.0 111.844 169.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -64.55 -28.67 69.8 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.458 -1.402 . . . . 0.0 112.352 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.19 -36.13 83.06 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.392 0.677 . . . . 0.0 112.484 168.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -70.59 -47.9 57.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.308 -0.853 . . . . 0.0 113.234 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.6 mp -48.41 -39.56 22.98 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 120.021 1.282 . . . . 0.0 112.858 166.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -71.33 -29.56 65.15 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -77.85 -32.58 52.16 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.637 1.575 . . . . 0.0 112.419 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.7 mt -86.4 -47.65 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.713 1.605 . . . . 0.0 112.149 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 1.635 ' HD2' ' CD1' ' A' ' 169' ' ' TYR . 30.0 m-85 -68.04 1.74 2.54 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.066 0.848 . . . . 0.0 112.015 166.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -124.23 24.35 8.11 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 164.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . 0.277 9.6 mmm180 . . . . . 0 N--CA 1.48 1.025 0 C-N-CA 128.722 2.809 . . . . 0.0 116.344 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 120.399 0.143 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.67 152.57 52.44 Favored Glycine 0 CA--C 1.535 1.305 0 N-CA-C 115.894 1.118 . . . . 0.0 115.894 -172.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -79.53 -15.63 57.38 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.223 1.409 . . . . 0.0 112.135 167.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.88 152.32 34.74 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.499 1.52 . . . . 0.0 111.037 156.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -133.46 99.24 4.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.441 0.696 . . . . 0.0 109.601 167.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.1 tp -80.24 106.24 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -170.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -51.2 128.43 22.02 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 112.681 -2.054 . . . . 0.0 109.316 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -63.51 -23.74 67.52 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -160.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -94.41 -28.91 15.25 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.378 0.99 . . . . 0.0 112.773 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.23 -54.49 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 118.778 0.717 . . . . 0.0 112.23 -171.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.08 -43.08 99.64 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 119.186 0.903 . . . . 0.0 112.16 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.12 74.85 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 117.749 0.775 . . . . 0.0 111.77 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -75.58 -31.76 60.09 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.92 -48.5 53.23 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.244 1.383 . . . . 0.0 111.654 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.18 -36.34 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 119.026 -0.511 . . . . 0.0 109.718 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 m -69.92 -43.53 71.5 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.549 1.068 . . . . 0.0 112.329 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -65.51 -39.08 91.43 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.222 -0.924 . . . . 0.0 111.29 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.73 -34.64 69.72 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.038 1.29 . . . . 0.0 112.297 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -52.88 -43.92 66.48 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 120.589 -1.319 . . . . 0.0 111.611 169.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -76.85 -43.34 36.58 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.597 1.159 . . . . 0.0 113.25 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.75 -31.99 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.035 1.334 . . . . 0.0 112.266 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.1 mt -89.85 -12.12 39.97 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.676 1.191 . . . . 0.0 113.065 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 60.21 25.7 15.1 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.783 2.033 . . . . 0.0 113.808 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 pp -117.91 155.55 29.99 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.87 1.268 . . . . 0.0 111.422 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -80.69 161.04 24.8 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -168.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -69.19 -19.28 63.98 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 119.771 -1.831 . . . . 0.0 115.381 -166.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -94.91 -5.76 44.13 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.609 1.563 . . . . 0.0 113.612 168.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -110.99 2.51 18.06 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.099 2.16 . . . . 0.0 110.801 -176.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 13.6 tp -90.54 124.11 34.74 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 128.692 2.797 . . . . 0.0 105.385 154.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.8 ttt-85 -85.39 119.82 26.18 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 117.951 -1.5 . . . . 0.0 107.766 166.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 47' ' ' ASP 0.276 0.8 OUTLIER -112.26 141.77 26.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.193 0.997 . . . . 0.0 112.393 170.269 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.6 m -157.74 141.24 15.51 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.07 1.348 . . . . 0.0 108.138 -159.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -163.3 60.76 0.18 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.521 1.153 . . . . 0.0 112.702 -172.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.9 t -93.55 -56.62 2.85 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.908 -1.12 . . . . 0.0 113.274 150.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.82 -54.3 4.99 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.308 1.051 . . . . 0.0 113.108 -146.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.43 ' H ' HD21 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -63.9 -9.82 17.41 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.326 1.85 . . . . 0.0 113.188 171.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mm -90.2 6.31 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.105 1.362 . . . . 0.0 110.731 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.4 p -69.01 -17.66 63.95 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -173.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.65 -53.78 49.29 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.917 1.235 . . . . 0.0 110.111 169.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -168.85 155.89 6.9 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 125.675 1.59 . . . . 0.0 109.038 169.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.51 -27.3 18.58 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 122.933 2.422 . . . . 0.0 114.961 166.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -110.15 18.77 19.63 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.147 2.979 . . . . 0.0 113.143 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -153.13 92.06 1.58 Allowed 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t 165.85 -169.19 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 130.073 3.349 . . . . 0.0 107.743 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.264 1.2 tm? -132.08 -79.77 0.51 Allowed 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 151.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 5.7 t -175.9 -178.33 1.03 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.917 1.687 . . . . 0.0 109.96 -168.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 6.1 t70 -143.3 126.65 16.68 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 120.676 -1.265 . . . . 0.0 109.882 -170.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.22 154.46 17.38 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.548 1.939 . . . . 0.0 110.538 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -124.58 129.39 50.5 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.413 1.006 . . . . 0.0 108.786 168.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.59 162.39 38.5 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 126.709 2.506 . . . . 0.0 114.826 -156.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 p -102.5 156.53 17.55 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.736 2.014 . . . . 0.0 114.734 -147.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 t -71.79 149.19 45.55 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.572 1.149 . . . . 0.0 113.565 173.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 t70 68.72 16.67 8.95 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 163.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.61 146.88 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.743 1.617 . . . . 0.0 109.542 168.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.6 p -97.48 139.47 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.559 1.544 . . . . 0.0 111.272 166.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -122.21 128.74 25.38 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.9 1.28 . . . . 0.0 110.472 -169.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.94 70.13 5.32 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 124.598 3.532 . . . . 0.0 110.782 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 p -65.48 -26.47 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.25 1.42 . . . . 0.0 113.956 -161.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -48.22 -45.99 34.71 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.531 1.533 . . . . 0.0 112.62 171.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -62.35 -39.68 93.89 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.591 0.632 . . . . 0.0 111.186 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.5 tp -69.63 -53.51 18.38 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.021 0.528 . . . . 0.0 110.814 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.18 -53.31 58.7 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.441 0.696 . . . . 0.0 111.479 177.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 72.7 m -76.72 -40.46 48.56 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -168.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -69.95 -33.48 72.17 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.596 1.089 . . . . 0.0 112.246 173.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -63.67 -48.22 78.08 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.106 0.866 . . . . 0.0 112.331 172.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -55.71 -41.9 74.47 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.434 0.694 . . . . 0.0 111.343 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.8 t -69.22 -17.92 63.84 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -63.28 -35.84 81.69 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.277 1.031 . . . . 0.0 113.414 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.9 m -115.99 -28.06 6.76 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.139 0.976 . . . . 0.0 112.223 167.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.88 77.35 0.95 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.956 2.217 . . . . 0.0 109.813 -169.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -160.63 117.98 2.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.517 2.327 . . . . 0.0 108.779 -174.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.4 m -61.78 130.15 44.38 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.517 0.727 . . . . 0.0 111.204 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.74 160.43 25.94 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.833 1.653 . . . . 0.0 114.502 -163.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 89.9 m -103.34 116.01 31.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.322 1.449 . . . . 0.0 112.49 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -91.14 114.51 27.05 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.639 1.575 . . . . 0.0 107.632 167.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 50.9 t -129.85 123.92 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 O-C-N 121.514 -0.742 . . . . 0.0 111.055 -162.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 1.661 ' HD1' ' CD2' ' A' ' 77' ' ' PHE . 35.3 m-85 -96.39 129.78 43.67 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 119.963 -1.71 . . . . 0.0 109.609 174.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.66 98.12 8.72 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 162.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -106.95 111.61 24.18 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 125.093 1.357 . . . . 0.0 114.438 -164.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.3 p -144.76 165.61 27.58 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 129.661 3.184 . . . . 0.0 105.206 -149.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.08 -123.2 0.0 OUTLIER Glycine 0 N--CA 1.49 2.289 0 C-N-CA 130.524 3.916 . . . . 0.0 115.6 -163.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.6 p -91.66 104.95 17.37 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 113.182 -3.407 . . . . 0.0 110.443 152.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -169.1 153.29 5.45 Favored 'General case' 0 N--CA 1.474 0.75 1 C-N-CA 134.638 5.175 . . . . 0.0 106.236 159.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.6 t -106.29 136.29 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 119.748 -1.845 . . . . 0.0 109.716 129.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.9 m -106.56 140.79 38.89 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 160.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.0 tp -110.82 107.67 17.24 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.5 1.52 . . . . 0.0 107.234 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.6 m -78.03 128.81 34.43 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.252 1.021 . . . . 0.0 108.904 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 77.3 m -120.49 116.51 25.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 1.638 ' HE1' ' CE2' ' A' ' 89' ' ' TYR . 15.2 p90 -140.33 141.09 35.73 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 173.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.48 99.97 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 149.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 175.32 178.3 45.06 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 118.108 2.003 . . . . 0.0 118.108 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 1.603 ' HD1' ' CD2' ' A' ' 92' ' ' PHE . 35.8 p90 -125.86 56.35 15.19 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.973 1.309 . . . . 0.0 112.802 164.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -59.8 142.28 98.35 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.736 2.291 . . . . 0.0 111.197 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -55.09 -17.11 3.58 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 -158.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -21.18 63.19 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.77 -1.206 . . . . 0.0 113.301 171.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.532 ' CD2' ' HH ' ' A' ' 89' ' ' TYR . 1.5 mm? -52.55 -33.2 44.54 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.297 1.839 . . . . 0.0 113.565 168.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -79.57 4.63 15.3 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.815 1.246 . . . . 0.0 112.648 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -130.09 -35.82 1.58 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.002 1.321 . . . . 0.0 114.142 177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.04 165.86 18.21 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 117.991 2.589 . . . . 0.0 117.991 -168.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -104.21 -172.62 2.14 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 126.784 2.033 . . . . 0.0 115.248 -161.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.65 158.95 16.83 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 126.823 2.049 . . . . 0.0 110.749 170.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.3 p -123.83 125.56 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 159.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 41.5 t -142.27 119.4 11.41 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 142.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -171.2 140.03 1.43 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.259 0.552 . . . . 0.0 110.335 -164.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -114.67 95.74 5.39 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.695 1.198 . . . . 0.0 108.997 141.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -160.96 177.51 10.29 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.983 -1.073 . . . . 0.0 113.636 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 1.632 ' HE1' ' CE2' ' A' ' 107' ' ' PHE . 0.8 OUTLIER -70.19 157.32 37.85 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 121.331 -0.856 . . . . 0.0 111.828 161.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.7 tp -145.13 143.79 30.56 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.865 1.666 . . . . 0.0 108.994 -170.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.9 m -104.04 -174.03 2.45 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.217 1.007 . . . . 0.0 112.881 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.356 89.1 t -66.65 1.92 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 128.371 2.668 . . . . 0.0 115.08 -173.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -50.5 -4.75 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 118.244 2.683 . . . . 0.0 118.244 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.373 4.7 pt-20 54.57 3.54 0.05 Allowed 'General case' 0 N--CA 1.466 0.364 1 N-CA-C 124.319 4.933 . . . . 0.0 124.319 153.705 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -163.13 123.83 2.35 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 123.139 2.7 . . . . 0.0 108.448 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.4 pp -155.88 150.01 25.53 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.595 1.558 . . . . 0.0 111.459 -174.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.6 t -115.3 144.86 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 127.349 2.26 . . . . 0.0 113.062 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.6 138.81 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 123.844 0.857 . . . . 0.0 110.853 146.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.4 p -114.82 167.27 10.93 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.338 1.055 . . . . 0.0 112.403 172.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -35.38 74.65 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 120.721 -1.237 . . . . 0.0 111.667 174.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.91 -36.04 82.63 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.334 0.653 . . . . 0.0 112.518 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -64.36 -47.57 78.81 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 118.693 -0.67 . . . . 0.0 111.256 172.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.93 -50.01 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 119.026 0.83 . . . . 0.0 110.846 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -57.51 -36.11 71.13 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.069 0.947 . . . . 0.0 113.067 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -78.88 -31.6 45.52 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.982 -1.074 . . . . 0.0 112.738 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.4 mt -71.04 -37.62 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.727 1.611 . . . . 0.0 111.238 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -158.75 -54.54 0.02 OUTLIER Pre-proline 0 N--CA 1.48 1.061 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 164.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -120.2 109.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.66 0 CA-C-N 121.349 1.517 . . . . 0.0 112.818 -159.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 82.8 m -73.66 128.18 34.79 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 145.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -179.99 135.33 0.11 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.272 1.829 . . . . 0.0 111.07 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -74.47 56.84 0.69 Allowed 'General case' 0 N--CA 1.482 1.134 0 O-C-N 120.586 -1.321 . . . . 0.0 110.71 159.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.11 19.1 0.04 OUTLIER Glycine 0 CA--C 1.544 1.886 0 C-N-CA 127.253 2.359 . . . . 0.0 114.571 -169.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.0 t -63.97 136.91 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.903 1.281 . . . . 0.0 111.551 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.3 85.04 2.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 122.68 1.228 . . . . 0.0 109.191 160.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.8 m -78.07 144.85 36.22 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 166.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -146.03 132.5 19.72 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -165.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 42.0 t -136.55 140.79 43.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.533 0.606 . . . . 0.0 112.48 -167.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.1 t -136.09 138.99 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 127.199 2.2 . . . . 0.0 108.369 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.2 m -130.84 140.9 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.992 -0.442 . . . . 0.0 109.845 166.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -114.6 143.42 45.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 122.281 1.039 . . . . 0.0 110.686 157.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.96 137.52 49.84 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.732 2.013 . . . . 0.0 107.699 163.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 53.0 m -140.45 131.23 25.82 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 123.711 0.632 . . . . 0.0 110.489 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 17.4 m120 45.82 65.09 1.23 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.847 2.059 . . . . 0.0 114.437 168.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 37.1 m 59.5 12.63 2.85 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 101.71 7.04 48.87 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.494 1.045 . . . . 0.0 114.945 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 23.3 mmt -64.88 -13.88 57.87 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.728 1.264 . . . . 0.0 113.258 171.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.3 t -139.68 141.01 37.0 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.8 1.24 . . . . 0.0 110.242 158.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 1.63 ' HD1' ' CD2' ' A' ' 146' ' ' TYR . 0.6 OUTLIER -115.59 152.24 33.45 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 157.143 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -134.53 146.42 49.68 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.161 -0.962 . . . . 0.0 109.689 170.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.3 tt -143.39 143.76 24.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.547 0.689 . . . . 0.0 112.327 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -134.57 130.94 37.29 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 161.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.22 131.07 35.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 122.907 1.337 . . . . 0.0 109.688 150.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.7 m -137.27 142.99 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 111.365 -2.652 . . . . 0.0 108.35 -162.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -123.47 132.96 54.08 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 1.635 ' HD1' ' CD2' ' A' ' 153' ' ' PHE . 98.5 m-85 -142.91 162.23 36.03 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.431 1.892 . . . . 0.0 110.21 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -70.14 -144.82 0.24 Allowed Glycine 0 CA--C 1.543 1.828 0 O-C-N 120.632 -1.293 . . . . 0.0 110.928 149.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.64 17.36 0.46 Allowed 'Trans proline' 0 CA--C 1.553 1.45 0 C-N-CA 123.126 2.551 . . . . 0.0 114.17 174.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -85.63 -17.37 36.33 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -164.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -77.67 54.48 1.22 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 123.28 1.514 . . . . 0.0 109.802 163.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.88 -21.28 65.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.995 1.718 . . . . 0.0 114.144 -161.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.24 -43.62 66.9 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.925 0.784 . . . . 0.0 111.985 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -73.0 -31.65 64.63 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.579 0.752 . . . . 0.0 111.424 175.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 1.649 ' HE2' ' CE1' ' A' ' 161' ' ' TYR . 24.3 t80 -64.05 -49.99 70.17 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.309 -0.869 . . . . 0.0 110.609 171.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -54.95 -36.54 65.42 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.004 -1.06 . . . . 0.0 113.668 172.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.89 85.62 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.432 0.56 . . . . 0.0 112.185 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -71.81 -48.2 48.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.29 1.036 . . . . 0.0 113.192 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 98.1 mt -54.74 -35.95 64.28 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.621 1.101 . . . . 0.0 112.539 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -70.89 -40.93 71.92 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 125.723 1.609 . . . . 0.0 112.902 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -77.34 -35.56 54.57 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.8 pt -75.07 -38.32 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.142 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -65.6 -10.41 35.34 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 120.259 1.39 . . . . 0.0 112.885 164.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -110.64 28.14 8.97 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.257 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 110.728 -0.101 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.56 -10.37 63.44 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 124.674 1.13 . . . . 0.0 115.419 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -139.31 177.85 7.62 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.321 2.649 . . . . 0.0 108.982 167.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.42 123.37 22.22 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.736 0.814 . . . . 0.0 112.902 172.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -138.26 136.52 36.58 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.12 1.768 . . . . 0.0 112.057 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.7 tp -73.97 107.36 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-O 123.069 1.414 . . . . 0.0 114.603 -157.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -43.65 121.61 2.39 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 112.126 -2.307 . . . . 0.0 110.679 -174.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -63.84 -30.55 71.63 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 -139.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.85 -15.56 15.64 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.38 0.991 . . . . 0.0 113.663 172.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.3 t -69.96 -62.26 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.841 1.256 . . . . 0.0 111.662 -173.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.0 -53.46 14.45 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.63 1.109 . . . . 0.0 112.248 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.36 -45.94 72.87 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 118.958 1.379 . . . . 0.0 113.504 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.89 -39.02 76.51 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.085 -1.009 . . . . 0.0 112.805 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -70.39 -42.89 71.12 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.236 0.925 . . . . 0.0 112.219 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.36 -42.71 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.285 1.034 . . . . 0.0 109.851 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.7 p -68.51 -40.36 80.86 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.74 0.7 . . . . 0.0 112.227 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -69.08 -36.89 78.11 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.223 -0.923 . . . . 0.0 112.466 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 87.7 m -66.92 -48.09 69.73 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.193 -0.942 . . . . 0.0 110.715 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.2 ptt-85 -59.32 -41.58 89.4 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.284 0.947 . . . . 0.0 111.26 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -62.24 -56.74 15.64 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.19 1.396 . . . . 0.0 112.286 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.82 -30.18 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 119.369 0.986 . . . . 0.0 112.202 -172.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.75 -8.33 59.18 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.22 0.918 . . . . 0.0 113.249 169.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 52.76 46.36 26.89 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.387 1.875 . . . . 0.0 111.921 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 pp -129.37 159.44 36.2 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.851 1.261 . . . . 0.0 111.051 172.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -73.5 160.54 31.56 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -60.52 -27.89 67.98 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.166 -1.583 . . . . 0.0 111.983 168.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -84.4 6.12 24.5 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 119.775 1.171 . . . . 0.0 113.056 171.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -116.1 -12.95 11.2 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.605 -1.309 . . . . 0.0 110.996 174.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 26.9 tp -89.68 113.16 24.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.494 1.918 . . . . 0.0 109.348 171.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -94.67 130.72 41.05 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 119.584 -0.846 . . . . 0.0 112.849 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' ASP . 37.4 mm -95.87 138.01 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 127.442 2.297 . . . . 0.0 113.308 -176.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 m -147.29 148.44 31.42 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.818 1.19 . . . . 0.0 109.476 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.7 p30 -150.76 56.43 0.91 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 122.886 1.327 . . . . 0.0 114.394 171.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.0 p -91.45 -56.15 3.24 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.112 1.365 . . . . 0.0 114.352 157.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.92 -52.2 5.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 122.744 1.259 . . . . 0.0 114.193 -152.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.511 ' H ' HD21 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -64.88 -27.54 68.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.112 1.765 . . . . 0.0 112.448 173.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.5 mp -71.43 -16.18 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.565 1.946 . . . . 0.0 112.6 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 54.7 m -61.04 -0.14 0.29 Allowed 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 118.069 2.618 . . . . 0.0 118.069 -166.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -90.07 -30.9 17.41 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 121.42 1.918 . . . . 0.0 113.298 169.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -134.41 84.3 41.13 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 165.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -69.98 21.95 0.18 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.535 3.49 . . . . 0.0 114.721 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -113.75 4.27 15.9 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.44 1.896 . . . . 0.0 111.587 169.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -130.14 164.27 24.8 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 120.302 1.41 . . . . 0.0 108.284 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 p -150.16 150.67 31.96 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.242 -0.911 . . . . 0.0 111.49 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.12 -82.77 0.64 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 117.036 -1.459 . . . . 0.0 110.692 147.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 30.5 p -170.88 163.5 7.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 121.681 2.037 . . . . 0.0 114.507 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 16.2 t70 -115.47 152.82 32.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 153.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.23 135.79 55.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 129.129 2.972 . . . . 0.0 108.743 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 55.7 mtm -112.04 134.05 53.83 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.9 1.227 . . . . 0.0 108.145 168.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.269 0.6 OUTLIER -147.79 131.93 17.34 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 118.493 2.775 . . . . 0.0 118.493 -155.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.25 160.22 18.53 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 110.539 -3.028 . . . . 0.0 114.395 -174.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.6 p -96.02 179.75 4.97 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.627 1.971 . . . . 0.0 115.464 -158.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . 0.268 28.9 t70 63.16 46.0 4.84 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.482 2.313 . . . . 0.0 115.349 177.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.36 164.28 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 127.065 2.146 . . . . 0.0 109.22 163.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 m -101.11 141.07 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.228 1.011 . . . . 0.0 108.548 161.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.65 110.52 44.49 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 119.829 1.195 . . . . 0.0 108.219 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -67.67 74.71 0.61 Allowed 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 125.159 3.906 . . . . 0.0 111.072 173.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.6 -24.65 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.644 1.978 . . . . 0.0 114.294 -152.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.11 -26.72 50.97 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.652 0.66 . . . . 0.0 112.26 172.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 1.655 ' HD1' ' CD2' ' A' ' 60' ' ' TYR . 7.3 t80 -57.26 -38.49 73.94 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.641 174.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.7 -43.09 63.49 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.434 1.015 . . . . 0.0 111.257 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -56.09 -48.72 75.58 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.166 0.986 . . . . 0.0 110.325 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.0 m -71.92 -42.89 66.17 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.391 1.476 . . . . 0.0 113.166 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -67.38 -33.96 76.29 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.909 1.231 . . . . 0.0 111.784 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -66.54 -46.99 74.29 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.524 0.602 . . . . 0.0 112.491 165.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -60.6 -30.06 69.59 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.786 -1.196 . . . . 0.0 112.717 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 79.2 m -76.66 -6.31 51.57 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.755 1.622 . . . . 0.0 114.234 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -82.38 -35.17 27.99 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 120.089 1.313 . . . . 0.0 112.971 -175.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.6 p -154.87 -23.98 0.12 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.534 1.134 . . . . 0.0 113.121 167.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.86 82.04 1.35 Allowed Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.761 2.124 . . . . 0.0 112.028 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.9 tpt85 -153.26 118.77 5.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 128.828 2.851 . . . . 0.0 104.957 169.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.6 m -62.03 150.99 36.54 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.705 0.802 . . . . 0.0 111.89 -175.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -141.04 149.91 42.3 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.146 1.378 . . . . 0.0 113.229 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 29.5 p -83.02 138.19 33.84 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.736 1.214 . . . . 0.0 111.484 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 1.664 ' HE2' ' CE1' ' A' ' 75' ' ' PHE . 53.0 m-85 -110.59 115.7 30.07 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 172.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.1 t -130.04 111.26 21.01 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.549 0 C-N-CA 123.76 0.824 . . . . 0.0 109.56 -154.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 1.667 ' HE1' ' CE2' ' A' ' 77' ' ' PHE . 2.3 m-85 -96.07 115.67 27.78 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 120.338 -1.476 . . . . 0.0 107.499 -170.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -108.49 107.87 18.57 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.89 1.276 . . . . 0.0 108.772 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -84.06 137.41 33.6 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.276 -0.89 . . . . 0.0 111.184 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.1 p -144.28 167.87 21.41 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 129.591 3.156 . . . . 0.0 104.626 -167.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -16.42 -123.32 0.0 OUTLIER Glycine 0 N--CA 1.489 2.169 1 C-N-CA 130.831 4.063 . . . . 0.0 116.636 -176.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 55.8 m -97.99 101.96 13.58 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 113.029 -3.468 . . . . 0.0 111.254 152.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.68 164.29 12.16 Favored 'General case' 0 CA--C 1.542 0.671 1 C-N-CA 133.465 4.706 . . . . 0.0 106.419 136.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.6 156.96 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 O-C-N 119.468 -2.02 . . . . 0.0 108.714 147.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -127.74 146.67 50.5 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.621 0.768 . . . . 0.0 110.242 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.0 tp -117.17 109.37 16.82 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.068 0.947 . . . . 0.0 108.657 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.2 m -76.69 132.02 39.13 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.103 1.361 . . . . 0.0 110.139 167.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.1 m -128.69 115.34 17.86 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.624 -1.298 . . . . 0.0 110.011 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 1.66 ' HD2' ' CD1' ' A' ' 89' ' ' TYR . 23.9 t80 -137.15 134.77 36.72 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.29 85.28 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 161.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 174.63 -176.61 46.89 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 117.694 1.837 . . . . 0.0 117.694 -174.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -111.15 79.97 2.23 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.734 1.214 . . . . 0.0 112.407 168.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -53.4 153.62 17.08 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 124.528 3.485 . . . . 0.0 116.479 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -72.56 -32.46 66.06 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -172.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -76.33 -10.02 59.08 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.943 1.247 . . . . 0.0 113.634 172.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.51 -2.71 9.38 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.524 1.93 . . . . 0.0 114.815 167.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 9.8 mmpt? -50.55 -41.02 53.59 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.489 -0.757 . . . . 0.0 110.753 151.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -118.98 -34.5 3.88 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -167.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.7 pp -83.87 160.6 21.11 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 120.69 1.586 . . . . 0.0 113.187 -163.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.3 pttt -164.08 129.08 2.83 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 -165.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.471 ' HG2' ' H ' ' A' ' 102' ' ' VAL 0.339 11.5 ttt180 -108.89 -173.59 2.31 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 125.472 1.509 . . . . 0.0 113.172 167.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.471 ' H ' ' HG2' ' A' ' 101' ' ' ARG . 7.4 p 179.9 166.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 128.105 2.562 . . . . 0.0 109.353 -133.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 57.3 m -118.12 122.3 42.75 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.155 0.889 . . . . 0.0 109.286 151.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -170.97 163.32 7.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.652 2.381 . . . . 0.0 106.756 -171.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 1.626 ' HE1' ' CE2' ' A' ' 105' ' ' PHE . 13.0 p90 -139.27 115.36 10.3 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 126.077 1.751 . . . . 0.0 112.903 174.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -159.88 -172.92 3.84 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.339 1.456 . . . . 0.0 111.904 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -66.94 160.78 25.58 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.124 0.97 . . . . 0.0 112.58 160.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.6 tp -135.22 145.96 48.18 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 129.142 2.977 . . . . 0.0 108.777 -172.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.7 t -109.27 155.51 21.04 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.932 2.093 . . . . 0.0 110.543 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.01 -15.81 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -157.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -130.35 46.72 2.61 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.34 1.056 . . . . 0.0 110.643 -170.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -104.69 150.66 24.53 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.505 1.522 . . . . 0.0 112.589 -167.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -144.13 136.09 26.28 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.166 -1.584 . . . . 0.0 110.042 -172.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.32 139.25 15.32 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 120.632 -1.292 . . . . 0.0 113.63 -170.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.6 t -108.87 132.77 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 125.745 1.618 . . . . 0.0 111.012 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . 0.254 0.8 OUTLIER -129.79 123.53 57.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 122.64 1.209 . . . . 0.0 110.065 157.086 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.9 t -124.73 158.53 33.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.596 2.358 . . . . 0.0 107.846 173.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -36.12 64.41 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.968 0.803 . . . . 0.0 112.006 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.11 -31.95 68.41 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -76.2 -28.96 57.44 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.611 -1.306 . . . . 0.0 112.258 174.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 41.3 mm -67.81 -40.65 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 121.556 -0.715 . . . . 0.0 110.562 164.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.23 -11.9 52.89 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.26 1.024 . . . . 0.0 113.191 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -79.29 -45.39 19.8 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 119.77 -1.831 . . . . 0.0 112.214 164.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.9 pt -92.04 -12.94 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -170.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -122.87 161.32 44.95 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 125.287 1.435 . . . . 0.0 112.422 174.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -68.32 -31.4 28.5 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.906 1.737 . . . . 0.0 115.694 -168.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.417 ' SG ' ' HE2' ' A' ' 129' ' ' LYS . 5.6 t -153.29 162.39 41.34 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -172.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -99.99 -137.32 0.31 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.148 2.579 . . . . 0.0 111.482 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.417 ' HE2' ' SG ' ' A' ' 127' ' ' CYS . 63.4 pttt 44.84 22.03 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 119.278 3.066 . . . . 0.0 119.278 165.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.46 21.66 0.04 OUTLIER Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.124 1.345 . . . . 0.0 115.946 168.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.1 t -65.89 132.9 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 118.698 1.249 . . . . 0.0 111.946 -169.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 20.7 mt -124.18 108.84 12.72 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 122.4 1.095 . . . . 0.0 109.138 151.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.2 t -101.69 147.25 26.67 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.855 1.662 . . . . 0.0 109.725 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -124.7 133.74 53.09 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.661 1.184 . . . . 0.0 108.394 -174.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 72.3 m -109.67 143.09 39.92 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.625 0.77 . . . . 0.0 111.057 171.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.71 129.33 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.727 1.611 . . . . 0.0 108.863 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.1 m -136.85 147.81 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -132.0 145.9 51.74 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.08 1.752 . . . . 0.0 112.699 172.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.667 ' HE2' ' CD1' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -129.12 93.14 3.52 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.565 2.346 . . . . 0.0 114.211 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 18.1 t -83.79 123.1 29.54 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.679 -0.638 . . . . 0.0 112.211 170.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -96.38 -41.13 8.77 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.591 1.557 . . . . 0.0 110.963 167.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 98.0 p -64.63 -18.38 64.88 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -131.73 23.33 4.22 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 125.824 1.678 . . . . 0.0 114.919 168.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.9 mmt 31.1 59.83 0.25 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 128.352 2.661 . . . . 0.0 116.326 172.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.9 t -164.62 146.55 8.36 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.174 0.99 . . . . 0.0 110.55 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 1.669 ' HD1' ' CD2' ' A' ' 146' ' ' TYR . 4.5 m-85 -129.21 158.11 39.95 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -158.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -144.07 144.98 31.87 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 120.946 -1.096 . . . . 0.0 108.847 -171.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.0 tt -144.94 142.67 22.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.843 -168.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -141.02 136.21 31.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.361 1.465 . . . . 0.0 107.46 174.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.52 136.52 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 122.051 0.929 . . . . 0.0 110.946 155.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.3 m -129.23 149.64 33.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 126.218 1.807 . . . . 0.0 109.734 -172.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.93 127.63 23.35 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -133.47 157.62 45.17 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.457 1.903 . . . . 0.0 110.867 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -90.61 -159.35 35.53 Favored Glycine 0 CA--C 1.541 1.702 0 C-N-CA 124.404 1.002 . . . . 0.0 113.519 174.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.25 -7.75 21.73 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.339 2.693 . . . . 0.0 115.522 -172.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -75.58 -2.91 31.38 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 171.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -76.73 57.27 1.25 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.347 1.859 . . . . 0.0 111.683 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.18 -23.14 61.97 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.334 1.454 . . . . 0.0 113.696 -174.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.57 -51.24 37.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.141 0.882 . . . . 0.0 111.591 178.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -71.21 -34.97 71.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.881 0.872 . . . . 0.0 112.729 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -58.9 -53.71 55.33 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.854 0.752 . . . . 0.0 110.689 171.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -57.02 -39.02 73.95 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.884 0.765 . . . . 0.0 112.07 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.82 -42.99 98.78 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.295 0.952 . . . . 0.0 112.926 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.21 -46.98 72.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.569 -0.707 . . . . 0.0 112.586 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 86.9 mt -57.31 -34.64 68.94 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.837 0.455 . . . . 0.0 111.497 175.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -75.63 -17.59 59.95 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.586 1.955 . . . . 0.0 113.549 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -101.9 -31.17 10.83 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.0 pt -86.54 -36.63 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 120.415 1.461 . . . . 0.0 113.547 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -76.32 12.62 1.15 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.381 1.446 . . . . 0.0 111.508 161.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.85 25.61 4.31 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 170.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 125.224 1.409 . . . . 0.0 112.495 168.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.28 32.11 83.11 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 119.213 -0.771 . . . . 0.0 114.092 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -127.98 -10.31 5.41 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.032 1.333 . . . . 0.0 113.71 -167.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.1 ptp -150.73 64.33 0.93 Allowed 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.923 -1.111 . . . . 0.0 110.787 158.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.12 115.2 9.73 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -168.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.5 tp -76.14 105.38 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 122.422 1.106 . . . . 0.0 111.248 169.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -44.38 127.16 5.68 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 112.251 -2.25 . . . . 0.0 112.122 -163.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -55.76 -20.95 16.68 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -162.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -97.17 -31.17 12.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.278 1.031 . . . . 0.0 112.603 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.9 -59.49 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.93 0.892 . . . . 0.0 112.079 -168.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.37 -42.38 97.42 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.534 -0.592 . . . . 0.0 111.845 171.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.61 -51.15 69.75 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.542 1.171 . . . . 0.0 112.757 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -64.45 -43.03 95.57 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.317 1.047 . . . . 0.0 112.445 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.44 -47.36 61.09 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.896 0.878 . . . . 0.0 111.893 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.16 -41.55 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.547 0.739 . . . . 0.0 109.646 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.5 m -59.29 -38.37 80.02 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.769 0.713 . . . . 0.0 112.387 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -76.0 -32.32 59.37 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.645 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -71.99 -43.66 64.74 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 120.454 1.479 . . . . 0.0 111.646 170.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -49.72 -43.64 47.78 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.456 1.502 . . . . 0.0 111.791 172.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -73.46 -59.57 2.65 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.245 1.418 . . . . 0.0 113.651 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.02 -31.81 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 120.699 1.59 . . . . 0.0 112.718 -168.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.0 mp -84.0 -13.43 53.31 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.152 -0.967 . . . . 0.0 112.543 173.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 54.44 60.1 3.76 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.82 1.648 . . . . 0.0 112.514 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 pp -130.89 148.66 52.69 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.89 0.876 . . . . 0.0 109.385 167.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -69.99 159.51 33.65 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.991 0.424 . . . . 0.0 110.585 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -65.42 -27.38 68.49 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.376 -1.452 . . . . 0.0 111.757 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -68.57 -9.01 46.8 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.97 1.308 . . . . 0.0 113.848 166.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -125.49 3.05 7.66 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.471 1.508 . . . . 0.0 111.639 -176.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 24.2 tp -93.34 128.68 39.47 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 156.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 131.91 50.17 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.906 0.775 . . . . 0.0 111.134 167.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.8 mm -93.71 143.44 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 127.236 2.215 . . . . 0.0 110.723 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.5 m -149.77 154.1 37.92 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 121.394 -0.816 . . . . 0.0 110.674 168.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.2 p30 -155.75 58.81 0.61 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.678 1.228 . . . . 0.0 112.999 -176.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 30.1 p -86.93 -60.2 2.05 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.626 -1.296 . . . . 0.0 111.341 169.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.16 -38.09 15.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 113.919 -1.491 . . . . 0.0 112.474 -158.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 pp -99.63 -1.94 36.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.054 2.142 . . . . 0.0 113.718 -171.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.5 5.53 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 126.53 1.932 . . . . 0.0 110.354 166.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.3 t -59.49 -29.71 68.03 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.354 1.462 . . . . 0.0 114.117 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -81.22 26.75 0.43 Allowed 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.059 -1.651 . . . . 0.0 112.913 169.354 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 m120 71.69 165.13 0.14 Allowed Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 128.646 2.779 . . . . 0.0 112.758 -168.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.12 -3.69 3.22 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.749 2.966 . . . . 0.0 114.896 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -97.82 5.71 48.75 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.409 2.284 . . . . 0.0 112.454 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 1.615 ' HE1' ' CE2' ' A' ' 43' ' ' TYR . 53.4 m-85 -157.36 94.54 1.39 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 171.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.4 p -175.24 168.76 3.34 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.501 -159.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -131.61 -81.51 0.52 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 116.78 -1.968 . . . . 0.0 115.345 132.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.38 -176.98 2.31 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.343 1.057 . . . . 0.0 111.408 -174.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -116.72 146.18 42.96 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 168.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.54 130.24 42.05 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.628 2.371 . . . . 0.0 107.682 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 18.4 mtt -123.6 134.16 53.85 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.018 -1.051 . . . . 0.0 110.61 -170.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.5 mt -130.77 142.26 50.4 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 126.154 2.159 . . . . 0.0 112.748 -147.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.6 p -110.7 161.58 15.61 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.058 2.543 . . . . 0.0 111.584 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.4 p -126.77 108.6 11.19 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -163.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -158.92 2.26 0.09 Allowed 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 125.584 1.554 . . . . 0.0 114.84 165.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.65 173.08 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 126.578 1.951 . . . . 0.0 113.196 -162.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 m -96.78 142.54 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.894 1.678 . . . . 0.0 112.178 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -109.2 106.41 58.65 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -73.51 71.53 3.85 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.668 3.579 . . . . 0.0 110.397 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.48 -28.58 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 114.088 -1.414 . . . . 0.0 114.653 -149.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -56.99 -35.01 68.7 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -67.13 -32.94 74.4 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.384 0.538 . . . . 0.0 111.722 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.0 mt -75.01 -45.0 44.82 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.748 0.704 . . . . 0.0 111.458 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 mp -55.27 -44.21 75.4 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.8 0.727 . . . . 0.0 111.261 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -63.62 -45.37 90.62 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.606 0.762 . . . . 0.0 112.501 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -63.69 -32.44 73.93 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.63 0.772 . . . . 0.0 112.593 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -69.1 -45.25 70.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.575 1.15 . . . . 0.0 111.823 171.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.09 -37.79 77.95 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 119.583 1.083 . . . . 0.0 112.095 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.1 t -62.97 -1.48 0.93 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.438 1.895 . . . . 0.0 115.706 -168.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -70.88 -18.22 62.69 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 120.287 -1.508 . . . . 0.0 113.58 172.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.7 p -164.21 -16.4 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.628 1.571 . . . . 0.0 113.813 166.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.5 83.55 1.12 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 126.941 2.21 . . . . 0.0 109.62 -165.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -161.76 114.87 1.84 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.469 2.308 . . . . 0.0 106.555 -168.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.4 m -71.93 126.28 29.34 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -167.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.11 143.52 36.75 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.858 1.663 . . . . 0.0 111.667 172.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 60.3 m -98.4 127.77 44.49 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.143 0.977 . . . . 0.0 109.389 176.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -93.89 104.2 16.27 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.909 1.684 . . . . 0.0 109.311 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.4 t -99.06 117.92 44.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 C-N-CA 124.787 1.235 . . . . 0.0 109.225 -171.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -94.37 109.03 20.91 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HE3' ' HB1' ' A' ' 113' ' ' ALA . 14.2 mmmm -111.14 101.83 10.32 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.727 2.011 . . . . 0.0 108.743 172.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -98.28 135.84 39.32 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.797 -1.19 . . . . 0.0 111.366 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.31 165.05 36.97 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 130.173 3.389 . . . . 0.0 104.407 -161.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -9.68 -123.01 0.0 OUTLIER Glycine 0 N--CA 1.486 1.996 0 C-N-CA 128.7 3.047 . . . . 0.0 115.286 -153.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 9.1 p -95.48 106.61 18.69 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 113.405 -3.318 . . . . 0.0 111.57 150.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.96 139.95 2.42 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 131.529 3.932 . . . . 0.0 107.276 131.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.1 t -63.38 133.41 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 117.104 -1.838 . . . . 0.0 108.482 152.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.68 140.44 39.54 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.7 0.682 . . . . 0.0 109.432 163.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.8 tp -110.64 106.15 15.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 163.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.9 m -86.93 118.64 26.45 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.88 1.672 . . . . 0.0 109.019 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 82.2 m -102.92 110.32 22.19 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.296 -1.502 . . . . 0.0 109.169 -172.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 1.632 ' HE1' ' CE2' ' A' ' 89' ' ' TYR . 8.1 m-30 -99.92 109.8 22.15 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.658 -175.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mp -82.33 98.08 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 129.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.47 178.89 47.44 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 118.621 2.208 . . . . 0.0 118.621 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 1.614 ' HD2' ' CD1' ' A' ' 92' ' ' PHE . 1.9 t80 -126.21 45.79 1.62 Allowed Pre-proline 0 CA--C 1.56 1.331 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 160.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -52.18 155.36 9.23 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.826 3.017 . . . . 0.0 117.689 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -49.86 -33.42 16.93 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.841 2.456 . . . . 0.0 116.249 -162.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -92.99 -17.32 24.06 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.14 -35.61 59.91 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.622 2.769 . . . . 0.0 113.653 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -57.24 -43.03 82.57 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 118.486 -0.768 . . . . 0.0 111.845 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -98.26 -34.34 10.74 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.982 1.264 . . . . 0.0 114.105 -174.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.92 157.8 35.92 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 121.113 1.778 . . . . 0.0 112.166 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -164.12 134.38 4.17 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 -163.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.546 ' HD3' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -120.2 -178.03 3.57 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.638 1.575 . . . . 0.0 114.332 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.546 ' H ' ' HD3' ' A' ' 101' ' ' ARG . 8.9 p -163.37 174.67 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 127.733 2.413 . . . . 0.0 112.278 -140.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 75.0 m -129.72 135.51 48.56 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.081 -1.012 . . . . 0.0 111.333 144.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.3 t0 178.57 166.76 0.85 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 127.865 2.466 . . . . 0.0 107.249 -168.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -128.76 121.39 28.3 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.166 1.386 . . . . 0.0 113.959 162.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -160.38 -176.68 5.75 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 126.027 1.731 . . . . 0.0 110.923 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -80.67 165.67 21.78 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.442 -1.411 . . . . 0.0 111.481 164.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.7 tp -144.67 141.2 29.16 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.555 1.142 . . . . 0.0 111.149 -170.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.3 m -77.98 151.67 33.5 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.09 1.756 . . . . 0.0 115.293 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.65 -8.62 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 127.094 2.158 . . . . 0.0 116.131 -161.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -137.6 38.65 2.43 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.769 1.228 . . . . 0.0 112.787 -170.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -106.05 165.95 10.85 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.257 1.423 . . . . 0.0 113.753 -164.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.416 ' HB1' ' HE3' ' A' ' 78' ' ' LYS . . . -146.95 133.73 20.06 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 125.537 1.535 . . . . 0.0 110.157 -170.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.8 144.28 20.2 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.823 1.249 . . . . 0.0 111.38 -174.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.77 141.76 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 121.472 1.942 . . . . 0.0 113.965 174.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.99 149.87 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.648 1.179 . . . . 0.0 110.784 175.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 t -146.6 172.59 13.34 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.013 0.925 . . . . 0.0 112.091 168.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.37 -34.17 66.4 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.71 -41.92 67.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.712 0.687 . . . . 0.0 112.385 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -75.4 -26.51 58.46 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.884 0.874 . . . . 0.0 112.734 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.2 tp -75.51 -38.96 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.212 1.005 . . . . 0.0 111.452 170.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -55.11 -39.96 69.96 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.23 1.012 . . . . 0.0 111.315 168.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -66.97 -20.22 65.85 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.344 1.058 . . . . 0.0 112.794 -173.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 66.9 mt -69.74 -41.43 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 118.67 0.668 . . . . 0.0 110.463 -177.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -167.39 -47.73 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.765 0 CA-C-O 116.559 -1.686 . . . . 0.0 112.301 175.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -82.58 -132.84 0.01 OUTLIER 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 122.606 2.204 . . . . 0.0 112.949 -170.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 20.9 t -166.7 133.94 2.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.2 1.8 . . . . 0.0 111.209 -164.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . 0.253 25.4 p30 -70.69 3.76 2.94 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 -161.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -104.67 10.4 34.8 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.61 1.964 . . . . 0.0 113.208 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.07 29.17 0.16 Allowed Glycine 0 CA--C 1.534 1.271 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.6 t -83.58 135.61 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 119.139 1.469 . . . . 0.0 112.349 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.49 105.67 11.9 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.992 0.917 . . . . 0.0 108.691 153.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.34 144.62 31.39 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.699 0.8 . . . . 0.0 110.086 166.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -137.05 136.93 38.83 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.692 0.797 . . . . 0.0 109.411 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 43.2 t -128.11 133.81 49.05 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.846 0.859 . . . . 0.0 111.42 -169.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.5 t -132.55 111.35 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.119 0.968 . . . . 0.0 109.483 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 29.7 m -105.22 151.61 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.573 1.549 . . . . 0.0 110.595 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -124.7 135.63 53.2 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.152 1.381 . . . . 0.0 111.256 157.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.462 ' HE3' ' CE2' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -77.32 144.52 38.0 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.278 1.031 . . . . 0.0 112.166 135.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.0 m -147.31 76.57 1.41 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.735 2.014 . . . . 0.0 109.061 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -65.66 -48.48 71.99 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.539 -1.351 . . . . 0.0 113.617 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.1 m -57.75 -39.66 77.89 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.072 -1.017 . . . . 0.0 111.715 174.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.05 -0.16 68.95 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 126.304 1.907 . . . . 0.0 115.938 173.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 75.9 mtm 43.37 53.14 5.68 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.078 2.551 . . . . 0.0 115.241 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 99.5 p -148.66 163.39 37.42 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 1.605 ' HD1' ' CD2' ' A' ' 146' ' ' TYR . 41.8 m-85 -100.2 151.84 20.97 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.684 147.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -134.95 141.85 46.36 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.04 137.31 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.81 0.814 . . . . 0.0 110.647 -161.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -135.79 139.26 43.38 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.498 1.519 . . . . 0.0 108.587 169.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.2 p -140.9 134.39 32.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 122.363 1.077 . . . . 0.0 109.196 149.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 30.2 m -116.65 143.18 27.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 127.95 2.5 . . . . 0.0 109.033 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.82 129.95 39.19 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -165.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 1.612 ' HD2' ' CD1' ' A' ' 153' ' ' PHE . 64.4 m-85 -134.43 156.05 49.24 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.576 1.551 . . . . 0.0 110.799 177.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.577 ' H ' ' CD ' ' A' ' 155' ' ' PRO . . . -171.78 33.33 0.14 Allowed Glycine 0 CA--C 1.546 1.97 0 CA-C-O 116.364 -2.354 . . . . 0.0 117.28 161.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.577 ' CD ' ' H ' ' A' ' 154' ' ' GLY . 59.5 Cg_endo -105.62 -49.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.037 0 CA-C-N 121.812 2.806 . . . . 0.0 113.353 160.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -117.74 -26.96 6.38 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 53.79 1.28 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 118.289 2.7 . . . . 0.0 118.289 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.97 -45.31 94.23 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -155.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.91 -53.07 29.25 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -169.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -69.04 -31.56 70.43 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.889 0.876 . . . . 0.0 112.241 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -60.63 -55.31 34.79 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.048 0.84 . . . . 0.0 110.84 172.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -64.5 -34.16 77.56 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.385 -0.822 . . . . 0.0 112.721 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.21 -33.19 74.96 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.99 1.268 . . . . 0.0 112.654 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -50.97 51.29 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.425 1.49 . . . . 0.0 108.868 173.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 76.7 mt -60.59 -38.09 83.51 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.231 1.012 . . . . 0.0 111.439 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -70.0 -32.16 70.2 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 127.059 2.143 . . . . 0.0 112.939 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -86.72 -37.96 17.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.31 1.044 . . . . 0.0 113.359 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.6 pt -77.55 -34.2 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 119.33 0.968 . . . . 0.0 111.629 -178.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -63.45 -19.83 65.05 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.826 -0.546 . . . . 0.0 111.256 166.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -117.01 26.49 9.76 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 . . . . . 0 C--O 1.252 1.186 0 C-N-CA 128.42 2.688 . . . . 0.0 114.886 168.874 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.91 -8.18 0.03 OUTLIER Glycine 0 CA--C 1.539 1.554 0 N-CA-C 116.759 1.464 . . . . 0.0 116.759 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -135.45 -13.84 2.0 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.758 1.623 . . . . 0.0 113.715 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.3 ptm -147.2 167.74 23.43 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.964 1.706 . . . . 0.0 112.373 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -129.77 110.9 12.12 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.996 0.918 . . . . 0.0 111.075 166.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 tp -75.15 103.06 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 123.328 1.537 . . . . 0.0 111.413 -176.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -45.68 128.14 8.29 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 111.12 -2.764 . . . . 0.0 111.443 -168.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -64.21 -6.27 6.44 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 118.379 2.733 . . . . 0.0 118.379 -139.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.6 -4.24 15.54 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 120.37 1.441 . . . . 0.0 114.033 172.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 78.6 t -69.51 -56.17 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.825 1.25 . . . . 0.0 111.649 -172.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.34 -43.18 98.88 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.6 -54.31 43.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 117.925 0.862 . . . . 0.0 112.147 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -67.11 -37.85 84.59 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.088 -1.007 . . . . 0.0 113.602 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -69.18 -45.91 68.8 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.848 1.204 . . . . 0.0 111.845 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.85 -43.09 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.299 0.64 . . . . 0.0 109.745 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -68.88 -37.15 78.84 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.588 0.631 . . . . 0.0 112.609 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -76.02 -30.63 58.55 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.061 -1.024 . . . . 0.0 111.695 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.4 m -62.98 -46.52 87.32 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.799 1.636 . . . . 0.0 110.397 169.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.5 ttt-85 -52.84 -34.73 55.48 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.086 1.754 . . . . 0.0 112.396 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -83.03 -49.1 9.9 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.741 -1.224 . . . . 0.0 113.258 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.03 -28.86 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.41 1.084 . . . . 0.0 111.878 -174.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -91.71 -8.71 46.18 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.809 1.243 . . . . 0.0 112.633 171.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.5 mtp-105 58.09 17.98 4.89 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.925 2.09 . . . . 0.0 115.07 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 pp -94.31 159.04 15.3 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.331 1.452 . . . . 0.0 111.734 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -81.89 163.16 22.45 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 119.641 1.109 . . . . 0.0 112.467 176.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -64.8 -34.74 79.06 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 119.512 -1.993 . . . . 0.0 111.393 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -60.42 -16.85 39.96 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.429 2.291 . . . . 0.0 113.382 166.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -105.6 -9.83 17.17 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.958 1.254 . . . . 0.0 111.708 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 26.5 tp -91.47 135.57 33.74 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.265 1.826 . . . . 0.0 108.868 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -106.39 128.36 53.98 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 118.363 0.529 . . . . 0.0 112.395 170.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.4 mm -97.26 142.0 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.919 2.087 . . . . 0.0 112.829 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.2 m -124.92 146.34 49.4 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.371 0.987 . . . . 0.0 108.836 167.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -123.56 -153.42 0.55 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.336 2.254 . . . . 0.0 110.642 -163.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 t -36.8 -36.04 0.1 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 128.306 2.643 . . . . 0.0 116.241 -167.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.1 -43.56 70.5 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 174.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.72 -22.83 25.78 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 121.164 1.802 . . . . 0.0 112.419 175.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.8 mm -58.29 -39.7 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.144 0.977 . . . . 0.0 109.45 173.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 57.0 m -55.65 6.73 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -117.59 13.92 14.4 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 121.518 1.963 . . . . 0.0 112.034 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.9 170.2 5.68 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 126.511 1.924 . . . . 0.0 109.145 146.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -66.92 -51.14 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 121.721 1.614 . . . . 0.0 114.693 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -124.82 -34.32 2.83 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 117.562 2.43 . . . . 0.0 117.562 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 1.583 ' HE1' ' CE2' ' A' ' 43' ' ' TYR . 3.0 t80 -161.12 100.24 1.22 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 122.893 1.33 . . . . 0.0 109.458 -137.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.9 m -140.44 165.62 26.92 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.261 2.224 . . . . 0.0 107.507 173.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.29 1.1 tm? -87.47 -77.2 0.35 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 117.288 -1.339 . . . . 0.0 113.058 -164.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 12.7 m -163.94 -175.56 4.12 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.954 1.706 . . . . 0.0 111.86 -172.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -119.82 156.98 29.62 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.301 1.44 . . . . 0.0 107.398 157.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -137.39 131.62 32.32 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.738 2.815 . . . . 0.0 108.07 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.5 ttp -121.93 134.47 54.85 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.232 1.378 . . . . 0.0 110.661 -169.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 mt -131.7 146.44 52.17 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 128.473 2.709 . . . . 0.0 113.385 -148.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.6 t -98.62 159.12 15.17 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.066 1.346 . . . . 0.0 113.581 -171.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -71.38 170.84 12.34 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.229 1.811 . . . . 0.0 112.66 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.7 t70 57.89 36.23 26.09 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 170.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.58 134.66 60.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.993 1.717 . . . . 0.0 110.079 -176.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.9 p -91.24 139.17 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.966 0.907 . . . . 0.0 109.456 159.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -134.28 136.93 26.88 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 118.862 0.756 . . . . 0.0 111.701 169.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.45 69.75 5.79 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.905 3.737 . . . . 0.0 111.105 177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.4 p -62.29 -43.53 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -152.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.97 -9.31 58.18 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.037 -1.039 . . . . 0.0 113.093 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -65.54 -33.37 75.77 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.775 1.171 . . . . 0.0 111.598 165.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.9 tp -70.18 -37.45 75.15 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.656 0.662 . . . . 0.0 111.32 173.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.92 -49.87 76.01 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.375 0.534 . . . . 0.0 111.911 173.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.3 p -67.45 -31.97 72.5 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 119.175 -0.44 . . . . 0.0 112.119 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 1.614 ' HD1' ' CD2' ' A' ' 64' ' ' TYR . 39.5 t80 -63.6 -39.15 93.63 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.947 0.794 . . . . 0.0 112.512 176.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -66.26 -51.71 54.85 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.492 1.042 . . . . 0.0 112.299 169.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.26 -41.07 83.45 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.662 0.385 . . . . 0.0 111.514 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 83.1 m -77.43 -2.57 35.96 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.95 -34.66 13.68 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.379 1.472 . . . . 0.0 114.046 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.2 m -137.29 -8.73 1.73 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.32 74.49 0.43 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 126.006 1.765 . . . . 0.0 112.523 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -166.9 136.44 2.94 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.304 1.442 . . . . 0.0 109.775 161.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.4 m -64.47 142.81 58.29 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.031 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.74 151.08 47.82 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 m -75.29 103.94 5.65 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.326 1.851 . . . . 0.0 109.768 167.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 1.595 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 9.4 m-85 -87.74 99.83 12.38 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 166.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.07 147.4 6.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 C-N-CA 126.585 1.954 . . . . 0.0 108.254 -171.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 1.61 ' HD2' ' CD1' ' A' ' 77' ' ' PHE . 82.7 m-85 -130.72 121.42 25.43 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 120.513 -1.367 . . . . 0.0 107.583 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -121.7 121.01 36.35 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.303 1.841 . . . . 0.0 109.412 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -95.84 125.41 40.38 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.895 1.678 . . . . 0.0 108.892 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.4 p -143.71 155.31 44.16 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -174.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.94 80.61 0.1 OUTLIER Glycine 0 N--CA 1.476 1.339 0 C-N-CA 130.39 3.852 . . . . 0.0 112.175 -172.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.3 t 168.95 -128.15 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 -136.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -129.28 178.7 6.25 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 130.379 3.472 . . . . 0.0 109.336 -176.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.8 t -75.96 136.66 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.574 -1.329 . . . . 0.0 109.203 164.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.3 m -114.78 152.62 31.78 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.858 0.754 . . . . 0.0 112.28 170.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 tp -108.81 108.68 19.58 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.084 2.154 . . . . 0.0 105.705 164.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.2 m -80.93 102.63 10.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 167.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 44.1 t -102.49 111.28 23.51 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 119.778 -1.826 . . . . 0.0 108.556 -173.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 1.626 ' HD2' ' CD1' ' A' ' 89' ' ' TYR . 0.8 OUTLIER -150.93 151.0 31.52 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 118.628 2.825 . . . . 0.0 118.628 174.695 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.493 ' H ' HD11 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -70.94 84.17 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 112.632 -2.077 . . . . 0.0 108.503 143.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.22 166.21 38.61 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 118.7 2.24 . . . . 0.0 118.7 -163.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -156.27 49.35 0.4 Allowed Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -170.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -47.4 121.25 5.22 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.241 1.961 . . . . 0.0 113.112 166.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -44.17 -13.69 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 118.615 2.82 . . . . 0.0 118.615 -169.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -59.89 -23.59 63.59 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.283 1.401 . . . . 0.0 113.856 163.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -50.93 -28.58 10.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.831 2.052 . . . . 0.0 112.72 166.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -62.28 -34.8 77.26 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.661 175.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -115.75 -22.39 9.16 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -174.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 pp -75.67 165.59 24.83 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 121.346 1.885 . . . . 0.0 114.1 -176.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -152.16 118.08 5.47 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -163.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.446 ' CD ' ' H ' ' A' ' 102' ' ' VAL . 0.1 OUTLIER -107.43 178.15 4.62 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 120.495 1.498 . . . . 0.0 111.926 161.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.446 ' H ' ' CD ' ' A' ' 101' ' ' ARG . 3.0 p -172.35 173.62 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.587 -140.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 64.8 m -120.86 124.82 45.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.33 0.652 . . . . 0.0 109.501 137.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -172.31 171.41 4.79 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.71 2.404 . . . . 0.0 107.514 -166.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 1.639 ' HD1' ' CD2' ' A' ' 105' ' ' PHE . 13.9 m-85 -122.72 99.85 6.61 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.006 2.522 . . . . 0.0 110.061 172.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -140.51 148.4 41.02 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 -173.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -82.19 142.04 32.52 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.914 1.286 . . . . 0.0 110.578 165.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 37.9 tp -148.23 141.59 25.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.076 0.95 . . . . 0.0 110.087 -150.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 p -93.09 168.9 10.81 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 116.941 2.201 . . . . 0.0 116.941 -169.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.6 t -69.76 -6.92 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 128.145 2.578 . . . . 0.0 113.083 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -134.74 45.84 2.51 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.469 1.108 . . . . 0.0 110.25 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -125.59 152.26 45.35 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 116.064 1.875 . . . . 0.0 116.064 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -149.3 142.46 25.0 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.632 -146.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.38 147.95 34.06 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.183 1.393 . . . . 0.0 111.521 -168.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -136.31 141.64 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 121.404 1.911 . . . . 0.0 113.166 158.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.59 153.28 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.88 0.872 . . . . 0.0 110.538 167.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.0 t -143.01 167.34 22.29 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.696 0.798 . . . . 0.0 109.979 162.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.93 -36.09 76.3 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -160.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.7 73.03 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.791 -1.193 . . . . 0.0 113.791 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -70.7 -30.83 67.51 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.394 -0.816 . . . . 0.0 111.627 175.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.0 mm -73.37 -35.51 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.012 0.925 . . . . 0.0 111.076 169.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -59.9 -25.48 65.14 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.448 -0.783 . . . . 0.0 111.931 170.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -83.2 -7.64 59.59 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 168.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.9 mt -89.21 -40.05 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.803 1.183 . . . . 0.0 109.987 167.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -143.31 124.36 8.16 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.603 1.161 . . . . 0.0 110.413 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -82.5 60.1 7.16 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 123.943 3.095 . . . . 0.0 114.355 -163.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 45.6 t -155.84 134.59 11.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.56 1.544 . . . . 0.0 110.201 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -122.85 -4.01 8.63 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -85.2 12.85 7.16 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.85 50.83 0.06 OUTLIER Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.71 1.148 . . . . 0.0 113.516 -176.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.83 125.12 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 117.947 0.873 . . . . 0.0 110.701 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.83 88.04 2.52 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.518 1.527 . . . . 0.0 108.229 169.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 17.6 p -83.83 146.39 28.14 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.908 0.883 . . . . 0.0 109.316 164.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.46 125.77 52.15 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 18.8 t -118.43 127.8 54.0 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.39 0.996 . . . . 0.0 109.131 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.4 t -138.43 116.91 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.411 1.084 . . . . 0.0 109.149 -167.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.1 m -112.3 140.59 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.268 -0.895 . . . . 0.0 111.421 -175.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 29.0 ttm105 -129.57 98.23 4.77 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 122.162 0.982 . . . . 0.0 110.343 171.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.251 9.0 tmtt? -120.13 134.98 55.11 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.767 1.227 . . . . 0.0 109.047 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.1 m -161.45 133.33 5.67 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.026 1.33 . . . . 0.0 110.585 -164.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -85.68 -35.55 20.81 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.766 -0.584 . . . . 0.0 112.496 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.1 p -48.45 -50.12 32.65 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.201 1.401 . . . . 0.0 113.398 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -96.29 11.25 67.28 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.258 1.885 . . . . 0.0 115.074 171.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 41.1 ttm 44.61 57.35 4.53 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.114 2.166 . . . . 0.0 115.397 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 97.9 p -147.82 142.86 27.02 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -106.65 144.54 33.17 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 163.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -150.87 147.26 27.01 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.445 -1.409 . . . . 0.0 109.492 -173.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.8 tt -141.62 140.31 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 122.213 1.006 . . . . 0.0 113.4 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -135.31 115.44 13.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.033 1.333 . . . . 0.0 109.941 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . 0.28 7.3 p -139.27 145.14 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 121.129 -0.982 . . . . 0.0 112.981 174.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.3 m -141.31 151.55 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 128.109 2.564 . . . . 0.0 109.643 -167.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -125.59 125.73 43.65 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -168.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 1.665 ' HD1' ' CD2' ' A' ' 153' ' ' PHE . 87.3 m-85 -142.18 156.88 45.36 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.686 1.194 . . . . 0.0 111.926 175.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -91.51 -148.92 22.87 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 124.519 1.057 . . . . 0.0 112.177 165.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.94 -22.72 10.69 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 124.53 3.487 . . . . 0.0 117.041 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.13 1.46 2.79 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 126.423 1.889 . . . . 0.0 115.595 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -90.86 38.84 0.97 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.192 1.797 . . . . 0.0 112.163 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -62.36 -28.85 70.05 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -167.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.32 -51.49 51.83 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.918 0.781 . . . . 0.0 112.099 -176.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -65.18 -34.21 77.84 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.934 0.894 . . . . 0.0 112.468 170.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -62.02 -49.31 76.53 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.427 1.012 . . . . 0.0 111.457 175.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -65.83 -29.67 70.17 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.81 -1.182 . . . . 0.0 112.701 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.42 83.91 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 119.189 0.904 . . . . 0.0 112.671 171.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.92 -54.29 19.84 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.523 1.129 . . . . 0.0 112.763 174.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.7 mp -46.79 -34.92 5.68 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.752 1.221 . . . . 0.0 113.983 167.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -74.67 -25.78 59.41 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.46 1.504 . . . . 0.0 113.357 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -89.71 -36.63 15.09 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.537 1.062 . . . . 0.0 113.664 170.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.2 pt -88.42 -42.37 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.063 -1.023 . . . . 0.0 112.724 -169.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -71.33 -6.15 37.78 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.622 1.555 . . . . 0.0 111.355 171.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -119.62 23.18 11.3 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 172.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 . . . . . 0 C--O 1.252 1.207 0 C-N-CA 126.472 1.909 . . . . 0.0 112.503 169.967 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.666 0 CA-C-O 120.19 0.043 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.4 170.82 53.4 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 123.941 0.782 . . . . 0.0 113.382 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -51.79 142.74 14.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.776 1.231 . . . . 0.0 113.391 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 12.4 ptm -102.64 150.53 23.34 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.443 1.497 . . . . 0.0 113.928 -161.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -83.11 94.96 7.93 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 124.078 1.894 . . . . 0.0 112.148 -170.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 tp -145.64 144.15 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 1 C-N-CA 132.541 4.336 . . . . 0.0 106.658 173.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.23 134.47 37.58 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.026 -1.443 . . . . 0.0 108.644 170.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -19.03 64.53 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -163.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -85.21 -24.0 28.05 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.798 0.839 . . . . 0.0 112.283 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.4 t -73.38 -53.68 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.682 1.193 . . . . 0.0 112.565 -165.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.12 -52.04 53.78 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 168.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.8 -39.93 59.53 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 118.443 1.121 . . . . 0.0 113.323 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -74.74 -39.24 61.96 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.867 -1.146 . . . . 0.0 113.972 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.12 -40.74 98.5 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.614 1.166 . . . . 0.0 111.7 173.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.52 -43.05 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.053 1.341 . . . . 0.0 109.721 174.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.4 m -66.64 -31.21 71.75 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.296 -0.878 . . . . 0.0 112.918 175.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -67.37 -44.19 79.57 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.318 -0.864 . . . . 0.0 109.345 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.3 m -60.55 -43.61 97.04 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.168 -1.582 . . . . 0.0 111.753 175.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -54.24 -32.09 55.11 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.27 1.828 . . . . 0.0 112.8 171.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.22 -46.79 10.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.053 1.341 . . . . 0.0 113.449 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.6 mm -66.63 -49.21 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 119.691 1.132 . . . . 0.0 110.889 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.66 -2.88 57.11 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.036 1.334 . . . . 0.0 112.528 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 59.33 11.52 2.21 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 127.629 2.372 . . . . 0.0 115.43 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.7 pp -94.45 154.97 17.17 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.112 0.965 . . . . 0.0 111.172 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.81 155.93 38.21 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.441 -0.787 . . . . 0.0 112.917 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.79 -24.13 63.87 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.83 -1.169 . . . . 0.0 112.546 171.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -97.04 8.74 43.85 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.489 1.516 . . . . 0.0 113.316 172.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -118.73 8.52 11.88 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.963 1.705 . . . . 0.0 111.478 167.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 21.3 tp -107.74 127.7 53.92 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.859 2.463 . . . . 0.0 107.521 166.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -94.34 115.39 27.61 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 120.076 1.307 . . . . 0.0 111.305 171.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.8 mm -91.02 143.06 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.292 1.437 . . . . 0.0 112.58 170.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.4 m -126.71 147.75 49.93 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 162.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.57 -148.29 0.26 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.309 1.444 . . . . 0.0 112.265 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.9 t -58.51 -29.17 66.08 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -162.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.77 -33.36 34.9 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -169.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.62 -4.84 27.66 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.45 14.42 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 124.806 1.242 . . . . 0.0 111.974 167.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.4 t -57.89 12.06 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 128.64 2.776 . . . . 0.0 117.985 -163.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -57.4 -40.37 78.12 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 119.798 -1.814 . . . . 0.0 113.033 -172.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -127.02 139.19 34.4 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 132.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -58.54 -31.06 93.61 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 CA-C-N 121.663 1.63 . . . . 0.0 112.571 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -96.46 30.97 2.37 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.237 1.815 . . . . 0.0 110.403 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -147.86 101.12 3.28 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.472 1.487 . . . . 0.0 107.299 159.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 p 179.91 151.24 0.4 Allowed 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.985 -1.072 . . . . 0.0 111.986 -139.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.36 -81.17 0.52 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 164.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.1 p -166.51 -174.48 2.85 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -174.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -122.82 154.98 37.51 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.403 1.881 . . . . 0.0 107.891 163.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.95 122.81 10.64 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.797 1.635 . . . . 0.0 109.094 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.3 ttm -117.94 129.28 55.52 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.748 -1.22 . . . . 0.0 111.564 -160.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.27 0.3 OUTLIER -138.4 156.6 47.44 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 124.677 2.18 . . . . 0.0 115.979 -159.019 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 t -99.24 167.96 10.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 130.446 3.498 . . . . 0.0 108.515 -172.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -50.95 114.0 1.06 Allowed 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.574 1.079 . . . . 0.0 109.334 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -151.69 156.8 41.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.754 1.264 . . . . 0.0 109.865 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.443 HG23 ' H ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -119.51 -176.8 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 113.243 -1.799 . . . . 0.0 109.044 -146.414 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.443 ' H ' HG23 ' A' ' 54' ' ' ILE . 9.5 p -70.16 121.65 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 121.485 -0.759 . . . . 0.0 111.598 -132.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 1.664 ' HD1' ' CD2' ' A' ' 56' ' ' TYR . 29.3 p90 -130.34 151.5 78.63 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -166.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -80.22 80.98 2.88 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 124.425 3.417 . . . . 0.0 111.031 -166.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 p -69.42 -39.17 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -164.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.2 -33.36 75.21 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 119.688 1.131 . . . . 0.0 113.26 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -57.7 -37.86 74.22 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 119.105 -0.474 . . . . 0.0 110.621 167.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.51 -44.88 61.6 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.917 1.287 . . . . 0.0 112.083 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mp -52.5 -46.73 66.77 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 122.147 0.975 . . . . 0.0 110.621 169.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.1 m -72.23 -39.81 68.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.616 0.766 . . . . 0.0 112.168 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 1.66 ' HD1' ' CD2' ' A' ' 64' ' ' TYR . 39.6 t80 -63.94 -41.78 97.51 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.736 0.698 . . . . 0.0 110.837 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.15 -55.65 29.86 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.272 1.029 . . . . 0.0 110.993 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.38 -29.36 68.05 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -176.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.1 t -76.35 -32.09 58.46 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -61.25 -25.68 67.24 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 -161.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.7 t -141.66 4.97 1.76 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.661 1.184 . . . . 0.0 113.289 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.52 78.4 0.2 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.895 1.712 . . . . 0.0 111.34 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -166.64 134.18 2.62 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.007 1.723 . . . . 0.0 107.555 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.3 m -76.64 149.73 36.47 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 128.19 2.596 . . . . 0.0 112.973 -173.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -152.05 165.43 34.74 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.628 1.171 . . . . 0.0 113.839 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 27.4 p -108.81 142.37 39.48 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.432 0.693 . . . . 0.0 111.551 156.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -82.6 132.58 35.19 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.442 1.097 . . . . 0.0 108.887 165.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.8 t -130.47 151.34 35.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 124.734 1.214 . . . . 0.0 109.348 -172.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 1.667 ' HE2' ' CE1' ' A' ' 77' ' ' PHE . 86.9 m-85 -131.05 122.59 27.03 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 176.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -124.62 108.77 12.4 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.906 2.083 . . . . 0.0 108.538 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -90.74 123.37 34.27 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.381 -0.824 . . . . 0.0 109.447 173.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.8 p -148.07 150.52 34.05 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 130.132 3.373 . . . . 0.0 104.147 -166.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -11.5 -133.53 0.0 OUTLIER Glycine 0 N--CA 1.481 1.648 0 O-C-N 117.802 -3.061 . . . . 0.0 114.841 -121.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 13.2 p -90.69 88.22 7.01 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 120.145 1.972 . . . . 0.0 108.434 169.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.0 ttt85 -169.61 144.02 2.85 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 128.605 2.762 . . . . 0.0 109.044 166.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.1 t -83.32 140.02 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 119.995 1.271 . . . . 0.0 109.675 171.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.45 143.8 40.23 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 121.007 -1.058 . . . . 0.0 111.328 157.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tp -107.95 107.0 17.52 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 171.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.412 ' HB3' ' CE1' ' A' ' 89' ' ' TYR . 7.5 m -98.1 130.26 44.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.383 -172.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 76.1 m -117.57 108.38 15.4 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.11 -1.619 . . . . 0.0 109.007 -170.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 1.614 ' HE2' ' CE1' ' A' ' 89' ' ' TYR . 14.4 m-30 -121.92 98.43 5.94 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.414 0.626 . . . . 0.0 110.619 -157.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.3 mt -59.88 -38.36 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.46 -177.54 16.37 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.802 1.668 . . . . 0.0 110.634 166.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 1.64 ' HE2' ' CE1' ' A' ' 92' ' ' PHE . 26.4 p90 -107.46 96.05 15.29 Favored Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -163.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.38 -177.76 3.23 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 124.126 3.217 . . . . 0.0 115.973 -173.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -50.37 -39.58 46.97 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 117.284 2.328 . . . . 0.0 117.284 -160.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.265 17.1 mmt180 -98.85 -3.67 34.86 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 175.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.55 -33.86 47.58 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.556 2.343 . . . . 0.0 114.052 175.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -50.82 -35.9 34.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.398 1.079 . . . . 0.0 111.45 169.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.01 -27.8 8.27 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -169.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.9 pp -87.37 144.54 26.72 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 121.042 1.746 . . . . 0.0 112.231 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -157.07 126.43 6.04 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -153.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -115.57 -172.3 2.13 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 128.369 2.668 . . . . 0.0 112.529 173.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -166.22 168.55 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 129.094 2.957 . . . . 0.0 108.842 -135.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -123.45 122.48 38.34 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.142 0.883 . . . . 0.0 110.695 138.542 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -176.88 175.53 1.6 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 129.029 2.931 . . . . 0.0 106.144 -165.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -105.93 117.91 35.23 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 128.28 2.632 . . . . 0.0 109.04 171.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -151.18 160.05 44.07 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 1.641 ' HE2' ' CE1' ' A' ' 107' ' ' PHE . 91.4 m-85 -92.55 162.7 14.09 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.892 1.677 . . . . 0.0 112.613 170.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.8 mt -141.06 152.05 44.51 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 129.441 3.096 . . . . 0.0 111.026 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 m -128.12 167.3 16.97 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.822 2.449 . . . . 0.0 110.224 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.283 0.9 OUTLIER -69.92 -4.88 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -173.536 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -122.25 32.9 5.63 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.556 1.143 . . . . 0.0 113.012 167.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -104.01 132.66 50.05 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.095 -1.003 . . . . 0.0 110.303 -173.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -140.25 138.08 34.77 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.122 0.969 . . . . 0.0 112.846 -166.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.22 141.15 29.71 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.974 1.31 . . . . 0.0 112.712 -165.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.0 t -118.42 137.9 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 126.603 1.961 . . . . 0.0 111.919 168.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.1 t -125.66 121.36 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.744 0.783 . . . . 0.0 109.711 157.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 73.3 p -90.02 163.95 14.71 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.075 0.95 . . . . 0.0 110.575 165.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.47 -35.23 73.68 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.332 -0.855 . . . . 0.0 111.08 174.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.38 -34.88 78.2 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -63.12 -33.52 75.63 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.953 1.251 . . . . 0.0 112.175 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.8 mm -77.18 -36.07 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.087 0.955 . . . . 0.0 111.433 172.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -54.88 -38.65 67.8 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.802 0.841 . . . . 0.0 111.294 174.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.3 mmt-85 -74.16 -12.77 60.68 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.422 ' C ' ' HE2' ' A' ' 125' ' ' LYS . 20.3 mt -73.25 -26.54 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 119.973 1.26 . . . . 0.0 110.192 175.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.422 ' HE2' ' C ' ' A' ' 124' ' ' ILE . 0.5 OUTLIER -105.12 161.5 22.56 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 125.127 1.371 . . . . 0.0 111.634 175.211 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -74.35 -39.69 1.45 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.623 2.215 . . . . 0.0 113.131 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 42.2 t -152.41 134.34 14.84 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.58 1.952 . . . . 0.0 108.439 174.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -73.8 -53.29 10.6 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 -154.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? 51.74 10.31 0.1 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 128.66 2.784 . . . . 0.0 116.823 166.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 132.75 67.45 0.08 OUTLIER Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.337 1.446 . . . . 0.0 112.536 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 76.8 t -72.85 130.48 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.216 0.607 . . . . 0.0 111.289 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 50.4 tp -119.37 157.59 27.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 123.147 1.451 . . . . 0.0 109.169 145.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 49.8 m -149.48 146.56 27.47 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 119.392 -2.068 . . . . 0.0 106.426 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -123.99 127.93 48.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -166.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 38.2 t -126.65 138.37 53.41 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.213 0.605 . . . . 0.0 109.945 -171.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.8 t -142.84 139.53 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.31 1.444 . . . . 0.0 108.966 -174.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.5 m -129.5 139.04 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.849 0.833 . . . . 0.0 112.152 174.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 43.2 mtm105 -126.0 150.58 47.97 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 127.985 2.514 . . . . 0.0 108.685 172.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.27 1.9 tmtt? -153.24 151.72 30.38 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.434 1.094 . . . . 0.0 109.07 172.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.6 t -134.22 127.83 32.71 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.787 1.176 . . . . 0.0 107.84 170.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -73.23 -55.61 6.21 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.084 0.402 . . . . 0.0 111.069 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.1 p -65.07 -31.87 73.3 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.176 1.391 . . . . 0.0 113.077 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.05 2.22 76.48 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.874 1.226 . . . . 0.0 115.222 170.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.8 mmt 48.12 40.74 14.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.095 1.758 . . . . 0.0 114.96 173.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.3 m -147.91 137.74 22.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.397 0.679 . . . . 0.0 111.58 -170.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 1.654 ' HE1' ' CE2' ' A' ' 146' ' ' TYR . 1.9 m-85 -125.35 131.42 53.0 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -177.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -152.46 112.27 3.97 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 120.468 1.486 . . . . 0.0 112.89 -147.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 4.8 pt -137.12 151.57 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 O-C-N 120.932 -1.105 . . . . 0.0 113.351 -163.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.34 144.15 36.16 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.938 0.875 . . . . 0.0 111.507 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.8 p -146.18 136.93 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 121.07 -1.019 . . . . 0.0 109.927 169.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.5 m -131.7 125.79 56.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.723 1.609 . . . . 0.0 108.843 -165.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -113.98 135.7 53.71 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.955 0.902 . . . . 0.0 112.409 -167.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -144.38 159.13 43.25 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.175 0.988 . . . . 0.0 113.614 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -89.74 -140.97 8.29 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 160.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.04 83.89 0.26 Allowed 'Trans proline' 0 CA--C 1.548 1.22 0 CA-C-N 119.344 1.572 . . . . 0.0 110.421 153.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -123.02 -25.29 4.57 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 172.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.11 74.91 1.42 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -172.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -51.05 -35.4 34.41 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.136 -1.393 . . . . 0.0 112.396 175.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.54 -35.1 75.18 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.464 1.029 . . . . 0.0 113.311 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.13 -44.04 55.22 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.345 1.058 . . . . 0.0 111.637 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 1.639 ' HE2' ' CE1' ' A' ' 161' ' ' TYR . 46.1 m-85 -54.75 -49.27 71.25 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.51 1.05 . . . . 0.0 111.36 175.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -63.98 -41.02 97.66 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.843 1.657 . . . . 0.0 112.261 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.23 -31.65 72.22 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.473 -0.767 . . . . 0.0 112.554 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.63 -47.24 61.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.226 -0.921 . . . . 0.0 112.982 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 96.6 mt -53.72 -37.69 63.56 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.011 0.525 . . . . 0.0 111.772 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 88.1 mtm-85 -75.54 -32.9 60.61 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -73.93 -39.18 63.97 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.353 1.061 . . . . 0.0 112.646 173.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.9 pt -90.91 -38.62 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.144 -0.972 . . . . 0.0 112.639 -168.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 1.651 ' HE1' ' CE2' ' A' ' 169' ' ' TYR . 13.7 t80 -85.81 4.41 37.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.657 0.662 . . . . 0.0 111.44 173.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.75 29.52 5.0 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 165.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 . . . . . 0 C--O 1.258 1.542 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 -179.512 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 119.75 -0.167 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 158.55 -178.62 34.69 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.479 1.038 . . . . 0.0 113.076 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -64.65 -17.69 64.27 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 -171.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.9 mmt -121.78 126.63 49.29 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.892 1.277 . . . . 0.0 110.153 160.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -141.54 153.54 44.93 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.126 1.37 . . . . 0.0 111.353 166.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.9 tp -136.41 107.82 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 126.818 2.047 . . . . 0.0 112.081 166.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -99.81 153.36 19.19 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -157.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -48.18 -32.51 7.15 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.246 2.218 . . . . 0.0 114.746 174.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -93.46 -25.09 17.79 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.084 0.856 . . . . 0.0 112.04 -177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.3 t -62.55 -51.02 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.064 0.946 . . . . 0.0 109.762 170.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.36 -50.49 59.63 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.233 -0.759 . . . . 0.0 112.291 168.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.42 -47.25 79.45 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.805 1.303 . . . . 0.0 113.055 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -74.07 -40.86 62.49 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.092 0.957 . . . . 0.0 112.615 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.51 -33.33 62.77 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.552 1.524 . . . . 0.0 113.074 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.1 mp -68.92 -38.92 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 119.06 0.845 . . . . 0.0 109.555 169.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.6 m -59.9 -45.44 92.51 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.054 -1.029 . . . . 0.0 112.483 171.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -77.55 -28.07 51.74 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -173.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 p -66.79 -53.2 35.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.135 1.334 . . . . 0.0 110.252 168.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -49.16 -46.65 45.66 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.611 1.564 . . . . 0.0 112.786 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -70.22 -49.21 52.5 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.014 1.726 . . . . 0.0 114.463 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.93 -26.49 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.687 1.131 . . . . 0.0 111.198 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.6 mt -82.07 -17.21 47.42 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 171.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 46.32 56.45 6.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.959 1.704 . . . . 0.0 112.343 -167.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 pp -125.99 166.53 16.76 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.886 1.274 . . . . 0.0 111.122 167.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -75.92 158.31 32.18 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.755 1.222 . . . . 0.0 112.503 176.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -61.94 -21.74 65.03 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 119.994 -1.692 . . . . 0.0 114.175 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -95.56 3.05 54.47 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.215 1.006 . . . . 0.0 112.932 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -101.54 -12.62 18.36 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.477 1.111 . . . . 0.0 111.487 169.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 18.2 tp -88.84 137.71 32.07 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.538 1.935 . . . . 0.0 105.863 165.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -102.48 124.77 48.63 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.938 160.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 41.3 mm -90.42 142.75 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 125.469 1.508 . . . . 0.0 110.815 168.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.3 m -117.62 136.51 53.25 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 149.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -87.0 -151.09 0.16 Allowed 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 t -59.79 -21.21 60.5 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -166.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.37 -32.07 24.55 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.267 0.9 OUTLIER -96.03 -8.67 32.95 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 176.531 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.3 11.52 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.323 1.449 . . . . 0.0 111.732 166.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.9 t -64.15 6.43 0.18 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.627 2.371 . . . . 0.0 115.352 -167.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -61.37 -21.49 64.09 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 121.042 -1.036 . . . . 0.0 111.167 174.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -142.54 124.84 8.95 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 140.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.86 -15.98 53.07 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 121.842 1.695 . . . . 0.0 114.119 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -105.96 23.29 14.22 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.369 2.267 . . . . 0.0 111.97 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 1.624 ' HD1' ' CD2' ' A' ' 43' ' ' TYR . 67.6 t80 -154.92 94.44 1.65 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 170.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.1 p 175.57 154.78 0.17 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.727 -1.579 . . . . 0.0 108.083 -142.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.92 -82.22 0.48 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.367 1.44 . . . . 0.0 114.446 151.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 9.2 m -163.99 177.72 8.28 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.734 1.214 . . . . 0.0 112.966 -172.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -115.95 155.87 27.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.06 1.744 . . . . 0.0 108.59 165.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.9 138.86 48.56 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.208 2.603 . . . . 0.0 107.481 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.1 tmm? -126.5 131.64 51.57 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.092 1.315 . . . . 0.0 109.329 -169.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 mt -123.27 142.36 51.02 Favored 'General case' 0 C--O 1.245 0.847 0 O-C-N 127.074 2.734 . . . . 0.0 111.736 -153.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.3 p -97.07 161.62 13.74 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.262 2.225 . . . . 0.0 112.673 -172.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.8 t -67.58 143.37 56.11 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . 0.271 12.7 t70 66.21 33.09 7.54 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.795 2.438 . . . . 0.0 114.646 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 tp -109.83 137.33 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.721 1.209 . . . . 0.0 111.858 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 p -110.4 141.12 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 125.701 1.6 . . . . 0.0 112.655 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -136.48 120.24 12.39 Favored Pre-proline 0 CA--C 1.548 0.9 0 O-C-N 120.803 -1.186 . . . . 0.0 111.64 166.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -65.29 80.23 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 125.03 3.82 . . . . 0.0 112.003 168.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.3 p -67.15 -30.75 50.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -151.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -55.2 -39.28 69.43 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 119.036 0.835 . . . . 0.0 112.538 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 1.59 ' HE2' ' CE1' ' A' ' 60' ' ' TYR . 38.9 t80 -62.38 -27.19 68.91 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.69 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.2 tp -81.3 -48.96 11.31 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.922 1.289 . . . . 0.0 112.511 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 mp -53.65 -49.2 68.45 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.461 0.704 . . . . 0.0 110.189 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.0 m -74.8 -27.54 60.35 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.254 1.022 . . . . 0.0 113.1 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 1.665 ' HD2' ' CD1' ' A' ' 64' ' ' TYR . 51.5 t80 -61.44 -34.69 75.84 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.294 1.406 . . . . 0.0 112.456 169.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 41.6 t-105 -70.63 -57.75 4.39 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.461 0.573 . . . . 0.0 112.05 167.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.54 -36.35 83.48 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -169.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 45.7 t -59.01 -17.49 25.54 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.686 1.594 . . . . 0.0 113.355 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.1 ttt85 -70.21 -43.64 70.26 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.199 -0.938 . . . . 0.0 112.768 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.5 m -159.22 3.35 0.09 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -169.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.93 82.72 0.11 Allowed Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.205 0.907 . . . . 0.0 111.481 -171.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -146.65 124.51 11.96 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 126.862 2.065 . . . . 0.0 106.833 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.3 m -78.42 117.09 19.31 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 126.25 1.82 . . . . 0.0 112.482 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.24 139.26 35.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.889 1.675 . . . . 0.0 110.828 168.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 39.1 m -102.24 145.48 29.36 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.887 0.851 . . . . 0.0 111.256 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.82 105.09 10.85 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.711 1.604 . . . . 0.0 108.923 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.7 t -96.32 154.04 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 126.677 1.991 . . . . 0.0 108.815 176.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -142.11 110.82 6.17 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.874 2.07 . . . . 0.0 106.856 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -111.15 115.35 29.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.021 2.128 . . . . 0.0 110.161 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -93.12 134.85 34.87 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.691 -0.671 . . . . 0.0 112.046 174.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.1 p -153.65 167.44 29.57 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 130.892 3.677 . . . . 0.0 107.088 -156.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -9.81 -124.99 0.0 OUTLIER Glycine 0 N--CA 1.49 2.294 0 C-N-CA 130.063 3.697 . . . . 0.0 116.296 -167.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 17.1 m -96.45 104.39 16.36 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 111.774 -3.97 . . . . 0.0 107.97 146.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.42 139.29 0.44 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 129.753 3.221 . . . . 0.0 109.272 151.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.9 t -74.73 134.77 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.97 1.259 . . . . 0.0 110.05 154.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.46 138.93 45.09 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.59 0.756 . . . . 0.0 110.288 163.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.2 tt -111.16 112.48 24.3 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.089 1.755 . . . . 0.0 106.452 170.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 m -95.87 126.88 41.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.256 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 49.0 t -108.5 111.03 22.68 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 119.976 -1.703 . . . . 0.0 107.9 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -116.44 100.38 7.83 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.971 0.415 . . . . 0.0 111.507 -169.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.9 mt -62.32 115.28 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 130.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -178.83 167.46 37.8 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 122.445 3.738 . . . . 0.0 122.445 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 1.662 ' HD1' ' CD2' ' A' ' 92' ' ' PHE . 49.1 m-85 -126.47 49.66 4.11 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 126.748 2.019 . . . . 0.0 113.895 155.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.04 172.73 14.91 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.595 2.863 . . . . 0.0 114.38 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.1 -40.78 59.7 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -156.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.268 11.7 tpt180 -95.68 -7.33 37.77 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 116.299 1.962 . . . . 0.0 116.299 -177.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -51.09 -42.29 60.52 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 128.774 2.829 . . . . 0.0 113.708 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -64.5 -27.4 68.95 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 117.434 -1.27 . . . . 0.0 112.52 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -106.15 -24.78 12.26 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 pp -75.41 161.06 29.56 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-N 121.358 1.89 . . . . 0.0 113.647 169.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -168.24 137.02 2.35 Favored 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 117.746 2.499 . . . . 0.0 117.746 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.533 ' CD ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -105.83 179.72 4.19 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 127.639 2.376 . . . . 0.0 111.453 178.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.533 ' H ' ' CD ' ' A' ' 101' ' ' ARG . 2.5 p -165.82 174.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.465 1.906 . . . . 0.0 112.172 -142.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 11.1 t -117.22 121.88 42.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.822 1.249 . . . . 0.0 109.354 151.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -171.55 153.7 3.54 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.369 1.868 . . . . 0.0 108.082 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 1.622 ' HE2' ' CE1' ' A' ' 105' ' ' PHE . 32.8 p90 -120.76 112.16 18.49 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.35 1.86 . . . . 0.0 110.724 172.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -160.06 -172.8 3.76 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.82 1.248 . . . . 0.0 112.04 -157.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -102.43 160.52 14.48 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.094 0.957 . . . . 0.0 111.84 164.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.4 tp -134.59 151.37 51.03 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 128.661 2.784 . . . . 0.0 108.668 -168.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 m -124.21 158.51 32.25 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.004 1.722 . . . . 0.0 111.818 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -5.17 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 126.143 1.777 . . . . 0.0 115.543 -166.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -127.14 55.13 1.59 Allowed 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.946 -1.096 . . . . 0.0 112.186 170.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.25 152.73 23.72 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 177.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -149.34 128.44 12.76 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 126.218 1.807 . . . . 0.0 107.402 -172.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.84 143.95 21.03 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 121.054 -1.029 . . . . 0.0 110.891 -172.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.73 140.69 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 125.285 1.434 . . . . 0.0 114.423 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.2 t -134.79 154.12 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.07 1.748 . . . . 0.0 111.442 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.6 t -143.07 170.34 15.9 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.27 1.828 . . . . 0.0 110.152 171.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.19 -31.47 63.49 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.873 -1.142 . . . . 0.0 113.875 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.14 -32.54 67.01 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 118.623 0.647 . . . . 0.0 112.579 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -67.92 -44.8 76.06 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.641 1.177 . . . . 0.0 110.249 176.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 37.5 mm -67.33 -33.67 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.705 -0.622 . . . . 0.0 111.252 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -62.65 -24.65 67.72 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.245 -0.909 . . . . 0.0 113.285 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -80.85 -15.67 55.74 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 120.741 1.61 . . . . 0.0 113.701 168.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.7 mt -73.81 -44.34 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 120.309 1.413 . . . . 0.0 111.392 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -173.24 -38.55 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.181 0 CA-C-O 116.687 -1.625 . . . . 0.0 112.092 168.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -73.21 -147.04 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.259 0 C-N-CA 123.068 2.512 . . . . 0.0 115.753 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 5.3 t -152.63 138.95 18.45 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 129.967 3.307 . . . . 0.0 108.844 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.04 -0.9 17.82 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 119.816 3.265 . . . . 0.0 119.816 -151.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.34 19.29 20.04 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -173.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.59 12.38 0.76 Allowed Glycine 0 N--CA 1.473 1.144 0 C-N-CA 124.322 0.963 . . . . 0.0 114.735 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.44 125.5 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 118.15 0.975 . . . . 0.0 111.907 -167.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.81 85.81 2.45 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.644 1.212 . . . . 0.0 108.097 162.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.1 t -90.83 148.35 22.57 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.978 0.911 . . . . 0.0 109.914 166.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -141.58 137.61 32.05 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.966 0.906 . . . . 0.0 110.203 -169.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 35.9 t -135.05 130.32 35.44 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.188 0.449 . . . . 0.0 110.11 -160.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.1 t -135.54 126.91 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.076 1.351 . . . . 0.0 109.655 -169.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.7 m -121.9 143.5 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.691 0.757 . . . . 0.0 111.907 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -127.56 159.86 33.34 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.136 2.174 . . . . 0.0 109.05 165.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.305 0.1 OUTLIER -148.44 155.51 41.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.104 1.361 . . . . 0.0 110.099 166.769 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.6 t -134.65 115.38 13.74 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.31 0.959 . . . . 0.0 109.437 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -71.03 -52.69 18.1 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.999 0.818 . . . . 0.0 110.886 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.1 p -56.8 -36.26 69.68 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.68 -4.3 90.26 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.648 1.118 . . . . 0.0 115.542 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 58.5 mtm 47.67 38.87 9.03 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.21 1.804 . . . . 0.0 114.986 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.8 t -149.55 166.04 30.4 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -130.27 137.26 49.91 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.61 1.564 . . . . 0.0 107.901 -173.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -130.47 132.25 45.58 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.596 0.634 . . . . 0.0 109.969 -166.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.15 132.69 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -153.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -140.03 132.31 28.28 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.304 1.842 . . . . 0.0 109.257 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.3 p -145.5 139.12 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 120.684 -1.26 . . . . 0.0 109.275 159.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.68 147.38 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.77 2.028 . . . . 0.0 109.542 -172.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.56 112.41 9.54 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.378 -0.826 . . . . 0.0 113.212 -170.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 1.653 ' HE2' ' CE1' ' A' ' 153' ' ' PHE . 32.4 m-85 -126.37 161.0 28.86 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.042 2.137 . . . . 0.0 110.661 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -75.94 -146.05 1.68 Allowed Glycine 0 CA--C 1.546 2.029 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 154.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.81 0.08 8.2 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.553 2.835 . . . . 0.0 114.728 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.01 -20.51 65.96 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.107 -1.621 . . . . 0.0 114.107 -177.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -83.37 61.58 6.25 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.842 1.306 . . . . 0.0 112.04 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -52.7 -32.87 44.92 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.489 1.515 . . . . 0.0 111.846 171.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.74 -51.71 66.1 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.908 0.883 . . . . 0.0 113.099 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.94 -36.12 79.59 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.791 1.178 . . . . 0.0 113.077 171.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 1.627 ' HE2' ' CE1' ' A' ' 161' ' ' TYR . 14.7 t80 -64.51 -52.86 55.65 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.95 1.25 . . . . 0.0 110.792 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -63.08 -32.38 73.75 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.836 -1.165 . . . . 0.0 113.192 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.89 -38.22 84.93 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.219 0.918 . . . . 0.0 112.277 171.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -76.02 -43.03 46.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.119 0.968 . . . . 0.0 113.547 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 93.8 mt -56.0 -36.03 67.46 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.212 0.914 . . . . 0.0 112.254 172.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -66.89 -51.08 59.67 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.467 1.107 . . . . 0.0 110.83 172.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.53 -26.81 64.69 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.2 pt -85.22 -34.95 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.681 0.793 . . . . 0.0 112.028 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -67.64 -0.96 4.43 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.684 1.129 . . . . 0.0 112.819 158.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -127.77 25.56 5.98 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 125.629 1.572 . . . . 0.0 112.293 179.852 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -101.83 -165.92 27.09 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.107 1.336 . . . . 0.0 114.767 -175.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -144.1 154.22 42.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.912 1.685 . . . . 0.0 111.179 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.94 73.76 0.6 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.564 1.546 . . . . 0.0 113.134 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -134.69 149.12 50.46 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.424 2.29 . . . . 0.0 109.246 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.7 tp -85.47 128.66 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 124.103 1.906 . . . . 0.0 113.568 -164.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -114.72 148.1 38.77 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 111.097 -2.774 . . . . 0.0 111.745 172.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -55.14 -17.8 4.75 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -75.08 -21.96 58.61 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.865 -1.147 . . . . 0.0 112.111 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 t -72.05 -44.0 66.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.483 1.513 . . . . 0.0 110.093 171.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.88 -51.83 56.57 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 169.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.07 -45.12 64.63 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.295 1.047 . . . . 0.0 112.709 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -74.54 -35.13 63.1 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.47 -33.67 60.84 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.572 -1.33 . . . . 0.0 112.668 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -70.41 -41.25 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.839 0.745 . . . . 0.0 109.78 170.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.0 m -55.54 -46.78 77.04 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.207 -0.933 . . . . 0.0 111.858 171.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -64.41 -43.91 92.91 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.513 -0.742 . . . . 0.0 112.453 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -71.5 -24.65 62.01 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . 0.274 22.9 ptt-85 -74.8 -55.78 5.47 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 120.606 1.548 . . . . 0.0 113.88 158.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.0 -42.28 15.03 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -158.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.41 -25.89 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-N 119.654 1.115 . . . . 0.0 110.871 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.06 -12.1 60.25 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.699 1.6 . . . . 0.0 112.58 169.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 52.23 46.32 26.85 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 128.057 2.543 . . . . 0.0 115.199 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 pp -121.12 161.03 22.5 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.995 1.718 . . . . 0.0 112.703 174.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.31 149.48 26.04 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.659 -0.651 . . . . 0.0 111.49 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -64.96 -25.17 67.76 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.614 -1.304 . . . . 0.0 113.295 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -69.24 -21.46 63.92 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.995 -1.066 . . . . 0.0 112.417 168.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -104.25 -3.96 23.63 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.425 1.89 . . . . 0.0 112.297 -172.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.2 tp -94.61 133.49 38.19 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.528 2.731 . . . . 0.0 108.462 163.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.89 122.66 44.43 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.573 0.624 . . . . 0.0 109.724 166.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.2 mm -94.62 138.61 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.388 1.075 . . . . 0.0 110.746 170.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 m -139.21 144.66 38.6 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -117.02 -146.13 0.4 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.632 1.573 . . . . 0.0 110.608 -161.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 t -42.53 -32.31 0.54 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 128.122 2.569 . . . . 0.0 115.884 -171.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.52 -26.99 67.27 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 120.201 1.364 . . . . 0.0 113.989 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.8 mt -76.79 -43.69 35.74 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.817 1.19 . . . . 0.0 112.824 174.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -96.61 16.09 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.505 1.922 . . . . 0.0 111.415 -170.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.2 t -57.37 5.6 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.93 2.892 . . . . 0.0 116.845 -165.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.57 -39.04 11.06 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.851 1.26 . . . . 0.0 110.99 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -121.96 67.62 24.01 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.215 1.406 . . . . 0.0 107.393 160.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.89 -44.42 49.38 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 123.323 2.682 . . . . 0.0 113.241 -165.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -93.3 6.57 47.64 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.617 -1.182 . . . . 0.0 110.784 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -128.58 100.2 5.66 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 121.172 1.805 . . . . 0.0 107.516 171.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.1 p 176.67 170.51 0.48 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.447 -0.783 . . . . 0.0 111.147 -141.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.7 tp -128.05 -83.93 0.59 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 118.576 -1.25 . . . . 0.0 112.967 145.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 77.3 m -170.58 -161.98 0.26 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.348 1.459 . . . . 0.0 109.175 -160.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -148.0 157.37 43.48 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.348 2.259 . . . . 0.0 107.838 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -131.68 134.49 46.0 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.075 2.55 . . . . 0.0 107.571 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.8 ttm -122.51 130.94 53.57 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.428 -1.42 . . . . 0.0 111.273 -166.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.0 147.86 52.48 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.368 1.467 . . . . 0.0 114.685 -158.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.9 t -99.95 154.93 17.98 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.411 1.884 . . . . 0.0 109.315 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.2 t -46.89 113.15 0.61 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.538 1.535 . . . . 0.0 110.992 -153.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.78 157.86 26.71 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.356 1.074 . . . . 0.0 113.21 -143.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.447 HG23 ' H ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -110.71 178.5 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 113.499 -1.682 . . . . 0.0 109.575 -160.197 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.447 ' H ' HG23 ' A' ' 54' ' ' ILE . 7.6 p -80.15 116.87 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.854 -168.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 1.62 ' HD2' ' CD1' ' A' ' 56' ' ' TYR . 66.4 m-85 -125.58 139.3 33.69 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 118.612 -0.708 . . . . 0.0 109.736 175.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -66.38 78.19 0.34 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.148 3.232 . . . . 0.0 113.688 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.2 p -56.39 -30.28 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 127.554 2.341 . . . . 0.0 113.745 -170.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.46 ' HB2' ' H ' ' A' ' 133' ' ' THR . 22.7 tp10 -62.52 -22.49 66.33 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -177.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 1.631 ' HD1' ' CD2' ' A' ' 60' ' ' TYR . 21.1 m-85 -55.59 -44.32 76.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.119 0.872 . . . . 0.0 111.117 169.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.1 mp -74.25 -44.5 52.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.941 1.296 . . . . 0.0 111.884 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mp -54.0 -50.04 67.48 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 172.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.1 m -63.72 -50.39 69.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.126 0.97 . . . . 0.0 112.056 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -60.02 -29.56 68.58 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 118.264 -0.874 . . . . 0.0 113.008 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -76.29 -57.63 3.75 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.107 1.321 . . . . 0.0 114.204 169.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -76.53 -40.43 50.01 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -167.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 6.5 p -75.95 -1.81 27.38 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.85 -1.156 . . . . 0.0 113.625 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -60.83 -37.0 80.52 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.173 1.789 . . . . 0.0 113.333 -172.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.7 p -165.76 27.1 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.576 1.55 . . . . 0.0 113.483 169.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.03 86.08 0.16 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.686 1.612 . . . . 0.0 113.936 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -150.08 118.88 6.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 128.85 2.86 . . . . 0.0 104.656 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.6 m -65.6 117.93 8.78 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 122.909 0.484 . . . . 0.0 110.02 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.12 144.91 50.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.476 1.51 . . . . 0.0 111.372 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 26.8 p -115.73 141.0 48.67 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.663 1.185 . . . . 0.0 111.43 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -90.11 151.45 21.6 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 157.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 t -137.67 156.37 32.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 126.534 1.933 . . . . 0.0 108.284 -173.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -123.85 138.52 54.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.044 0.926 . . . . 0.0 109.865 159.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -116.92 103.12 9.96 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.997 2.119 . . . . 0.0 108.246 172.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -87.84 127.36 35.34 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.036 1.334 . . . . 0.0 110.166 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.6 t -148.41 166.76 27.13 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 130.318 3.447 . . . . 0.0 105.405 -151.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -18.02 -122.81 0.0 OUTLIER Glycine 0 N--CA 1.486 1.986 1 C-N-CA 131.241 4.258 . . . . 0.0 116.327 -176.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 45.9 t -96.23 101.03 12.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 113.897 -3.121 . . . . 0.0 109.651 150.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.7 mtt180 -171.64 -177.16 1.95 Allowed 'General case' 0 CA--C 1.549 0.934 1 C-N-CA 133.496 4.718 . . . . 0.0 107.05 123.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.5 t -95.26 146.34 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 120.265 -1.522 . . . . 0.0 111.5 145.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.11 136.91 43.73 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.09 1.356 . . . . 0.0 110.359 162.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -110.94 109.35 19.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.032 2.133 . . . . 0.0 106.175 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 m -104.3 144.78 31.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.332 1.053 . . . . 0.0 110.82 -164.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 74.1 m -127.53 114.32 17.28 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 120.908 -1.12 . . . . 0.0 110.79 -171.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -128.31 117.02 20.73 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.7 pt -88.45 62.54 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 122.792 1.282 . . . . 0.0 109.082 144.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.36 -179.38 43.99 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 121.618 3.407 . . . . 0.0 121.618 -145.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 1.665 ' HD1' ' CD2' ' A' ' 92' ' ' PHE . 95.4 m-85 -144.46 116.22 5.43 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 126.162 1.785 . . . . 0.0 111.702 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -82.97 163.65 15.65 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.556 2.837 . . . . 0.0 111.706 153.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.72 -18.73 56.11 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.546 1.138 . . . . 0.0 114.061 175.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 -25.64 36.21 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.42 1.488 . . . . 0.0 114.966 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.4 -44.08 65.16 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.45 2.7 . . . . 0.0 114.289 -169.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -36.84 76.29 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.001 0.52 . . . . 0.0 110.907 175.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -98.04 -23.63 15.69 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -170.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 pp -76.68 175.42 9.36 Favored 'General case' 0 CA--C 1.556 1.173 0 CA-C-N 119.926 1.239 . . . . 0.0 112.375 172.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -119.62 -162.51 0.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.878 -1.139 . . . . 0.0 113.917 -162.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -121.88 149.07 43.91 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.451 1.501 . . . . 0.0 111.693 172.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.4 p -127.89 136.7 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.155 0.982 . . . . 0.0 111.607 164.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.96 123.81 8.0 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 123.131 1.443 . . . . 0.0 108.793 116.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 170.89 -179.47 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 130.088 3.355 . . . . 0.0 105.156 -153.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 1.607 ' HD1' ' CD2' ' A' ' 105' ' ' PHE . 11.2 p90 -124.96 133.25 53.09 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.244 1.018 . . . . 0.0 112.331 159.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -150.85 149.89 30.25 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.63 1.172 . . . . 0.0 112.666 -164.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -73.29 132.62 43.33 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.131 0.972 . . . . 0.0 110.801 170.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.1 tp -119.13 148.7 42.78 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.049 1.739 . . . . 0.0 111.233 -163.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.7 t -117.26 168.56 10.21 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.07 2.148 . . . . 0.0 110.979 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -77.24 -8.9 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.331 1.452 . . . . 0.0 113.931 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -130.57 70.51 1.45 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.488 1.915 . . . . 0.0 109.175 172.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -133.44 142.06 48.12 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.295 -0.878 . . . . 0.0 111.115 173.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -149.79 129.26 13.02 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.183 1.393 . . . . 0.0 108.077 -163.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.4 pp -157.94 156.14 30.75 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -159.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.4 t -105.03 145.37 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 127.33 2.252 . . . . 0.0 111.644 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.41 123.39 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 122.489 1.138 . . . . 0.0 111.156 152.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.0 t -146.65 153.55 40.43 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.043 1.337 . . . . 0.0 111.191 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.87 -27.22 67.96 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.469 1.107 . . . . 0.0 113.393 -173.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.19 83.2 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 120.805 1.639 . . . . 0.0 112.628 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.18 -33.97 59.32 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.742 0.817 . . . . 0.0 112.672 172.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.52 -37.09 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.851 1.205 . . . . 0.0 110.714 168.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.33 -19.52 65.46 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.937 1.695 . . . . 0.0 112.761 171.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.2 mtm-85 -80.07 -30.33 39.3 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 121.935 2.152 . . . . 0.0 113.365 161.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 73.1 mt -82.63 -34.51 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.417 1.487 . . . . 0.0 113.461 -172.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -120.5 150.95 53.18 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 125.254 1.422 . . . . 0.0 110.845 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.31 -7.87 21.71 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.149 2.566 . . . . 0.0 113.522 173.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 35.3 m -121.31 131.17 54.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.74 1.616 . . . . 0.0 109.569 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -103.61 -137.43 0.35 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.143 1.377 . . . . 0.0 111.124 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -36.57 125.62 0.84 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.721 1.608 . . . . 0.0 111.701 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 116.69 -30.28 6.48 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.243 1.402 . . . . 0.0 112.293 -149.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 t -60.52 147.84 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.943 1.297 . . . . 0.0 113.153 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 26.4 tp -122.28 92.64 3.77 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.548 1.539 . . . . 0.0 109.481 159.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.46 ' H ' ' HB2' ' A' ' 59' ' ' GLU . 17.9 m -75.29 154.78 37.22 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.201 2.201 . . . . 0.0 109.933 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -142.11 134.57 28.03 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.773 1.229 . . . . 0.0 108.208 -168.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 34.7 t -139.28 142.04 37.76 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.252 0.933 . . . . 0.0 112.136 -163.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.7 t -147.2 141.44 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.976 2.11 . . . . 0.0 109.888 -168.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.91 138.21 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 O-C-N 121.208 -0.933 . . . . 0.0 111.068 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.02 113.2 26.57 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.472 1.109 . . . . 0.0 108.981 166.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.677 ' HE2' ' CD1' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -88.79 128.83 35.65 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 143.573 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.8 m -149.74 175.31 11.7 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -167.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 69.89 160.39 0.2 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 128.244 2.618 . . . . 0.0 115.154 167.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 84.4 p -89.82 -47.71 7.72 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.568 1.547 . . . . 0.0 110.526 171.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -65.88 -1.28 8.71 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 125.629 1.585 . . . . 0.0 115.082 165.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.4 mmt 64.78 128.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 129.032 2.933 . . . . 0.0 114.754 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.4 p -172.31 155.67 3.61 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.877 2.071 . . . . 0.0 108.476 169.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.677 ' CD1' ' HE2' ' A' ' 139' ' ' LYS . 2.5 m-85 -136.08 163.95 29.14 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -166.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -151.46 155.7 39.11 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.35 -1.469 . . . . 0.0 107.55 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.1 tt -136.59 138.94 45.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.092 -0.38 . . . . 0.0 110.516 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -141.69 123.61 15.34 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.321 0.648 . . . . 0.0 110.389 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.1 p -140.61 133.07 31.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-O 122.356 1.074 . . . . 0.0 110.201 168.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.4 m -135.6 130.88 50.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 127.102 2.161 . . . . 0.0 110.735 -163.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -107.65 111.13 23.2 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.094 0.957 . . . . 0.0 111.62 -171.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 1.647 ' HE2' ' CE1' ' A' ' 153' ' ' PHE . 21.2 m-85 -109.95 159.47 17.23 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.25 1.42 . . . . 0.0 110.719 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -74.79 -170.79 26.32 Favored Glycine 0 CA--C 1.542 1.735 0 O-C-N 121.314 -0.866 . . . . 0.0 113.728 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.27 -25.8 64.4 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.37 2.047 . . . . 0.0 112.085 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.52 9.0 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 129.349 3.06 . . . . 0.0 114.963 171.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -82.51 46.86 1.1 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.085 2.154 . . . . 0.0 108.605 169.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -58.2 -39.6 79.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.289 2.236 . . . . 0.0 111.824 -165.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.57 -44.42 78.27 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.832 -0.604 . . . . 0.0 112.585 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.91 -40.87 75.34 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.657 0.783 . . . . 0.0 111.783 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 1.636 ' HE1' ' CE2' ' A' ' 161' ' ' TYR . 80.9 t80 -53.69 -59.08 5.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.224 1.01 . . . . 0.0 110.433 175.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -60.55 -43.11 97.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.962 0.905 . . . . 0.0 112.91 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.43 -38.01 88.07 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.293 0.951 . . . . 0.0 113.058 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.7 -42.7 70.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.314 -0.866 . . . . 0.0 111.962 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.05 -35.12 74.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.33 0.513 . . . . 0.0 111.7 173.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -63.06 -31.66 72.85 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.597 1.559 . . . . 0.0 111.803 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -88.37 -45.11 10.27 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -106.7 -24.82 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 118.013 2.597 . . . . 0.0 118.013 -167.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -103.47 -11.49 17.78 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.707 1.203 . . . . 0.0 110.05 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -125.21 25.8 7.08 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.482 1.513 . . . . 0.0 114.134 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 160.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 111.144 0.053 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -48.2 -38.14 17.57 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -165.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -94.68 -22.24 18.26 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.281 0.946 . . . . 0.0 112.151 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.6 t -72.44 -51.12 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.697 1.599 . . . . 0.0 113.164 -168.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.94 -46.66 94.11 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.27 -35.91 67.98 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.222 1.011 . . . . 0.0 112.584 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -68.43 -47.47 67.11 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.405 1.482 . . . . 0.0 112.534 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.48 -38.31 77.64 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.209 -0.932 . . . . 0.0 111.977 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.58 -39.83 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.505 1.522 . . . . 0.0 110.497 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.2 t -58.97 -48.27 82.16 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.197 0.999 . . . . 0.0 111.51 172.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -60.36 -43.01 96.92 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.66 -0.65 . . . . 0.0 111.156 173.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.9 m -62.75 -45.97 90.21 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.621 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.7 ptt-85 -65.81 -36.65 84.09 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.587 1.54 . . . . 0.0 112.592 174.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -68.66 -42.85 77.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.408 1.883 . . . . 0.0 114.375 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . 0.3 0.8 OUTLIER -88.24 -17.34 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 173.323 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.13 -5.72 58.64 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 121.022 1.737 . . . . 0.0 112.309 163.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 48.86 41.67 18.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 128.05 2.54 . . . . 0.0 114.468 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 pp -120.48 169.82 9.97 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.458 2.303 . . . . 0.0 110.804 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -92.74 168.41 11.22 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -66.95 -18.24 65.29 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.698 1.599 . . . . 0.0 114.427 -173.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -102.97 12.14 36.46 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.043 1.337 . . . . 0.0 112.314 171.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -127.48 -14.02 5.34 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.101 1.76 . . . . 0.0 110.953 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.462 HD11 ' HB1' ' A' ' 48' ' ' ALA . 35.6 tp -83.93 122.35 28.62 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 155.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.439 ' H ' ' HB3' ' A' ' 49' ' ' MET . 8.9 ttp-105 -92.19 126.43 37.26 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 118.932 -1.107 . . . . 0.0 110.839 172.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.8 mm -98.99 142.42 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.946 1.699 . . . . 0.0 112.007 173.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.9 m -140.8 143.14 34.68 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.318 0.508 . . . . 0.0 110.116 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -96.85 -142.38 0.29 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.386 1.474 . . . . 0.0 111.656 176.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.9 p -46.92 -38.55 10.71 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.16 2.184 . . . . 0.0 115.706 -156.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.45 -29.61 64.33 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -165.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.39 -15.2 16.6 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 115.961 1.838 . . . . 0.0 115.961 173.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 pt -112.62 -14.0 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 -175.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.5 t -61.53 9.33 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 -166.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -83.79 -15.7 47.4 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 119.657 -1.902 . . . . 0.0 113.075 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -91.49 113.44 58.56 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 141.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.99 -11.1 11.29 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.125 1.883 . . . . 0.0 115.871 -160.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -121.9 -10.97 8.6 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 120.806 1.639 . . . . 0.0 115.164 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -162.1 160.19 27.04 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.078 1.351 . . . . 0.0 108.325 -169.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.7 p 164.61 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.273 1.829 . . . . 0.0 106.426 -155.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.0 tp -122.33 -78.16 0.6 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 119.16 -1.016 . . . . 0.0 112.42 147.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.5 m -177.34 -160.04 0.05 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.794 2.038 . . . . 0.0 108.004 -165.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -131.78 157.83 42.84 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.921 2.088 . . . . 0.0 107.937 169.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -135.17 130.97 36.19 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 128.815 2.846 . . . . 0.0 108.951 -177.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.439 ' HB3' ' H ' ' A' ' 30' ' ' ARG . 35.8 ttp -118.22 131.67 56.36 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.096 -1.003 . . . . 0.0 110.844 -166.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 mt -127.51 149.03 50.31 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.348 2.659 . . . . 0.0 112.711 -151.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.1 p -96.93 159.02 15.15 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.063 2.145 . . . . 0.0 113.176 -169.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.5 t -72.07 158.61 35.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.903 1.281 . . . . 0.0 112.537 173.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.3 t70 57.11 43.69 23.73 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.113 1.765 . . . . 0.0 113.7 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 tp -132.74 139.73 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.546 1.139 . . . . 0.0 111.266 -171.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.2 p -123.37 140.92 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.424 1.49 . . . . 0.0 111.769 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -138.35 153.1 72.57 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 157.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.82 78.09 1.78 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.847 3.032 . . . . 0.0 109.949 167.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -47.73 -36.7 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 127.547 2.339 . . . . 0.0 115.047 -167.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.98 -18.61 60.35 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -59.55 -34.23 72.4 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.268 -0.895 . . . . 0.0 111.011 167.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.6 tp -78.87 -44.57 22.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.523 1.129 . . . . 0.0 112.409 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.7 mp -54.25 -45.93 72.51 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.733 1.151 . . . . 0.0 110.627 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.4 t -57.57 -50.36 73.35 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.924 1.29 . . . . 0.0 111.864 175.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -61.87 -37.69 85.46 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -59.55 -54.92 41.01 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.711 1.604 . . . . 0.0 111.95 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -72.1 -31.38 66.0 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 9.9 t -72.27 -18.26 61.82 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 -69.59 -35.14 75.06 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -168.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.1 m -147.17 8.04 0.92 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.84 71.76 0.79 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.986 1.279 . . . . 0.0 111.784 -170.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -168.0 135.31 2.18 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 128.425 2.69 . . . . 0.0 105.76 172.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -100.79 154.99 18.18 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 127.832 2.453 . . . . 0.0 111.734 -170.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.74 147.27 44.6 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.599 1.16 . . . . 0.0 112.566 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.49 ' HA ' HG23 ' A' ' 117' ' ' THR . 26.9 p -86.9 142.29 28.13 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.661 0.743 . . . . 0.0 110.517 160.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -92.06 108.61 20.06 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 167.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.518 HG22 HG22 ' A' ' 115' ' ' VAL . 59.3 t -101.48 109.02 24.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -92.36 113.12 25.31 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 120.712 -1.243 . . . . 0.0 107.677 -173.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -107.52 101.68 11.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.383 1.473 . . . . 0.0 108.851 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -79.62 129.02 34.1 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.801 1.64 . . . . 0.0 109.511 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.8 p -145.18 168.71 19.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.075 2.55 . . . . 0.0 104.57 -170.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -12.75 -119.44 0.0 OUTLIER Glycine 0 N--CA 1.487 2.051 0 C-N-CA 129.542 3.449 . . . . 0.0 116.098 -171.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.8 p -95.45 105.84 17.85 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 113.96 -3.096 . . . . 0.0 111.082 153.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -178.75 145.88 0.31 Allowed 'General case' 0 N--CA 1.474 0.728 1 C-N-CA 132.179 4.192 . . . . 0.0 108.477 146.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 t -78.73 142.27 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 119.246 -2.159 . . . . 0.0 110.431 145.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.0 p -125.23 161.95 25.77 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.77 -1.207 . . . . 0.0 112.69 154.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 pp -112.44 116.11 29.77 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 122.11 0.957 . . . . 0.0 109.034 158.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.4 m -80.23 121.26 25.4 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.389 1.476 . . . . 0.0 108.006 169.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 42.4 t -104.91 113.68 27.43 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.028 -1.045 . . . . 0.0 110.98 -172.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -105.11 108.84 20.57 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.75 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.7 mt -76.67 72.09 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 140.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.77 -179.11 48.43 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 121.445 3.338 . . . . 0.0 121.445 -155.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -115.57 105.49 51.88 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-N 111.134 -2.533 . . . . 0.0 110.035 -171.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.444 ' HG2' HD23 ' A' ' 96' ' ' LEU . 20.4 Cg_exo -86.12 152.68 9.58 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.639 2.226 . . . . 0.0 114.636 -173.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -42.93 62.52 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -177.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 ttt85 -88.76 3.63 50.28 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.444 HD23 ' HG2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -49.88 -29.36 8.0 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.339 2.256 . . . . 0.0 113.612 178.698 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -53.49 -45.03 69.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.413 1.885 . . . . 0.0 113.543 168.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -122.08 -20.18 6.35 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -166.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.427 ' C ' HD12 ' A' ' 99' ' ' LEU . 2.7 pp -60.93 168.92 2.15 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 121.578 1.99 . . . . 0.0 114.711 165.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -117.25 172.88 7.01 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -160.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.595 ' CZ ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -131.0 155.14 47.33 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.984 1.313 . . . . 0.0 113.992 157.832 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.595 ' H ' ' CZ ' ' A' ' 101' ' ' ARG . 1.5 p -136.67 137.61 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.327 1.451 . . . . 0.0 113.432 174.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 28.1 p -123.38 112.66 17.83 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.448 133.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 t0 176.49 -167.23 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 128.521 2.729 . . . . 0.0 107.601 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -113.59 138.83 49.62 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.064 1.346 . . . . 0.0 111.396 150.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -158.09 159.66 36.52 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -60.77 142.59 55.81 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.306 1.042 . . . . 0.0 111.034 160.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 20.9 tp -142.4 133.39 25.84 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.848 1.659 . . . . 0.0 110.172 -173.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 m -71.68 156.57 39.21 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -174.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.47 -10.43 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -169.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.99 41.73 3.12 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.052 1.341 . . . . 0.0 112.201 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.41 ' HG3' ' H ' ' A' ' 113' ' ' ALA . 8.3 tp10 -105.04 172.42 6.8 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.058 2.143 . . . . 0.0 113.481 -169.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.41 ' H ' ' HG3' ' A' ' 112' ' ' GLU . . . -149.8 139.07 21.31 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 126.579 1.952 . . . . 0.0 106.315 -167.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.54 133.21 9.19 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.263 0.938 . . . . 0.0 113.445 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.518 HG22 HG22 ' A' ' 76' ' ' VAL . 3.6 t -95.88 136.43 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 117.252 -1.356 . . . . 0.0 109.315 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.491 ' HB ' ' CZ ' ' A' ' 101' ' ' ARG . 11.4 p -138.23 115.39 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 120.322 1.419 . . . . 0.0 109.354 164.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.49 HG23 ' HA ' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -138.01 171.29 14.63 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.002 1.721 . . . . 0.0 111.282 -175.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 79.4 mt -59.71 -29.99 68.49 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.534 0.734 . . . . 0.0 112.913 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.98 -33.32 65.75 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 119.712 1.142 . . . . 0.0 113.043 173.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -74.39 -45.64 45.46 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.802 1.241 . . . . 0.0 111.862 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 28.4 mm -60.34 -40.98 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.493 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -61.44 -29.99 70.3 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 172.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -70.1 -41.05 74.54 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 121.692 2.042 . . . . 0.0 111.864 172.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.5 pt -96.72 -11.9 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -168.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -154.15 150.67 22.89 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 126.539 1.936 . . . . 0.0 110.748 166.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -61.34 113.2 1.67 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 121.775 1.65 . . . . 0.0 110.926 168.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 19.7 p -83.32 161.64 21.36 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.608 0.718 . . . . 0.0 112.672 -176.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -151.19 147.96 27.66 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.264 1.826 . . . . 0.0 108.233 -171.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.257 0.1 OUTLIER -67.14 54.23 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 127.859 2.464 . . . . 0.0 112.635 170.244 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 179.6 -0.58 0.02 OUTLIER Glycine 0 CA--C 1.539 1.562 0 C-N-CA 127.516 2.484 . . . . 0.0 114.215 -167.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.1 t -65.42 131.15 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.011 1.405 . . . . 0.0 111.28 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 90.5 mt -118.44 89.21 3.08 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.982 1.713 . . . . 0.0 108.281 159.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.0 m -72.95 148.36 44.35 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 170.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -133.28 134.29 43.71 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.427 1.491 . . . . 0.0 108.661 -165.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 41.9 t -140.89 135.97 31.84 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.525 1.057 . . . . 0.0 112.027 -169.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.5 124.17 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.374 1.869 . . . . 0.0 110.175 -167.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.0 m -121.65 145.86 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.213 -0.93 . . . . 0.0 112.831 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -130.22 138.6 50.65 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.389 1.076 . . . . 0.0 112.12 158.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.51 ' HD2' ' CE1' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -77.58 146.08 36.45 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 129.034 2.934 . . . . 0.0 112.423 152.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.5 t -139.51 143.49 37.47 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.518 1.127 . . . . 0.0 110.217 162.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -101.29 -41.18 6.79 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.453 1.501 . . . . 0.0 110.755 169.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.9 t -54.76 -33.75 61.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.832 0.853 . . . . 0.0 112.808 174.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -102.49 1.2 49.65 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 117.71 -1.605 . . . . 0.0 115.849 172.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.3 mmt 39.44 57.85 2.04 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.837 1.819 . . . . 0.0 113.455 -173.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.0 m -149.46 163.52 37.55 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.002 0.921 . . . . 0.0 113.13 -163.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.51 ' CE1' ' HD2' ' A' ' 139' ' ' LYS . 76.7 m-85 -107.29 154.34 21.4 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.098 0.959 . . . . 0.0 111.098 154.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -130.83 106.19 8.28 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.61 139.19 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 123.972 0.909 . . . . 0.0 109.683 -163.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -141.46 134.3 28.82 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.689 0.796 . . . . 0.0 109.45 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.5 p -150.44 132.58 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 122.42 1.105 . . . . 0.0 110.642 164.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.4 m -137.28 145.69 29.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 126.505 1.922 . . . . 0.0 109.013 -162.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -112.36 118.11 34.32 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.689 -0.632 . . . . 0.0 112.392 -169.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -121.59 157.21 31.28 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.384 1.074 . . . . 0.0 111.338 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -85.6 -146.97 9.25 Favored Glycine 0 CA--C 1.54 1.626 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 159.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -63.39 -3.44 5.22 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.564 2.843 . . . . 0.0 115.973 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -63.76 -18.7 64.32 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.133 1.373 . . . . 0.0 114.01 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -77.37 30.24 0.15 Allowed 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.478 1.111 . . . . 0.0 112.172 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -61.54 -26.79 68.17 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.433 1.893 . . . . 0.0 114.177 -171.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.88 -52.57 12.54 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.404 1.082 . . . . 0.0 112.051 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -61.38 -39.78 91.93 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.375 1.07 . . . . 0.0 112.188 171.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -52.44 -54.68 29.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.611 0.764 . . . . 0.0 110.873 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -59.04 -45.29 91.11 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.565 -0.71 . . . . 0.0 112.852 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.36 -34.81 75.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.319 0.648 . . . . 0.0 112.309 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.43 -45.33 60.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.434 -0.791 . . . . 0.0 111.942 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 88.9 mt -56.85 -34.38 67.74 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.824 0.738 . . . . 0.0 111.683 171.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -79.38 -7.93 58.72 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.229 1.812 . . . . 0.0 114.231 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -99.78 -57.23 2.19 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.987 1.315 . . . . 0.0 113.053 160.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.8 pt -83.8 -32.12 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -160.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -90.69 10.98 23.66 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.017 0.927 . . . . 0.0 109.449 168.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.91 24.87 5.31 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.399 1.48 . . . . 0.0 114.638 174.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 16.7 mmt85 . . . . . 0 C--O 1.252 1.233 0 CA-C-O 117.628 -1.177 . . . . 0.0 111.319 157.46 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.4 t0 . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 121.608 0.718 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -68.5 -23.48 64.56 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 -135.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -112.8 -17.17 12.6 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.039 1.336 . . . . 0.0 113.425 172.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 80.1 t -67.18 -60.64 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.298 1.039 . . . . 0.0 111.532 -173.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.28 -37.35 80.48 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.282 -0.732 . . . . 0.0 113.472 175.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.71 -59.2 5.79 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.245 1.023 . . . . 0.0 110.916 175.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -65.77 -46.95 76.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.616 1.166 . . . . 0.0 111.668 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.0 mp -70.46 -43.7 69.28 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.643 -0.66 . . . . 0.0 111.637 -173.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.29 -34.56 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 119.203 0.91 . . . . 0.0 110.231 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.2 t -59.49 -52.33 66.02 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.41 1.005 . . . . 0.0 111.761 174.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -64.73 -31.51 72.76 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.416 -0.803 . . . . 0.0 111.581 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 m -68.72 -50.09 53.57 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.196 -0.94 . . . . 0.0 111.685 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.1 ptt85 -61.87 -22.06 65.22 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.002 1.274 . . . . 0.0 113.577 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -85.1 -52.56 5.86 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.446 1.099 . . . . 0.0 112.953 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.85 -30.48 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 118.635 0.652 . . . . 0.0 112.201 -175.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -84.38 -7.66 59.23 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.912 1.233 . . . . 0.0 111.633 171.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 65.65 5.13 3.14 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 128.243 2.617 . . . . 0.0 115.249 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 pp -97.37 147.1 24.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.153 1.381 . . . . 0.0 111.497 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -76.01 165.23 25.26 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -168.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -58.77 -39.77 81.97 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.196 -1.565 . . . . 0.0 112.51 -174.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -88.27 6.92 34.64 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.84 0.856 . . . . 0.0 112.784 176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -108.87 -5.59 16.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.321 1.448 . . . . 0.0 111.769 172.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.6 tp -89.06 112.61 23.61 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 166.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.59 93.17 8.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 118.701 -1.199 . . . . 0.0 109.193 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -87.69 146.69 5.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 125.609 1.563 . . . . 0.0 112.541 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 m -145.86 153.3 40.71 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.925 1.29 . . . . 0.0 110.425 -171.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -117.72 -165.69 1.12 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.368 1.467 . . . . 0.0 112.609 -163.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.4 t -41.34 -41.15 1.88 Allowed 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 118.081 2.622 . . . . 0.0 118.081 -147.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.7 -17.24 61.15 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 -160.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.42 -14.25 17.64 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.3 pt -102.85 -6.65 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 126.703 2.001 . . . . 0.0 113.583 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -41.53 8.14 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.055 1 C-N-CA 133.641 4.776 . . . . 0.0 121.397 -169.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -65.48 -21.39 66.63 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 122.468 2.395 . . . . 0.0 113.391 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -92.65 117.51 67.62 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 144.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -73.26 -8.31 21.77 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.052 2.501 . . . . 0.0 114.561 -171.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -108.69 -43.43 4.27 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 120.099 1.318 . . . . 0.0 112.007 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -165.51 126.69 1.93 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.539 1.535 . . . . 0.0 110.062 159.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 t -92.94 -162.03 0.9 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 147.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.96 -82.48 0.17 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -168.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 2.4 t -164.9 175.99 9.08 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 120.803 1.638 . . . . 0.0 113.562 -170.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -147.61 106.88 3.88 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.83 158.54 15.46 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.91 2.884 . . . . 0.0 112.059 -168.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 12.8 tmm? -125.57 137.2 53.9 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.895 1.225 . . . . 0.0 110.944 172.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.1 mt -129.86 128.99 43.38 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 129.204 3.002 . . . . 0.0 111.095 -157.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.7 t -128.95 162.7 26.96 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 128.021 2.528 . . . . 0.0 110.383 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.6 p -39.11 113.03 0.28 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.744 1.618 . . . . 0.0 113.515 -149.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.544 ' C ' HD13 ' A' ' 54' ' ' ILE . 1.4 p30 -106.81 159.05 16.53 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.939 172.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.544 HD13 ' C ' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -121.78 177.44 3.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 113.69 -1.596 . . . . 0.0 106.721 -173.84 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.471 ' H ' HG22 ' A' ' 54' ' ' ILE . 11.7 p -77.15 103.38 4.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.912 -155.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -137.72 158.22 72.08 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.433 1.093 . . . . 0.0 111.913 -166.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.46 ' HD3' HD13 ' A' ' 164' ' ' LEU . 58.7 Cg_endo -66.53 88.27 0.27 Allowed 'Trans proline' 0 C--N 1.357 0.999 1 C-N-CA 125.741 4.294 . . . . 0.0 112.187 -178.218 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.64 -40.83 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.451 0.7 . . . . 0.0 112.541 -172.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -12.52 60.39 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -55.39 -27.72 49.43 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.192 0.905 . . . . 0.0 112.687 167.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.3 mp -77.97 -44.32 27.12 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.885 0.874 . . . . 0.0 111.554 171.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mp -56.71 -43.57 80.71 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 118.138 0.426 . . . . 0.0 111.37 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.3 p -72.31 -30.74 65.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.801 0.84 . . . . 0.0 112.515 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -37.6 80.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.381 0.991 . . . . 0.0 112.865 171.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -50.63 16.2 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.105 0.866 . . . . 0.0 111.866 172.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -61.24 -33.62 73.81 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.775 -1.203 . . . . 0.0 113.325 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 69.5 m -79.17 -20.56 48.15 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 172.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -38.36 79.34 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.641 1.11 . . . . 0.0 113.269 -169.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.6 m -150.81 0.23 0.41 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.97 82.3 0.16 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.19 1.376 . . . . 0.0 110.952 -165.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -153.71 115.91 4.34 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 125.665 1.586 . . . . 0.0 107.841 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 79.4 m -91.89 113.12 25.3 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.942 1.297 . . . . 0.0 109.792 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.47 148.38 40.81 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.056 1.342 . . . . 0.0 113.285 -168.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 74.4 m -89.21 127.14 35.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.702 0.801 . . . . 0.0 109.535 165.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -91.91 103.48 16.01 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 164.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.6 t -105.46 141.62 20.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 C-N-CA 125.07 1.348 . . . . 0.0 109.204 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -124.93 123.28 39.56 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.245 -0.909 . . . . 0.0 110.08 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.1 112.86 25.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.054 1.741 . . . . 0.0 109.262 172.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -86.26 126.68 34.47 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.074 -1.016 . . . . 0.0 111.281 165.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.8 p -143.69 157.11 44.64 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.732 3.213 . . . . 0.0 103.369 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -7.07 -129.85 0.0 OUTLIER Glycine 0 N--CA 1.486 1.993 0 O-C-N 117.707 -3.121 . . . . 0.0 112.83 -116.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 82.4 m -97.58 107.5 20.02 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 113.666 -3.213 . . . . 0.0 108.601 149.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -169.66 125.14 0.83 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 130.754 3.622 . . . . 0.0 106.203 161.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.431 HG23 ' CZ ' ' A' ' 146' ' ' TYR . 2.6 t -78.03 135.45 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 117.978 -1.489 . . . . 0.0 110.938 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.8 m -110.22 146.19 36.02 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.21 0.604 . . . . 0.0 110.477 163.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.1 tp -110.73 108.79 18.78 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 126.208 1.803 . . . . 0.0 107.082 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.6 m -80.12 101.47 8.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 167.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 45.3 t -103.81 108.12 19.29 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 120.73 -1.231 . . . . 0.0 108.23 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.4 151.17 48.26 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -175.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.59 96.1 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 141.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.91 142.75 6.67 Favored Glycine 0 N--CA 1.471 1.015 0 N-CA-C 118.332 2.093 . . . . 0.0 118.332 -167.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -133.28 64.81 71.02 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.626 1.571 . . . . 0.0 112.267 175.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.58 158.12 32.24 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.369 2.713 . . . . 0.0 115.495 -172.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -50.52 -19.89 1.01 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.252 2.621 . . . . 0.0 115.752 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -69.83 -11.62 61.0 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.182 -1.574 . . . . 0.0 113.242 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.71 -4.7 16.76 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 164.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 1.67 32.76 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 120.051 1.296 . . . . 0.0 112.241 160.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -131.16 -34.2 1.45 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.533 1.933 . . . . 0.0 114.154 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 pp -100.49 160.0 14.7 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 120.196 1.362 . . . . 0.0 114.628 -172.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -108.69 -160.97 0.74 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 125.714 1.606 . . . . 0.0 113.069 -166.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.45 166.11 13.08 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.711 1.205 . . . . 0.0 111.833 162.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.1 p -125.13 130.97 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 170.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.514 ' HB2' HD13 ' A' ' 124' ' ' ILE . 10.8 t -147.58 112.1 5.3 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 127.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -176.91 175.29 1.62 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.507 1.923 . . . . 0.0 107.886 -170.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -115.82 121.06 41.27 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.384 1.873 . . . . 0.0 110.667 161.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -159.0 165.95 32.88 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -74.09 149.42 41.11 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.517 -0.74 . . . . 0.0 111.71 164.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.8 tp -135.87 143.09 44.86 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.596 1.958 . . . . 0.0 108.87 -171.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.8 p -117.44 173.21 6.83 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -166.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.9 t -67.11 -9.77 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 128.433 2.693 . . . . 0.0 115.422 -163.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -135.21 25.11 3.54 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.996 -1.065 . . . . 0.0 112.803 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -116.2 151.75 35.1 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.141 -0.974 . . . . 0.0 111.803 -163.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.61 166.15 31.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.077 -1.014 . . . . 0.0 112.549 -165.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.69 164.1 37.67 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.276 1.03 . . . . 0.0 113.46 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.402 ' CG1' HG23 ' A' ' 117' ' ' THR . 6.8 t -99.76 145.45 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 127.788 2.435 . . . . 0.0 109.275 163.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.6 128.7 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.565 0.698 . . . . 0.0 109.287 151.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.402 HG23 ' CG1' ' A' ' 115' ' ' VAL . 4.7 p -128.97 159.13 36.87 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.444 1.498 . . . . 0.0 111.001 174.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -59.44 -38.46 80.73 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.383 0.673 . . . . 0.0 111.672 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.18 -32.53 74.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.046 0.938 . . . . 0.0 112.58 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -71.47 -33.14 69.06 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 117.575 -1.202 . . . . 0.0 111.996 173.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 31.9 mm -66.7 -41.39 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 119.742 1.156 . . . . 0.0 110.786 170.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.54 -27.89 66.6 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 171.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -86.52 -21.84 26.72 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.97 1.708 . . . . 0.0 115.178 171.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.514 HD13 ' HB2' ' A' ' 103' ' ' CYS . 6.3 mt -77.2 -38.54 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.056 1.342 . . . . 0.0 111.007 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -145.06 172.31 5.52 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 125.715 1.606 . . . . 0.0 111.858 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -57.43 20.97 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.335 1 C-N-CA 126.262 4.641 . . . . 0.0 117.086 164.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 77.9 m -74.75 160.38 30.81 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.676 1.99 . . . . 0.0 112.097 176.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -125.02 -166.42 1.53 Allowed 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 128.002 2.521 . . . . 0.0 108.7 173.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.26 -24.69 67.75 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -173.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -85.86 15.24 48.92 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 118.155 -1.358 . . . . 0.0 115.98 -175.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.73 158.61 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.219 1.509 . . . . 0.0 113.801 -165.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.7 tt -116.43 126.71 53.8 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 122.352 1.072 . . . . 0.0 110.618 154.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 2.4 p -123.26 148.38 45.96 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 127.496 2.318 . . . . 0.0 109.711 -173.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -130.98 128.47 40.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -164.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 46.3 t -136.38 138.92 42.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.467 0.707 . . . . 0.0 110.728 -165.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.5 t -146.23 114.76 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.892 0.877 . . . . 0.0 110.98 -167.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 m -109.01 129.95 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -115.51 140.92 48.72 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.46 2.304 . . . . 0.0 107.261 168.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.451 ' HB2' ' CD2' ' A' ' 146' ' ' TYR 0.304 0.2 OUTLIER -149.69 152.84 36.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.504 0.722 . . . . 0.0 110.664 169.845 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.7 t -136.8 123.34 20.92 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.846 0.748 . . . . 0.0 109.16 171.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -76.0 -57.08 4.09 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.213 1.405 . . . . 0.0 110.67 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.6 t -61.09 -36.32 79.35 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.04 0.936 . . . . 0.0 112.591 169.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.66 14.16 48.7 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.361 -1.244 . . . . 0.0 114.896 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 28.0 ptm 42.63 49.46 4.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.268 2.227 . . . . 0.0 116.985 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.5 t -157.82 148.74 21.09 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.451 ' CD2' ' HB2' ' A' ' 139' ' ' LYS . 1.4 t80 -108.93 140.08 42.9 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.706 1.202 . . . . 0.0 111.267 163.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -140.79 121.32 14.16 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 122.17 0.986 . . . . 0.0 111.447 -173.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -133.5 134.58 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.097 -1.002 . . . . 0.0 110.828 -151.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -142.66 131.76 23.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.675 1.19 . . . . 0.0 111.064 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.8 p -145.19 139.37 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.545 -0.722 . . . . 0.0 110.588 161.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.9 m -136.04 151.43 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 127.772 2.429 . . . . 0.0 109.821 -165.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.12 128.85 23.12 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -166.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -148.12 133.25 18.3 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 170.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.54 -162.21 0.27 Allowed Glycine 0 CA--C 1.549 2.185 0 C-N-CA 127.558 2.504 . . . . 0.0 116.344 166.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.6 -20.77 12.92 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.892 3.728 . . . . 0.0 119.521 -160.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -75.58 -2.39 28.95 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 120.58 1.537 . . . . 0.0 114.03 173.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 45.7 p30 -58.82 13.03 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 129.304 3.042 . . . . 0.0 117.861 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -49.4 -40.02 34.67 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.389 1.876 . . . . 0.0 112.623 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.43 -51.44 65.72 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -74.2 -26.7 60.42 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.086 -1.009 . . . . 0.0 112.427 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -64.98 -48.56 73.56 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.709 0.804 . . . . 0.0 111.74 168.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -62.61 -38.11 88.91 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.332 -0.855 . . . . 0.0 112.087 174.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.55 -30.85 70.03 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.46 HD13 ' HD3' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -79.09 -51.72 9.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.724 1.21 . . . . 0.0 110.887 -179.18 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.5 pp -66.43 -27.55 67.91 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.316 -0.865 . . . . 0.0 110.972 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -77.21 -24.42 51.29 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 117.895 -1.05 . . . . 0.0 112.828 172.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.64 -30.86 64.67 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 167.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.1 mt -76.03 -36.8 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 120.708 -1.245 . . . . 0.0 110.977 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -64.83 -4.9 4.9 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 158.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -108.56 25.17 12.02 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 170.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.171 0 C-N-CA 128.539 2.736 . . . . 0.0 116.52 162.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.6 t0 . . . . . 0 CA--C 1.552 1.05 0 CA-C-O 121.147 0.499 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -57.86 -35.58 71.16 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 -143.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -102.92 -19.73 14.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.211 1.404 . . . . 0.0 112.349 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.27 -52.41 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.986 0.915 . . . . 0.0 112.388 -168.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.73 -49.92 73.33 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 119.179 0.9 . . . . 0.0 111.885 174.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.51 76.84 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.278 1.039 . . . . 0.0 112.156 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.76 -42.41 73.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.334 1.054 . . . . 0.0 113.303 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.4 tp -76.58 -31.44 57.5 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.271 1.029 . . . . 0.0 112.914 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.9 -40.41 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 121.487 -0.758 . . . . 0.0 109.344 168.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.1 m -59.58 -35.24 73.9 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 119.688 1.131 . . . . 0.0 112.495 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -72.0 -40.09 68.75 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.675 1.19 . . . . 0.0 111.452 177.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.7 m -64.87 -42.51 94.78 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.989 -1.069 . . . . 0.0 110.514 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -54.33 -37.21 64.61 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.977 1.711 . . . . 0.0 112.353 171.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -83.84 -49.28 9.2 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.519 1.528 . . . . 0.0 113.473 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.8 -42.49 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 118.989 0.813 . . . . 0.0 111.093 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.01 -2.52 58.38 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.471 0.708 . . . . 0.0 112.785 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . 0.273 32.8 ptt180 51.88 22.99 1.92 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.07 2.548 . . . . 0.0 116.179 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.411 HD11 HD23 ' A' ' 29' ' ' LEU . 3.6 pp -92.36 153.41 19.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.145 1.778 . . . . 0.0 112.139 175.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -80.41 160.12 25.45 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.006 0.922 . . . . 0.0 113.454 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -69.76 -24.37 63.52 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 119.903 -1.748 . . . . 0.0 115.586 -168.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -96.14 8.06 44.8 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.673 1.124 . . . . 0.0 112.517 167.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -110.62 -1.35 16.86 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.842 1.657 . . . . 0.0 111.013 172.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.411 HD23 HD11 ' A' ' 24' ' ' LEU . 2.0 tm? -94.8 117.67 30.52 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 127.839 2.456 . . . . 0.0 105.804 165.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -89.09 134.18 34.1 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.537 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.656 HD12 ' H ' ' A' ' 31' ' ' ILE . 0.3 OUTLIER -125.83 142.95 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 124.71 1.204 . . . . 0.0 112.21 173.025 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.4 p -154.3 145.12 22.52 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.974 1.31 . . . . 0.0 110.123 -166.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -166.94 59.89 0.09 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 122.935 1.35 . . . . 0.0 112.329 -170.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 76.1 p -89.89 -58.3 2.56 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.38 -0.825 . . . . 0.0 111.836 153.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.95 -55.95 4.09 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.959 0.885 . . . . 0.0 113.016 -151.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -61.25 -30.15 70.28 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.801 1.241 . . . . 0.0 112.344 172.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.661 ' HA ' ' H ' ' A' ' 44' ' ' SER . 1.5 mp -66.03 -29.87 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.922 0.889 . . . . 0.0 111.174 175.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.8 m -84.71 4.89 30.54 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.394 1.478 . . . . 0.0 114.612 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -84.47 -14.42 49.22 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.531 1.514 . . . . 0.0 112.346 170.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -120.66 161.96 37.02 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 127.045 2.138 . . . . 0.0 110.389 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -58.83 -38.26 89.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.52 2.147 . . . . 0.0 114.26 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -121.57 -35.78 3.17 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 116.852 2.168 . . . . 0.0 116.852 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -166.31 143.68 5.23 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 120.705 1.593 . . . . 0.0 109.387 -171.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.661 ' H ' ' HA ' ' A' ' 37' ' ' ILE . 96.8 p -106.57 -168.09 1.37 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 135.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -75.62 -75.45 0.18 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.768 1.622 . . . . 0.0 112.195 -166.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -178.13 -174.65 0.43 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.926 0.89 . . . . 0.0 109.541 -173.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 11.5 t0 -139.13 136.38 35.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.74 140.87 49.24 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.527 1.531 . . . . 0.0 112.154 -169.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.8 mtt -114.48 130.53 56.74 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 120.56 1.527 . . . . 0.0 111.857 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.0 mt -131.55 161.24 33.08 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 128.536 2.734 . . . . 0.0 112.936 -153.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.5 p -93.93 179.81 5.22 Favored 'General case' 0 N--CA 1.48 1.062 1 C-N-CA 132.876 4.47 . . . . 0.0 114.573 -153.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 t -120.34 109.01 14.85 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.52 -1.362 . . . . 0.0 108.082 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.468 ' HB3' ' H ' ' A' ' 54' ' ' ILE . 6.0 m-20 -161.01 -154.97 0.39 Allowed 'General case' 0 CA--C 1.561 1.367 0 O-C-N 120.88 -1.138 . . . . 0.0 112.898 -136.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.468 ' H ' ' HB3' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -145.35 178.85 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 1 C-N-CA 132.359 4.264 . . . . 0.0 109.09 -157.066 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.7 p -76.22 123.44 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.973 1.309 . . . . 0.0 112.294 -164.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -122.56 148.08 52.06 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.84 1.256 . . . . 0.0 112.315 -173.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.62 72.74 5.92 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 125.234 3.956 . . . . 0.0 111.986 -172.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.3 p -66.12 -24.09 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.075 0.95 . . . . 0.0 113.3 -169.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.61 -40.08 51.79 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.514 1.126 . . . . 0.0 113.765 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -60.82 -38.5 85.62 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.032 0.533 . . . . 0.0 111.784 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.7 -46.7 62.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.294 1.038 . . . . 0.0 111.037 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -58.35 -44.72 88.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.206 1.002 . . . . 0.0 111.673 173.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.5 m -73.59 -48.09 35.42 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.977 0.911 . . . . 0.0 112.307 -172.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -59.43 -45.2 92.23 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.215 174.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -58.64 -48.42 81.1 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.106 0.866 . . . . 0.0 112.497 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -58.98 -43.67 91.46 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 70.9 m -74.17 -23.46 59.24 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -74.14 -17.16 60.96 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -167.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.7 p -144.2 2.84 1.16 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 175.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.34 71.27 0.86 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 127.062 2.267 . . . . 0.0 110.342 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -165.5 128.85 2.2 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 127.882 2.473 . . . . 0.0 105.677 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.0 m -84.55 141.73 30.5 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 126.412 1.885 . . . . 0.0 110.496 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.93 151.04 31.58 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -170.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 24.9 p -101.06 133.86 44.94 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.819 0.848 . . . . 0.0 111.427 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -89.35 117.61 28.42 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 168.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 115' ' ' VAL . 42.1 t -121.86 113.85 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 123.464 0.706 . . . . 0.0 109.284 -169.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -89.86 125.12 35.21 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.518 -1.364 . . . . 0.0 107.581 -176.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.8 97.82 6.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 123.293 1.52 . . . . 0.0 107.55 168.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -73.7 116.77 14.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.545 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.0 p -147.41 158.27 43.91 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 128.521 2.728 . . . . 0.0 104.674 -161.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -11.42 -131.09 0.0 OUTLIER Glycine 0 N--CA 1.483 1.783 0 O-C-N 119.304 -2.122 . . . . 0.0 114.442 -127.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 30.3 p -94.03 101.01 13.03 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 115.058 -2.657 . . . . 0.0 108.308 161.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -172.67 165.87 5.43 Favored 'General case' 0 N--CA 1.469 0.516 1 C-N-CA 131.76 4.024 . . . . 0.0 106.835 158.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.4 t -87.98 124.77 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.02 -1.05 . . . . 0.0 110.218 159.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.78 141.55 37.84 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.991 0.814 . . . . 0.0 108.861 164.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 31.4 tp -119.72 106.1 11.81 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.416 1.086 . . . . 0.0 108.617 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.4 m -80.17 125.62 30.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.122 0.569 . . . . 0.0 110.916 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 10.8 m -111.38 107.04 16.15 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 120.893 -1.129 . . . . 0.0 109.751 -173.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -103.73 97.65 7.63 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.028 0.531 . . . . 0.0 112.32 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.3 mt -75.7 82.81 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 139.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -178.03 179.87 48.29 Favored Glycine 0 N--CA 1.468 0.791 0 N-CA-C 122.413 3.725 . . . . 0.0 122.413 -161.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -108.88 66.73 0.32 Allowed Pre-proline 0 CA--C 1.551 1.002 0 CA-C-N 112.886 -1.657 . . . . 0.0 113.346 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.67 134.78 45.69 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.192 2.594 . . . . 0.0 113.428 -176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -76.33 -41.74 47.39 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.3 1.04 . . . . 0.0 111.77 171.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -69.84 -11.67 61.03 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -172.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.11 -18.29 5.36 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.478 1.911 . . . . 0.0 114.017 163.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -78.37 -2.22 37.19 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.879 1.272 . . . . 0.0 114.063 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -134.35 -35.7 0.91 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.12 0.873 . . . . 0.0 113.188 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 pp -77.0 166.26 23.56 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -164.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -92.13 -175.17 3.99 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.515 1.126 . . . . 0.0 112.808 -162.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -122.07 168.63 11.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.566 1.546 . . . . 0.0 109.541 159.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.5 p -122.69 124.9 71.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 167.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 47.3 t -125.14 114.39 18.96 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 122.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -178.23 168.16 1.93 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 123.126 1.441 . . . . 0.0 109.126 -165.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -141.99 109.16 5.52 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 127.045 2.138 . . . . 0.0 109.591 164.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -151.04 162.8 40.15 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -168.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -73.69 149.71 41.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.17 0.988 . . . . 0.0 111.946 164.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.4 tp -142.45 147.54 36.29 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 128.125 2.57 . . . . 0.0 109.696 -157.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.7 p -114.75 176.0 5.25 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.919 2.088 . . . . 0.0 114.013 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.83 -13.19 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 126.166 1.787 . . . . 0.0 114.548 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -115.02 33.07 5.63 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.672 -1.268 . . . . 0.0 112.46 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.07 153.13 19.82 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.733 -1.229 . . . . 0.0 114.114 -172.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -156.92 128.15 6.89 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.491 1.516 . . . . 0.0 108.854 -174.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.4 pp -158.18 152.26 24.1 Favored 'General case' 0 CA--C 1.554 1.096 0 O-C-N 121.062 -1.024 . . . . 0.0 113.194 -168.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 76' ' ' VAL . 29.8 t -99.91 146.46 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 126.585 1.954 . . . . 0.0 111.981 175.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.41 133.51 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.317 0.579 . . . . 0.0 110.841 145.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.2 t -154.42 153.83 32.23 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.027 1.331 . . . . 0.0 111.839 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -27.67 68.24 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.157 1.383 . . . . 0.0 114.34 -166.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.7 -30.72 46.21 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.524 -1.36 . . . . 0.0 113.307 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.29 -33.65 65.33 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.129 -0.982 . . . . 0.0 111.39 168.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.6 mm -60.95 -38.67 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 118.626 0.648 . . . . 0.0 111.004 166.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -65.79 -23.7 66.76 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 173.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -70.4 -29.69 66.39 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 120.243 -1.535 . . . . 0.0 112.269 167.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 27.4 mt -78.58 -38.31 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.715 0.806 . . . . 0.0 110.717 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.482 ' HE3' ' HA ' ' A' ' 153' ' ' PHE . 54.9 mmtt -136.08 109.78 9.88 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 126.549 1.94 . . . . 0.0 111.82 -174.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -62.33 -12.59 28.05 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 N-CA-C 120.083 3.07 . . . . 0.0 120.083 -166.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 9.5 m -133.95 130.96 38.45 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.824 1.647 . . . . 0.0 112.303 173.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -96.59 12.57 31.2 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 -167.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -77.71 14.16 1.12 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -171.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.49 41.16 0.08 OUTLIER Glycine 0 N--CA 1.47 0.951 0 O-C-N 120.918 -1.113 . . . . 0.0 112.856 -172.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.8 115.65 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.383 0.673 . . . . 0.0 111.65 -172.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.42 88.21 3.6 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 158.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 88.7 m -88.3 133.67 34.01 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 163.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -131.78 128.79 39.53 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.655 1.182 . . . . 0.0 108.431 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 51.7 t -136.6 136.04 38.88 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.938 -1.101 . . . . 0.0 111.786 -162.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -142.87 129.83 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.489 1.116 . . . . 0.0 109.855 -167.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.404 HG12 HD12 ' A' ' 148' ' ' ILE . 14.0 m -131.94 144.6 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 121.454 -0.778 . . . . 0.0 110.68 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -132.51 152.08 51.69 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 125.256 1.423 . . . . 0.0 108.384 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.29 0.9 OUTLIER -148.43 152.68 37.37 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.938 1.295 . . . . 0.0 108.507 167.126 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.0 t -128.33 139.77 52.23 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -93.43 -53.26 4.15 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.989 0.916 . . . . 0.0 109.614 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.3 m -50.3 -41.44 50.85 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.253 1.421 . . . . 0.0 113.18 172.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -100.5 13.32 59.75 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.589 1.566 . . . . 0.0 115.007 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 92.7 mtp 28.96 63.53 0.12 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 127.961 2.504 . . . . 0.0 114.754 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.8 t -159.68 139.76 11.77 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.292 -0.88 . . . . 0.0 110.279 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -130.92 156.92 44.26 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 122.129 -0.357 . . . . 0.0 110.262 -162.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -149.85 136.93 19.6 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.038 0.835 . . . . 0.0 113.139 -163.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.404 HD12 HG12 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -146.56 115.27 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.184 0.516 . . . . 0.0 110.519 -159.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -142.86 137.42 29.56 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.178 -0.951 . . . . 0.0 112.311 -169.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.1 p -150.43 140.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 120.912 -1.118 . . . . 0.0 110.563 162.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.7 m -118.84 149.29 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 128.281 2.633 . . . . 0.0 109.552 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -134.34 135.25 42.6 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.482 ' HA ' ' HE3' ' A' ' 125' ' ' LYS . 64.8 m-85 -135.81 158.54 44.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.901 2.081 . . . . 0.0 110.537 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -104.1 -143.3 12.34 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 164.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -45.41 -35.47 11.94 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.931 3.087 . . . . 0.0 114.653 169.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -62.68 -10.02 11.1 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -172.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -107.77 70.21 0.77 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 123.17 1.462 . . . . 0.0 111.195 167.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.1 -25.25 58.45 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.726 1.611 . . . . 0.0 112.096 165.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.44 -53.89 8.65 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -74.61 -20.44 59.91 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 120.598 1.545 . . . . 0.0 113.107 170.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.84 -57.45 12.6 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.488 1.495 . . . . 0.0 110.978 165.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -63.4 -29.64 70.91 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.981 -1.074 . . . . 0.0 112.995 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.16 -33.79 76.84 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.364 0.984 . . . . 0.0 113.088 172.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -75.13 -52.45 10.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.255 -0.903 . . . . 0.0 112.091 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 10.0 mp -50.93 -34.82 30.23 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.627 1.103 . . . . 0.0 113.963 170.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -60.41 -50.97 71.49 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.989 1.716 . . . . 0.0 110.689 171.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -72.88 -18.2 61.45 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.2 mm -83.29 -38.38 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 120.288 1.403 . . . . 0.0 110.707 171.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -62.21 -22.63 66.09 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.512 -1.367 . . . . 0.0 112.558 166.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -101.33 28.68 5.25 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.589 1.556 . . . . 0.0 114.362 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 C-N-CA 126.205 1.802 . . . . 0.0 115.831 170.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.541 0.598 0 CA-C-O 121.564 0.697 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -59.99 -24.34 64.36 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 116.618 2.081 . . . . 0.0 116.618 -155.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -106.08 -27.05 11.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.127 0.971 . . . . 0.0 112.436 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.9 t -74.35 -61.0 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.754 1.221 . . . . 0.0 111.687 -172.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.8 -45.93 92.91 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.471 -0.627 . . . . 0.0 111.829 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.15 -53.04 30.37 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.936 0.894 . . . . 0.0 112.741 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -68.29 -41.08 81.48 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 mp -75.98 -40.08 54.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.987 1.267 . . . . 0.0 111.92 -172.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.56 -46.31 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.424 -0.797 . . . . 0.0 109.863 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.4 m -70.16 -41.29 74.0 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.536 -0.727 . . . . 0.0 111.666 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -69.35 -22.27 63.76 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.685 -1.26 . . . . 0.0 112.833 172.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.3 m -63.83 -48.15 77.93 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.772 1.624 . . . . 0.0 109.804 168.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -43.09 92.04 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.996 0.816 . . . . 0.0 112.105 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.8 ttt85 -71.22 -42.08 69.38 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.228 1.811 . . . . 0.0 113.54 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.7 -40.26 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 119.44 1.018 . . . . 0.0 110.036 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -79.46 -8.12 58.9 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 55.57 37.11 28.45 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.978 1.711 . . . . 0.0 114.247 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 pp -112.46 160.07 18.12 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.821 1.248 . . . . 0.0 110.878 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.9 156.08 39.61 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.239 0.542 . . . . 0.0 112.282 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -60.23 -26.97 66.83 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.308 -1.495 . . . . 0.0 112.033 170.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -91.88 12.48 21.45 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.314 1.845 . . . . 0.0 113.27 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -119.38 -10.41 9.7 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.511 1.124 . . . . 0.0 111.945 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.52 HD11 ' HB1' ' A' ' 48' ' ' ALA . 26.8 tp -88.54 111.32 21.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 171.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -85.46 124.78 32.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.258 175.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.0 mm -89.7 141.33 14.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 125.581 1.553 . . . . 0.0 109.875 172.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 54.6 m -118.68 141.77 48.3 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 164.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.71 -152.62 0.32 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.392 2.277 . . . . 0.0 112.513 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.0 t -51.41 -32.13 25.34 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -158.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.4 -42.3 61.33 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -167.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.99 -8.17 24.2 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.0 pt -110.3 -2.85 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 127.186 2.194 . . . . 0.0 115.051 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.3 m -42.08 11.17 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 130.256 3.422 . . . . 0.0 117.468 160.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -67.58 -48.9 65.56 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.106 -1.621 . . . . 0.0 109.282 171.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -69.91 160.15 81.35 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.949 162.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -52.73 -35.03 67.25 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.264 2.643 . . . . 0.0 114.817 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -118.71 -52.9 2.33 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.243 0.929 . . . . 0.0 112.852 161.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -145.51 123.85 12.31 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.312 1.968 . . . . 0.0 116.312 -163.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.4 m -73.89 -159.27 0.07 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.834 1.253 . . . . 0.0 109.83 144.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.4 tp -70.15 -76.43 0.1 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 121.272 1.851 . . . . 0.0 112.528 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 11.8 p -174.96 -161.69 0.1 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.974 0.91 . . . . 0.0 111.735 -167.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -127.25 158.31 37.51 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.635 1.574 . . . . 0.0 108.676 161.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -131.31 133.69 45.61 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.909 2.884 . . . . 0.0 108.93 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.1 ttp -124.89 132.61 53.28 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.161 -0.962 . . . . 0.0 111.32 -168.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.6 mt -137.22 163.86 29.9 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.37 1.868 . . . . 0.0 114.296 -139.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.2 t -92.76 179.51 5.46 Favored 'General case' 0 N--CA 1.475 0.811 1 C-N-CA 132.596 4.358 . . . . 0.0 114.303 -145.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.2 t -134.15 112.96 11.55 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 170.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.605 ' C ' HD13 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -164.54 -151.89 0.17 Allowed 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -141.701 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.605 HD13 ' C ' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -125.8 -176.03 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 131.391 3.876 . . . . 0.0 109.546 -165.526 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 54' ' ' ILE . 32.9 m -76.04 133.7 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.499 0.719 . . . . 0.0 111.563 -177.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -132.2 145.3 56.75 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.044 0.938 . . . . 0.0 113.255 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -76.45 71.42 5.91 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 125.175 3.917 . . . . 0.0 111.784 -173.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.8 p -58.88 -29.38 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.307 1.843 . . . . 0.0 113.221 -169.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -52.48 -37.42 57.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.073 1.749 . . . . 0.0 113.817 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -66.15 -35.2 79.86 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.241 -0.912 . . . . 0.0 110.697 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 37.4 tp -74.97 -42.49 57.51 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.623 0.769 . . . . 0.0 112.207 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 mp -57.62 -32.15 66.95 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.973 0.806 . . . . 0.0 112.122 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.7 m -73.77 -50.95 18.14 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.823 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -58.29 -34.97 71.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.258 0.935 . . . . 0.0 112.894 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 47.8 t-105 -66.64 -58.71 4.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.749 1.22 . . . . 0.0 112.825 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -75.85 -36.96 59.41 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -174.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.5 t -69.08 -13.81 62.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.012 0.925 . . . . 0.0 113.352 -175.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.4 tpt85 -68.45 -16.13 63.79 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 119.537 1.062 . . . . 0.0 113.151 -172.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.2 p -140.46 -28.79 0.71 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.401 1.48 . . . . 0.0 112.259 165.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.18 79.99 0.67 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 125.796 1.665 . . . . 0.0 108.983 -164.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -158.17 119.95 3.6 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 127.871 2.469 . . . . 0.0 107.168 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.0 m -64.89 116.29 6.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 122.111 0.958 . . . . 0.0 111.268 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.52 143.46 31.56 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.189 1.795 . . . . 0.0 111.857 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 79.3 m -96.25 128.86 43.54 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.748 -0.595 . . . . 0.0 111.791 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -80.31 129.31 34.42 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 149.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.8 t -123.81 114.37 41.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -174.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -87.43 110.97 20.66 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -173.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -112.56 102.17 10.27 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -74.33 125.92 29.54 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.394 -0.817 . . . . 0.0 109.92 170.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.3 p -145.48 160.19 41.97 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 128.285 2.634 . . . . 0.0 104.772 -165.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -11.09 -128.39 0.0 OUTLIER Glycine 0 N--CA 1.486 1.967 0 C-N-CA 126.809 2.147 . . . . 0.0 116.267 -146.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 53.5 t -92.95 98.08 11.13 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 116.27 -2.172 . . . . 0.0 108.588 162.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.68 154.91 2.58 Favored 'General case' 0 CA--C 1.538 0.519 1 C-N-CA 132.412 4.285 . . . . 0.0 106.628 159.199 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.07 148.85 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 119.714 -1.866 . . . . 0.0 109.429 149.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.2 p -139.61 163.62 32.09 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 119.597 -1.939 . . . . 0.0 110.764 162.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 pp -128.93 130.14 46.37 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.696 0.76 . . . . 0.0 110.467 164.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.3 m -83.78 133.6 34.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.99 1.316 . . . . 0.0 109.845 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 61.6 m -104.37 108.85 20.45 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 121.099 -1.001 . . . . 0.0 110.029 -172.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -111.05 94.71 5.13 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.5 mt -74.96 78.32 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 135.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.34 178.6 47.12 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 116.517 1.367 . . . . 0.0 116.517 -169.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -110.25 74.82 0.87 Allowed Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.919 1.288 . . . . 0.0 114.196 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -70.52 105.38 1.6 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.769 2.979 . . . . 0.0 112.27 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.85 -21.67 30.91 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -73.09 -20.23 61.0 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.862 1.665 . . . . 0.0 112.93 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.34 -21.18 22.78 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.14 2.176 . . . . 0.0 114.135 171.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.13 -38.82 54.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.14 0.976 . . . . 0.0 111.515 167.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -125.45 -17.15 5.66 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 118.119 2.637 . . . . 0.0 118.119 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.406 HD22 ' HB1' ' A' ' 113' ' ' ALA 0.26 3.9 pp -70.31 167.49 17.93 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 123.174 2.716 . . . . 0.0 112.83 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -89.5 -163.94 1.08 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.811 1.244 . . . . 0.0 113.659 -157.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.27 170.32 8.03 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 126.673 1.989 . . . . 0.0 112.787 163.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.426 HG21 HG23 ' A' ' 116' ' ' VAL . 19.2 m -73.47 151.13 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.423 -0.798 . . . . 0.0 112.721 155.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 27.2 p -152.4 -178.57 6.91 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 128.054 2.542 . . . . 0.0 108.796 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -56.84 -141.88 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.848 1 C-N-CA 133.302 4.641 . . . . 0.0 107.767 161.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -86.49 127.05 34.83 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 118.089 -1.444 . . . . 0.0 114.068 -149.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -154.08 145.33 22.93 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.759 1.224 . . . . 0.0 112.409 -172.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -105.46 131.56 52.72 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.327 1.451 . . . . 0.0 110.358 169.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.4 pp -141.83 150.32 41.48 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.119 1.368 . . . . 0.0 114.537 -167.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.1 m -96.2 174.19 7.02 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 -166.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.25 -10.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 128.772 2.829 . . . . 0.0 114.8 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -134.84 35.63 3.11 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.212 -0.93 . . . . 0.0 111.412 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -110.07 147.5 33.49 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -175.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.406 ' HB1' HD22 ' A' ' 99' ' ' LEU . . . -152.75 135.26 15.18 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.255 1.022 . . . . 0.0 108.406 -148.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.01 157.9 38.33 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.067 1.347 . . . . 0.0 112.287 -175.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.8 t -97.35 143.67 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.859 1.264 . . . . 0.0 110.491 169.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.426 HG23 HG21 ' A' ' 102' ' ' VAL . 9.9 p -124.76 106.07 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 122.991 1.377 . . . . 0.0 109.749 157.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.5 p -123.46 163.93 19.91 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.077 1.751 . . . . 0.0 108.773 165.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -59.57 -21.32 60.15 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.571 -0.705 . . . . 0.0 112.414 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.17 -32.85 65.09 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.66 1.184 . . . . 0.0 113.566 173.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -69.96 -29.36 66.46 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 120.496 -1.378 . . . . 0.0 111.636 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.3 mp -72.25 -40.8 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.096 0.958 . . . . 0.0 109.924 167.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -55.26 -27.36 45.92 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.694 0.798 . . . . 0.0 112.414 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -79.71 -20.19 47.1 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.368 -1.458 . . . . 0.0 114.918 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 88.7 mt -84.13 -41.63 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 120.001 1.273 . . . . 0.0 110.01 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -153.17 139.89 12.71 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 127.25 2.22 . . . . 0.0 109.444 165.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.12 119.75 7.22 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.409 2.073 . . . . 0.0 112.201 174.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 71.2 m -68.98 162.03 27.65 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.707 0.803 . . . . 0.0 112.421 -172.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.38 149.46 28.64 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.168 2.187 . . . . 0.0 106.509 169.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -50.62 114.51 1.16 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 169.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.91 11.11 13.01 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 117.937 -1.479 . . . . 0.0 116.357 -166.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.8 t -59.63 147.76 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 120.938 2.369 . . . . 0.0 111.045 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.25 86.49 2.37 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.566 1.546 . . . . 0.0 109.345 160.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.8 m -78.32 137.96 38.33 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 168.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -123.12 130.1 52.33 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -174.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 21.7 p -116.8 136.22 53.13 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.029 -0.419 . . . . 0.0 110.771 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.0 t -113.1 130.26 67.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 125.454 1.502 . . . . 0.0 106.972 165.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.8 m -119.98 145.2 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.633 0.73 . . . . 0.0 109.933 160.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 45.5 ttm180 -146.14 154.82 42.23 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.797 1.639 . . . . 0.0 108.092 -169.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.311 0.0 OUTLIER -144.51 148.19 34.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.108 -0.995 . . . . 0.0 110.042 164.234 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.1 t -153.97 -171.28 3.83 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.233 1.013 . . . . 0.0 112.2 -155.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.3 m120 48.73 80.53 0.06 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.07 2.548 . . . . 0.0 111.664 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 63.2 p 53.55 -1.2 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -165.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.15 34.68 8.6 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.653 1.12 . . . . 0.0 113.003 -165.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 36.5 tpp -124.36 5.15 8.4 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.109 1.764 . . . . 0.0 113.203 -175.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.2 t -143.68 155.37 44.2 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.295 1.438 . . . . 0.0 111.05 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -134.57 144.37 47.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.852 1.261 . . . . 0.0 109.085 -164.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -151.45 147.44 26.86 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.658 -1.276 . . . . 0.0 111.333 -151.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.5 tt -145.78 147.01 18.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -170.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -139.82 122.97 16.86 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.757 0.823 . . . . 0.0 109.599 163.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.99 127.23 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 122.816 1.293 . . . . 0.0 112.777 172.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.5 m -132.61 150.51 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.819 2.048 . . . . 0.0 110.394 -164.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -126.77 138.17 53.33 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -173.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -139.92 157.0 46.4 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.236 1.415 . . . . 0.0 110.196 167.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.23 -153.11 29.59 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 124.548 1.071 . . . . 0.0 113.451 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.32 -16.12 16.86 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 124.908 3.738 . . . . 0.0 115.07 177.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -71.79 -12.47 61.31 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.438 2.695 . . . . 0.0 115.965 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -81.87 41.31 0.65 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 122.861 1.315 . . . . 0.0 112.916 -174.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -64.12 -20.58 66.08 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.528 1.531 . . . . 0.0 113.78 -168.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.83 -52.58 12.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.52 1.054 . . . . 0.0 110.921 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -60.19 -41.98 94.09 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.176 0.99 . . . . 0.0 112.121 171.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -61.16 -52.96 62.66 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 122.564 0.345 . . . . 0.0 110.908 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -65.21 -34.51 78.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.452 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.72 -33.07 74.83 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 119.386 0.994 . . . . 0.0 113.135 175.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.54 -50.13 34.17 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.463 0.705 . . . . 0.0 112.36 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.7 mt -55.26 -37.86 67.81 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.643 0.656 . . . . 0.0 111.582 175.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -69.91 -29.69 66.94 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.392 1.877 . . . . 0.0 112.267 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -88.03 -52.26 5.35 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . 0.287 1.3 pp -104.87 -7.15 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 -165.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -116.82 8.5 13.64 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.88 1.218 . . . . 0.0 111.927 163.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -137.29 27.76 2.83 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.877 1.271 . . . . 0.0 113.825 172.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.261 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 168.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 t70 . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -56.43 -46.08 80.45 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -139.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -92.37 -28.05 17.15 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.152 0.981 . . . . 0.0 111.985 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.1 t -67.33 -55.04 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 124.47 1.108 . . . . 0.0 111.386 -169.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.66 -55.13 31.52 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 168.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.7 -41.65 70.53 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.735 1.268 . . . . 0.0 113.898 -174.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -73.16 -40.99 64.4 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.894 1.278 . . . . 0.0 112.425 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 mp -70.62 -37.63 73.85 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.099 -1.001 . . . . 0.0 112.523 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.62 -43.57 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.087 1.355 . . . . 0.0 109.491 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.2 p -66.19 -40.63 90.55 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.109 0.413 . . . . 0.0 111.643 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -63.6 -41.86 98.3 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 118.838 0.744 . . . . 0.0 112.263 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.3 m -60.44 -49.15 78.7 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.205 -0.935 . . . . 0.0 110.64 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.2 ptt85 -69.35 -32.9 72.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 118.241 -0.885 . . . . 0.0 113.251 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.1 ttt-85 -62.18 -48.4 80.24 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.29 1.436 . . . . 0.0 111.349 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.19 -33.03 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.978 0.911 . . . . 0.0 111.828 -174.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -90.51 -0.6 57.73 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 172.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 58.23 30.8 19.97 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.637 1.975 . . . . 0.0 114.874 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 pp -100.9 162.64 12.76 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.374 0.988 . . . . 0.0 112.311 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.75 155.37 33.25 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.12 0.968 . . . . 0.0 111.302 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.35 -21.24 66.67 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.073 -1.642 . . . . 0.0 113.542 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -96.2 10.5 37.6 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.294 1.438 . . . . 0.0 113.614 168.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -113.28 14.82 19.38 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.477 1.511 . . . . 0.0 110.215 168.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.9 tp -112.42 120.84 43.04 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 165.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -85.33 125.34 32.86 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 118.462 -1.295 . . . . 0.0 107.589 162.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.489 HD12 ' H ' ' A' ' 31' ' ' ILE 0.255 0.7 OUTLIER -117.08 144.24 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.602 1.961 . . . . 0.0 114.463 167.715 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -154.93 144.51 21.38 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.123 1.369 . . . . 0.0 109.346 -160.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -167.72 62.22 0.07 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.429 1.492 . . . . 0.0 112.298 -167.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.3 t -91.78 -58.35 2.44 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.742 -1.224 . . . . 0.0 112.888 154.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.24 -59.15 2.32 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.02 -152.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.542 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -54.42 -38.95 66.84 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.886 1.674 . . . . 0.0 112.979 177.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.544 ' HA ' ' H ' ' A' ' 44' ' ' SER . 1.4 mp -55.6 -25.98 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.156 1.382 . . . . 0.0 111.289 174.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 63.5 m -110.05 3.19 20.09 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.386 2.274 . . . . 0.0 115.38 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -94.49 20.39 8.46 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 120.378 1.444 . . . . 0.0 112.699 169.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -144.46 170.17 8.76 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 128.574 2.75 . . . . 0.0 107.412 173.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -58.74 -45.35 29.8 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.292 1.995 . . . . 0.0 114.861 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -119.44 -52.91 2.25 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 -171.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -170.31 133.47 1.09 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.201 2.2 . . . . 0.0 106.945 -166.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.544 ' H ' ' HA ' ' A' ' 37' ' ' ILE . 5.9 t -93.07 -156.69 0.49 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 117.695 -1.145 . . . . 0.0 108.146 173.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -88.84 -81.91 0.26 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 118.046 -1.462 . . . . 0.0 112.04 165.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 t 179.63 -176.41 0.3 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.235 1.016 . . . . 0.0 109.055 -170.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 17.6 t70 -136.68 115.88 12.54 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.52 132.81 48.32 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.725 1.61 . . . . 0.0 111.099 -158.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.1 ttm -128.73 123.47 33.1 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.705 -1.247 . . . . 0.0 112.785 -156.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.3 mt -120.77 141.73 50.23 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 127.129 2.172 . . . . 0.0 113.351 -144.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.6 p -96.96 160.0 14.59 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.559 1.544 . . . . 0.0 110.334 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 69.2 p -124.98 177.9 5.8 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -153.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.476 ' H ' ' HA ' ' A' ' 138' ' ' ARG . 10.7 t70 59.47 50.77 7.17 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.69 1.996 . . . . 0.0 110.394 -162.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.5 tp -142.75 145.32 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.647 1.579 . . . . 0.0 110.955 -167.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.8 p -109.18 140.56 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.964 1.306 . . . . 0.0 111.772 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -133.72 138.59 31.33 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 119.361 0.982 . . . . 0.0 111.896 170.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.99 71.4 2.15 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 125.142 3.895 . . . . 0.0 109.356 171.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 p -52.32 -38.55 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.326 1.45 . . . . 0.0 114.254 -157.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -70.19 -21.97 62.99 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.552 1.141 . . . . 0.0 112.472 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -66.29 -29.79 70.08 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.379 -0.826 . . . . 0.0 112.204 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 36.6 tp -76.52 -47.01 24.14 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.598 1.09 . . . . 0.0 110.572 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.2 mp -53.68 -49.4 68.08 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.022 0.529 . . . . 0.0 110.99 174.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.2 p -71.67 -29.37 64.52 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -65.76 -33.35 75.66 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.963 0.905 . . . . 0.0 112.086 174.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -75.7 -58.35 3.33 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 160.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.61 -34.46 77.05 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.251 -0.906 . . . . 0.0 112.365 -156.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 71.7 m -78.76 -11.51 59.99 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 ttt85 -69.49 -37.47 77.25 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.011 1.325 . . . . 0.0 114.019 -163.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.9 p -152.39 15.99 0.61 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.349 1.46 . . . . 0.0 112.46 171.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.31 81.8 0.14 Allowed Glycine 0 C--N 1.341 0.835 0 C-N-CA 125.705 1.622 . . . . 0.0 113.237 173.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -151.44 113.64 4.54 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.131 0.967 . . . . 0.0 111.809 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.0 m -66.19 133.59 50.97 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.152 1.381 . . . . 0.0 112.695 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -131.93 159.35 38.93 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.555 1.542 . . . . 0.0 114.439 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 81.8 m -96.76 108.03 20.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.069 2.547 . . . . 0.0 108.543 164.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -91.13 96.39 10.57 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.216 -0.927 . . . . 0.0 108.784 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.53 114.86 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.856 0.862 . . . . 0.0 110.852 -164.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -91.35 117.28 29.53 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 120.323 -1.486 . . . . 0.0 107.704 176.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.06 126.74 54.32 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.685 1.594 . . . . 0.0 111.094 174.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -95.4 128.61 42.4 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.527 1.131 . . . . 0.0 109.147 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.5 p -144.56 165.31 28.37 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 130.512 3.525 . . . . 0.0 105.711 -165.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.35 -121.54 0.0 OUTLIER Glycine 0 N--CA 1.491 2.314 0 C-N-CA 129.868 3.604 . . . . 0.0 115.935 -174.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.9 p -93.51 104.81 16.91 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 114.649 -2.82 . . . . 0.0 109.854 150.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.8 mtt85 -178.54 145.39 0.32 Allowed 'General case' 0 CA--C 1.555 1.138 1 C-N-CA 134.376 5.07 . . . . 0.0 106.753 131.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.14 135.52 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 121.839 2.109 . . . . 0.0 109.731 149.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.5 t -107.05 147.12 30.35 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.427 -1.421 . . . . 0.0 110.77 170.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 18.2 tp -110.98 106.32 15.37 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 159.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.5 m -78.64 111.33 14.61 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.126 164.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.7 t -103.88 110.75 23.0 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 119.613 -1.929 . . . . 0.0 110.733 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -111.13 113.35 25.8 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -173.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.9 mp -77.33 88.73 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 133.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.3 172.38 42.64 Favored Glycine 0 N--CA 1.475 1.299 0 N-CA-C 121.219 3.248 . . . . 0.0 121.219 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -110.91 49.61 0.27 Allowed Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 127.181 2.193 . . . . 0.0 116.457 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -63.25 166.94 13.65 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 CA-C-N 122.607 1.967 . . . . 0.0 115.514 173.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -77.52 -28.43 52.02 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -84.02 -16.73 42.85 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -172.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -50.74 -28.07 8.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 128.02 2.528 . . . . 0.0 112.908 172.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -61.88 -39.62 92.59 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.788 -0.625 . . . . 0.0 112.302 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -112.19 -17.3 12.82 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -173.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 pp -80.62 157.97 25.82 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 120.675 1.58 . . . . 0.0 111.894 168.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -168.45 138.17 2.42 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -172.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.669 ' CD ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -112.18 -179.14 3.6 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.851 1.66 . . . . 0.0 112.502 177.042 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.669 ' H ' ' CD ' ' A' ' 101' ' ' ARG . 3.1 p -162.6 173.91 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 125.764 1.626 . . . . 0.0 112.732 -142.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.483 ' HA ' HG13 ' A' ' 150' ' ' VAL . 46.3 t -121.56 122.21 39.18 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.716 0.806 . . . . 0.0 108.949 144.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -175.14 170.2 3.19 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.646 1.578 . . . . 0.0 108.823 -172.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -109.78 104.11 13.02 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.597 2.359 . . . . 0.0 110.436 165.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -129.93 165.93 21.08 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -171.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -137.22 137.01 38.64 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.632 1.173 . . . . 0.0 113.31 167.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.6 tt -149.82 144.04 25.74 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.277 1.031 . . . . 0.0 112.192 -135.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 m -71.5 156.0 39.94 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -6.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 129.364 3.065 . . . . 0.0 114.066 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -138.1 60.1 1.63 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.624 2.37 . . . . 0.0 108.587 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -142.36 150.42 40.71 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 121.014 -1.054 . . . . 0.0 113.091 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.722 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -150.9 155.27 38.81 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.08 -1.637 . . . . 0.0 112.976 -155.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.722 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -150.68 145.76 26.04 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.166 1.386 . . . . 0.0 111.038 -165.658 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.99 134.9 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 120.987 1.722 . . . . 0.0 112.885 162.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.83 157.68 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.47 1.108 . . . . 0.0 109.811 171.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.9 t -157.82 161.97 38.4 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.608 1.963 . . . . 0.0 108.288 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.43 -25.38 24.58 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.37 -37.33 28.41 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 120.302 1.41 . . . . 0.0 113.552 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.41 -31.62 63.97 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.67 -1.269 . . . . 0.0 111.319 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.1 tp -70.97 -32.92 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 121.645 -0.66 . . . . 0.0 111.764 167.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -65.51 -12.99 57.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.274 1.03 . . . . 0.0 112.882 171.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.33 -30.38 68.41 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.421 -1.425 . . . . 0.0 113.656 163.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 14.3 mt -87.2 -40.73 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.711 1.204 . . . . 0.0 111.223 -169.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -155.49 155.44 29.75 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 128.382 2.673 . . . . 0.0 107.597 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -53.8 130.22 38.0 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 121.915 1.744 . . . . 0.0 112.32 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 25.7 t -99.54 153.16 19.26 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.9 1.68 . . . . 0.0 111.046 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -156.8 162.71 39.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.502 1.521 . . . . 0.0 109.476 -170.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -58.44 126.9 29.51 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 127.055 2.142 . . . . 0.0 109.999 170.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.77 15.22 65.98 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-O 118.419 -1.212 . . . . 0.0 115.032 -173.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.77 138.94 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.253 1.526 . . . . 0.0 110.34 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 tp -132.7 82.48 2.01 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 123.781 1.753 . . . . 0.0 109.458 173.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 16.8 m -77.31 142.44 39.41 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 155.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -131.63 133.44 44.95 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 121.408 -0.808 . . . . 0.0 109.506 -167.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 46.1 t -127.04 130.54 50.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.215 0.461 . . . . 0.0 110.602 -166.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.78 113.4 40.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.584 1.554 . . . . 0.0 107.735 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.1 m -111.12 135.59 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 122.189 0.995 . . . . 0.0 111.152 173.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.476 ' HA ' ' H ' ' A' ' 53' ' ' ASP . 54.6 ttt85 -131.12 160.45 34.68 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.23 2.612 . . . . 0.0 106.901 170.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.274 0.0 OUTLIER -143.6 147.67 34.73 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.364 -0.835 . . . . 0.0 109.29 167.725 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.5 m -97.99 137.34 36.94 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.62 0.645 . . . . 0.0 109.548 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -61.09 168.54 2.44 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -169.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.7 m 53.08 28.26 6.64 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.613 1.165 . . . . 0.0 114.062 -170.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 69.48 25.37 75.56 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.416 1.008 . . . . 0.0 114.706 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 86.1 mtp -83.2 -22.1 33.27 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -166.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 t -165.99 156.32 12.74 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 174.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -104.66 137.27 42.74 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.075 0.95 . . . . 0.0 111.14 149.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -126.07 108.29 11.22 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -175.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.3 tp -140.64 103.14 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 122.659 1.219 . . . . 0.0 108.895 -142.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -136.48 141.54 43.51 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.67 -158.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.483 HG13 ' HA ' ' A' ' 103' ' ' CYS . 2.5 p -154.15 146.02 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.717 0.807 . . . . 0.0 111.083 177.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.2 m -132.14 134.39 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 127.189 2.196 . . . . 0.0 110.464 -174.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.85 116.18 31.56 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -168.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -137.61 158.15 44.99 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.876 0.845 . . . . 0.0 112.201 172.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -86.32 -160.6 34.43 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 125.568 1.556 . . . . 0.0 113.31 172.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.23 -16.27 27.27 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.67 2.913 . . . . 0.0 115.787 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -90.19 16.97 7.6 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.905 1.682 . . . . 0.0 114.273 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -70.43 56.24 0.16 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.565 1.546 . . . . 0.0 111.309 165.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.81 -26.15 65.54 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.304 1.042 . . . . 0.0 112.347 -173.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.51 -53.69 13.04 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -76.64 -26.34 54.77 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.662 0.665 . . . . 0.0 112.518 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -63.24 -56.25 18.16 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.268 0.94 . . . . 0.0 109.871 172.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -55.83 -33.48 64.51 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.115 -0.991 . . . . 0.0 112.949 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.86 -34.11 76.04 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.78 -48.13 64.46 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 120.687 -1.258 . . . . 0.0 112.537 171.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -59.49 -25.96 64.87 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 121.423 1.919 . . . . 0.0 114.484 172.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.0 ttp85 -68.49 -39.62 81.26 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.715 1.206 . . . . 0.0 111.975 169.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -72.21 -29.98 64.48 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.402 1.081 . . . . 0.0 113.486 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.69 -47.34 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.156 1.382 . . . . 0.0 109.589 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -62.6 -3.46 1.49 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 166.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -124.72 26.91 7.01 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 . . . . . 0 C--O 1.254 1.317 0 O-C-N 121.112 -0.993 . . . . 0.0 111.561 168.229 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.3 t70 . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 120.546 0.212 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -52.95 -28.27 22.85 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -78.71 -25.53 44.67 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.497 -0.752 . . . . 0.0 111.564 -174.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.4 t -70.5 -46.25 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.613 1.165 . . . . 0.0 110.243 173.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.32 -52.58 52.37 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 169.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.6 -28.71 70.08 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.37 -1.076 . . . . 0.0 113.428 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -75.08 -43.71 51.61 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.232 1.378 . . . . 0.0 114.097 169.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.95 -40.14 83.28 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.321 0.964 . . . . 0.0 111.378 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -66.63 -41.9 88.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 O-C-N 121.256 -0.902 . . . . 0.0 110.238 172.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.3 t -57.7 -47.43 82.4 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.248 0.931 . . . . 0.0 112.506 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -72.38 -29.06 63.42 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.602 -0.686 . . . . 0.0 111.666 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.9 m -63.42 -47.66 81.02 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.701 1.137 . . . . 0.0 110.456 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -51.55 -50.54 59.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.61 1.164 . . . . 0.0 111.283 171.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -77.05 -38.71 52.14 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -168.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -78.97 -42.87 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.191 0.905 . . . . 0.0 110.755 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.04 -8.2 59.72 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 118.815 0.734 . . . . 0.0 112.695 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.4 mmt85 56.57 41.21 28.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.432 1.893 . . . . 0.0 113.034 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 pp -114.59 150.44 35.03 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.454 1.502 . . . . 0.0 110.255 168.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -66.85 153.3 43.78 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.807 -0.558 . . . . 0.0 111.151 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.53 -19.04 63.71 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.518 -1.364 . . . . 0.0 113.2 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -92.17 7.43 42.59 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.305 1.442 . . . . 0.0 113.258 166.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -119.33 10.55 11.98 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.948 1.699 . . . . 0.0 111.7 168.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.8 tp -99.63 130.58 45.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.225 2.21 . . . . 0.0 105.311 161.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -95.48 112.59 24.28 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.168 170.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.409 HD12 ' H ' ' A' ' 31' ' ' ILE . 0.9 OUTLIER -108.16 143.74 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 126.073 1.749 . . . . 0.0 112.411 173.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 m -155.55 131.0 9.65 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -139.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -171.27 57.73 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.774 0.797 . . . . 0.0 111.695 -161.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.5 p -87.55 -54.97 4.0 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.937 -1.102 . . . . 0.0 110.249 153.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.17 -45.37 16.47 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -158.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.485 ' CD1' ' H ' ' A' ' 36' ' ' LEU . 3.0 mp -60.02 -41.64 92.63 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.379 1.072 . . . . 0.0 109.557 176.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mp -75.92 -20.99 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 127.626 2.37 . . . . 0.0 111.107 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 15.4 t -74.09 -39.44 63.41 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.561 -1.337 . . . . 0.0 111.82 172.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.9 mmpt? -72.0 -46.27 57.85 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.96 0.8 . . . . 0.0 110.663 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -148.77 95.53 3.93 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 124.709 1.203 . . . . 0.0 109.59 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -66.33 -56.85 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 121.885 1.724 . . . . 0.0 112.596 -173.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -92.77 29.24 1.83 Allowed 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.516 1.126 . . . . 0.0 110.548 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -160.42 99.53 1.31 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 155.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.5 p -178.66 -178.55 0.58 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.778 1.631 . . . . 0.0 110.0 -173.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.5 tp -127.35 -87.03 0.58 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 168.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 p -178.67 176.04 1.02 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.815 1.293 . . . . 0.0 112.451 -159.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -148.91 120.16 7.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.334 1.454 . . . . 0.0 107.989 -177.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.5 144.05 45.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.199 2.2 . . . . 0.0 110.05 -157.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.5 mtt -132.83 131.68 41.3 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.369 1.44 . . . . 0.0 112.532 -162.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.3 mt -128.96 145.42 51.24 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 127.706 3.128 . . . . 0.0 112.15 -144.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.2 p -123.09 163.24 20.9 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 128.062 2.545 . . . . 0.0 111.558 -170.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.6 p -51.98 127.99 22.95 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.59 1.556 . . . . 0.0 113.489 -164.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.37 151.88 32.58 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 118.081 2.623 . . . . 0.0 118.081 -135.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.83 118.37 54.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 165.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.419 HG12 HG22 ' A' ' 136' ' ' VAL . 3.1 m -79.04 130.49 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.858 -154.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -136.29 148.81 65.79 Favored Pre-proline 0 C--O 1.236 0.367 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -166.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.55 76.67 2.3 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.061 3.174 . . . . 0.0 110.807 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.36 -45.44 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 126.526 1.93 . . . . 0.0 113.261 -167.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -78.26 -13.29 59.91 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -70.91 -35.98 72.52 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.409 -1.432 . . . . 0.0 110.146 162.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.0 tp -61.7 -43.95 97.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.745 0.818 . . . . 0.0 111.099 170.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp -56.29 -43.2 78.63 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.326 0.966 . . . . 0.0 112.6 170.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.1 t -61.83 -45.38 94.05 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.401 0.546 . . . . 0.0 111.575 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -66.5 -38.75 87.94 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.19 0.596 . . . . 0.0 112.511 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -57.49 12.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.406 1.483 . . . . 0.0 110.733 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.9 -35.81 81.3 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.198 0.599 . . . . 0.0 111.687 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.2 t -76.1 -23.45 54.93 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.54 -28.64 60.56 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 120.847 1.658 . . . . 0.0 115.163 -165.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.8 p -139.01 14.48 2.65 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.838 1.255 . . . . 0.0 113.415 157.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.47 79.73 0.2 Allowed Glycine 0 N--CA 1.472 1.051 0 C-N-CA 126.454 1.978 . . . . 0.0 113.305 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 74.5 mtt85 -157.58 115.91 3.16 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.033 1.733 . . . . 0.0 110.877 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.67 145.16 29.78 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -152.39 159.15 43.45 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.786 1.634 . . . . 0.0 113.373 -165.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.6 m -76.39 113.81 14.39 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.756 1.222 . . . . 0.0 109.725 162.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -96.2 98.38 10.27 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 122.559 1.171 . . . . 0.0 108.352 173.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.6 t -101.45 150.63 5.86 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 C-N-CA 127.206 2.202 . . . . 0.0 109.419 -164.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -121.76 129.71 52.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.073 -1.017 . . . . 0.0 108.837 164.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -123.04 116.32 23.31 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.805 1.642 . . . . 0.0 110.086 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -95.09 115.94 28.07 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.398 1.479 . . . . 0.0 109.13 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.6 t -147.79 159.7 43.54 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 -170.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -6.75 -126.2 0.0 OUTLIER Glycine 0 N--CA 1.48 1.574 0 O-C-N 119.021 -2.3 . . . . 0.0 112.959 -133.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.465 ' HB3' ' HE3' ' A' ' 139' ' ' LYS . 57.3 m -94.45 111.32 23.06 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 113.642 -3.223 . . . . 0.0 110.17 149.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -169.58 146.22 3.3 Favored 'General case' 0 N--CA 1.475 0.824 1 C-N-CA 132.111 4.164 . . . . 0.0 107.581 133.228 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.9 t -72.23 139.5 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.068 -1.645 . . . . 0.0 110.294 165.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.58 148.5 29.2 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.616 0.766 . . . . 0.0 111.636 165.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.3 tp -108.84 110.37 21.7 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 157.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.4 m -97.83 114.26 26.27 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.868 1.667 . . . . 0.0 108.723 -174.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 99.0 m -103.93 108.36 19.66 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.063 -1.648 . . . . 0.0 109.449 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -103.49 94.2 5.35 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.643 0.735 . . . . 0.0 111.74 -172.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.2 mp -72.99 94.67 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 126.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.36 149.73 10.02 Favored Glycine 0 N--CA 1.468 0.79 0 N-CA-C 119.113 2.405 . . . . 0.0 119.113 -169.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -114.46 58.05 0.93 Allowed Pre-proline 0 CA--C 1.556 1.178 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 170.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -67.77 174.09 8.14 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.993 2.462 . . . . 0.0 114.281 166.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -82.66 -39.08 22.56 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -75.31 -13.05 60.39 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -158.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.416 HD22 ' H ' ' A' ' 96' ' ' LEU . 3.3 mm? -51.57 -30.56 21.33 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 128.046 2.539 . . . . 0.0 112.994 170.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -52.95 -42.07 65.12 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.705 0.802 . . . . 0.0 111.206 170.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -100.77 -34.39 9.86 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -171.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.2 pp -85.61 155.99 20.91 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -167.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -151.47 122.74 7.76 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -159.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.469 ' HB3' HG23 ' A' ' 116' ' ' VAL . 0.8 OUTLIER -106.38 179.5 4.25 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 126.992 2.117 . . . . 0.0 110.104 171.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 p -165.07 173.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -149.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.465 ' HA ' HG13 ' A' ' 150' ' ' VAL . 97.7 m -128.32 120.63 27.44 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.723 1.147 . . . . 0.0 111.258 137.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -176.49 179.52 1.16 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 129.507 3.123 . . . . 0.0 105.237 -172.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -111.42 127.58 55.72 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.456 1.502 . . . . 0.0 110.875 162.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -148.45 159.36 44.12 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.455 1.102 . . . . 0.0 113.658 -161.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -109.13 151.47 26.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.447 2.299 . . . . 0.0 111.162 174.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 mt -142.48 146.8 35.13 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.836 1.255 . . . . 0.0 111.925 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.9 m -106.69 178.49 4.55 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.747 1.219 . . . . 0.0 114.001 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.82 -5.13 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 128.809 2.844 . . . . 0.0 116.113 -161.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -138.3 47.9 1.97 Allowed 'General case' 0 CA--C 1.551 1.015 0 O-C-N 120.608 -1.308 . . . . 0.0 112.794 168.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -111.18 146.76 36.32 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.911 1.284 . . . . 0.0 112.064 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.689 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -150.02 147.06 27.38 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 119.687 -1.883 . . . . 0.0 111.296 -154.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.689 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -142.17 147.5 36.72 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.999 1.32 . . . . 0.0 112.73 -169.252 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.47 141.75 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-N 121.396 1.907 . . . . 0.0 114.065 162.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 101' ' ' ARG . 1.0 OUTLIER -133.91 148.86 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.179 1.392 . . . . 0.0 109.831 173.82 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.9 t -140.42 159.83 41.33 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.738 2.015 . . . . 0.0 106.542 161.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -49.74 -30.66 9.82 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -171.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.36 -33.35 75.04 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 121.145 1.793 . . . . 0.0 113.734 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.49 -26.36 63.58 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.225 -0.922 . . . . 0.0 112.027 172.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 37.0 mm -77.95 -30.18 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.755 0.822 . . . . 0.0 111.48 167.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.96 -13.98 62.6 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.252 -0.905 . . . . 0.0 113.196 170.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -70.0 -36.25 74.99 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 120.107 -1.621 . . . . 0.0 113.3 158.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.83 -37.67 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.852 1.261 . . . . 0.0 110.593 -176.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.5 135.37 15.82 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 125.112 1.365 . . . . 0.0 111.323 169.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.54 -24.73 63.02 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.893 3.062 . . . . 0.0 116.39 -157.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.7 t -147.65 130.1 15.79 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.393 1.077 . . . . 0.0 110.436 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -168.5 158.5 9.58 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.951 2.1 . . . . 0.0 108.206 169.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -136.07 -31.95 0.89 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.903 1.681 . . . . 0.0 113.64 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -101.76 21.73 41.16 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.949 1.738 . . . . 0.0 114.982 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.87 146.25 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.017 1.408 . . . . 0.0 113.527 -159.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.7 mp -113.63 81.58 1.54 Allowed 'General case' 0 C--O 1.24 0.554 0 CA-C-O 123.431 1.586 . . . . 0.0 108.531 169.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.0 m -75.44 146.27 40.83 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 162.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -124.07 132.56 53.68 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 44.5 t -124.34 133.64 53.39 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.005 0.82 . . . . 0.0 111.168 -169.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.419 HG22 HG12 ' A' ' 55' ' ' VAL . 10.1 t -144.79 108.89 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.398 0.679 . . . . 0.0 111.027 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.1 m -99.59 141.4 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.996 1.319 . . . . 0.0 113.33 173.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -122.98 162.0 23.16 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.63 1.172 . . . . 0.0 109.456 155.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.465 ' HE3' ' HB3' ' A' ' 82' ' ' CYS 0.273 0.1 OUTLIER -147.61 154.49 40.73 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.006 1.722 . . . . 0.0 108.019 169.589 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.8 t -132.88 121.03 22.29 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -73.14 -43.52 61.45 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 118.068 0.394 . . . . 0.0 110.337 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.9 m -45.76 -46.19 15.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.782 1.633 . . . . 0.0 112.762 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -91.18 5.44 81.32 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.449 1.499 . . . . 0.0 115.692 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 43.9 tpp 41.89 50.11 4.09 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.201 1.8 . . . . 0.0 113.63 -173.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.3 t -138.69 140.18 38.69 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.309 -0.869 . . . . 0.0 111.652 -162.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -109.08 139.49 43.89 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.265 1.026 . . . . 0.0 109.603 162.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -143.15 106.44 4.57 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.9 pt -136.32 152.22 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.577 0.751 . . . . 0.0 112.936 -160.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -136.77 149.15 47.64 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.311 0.577 . . . . 0.0 112.245 165.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 103' ' ' CYS . 7.2 p -141.18 132.9 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.137 0.975 . . . . 0.0 109.169 169.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.9 m -138.17 122.98 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.33 1.052 . . . . 0.0 111.668 -156.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -103.95 122.78 45.91 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -164.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -141.24 148.19 39.48 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.256 1.423 . . . . 0.0 110.186 165.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -74.61 -162.43 9.17 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.322 1.439 . . . . 0.0 115.164 169.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -56.15 -13.49 9.64 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 124.401 3.401 . . . . 0.0 117.04 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -63.33 -4.87 2.89 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.746 1.618 . . . . 0.0 113.882 166.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -73.55 43.59 0.15 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 126.075 1.75 . . . . 0.0 112.86 172.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -50.32 -30.44 12.07 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.617 2.767 . . . . 0.0 113.673 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.75 -42.89 57.38 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.377 1.471 . . . . 0.0 114.415 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -71.21 -32.44 68.81 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.404 -1.435 . . . . 0.0 111.629 170.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -58.16 -54.0 51.96 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.478 1.035 . . . . 0.0 111.364 169.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -54.63 -49.31 70.82 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.493 0.588 . . . . 0.0 111.527 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -57.24 -44.45 83.82 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.032 0.833 . . . . 0.0 112.837 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.01 -60.95 2.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.1 mp -53.15 -35.86 60.2 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.269 1.427 . . . . 0.0 112.924 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -68.07 -35.74 78.7 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.148 1.379 . . . . 0.0 111.852 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.65 -26.1 24.52 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.8 pt -104.74 -44.85 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -171.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -90.2 -32.62 16.52 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.247 1.385 . . . . 0.0 109.93 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -97.45 24.11 6.93 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.084 0.954 . . . . 0.0 112.982 171.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.492 -1.242 . . . . 0.0 112.637 163.009 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 CA--C 1.543 0.692 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -65.09 -4.23 4.59 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -155.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -93.7 -22.33 18.8 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.482 1.113 . . . . 0.0 113.511 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.73 -42.82 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.664 1.186 . . . . 0.0 113.539 -168.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.88 -47.33 89.75 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 168.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.77 -37.29 70.89 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.966 1.383 . . . . 0.0 112.493 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.43 -35.19 63.38 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.591 1.556 . . . . 0.0 114.129 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.4 tp -75.39 -37.07 60.75 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.136 1.374 . . . . 0.0 112.22 176.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -67.76 -44.32 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.604 1.562 . . . . 0.0 109.368 170.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.5 t -53.87 -44.85 70.74 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.234 1.014 . . . . 0.0 111.742 168.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -60.41 -37.05 79.6 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.495 -0.753 . . . . 0.0 111.451 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.5 m -67.01 -49.04 66.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.834 0.854 . . . . 0.0 111.501 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -64.79 -38.75 92.04 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 119.926 1.239 . . . . 0.0 112.77 173.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -78.79 -35.59 44.09 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -172.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.91 -23.7 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.965 1.257 . . . . 0.0 111.509 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.0 mp -86.75 -11.96 49.54 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 167.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 53.55 43.29 31.43 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.835 1.654 . . . . 0.0 112.08 -177.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 pp -107.18 162.63 13.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.545 0.738 . . . . 0.0 110.555 171.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.36 148.81 43.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.758 0.423 . . . . 0.0 111.777 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -25.41 67.94 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.447 -1.408 . . . . 0.0 112.881 173.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -79.11 2.38 20.97 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.945 1.698 . . . . 0.0 113.696 168.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -130.18 -5.93 4.36 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.522 1.529 . . . . 0.0 110.772 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.499 HD11 ' HB1' ' A' ' 48' ' ' ALA . 26.0 tp -87.78 138.49 31.42 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.306 1.842 . . . . 0.0 106.774 154.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.73 138.9 51.72 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 164.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.0 mm -98.79 141.11 16.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 O-C-N 125.8 1.938 . . . . 0.0 111.796 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.61 149.22 37.01 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.691 0.397 . . . . 0.0 110.808 174.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -158.26 56.29 0.46 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 166.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.7 p -87.43 -56.78 3.21 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.024 -1.672 . . . . 0.0 112.294 162.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.64 -55.99 3.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.808 0.813 . . . . 0.0 113.041 -158.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -64.39 -42.11 96.31 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.951 1.701 . . . . 0.0 112.482 -175.114 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.87 -27.17 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.393 1.077 . . . . 0.0 110.278 174.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.8 m -92.81 4.14 54.38 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.246 1.418 . . . . 0.0 114.272 174.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.24 -41.75 9.3 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.23 1.377 . . . . 0.0 110.737 172.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -100.38 77.64 0.17 Allowed Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 162.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -72.63 -0.09 8.34 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 N-CA-C 118.833 2.59 . . . . 0.0 118.833 -121.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -119.82 3.97 11.04 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 126.072 1.749 . . . . 0.0 113.234 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -133.02 170.6 15.14 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.735 1.607 . . . . 0.0 113.636 -148.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.5 m -67.58 158.71 31.41 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.162 1.385 . . . . 0.0 113.991 -169.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.78 -77.88 0.57 Allowed 'General case' 0 CA--C 1.541 0.629 0 O-C-N 117.738 -3.101 . . . . 0.0 115.722 14.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.48 -171.84 0.85 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.944 1.247 . . . . 0.0 112.736 -172.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -132.29 149.96 52.26 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.499 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -130.81 141.73 50.36 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 129.784 3.234 . . . . 0.0 108.326 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.3 ttp -124.89 128.25 48.35 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.888 -1.132 . . . . 0.0 108.331 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.5 mt -133.79 147.63 51.28 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.468 1.907 . . . . 0.0 114.73 -147.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.5 t -124.22 169.13 12.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.833 2.853 . . . . 0.0 112.999 -169.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.9 p -96.77 176.25 6.06 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.323 2.649 . . . . 0.0 115.419 -159.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 66.66 21.98 10.52 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 116.995 2.22 . . . . 0.0 116.995 166.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.52 161.38 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.86 1.264 . . . . 0.0 111.077 165.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.461 HG12 HG22 ' A' ' 136' ' ' VAL . 1.5 m -101.3 139.73 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.996 1.318 . . . . 0.0 109.235 171.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -133.28 125.25 18.72 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 118.995 0.816 . . . . 0.0 110.022 171.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -63.4 65.53 0.18 Allowed 'Trans proline' 0 C--N 1.357 1.005 1 C-N-CA 125.508 4.138 . . . . 0.0 113.129 170.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.12 -38.67 39.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 127.78 2.432 . . . . 0.0 114.292 -156.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -75.0 -10.47 59.5 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.33 -0.856 . . . . 0.0 113.032 -177.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -59.38 -31.49 69.27 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.616 -1.303 . . . . 0.0 112.058 161.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.8 tp -72.38 -42.98 64.61 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.268 0.94 . . . . 0.0 111.246 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mp -57.83 -43.73 86.01 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 122.128 -0.358 . . . . 0.0 111.062 169.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.9 m -62.63 -38.76 91.51 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.948 0.899 . . . . 0.0 111.52 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -65.73 -36.13 82.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 118.618 -0.706 . . . . 0.0 112.041 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -69.39 -53.66 18.3 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 168.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -63.04 -36.5 83.79 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.315 -0.865 . . . . 0.0 111.865 -172.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 73.6 m -73.57 -9.94 59.2 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.0 tpt85 -75.5 -32.56 60.58 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.395 0.998 . . . . 0.0 112.426 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.9 p -148.61 -36.91 0.18 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.401 1.08 . . . . 0.0 112.749 173.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.35 81.94 1.63 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 126.755 2.121 . . . . 0.0 110.816 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 72.6 mtt85 -148.44 114.15 5.69 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.321 1.848 . . . . 0.0 110.071 170.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.9 m -65.29 140.37 58.69 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.589 1.156 . . . . 0.0 113.099 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.8 147.86 33.39 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -170.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 64.4 m -76.39 108.79 9.59 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.896 2.878 . . . . 0.0 111.694 165.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -91.62 99.63 12.51 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.555 -1.341 . . . . 0.0 108.323 167.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.7 t -99.7 115.79 41.45 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 C-N-CA 125.906 1.682 . . . . 0.0 109.348 -168.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -96.8 124.97 40.93 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 120.351 -1.468 . . . . 0.0 108.365 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -118.06 122.57 43.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.858 1.263 . . . . 0.0 111.832 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -95.89 114.85 26.61 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.546 1.538 . . . . 0.0 109.692 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 p -144.17 160.16 41.42 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 -173.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -7.92 -130.56 0.0 OUTLIER Glycine 0 N--CA 1.483 1.801 0 O-C-N 118.642 -2.537 . . . . 0.0 113.492 -137.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.2 p -96.41 101.86 13.56 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 121.798 2.799 . . . . 0.0 110.124 158.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 mtt85 -173.84 141.63 0.83 Allowed 'General case' 0 N--CA 1.471 0.607 1 C-N-CA 132.982 4.513 . . . . 0.0 107.92 144.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.6 t -68.35 137.43 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 120.244 1.384 . . . . 0.0 110.405 165.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.9 m -104.49 145.7 29.91 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.101 -0.999 . . . . 0.0 110.374 158.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.8 tp -109.62 109.7 20.53 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 160.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.2 m -88.84 96.64 10.78 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.398 1.079 . . . . 0.0 109.19 170.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 7.9 p -101.9 111.16 23.33 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 119.396 -2.065 . . . . 0.0 109.927 -172.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -146.64 150.5 35.57 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 116.828 2.159 . . . . 0.0 116.828 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.17 109.04 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 168.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.41 139.9 14.74 Favored Glycine 0 CA--C 1.536 1.357 0 N-CA-C 117.864 1.906 . . . . 0.0 117.864 -138.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.3 62.93 46.93 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 152.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.49 106.35 1.6 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.688 2.926 . . . . 0.0 114.604 -170.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.49 -30.74 61.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.687 1.195 . . . . 0.0 113.85 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.3 tpt85 -92.68 3.13 56.17 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.2 tp -70.89 1.0 6.09 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.728 -1.232 . . . . 0.0 114.287 166.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -51.81 -37.8 53.17 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.656 -0.652 . . . . 0.0 111.099 150.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -123.78 -35.3 2.9 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 -169.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 pp -82.81 167.4 18.14 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 121.999 2.181 . . . . 0.0 114.862 -167.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -168.2 126.22 1.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 -165.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.458 ' NE ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -105.21 178.22 4.62 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.547 1.539 . . . . 0.0 110.261 170.147 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.458 ' H ' ' NE ' ' A' ' 101' ' ' ARG . 1.1 p -162.38 169.81 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -147.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.448 ' HA ' HG13 ' A' ' 150' ' ' VAL . 99.4 m -123.82 122.42 37.96 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.029 -1.044 . . . . 0.0 111.125 136.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -176.15 175.17 1.93 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 129.083 2.953 . . . . 0.0 106.838 -174.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -122.36 121.72 37.35 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.296 2.239 . . . . 0.0 111.476 164.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -159.09 171.43 19.98 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -100.14 137.53 38.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.485 2.314 . . . . 0.0 110.376 175.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.8 tp -146.2 142.97 28.93 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.139 1.376 . . . . 0.0 111.039 -158.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 p -92.38 177.16 6.22 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 118.161 2.652 . . . . 0.0 118.161 -172.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.6 t -76.54 -6.87 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 129.486 3.114 . . . . 0.0 114.551 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -122.43 32.65 5.7 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.233 1.413 . . . . 0.0 111.746 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -136.01 159.9 40.27 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.25 -1.531 . . . . 0.0 113.079 -162.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.666 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -155.17 148.71 25.21 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.667 -1.271 . . . . 0.0 110.356 -151.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.666 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -143.4 148.0 35.5 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.767 1.227 . . . . 0.0 110.971 -169.868 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.46 138.42 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 120.639 1.563 . . . . 0.0 113.229 160.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.92 156.37 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.659 1.184 . . . . 0.0 109.5 169.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.6 t -145.01 167.25 23.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.654 1.582 . . . . 0.0 108.27 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.53 -33.53 71.51 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.14 0.882 . . . . 0.0 113.324 -172.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.05 -30.74 70.89 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 172.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -73.19 -35.48 66.39 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.298 -0.876 . . . . 0.0 111.045 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.1 mm -77.53 -33.43 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.359 1.064 . . . . 0.0 111.647 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -57.98 -34.5 70.03 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.059 -1.025 . . . . 0.0 111.015 168.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -70.97 -25.47 62.73 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.618 171.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 54.0 mt -72.61 -44.85 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.394 1.452 . . . . 0.0 110.157 171.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.6 tptp 168.39 -49.62 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 128.291 2.636 . . . . 0.0 110.15 168.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -62.96 112.64 1.72 Allowed 'Trans proline' 0 C--N 1.357 0.985 0 CA-C-N 121.653 1.626 . . . . 0.0 114.604 -167.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 87.8 m -66.36 154.44 40.04 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.328 1.851 . . . . 0.0 112.933 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -80.36 -5.96 57.24 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 117.311 2.337 . . . . 0.0 117.311 -149.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -93.72 9.28 37.66 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.48 1.912 . . . . 0.0 115.413 -176.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -166.49 14.31 0.08 OUTLIER Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.506 1.363 . . . . 0.0 116.506 -166.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 63.9 t -70.1 122.73 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 118.724 1.262 . . . . 0.0 111.683 -171.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.9 mp -127.76 80.05 1.93 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 123.777 1.751 . . . . 0.0 108.344 153.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.6 m -85.09 129.91 34.71 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 160.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -125.86 132.64 52.16 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.146 0.979 . . . . 0.0 110.796 -158.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 49.3 t -124.4 141.45 52.07 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.546 1.138 . . . . 0.0 111.334 -167.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 55' ' ' VAL . 10.9 t -137.21 125.33 32.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.547 1.539 . . . . 0.0 108.87 -173.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.23 143.87 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 28.4 mtt-85 -133.12 159.14 41.0 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 128.087 2.555 . . . . 0.0 107.987 164.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.301 0.0 OUTLIER -145.67 100.89 3.49 Favored 'General case' 0 CA--C 1.558 1.258 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 173.085 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.1 t -58.44 125.18 22.22 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.044 -1.66 . . . . 0.0 112.642 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -81.34 -53.85 5.98 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.904 0.882 . . . . 0.0 112.141 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.0 m -57.12 -22.41 39.63 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -119.2 22.39 9.0 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 117.333 -1.815 . . . . 0.0 114.216 174.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 91.7 mmm 22.77 71.49 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 128.454 2.702 . . . . 0.0 114.876 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.7 p -164.35 170.43 16.13 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.373 -0.829 . . . . 0.0 112.312 -169.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -113.24 149.39 33.85 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.783 1.633 . . . . 0.0 112.055 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -123.85 115.76 21.84 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 166.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.8 tt -122.05 142.5 38.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.703 -170.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -140.03 145.96 38.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.198 0.523 . . . . 0.0 110.628 159.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.448 HG13 ' HA ' ' A' ' 103' ' ' CYS . 4.4 p -145.27 136.68 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 122.394 1.092 . . . . 0.0 111.179 167.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.4 m -130.54 129.67 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 126.38 1.872 . . . . 0.0 110.065 -163.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -100.12 120.68 40.23 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -164.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -140.3 153.21 46.38 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.953 0.883 . . . . 0.0 112.742 171.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -87.28 -143.78 8.39 Favored Glycine 0 CA--C 1.543 1.784 0 C-N-CA 125.267 1.413 . . . . 0.0 111.718 162.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.58 -13.88 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.712 3.608 . . . . 0.0 116.048 174.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -58.81 -14.58 9.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.487 1.915 . . . . 0.0 113.977 171.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -95.67 18.6 12.63 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -54.72 -30.3 55.68 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.22 -36.04 82.01 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.626 -1.296 . . . . 0.0 113.277 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -73.06 -37.6 66.76 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.593 -1.317 . . . . 0.0 111.113 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -56.17 -47.23 78.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.413 0.685 . . . . 0.0 111.048 171.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -60.48 -37.25 80.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.55 1.14 . . . . 0.0 112.461 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.92 -38.2 79.41 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.312 0.96 . . . . 0.0 113.518 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.04 -57.31 12.12 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.979 0.911 . . . . 0.0 113.017 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.7 mp -43.99 -39.88 4.36 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.847 1.659 . . . . 0.0 112.517 166.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 53.3 tpt85 -73.02 -21.5 60.81 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -92.46 -37.38 12.57 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.824 1.193 . . . . 0.0 113.103 171.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.4 pt -81.86 -34.61 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.028 0.931 . . . . 0.0 113.185 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -74.55 6.44 3.8 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.456 -0.778 . . . . 0.0 111.481 161.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -124.85 23.14 7.98 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 167.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 . . . . . 0 C--O 1.254 1.305 0 C-N-CA 126.054 1.742 . . . . 0.0 109.963 162.06 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.8 t70 . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -53.75 -10.5 0.3 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.859 2.064 . . . . 0.0 115.104 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -113.14 -28.97 7.46 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.49 1.516 . . . . 0.0 114.551 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.1 t -72.0 -46.98 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.646 1.112 . . . . 0.0 112.433 -169.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.41 -45.02 95.89 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 171.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.28 -44.35 71.83 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 117.843 0.822 . . . . 0.0 112.539 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -74.89 -41.09 60.43 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.822 1.249 . . . . 0.0 114.25 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.63 -47.87 74.12 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.062 1.301 . . . . 0.0 111.012 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.12 -40.53 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.274 0.63 . . . . 0.0 109.567 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.9 t -56.56 -44.7 81.22 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.741 0.817 . . . . 0.0 112.337 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -64.43 -37.94 89.27 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.284 -0.885 . . . . 0.0 112.303 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.03 -49.25 78.39 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 120.57 1.532 . . . . 0.0 112.427 171.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 ptt85 -64.1 -39.59 94.39 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 120.328 1.422 . . . . 0.0 113.298 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -58.78 -44.17 90.64 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.809 2.044 . . . . 0.0 113.453 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.49 -30.77 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.307 1.043 . . . . 0.0 112.318 -175.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.411 HD21 HD23 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -87.4 -7.48 57.66 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.001 1.32 . . . . 0.0 112.455 174.819 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 64.31 9.35 4.8 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.488 2.715 . . . . 0.0 115.61 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . 0.262 4.3 pp -94.1 178.64 5.58 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.726 -1.234 . . . . 0.0 112.8 -173.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -95.96 154.32 17.3 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.275 1.03 . . . . 0.0 111.765 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -64.23 -24.18 67.57 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 119.488 -2.007 . . . . 0.0 112.81 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -78.36 0.26 26.26 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.811 1.644 . . . . 0.0 112.648 169.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -109.86 -18.8 13.32 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.149 1.38 . . . . 0.0 111.202 170.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.9 tp -88.23 111.81 22.07 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.629 1.572 . . . . 0.0 106.9 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.497 ' H ' ' HB3' ' A' ' 49' ' ' MET . 12.3 tpp180 -84.65 97.79 9.83 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 118.424 -1.31 . . . . 0.0 107.777 175.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.255 1.1 pp -92.46 148.63 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 126.646 1.978 . . . . 0.0 111.752 172.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.2 m -147.65 150.03 33.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.863 0.865 . . . . 0.0 108.921 -170.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -123.05 -158.68 0.8 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.829 1.252 . . . . 0.0 112.453 -161.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.8 t -41.49 -42.83 2.47 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 126.185 1.794 . . . . 0.0 115.252 -160.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.01 -30.08 65.82 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -171.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.23 -9.66 20.25 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 pt -110.14 -19.9 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.1 t -60.72 10.99 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 127.187 2.195 . . . . 0.0 116.781 -169.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -72.95 -20.12 61.11 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.714 2.006 . . . . 0.0 112.385 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -60.2 177.27 0.3 Allowed Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 127.433 2.293 . . . . 0.0 112.532 163.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -63.44 -86.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.936 2.424 . . . . 0.0 112.67 163.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -129.69 25.57 5.35 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 117.349 2.352 . . . . 0.0 117.349 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -162.68 142.13 9.14 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 118.811 -2.431 . . . . 0.0 110.717 -153.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m 176.54 -174.66 0.11 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.895 2.078 . . . . 0.0 108.895 -175.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.454 ' H ' ' HB3' ' A' ' 89' ' ' TYR . 30.1 tp -122.5 -75.41 0.6 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 119.174 -0.441 . . . . 0.0 111.306 150.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 15.0 p -163.35 -170.3 2.22 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.479 1.133 . . . . 0.0 113.223 -163.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 87' ' ' SER . 42.0 t0 -146.3 115.08 6.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.057 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.7 144.14 47.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.941 2.897 . . . . 0.0 109.287 -153.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.497 ' HB3' ' H ' ' A' ' 30' ' ' ARG . 29.5 ttp -122.3 128.1 50.66 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.904 1.684 . . . . 0.0 110.854 -165.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.411 HD23 HD21 ' A' ' 22' ' ' LEU . 0.6 OUTLIER -145.0 162.09 37.78 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 127.001 2.688 . . . . 0.0 115.439 -159.206 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.26 148.49 25.06 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 111.887 -2.415 . . . . 0.0 111.887 -142.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 t -66.03 156.37 33.93 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.072 0.949 . . . . 0.0 112.483 166.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 69.62 -0.85 2.47 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.109 2.164 . . . . 0.0 115.525 168.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.5 mp -103.98 147.01 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 126.08 1.752 . . . . 0.0 111.011 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.9 p -87.52 136.66 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.023 1.329 . . . . 0.0 111.714 170.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -107.54 110.25 62.78 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.56 1.144 . . . . 0.0 108.663 172.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -60.43 66.65 0.08 OUTLIER 'Trans proline' 0 CA--C 1.542 0.884 1 C-N-CA 126.521 4.814 . . . . 0.0 113.726 164.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.422 ' CG1' HG23 ' A' ' 133' ' ' THR . 3.6 p -68.75 -27.02 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.098 1.359 . . . . 0.0 114.424 -157.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -46.86 -45.19 20.15 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 126.46 1.904 . . . . 0.0 112.716 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -69.72 -30.67 68.34 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.996 -0.44 . . . . 0.0 112.164 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.1 mt -75.74 -45.26 37.52 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.824 0.85 . . . . 0.0 111.737 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 mp -53.58 -49.47 67.67 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.722 0.692 . . . . 0.0 109.813 171.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.8 m -64.97 -39.42 93.46 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -74.7 -33.75 62.48 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.444 -0.785 . . . . 0.0 112.408 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -63.89 -53.03 56.8 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.91 0.777 . . . . 0.0 111.375 171.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -73.67 -33.49 64.49 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -168.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.6 t -79.78 -19.15 49.28 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.904 1.282 . . . . 0.0 114.316 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -86.22 -26.1 25.24 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -166.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.2 m -138.79 -2.81 1.69 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -174.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.22 80.47 0.17 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.042 1.306 . . . . 0.0 111.384 -174.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.0 mtp85 -162.11 141.77 9.8 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 128.09 2.556 . . . . 0.0 105.642 169.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.2 m -65.61 140.98 58.56 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 125.064 1.346 . . . . 0.0 111.396 170.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.49 117.09 31.42 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 80.8 m -75.4 102.06 5.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.069 1.748 . . . . 0.0 108.333 157.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -85.12 96.15 9.36 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 167.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.9 t -99.75 141.3 17.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 C-N-CA 125.876 1.671 . . . . 0.0 108.165 -170.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -127.91 123.5 35.09 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 120.264 -1.523 . . . . 0.0 107.748 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -113.02 117.0 30.81 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.737 1.615 . . . . 0.0 108.842 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.75 115.79 31.12 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.309 1.844 . . . . 0.0 109.451 -172.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.3 p -143.25 165.09 28.41 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.409 2.684 . . . . 0.0 104.699 -160.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -13.66 -125.08 0.0 OUTLIER Glycine 0 N--CA 1.485 1.958 0 C-N-CA 129.58 3.466 . . . . 0.0 114.827 -152.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.7 p -92.89 99.78 12.37 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 113.862 -3.135 . . . . 0.0 110.151 152.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -170.75 162.49 7.71 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 130.605 3.562 . . . . 0.0 109.729 157.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.3 t -105.91 138.45 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 121.24 1.836 . . . . 0.0 112.443 148.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.7 t -104.42 138.91 40.13 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.932 0.893 . . . . 0.0 109.842 163.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tp -107.82 108.46 19.66 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 168.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 12.1 m -82.5 93.54 7.28 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 172.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.7 p -106.38 104.79 14.56 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 119.995 -1.691 . . . . 0.0 108.43 -169.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.454 ' HB3' ' H ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -142.9 149.92 39.12 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 117.022 2.231 . . . . 0.0 117.022 -177.026 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.7 pt -78.58 72.49 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 113.026 -1.897 . . . . 0.0 107.856 154.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -174.34 178.13 46.28 Favored Glycine 0 N--CA 1.478 1.471 0 N-CA-C 120.088 2.795 . . . . 0.0 120.088 -160.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -140.77 136.16 16.13 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.996 1.318 . . . . 0.0 114.499 -172.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -93.56 -166.71 0.15 Allowed 'Trans proline' 0 CA--C 1.549 1.241 1 C-N-CA 125.797 4.332 . . . . 0.0 112.492 172.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -79.26 -36.66 39.5 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 164.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -96.87 0.18 48.75 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 119.339 3.088 . . . . 0.0 119.339 -167.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.463 ' HA ' ' HG ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -54.1 -27.97 36.36 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 122.395 2.361 . . . . 0.0 114.383 -177.326 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.6 pttm -57.98 -30.41 66.01 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.275 1.03 . . . . 0.0 113.251 170.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -111.49 -29.97 7.56 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 99' ' ' LEU . 1.9 pp -74.31 165.31 25.39 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 121.753 2.07 . . . . 0.0 112.07 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -155.01 107.33 2.72 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 118.415 2.746 . . . . 0.0 118.415 -156.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.501 ' HE ' ' H ' ' A' ' 102' ' ' VAL . 0.1 OUTLIER -103.11 177.53 4.81 Favored 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 126.437 1.895 . . . . 0.0 111.533 169.586 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.501 ' H ' ' HE ' ' A' ' 101' ' ' ARG . 0.5 OUTLIER -165.82 170.64 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 -142.692 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 37.1 t -121.08 124.7 45.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.901 1.28 . . . . 0.0 109.918 141.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -172.86 167.91 5.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.4 1.88 . . . . 0.0 108.807 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -107.81 126.83 53.11 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.402 1.481 . . . . 0.0 109.522 150.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -152.12 165.65 34.11 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -165.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -101.0 145.43 28.71 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.023 1.729 . . . . 0.0 111.245 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.7 tp -140.89 143.04 34.43 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.133 0.973 . . . . 0.0 110.897 -158.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.9 p -111.43 -171.69 1.89 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.525 1.93 . . . . 0.0 114.639 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 65.9 t -73.32 -8.46 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 127.24 2.216 . . . . 0.0 113.58 172.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 -99.89 -3.41 32.51 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -165.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -96.98 148.95 22.45 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.503 1.501 . . . . 0.0 113.273 -147.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.633 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -144.73 143.76 30.86 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.144 -1.597 . . . . 0.0 109.061 -175.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -145.94 149.75 34.79 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-O 117.512 -1.232 . . . . 0.0 112.434 -168.089 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.41 141.94 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-N 121.338 1.881 . . . . 0.0 114.809 157.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.82 149.63 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.714 0.806 . . . . 0.0 111.123 169.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 39.8 m -146.29 154.43 41.68 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.844 2.057 . . . . 0.0 108.376 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -56.65 -36.9 70.05 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -163.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.02 -32.86 69.75 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.594 -1.316 . . . . 0.0 113.028 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -78.18 -29.37 48.49 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.373 1.069 . . . . 0.0 112.222 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.8 tp -76.97 -35.02 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 123.093 0.557 . . . . 0.0 111.889 168.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -61.14 -27.53 68.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.466 0.706 . . . . 0.0 112.27 171.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 22.3 ttm105 -77.44 -3.99 43.14 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.293 1.437 . . . . 0.0 114.622 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.8 mt -78.54 -25.22 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 O-C-N 120.955 -1.091 . . . . 0.0 110.616 168.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -91.09 179.5 1.42 Allowed Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.324 1.45 . . . . 0.0 108.855 153.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.6 -43.07 2.12 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 121.39 1.393 . . . . 0.0 111.435 160.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 38.2 t -158.53 148.72 19.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.925 2.49 . . . . 0.0 107.632 170.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -160.19 91.98 0.97 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.688 1.131 . . . . 0.0 111.732 171.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.7 63.34 0.19 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.56 1.944 . . . . 0.0 110.516 174.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 162.44 28.37 0.02 OUTLIER Glycine 0 CA--C 1.539 1.541 0 C-N-CA 125.195 1.378 . . . . 0.0 115.735 -171.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.7 t -61.58 128.0 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 120.132 1.966 . . . . 0.0 111.539 -174.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.18 89.05 2.98 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.459 1.904 . . . . 0.0 107.848 168.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.422 HG23 ' CG1' ' A' ' 58' ' ' VAL . 6.0 t -98.83 145.29 27.12 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.763 1.225 . . . . 0.0 111.488 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -138.72 132.78 31.33 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.267 1.027 . . . . 0.0 109.007 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 31.3 t -117.33 136.02 53.43 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.201 1.0 . . . . 0.0 111.038 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.4 t -136.71 138.14 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.457 1.903 . . . . 0.0 109.301 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.81 142.72 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.907 0.883 . . . . 0.0 110.943 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 31.5 mmm-85 -111.21 113.57 26.16 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.02 0.928 . . . . 0.0 108.734 163.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.608 ' HE2' ' CG ' ' A' ' 146' ' ' TYR . 0.0 OUTLIER -89.79 118.08 29.12 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 155.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.7 t -147.98 -167.94 2.94 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.027 0.831 . . . . 0.0 111.987 -169.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.2 m120 50.07 72.36 0.33 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.429 2.292 . . . . 0.0 112.321 168.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.9 m 54.01 3.45 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 -173.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.03 38.16 8.75 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.791 0.71 . . . . 0.0 112.288 -168.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 61.6 mtt -133.77 -13.23 2.56 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.73 142.33 24.48 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.875 0.845 . . . . 0.0 112.789 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.608 ' CG ' ' HE2' ' A' ' 139' ' ' LYS . 7.3 m-85 -140.82 173.63 11.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.666 -155.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -151.95 151.51 31.31 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.9 tt -141.19 136.5 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.405 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -137.53 125.7 23.05 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.386 1.074 . . . . 0.0 109.493 177.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.8 133.13 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.01 -1.056 . . . . 0.0 111.073 170.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.5 m -116.39 147.81 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.894 1.678 . . . . 0.0 110.966 -166.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.18 100.54 4.43 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.358 1.063 . . . . 0.0 111.609 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -119.85 161.77 20.25 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.718 1.607 . . . . 0.0 109.843 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -78.72 -147.35 3.58 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 118.639 0.654 . . . . 0.0 112.034 166.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.29 -11.99 7.11 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.625 2.883 . . . . 0.0 113.624 164.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -22.54 51.1 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.82 2.048 . . . . 0.0 113.012 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -87.36 57.09 4.25 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.946 1.355 . . . . 0.0 111.344 172.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -31.91 65.47 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.326 1.05 . . . . 0.0 111.531 171.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.78 -53.23 57.46 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -76.85 -25.52 53.23 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.186 0.903 . . . . 0.0 112.494 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -62.35 -54.02 46.57 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.986 1.267 . . . . 0.0 111.844 169.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -64.55 -28.67 69.8 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.458 -1.402 . . . . 0.0 112.352 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.19 -36.13 83.06 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.392 0.677 . . . . 0.0 112.484 168.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -70.59 -47.9 57.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.308 -0.853 . . . . 0.0 113.234 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.6 mp -48.41 -39.56 22.98 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 120.021 1.282 . . . . 0.0 112.858 166.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -71.33 -29.56 65.15 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -77.85 -32.58 52.16 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.637 1.575 . . . . 0.0 112.419 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.7 mt -86.4 -47.65 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.713 1.605 . . . . 0.0 112.149 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -68.04 1.74 2.54 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.066 0.848 . . . . 0.0 112.015 166.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -124.23 24.35 8.11 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 164.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . 0.277 9.6 mmm180 . . . . . 0 N--CA 1.48 1.025 0 C-N-CA 128.722 2.809 . . . . 0.0 116.344 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.3 t70 . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 121.678 0.751 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -63.51 -23.74 67.52 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -160.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -94.41 -28.91 15.25 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.378 0.99 . . . . 0.0 112.773 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.23 -54.49 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 118.778 0.717 . . . . 0.0 112.23 -171.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.08 -43.08 99.64 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 119.186 0.903 . . . . 0.0 112.16 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.12 74.85 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 117.749 0.775 . . . . 0.0 111.77 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -75.58 -31.76 60.09 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.92 -48.5 53.23 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.244 1.383 . . . . 0.0 111.654 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.18 -36.34 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 119.026 -0.511 . . . . 0.0 109.718 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 m -69.92 -43.53 71.5 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.549 1.068 . . . . 0.0 112.329 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -65.51 -39.08 91.43 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.222 -0.924 . . . . 0.0 111.29 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.73 -34.64 69.72 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.038 1.29 . . . . 0.0 112.297 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -52.88 -43.92 66.48 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 120.589 -1.319 . . . . 0.0 111.611 169.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -76.85 -43.34 36.58 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.597 1.159 . . . . 0.0 113.25 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.75 -31.99 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.035 1.334 . . . . 0.0 112.266 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.1 mt -89.85 -12.12 39.97 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.676 1.191 . . . . 0.0 113.065 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 60.21 25.7 15.1 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.783 2.033 . . . . 0.0 113.808 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 pp -117.91 155.55 29.99 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.87 1.268 . . . . 0.0 111.422 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -80.69 161.04 24.8 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -168.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -69.19 -19.28 63.98 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 119.771 -1.831 . . . . 0.0 115.381 -166.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -94.91 -5.76 44.13 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.609 1.563 . . . . 0.0 113.612 168.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -110.99 2.51 18.06 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.099 2.16 . . . . 0.0 110.801 -176.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 13.6 tp -90.54 124.11 34.74 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 128.692 2.797 . . . . 0.0 105.385 154.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.8 ttt-85 -85.39 119.82 26.18 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 117.951 -1.5 . . . . 0.0 107.766 166.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.497 HD12 ' H ' ' A' ' 31' ' ' ILE 0.276 0.8 OUTLIER -112.26 141.77 26.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.193 0.997 . . . . 0.0 112.393 170.269 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.6 m -157.74 141.24 15.51 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.07 1.348 . . . . 0.0 108.138 -159.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -163.3 60.76 0.18 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.521 1.153 . . . . 0.0 112.702 -172.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.9 t -93.55 -56.62 2.85 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.908 -1.12 . . . . 0.0 113.274 150.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.82 -54.3 4.99 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.308 1.051 . . . . 0.0 113.108 -146.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.542 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -63.9 -9.82 17.41 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.326 1.85 . . . . 0.0 113.188 171.692 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mm -90.2 6.31 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.105 1.362 . . . . 0.0 110.731 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.4 p -69.01 -17.66 63.95 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -173.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.416 ' O ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -62.65 -53.78 49.29 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.917 1.235 . . . . 0.0 110.111 169.31 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -168.85 155.89 6.9 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 125.675 1.59 . . . . 0.0 109.038 169.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.51 -27.3 18.58 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 122.933 2.422 . . . . 0.0 114.961 166.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -110.15 18.77 19.63 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.147 2.979 . . . . 0.0 113.143 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -153.13 92.06 1.58 Allowed 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t 165.85 -169.19 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 130.073 3.349 . . . . 0.0 107.743 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.264 1.2 tm? -132.08 -79.77 0.51 Allowed 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 151.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 5.7 t -175.9 -178.33 1.03 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.917 1.687 . . . . 0.0 109.96 -168.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 6.1 t70 -143.3 126.65 16.68 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 120.676 -1.265 . . . . 0.0 109.882 -170.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.22 154.46 17.38 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.548 1.939 . . . . 0.0 110.538 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -124.58 129.39 50.5 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.413 1.006 . . . . 0.0 108.786 168.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.59 162.39 38.5 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 126.709 2.506 . . . . 0.0 114.826 -156.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 p -102.5 156.53 17.55 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.736 2.014 . . . . 0.0 114.734 -147.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 t -71.79 149.19 45.55 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.572 1.149 . . . . 0.0 113.565 173.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 t70 68.72 16.67 8.95 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 163.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.61 146.88 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.743 1.617 . . . . 0.0 109.542 168.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.6 p -97.48 139.47 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.559 1.544 . . . . 0.0 111.272 166.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -122.21 128.74 25.38 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.9 1.28 . . . . 0.0 110.472 -169.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.94 70.13 5.32 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 124.598 3.532 . . . . 0.0 110.782 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 p -65.48 -26.47 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.25 1.42 . . . . 0.0 113.956 -161.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -48.22 -45.99 34.71 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.531 1.533 . . . . 0.0 112.62 171.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -62.35 -39.68 93.89 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.591 0.632 . . . . 0.0 111.186 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.5 tp -69.63 -53.51 18.38 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.021 0.528 . . . . 0.0 110.814 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.18 -53.31 58.7 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.441 0.696 . . . . 0.0 111.479 177.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 72.7 m -76.72 -40.46 48.56 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -168.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -69.95 -33.48 72.17 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.596 1.089 . . . . 0.0 112.246 173.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -63.67 -48.22 78.08 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.106 0.866 . . . . 0.0 112.331 172.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -55.71 -41.9 74.47 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.434 0.694 . . . . 0.0 111.343 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.8 t -69.22 -17.92 63.84 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -175.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -63.28 -35.84 81.69 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.277 1.031 . . . . 0.0 113.414 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.9 m -115.99 -28.06 6.76 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.139 0.976 . . . . 0.0 112.223 167.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.88 77.35 0.95 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.956 2.217 . . . . 0.0 109.813 -169.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -160.63 117.98 2.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.517 2.327 . . . . 0.0 108.779 -174.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.4 m -61.78 130.15 44.38 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.517 0.727 . . . . 0.0 111.204 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.74 160.43 25.94 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.833 1.653 . . . . 0.0 114.502 -163.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 89.9 m -103.34 116.01 31.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.322 1.449 . . . . 0.0 112.49 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -91.14 114.51 27.05 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.639 1.575 . . . . 0.0 107.632 167.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.869 HG22 HG22 ' A' ' 115' ' ' VAL . 50.9 t -129.85 123.92 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 O-C-N 121.514 -0.742 . . . . 0.0 111.055 -162.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -96.39 129.78 43.67 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 119.963 -1.71 . . . . 0.0 109.609 174.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.66 98.12 8.72 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 162.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -106.95 111.61 24.18 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 125.093 1.357 . . . . 0.0 114.438 -164.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.3 p -144.76 165.61 27.58 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 129.661 3.184 . . . . 0.0 105.206 -149.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.08 -123.2 0.0 OUTLIER Glycine 0 N--CA 1.49 2.289 0 C-N-CA 130.524 3.916 . . . . 0.0 115.6 -163.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.6 p -91.66 104.95 17.37 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 113.182 -3.407 . . . . 0.0 110.443 152.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -169.1 153.29 5.45 Favored 'General case' 0 N--CA 1.474 0.75 1 C-N-CA 134.638 5.175 . . . . 0.0 106.236 159.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.6 t -106.29 136.29 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 119.748 -1.845 . . . . 0.0 109.716 129.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.9 m -106.56 140.79 38.89 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 160.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.0 tp -110.82 107.67 17.24 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.5 1.52 . . . . 0.0 107.234 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.6 m -78.03 128.81 34.43 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.252 1.021 . . . . 0.0 108.904 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 77.3 m -120.49 116.51 25.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -140.33 141.09 35.73 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 173.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.468 HD13 ' H ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -83.48 99.97 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 149.376 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 175.32 178.3 45.06 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 118.108 2.003 . . . . 0.0 118.108 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -125.86 56.35 15.19 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.973 1.309 . . . . 0.0 112.802 164.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -59.8 142.28 98.35 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.736 2.291 . . . . 0.0 111.197 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -55.09 -17.11 3.58 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 -158.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -21.18 63.19 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.77 -1.206 . . . . 0.0 113.301 171.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -52.55 -33.2 44.54 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.297 1.839 . . . . 0.0 113.565 168.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -79.57 4.63 15.3 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.815 1.246 . . . . 0.0 112.648 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -130.09 -35.82 1.58 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.002 1.321 . . . . 0.0 114.142 177.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.511 HD11 HG23 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -84.04 165.86 18.21 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 117.991 2.589 . . . . 0.0 117.991 -168.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -104.21 -172.62 2.14 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 126.784 2.033 . . . . 0.0 115.248 -161.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.65 158.95 16.83 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 126.823 2.049 . . . . 0.0 110.749 170.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.3 p -123.83 125.56 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 159.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 41.5 t -142.27 119.4 11.41 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 142.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -171.2 140.03 1.43 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.259 0.552 . . . . 0.0 110.335 -164.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -114.67 95.74 5.39 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.695 1.198 . . . . 0.0 108.997 141.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -160.96 177.51 10.29 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.983 -1.073 . . . . 0.0 113.636 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.19 157.32 37.85 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 121.331 -0.856 . . . . 0.0 111.828 161.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.7 tp -145.13 143.79 30.56 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.865 1.666 . . . . 0.0 108.994 -170.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.9 m -104.04 -174.03 2.45 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.217 1.007 . . . . 0.0 112.881 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.356 89.1 t -66.65 1.92 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 128.371 2.668 . . . . 0.0 115.08 -173.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -50.5 -4.75 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 118.244 2.683 . . . . 0.0 118.244 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.373 4.7 pt-20 54.57 3.54 0.05 Allowed 'General case' 0 N--CA 1.466 0.364 1 N-CA-C 124.319 4.933 . . . . 0.0 124.319 153.705 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -163.13 123.83 2.35 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 123.139 2.7 . . . . 0.0 108.448 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.4 pp -155.88 150.01 25.53 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.595 1.558 . . . . 0.0 111.459 -174.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.869 HG22 HG22 ' A' ' 76' ' ' VAL . 11.6 t -115.3 144.86 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 127.349 2.26 . . . . 0.0 113.062 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.6 138.81 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 123.844 0.857 . . . . 0.0 110.853 146.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.4 p -114.82 167.27 10.93 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.338 1.055 . . . . 0.0 112.403 172.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -35.38 74.65 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 120.721 -1.237 . . . . 0.0 111.667 174.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.91 -36.04 82.63 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.334 0.653 . . . . 0.0 112.518 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -64.36 -47.57 78.81 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 118.693 -0.67 . . . . 0.0 111.256 172.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.93 -50.01 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 119.026 0.83 . . . . 0.0 110.846 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -57.51 -36.11 71.13 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.069 0.947 . . . . 0.0 113.067 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -78.88 -31.6 45.52 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.982 -1.074 . . . . 0.0 112.738 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.4 mt -71.04 -37.62 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.727 1.611 . . . . 0.0 111.238 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -158.75 -54.54 0.02 OUTLIER Pre-proline 0 N--CA 1.48 1.061 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 164.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -120.2 109.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.66 0 CA-C-N 121.349 1.517 . . . . 0.0 112.818 -159.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 82.8 m -73.66 128.18 34.79 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 145.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -179.99 135.33 0.11 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.272 1.829 . . . . 0.0 111.07 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -74.47 56.84 0.69 Allowed 'General case' 0 N--CA 1.482 1.134 0 O-C-N 120.586 -1.321 . . . . 0.0 110.71 159.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.11 19.1 0.04 OUTLIER Glycine 0 CA--C 1.544 1.886 0 C-N-CA 127.253 2.359 . . . . 0.0 114.571 -169.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.0 t -63.97 136.91 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.903 1.281 . . . . 0.0 111.551 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.3 85.04 2.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 122.68 1.228 . . . . 0.0 109.191 160.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.8 m -78.07 144.85 36.22 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 166.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -146.03 132.5 19.72 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -165.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 42.0 t -136.55 140.79 43.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.533 0.606 . . . . 0.0 112.48 -167.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.1 t -136.09 138.99 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 127.199 2.2 . . . . 0.0 108.369 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.2 m -130.84 140.9 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.992 -0.442 . . . . 0.0 109.845 166.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -114.6 143.42 45.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 122.281 1.039 . . . . 0.0 110.686 157.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.96 137.52 49.84 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.732 2.013 . . . . 0.0 107.699 163.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 53.0 m -140.45 131.23 25.82 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 123.711 0.632 . . . . 0.0 110.489 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 17.4 m120 45.82 65.09 1.23 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.847 2.059 . . . . 0.0 114.437 168.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 37.1 m 59.5 12.63 2.85 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 101.71 7.04 48.87 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.494 1.045 . . . . 0.0 114.945 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 23.3 mmt -64.88 -13.88 57.87 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.728 1.264 . . . . 0.0 113.258 171.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.3 t -139.68 141.01 37.0 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.8 1.24 . . . . 0.0 110.242 158.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -115.59 152.24 33.45 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 157.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -134.53 146.42 49.68 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.161 -0.962 . . . . 0.0 109.689 170.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.3 tt -143.39 143.76 24.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.547 0.689 . . . . 0.0 112.327 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -134.57 130.94 37.29 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 161.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.22 131.07 35.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 122.907 1.337 . . . . 0.0 109.688 150.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.7 m -137.27 142.99 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 111.365 -2.652 . . . . 0.0 108.35 -162.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -123.47 132.96 54.08 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -142.91 162.23 36.03 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.431 1.892 . . . . 0.0 110.21 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -70.14 -144.82 0.24 Allowed Glycine 0 CA--C 1.543 1.828 0 O-C-N 120.632 -1.293 . . . . 0.0 110.928 149.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.64 17.36 0.46 Allowed 'Trans proline' 0 CA--C 1.553 1.45 0 C-N-CA 123.126 2.551 . . . . 0.0 114.17 174.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -85.63 -17.37 36.33 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -164.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -77.67 54.48 1.22 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 123.28 1.514 . . . . 0.0 109.802 163.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.88 -21.28 65.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.995 1.718 . . . . 0.0 114.144 -161.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.24 -43.62 66.9 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.925 0.784 . . . . 0.0 111.985 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -73.0 -31.65 64.63 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.579 0.752 . . . . 0.0 111.424 175.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -64.05 -49.99 70.17 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.309 -0.869 . . . . 0.0 110.609 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -54.95 -36.54 65.42 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.004 -1.06 . . . . 0.0 113.668 172.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.89 85.62 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.432 0.56 . . . . 0.0 112.185 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -71.81 -48.2 48.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.29 1.036 . . . . 0.0 113.192 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 98.1 mt -54.74 -35.95 64.28 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.621 1.101 . . . . 0.0 112.539 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -70.89 -40.93 71.92 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 125.723 1.609 . . . . 0.0 112.902 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -77.34 -35.56 54.57 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.8 pt -75.07 -38.32 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.142 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -65.6 -10.41 35.34 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 120.259 1.39 . . . . 0.0 112.885 164.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -110.64 28.14 8.97 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.257 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.8 t0 . . . . . 0 CA--C 1.551 1.008 0 CA-C-O 121.232 0.539 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -63.84 -30.55 71.63 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 -139.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.85 -15.56 15.64 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.38 0.991 . . . . 0.0 113.663 172.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.3 t -69.96 -62.26 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.841 1.256 . . . . 0.0 111.662 -173.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.0 -53.46 14.45 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.63 1.109 . . . . 0.0 112.248 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.36 -45.94 72.87 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 118.958 1.379 . . . . 0.0 113.504 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.89 -39.02 76.51 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.085 -1.009 . . . . 0.0 112.805 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -70.39 -42.89 71.12 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.236 0.925 . . . . 0.0 112.219 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.36 -42.71 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.285 1.034 . . . . 0.0 109.851 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.7 p -68.51 -40.36 80.86 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.74 0.7 . . . . 0.0 112.227 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -69.08 -36.89 78.11 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.223 -0.923 . . . . 0.0 112.466 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 87.7 m -66.92 -48.09 69.73 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.193 -0.942 . . . . 0.0 110.715 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.2 ptt-85 -59.32 -41.58 89.4 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.284 0.947 . . . . 0.0 111.26 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -62.24 -56.74 15.64 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.19 1.396 . . . . 0.0 112.286 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.82 -30.18 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 119.369 0.986 . . . . 0.0 112.202 -172.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.75 -8.33 59.18 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.22 0.918 . . . . 0.0 113.249 169.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 52.76 46.36 26.89 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.387 1.875 . . . . 0.0 111.921 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 pp -129.37 159.44 36.2 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.851 1.261 . . . . 0.0 111.051 172.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -73.5 160.54 31.56 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -60.52 -27.89 67.98 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.166 -1.583 . . . . 0.0 111.983 168.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -84.4 6.12 24.5 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 119.775 1.171 . . . . 0.0 113.056 171.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -116.1 -12.95 11.2 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.605 -1.309 . . . . 0.0 110.996 174.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.589 HD11 ' HB1' ' A' ' 48' ' ' ALA . 26.9 tp -89.68 113.16 24.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.494 1.918 . . . . 0.0 109.348 171.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -94.67 130.72 41.05 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 119.584 -0.846 . . . . 0.0 112.849 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 47' ' ' ASP . 37.4 mm -95.87 138.01 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 127.442 2.297 . . . . 0.0 113.308 -176.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 m -147.29 148.44 31.42 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.818 1.19 . . . . 0.0 109.476 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.7 p30 -150.76 56.43 0.91 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 122.886 1.327 . . . . 0.0 114.394 171.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.0 p -91.45 -56.15 3.24 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.112 1.365 . . . . 0.0 114.352 157.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.92 -52.2 5.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 122.744 1.259 . . . . 0.0 114.193 -152.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.606 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -64.88 -27.54 68.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.112 1.765 . . . . 0.0 112.448 173.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.5 mp -71.43 -16.18 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.565 1.946 . . . . 0.0 112.6 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 54.7 m -61.04 -0.14 0.29 Allowed 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 118.069 2.618 . . . . 0.0 118.069 -166.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -90.07 -30.9 17.41 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 121.42 1.918 . . . . 0.0 113.298 169.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -134.41 84.3 41.13 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 165.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -69.98 21.95 0.18 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.535 3.49 . . . . 0.0 114.721 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -113.75 4.27 15.9 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.44 1.896 . . . . 0.0 111.587 169.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -130.14 164.27 24.8 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 120.302 1.41 . . . . 0.0 108.284 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 p -150.16 150.67 31.96 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.242 -0.911 . . . . 0.0 111.49 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.12 -82.77 0.64 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 117.036 -1.459 . . . . 0.0 110.692 147.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 30.5 p -170.88 163.5 7.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 121.681 2.037 . . . . 0.0 114.507 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 16.2 t70 -115.47 152.82 32.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 153.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -121.23 135.79 55.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 129.129 2.972 . . . . 0.0 108.743 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 55.7 mtm -112.04 134.05 53.83 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.9 1.227 . . . . 0.0 108.145 168.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.269 0.6 OUTLIER -147.79 131.93 17.34 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 118.493 2.775 . . . . 0.0 118.493 -155.761 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.25 160.22 18.53 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 110.539 -3.028 . . . . 0.0 114.395 -174.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.6 p -96.02 179.75 4.97 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.627 1.971 . . . . 0.0 115.464 -158.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . 0.268 28.9 t70 63.16 46.0 4.84 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.482 2.313 . . . . 0.0 115.349 177.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.36 164.28 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 127.065 2.146 . . . . 0.0 109.22 163.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 m -101.11 141.07 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.228 1.011 . . . . 0.0 108.548 161.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.65 110.52 44.49 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 119.829 1.195 . . . . 0.0 108.219 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -67.67 74.71 0.61 Allowed 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 125.159 3.906 . . . . 0.0 111.072 173.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.6 -24.65 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.644 1.978 . . . . 0.0 114.294 -152.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.11 -26.72 50.97 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.652 0.66 . . . . 0.0 112.26 172.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -57.26 -38.49 73.94 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.641 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.7 -43.09 63.49 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.434 1.015 . . . . 0.0 111.257 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -56.09 -48.72 75.58 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.166 0.986 . . . . 0.0 110.325 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.0 m -71.92 -42.89 66.17 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.391 1.476 . . . . 0.0 113.166 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -67.38 -33.96 76.29 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.909 1.231 . . . . 0.0 111.784 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -66.54 -46.99 74.29 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.524 0.602 . . . . 0.0 112.491 165.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -60.6 -30.06 69.59 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.786 -1.196 . . . . 0.0 112.717 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 79.2 m -76.66 -6.31 51.57 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.755 1.622 . . . . 0.0 114.234 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -82.38 -35.17 27.99 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 120.089 1.313 . . . . 0.0 112.971 -175.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.6 p -154.87 -23.98 0.12 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.534 1.134 . . . . 0.0 113.121 167.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.86 82.04 1.35 Allowed Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.761 2.124 . . . . 0.0 112.028 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.9 tpt85 -153.26 118.77 5.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 128.828 2.851 . . . . 0.0 104.957 169.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.6 m -62.03 150.99 36.54 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.705 0.802 . . . . 0.0 111.89 -175.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -141.04 149.91 42.3 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.146 1.378 . . . . 0.0 113.229 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 29.5 p -83.02 138.19 33.84 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.736 1.214 . . . . 0.0 111.484 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -110.59 115.7 30.07 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 172.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 1.072 HG22 HG22 ' A' ' 115' ' ' VAL . 95.1 t -130.04 111.26 21.01 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.549 0 C-N-CA 123.76 0.824 . . . . 0.0 109.56 -154.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -96.07 115.67 27.78 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 120.338 -1.476 . . . . 0.0 107.499 -170.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -108.49 107.87 18.57 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.89 1.276 . . . . 0.0 108.772 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -84.06 137.41 33.6 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.276 -0.89 . . . . 0.0 111.184 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.1 p -144.28 167.87 21.41 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 129.591 3.156 . . . . 0.0 104.626 -167.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -16.42 -123.32 0.0 OUTLIER Glycine 0 N--CA 1.489 2.169 1 C-N-CA 130.831 4.063 . . . . 0.0 116.636 -176.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 55.8 m -97.99 101.96 13.58 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 113.029 -3.468 . . . . 0.0 111.254 152.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.68 164.29 12.16 Favored 'General case' 0 CA--C 1.542 0.671 1 C-N-CA 133.465 4.706 . . . . 0.0 106.419 136.793 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.6 156.96 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 O-C-N 119.468 -2.02 . . . . 0.0 108.714 147.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -127.74 146.67 50.5 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.621 0.768 . . . . 0.0 110.242 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.0 tp -117.17 109.37 16.82 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.068 0.947 . . . . 0.0 108.657 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.2 m -76.69 132.02 39.13 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.103 1.361 . . . . 0.0 110.139 167.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.1 m -128.69 115.34 17.86 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.624 -1.298 . . . . 0.0 110.011 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -137.15 134.77 36.72 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.29 85.28 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 161.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 174.63 -176.61 46.89 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 117.694 1.837 . . . . 0.0 117.694 -174.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -111.15 79.97 2.23 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.734 1.214 . . . . 0.0 112.407 168.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -53.4 153.62 17.08 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 124.528 3.485 . . . . 0.0 116.479 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -72.56 -32.46 66.06 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -172.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -76.33 -10.02 59.08 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.943 1.247 . . . . 0.0 113.634 172.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.607 HD11 HG21 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -68.51 -2.71 9.38 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.524 1.93 . . . . 0.0 114.815 167.314 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 9.8 mmpt? -50.55 -41.02 53.59 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.489 -0.757 . . . . 0.0 110.753 151.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -118.98 -34.5 3.88 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -167.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.661 HD11 HG23 ' A' ' 115' ' ' VAL . 3.7 pp -83.87 160.6 21.11 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 120.69 1.586 . . . . 0.0 113.187 -163.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.3 pttt -164.08 129.08 2.83 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 -165.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.339 11.5 ttt180 -108.89 -173.59 2.31 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 125.472 1.509 . . . . 0.0 113.172 167.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.4 p 179.9 166.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 128.105 2.562 . . . . 0.0 109.353 -133.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 57.3 m -118.12 122.3 42.75 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.155 0.889 . . . . 0.0 109.286 151.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -170.97 163.32 7.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.652 2.381 . . . . 0.0 106.756 -171.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -139.27 115.36 10.3 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 126.077 1.751 . . . . 0.0 112.903 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -159.88 -172.92 3.84 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.339 1.456 . . . . 0.0 111.904 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -66.94 160.78 25.58 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.124 0.97 . . . . 0.0 112.58 160.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.6 tp -135.22 145.96 48.18 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 129.142 2.977 . . . . 0.0 108.777 -172.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.7 t -109.27 155.51 21.04 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.932 2.093 . . . . 0.0 110.543 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.01 -15.81 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -157.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -130.35 46.72 2.61 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.34 1.056 . . . . 0.0 110.643 -170.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -104.69 150.66 24.53 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.505 1.522 . . . . 0.0 112.589 -167.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.446 ' HB1' HD22 ' A' ' 99' ' ' LEU . . . -144.13 136.09 26.28 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.166 -1.584 . . . . 0.0 110.042 -172.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.32 139.25 15.32 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 120.632 -1.292 . . . . 0.0 113.63 -170.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 1.072 HG22 HG22 ' A' ' 76' ' ' VAL . 6.6 t -108.87 132.77 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 125.745 1.618 . . . . 0.0 111.012 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . 0.254 0.8 OUTLIER -129.79 123.53 57.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 122.64 1.209 . . . . 0.0 110.065 157.086 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.9 t -124.73 158.53 33.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.596 2.358 . . . . 0.0 107.846 173.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -36.12 64.41 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.968 0.803 . . . . 0.0 112.006 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.11 -31.95 68.41 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -76.2 -28.96 57.44 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.611 -1.306 . . . . 0.0 112.258 174.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 41.3 mm -67.81 -40.65 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 121.556 -0.715 . . . . 0.0 110.562 164.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.23 -11.9 52.89 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.26 1.024 . . . . 0.0 113.191 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -79.29 -45.39 19.8 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 119.77 -1.831 . . . . 0.0 112.214 164.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.9 pt -92.04 -12.94 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -170.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -122.87 161.32 44.95 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 125.287 1.435 . . . . 0.0 112.422 174.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -68.32 -31.4 28.5 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.906 1.737 . . . . 0.0 115.694 -168.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.428 ' SG ' ' HE2' ' A' ' 129' ' ' LYS . 5.6 t -153.29 162.39 41.34 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -172.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -99.99 -137.32 0.31 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.148 2.579 . . . . 0.0 111.482 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.428 ' HE2' ' SG ' ' A' ' 127' ' ' CYS . 63.4 pttt 44.84 22.03 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 119.278 3.066 . . . . 0.0 119.278 165.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.46 21.66 0.04 OUTLIER Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.124 1.345 . . . . 0.0 115.946 168.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.1 t -65.89 132.9 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 118.698 1.249 . . . . 0.0 111.946 -169.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 20.7 mt -124.18 108.84 12.72 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 122.4 1.095 . . . . 0.0 109.138 151.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.2 t -101.69 147.25 26.67 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.855 1.662 . . . . 0.0 109.725 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -124.7 133.74 53.09 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.661 1.184 . . . . 0.0 108.394 -174.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 72.3 m -109.67 143.09 39.92 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.625 0.77 . . . . 0.0 111.057 171.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.71 129.33 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.727 1.611 . . . . 0.0 108.863 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.1 m -136.85 147.81 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -132.0 145.9 51.74 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.08 1.752 . . . . 0.0 112.699 172.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.663 ' HE2' ' CD1' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -129.12 93.14 3.52 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.565 2.346 . . . . 0.0 114.211 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 18.1 t -83.79 123.1 29.54 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.679 -0.638 . . . . 0.0 112.211 170.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -96.38 -41.13 8.77 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.591 1.557 . . . . 0.0 110.963 167.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 98.0 p -64.63 -18.38 64.88 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -131.73 23.33 4.22 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 125.824 1.678 . . . . 0.0 114.919 168.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.9 mmt 31.1 59.83 0.25 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 128.352 2.661 . . . . 0.0 116.326 172.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.9 t -164.62 146.55 8.36 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.174 0.99 . . . . 0.0 110.55 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.663 ' CD1' ' HE2' ' A' ' 139' ' ' LYS . 4.5 m-85 -129.21 158.11 39.95 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -158.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -144.07 144.98 31.87 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 120.946 -1.096 . . . . 0.0 108.847 -171.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.0 tt -144.94 142.67 22.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.843 -168.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -141.02 136.21 31.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.361 1.465 . . . . 0.0 107.46 174.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.52 136.52 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 122.051 0.929 . . . . 0.0 110.946 155.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.3 m -129.23 149.64 33.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 126.218 1.807 . . . . 0.0 109.734 -172.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.93 127.63 23.35 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -133.47 157.62 45.17 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.457 1.903 . . . . 0.0 110.867 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -90.61 -159.35 35.53 Favored Glycine 0 CA--C 1.541 1.702 0 C-N-CA 124.404 1.002 . . . . 0.0 113.519 174.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.25 -7.75 21.73 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.339 2.693 . . . . 0.0 115.522 -172.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -75.58 -2.91 31.38 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 171.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -76.73 57.27 1.25 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.347 1.859 . . . . 0.0 111.683 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.18 -23.14 61.97 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.334 1.454 . . . . 0.0 113.696 -174.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.57 -51.24 37.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.141 0.882 . . . . 0.0 111.591 178.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -71.21 -34.97 71.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.881 0.872 . . . . 0.0 112.729 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -58.9 -53.71 55.33 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.854 0.752 . . . . 0.0 110.689 171.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -57.02 -39.02 73.95 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.884 0.765 . . . . 0.0 112.07 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.82 -42.99 98.78 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.295 0.952 . . . . 0.0 112.926 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.21 -46.98 72.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.569 -0.707 . . . . 0.0 112.586 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 86.9 mt -57.31 -34.64 68.94 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.837 0.455 . . . . 0.0 111.497 175.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -75.63 -17.59 59.95 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.586 1.955 . . . . 0.0 113.549 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -101.9 -31.17 10.83 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.0 pt -86.54 -36.63 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 120.415 1.461 . . . . 0.0 113.547 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -76.32 12.62 1.15 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.381 1.446 . . . . 0.0 111.508 161.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.85 25.61 4.31 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 170.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 125.224 1.409 . . . . 0.0 112.495 168.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 120.984 0.421 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -55.76 -20.95 16.68 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -162.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -97.17 -31.17 12.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.278 1.031 . . . . 0.0 112.603 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.9 -59.49 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.93 0.892 . . . . 0.0 112.079 -168.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.37 -42.38 97.42 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.534 -0.592 . . . . 0.0 111.845 171.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.61 -51.15 69.75 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.542 1.171 . . . . 0.0 112.757 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -64.45 -43.03 95.57 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.317 1.047 . . . . 0.0 112.445 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.44 -47.36 61.09 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.896 0.878 . . . . 0.0 111.893 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.16 -41.55 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.547 0.739 . . . . 0.0 109.646 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.5 m -59.29 -38.37 80.02 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.769 0.713 . . . . 0.0 112.387 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -76.0 -32.32 59.37 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.645 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -71.99 -43.66 64.74 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 120.454 1.479 . . . . 0.0 111.646 170.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -49.72 -43.64 47.78 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.456 1.502 . . . . 0.0 111.791 172.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -73.46 -59.57 2.65 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.245 1.418 . . . . 0.0 113.651 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.02 -31.81 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 120.699 1.59 . . . . 0.0 112.718 -168.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.0 mp -84.0 -13.43 53.31 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.152 -0.967 . . . . 0.0 112.543 173.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 54.44 60.1 3.76 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.82 1.648 . . . . 0.0 112.514 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 pp -130.89 148.66 52.69 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.89 0.876 . . . . 0.0 109.385 167.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -69.99 159.51 33.65 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.991 0.424 . . . . 0.0 110.585 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -65.42 -27.38 68.49 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.376 -1.452 . . . . 0.0 111.757 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -68.57 -9.01 46.8 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.97 1.308 . . . . 0.0 113.848 166.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -125.49 3.05 7.66 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.471 1.508 . . . . 0.0 111.639 -176.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.472 HD11 ' HB1' ' A' ' 48' ' ' ALA . 24.2 tp -93.34 128.68 39.47 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 156.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 131.91 50.17 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.906 0.775 . . . . 0.0 111.134 167.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.8 mm -93.71 143.44 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 127.236 2.215 . . . . 0.0 110.723 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.5 m -149.77 154.1 37.92 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 121.394 -0.816 . . . . 0.0 110.674 168.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.2 p30 -155.75 58.81 0.61 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.678 1.228 . . . . 0.0 112.999 -176.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 30.1 p -86.93 -60.2 2.05 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.626 -1.296 . . . . 0.0 111.341 169.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.16 -38.09 15.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 113.919 -1.491 . . . . 0.0 112.474 -158.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.528 HD12 HD12 ' A' ' 37' ' ' ILE . 2.4 pp -99.63 -1.94 36.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.054 2.142 . . . . 0.0 113.718 -171.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.528 HD12 HD12 ' A' ' 36' ' ' LEU . 1.7 mp -97.5 5.53 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 126.53 1.932 . . . . 0.0 110.354 166.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.3 t -59.49 -29.71 68.03 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.354 1.462 . . . . 0.0 114.117 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.463 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -81.22 26.75 0.43 Allowed 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.059 -1.651 . . . . 0.0 112.913 169.354 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 m120 71.69 165.13 0.14 Allowed Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 128.646 2.779 . . . . 0.0 112.758 -168.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.12 -3.69 3.22 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.749 2.966 . . . . 0.0 114.896 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -97.82 5.71 48.75 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.409 2.284 . . . . 0.0 112.454 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -157.36 94.54 1.39 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 171.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.4 p -175.24 168.76 3.34 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.501 -159.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -131.61 -81.51 0.52 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 116.78 -1.968 . . . . 0.0 115.345 132.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.38 -176.98 2.31 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.343 1.057 . . . . 0.0 111.408 -174.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -116.72 146.18 42.96 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 168.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.472 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -131.54 130.24 42.05 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.628 2.371 . . . . 0.0 107.682 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 18.4 mtt -123.6 134.16 53.85 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.018 -1.051 . . . . 0.0 110.61 -170.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.5 mt -130.77 142.26 50.4 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 126.154 2.159 . . . . 0.0 112.748 -147.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.6 p -110.7 161.58 15.61 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.058 2.543 . . . . 0.0 111.584 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.658 HG22 HG23 ' A' ' 137' ' ' VAL . 28.4 p -126.77 108.6 11.19 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -163.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -158.92 2.26 0.09 Allowed 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 125.584 1.554 . . . . 0.0 114.84 165.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.65 173.08 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 126.578 1.951 . . . . 0.0 113.196 -162.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.457 HG21 HD21 ' A' ' 134' ' ' ASN . 1.4 m -96.78 142.54 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.894 1.678 . . . . 0.0 112.178 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -109.2 106.41 58.65 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -73.51 71.53 3.85 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.668 3.579 . . . . 0.0 110.397 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.48 -28.58 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 114.088 -1.414 . . . . 0.0 114.653 -149.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -56.99 -35.01 68.7 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -67.13 -32.94 74.4 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.384 0.538 . . . . 0.0 111.722 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.0 mt -75.01 -45.0 44.82 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.748 0.704 . . . . 0.0 111.458 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 mp -55.27 -44.21 75.4 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.8 0.727 . . . . 0.0 111.261 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -63.62 -45.37 90.62 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.606 0.762 . . . . 0.0 112.501 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -63.69 -32.44 73.93 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.63 0.772 . . . . 0.0 112.593 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -69.1 -45.25 70.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.575 1.15 . . . . 0.0 111.823 171.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.09 -37.79 77.95 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 119.583 1.083 . . . . 0.0 112.095 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.1 t -62.97 -1.48 0.93 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.438 1.895 . . . . 0.0 115.706 -168.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -70.88 -18.22 62.69 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 120.287 -1.508 . . . . 0.0 113.58 172.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.7 p -164.21 -16.4 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.628 1.571 . . . . 0.0 113.813 166.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.5 83.55 1.12 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 126.941 2.21 . . . . 0.0 109.62 -165.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -161.76 114.87 1.84 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.469 2.308 . . . . 0.0 106.555 -168.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.4 m -71.93 126.28 29.34 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -167.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.11 143.52 36.75 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.858 1.663 . . . . 0.0 111.667 172.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 60.3 m -98.4 127.77 44.49 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.143 0.977 . . . . 0.0 109.389 176.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -93.89 104.2 16.27 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.909 1.684 . . . . 0.0 109.311 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.453 HG22 ' CG2' ' A' ' 115' ' ' VAL . 44.4 t -99.06 117.92 44.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 C-N-CA 124.787 1.235 . . . . 0.0 109.225 -171.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -94.37 109.03 20.91 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.57 ' HE3' ' HB2' ' A' ' 113' ' ' ALA . 14.2 mmmm -111.14 101.83 10.32 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.727 2.011 . . . . 0.0 108.743 172.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -98.28 135.84 39.32 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.797 -1.19 . . . . 0.0 111.366 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.31 165.05 36.97 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 130.173 3.389 . . . . 0.0 104.407 -161.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -9.68 -123.01 0.0 OUTLIER Glycine 0 N--CA 1.486 1.996 0 C-N-CA 128.7 3.047 . . . . 0.0 115.286 -153.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 9.1 p -95.48 106.61 18.69 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 113.405 -3.318 . . . . 0.0 111.57 150.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.96 139.95 2.42 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 131.529 3.932 . . . . 0.0 107.276 131.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.1 t -63.38 133.41 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 117.104 -1.838 . . . . 0.0 108.482 152.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.68 140.44 39.54 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.7 0.682 . . . . 0.0 109.432 163.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.8 tp -110.64 106.15 15.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 163.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.9 m -86.93 118.64 26.45 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.88 1.672 . . . . 0.0 109.019 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 82.2 m -102.92 110.32 22.19 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.296 -1.502 . . . . 0.0 109.169 -172.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -99.92 109.8 22.15 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.658 -175.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mp -82.33 98.08 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 129.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.47 178.89 47.44 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 118.621 2.208 . . . . 0.0 118.621 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -126.21 45.79 1.62 Allowed Pre-proline 0 CA--C 1.56 1.331 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 160.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -52.18 155.36 9.23 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.826 3.017 . . . . 0.0 117.689 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -49.86 -33.42 16.93 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.841 2.456 . . . . 0.0 116.249 -162.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -92.99 -17.32 24.06 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.14 -35.61 59.91 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.622 2.769 . . . . 0.0 113.653 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -57.24 -43.03 82.57 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 118.486 -0.768 . . . . 0.0 111.845 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -98.26 -34.34 10.74 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.982 1.264 . . . . 0.0 114.105 -174.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.92 157.8 35.92 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 121.113 1.778 . . . . 0.0 112.166 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -164.12 134.38 4.17 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 -163.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.511 ' HD3' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -120.2 -178.03 3.57 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.638 1.575 . . . . 0.0 114.332 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.511 ' H ' ' HD3' ' A' ' 101' ' ' ARG . 8.9 p -163.37 174.67 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 127.733 2.413 . . . . 0.0 112.278 -140.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.425 ' HA ' HG13 ' A' ' 150' ' ' VAL . 75.0 m -129.72 135.51 48.56 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.081 -1.012 . . . . 0.0 111.333 144.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.3 t0 178.57 166.76 0.85 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 127.865 2.466 . . . . 0.0 107.249 -168.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -128.76 121.39 28.3 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.166 1.386 . . . . 0.0 113.959 162.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -160.38 -176.68 5.75 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 126.027 1.731 . . . . 0.0 110.923 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -80.67 165.67 21.78 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.442 -1.411 . . . . 0.0 111.481 164.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.7 tp -144.67 141.2 29.16 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.555 1.142 . . . . 0.0 111.149 -170.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.3 m -77.98 151.67 33.5 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.09 1.756 . . . . 0.0 115.293 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.65 -8.62 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 127.094 2.158 . . . . 0.0 116.131 -161.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -137.6 38.65 2.43 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.769 1.228 . . . . 0.0 112.787 -170.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -106.05 165.95 10.85 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.257 1.423 . . . . 0.0 113.753 -164.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.57 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . . . -146.95 133.73 20.06 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 125.537 1.535 . . . . 0.0 110.157 -170.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.8 144.28 20.2 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.823 1.249 . . . . 0.0 111.38 -174.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.453 ' CG2' HG22 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -129.77 141.76 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 121.472 1.942 . . . . 0.0 113.965 174.628 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.99 149.87 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.648 1.179 . . . . 0.0 110.784 175.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 t -146.6 172.59 13.34 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.013 0.925 . . . . 0.0 112.091 168.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.37 -34.17 66.4 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.71 -41.92 67.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.712 0.687 . . . . 0.0 112.385 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -75.4 -26.51 58.46 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.884 0.874 . . . . 0.0 112.734 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.2 tp -75.51 -38.96 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.212 1.005 . . . . 0.0 111.452 170.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -55.11 -39.96 69.96 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.23 1.012 . . . . 0.0 111.315 168.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -66.97 -20.22 65.85 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.344 1.058 . . . . 0.0 112.794 -173.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 66.9 mt -69.74 -41.43 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 118.67 0.668 . . . . 0.0 110.463 -177.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.499 ' H ' ' HD2' ' A' ' 126' ' ' PRO . 33.5 ttpt -167.39 -47.73 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.765 0 CA-C-O 116.559 -1.686 . . . . 0.0 112.301 175.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.499 ' HD2' ' H ' ' A' ' 125' ' ' LYS . 41.2 Cg_endo -82.58 -132.84 0.01 OUTLIER 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 122.606 2.204 . . . . 0.0 112.949 -170.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 20.9 t -166.7 133.94 2.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.2 1.8 . . . . 0.0 111.209 -164.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . 0.253 25.4 p30 -70.69 3.76 2.94 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 -161.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -104.67 10.4 34.8 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.61 1.964 . . . . 0.0 113.208 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.07 29.17 0.16 Allowed Glycine 0 CA--C 1.534 1.271 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.6 t -83.58 135.61 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 119.139 1.469 . . . . 0.0 112.349 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.49 105.67 11.9 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.992 0.917 . . . . 0.0 108.691 153.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.34 144.62 31.39 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.699 0.8 . . . . 0.0 110.086 166.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.457 HD21 HG21 ' A' ' 55' ' ' VAL . 48.0 t30 -137.05 136.93 38.83 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.692 0.797 . . . . 0.0 109.411 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 43.2 t -128.11 133.81 49.05 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.846 0.859 . . . . 0.0 111.42 -169.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.5 t -132.55 111.35 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.119 0.968 . . . . 0.0 109.483 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.658 HG23 HG22 ' A' ' 52' ' ' THR . 29.7 m -105.22 151.61 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.573 1.549 . . . . 0.0 110.595 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -124.7 135.63 53.2 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.152 1.381 . . . . 0.0 111.256 157.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.457 ' HE3' ' CE2' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -77.32 144.52 38.0 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.278 1.031 . . . . 0.0 112.166 135.516 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.0 m -147.31 76.57 1.41 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.735 2.014 . . . . 0.0 109.061 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -65.66 -48.48 71.99 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.539 -1.351 . . . . 0.0 113.617 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.1 m -57.75 -39.66 77.89 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.072 -1.017 . . . . 0.0 111.715 174.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.05 -0.16 68.95 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 126.304 1.907 . . . . 0.0 115.938 173.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 75.9 mtm 43.37 53.14 5.68 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.078 2.551 . . . . 0.0 115.241 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 99.5 p -148.66 163.39 37.42 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.457 ' CE2' ' HE3' ' A' ' 139' ' ' LYS . 41.8 m-85 -100.2 151.84 20.97 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.684 147.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -134.95 141.85 46.36 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.04 137.31 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.81 0.814 . . . . 0.0 110.647 -161.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -135.79 139.26 43.38 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.498 1.519 . . . . 0.0 108.587 169.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 103' ' ' CYS . 2.2 p -140.9 134.39 32.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 122.363 1.077 . . . . 0.0 109.196 149.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 30.2 m -116.65 143.18 27.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 127.95 2.5 . . . . 0.0 109.033 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.82 129.95 39.19 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -165.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -134.43 156.05 49.24 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.576 1.551 . . . . 0.0 110.799 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.552 ' H ' ' CD ' ' A' ' 155' ' ' PRO . . . -171.78 33.33 0.14 Allowed Glycine 0 CA--C 1.546 1.97 0 CA-C-O 116.364 -2.354 . . . . 0.0 117.28 161.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.552 ' CD ' ' H ' ' A' ' 154' ' ' GLY . 59.5 Cg_endo -105.62 -49.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.037 0 CA-C-N 121.812 2.806 . . . . 0.0 113.353 160.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -117.74 -26.96 6.38 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 53.79 1.28 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 118.289 2.7 . . . . 0.0 118.289 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.97 -45.31 94.23 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -155.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.91 -53.07 29.25 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -169.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -69.04 -31.56 70.43 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.889 0.876 . . . . 0.0 112.241 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -60.63 -55.31 34.79 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.048 0.84 . . . . 0.0 110.84 172.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -64.5 -34.16 77.56 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.385 -0.822 . . . . 0.0 112.721 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.21 -33.19 74.96 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.99 1.268 . . . . 0.0 112.654 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -50.97 51.29 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.425 1.49 . . . . 0.0 108.868 173.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 76.7 mt -60.59 -38.09 83.51 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.231 1.012 . . . . 0.0 111.439 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -70.0 -32.16 70.2 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 127.059 2.143 . . . . 0.0 112.939 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -86.72 -37.96 17.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.31 1.044 . . . . 0.0 113.359 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.6 pt -77.55 -34.2 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 119.33 0.968 . . . . 0.0 111.629 -178.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -63.45 -19.83 65.05 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.826 -0.546 . . . . 0.0 111.256 166.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -117.01 26.49 9.76 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 . . . . . 0 C--O 1.252 1.186 0 C-N-CA 128.42 2.688 . . . . 0.0 114.886 168.874 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 121.16 0.505 . . . . 0.0 111.443 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -64.21 -6.27 6.44 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 118.379 2.733 . . . . 0.0 118.379 -139.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.6 -4.24 15.54 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 120.37 1.441 . . . . 0.0 114.033 172.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 78.6 t -69.51 -56.17 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.825 1.25 . . . . 0.0 111.649 -172.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.34 -43.18 98.88 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.6 -54.31 43.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 117.925 0.862 . . . . 0.0 112.147 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -67.11 -37.85 84.59 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.088 -1.007 . . . . 0.0 113.602 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -69.18 -45.91 68.8 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.848 1.204 . . . . 0.0 111.845 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.85 -43.09 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.299 0.64 . . . . 0.0 109.745 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -68.88 -37.15 78.84 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.588 0.631 . . . . 0.0 112.609 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -76.02 -30.63 58.55 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.061 -1.024 . . . . 0.0 111.695 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.4 m -62.98 -46.52 87.32 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.799 1.636 . . . . 0.0 110.397 169.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.5 ttt-85 -52.84 -34.73 55.48 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.086 1.754 . . . . 0.0 112.396 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -83.03 -49.1 9.9 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.741 -1.224 . . . . 0.0 113.258 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.03 -28.86 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.41 1.084 . . . . 0.0 111.878 -174.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -91.71 -8.71 46.18 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.809 1.243 . . . . 0.0 112.633 171.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.5 mtp-105 58.09 17.98 4.89 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.925 2.09 . . . . 0.0 115.07 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 pp -94.31 159.04 15.3 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.331 1.452 . . . . 0.0 111.734 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -81.89 163.16 22.45 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 119.641 1.109 . . . . 0.0 112.467 176.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -64.8 -34.74 79.06 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 119.512 -1.993 . . . . 0.0 111.393 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -60.42 -16.85 39.96 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.429 2.291 . . . . 0.0 113.382 166.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -105.6 -9.83 17.17 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.958 1.254 . . . . 0.0 111.708 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.462 HD11 ' HB1' ' A' ' 48' ' ' ALA . 26.5 tp -91.47 135.57 33.74 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.265 1.826 . . . . 0.0 108.868 176.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -106.39 128.36 53.98 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 118.363 0.529 . . . . 0.0 112.395 170.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.4 mm -97.26 142.0 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.919 2.087 . . . . 0.0 112.829 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.2 m -124.92 146.34 49.4 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.371 0.987 . . . . 0.0 108.836 167.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -123.56 -153.42 0.55 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.336 2.254 . . . . 0.0 110.642 -163.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 t -36.8 -36.04 0.1 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 128.306 2.643 . . . . 0.0 116.241 -167.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.1 -43.56 70.5 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 174.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.72 -22.83 25.78 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 121.164 1.802 . . . . 0.0 112.419 175.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.8 mm -58.29 -39.7 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.144 0.977 . . . . 0.0 109.45 173.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 57.0 m -55.65 6.73 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -117.59 13.92 14.4 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 121.518 1.963 . . . . 0.0 112.034 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.9 170.2 5.68 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 126.511 1.924 . . . . 0.0 109.145 146.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -66.92 -51.14 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 121.721 1.614 . . . . 0.0 114.693 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -124.82 -34.32 2.83 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 117.562 2.43 . . . . 0.0 117.562 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -161.12 100.24 1.22 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 122.893 1.33 . . . . 0.0 109.458 -137.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.9 m -140.44 165.62 26.92 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.261 2.224 . . . . 0.0 107.507 173.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.46 HD13 ' HB2' ' A' ' 46' ' ' CYS 0.29 1.1 tm? -87.47 -77.2 0.35 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 117.288 -1.339 . . . . 0.0 113.058 -164.088 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.46 ' HB2' HD13 ' A' ' 45' ' ' LEU . 12.7 m -163.94 -175.56 4.12 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.954 1.706 . . . . 0.0 111.86 -172.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -119.82 156.98 29.62 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.301 1.44 . . . . 0.0 107.398 157.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -137.39 131.62 32.32 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.738 2.815 . . . . 0.0 108.07 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.5 ttp -121.93 134.47 54.85 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.232 1.378 . . . . 0.0 110.661 -169.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 mt -131.7 146.44 52.17 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 128.473 2.709 . . . . 0.0 113.385 -148.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.6 t -98.62 159.12 15.17 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.066 1.346 . . . . 0.0 113.581 -171.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -71.38 170.84 12.34 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.229 1.811 . . . . 0.0 112.66 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.7 t70 57.89 36.23 26.09 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 170.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.58 134.66 60.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.993 1.717 . . . . 0.0 110.079 -176.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.9 p -91.24 139.17 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.966 0.907 . . . . 0.0 109.456 159.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -134.28 136.93 26.88 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 118.862 0.756 . . . . 0.0 111.701 169.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.45 69.75 5.79 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.905 3.737 . . . . 0.0 111.105 177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.4 p -62.29 -43.53 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -152.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.97 -9.31 58.18 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.037 -1.039 . . . . 0.0 113.093 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -65.54 -33.37 75.77 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.775 1.171 . . . . 0.0 111.598 165.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.9 tp -70.18 -37.45 75.15 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.656 0.662 . . . . 0.0 111.32 173.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.92 -49.87 76.01 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.375 0.534 . . . . 0.0 111.911 173.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.3 p -67.45 -31.97 72.5 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 119.175 -0.44 . . . . 0.0 112.119 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -63.6 -39.15 93.63 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.947 0.794 . . . . 0.0 112.512 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -66.26 -51.71 54.85 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.492 1.042 . . . . 0.0 112.299 169.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.26 -41.07 83.45 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.662 0.385 . . . . 0.0 111.514 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 83.1 m -77.43 -2.57 35.96 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.95 -34.66 13.68 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.379 1.472 . . . . 0.0 114.046 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.2 m -137.29 -8.73 1.73 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.32 74.49 0.43 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 126.006 1.765 . . . . 0.0 112.523 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -166.9 136.44 2.94 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.304 1.442 . . . . 0.0 109.775 161.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.4 m -64.47 142.81 58.29 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.031 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.74 151.08 47.82 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 m -75.29 103.94 5.65 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.326 1.851 . . . . 0.0 109.768 167.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -87.74 99.83 12.38 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 166.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.07 147.4 6.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 C-N-CA 126.585 1.954 . . . . 0.0 108.254 -171.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -130.72 121.42 25.43 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 120.513 -1.367 . . . . 0.0 107.583 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -121.7 121.01 36.35 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.303 1.841 . . . . 0.0 109.412 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -95.84 125.41 40.38 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.895 1.678 . . . . 0.0 108.892 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.4 p -143.71 155.31 44.16 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -174.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.94 80.61 0.1 OUTLIER Glycine 0 N--CA 1.476 1.339 0 C-N-CA 130.39 3.852 . . . . 0.0 112.175 -172.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.3 t 168.95 -128.15 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 -136.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -129.28 178.7 6.25 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 130.379 3.472 . . . . 0.0 109.336 -176.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.8 t -75.96 136.66 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.574 -1.329 . . . . 0.0 109.203 164.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.3 m -114.78 152.62 31.78 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.858 0.754 . . . . 0.0 112.28 170.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 tp -108.81 108.68 19.58 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.084 2.154 . . . . 0.0 105.705 164.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.2 m -80.93 102.63 10.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 167.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 44.1 t -102.49 111.28 23.51 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 119.778 -1.826 . . . . 0.0 108.556 -173.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -150.93 151.0 31.52 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 118.628 2.825 . . . . 0.0 118.628 174.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.631 HD13 ' H ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -70.94 84.17 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 112.632 -2.077 . . . . 0.0 108.503 143.768 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.22 166.21 38.61 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 118.7 2.24 . . . . 0.0 118.7 -163.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -156.27 49.35 0.4 Allowed Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -170.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -47.4 121.25 5.22 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.241 1.961 . . . . 0.0 113.112 166.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -44.17 -13.69 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 118.615 2.82 . . . . 0.0 118.615 -169.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 95' ' ' ARG . 3.7 mmp_? -59.89 -23.59 63.59 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.283 1.401 . . . . 0.0 113.856 163.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -50.93 -28.58 10.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.831 2.052 . . . . 0.0 112.72 166.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -62.28 -34.8 77.26 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.661 175.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -115.75 -22.39 9.16 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -174.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.502 ' C ' HD12 ' A' ' 99' ' ' LEU . 2.4 pp -75.67 165.59 24.83 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 121.346 1.885 . . . . 0.0 114.1 -176.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -152.16 118.08 5.47 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -163.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.471 ' HD2' ' H ' ' A' ' 102' ' ' VAL . 0.1 OUTLIER -107.43 178.15 4.62 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 120.495 1.498 . . . . 0.0 111.926 161.874 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.471 ' H ' ' HD2' ' A' ' 101' ' ' ARG . 3.0 p -172.35 173.62 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.587 -140.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.421 ' HA ' HG13 ' A' ' 150' ' ' VAL . 64.8 m -120.86 124.82 45.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.33 0.652 . . . . 0.0 109.501 137.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -172.31 171.41 4.79 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.71 2.404 . . . . 0.0 107.514 -166.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -122.72 99.85 6.61 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.006 2.522 . . . . 0.0 110.061 172.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -140.51 148.4 41.02 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 -173.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -82.19 142.04 32.52 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.914 1.286 . . . . 0.0 110.578 165.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 37.9 tp -148.23 141.59 25.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.076 0.95 . . . . 0.0 110.087 -150.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 p -93.09 168.9 10.81 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 116.941 2.201 . . . . 0.0 116.941 -169.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.6 t -69.76 -6.92 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 128.145 2.578 . . . . 0.0 113.083 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -134.74 45.84 2.51 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.469 1.108 . . . . 0.0 110.25 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -125.59 152.26 45.35 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 116.064 1.875 . . . . 0.0 116.064 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.696 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -149.3 142.46 25.0 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.632 -146.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.696 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -144.38 147.95 34.06 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.183 1.393 . . . . 0.0 111.521 -168.485 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -136.31 141.64 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 121.404 1.911 . . . . 0.0 113.166 158.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.59 153.28 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.88 0.872 . . . . 0.0 110.538 167.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.0 t -143.01 167.34 22.29 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.696 0.798 . . . . 0.0 109.979 162.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.93 -36.09 76.3 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -160.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.7 73.03 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.791 -1.193 . . . . 0.0 113.791 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -70.7 -30.83 67.51 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.394 -0.816 . . . . 0.0 111.627 175.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.0 mm -73.37 -35.51 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.012 0.925 . . . . 0.0 111.076 169.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -59.9 -25.48 65.14 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.448 -0.783 . . . . 0.0 111.931 170.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -83.2 -7.64 59.59 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 168.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.9 mt -89.21 -40.05 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.803 1.183 . . . . 0.0 109.987 167.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -143.31 124.36 8.16 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.603 1.161 . . . . 0.0 110.413 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -82.5 60.1 7.16 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 123.943 3.095 . . . . 0.0 114.355 -163.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 45.6 t -155.84 134.59 11.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.56 1.544 . . . . 0.0 110.201 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -122.85 -4.01 8.63 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -85.2 12.85 7.16 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.85 50.83 0.06 OUTLIER Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.71 1.148 . . . . 0.0 113.516 -176.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.83 125.12 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 117.947 0.873 . . . . 0.0 110.701 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.83 88.04 2.52 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.518 1.527 . . . . 0.0 108.229 169.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.608 HG22 ' HA ' ' A' ' 152' ' ' ALA . 17.6 p -83.83 146.39 28.14 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.908 0.883 . . . . 0.0 109.316 164.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.46 125.77 52.15 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 18.8 t -118.43 127.8 54.0 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.39 0.996 . . . . 0.0 109.131 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.4 t -138.43 116.91 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.411 1.084 . . . . 0.0 109.149 -167.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 148' ' ' ILE . 20.1 m -112.3 140.59 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.268 -0.895 . . . . 0.0 111.421 -175.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 29.0 ttm105 -129.57 98.23 4.77 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 122.162 0.982 . . . . 0.0 110.343 171.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.473 ' HG3' ' CD2' ' A' ' 146' ' ' TYR 0.251 9.0 tmtt? -120.13 134.98 55.11 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.767 1.227 . . . . 0.0 109.047 -178.202 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.1 m -161.45 133.33 5.67 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.026 1.33 . . . . 0.0 110.585 -164.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -85.68 -35.55 20.81 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.766 -0.584 . . . . 0.0 112.496 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.1 p -48.45 -50.12 32.65 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.201 1.401 . . . . 0.0 113.398 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -96.29 11.25 67.28 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.258 1.885 . . . . 0.0 115.074 171.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 41.1 ttm 44.61 57.35 4.53 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.114 2.166 . . . . 0.0 115.397 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 97.9 p -147.82 142.86 27.02 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.473 ' CD2' ' HG3' ' A' ' 139' ' ' LYS . 1.0 OUTLIER -106.65 144.54 33.17 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 163.489 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -150.87 147.26 27.01 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.445 -1.409 . . . . 0.0 109.492 -173.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ILE . . . . . 0.428 HG13 HG12 ' A' ' 137' ' ' VAL . 6.8 tt -141.62 140.31 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 122.213 1.006 . . . . 0.0 113.4 -176.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -135.31 115.44 13.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.033 1.333 . . . . 0.0 109.941 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.421 HG13 ' HA ' ' A' ' 103' ' ' CYS 0.28 7.3 p -139.27 145.14 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 121.129 -0.982 . . . . 0.0 112.981 174.385 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.3 m -141.31 151.55 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 128.109 2.564 . . . . 0.0 109.643 -167.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.608 ' HA ' HG22 ' A' ' 133' ' ' THR . . . -125.59 125.73 43.65 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -168.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -142.18 156.88 45.36 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.686 1.194 . . . . 0.0 111.926 175.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -91.51 -148.92 22.87 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 124.519 1.057 . . . . 0.0 112.177 165.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.94 -22.72 10.69 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 124.53 3.487 . . . . 0.0 117.041 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.13 1.46 2.79 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 126.423 1.889 . . . . 0.0 115.595 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -90.86 38.84 0.97 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.192 1.797 . . . . 0.0 112.163 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -62.36 -28.85 70.05 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -167.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.32 -51.49 51.83 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.918 0.781 . . . . 0.0 112.099 -176.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -65.18 -34.21 77.84 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.934 0.894 . . . . 0.0 112.468 170.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -62.02 -49.31 76.53 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.427 1.012 . . . . 0.0 111.457 175.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -65.83 -29.67 70.17 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.81 -1.182 . . . . 0.0 112.701 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.42 83.91 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 119.189 0.904 . . . . 0.0 112.671 171.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.92 -54.29 19.84 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.523 1.129 . . . . 0.0 112.763 174.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.7 mp -46.79 -34.92 5.68 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.752 1.221 . . . . 0.0 113.983 167.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -74.67 -25.78 59.41 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.46 1.504 . . . . 0.0 113.357 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -89.71 -36.63 15.09 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.537 1.062 . . . . 0.0 113.664 170.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.2 pt -88.42 -42.37 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.063 -1.023 . . . . 0.0 112.724 -169.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -71.33 -6.15 37.78 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.622 1.555 . . . . 0.0 111.355 171.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -119.62 23.18 11.3 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 172.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 . . . . . 0 C--O 1.252 1.207 0 C-N-CA 126.472 1.909 . . . . 0.0 112.503 169.967 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -19.03 64.53 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -163.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -85.21 -24.0 28.05 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.798 0.839 . . . . 0.0 112.283 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.4 t -73.38 -53.68 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.682 1.193 . . . . 0.0 112.565 -165.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.12 -52.04 53.78 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 168.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.8 -39.93 59.53 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 118.443 1.121 . . . . 0.0 113.323 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -74.74 -39.24 61.96 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.867 -1.146 . . . . 0.0 113.972 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.12 -40.74 98.5 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.614 1.166 . . . . 0.0 111.7 173.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.52 -43.05 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.053 1.341 . . . . 0.0 109.721 174.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.4 m -66.64 -31.21 71.75 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.296 -0.878 . . . . 0.0 112.918 175.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -67.37 -44.19 79.57 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.318 -0.864 . . . . 0.0 109.345 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.3 m -60.55 -43.61 97.04 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.168 -1.582 . . . . 0.0 111.753 175.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -54.24 -32.09 55.11 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.27 1.828 . . . . 0.0 112.8 171.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.22 -46.79 10.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.053 1.341 . . . . 0.0 113.449 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.6 mm -66.63 -49.21 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 119.691 1.132 . . . . 0.0 110.889 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.66 -2.88 57.11 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.036 1.334 . . . . 0.0 112.528 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 59.33 11.52 2.21 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 127.629 2.372 . . . . 0.0 115.43 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.458 HD11 HD13 ' A' ' 29' ' ' LEU . 2.7 pp -94.45 154.97 17.17 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.112 0.965 . . . . 0.0 111.172 -176.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.81 155.93 38.21 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.441 -0.787 . . . . 0.0 112.917 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.79 -24.13 63.87 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.83 -1.169 . . . . 0.0 112.546 171.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -97.04 8.74 43.85 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.489 1.516 . . . . 0.0 113.316 172.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -118.73 8.52 11.88 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.963 1.705 . . . . 0.0 111.478 167.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.458 HD13 HD11 ' A' ' 24' ' ' LEU . 21.3 tp -107.74 127.7 53.92 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.859 2.463 . . . . 0.0 107.521 166.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -94.34 115.39 27.61 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 120.076 1.307 . . . . 0.0 111.305 171.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.451 HD11 HD23 ' A' ' 29' ' ' LEU . 32.8 mm -91.02 143.06 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.292 1.437 . . . . 0.0 112.58 170.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.4 m -126.71 147.75 49.93 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 162.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.57 -148.29 0.26 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.309 1.444 . . . . 0.0 112.265 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.9 t -58.51 -29.17 66.08 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -162.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.77 -33.36 34.9 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -169.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.62 -4.84 27.66 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.45 14.42 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 124.806 1.242 . . . . 0.0 111.974 167.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.4 t -57.89 12.06 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 128.64 2.776 . . . . 0.0 117.985 -163.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.407 ' HE2' ' CD1' ' A' ' 92' ' ' PHE . 48.9 tptt -57.4 -40.37 78.12 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 119.798 -1.814 . . . . 0.0 113.033 -172.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -127.02 139.19 34.4 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 132.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -58.54 -31.06 93.61 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 CA-C-N 121.663 1.63 . . . . 0.0 112.571 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -96.46 30.97 2.37 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.237 1.815 . . . . 0.0 110.403 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -147.86 101.12 3.28 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.472 1.487 . . . . 0.0 107.299 159.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 p 179.91 151.24 0.4 Allowed 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.985 -1.072 . . . . 0.0 111.986 -139.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.36 -81.17 0.52 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 164.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.1 p -166.51 -174.48 2.85 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -174.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -122.82 154.98 37.51 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.403 1.881 . . . . 0.0 107.891 163.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.95 122.81 10.64 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.797 1.635 . . . . 0.0 109.094 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.3 ttm -117.94 129.28 55.52 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.748 -1.22 . . . . 0.0 111.564 -160.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.27 0.3 OUTLIER -138.4 156.6 47.44 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 124.677 2.18 . . . . 0.0 115.979 -159.019 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 t -99.24 167.96 10.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 130.446 3.498 . . . . 0.0 108.515 -172.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -50.95 114.0 1.06 Allowed 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.574 1.079 . . . . 0.0 109.334 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.471 ' C ' HD13 ' A' ' 54' ' ' ILE . 1.3 t70 -151.69 156.8 41.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.754 1.264 . . . . 0.0 109.865 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.471 HD13 ' C ' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -119.51 -176.8 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 113.243 -1.799 . . . . 0.0 109.044 -146.414 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.5 p -70.16 121.65 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 121.485 -0.759 . . . . 0.0 111.598 -132.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -130.34 151.5 78.63 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -166.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -80.22 80.98 2.88 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 124.425 3.417 . . . . 0.0 111.031 -166.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 p -69.42 -39.17 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -164.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.2 -33.36 75.21 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 119.688 1.131 . . . . 0.0 113.26 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -57.7 -37.86 74.22 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 119.105 -0.474 . . . . 0.0 110.621 167.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.51 -44.88 61.6 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.917 1.287 . . . . 0.0 112.083 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.405 ' HA ' ' CE1' ' A' ' 75' ' ' PHE . 5.1 mp -52.5 -46.73 66.77 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 122.147 0.975 . . . . 0.0 110.621 169.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.1 m -72.23 -39.81 68.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.616 0.766 . . . . 0.0 112.168 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -63.94 -41.78 97.51 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.736 0.698 . . . . 0.0 110.837 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.15 -55.65 29.86 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.272 1.029 . . . . 0.0 110.993 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.38 -29.36 68.05 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -176.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.1 t -76.35 -32.09 58.46 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -61.25 -25.68 67.24 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 -161.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.7 t -141.66 4.97 1.76 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.661 1.184 . . . . 0.0 113.289 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.52 78.4 0.2 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.895 1.712 . . . . 0.0 111.34 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -166.64 134.18 2.62 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.007 1.723 . . . . 0.0 107.555 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.3 m -76.64 149.73 36.47 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 128.19 2.596 . . . . 0.0 112.973 -173.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -152.05 165.43 34.74 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.628 1.171 . . . . 0.0 113.839 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 27.4 p -108.81 142.37 39.48 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.432 0.693 . . . . 0.0 111.551 156.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.405 ' CE1' ' HA ' ' A' ' 62' ' ' LEU . 3.0 m-85 -82.6 132.58 35.19 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.442 1.097 . . . . 0.0 108.887 165.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.852 HG22 HG22 ' A' ' 115' ' ' VAL . 61.8 t -130.47 151.34 35.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 124.734 1.214 . . . . 0.0 109.348 -172.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -131.05 122.59 27.03 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -124.62 108.77 12.4 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.906 2.083 . . . . 0.0 108.538 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -90.74 123.37 34.27 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.381 -0.824 . . . . 0.0 109.447 173.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.8 p -148.07 150.52 34.05 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 130.132 3.373 . . . . 0.0 104.147 -166.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -11.5 -133.53 0.0 OUTLIER Glycine 0 N--CA 1.481 1.648 0 O-C-N 117.802 -3.061 . . . . 0.0 114.841 -121.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 13.2 p -90.69 88.22 7.01 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 120.145 1.972 . . . . 0.0 108.434 169.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.0 ttt85 -169.61 144.02 2.85 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 128.605 2.762 . . . . 0.0 109.044 166.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.1 t -83.32 140.02 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 119.995 1.271 . . . . 0.0 109.675 171.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.45 143.8 40.23 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 121.007 -1.058 . . . . 0.0 111.328 157.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tp -107.95 107.0 17.52 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 171.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.436 ' HB3' ' CE1' ' A' ' 89' ' ' TYR . 7.5 m -98.1 130.26 44.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.383 -172.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 76.1 m -117.57 108.38 15.4 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.11 -1.619 . . . . 0.0 109.007 -170.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CE1' ' HB3' ' A' ' 87' ' ' SER . 14.4 m-30 -121.92 98.43 5.94 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.414 0.626 . . . . 0.0 110.619 -157.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.3 mt -59.88 -38.36 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.46 -177.54 16.37 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.802 1.668 . . . . 0.0 110.634 166.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.407 ' CD1' ' HE2' ' A' ' 39' ' ' LYS . 26.4 p90 -107.46 96.05 15.29 Favored Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -163.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.38 -177.76 3.23 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 124.126 3.217 . . . . 0.0 115.973 -173.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -50.37 -39.58 46.97 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 117.284 2.328 . . . . 0.0 117.284 -160.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.265 17.1 mmt180 -98.85 -3.67 34.86 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 175.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.55 -33.86 47.58 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.556 2.343 . . . . 0.0 114.052 175.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -50.82 -35.9 34.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.398 1.079 . . . . 0.0 111.45 169.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.01 -27.8 8.27 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -169.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.439 HD12 HG23 ' A' ' 115' ' ' VAL . 3.9 pp -87.37 144.54 26.72 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 121.042 1.746 . . . . 0.0 112.231 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -157.07 126.43 6.04 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -153.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -115.57 -172.3 2.13 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 128.369 2.668 . . . . 0.0 112.529 173.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -166.22 168.55 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 129.094 2.957 . . . . 0.0 108.842 -135.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -123.45 122.48 38.34 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.142 0.883 . . . . 0.0 110.695 138.542 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -176.88 175.53 1.6 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 129.029 2.931 . . . . 0.0 106.144 -165.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -105.93 117.91 35.23 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 128.28 2.632 . . . . 0.0 109.04 171.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -151.18 160.05 44.07 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -92.55 162.7 14.09 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.892 1.677 . . . . 0.0 112.613 170.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.8 mt -141.06 152.05 44.51 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 129.441 3.096 . . . . 0.0 111.026 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 m -128.12 167.3 16.97 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.822 2.449 . . . . 0.0 110.224 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.283 0.9 OUTLIER -69.92 -4.88 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -173.536 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -122.25 32.9 5.63 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.556 1.143 . . . . 0.0 113.012 167.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -104.01 132.66 50.05 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.095 -1.003 . . . . 0.0 110.303 -173.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.728 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -140.25 138.08 34.77 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.122 0.969 . . . . 0.0 112.846 -166.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.728 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -144.22 141.15 29.71 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.974 1.31 . . . . 0.0 112.712 -165.978 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.852 HG22 HG22 ' A' ' 76' ' ' VAL . 17.0 t -118.42 137.9 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 126.603 1.961 . . . . 0.0 111.919 168.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.1 t -125.66 121.36 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.744 0.783 . . . . 0.0 109.711 157.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 73.3 p -90.02 163.95 14.71 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.075 0.95 . . . . 0.0 110.575 165.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.47 -35.23 73.68 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.332 -0.855 . . . . 0.0 111.08 174.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.38 -34.88 78.2 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -63.12 -33.52 75.63 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.953 1.251 . . . . 0.0 112.175 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.8 mm -77.18 -36.07 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.087 0.955 . . . . 0.0 111.433 172.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -54.88 -38.65 67.8 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.802 0.841 . . . . 0.0 111.294 174.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.3 mmt-85 -74.16 -12.77 60.68 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.427 ' C ' ' HE2' ' A' ' 125' ' ' LYS . 20.3 mt -73.25 -26.54 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 119.973 1.26 . . . . 0.0 110.192 175.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.427 ' HE2' ' C ' ' A' ' 124' ' ' ILE . 0.5 OUTLIER -105.12 161.5 22.56 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 125.127 1.371 . . . . 0.0 111.634 175.211 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -74.35 -39.69 1.45 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.623 2.215 . . . . 0.0 113.131 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 42.2 t -152.41 134.34 14.84 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.58 1.952 . . . . 0.0 108.439 174.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -73.8 -53.29 10.6 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 -154.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? 51.74 10.31 0.1 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 128.66 2.784 . . . . 0.0 116.823 166.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 132.75 67.45 0.08 OUTLIER Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.337 1.446 . . . . 0.0 112.536 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 76.8 t -72.85 130.48 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.216 0.607 . . . . 0.0 111.289 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 50.4 tp -119.37 157.59 27.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 123.147 1.451 . . . . 0.0 109.169 145.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 49.8 m -149.48 146.56 27.47 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 119.392 -2.068 . . . . 0.0 106.426 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -123.99 127.93 48.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -166.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 38.2 t -126.65 138.37 53.41 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.213 0.605 . . . . 0.0 109.945 -171.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.8 t -142.84 139.53 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.31 1.444 . . . . 0.0 108.966 -174.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.5 m -129.5 139.04 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.849 0.833 . . . . 0.0 112.152 174.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 43.2 mtm105 -126.0 150.58 47.97 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 127.985 2.514 . . . . 0.0 108.685 172.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.27 1.9 tmtt? -153.24 151.72 30.38 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.434 1.094 . . . . 0.0 109.07 172.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.6 t -134.22 127.83 32.71 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.787 1.176 . . . . 0.0 107.84 170.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -73.23 -55.61 6.21 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.084 0.402 . . . . 0.0 111.069 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.1 p -65.07 -31.87 73.3 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.176 1.391 . . . . 0.0 113.077 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.05 2.22 76.48 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.874 1.226 . . . . 0.0 115.222 170.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.8 mmt 48.12 40.74 14.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.095 1.758 . . . . 0.0 114.96 173.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.3 m -147.91 137.74 22.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.397 0.679 . . . . 0.0 111.58 -170.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -125.35 131.42 53.0 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -152.46 112.27 3.97 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 120.468 1.486 . . . . 0.0 112.89 -147.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 4.8 pt -137.12 151.57 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 O-C-N 120.932 -1.105 . . . . 0.0 113.351 -163.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.34 144.15 36.16 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.938 0.875 . . . . 0.0 111.507 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.8 p -146.18 136.93 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 121.07 -1.019 . . . . 0.0 109.927 169.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.5 m -131.7 125.79 56.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.723 1.609 . . . . 0.0 108.843 -165.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -113.98 135.7 53.71 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.955 0.902 . . . . 0.0 112.409 -167.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -144.38 159.13 43.25 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.175 0.988 . . . . 0.0 113.614 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -89.74 -140.97 8.29 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 160.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.04 83.89 0.26 Allowed 'Trans proline' 0 CA--C 1.548 1.22 0 CA-C-N 119.344 1.572 . . . . 0.0 110.421 153.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -123.02 -25.29 4.57 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 172.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.11 74.91 1.42 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -172.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -51.05 -35.4 34.41 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.136 -1.393 . . . . 0.0 112.396 175.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.54 -35.1 75.18 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.464 1.029 . . . . 0.0 113.311 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.13 -44.04 55.22 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.345 1.058 . . . . 0.0 111.637 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -54.75 -49.27 71.25 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.51 1.05 . . . . 0.0 111.36 175.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -63.98 -41.02 97.66 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.843 1.657 . . . . 0.0 112.261 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.23 -31.65 72.22 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.473 -0.767 . . . . 0.0 112.554 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.63 -47.24 61.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.226 -0.921 . . . . 0.0 112.982 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 96.6 mt -53.72 -37.69 63.56 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.011 0.525 . . . . 0.0 111.772 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 88.1 mtm-85 -75.54 -32.9 60.61 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -73.93 -39.18 63.97 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.353 1.061 . . . . 0.0 112.646 173.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.9 pt -90.91 -38.62 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.144 -0.972 . . . . 0.0 112.639 -168.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -85.81 4.41 37.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.657 0.662 . . . . 0.0 111.44 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.75 29.52 5.0 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 165.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 . . . . . 0 C--O 1.258 1.542 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 -179.512 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -48.18 -32.51 7.15 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.246 2.218 . . . . 0.0 114.746 174.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -93.46 -25.09 17.79 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.084 0.856 . . . . 0.0 112.04 -177.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.3 t -62.55 -51.02 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.064 0.946 . . . . 0.0 109.762 170.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.36 -50.49 59.63 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.233 -0.759 . . . . 0.0 112.291 168.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.42 -47.25 79.45 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.805 1.303 . . . . 0.0 113.055 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -74.07 -40.86 62.49 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.092 0.957 . . . . 0.0 112.615 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.51 -33.33 62.77 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.552 1.524 . . . . 0.0 113.074 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.1 mp -68.92 -38.92 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 119.06 0.845 . . . . 0.0 109.555 169.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.6 m -59.9 -45.44 92.51 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.054 -1.029 . . . . 0.0 112.483 171.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -77.55 -28.07 51.74 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -173.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 p -66.79 -53.2 35.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.135 1.334 . . . . 0.0 110.252 168.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -49.16 -46.65 45.66 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.611 1.564 . . . . 0.0 112.786 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -70.22 -49.21 52.5 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.014 1.726 . . . . 0.0 114.463 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.93 -26.49 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.687 1.131 . . . . 0.0 111.198 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.6 mt -82.07 -17.21 47.42 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 171.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 46.32 56.45 6.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.959 1.704 . . . . 0.0 112.343 -167.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 pp -125.99 166.53 16.76 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.886 1.274 . . . . 0.0 111.122 167.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -75.92 158.31 32.18 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.755 1.222 . . . . 0.0 112.503 176.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -61.94 -21.74 65.03 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 119.994 -1.692 . . . . 0.0 114.175 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -95.56 3.05 54.47 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.215 1.006 . . . . 0.0 112.932 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -101.54 -12.62 18.36 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.477 1.111 . . . . 0.0 111.487 169.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.48 HD23 HD11 ' A' ' 31' ' ' ILE . 18.2 tp -88.84 137.71 32.07 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.538 1.935 . . . . 0.0 105.863 165.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.477 ' H ' ' HB3' ' A' ' 49' ' ' MET . 39.9 ttt-85 -102.48 124.77 48.63 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.938 160.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.48 HD11 HD23 ' A' ' 29' ' ' LEU . 41.3 mm -90.42 142.75 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 125.469 1.508 . . . . 0.0 110.815 168.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.3 m -117.62 136.51 53.25 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 149.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -87.0 -151.09 0.16 Allowed 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 t -59.79 -21.21 60.5 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -166.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.37 -32.07 24.55 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.267 0.9 OUTLIER -96.03 -8.67 32.95 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 176.531 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.3 11.52 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.323 1.449 . . . . 0.0 111.732 166.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.9 t -64.15 6.43 0.18 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.627 2.371 . . . . 0.0 115.352 -167.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -61.37 -21.49 64.09 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 121.042 -1.036 . . . . 0.0 111.167 174.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -142.54 124.84 8.95 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 140.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.86 -15.98 53.07 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 121.842 1.695 . . . . 0.0 114.119 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -105.96 23.29 14.22 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.369 2.267 . . . . 0.0 111.97 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -154.92 94.44 1.65 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 170.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.1 p 175.57 154.78 0.17 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.727 -1.579 . . . . 0.0 108.083 -142.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.92 -82.22 0.48 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.367 1.44 . . . . 0.0 114.446 151.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 9.2 m -163.99 177.72 8.28 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.734 1.214 . . . . 0.0 112.966 -172.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -115.95 155.87 27.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.06 1.744 . . . . 0.0 108.59 165.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -131.9 138.86 48.56 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.208 2.603 . . . . 0.0 107.481 175.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.477 ' HB3' ' H ' ' A' ' 30' ' ' ARG . 11.1 tmm? -126.5 131.64 51.57 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.092 1.315 . . . . 0.0 109.329 -169.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 mt -123.27 142.36 51.02 Favored 'General case' 0 C--O 1.245 0.847 0 O-C-N 127.074 2.734 . . . . 0.0 111.736 -153.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.3 p -97.07 161.62 13.74 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.262 2.225 . . . . 0.0 112.673 -172.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.8 t -67.58 143.37 56.11 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . 0.271 12.7 t70 66.21 33.09 7.54 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.795 2.438 . . . . 0.0 114.646 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 tp -109.83 137.33 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.721 1.209 . . . . 0.0 111.858 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 p -110.4 141.12 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 125.701 1.6 . . . . 0.0 112.655 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -136.48 120.24 12.39 Favored Pre-proline 0 CA--C 1.548 0.9 0 O-C-N 120.803 -1.186 . . . . 0.0 111.64 166.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -65.29 80.23 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 125.03 3.82 . . . . 0.0 112.003 168.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.3 p -67.15 -30.75 50.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -151.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -55.2 -39.28 69.43 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 119.036 0.835 . . . . 0.0 112.538 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -62.38 -27.19 68.91 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.69 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.2 tp -81.3 -48.96 11.31 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.922 1.289 . . . . 0.0 112.511 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 mp -53.65 -49.2 68.45 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.461 0.704 . . . . 0.0 110.189 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.0 m -74.8 -27.54 60.35 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.254 1.022 . . . . 0.0 113.1 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -61.44 -34.69 75.84 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.294 1.406 . . . . 0.0 112.456 169.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TRP . . . . . 0.421 ' CZ2' HD11 ' A' ' 90' ' ' ILE . 41.6 t-105 -70.63 -57.75 4.39 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.461 0.573 . . . . 0.0 112.05 167.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.54 -36.35 83.48 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -169.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 45.7 t -59.01 -17.49 25.54 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.686 1.594 . . . . 0.0 113.355 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.1 ttt85 -70.21 -43.64 70.26 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.199 -0.938 . . . . 0.0 112.768 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.5 m -159.22 3.35 0.09 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -169.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.93 82.72 0.11 Allowed Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.205 0.907 . . . . 0.0 111.481 -171.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -146.65 124.51 11.96 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 126.862 2.065 . . . . 0.0 106.833 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.3 m -78.42 117.09 19.31 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 126.25 1.82 . . . . 0.0 112.482 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.24 139.26 35.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.889 1.675 . . . . 0.0 110.828 168.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 39.1 m -102.24 145.48 29.36 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.887 0.851 . . . . 0.0 111.256 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.82 105.09 10.85 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.711 1.604 . . . . 0.0 108.923 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.7 t -96.32 154.04 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 126.677 1.991 . . . . 0.0 108.815 176.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -142.11 110.82 6.17 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.874 2.07 . . . . 0.0 106.856 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -111.15 115.35 29.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.021 2.128 . . . . 0.0 110.161 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -93.12 134.85 34.87 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.691 -0.671 . . . . 0.0 112.046 174.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.1 p -153.65 167.44 29.57 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 130.892 3.677 . . . . 0.0 107.088 -156.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -9.81 -124.99 0.0 OUTLIER Glycine 0 N--CA 1.49 2.294 0 C-N-CA 130.063 3.697 . . . . 0.0 116.296 -167.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 17.1 m -96.45 104.39 16.36 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 111.774 -3.97 . . . . 0.0 107.97 146.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.42 139.29 0.44 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 129.753 3.221 . . . . 0.0 109.272 151.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.9 t -74.73 134.77 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.97 1.259 . . . . 0.0 110.05 154.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.46 138.93 45.09 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.59 0.756 . . . . 0.0 110.288 163.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.2 tt -111.16 112.48 24.3 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.089 1.755 . . . . 0.0 106.452 170.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.421 ' HB3' ' CE1' ' A' ' 89' ' ' TYR . 2.3 m -95.87 126.88 41.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.256 -178.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 49.0 t -108.5 111.03 22.68 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 119.976 -1.703 . . . . 0.0 107.9 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 87' ' ' SER . 21.9 m-30 -116.44 100.38 7.83 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.971 0.415 . . . . 0.0 111.507 -169.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.421 HD11 ' CZ2' ' A' ' 65' ' ' TRP . 42.9 mt -62.32 115.28 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 130.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -178.83 167.46 37.8 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 122.445 3.738 . . . . 0.0 122.445 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -126.47 49.66 4.11 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 126.748 2.019 . . . . 0.0 113.895 155.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.04 172.73 14.91 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.595 2.863 . . . . 0.0 114.38 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.1 -40.78 59.7 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -156.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.268 11.7 tpt180 -95.68 -7.33 37.77 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 116.299 1.962 . . . . 0.0 116.299 -177.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -51.09 -42.29 60.52 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 128.774 2.829 . . . . 0.0 113.708 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -64.5 -27.4 68.95 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 117.434 -1.27 . . . . 0.0 112.52 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -106.15 -24.78 12.26 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.411 HD22 ' HB1' ' A' ' 113' ' ' ALA . 3.8 pp -75.41 161.06 29.56 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-N 121.358 1.89 . . . . 0.0 113.647 169.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -168.24 137.02 2.35 Favored 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 117.746 2.499 . . . . 0.0 117.746 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.401 ' CG ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -105.83 179.72 4.19 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 127.639 2.376 . . . . 0.0 111.453 178.872 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.401 ' H ' ' CG ' ' A' ' 101' ' ' ARG . 2.5 p -165.82 174.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.465 1.906 . . . . 0.0 112.172 -142.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.449 ' HA ' HG13 ' A' ' 150' ' ' VAL . 11.1 t -117.22 121.88 42.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.822 1.249 . . . . 0.0 109.354 151.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -171.55 153.7 3.54 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.369 1.868 . . . . 0.0 108.082 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -120.76 112.16 18.49 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.35 1.86 . . . . 0.0 110.724 172.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -160.06 -172.8 3.76 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.82 1.248 . . . . 0.0 112.04 -157.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -102.43 160.52 14.48 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.094 0.957 . . . . 0.0 111.84 164.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.4 tp -134.59 151.37 51.03 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 128.661 2.784 . . . . 0.0 108.668 -168.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 m -124.21 158.51 32.25 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.004 1.722 . . . . 0.0 111.818 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -5.17 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 126.143 1.777 . . . . 0.0 115.543 -166.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -127.14 55.13 1.59 Allowed 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.946 -1.096 . . . . 0.0 112.186 170.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.25 152.73 23.72 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 177.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.411 ' HB1' HD22 ' A' ' 99' ' ' LEU . . . -149.34 128.44 12.76 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 126.218 1.807 . . . . 0.0 107.402 -172.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.84 143.95 21.03 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 121.054 -1.029 . . . . 0.0 110.891 -172.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.73 140.69 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 125.285 1.434 . . . . 0.0 114.423 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.2 t -134.79 154.12 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.07 1.748 . . . . 0.0 111.442 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.6 t -143.07 170.34 15.9 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.27 1.828 . . . . 0.0 110.152 171.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.19 -31.47 63.49 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.873 -1.142 . . . . 0.0 113.875 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.14 -32.54 67.01 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 118.623 0.647 . . . . 0.0 112.579 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -67.92 -44.8 76.06 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.641 1.177 . . . . 0.0 110.249 176.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 37.5 mm -67.33 -33.67 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.705 -0.622 . . . . 0.0 111.252 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -62.65 -24.65 67.72 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.245 -0.909 . . . . 0.0 113.285 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -80.85 -15.67 55.74 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 120.741 1.61 . . . . 0.0 113.701 168.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.7 mt -73.81 -44.34 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 120.309 1.413 . . . . 0.0 111.392 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -173.24 -38.55 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.181 0 CA-C-O 116.687 -1.625 . . . . 0.0 112.092 168.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -73.21 -147.04 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.259 0 C-N-CA 123.068 2.512 . . . . 0.0 115.753 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 5.3 t -152.63 138.95 18.45 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 129.967 3.307 . . . . 0.0 108.844 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.04 -0.9 17.82 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 119.816 3.265 . . . . 0.0 119.816 -151.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.34 19.29 20.04 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -173.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.59 12.38 0.76 Allowed Glycine 0 N--CA 1.473 1.144 0 C-N-CA 124.322 0.963 . . . . 0.0 114.735 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.44 125.5 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 118.15 0.975 . . . . 0.0 111.907 -167.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.81 85.81 2.45 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.644 1.212 . . . . 0.0 108.097 162.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.1 t -90.83 148.35 22.57 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.978 0.911 . . . . 0.0 109.914 166.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -141.58 137.61 32.05 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.966 0.906 . . . . 0.0 110.203 -169.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 35.9 t -135.05 130.32 35.44 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.188 0.449 . . . . 0.0 110.11 -160.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.1 t -135.54 126.91 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.076 1.351 . . . . 0.0 109.655 -169.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.7 m -121.9 143.5 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.691 0.757 . . . . 0.0 111.907 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -127.56 159.86 33.34 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.136 2.174 . . . . 0.0 109.05 165.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.305 0.1 OUTLIER -148.44 155.51 41.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.104 1.361 . . . . 0.0 110.099 166.769 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.6 t -134.65 115.38 13.74 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.31 0.959 . . . . 0.0 109.437 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -71.03 -52.69 18.1 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.999 0.818 . . . . 0.0 110.886 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.1 p -56.8 -36.26 69.68 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.68 -4.3 90.26 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.648 1.118 . . . . 0.0 115.542 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 58.5 mtm 47.67 38.87 9.03 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.21 1.804 . . . . 0.0 114.986 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.8 t -149.55 166.04 30.4 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -130.27 137.26 49.91 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.61 1.564 . . . . 0.0 107.901 -173.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -130.47 132.25 45.58 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.596 0.634 . . . . 0.0 109.969 -166.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.15 132.69 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -153.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -140.03 132.31 28.28 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.304 1.842 . . . . 0.0 109.257 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.449 HG13 ' HA ' ' A' ' 103' ' ' CYS . 3.3 p -145.5 139.12 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 120.684 -1.26 . . . . 0.0 109.275 159.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.68 147.38 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.77 2.028 . . . . 0.0 109.542 -172.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.56 112.41 9.54 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.378 -0.826 . . . . 0.0 113.212 -170.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -126.37 161.0 28.86 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.042 2.137 . . . . 0.0 110.661 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -75.94 -146.05 1.68 Allowed Glycine 0 CA--C 1.546 2.029 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 154.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.81 0.08 8.2 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.553 2.835 . . . . 0.0 114.728 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.01 -20.51 65.96 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.107 -1.621 . . . . 0.0 114.107 -177.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -83.37 61.58 6.25 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.842 1.306 . . . . 0.0 112.04 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -52.7 -32.87 44.92 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.489 1.515 . . . . 0.0 111.846 171.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.74 -51.71 66.1 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.908 0.883 . . . . 0.0 113.099 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.94 -36.12 79.59 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.791 1.178 . . . . 0.0 113.077 171.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -64.51 -52.86 55.65 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.95 1.25 . . . . 0.0 110.792 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -63.08 -32.38 73.75 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.836 -1.165 . . . . 0.0 113.192 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.89 -38.22 84.93 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.219 0.918 . . . . 0.0 112.277 171.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -76.02 -43.03 46.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.119 0.968 . . . . 0.0 113.547 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 93.8 mt -56.0 -36.03 67.46 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.212 0.914 . . . . 0.0 112.254 172.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -66.89 -51.08 59.67 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.467 1.107 . . . . 0.0 110.83 172.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.53 -26.81 64.69 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.2 pt -85.22 -34.95 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.681 0.793 . . . . 0.0 112.028 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -67.64 -0.96 4.43 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.684 1.129 . . . . 0.0 112.819 158.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -127.77 25.56 5.98 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 125.629 1.572 . . . . 0.0 112.293 179.852 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.3 t70 . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -55.14 -17.8 4.75 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -75.08 -21.96 58.61 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.865 -1.147 . . . . 0.0 112.111 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 t -72.05 -44.0 66.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.483 1.513 . . . . 0.0 110.093 171.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.88 -51.83 56.57 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 169.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.07 -45.12 64.63 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.295 1.047 . . . . 0.0 112.709 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -74.54 -35.13 63.1 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.47 -33.67 60.84 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.572 -1.33 . . . . 0.0 112.668 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -70.41 -41.25 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.839 0.745 . . . . 0.0 109.78 170.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.0 m -55.54 -46.78 77.04 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.207 -0.933 . . . . 0.0 111.858 171.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -64.41 -43.91 92.91 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.513 -0.742 . . . . 0.0 112.453 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -71.5 -24.65 62.01 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . 0.274 22.9 ptt-85 -74.8 -55.78 5.47 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 120.606 1.548 . . . . 0.0 113.88 158.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.0 -42.28 15.03 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -158.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.41 -25.89 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-N 119.654 1.115 . . . . 0.0 110.871 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.06 -12.1 60.25 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.699 1.6 . . . . 0.0 112.58 169.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 52.23 46.32 26.85 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 128.057 2.543 . . . . 0.0 115.199 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.564 HD11 HD13 ' A' ' 29' ' ' LEU . 4.7 pp -121.12 161.03 22.5 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.995 1.718 . . . . 0.0 112.703 174.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.31 149.48 26.04 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.659 -0.651 . . . . 0.0 111.49 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -64.96 -25.17 67.76 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.614 -1.304 . . . . 0.0 113.295 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -69.24 -21.46 63.92 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.995 -1.066 . . . . 0.0 112.417 168.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -104.25 -3.96 23.63 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.425 1.89 . . . . 0.0 112.297 -172.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.803 HD11 ' HB1' ' A' ' 48' ' ' ALA . 15.2 tp -94.61 133.49 38.19 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.528 2.731 . . . . 0.0 108.462 163.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.89 122.66 44.43 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.573 0.624 . . . . 0.0 109.724 166.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.2 mm -94.62 138.61 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.388 1.075 . . . . 0.0 110.746 170.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 36' ' ' LEU . 3.5 m -139.21 144.66 38.6 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -117.02 -146.13 0.4 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.632 1.573 . . . . 0.0 110.608 -161.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 t -42.53 -32.31 0.54 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 128.122 2.569 . . . . 0.0 115.884 -171.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.52 -26.99 67.27 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 120.201 1.364 . . . . 0.0 113.989 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' A' ' 32' ' ' THR . 40.8 mt -76.79 -43.69 35.74 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.817 1.19 . . . . 0.0 112.824 174.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -96.61 16.09 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.505 1.922 . . . . 0.0 111.415 -170.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.2 t -57.37 5.6 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.93 2.892 . . . . 0.0 116.845 -165.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.57 -39.04 11.06 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.851 1.26 . . . . 0.0 110.99 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -121.96 67.62 24.01 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.215 1.406 . . . . 0.0 107.393 160.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.89 -44.42 49.38 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 123.323 2.682 . . . . 0.0 113.241 -165.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -93.3 6.57 47.64 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.617 -1.182 . . . . 0.0 110.784 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -128.58 100.2 5.66 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 121.172 1.805 . . . . 0.0 107.516 171.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.1 p 176.67 170.51 0.48 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.447 -0.783 . . . . 0.0 111.147 -141.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.7 tp -128.05 -83.93 0.59 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 118.576 -1.25 . . . . 0.0 112.967 145.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 77.3 m -170.58 -161.98 0.26 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.348 1.459 . . . . 0.0 109.175 -160.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -148.0 157.37 43.48 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.348 2.259 . . . . 0.0 107.838 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.803 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -131.68 134.49 46.0 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.075 2.55 . . . . 0.0 107.571 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.8 ttm -122.51 130.94 53.57 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.428 -1.42 . . . . 0.0 111.273 -166.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.0 147.86 52.48 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.368 1.467 . . . . 0.0 114.685 -158.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.9 t -99.95 154.93 17.98 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.411 1.884 . . . . 0.0 109.315 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.2 t -46.89 113.15 0.61 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.538 1.535 . . . . 0.0 110.992 -153.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.78 157.86 26.71 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.356 1.074 . . . . 0.0 113.21 -143.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.419 HG22 ' H ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -110.71 178.5 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 113.499 -1.682 . . . . 0.0 109.575 -160.197 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.419 ' H ' HG22 ' A' ' 54' ' ' ILE . 7.6 p -80.15 116.87 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.854 -168.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -125.58 139.3 33.69 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 118.612 -0.708 . . . . 0.0 109.736 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -66.38 78.19 0.34 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.148 3.232 . . . . 0.0 113.688 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.2 p -56.39 -30.28 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 127.554 2.341 . . . . 0.0 113.745 -170.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.555 ' HB2' ' H ' ' A' ' 133' ' ' THR . 22.7 tp10 -62.52 -22.49 66.33 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -177.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -55.59 -44.32 76.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.119 0.872 . . . . 0.0 111.117 169.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.1 mp -74.25 -44.5 52.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.941 1.296 . . . . 0.0 111.884 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mp -54.0 -50.04 67.48 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 172.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.1 m -63.72 -50.39 69.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.126 0.97 . . . . 0.0 112.056 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -60.02 -29.56 68.58 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 118.264 -0.874 . . . . 0.0 113.008 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -76.29 -57.63 3.75 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.107 1.321 . . . . 0.0 114.204 169.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -76.53 -40.43 50.01 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -167.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 6.5 p -75.95 -1.81 27.38 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.85 -1.156 . . . . 0.0 113.625 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -60.83 -37.0 80.52 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.173 1.789 . . . . 0.0 113.333 -172.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.7 p -165.76 27.1 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.576 1.55 . . . . 0.0 113.483 169.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.03 86.08 0.16 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.686 1.612 . . . . 0.0 113.936 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -150.08 118.88 6.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 128.85 2.86 . . . . 0.0 104.656 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.6 m -65.6 117.93 8.78 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 122.909 0.484 . . . . 0.0 110.02 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.12 144.91 50.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.476 1.51 . . . . 0.0 111.372 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 26.8 p -115.73 141.0 48.67 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.663 1.185 . . . . 0.0 111.43 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -90.11 151.45 21.6 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 157.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 t -137.67 156.37 32.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 126.534 1.933 . . . . 0.0 108.284 -173.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.555 ' HB2' HD11 ' A' ' 114' ' ' LEU . 86.6 m-85 -123.85 138.52 54.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.044 0.926 . . . . 0.0 109.865 159.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -116.92 103.12 9.96 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.997 2.119 . . . . 0.0 108.246 172.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -87.84 127.36 35.34 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.036 1.334 . . . . 0.0 110.166 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.6 t -148.41 166.76 27.13 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 130.318 3.447 . . . . 0.0 105.405 -151.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -18.02 -122.81 0.0 OUTLIER Glycine 0 N--CA 1.486 1.986 1 C-N-CA 131.241 4.258 . . . . 0.0 116.327 -176.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 45.9 t -96.23 101.03 12.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 113.897 -3.121 . . . . 0.0 109.651 150.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.7 mtt180 -171.64 -177.16 1.95 Allowed 'General case' 0 CA--C 1.549 0.934 1 C-N-CA 133.496 4.718 . . . . 0.0 107.05 123.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.5 t -95.26 146.34 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 120.265 -1.522 . . . . 0.0 111.5 145.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.11 136.91 43.73 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.09 1.356 . . . . 0.0 110.359 162.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -110.94 109.35 19.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.032 2.133 . . . . 0.0 106.175 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 m -104.3 144.78 31.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.332 1.053 . . . . 0.0 110.82 -164.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 74.1 m -127.53 114.32 17.28 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 120.908 -1.12 . . . . 0.0 110.79 -171.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -128.31 117.02 20.73 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.7 pt -88.45 62.54 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 122.792 1.282 . . . . 0.0 109.082 144.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.36 -179.38 43.99 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 121.618 3.407 . . . . 0.0 121.618 -145.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -144.46 116.22 5.43 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 126.162 1.785 . . . . 0.0 111.702 177.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -82.97 163.65 15.65 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.556 2.837 . . . . 0.0 111.706 153.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.72 -18.73 56.11 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.546 1.138 . . . . 0.0 114.061 175.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 -25.64 36.21 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.42 1.488 . . . . 0.0 114.966 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.4 -44.08 65.16 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.45 2.7 . . . . 0.0 114.289 -169.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -36.84 76.29 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.001 0.52 . . . . 0.0 110.907 175.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -98.04 -23.63 15.69 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -170.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 pp -76.68 175.42 9.36 Favored 'General case' 0 CA--C 1.556 1.173 0 CA-C-N 119.926 1.239 . . . . 0.0 112.375 172.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -119.62 -162.51 0.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.878 -1.139 . . . . 0.0 113.917 -162.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -121.88 149.07 43.91 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.451 1.501 . . . . 0.0 111.693 172.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.4 p -127.89 136.7 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.155 0.982 . . . . 0.0 111.607 164.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.439 ' HA ' HG13 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -151.96 123.81 8.0 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 123.131 1.443 . . . . 0.0 108.793 116.213 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 170.89 -179.47 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 130.088 3.355 . . . . 0.0 105.156 -153.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -124.96 133.25 53.09 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.244 1.018 . . . . 0.0 112.331 159.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -150.85 149.89 30.25 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.63 1.172 . . . . 0.0 112.666 -164.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -73.29 132.62 43.33 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.131 0.972 . . . . 0.0 110.801 170.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.1 tp -119.13 148.7 42.78 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.049 1.739 . . . . 0.0 111.233 -163.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.7 t -117.26 168.56 10.21 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.07 2.148 . . . . 0.0 110.979 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -77.24 -8.9 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.331 1.452 . . . . 0.0 113.931 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -130.57 70.51 1.45 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.488 1.915 . . . . 0.0 109.175 172.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -133.44 142.06 48.12 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.295 -0.878 . . . . 0.0 111.115 173.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -149.79 129.26 13.02 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.183 1.393 . . . . 0.0 108.077 -163.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 77' ' ' PHE . 4.4 pp -157.94 156.14 30.75 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -159.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.4 t -105.03 145.37 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 127.33 2.252 . . . . 0.0 111.644 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.41 123.39 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 122.489 1.138 . . . . 0.0 111.156 152.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.0 t -146.65 153.55 40.43 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.043 1.337 . . . . 0.0 111.191 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.87 -27.22 67.96 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.469 1.107 . . . . 0.0 113.393 -173.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.19 83.2 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 120.805 1.639 . . . . 0.0 112.628 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.18 -33.97 59.32 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.742 0.817 . . . . 0.0 112.672 172.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.52 -37.09 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.851 1.205 . . . . 0.0 110.714 168.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.33 -19.52 65.46 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.937 1.695 . . . . 0.0 112.761 171.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.2 mtm-85 -80.07 -30.33 39.3 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 121.935 2.152 . . . . 0.0 113.365 161.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 73.1 mt -82.63 -34.51 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.417 1.487 . . . . 0.0 113.461 -172.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -120.5 150.95 53.18 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 125.254 1.422 . . . . 0.0 110.845 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.31 -7.87 21.71 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.149 2.566 . . . . 0.0 113.522 173.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 35.3 m -121.31 131.17 54.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.74 1.616 . . . . 0.0 109.569 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -103.61 -137.43 0.35 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.143 1.377 . . . . 0.0 111.124 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -36.57 125.62 0.84 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.721 1.608 . . . . 0.0 111.701 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 116.69 -30.28 6.48 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.243 1.402 . . . . 0.0 112.293 -149.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 t -60.52 147.84 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.943 1.297 . . . . 0.0 113.153 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 26.4 tp -122.28 92.64 3.77 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.548 1.539 . . . . 0.0 109.481 159.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.555 ' H ' ' HB2' ' A' ' 59' ' ' GLU . 17.9 m -75.29 154.78 37.22 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.201 2.201 . . . . 0.0 109.933 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -142.11 134.57 28.03 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.773 1.229 . . . . 0.0 108.208 -168.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 34.7 t -139.28 142.04 37.76 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.252 0.933 . . . . 0.0 112.136 -163.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.7 t -147.2 141.44 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.976 2.11 . . . . 0.0 109.888 -168.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.91 138.21 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 O-C-N 121.208 -0.933 . . . . 0.0 111.068 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.02 113.2 26.57 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.472 1.109 . . . . 0.0 108.981 166.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.665 ' HE2' ' CD1' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -88.79 128.83 35.65 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 143.573 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.8 m -149.74 175.31 11.7 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -167.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 69.89 160.39 0.2 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 128.244 2.618 . . . . 0.0 115.154 167.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 84.4 p -89.82 -47.71 7.72 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.568 1.547 . . . . 0.0 110.526 171.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -65.88 -1.28 8.71 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 125.629 1.585 . . . . 0.0 115.082 165.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.4 mmt 64.78 128.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 129.032 2.933 . . . . 0.0 114.754 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.4 p -172.31 155.67 3.61 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.877 2.071 . . . . 0.0 108.476 169.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.665 ' CD1' ' HE2' ' A' ' 139' ' ' LYS . 2.5 m-85 -136.08 163.95 29.14 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -166.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -151.46 155.7 39.11 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.35 -1.469 . . . . 0.0 107.55 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.1 tt -136.59 138.94 45.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.092 -0.38 . . . . 0.0 110.516 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -141.69 123.61 15.34 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.321 0.648 . . . . 0.0 110.389 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' A' ' 103' ' ' CYS . 2.1 p -140.61 133.07 31.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-O 122.356 1.074 . . . . 0.0 110.201 168.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.4 m -135.6 130.88 50.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 127.102 2.161 . . . . 0.0 110.735 -163.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -107.65 111.13 23.2 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.094 0.957 . . . . 0.0 111.62 -171.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -109.95 159.47 17.23 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.25 1.42 . . . . 0.0 110.719 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -74.79 -170.79 26.32 Favored Glycine 0 CA--C 1.542 1.735 0 O-C-N 121.314 -0.866 . . . . 0.0 113.728 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.27 -25.8 64.4 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.37 2.047 . . . . 0.0 112.085 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.52 9.0 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 129.349 3.06 . . . . 0.0 114.963 171.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -82.51 46.86 1.1 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.085 2.154 . . . . 0.0 108.605 169.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -58.2 -39.6 79.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.289 2.236 . . . . 0.0 111.824 -165.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.57 -44.42 78.27 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.832 -0.604 . . . . 0.0 112.585 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.91 -40.87 75.34 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.657 0.783 . . . . 0.0 111.783 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -53.69 -59.08 5.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.224 1.01 . . . . 0.0 110.433 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -60.55 -43.11 97.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.962 0.905 . . . . 0.0 112.91 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.43 -38.01 88.07 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.293 0.951 . . . . 0.0 113.058 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.7 -42.7 70.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.314 -0.866 . . . . 0.0 111.962 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.05 -35.12 74.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.33 0.513 . . . . 0.0 111.7 173.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -63.06 -31.66 72.85 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.597 1.559 . . . . 0.0 111.803 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -88.37 -45.11 10.27 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -106.7 -24.82 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 118.013 2.597 . . . . 0.0 118.013 -167.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -103.47 -11.49 17.78 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.707 1.203 . . . . 0.0 110.05 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -125.21 25.8 7.08 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.482 1.513 . . . . 0.0 114.134 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 160.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 120.691 0.282 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.44 -142.27 5.64 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.739 0.685 . . . . 0.0 114.342 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -89.86 0.6 56.95 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.63 151.27 26.37 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.668 1.187 . . . . 0.0 110.182 156.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -138.24 109.46 6.86 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.468 -0.77 . . . . 0.0 111.586 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 6' ' ' ILE . 2.4 tp -126.81 143.72 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 C-N-CA 130.113 3.365 . . . . 0.0 108.509 163.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -74.31 148.39 41.42 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 126.356 1.862 . . . . 0.0 111.144 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -48.2 -38.14 17.57 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -165.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -94.68 -22.24 18.26 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.281 0.946 . . . . 0.0 112.151 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.6 t -72.44 -51.12 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.697 1.599 . . . . 0.0 113.164 -168.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.94 -46.66 94.11 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.27 -35.91 67.98 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.222 1.011 . . . . 0.0 112.584 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -68.43 -47.47 67.11 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.405 1.482 . . . . 0.0 112.534 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.48 -38.31 77.64 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.209 -0.932 . . . . 0.0 111.977 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.58 -39.83 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.505 1.522 . . . . 0.0 110.497 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.2 t -58.97 -48.27 82.16 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.197 0.999 . . . . 0.0 111.51 172.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -60.36 -43.01 96.92 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.66 -0.65 . . . . 0.0 111.156 173.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.9 m -62.75 -45.97 90.21 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.621 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.7 ptt-85 -65.81 -36.65 84.09 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.587 1.54 . . . . 0.0 112.592 174.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -68.66 -42.85 77.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.408 1.883 . . . . 0.0 114.375 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . 0.3 0.8 OUTLIER -88.24 -17.34 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 173.323 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.13 -5.72 58.64 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 121.022 1.737 . . . . 0.0 112.309 163.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 48.86 41.67 18.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 128.05 2.54 . . . . 0.0 114.468 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 pp -120.48 169.82 9.97 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.458 2.303 . . . . 0.0 110.804 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -92.74 168.41 11.22 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -66.95 -18.24 65.29 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.698 1.599 . . . . 0.0 114.427 -173.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -102.97 12.14 36.46 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.043 1.337 . . . . 0.0 112.314 171.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -127.48 -14.02 5.34 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.101 1.76 . . . . 0.0 110.953 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.462 HD11 ' HB1' ' A' ' 48' ' ' ALA . 35.6 tp -83.93 122.35 28.62 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 155.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.439 ' H ' ' HB3' ' A' ' 49' ' ' MET . 8.9 ttp-105 -92.19 126.43 37.26 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 118.932 -1.107 . . . . 0.0 110.839 172.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.8 mm -98.99 142.42 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.946 1.699 . . . . 0.0 112.007 173.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.9 m -140.8 143.14 34.68 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.318 0.508 . . . . 0.0 110.116 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -96.85 -142.38 0.29 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.386 1.474 . . . . 0.0 111.656 176.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.9 p -46.92 -38.55 10.71 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.16 2.184 . . . . 0.0 115.706 -156.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.45 -29.61 64.33 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -165.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.39 -15.2 16.6 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 115.961 1.838 . . . . 0.0 115.961 173.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 pt -112.62 -14.0 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 -175.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.5 t -61.53 9.33 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 -166.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -83.79 -15.7 47.4 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 119.657 -1.902 . . . . 0.0 113.075 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -91.49 113.44 58.56 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 141.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.99 -11.1 11.29 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.125 1.883 . . . . 0.0 115.871 -160.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -121.9 -10.97 8.6 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 120.806 1.639 . . . . 0.0 115.164 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -162.1 160.19 27.04 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.078 1.351 . . . . 0.0 108.325 -169.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.7 p 164.61 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.273 1.829 . . . . 0.0 106.426 -155.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.0 tp -122.33 -78.16 0.6 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 119.16 -1.016 . . . . 0.0 112.42 147.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.5 m -177.34 -160.04 0.05 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.794 2.038 . . . . 0.0 108.004 -165.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -131.78 157.83 42.84 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.921 2.088 . . . . 0.0 107.937 169.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -135.17 130.97 36.19 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 128.815 2.846 . . . . 0.0 108.951 -177.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.439 ' HB3' ' H ' ' A' ' 30' ' ' ARG . 35.8 ttp -118.22 131.67 56.36 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.096 -1.003 . . . . 0.0 110.844 -166.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 mt -127.51 149.03 50.31 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.348 2.659 . . . . 0.0 112.711 -151.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.1 p -96.93 159.02 15.15 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.063 2.145 . . . . 0.0 113.176 -169.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.5 t -72.07 158.61 35.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.903 1.281 . . . . 0.0 112.537 173.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.3 t70 57.11 43.69 23.73 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.113 1.765 . . . . 0.0 113.7 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 tp -132.74 139.73 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.546 1.139 . . . . 0.0 111.266 -171.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.2 p -123.37 140.92 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.424 1.49 . . . . 0.0 111.769 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -138.35 153.1 72.57 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 157.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.82 78.09 1.78 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.847 3.032 . . . . 0.0 109.949 167.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -47.73 -36.7 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 127.547 2.339 . . . . 0.0 115.047 -167.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.98 -18.61 60.35 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -59.55 -34.23 72.4 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.268 -0.895 . . . . 0.0 111.011 167.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.6 tp -78.87 -44.57 22.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.523 1.129 . . . . 0.0 112.409 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.7 mp -54.25 -45.93 72.51 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.733 1.151 . . . . 0.0 110.627 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.4 t -57.57 -50.36 73.35 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.924 1.29 . . . . 0.0 111.864 175.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -61.87 -37.69 85.46 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -59.55 -54.92 41.01 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.711 1.604 . . . . 0.0 111.95 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -72.1 -31.38 66.0 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 9.9 t -72.27 -18.26 61.82 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 -69.59 -35.14 75.06 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -168.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.1 m -147.17 8.04 0.92 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.84 71.76 0.79 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.986 1.279 . . . . 0.0 111.784 -170.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -168.0 135.31 2.18 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 128.425 2.69 . . . . 0.0 105.76 172.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -100.79 154.99 18.18 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 127.832 2.453 . . . . 0.0 111.734 -170.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.74 147.27 44.6 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.599 1.16 . . . . 0.0 112.566 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.49 ' HA ' HG23 ' A' ' 117' ' ' THR . 26.9 p -86.9 142.29 28.13 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.661 0.743 . . . . 0.0 110.517 160.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -92.06 108.61 20.06 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 167.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.518 HG22 HG22 ' A' ' 115' ' ' VAL . 59.3 t -101.48 109.02 24.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -92.36 113.12 25.31 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 120.712 -1.243 . . . . 0.0 107.677 -173.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -107.52 101.68 11.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.383 1.473 . . . . 0.0 108.851 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -79.62 129.02 34.1 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.801 1.64 . . . . 0.0 109.511 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.8 p -145.18 168.71 19.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.075 2.55 . . . . 0.0 104.57 -170.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -12.75 -119.44 0.0 OUTLIER Glycine 0 N--CA 1.487 2.051 0 C-N-CA 129.542 3.449 . . . . 0.0 116.098 -171.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.8 p -95.45 105.84 17.85 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 113.96 -3.096 . . . . 0.0 111.082 153.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -178.75 145.88 0.31 Allowed 'General case' 0 N--CA 1.474 0.728 1 C-N-CA 132.179 4.192 . . . . 0.0 108.477 146.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 t -78.73 142.27 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 119.246 -2.159 . . . . 0.0 110.431 145.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.0 p -125.23 161.95 25.77 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.77 -1.207 . . . . 0.0 112.69 154.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 pp -112.44 116.11 29.77 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 122.11 0.957 . . . . 0.0 109.034 158.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.4 m -80.23 121.26 25.4 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.389 1.476 . . . . 0.0 108.006 169.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 42.4 t -104.91 113.68 27.43 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.028 -1.045 . . . . 0.0 110.98 -172.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -105.11 108.84 20.57 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.75 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.7 mt -76.67 72.09 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 140.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.77 -179.11 48.43 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 121.445 3.338 . . . . 0.0 121.445 -155.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -115.57 105.49 51.88 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-N 111.134 -2.533 . . . . 0.0 110.035 -171.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.444 ' HG2' HD23 ' A' ' 96' ' ' LEU . 20.4 Cg_exo -86.12 152.68 9.58 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.639 2.226 . . . . 0.0 114.636 -173.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -42.93 62.52 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -177.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 ttt85 -88.76 3.63 50.28 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.444 HD23 ' HG2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -49.88 -29.36 8.0 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.339 2.256 . . . . 0.0 113.612 178.698 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -53.49 -45.03 69.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.413 1.885 . . . . 0.0 113.543 168.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -122.08 -20.18 6.35 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -166.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.427 ' C ' HD12 ' A' ' 99' ' ' LEU . 2.7 pp -60.93 168.92 2.15 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 121.578 1.99 . . . . 0.0 114.711 165.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -117.25 172.88 7.01 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -160.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.595 ' CZ ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -131.0 155.14 47.33 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.984 1.313 . . . . 0.0 113.992 157.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.595 ' H ' ' CZ ' ' A' ' 101' ' ' ARG . 1.5 p -136.67 137.61 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.327 1.451 . . . . 0.0 113.432 174.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 28.1 p -123.38 112.66 17.83 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.448 133.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 t0 176.49 -167.23 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 128.521 2.729 . . . . 0.0 107.601 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -113.59 138.83 49.62 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.064 1.346 . . . . 0.0 111.396 150.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -158.09 159.66 36.52 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -60.77 142.59 55.81 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.306 1.042 . . . . 0.0 111.034 160.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 20.9 tp -142.4 133.39 25.84 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.848 1.659 . . . . 0.0 110.172 -173.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 m -71.68 156.57 39.21 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -174.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.47 -10.43 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -169.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.99 41.73 3.12 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.052 1.341 . . . . 0.0 112.201 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.41 ' HG3' ' H ' ' A' ' 113' ' ' ALA . 8.3 tp10 -105.04 172.42 6.8 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.058 2.143 . . . . 0.0 113.481 -169.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.41 ' H ' ' HG3' ' A' ' 112' ' ' GLU . . . -149.8 139.07 21.31 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 126.579 1.952 . . . . 0.0 106.315 -167.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.54 133.21 9.19 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.263 0.938 . . . . 0.0 113.445 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.518 HG22 HG22 ' A' ' 76' ' ' VAL . 3.6 t -95.88 136.43 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 117.252 -1.356 . . . . 0.0 109.315 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.491 ' HB ' ' CZ ' ' A' ' 101' ' ' ARG . 11.4 p -138.23 115.39 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 120.322 1.419 . . . . 0.0 109.354 164.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.49 HG23 ' HA ' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -138.01 171.29 14.63 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.002 1.721 . . . . 0.0 111.282 -175.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 79.4 mt -59.71 -29.99 68.49 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.534 0.734 . . . . 0.0 112.913 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.98 -33.32 65.75 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 119.712 1.142 . . . . 0.0 113.043 173.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -74.39 -45.64 45.46 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.802 1.241 . . . . 0.0 111.862 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 28.4 mm -60.34 -40.98 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.493 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -61.44 -29.99 70.3 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 172.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -70.1 -41.05 74.54 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 121.692 2.042 . . . . 0.0 111.864 172.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.5 pt -96.72 -11.9 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -168.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -154.15 150.67 22.89 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 126.539 1.936 . . . . 0.0 110.748 166.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -61.34 113.2 1.67 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 121.775 1.65 . . . . 0.0 110.926 168.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 19.7 p -83.32 161.64 21.36 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.608 0.718 . . . . 0.0 112.672 -176.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -151.19 147.96 27.66 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.264 1.826 . . . . 0.0 108.233 -171.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.257 0.1 OUTLIER -67.14 54.23 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 127.859 2.464 . . . . 0.0 112.635 170.244 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 179.6 -0.58 0.02 OUTLIER Glycine 0 CA--C 1.539 1.562 0 C-N-CA 127.516 2.484 . . . . 0.0 114.215 -167.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.1 t -65.42 131.15 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.011 1.405 . . . . 0.0 111.28 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 90.5 mt -118.44 89.21 3.08 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.982 1.713 . . . . 0.0 108.281 159.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.0 m -72.95 148.36 44.35 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 170.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -133.28 134.29 43.71 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.427 1.491 . . . . 0.0 108.661 -165.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 41.9 t -140.89 135.97 31.84 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.525 1.057 . . . . 0.0 112.027 -169.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.5 124.17 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.374 1.869 . . . . 0.0 110.175 -167.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.0 m -121.65 145.86 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.213 -0.93 . . . . 0.0 112.831 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -130.22 138.6 50.65 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.389 1.076 . . . . 0.0 112.12 158.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.51 ' HD2' ' CE1' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -77.58 146.08 36.45 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 129.034 2.934 . . . . 0.0 112.423 152.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.5 t -139.51 143.49 37.47 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.518 1.127 . . . . 0.0 110.217 162.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -101.29 -41.18 6.79 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.453 1.501 . . . . 0.0 110.755 169.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.9 t -54.76 -33.75 61.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.832 0.853 . . . . 0.0 112.808 174.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -102.49 1.2 49.65 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 117.71 -1.605 . . . . 0.0 115.849 172.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.3 mmt 39.44 57.85 2.04 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.837 1.819 . . . . 0.0 113.455 -173.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.0 m -149.46 163.52 37.55 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.002 0.921 . . . . 0.0 113.13 -163.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.51 ' CE1' ' HD2' ' A' ' 139' ' ' LYS . 76.7 m-85 -107.29 154.34 21.4 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.098 0.959 . . . . 0.0 111.098 154.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -130.83 106.19 8.28 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.61 139.19 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 123.972 0.909 . . . . 0.0 109.683 -163.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -141.46 134.3 28.82 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.689 0.796 . . . . 0.0 109.45 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.5 p -150.44 132.58 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 122.42 1.105 . . . . 0.0 110.642 164.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.4 m -137.28 145.69 29.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 126.505 1.922 . . . . 0.0 109.013 -162.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -112.36 118.11 34.32 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.689 -0.632 . . . . 0.0 112.392 -169.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -121.59 157.21 31.28 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.384 1.074 . . . . 0.0 111.338 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -85.6 -146.97 9.25 Favored Glycine 0 CA--C 1.54 1.626 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 159.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -63.39 -3.44 5.22 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.564 2.843 . . . . 0.0 115.973 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -63.76 -18.7 64.32 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.133 1.373 . . . . 0.0 114.01 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -77.37 30.24 0.15 Allowed 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.478 1.111 . . . . 0.0 112.172 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -61.54 -26.79 68.17 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.433 1.893 . . . . 0.0 114.177 -171.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.88 -52.57 12.54 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.404 1.082 . . . . 0.0 112.051 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -61.38 -39.78 91.93 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.375 1.07 . . . . 0.0 112.188 171.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -52.44 -54.68 29.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.611 0.764 . . . . 0.0 110.873 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -59.04 -45.29 91.11 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.565 -0.71 . . . . 0.0 112.852 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.36 -34.81 75.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.319 0.648 . . . . 0.0 112.309 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.43 -45.33 60.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.434 -0.791 . . . . 0.0 111.942 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 88.9 mt -56.85 -34.38 67.74 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.824 0.738 . . . . 0.0 111.683 171.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -79.38 -7.93 58.72 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.229 1.812 . . . . 0.0 114.231 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -99.78 -57.23 2.19 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.987 1.315 . . . . 0.0 113.053 160.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.8 pt -83.8 -32.12 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -160.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -90.69 10.98 23.66 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.017 0.927 . . . . 0.0 109.449 168.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.91 24.87 5.31 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.399 1.48 . . . . 0.0 114.638 174.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 16.7 mmt85 . . . . . 0 C--O 1.252 1.233 0 CA-C-O 117.628 -1.177 . . . . 0.0 111.319 157.46 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.04 -175.24 47.15 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.822 0.725 . . . . 0.0 113.311 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -82.9 -33.7 26.83 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.847 0.859 . . . . 0.0 111.029 173.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -125.78 131.01 52.57 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.286 1.434 . . . . 0.0 110.235 169.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -136.63 152.51 50.51 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.449 1.499 . . . . 0.0 110.357 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.5 tp -140.04 145.7 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 128.899 2.88 . . . . 0.0 111.617 -169.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -44.12 131.09 6.07 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.46 1.504 . . . . 0.0 111.673 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -68.5 -23.48 64.56 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 -135.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -112.8 -17.17 12.6 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.039 1.336 . . . . 0.0 113.425 172.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 80.1 t -67.18 -60.64 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.298 1.039 . . . . 0.0 111.532 -173.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.28 -37.35 80.48 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.282 -0.732 . . . . 0.0 113.472 175.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.71 -59.2 5.79 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.245 1.023 . . . . 0.0 110.916 175.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -65.77 -46.95 76.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.616 1.166 . . . . 0.0 111.668 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.0 mp -70.46 -43.7 69.28 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.643 -0.66 . . . . 0.0 111.637 -173.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.29 -34.56 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 119.203 0.91 . . . . 0.0 110.231 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.2 t -59.49 -52.33 66.02 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.41 1.005 . . . . 0.0 111.761 174.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -64.73 -31.51 72.76 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.416 -0.803 . . . . 0.0 111.581 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 m -68.72 -50.09 53.57 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.196 -0.94 . . . . 0.0 111.685 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.1 ptt85 -61.87 -22.06 65.22 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.002 1.274 . . . . 0.0 113.577 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -85.1 -52.56 5.86 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.446 1.099 . . . . 0.0 112.953 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.85 -30.48 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 118.635 0.652 . . . . 0.0 112.201 -175.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -84.38 -7.66 59.23 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.912 1.233 . . . . 0.0 111.633 171.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 65.65 5.13 3.14 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 128.243 2.617 . . . . 0.0 115.249 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 pp -97.37 147.1 24.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.153 1.381 . . . . 0.0 111.497 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -76.01 165.23 25.26 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -168.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -58.77 -39.77 81.97 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.196 -1.565 . . . . 0.0 112.51 -174.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -88.27 6.92 34.64 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.84 0.856 . . . . 0.0 112.784 176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -108.87 -5.59 16.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.321 1.448 . . . . 0.0 111.769 172.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.6 tp -89.06 112.61 23.61 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 166.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.59 93.17 8.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 118.701 -1.199 . . . . 0.0 109.193 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -87.69 146.69 5.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 125.609 1.563 . . . . 0.0 112.541 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 m -145.86 153.3 40.71 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.925 1.29 . . . . 0.0 110.425 -171.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -117.72 -165.69 1.12 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.368 1.467 . . . . 0.0 112.609 -163.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.4 t -41.34 -41.15 1.88 Allowed 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 118.081 2.622 . . . . 0.0 118.081 -147.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.7 -17.24 61.15 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 -160.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.42 -14.25 17.64 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.3 pt -102.85 -6.65 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 126.703 2.001 . . . . 0.0 113.583 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -41.53 8.14 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.055 1 C-N-CA 133.641 4.776 . . . . 0.0 121.397 -169.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -65.48 -21.39 66.63 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 122.468 2.395 . . . . 0.0 113.391 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -92.65 117.51 67.62 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 144.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -73.26 -8.31 21.77 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.052 2.501 . . . . 0.0 114.561 -171.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -108.69 -43.43 4.27 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 120.099 1.318 . . . . 0.0 112.007 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -165.51 126.69 1.93 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.539 1.535 . . . . 0.0 110.062 159.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 t -92.94 -162.03 0.9 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 147.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.96 -82.48 0.17 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -168.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 2.4 t -164.9 175.99 9.08 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 120.803 1.638 . . . . 0.0 113.562 -170.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -147.61 106.88 3.88 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.83 158.54 15.46 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.91 2.884 . . . . 0.0 112.059 -168.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 12.8 tmm? -125.57 137.2 53.9 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.895 1.225 . . . . 0.0 110.944 172.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.1 mt -129.86 128.99 43.38 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 129.204 3.002 . . . . 0.0 111.095 -157.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.7 t -128.95 162.7 26.96 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 128.021 2.528 . . . . 0.0 110.383 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.6 p -39.11 113.03 0.28 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.744 1.618 . . . . 0.0 113.515 -149.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.544 ' C ' HD13 ' A' ' 54' ' ' ILE . 1.4 p30 -106.81 159.05 16.53 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.939 172.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.544 HD13 ' C ' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -121.78 177.44 3.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 113.69 -1.596 . . . . 0.0 106.721 -173.84 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.471 ' H ' HG22 ' A' ' 54' ' ' ILE . 11.7 p -77.15 103.38 4.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.912 -155.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -137.72 158.22 72.08 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.433 1.093 . . . . 0.0 111.913 -166.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.46 ' HD3' HD13 ' A' ' 164' ' ' LEU . 58.7 Cg_endo -66.53 88.27 0.27 Allowed 'Trans proline' 0 C--N 1.357 0.999 1 C-N-CA 125.741 4.294 . . . . 0.0 112.187 -178.218 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.64 -40.83 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.451 0.7 . . . . 0.0 112.541 -172.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -12.52 60.39 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -55.39 -27.72 49.43 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.192 0.905 . . . . 0.0 112.687 167.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.3 mp -77.97 -44.32 27.12 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.885 0.874 . . . . 0.0 111.554 171.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mp -56.71 -43.57 80.71 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 118.138 0.426 . . . . 0.0 111.37 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.3 p -72.31 -30.74 65.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.801 0.84 . . . . 0.0 112.515 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -37.6 80.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.381 0.991 . . . . 0.0 112.865 171.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -50.63 16.2 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.105 0.866 . . . . 0.0 111.866 172.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -61.24 -33.62 73.81 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.775 -1.203 . . . . 0.0 113.325 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 69.5 m -79.17 -20.56 48.15 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 172.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -38.36 79.34 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.641 1.11 . . . . 0.0 113.269 -169.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.6 m -150.81 0.23 0.41 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.97 82.3 0.16 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.19 1.376 . . . . 0.0 110.952 -165.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -153.71 115.91 4.34 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 125.665 1.586 . . . . 0.0 107.841 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 79.4 m -91.89 113.12 25.3 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.942 1.297 . . . . 0.0 109.792 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.47 148.38 40.81 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.056 1.342 . . . . 0.0 113.285 -168.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 74.4 m -89.21 127.14 35.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.702 0.801 . . . . 0.0 109.535 165.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -91.91 103.48 16.01 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 164.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.6 t -105.46 141.62 20.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 C-N-CA 125.07 1.348 . . . . 0.0 109.204 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -124.93 123.28 39.56 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.245 -0.909 . . . . 0.0 110.08 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.1 112.86 25.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.054 1.741 . . . . 0.0 109.262 172.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -86.26 126.68 34.47 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.074 -1.016 . . . . 0.0 111.281 165.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.8 p -143.69 157.11 44.64 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.732 3.213 . . . . 0.0 103.369 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -7.07 -129.85 0.0 OUTLIER Glycine 0 N--CA 1.486 1.993 0 O-C-N 117.707 -3.121 . . . . 0.0 112.83 -116.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 82.4 m -97.58 107.5 20.02 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 113.666 -3.213 . . . . 0.0 108.601 149.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -169.66 125.14 0.83 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 130.754 3.622 . . . . 0.0 106.203 161.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.431 HG23 ' CZ ' ' A' ' 146' ' ' TYR . 2.6 t -78.03 135.45 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 117.978 -1.489 . . . . 0.0 110.938 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.8 m -110.22 146.19 36.02 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.21 0.604 . . . . 0.0 110.477 163.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.1 tp -110.73 108.79 18.78 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 126.208 1.803 . . . . 0.0 107.082 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.6 m -80.12 101.47 8.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 167.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 45.3 t -103.81 108.12 19.29 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 120.73 -1.231 . . . . 0.0 108.23 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.4 151.17 48.26 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -175.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.59 96.1 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 141.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.91 142.75 6.67 Favored Glycine 0 N--CA 1.471 1.015 0 N-CA-C 118.332 2.093 . . . . 0.0 118.332 -167.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -133.28 64.81 71.02 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.626 1.571 . . . . 0.0 112.267 175.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.58 158.12 32.24 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.369 2.713 . . . . 0.0 115.495 -172.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -50.52 -19.89 1.01 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.252 2.621 . . . . 0.0 115.752 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -69.83 -11.62 61.0 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.182 -1.574 . . . . 0.0 113.242 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.71 -4.7 16.76 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 164.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 1.67 32.76 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 120.051 1.296 . . . . 0.0 112.241 160.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -131.16 -34.2 1.45 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.533 1.933 . . . . 0.0 114.154 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 pp -100.49 160.0 14.7 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 120.196 1.362 . . . . 0.0 114.628 -172.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -108.69 -160.97 0.74 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 125.714 1.606 . . . . 0.0 113.069 -166.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.45 166.11 13.08 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.711 1.205 . . . . 0.0 111.833 162.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.1 p -125.13 130.97 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 170.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.514 ' HB2' HD13 ' A' ' 124' ' ' ILE . 10.8 t -147.58 112.1 5.3 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 127.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -176.91 175.29 1.62 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.507 1.923 . . . . 0.0 107.886 -170.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -115.82 121.06 41.27 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.384 1.873 . . . . 0.0 110.667 161.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -159.0 165.95 32.88 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -74.09 149.42 41.11 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.517 -0.74 . . . . 0.0 111.71 164.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.8 tp -135.87 143.09 44.86 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.596 1.958 . . . . 0.0 108.87 -171.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.8 p -117.44 173.21 6.83 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -166.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.9 t -67.11 -9.77 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 128.433 2.693 . . . . 0.0 115.422 -163.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -135.21 25.11 3.54 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.996 -1.065 . . . . 0.0 112.803 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -116.2 151.75 35.1 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.141 -0.974 . . . . 0.0 111.803 -163.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.61 166.15 31.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.077 -1.014 . . . . 0.0 112.549 -165.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.69 164.1 37.67 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.276 1.03 . . . . 0.0 113.46 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.402 ' CG1' HG23 ' A' ' 117' ' ' THR . 6.8 t -99.76 145.45 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 127.788 2.435 . . . . 0.0 109.275 163.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.6 128.7 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.565 0.698 . . . . 0.0 109.287 151.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.402 HG23 ' CG1' ' A' ' 115' ' ' VAL . 4.7 p -128.97 159.13 36.87 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.444 1.498 . . . . 0.0 111.001 174.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -59.44 -38.46 80.73 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.383 0.673 . . . . 0.0 111.672 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.18 -32.53 74.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.046 0.938 . . . . 0.0 112.58 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -71.47 -33.14 69.06 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 117.575 -1.202 . . . . 0.0 111.996 173.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 31.9 mm -66.7 -41.39 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 119.742 1.156 . . . . 0.0 110.786 170.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.54 -27.89 66.6 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 171.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -86.52 -21.84 26.72 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.97 1.708 . . . . 0.0 115.178 171.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.514 HD13 ' HB2' ' A' ' 103' ' ' CYS . 6.3 mt -77.2 -38.54 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.056 1.342 . . . . 0.0 111.007 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -145.06 172.31 5.52 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 125.715 1.606 . . . . 0.0 111.858 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -57.43 20.97 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.335 1 C-N-CA 126.262 4.641 . . . . 0.0 117.086 164.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 77.9 m -74.75 160.38 30.81 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.676 1.99 . . . . 0.0 112.097 176.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -125.02 -166.42 1.53 Allowed 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 128.002 2.521 . . . . 0.0 108.7 173.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.26 -24.69 67.75 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -173.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -85.86 15.24 48.92 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 118.155 -1.358 . . . . 0.0 115.98 -175.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.73 158.61 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.219 1.509 . . . . 0.0 113.801 -165.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.7 tt -116.43 126.71 53.8 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 122.352 1.072 . . . . 0.0 110.618 154.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 2.4 p -123.26 148.38 45.96 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 127.496 2.318 . . . . 0.0 109.711 -173.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -130.98 128.47 40.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -164.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 46.3 t -136.38 138.92 42.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.467 0.707 . . . . 0.0 110.728 -165.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.5 t -146.23 114.76 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.892 0.877 . . . . 0.0 110.98 -167.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 m -109.01 129.95 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -115.51 140.92 48.72 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.46 2.304 . . . . 0.0 107.261 168.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.451 ' HB2' ' CD2' ' A' ' 146' ' ' TYR 0.304 0.2 OUTLIER -149.69 152.84 36.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.504 0.722 . . . . 0.0 110.664 169.845 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.7 t -136.8 123.34 20.92 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.846 0.748 . . . . 0.0 109.16 171.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -76.0 -57.08 4.09 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.213 1.405 . . . . 0.0 110.67 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.6 t -61.09 -36.32 79.35 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.04 0.936 . . . . 0.0 112.591 169.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.66 14.16 48.7 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.361 -1.244 . . . . 0.0 114.896 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 28.0 ptm 42.63 49.46 4.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.268 2.227 . . . . 0.0 116.985 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.5 t -157.82 148.74 21.09 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.451 ' CD2' ' HB2' ' A' ' 139' ' ' LYS . 1.4 t80 -108.93 140.08 42.9 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.706 1.202 . . . . 0.0 111.267 163.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -140.79 121.32 14.16 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 122.17 0.986 . . . . 0.0 111.447 -173.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -133.5 134.58 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.097 -1.002 . . . . 0.0 110.828 -151.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -142.66 131.76 23.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.675 1.19 . . . . 0.0 111.064 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.8 p -145.19 139.37 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.545 -0.722 . . . . 0.0 110.588 161.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.9 m -136.04 151.43 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 127.772 2.429 . . . . 0.0 109.821 -165.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.12 128.85 23.12 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -166.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -148.12 133.25 18.3 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 170.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.54 -162.21 0.27 Allowed Glycine 0 CA--C 1.549 2.185 0 C-N-CA 127.558 2.504 . . . . 0.0 116.344 166.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.6 -20.77 12.92 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.892 3.728 . . . . 0.0 119.521 -160.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -75.58 -2.39 28.95 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 120.58 1.537 . . . . 0.0 114.03 173.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 45.7 p30 -58.82 13.03 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 129.304 3.042 . . . . 0.0 117.861 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -49.4 -40.02 34.67 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.389 1.876 . . . . 0.0 112.623 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.43 -51.44 65.72 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -74.2 -26.7 60.42 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.086 -1.009 . . . . 0.0 112.427 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -64.98 -48.56 73.56 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.709 0.804 . . . . 0.0 111.74 168.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -62.61 -38.11 88.91 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.332 -0.855 . . . . 0.0 112.087 174.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.55 -30.85 70.03 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.46 HD13 ' HD3' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -79.09 -51.72 9.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.724 1.21 . . . . 0.0 110.887 -179.18 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.5 pp -66.43 -27.55 67.91 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.316 -0.865 . . . . 0.0 110.972 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -77.21 -24.42 51.29 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 117.895 -1.05 . . . . 0.0 112.828 172.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.64 -30.86 64.67 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 167.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.1 mt -76.03 -36.8 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 120.708 -1.245 . . . . 0.0 110.977 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -64.83 -4.9 4.9 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 158.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -108.56 25.17 12.02 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 170.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.171 0 C-N-CA 128.539 2.736 . . . . 0.0 116.52 162.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.675 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.23 -17.6 9.66 Favored Glycine 0 CA--C 1.542 1.752 0 N-CA-C 116.548 1.379 . . . . 0.0 116.548 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -132.31 -157.01 0.79 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.173 1.789 . . . . 0.0 112.144 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.46 159.41 15.64 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 119.873 -1.767 . . . . 0.0 113.175 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -126.82 97.97 5.18 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.355 -0.841 . . . . 0.0 112.497 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 6' ' ' ILE . 7.6 tp -76.32 106.07 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 123.1 1.428 . . . . 0.0 112.442 -176.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -45.19 123.85 4.26 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 111.831 -2.441 . . . . 0.0 110.613 -173.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -57.86 -35.58 71.16 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 -143.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -102.92 -19.73 14.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.211 1.404 . . . . 0.0 112.349 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.27 -52.41 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.986 0.915 . . . . 0.0 112.388 -168.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.73 -49.92 73.33 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 119.179 0.9 . . . . 0.0 111.885 174.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.51 76.84 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.278 1.039 . . . . 0.0 112.156 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.76 -42.41 73.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.334 1.054 . . . . 0.0 113.303 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.4 tp -76.58 -31.44 57.5 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.271 1.029 . . . . 0.0 112.914 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.9 -40.41 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 121.487 -0.758 . . . . 0.0 109.344 168.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.1 m -59.58 -35.24 73.9 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 119.688 1.131 . . . . 0.0 112.495 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -72.0 -40.09 68.75 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.675 1.19 . . . . 0.0 111.452 177.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.7 m -64.87 -42.51 94.78 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.989 -1.069 . . . . 0.0 110.514 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -54.33 -37.21 64.61 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.977 1.711 . . . . 0.0 112.353 171.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -83.84 -49.28 9.2 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.519 1.528 . . . . 0.0 113.473 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.8 -42.49 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 118.989 0.813 . . . . 0.0 111.093 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.01 -2.52 58.38 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.471 0.708 . . . . 0.0 112.785 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . 0.273 32.8 ptt180 51.88 22.99 1.92 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.07 2.548 . . . . 0.0 116.179 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.411 HD11 HD23 ' A' ' 29' ' ' LEU . 3.6 pp -92.36 153.41 19.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.145 1.778 . . . . 0.0 112.139 175.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -80.41 160.12 25.45 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.006 0.922 . . . . 0.0 113.454 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -69.76 -24.37 63.52 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 119.903 -1.748 . . . . 0.0 115.586 -168.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -96.14 8.06 44.8 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.673 1.124 . . . . 0.0 112.517 167.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -110.62 -1.35 16.86 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.842 1.657 . . . . 0.0 111.013 172.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.411 HD23 HD11 ' A' ' 24' ' ' LEU . 2.0 tm? -94.8 117.67 30.52 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 127.839 2.456 . . . . 0.0 105.804 165.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -89.09 134.18 34.1 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.537 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.656 HD12 ' H ' ' A' ' 31' ' ' ILE . 0.3 OUTLIER -125.83 142.95 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 124.71 1.204 . . . . 0.0 112.21 173.025 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.4 p -154.3 145.12 22.52 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.974 1.31 . . . . 0.0 110.123 -166.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -166.94 59.89 0.09 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 122.935 1.35 . . . . 0.0 112.329 -170.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 76.1 p -89.89 -58.3 2.56 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.38 -0.825 . . . . 0.0 111.836 153.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.95 -55.95 4.09 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.959 0.885 . . . . 0.0 113.016 -151.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -61.25 -30.15 70.28 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.801 1.241 . . . . 0.0 112.344 172.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.661 ' HA ' ' H ' ' A' ' 44' ' ' SER . 1.5 mp -66.03 -29.87 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.922 0.889 . . . . 0.0 111.174 175.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.8 m -84.71 4.89 30.54 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.394 1.478 . . . . 0.0 114.612 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -84.47 -14.42 49.22 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.531 1.514 . . . . 0.0 112.346 170.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -120.66 161.96 37.02 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 127.045 2.138 . . . . 0.0 110.389 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -58.83 -38.26 89.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.52 2.147 . . . . 0.0 114.26 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -121.57 -35.78 3.17 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 116.852 2.168 . . . . 0.0 116.852 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -166.31 143.68 5.23 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 120.705 1.593 . . . . 0.0 109.387 -171.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.661 ' H ' ' HA ' ' A' ' 37' ' ' ILE . 96.8 p -106.57 -168.09 1.37 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 135.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -75.62 -75.45 0.18 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.768 1.622 . . . . 0.0 112.195 -166.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -178.13 -174.65 0.43 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.926 0.89 . . . . 0.0 109.541 -173.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 11.5 t0 -139.13 136.38 35.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.74 140.87 49.24 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.527 1.531 . . . . 0.0 112.154 -169.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.8 mtt -114.48 130.53 56.74 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 120.56 1.527 . . . . 0.0 111.857 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.0 mt -131.55 161.24 33.08 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 128.536 2.734 . . . . 0.0 112.936 -153.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.5 p -93.93 179.81 5.22 Favored 'General case' 0 N--CA 1.48 1.062 1 C-N-CA 132.876 4.47 . . . . 0.0 114.573 -153.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 t -120.34 109.01 14.85 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.52 -1.362 . . . . 0.0 108.082 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.468 ' HB3' ' H ' ' A' ' 54' ' ' ILE . 6.0 m-20 -161.01 -154.97 0.39 Allowed 'General case' 0 CA--C 1.561 1.367 0 O-C-N 120.88 -1.138 . . . . 0.0 112.898 -136.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.468 ' H ' ' HB3' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -145.35 178.85 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 1 C-N-CA 132.359 4.264 . . . . 0.0 109.09 -157.066 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.7 p -76.22 123.44 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.973 1.309 . . . . 0.0 112.294 -164.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -122.56 148.08 52.06 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.84 1.256 . . . . 0.0 112.315 -173.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.62 72.74 5.92 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 125.234 3.956 . . . . 0.0 111.986 -172.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.3 p -66.12 -24.09 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.075 0.95 . . . . 0.0 113.3 -169.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.61 -40.08 51.79 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.514 1.126 . . . . 0.0 113.765 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -60.82 -38.5 85.62 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.032 0.533 . . . . 0.0 111.784 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.7 -46.7 62.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.294 1.038 . . . . 0.0 111.037 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -58.35 -44.72 88.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.206 1.002 . . . . 0.0 111.673 173.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.5 m -73.59 -48.09 35.42 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.977 0.911 . . . . 0.0 112.307 -172.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -59.43 -45.2 92.23 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.215 174.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -58.64 -48.42 81.1 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.106 0.866 . . . . 0.0 112.497 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -58.98 -43.67 91.46 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 70.9 m -74.17 -23.46 59.24 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -74.14 -17.16 60.96 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -167.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.7 p -144.2 2.84 1.16 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 175.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.34 71.27 0.86 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 127.062 2.267 . . . . 0.0 110.342 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -165.5 128.85 2.2 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 127.882 2.473 . . . . 0.0 105.677 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.0 m -84.55 141.73 30.5 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 126.412 1.885 . . . . 0.0 110.496 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.93 151.04 31.58 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -170.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 24.9 p -101.06 133.86 44.94 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.819 0.848 . . . . 0.0 111.427 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -89.35 117.61 28.42 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 168.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 115' ' ' VAL . 42.1 t -121.86 113.85 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 123.464 0.706 . . . . 0.0 109.284 -169.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -89.86 125.12 35.21 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.518 -1.364 . . . . 0.0 107.581 -176.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.8 97.82 6.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 123.293 1.52 . . . . 0.0 107.55 168.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -73.7 116.77 14.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.545 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.0 p -147.41 158.27 43.91 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 128.521 2.728 . . . . 0.0 104.674 -161.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -11.42 -131.09 0.0 OUTLIER Glycine 0 N--CA 1.483 1.783 0 O-C-N 119.304 -2.122 . . . . 0.0 114.442 -127.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 30.3 p -94.03 101.01 13.03 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 115.058 -2.657 . . . . 0.0 108.308 161.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -172.67 165.87 5.43 Favored 'General case' 0 N--CA 1.469 0.516 1 C-N-CA 131.76 4.024 . . . . 0.0 106.835 158.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.4 t -87.98 124.77 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.02 -1.05 . . . . 0.0 110.218 159.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.78 141.55 37.84 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.991 0.814 . . . . 0.0 108.861 164.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 31.4 tp -119.72 106.1 11.81 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.416 1.086 . . . . 0.0 108.617 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.4 m -80.17 125.62 30.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.122 0.569 . . . . 0.0 110.916 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 10.8 m -111.38 107.04 16.15 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 120.893 -1.129 . . . . 0.0 109.751 -173.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -103.73 97.65 7.63 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.028 0.531 . . . . 0.0 112.32 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.3 mt -75.7 82.81 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 139.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -178.03 179.87 48.29 Favored Glycine 0 N--CA 1.468 0.791 0 N-CA-C 122.413 3.725 . . . . 0.0 122.413 -161.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -108.88 66.73 0.32 Allowed Pre-proline 0 CA--C 1.551 1.002 0 CA-C-N 112.886 -1.657 . . . . 0.0 113.346 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.67 134.78 45.69 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.192 2.594 . . . . 0.0 113.428 -176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -76.33 -41.74 47.39 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.3 1.04 . . . . 0.0 111.77 171.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -69.84 -11.67 61.03 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -172.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.11 -18.29 5.36 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.478 1.911 . . . . 0.0 114.017 163.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -78.37 -2.22 37.19 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.879 1.272 . . . . 0.0 114.063 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -134.35 -35.7 0.91 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.12 0.873 . . . . 0.0 113.188 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 pp -77.0 166.26 23.56 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -164.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -92.13 -175.17 3.99 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.515 1.126 . . . . 0.0 112.808 -162.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -122.07 168.63 11.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.566 1.546 . . . . 0.0 109.541 159.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.5 p -122.69 124.9 71.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 167.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 47.3 t -125.14 114.39 18.96 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 122.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -178.23 168.16 1.93 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 123.126 1.441 . . . . 0.0 109.126 -165.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -141.99 109.16 5.52 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 127.045 2.138 . . . . 0.0 109.591 164.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -151.04 162.8 40.15 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -168.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -73.69 149.71 41.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.17 0.988 . . . . 0.0 111.946 164.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.4 tp -142.45 147.54 36.29 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 128.125 2.57 . . . . 0.0 109.696 -157.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.7 p -114.75 176.0 5.25 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.919 2.088 . . . . 0.0 114.013 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.83 -13.19 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 126.166 1.787 . . . . 0.0 114.548 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -115.02 33.07 5.63 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.672 -1.268 . . . . 0.0 112.46 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.07 153.13 19.82 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.733 -1.229 . . . . 0.0 114.114 -172.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -156.92 128.15 6.89 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.491 1.516 . . . . 0.0 108.854 -174.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.4 pp -158.18 152.26 24.1 Favored 'General case' 0 CA--C 1.554 1.096 0 O-C-N 121.062 -1.024 . . . . 0.0 113.194 -168.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 76' ' ' VAL . 29.8 t -99.91 146.46 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 126.585 1.954 . . . . 0.0 111.981 175.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.41 133.51 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.317 0.579 . . . . 0.0 110.841 145.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.2 t -154.42 153.83 32.23 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.027 1.331 . . . . 0.0 111.839 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -27.67 68.24 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.157 1.383 . . . . 0.0 114.34 -166.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.7 -30.72 46.21 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.524 -1.36 . . . . 0.0 113.307 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.29 -33.65 65.33 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.129 -0.982 . . . . 0.0 111.39 168.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.6 mm -60.95 -38.67 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 118.626 0.648 . . . . 0.0 111.004 166.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -65.79 -23.7 66.76 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 173.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -70.4 -29.69 66.39 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 120.243 -1.535 . . . . 0.0 112.269 167.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 27.4 mt -78.58 -38.31 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.715 0.806 . . . . 0.0 110.717 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.482 ' HE3' ' HA ' ' A' ' 153' ' ' PHE . 54.9 mmtt -136.08 109.78 9.88 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 126.549 1.94 . . . . 0.0 111.82 -174.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -62.33 -12.59 28.05 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 N-CA-C 120.083 3.07 . . . . 0.0 120.083 -166.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 9.5 m -133.95 130.96 38.45 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.824 1.647 . . . . 0.0 112.303 173.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -96.59 12.57 31.2 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 -167.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -77.71 14.16 1.12 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -171.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.49 41.16 0.08 OUTLIER Glycine 0 N--CA 1.47 0.951 0 O-C-N 120.918 -1.113 . . . . 0.0 112.856 -172.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.8 115.65 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.383 0.673 . . . . 0.0 111.65 -172.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.42 88.21 3.6 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 158.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 88.7 m -88.3 133.67 34.01 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 163.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -131.78 128.79 39.53 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.655 1.182 . . . . 0.0 108.431 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 51.7 t -136.6 136.04 38.88 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.938 -1.101 . . . . 0.0 111.786 -162.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -142.87 129.83 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.489 1.116 . . . . 0.0 109.855 -167.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.404 HG12 HD12 ' A' ' 148' ' ' ILE . 14.0 m -131.94 144.6 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 121.454 -0.778 . . . . 0.0 110.68 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -132.51 152.08 51.69 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 125.256 1.423 . . . . 0.0 108.384 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.29 0.9 OUTLIER -148.43 152.68 37.37 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.938 1.295 . . . . 0.0 108.507 167.126 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.0 t -128.33 139.77 52.23 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -93.43 -53.26 4.15 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.989 0.916 . . . . 0.0 109.614 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.3 m -50.3 -41.44 50.85 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.253 1.421 . . . . 0.0 113.18 172.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -100.5 13.32 59.75 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.589 1.566 . . . . 0.0 115.007 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 92.7 mtp 28.96 63.53 0.12 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 127.961 2.504 . . . . 0.0 114.754 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.8 t -159.68 139.76 11.77 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.292 -0.88 . . . . 0.0 110.279 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -130.92 156.92 44.26 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 122.129 -0.357 . . . . 0.0 110.262 -162.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -149.85 136.93 19.6 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.038 0.835 . . . . 0.0 113.139 -163.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.404 HD12 HG12 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -146.56 115.27 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.184 0.516 . . . . 0.0 110.519 -159.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -142.86 137.42 29.56 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.178 -0.951 . . . . 0.0 112.311 -169.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.1 p -150.43 140.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 120.912 -1.118 . . . . 0.0 110.563 162.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.7 m -118.84 149.29 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 128.281 2.633 . . . . 0.0 109.552 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -134.34 135.25 42.6 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.482 ' HA ' ' HE3' ' A' ' 125' ' ' LYS . 64.8 m-85 -135.81 158.54 44.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.901 2.081 . . . . 0.0 110.537 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -104.1 -143.3 12.34 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 164.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -45.41 -35.47 11.94 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.931 3.087 . . . . 0.0 114.653 169.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -62.68 -10.02 11.1 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -172.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -107.77 70.21 0.77 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 123.17 1.462 . . . . 0.0 111.195 167.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.1 -25.25 58.45 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.726 1.611 . . . . 0.0 112.096 165.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.44 -53.89 8.65 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -74.61 -20.44 59.91 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 120.598 1.545 . . . . 0.0 113.107 170.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.84 -57.45 12.6 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.488 1.495 . . . . 0.0 110.978 165.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -63.4 -29.64 70.91 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.981 -1.074 . . . . 0.0 112.995 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.16 -33.79 76.84 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.364 0.984 . . . . 0.0 113.088 172.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -75.13 -52.45 10.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.255 -0.903 . . . . 0.0 112.091 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 10.0 mp -50.93 -34.82 30.23 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.627 1.103 . . . . 0.0 113.963 170.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -60.41 -50.97 71.49 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.989 1.716 . . . . 0.0 110.689 171.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -72.88 -18.2 61.45 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.2 mm -83.29 -38.38 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 120.288 1.403 . . . . 0.0 110.707 171.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -62.21 -22.63 66.09 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.512 -1.367 . . . . 0.0 112.558 166.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -101.33 28.68 5.25 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.589 1.556 . . . . 0.0 114.362 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 C-N-CA 126.205 1.802 . . . . 0.0 115.831 170.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 120.773 0.321 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.69 -0.73 85.4 Favored Glycine 0 CA--C 1.537 1.446 0 N-CA-C 117.252 1.661 . . . . 0.0 117.252 168.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -56.8 143.72 35.83 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 120.157 1.979 . . . . 0.0 111.821 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 94.0 mtp -72.05 96.54 1.76 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.727 1.211 . . . . 0.0 112.599 -171.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -83.78 92.85 7.83 Favored 'General case' 0 C--O 1.24 0.579 0 O-C-N 121.478 -0.764 . . . . 0.0 109.377 177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 6' ' ' ILE . 9.2 tp -80.67 104.93 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 123.137 1.446 . . . . 0.0 113.073 -172.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.2 125.92 10.14 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 111.786 -2.461 . . . . 0.0 111.309 -173.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -59.99 -24.34 64.36 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 116.618 2.081 . . . . 0.0 116.618 -155.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -106.08 -27.05 11.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.127 0.971 . . . . 0.0 112.436 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.9 t -74.35 -61.0 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.754 1.221 . . . . 0.0 111.687 -172.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.8 -45.93 92.91 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.471 -0.627 . . . . 0.0 111.829 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.15 -53.04 30.37 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.936 0.894 . . . . 0.0 112.741 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -68.29 -41.08 81.48 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 mp -75.98 -40.08 54.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.987 1.267 . . . . 0.0 111.92 -172.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.56 -46.31 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.424 -0.797 . . . . 0.0 109.863 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.4 m -70.16 -41.29 74.0 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.536 -0.727 . . . . 0.0 111.666 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -69.35 -22.27 63.76 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.685 -1.26 . . . . 0.0 112.833 172.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.3 m -63.83 -48.15 77.93 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.772 1.624 . . . . 0.0 109.804 168.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -43.09 92.04 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.996 0.816 . . . . 0.0 112.105 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.8 ttt85 -71.22 -42.08 69.38 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.228 1.811 . . . . 0.0 113.54 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.7 -40.26 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 119.44 1.018 . . . . 0.0 110.036 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -79.46 -8.12 58.9 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 55.57 37.11 28.45 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.978 1.711 . . . . 0.0 114.247 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 pp -112.46 160.07 18.12 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.821 1.248 . . . . 0.0 110.878 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.9 156.08 39.61 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.239 0.542 . . . . 0.0 112.282 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -60.23 -26.97 66.83 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.308 -1.495 . . . . 0.0 112.033 170.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -91.88 12.48 21.45 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.314 1.845 . . . . 0.0 113.27 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -119.38 -10.41 9.7 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.511 1.124 . . . . 0.0 111.945 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.52 HD11 ' HB1' ' A' ' 48' ' ' ALA . 26.8 tp -88.54 111.32 21.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 171.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -85.46 124.78 32.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.258 175.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.0 mm -89.7 141.33 14.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 125.581 1.553 . . . . 0.0 109.875 172.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 54.6 m -118.68 141.77 48.3 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 164.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.71 -152.62 0.32 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.392 2.277 . . . . 0.0 112.513 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.0 t -51.41 -32.13 25.34 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -158.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.4 -42.3 61.33 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -167.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.99 -8.17 24.2 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.0 pt -110.3 -2.85 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 127.186 2.194 . . . . 0.0 115.051 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.3 m -42.08 11.17 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 130.256 3.422 . . . . 0.0 117.468 160.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -67.58 -48.9 65.56 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.106 -1.621 . . . . 0.0 109.282 171.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -69.91 160.15 81.35 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.949 162.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -52.73 -35.03 67.25 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.264 2.643 . . . . 0.0 114.817 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -118.71 -52.9 2.33 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.243 0.929 . . . . 0.0 112.852 161.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -145.51 123.85 12.31 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.312 1.968 . . . . 0.0 116.312 -163.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.4 m -73.89 -159.27 0.07 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.834 1.253 . . . . 0.0 109.83 144.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.4 tp -70.15 -76.43 0.1 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 121.272 1.851 . . . . 0.0 112.528 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 11.8 p -174.96 -161.69 0.1 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.974 0.91 . . . . 0.0 111.735 -167.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -127.25 158.31 37.51 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.635 1.574 . . . . 0.0 108.676 161.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -131.31 133.69 45.61 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.909 2.884 . . . . 0.0 108.93 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.1 ttp -124.89 132.61 53.28 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.161 -0.962 . . . . 0.0 111.32 -168.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.6 mt -137.22 163.86 29.9 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.37 1.868 . . . . 0.0 114.296 -139.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.2 t -92.76 179.51 5.46 Favored 'General case' 0 N--CA 1.475 0.811 1 C-N-CA 132.596 4.358 . . . . 0.0 114.303 -145.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.2 t -134.15 112.96 11.55 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 170.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.605 ' C ' HD13 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -164.54 -151.89 0.17 Allowed 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -141.701 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.605 HD13 ' C ' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -125.8 -176.03 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 131.391 3.876 . . . . 0.0 109.546 -165.526 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 54' ' ' ILE . 32.9 m -76.04 133.7 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.499 0.719 . . . . 0.0 111.563 -177.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -132.2 145.3 56.75 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.044 0.938 . . . . 0.0 113.255 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -76.45 71.42 5.91 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 125.175 3.917 . . . . 0.0 111.784 -173.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.8 p -58.88 -29.38 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.307 1.843 . . . . 0.0 113.221 -169.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -52.48 -37.42 57.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.073 1.749 . . . . 0.0 113.817 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -66.15 -35.2 79.86 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.241 -0.912 . . . . 0.0 110.697 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 37.4 tp -74.97 -42.49 57.51 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.623 0.769 . . . . 0.0 112.207 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 mp -57.62 -32.15 66.95 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.973 0.806 . . . . 0.0 112.122 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.7 m -73.77 -50.95 18.14 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.823 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -58.29 -34.97 71.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.258 0.935 . . . . 0.0 112.894 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 47.8 t-105 -66.64 -58.71 4.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.749 1.22 . . . . 0.0 112.825 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -75.85 -36.96 59.41 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -174.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.5 t -69.08 -13.81 62.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.012 0.925 . . . . 0.0 113.352 -175.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.4 tpt85 -68.45 -16.13 63.79 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 119.537 1.062 . . . . 0.0 113.151 -172.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.2 p -140.46 -28.79 0.71 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.401 1.48 . . . . 0.0 112.259 165.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.18 79.99 0.67 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 125.796 1.665 . . . . 0.0 108.983 -164.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -158.17 119.95 3.6 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 127.871 2.469 . . . . 0.0 107.168 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.0 m -64.89 116.29 6.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 122.111 0.958 . . . . 0.0 111.268 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.52 143.46 31.56 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.189 1.795 . . . . 0.0 111.857 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 79.3 m -96.25 128.86 43.54 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.748 -0.595 . . . . 0.0 111.791 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -80.31 129.31 34.42 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 149.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.8 t -123.81 114.37 41.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -174.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -87.43 110.97 20.66 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -173.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -112.56 102.17 10.27 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -74.33 125.92 29.54 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.394 -0.817 . . . . 0.0 109.92 170.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.3 p -145.48 160.19 41.97 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 128.285 2.634 . . . . 0.0 104.772 -165.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -11.09 -128.39 0.0 OUTLIER Glycine 0 N--CA 1.486 1.967 0 C-N-CA 126.809 2.147 . . . . 0.0 116.267 -146.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 53.5 t -92.95 98.08 11.13 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 116.27 -2.172 . . . . 0.0 108.588 162.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.68 154.91 2.58 Favored 'General case' 0 CA--C 1.538 0.519 1 C-N-CA 132.412 4.285 . . . . 0.0 106.628 159.199 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.07 148.85 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 119.714 -1.866 . . . . 0.0 109.429 149.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.2 p -139.61 163.62 32.09 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 119.597 -1.939 . . . . 0.0 110.764 162.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 pp -128.93 130.14 46.37 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.696 0.76 . . . . 0.0 110.467 164.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.3 m -83.78 133.6 34.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.99 1.316 . . . . 0.0 109.845 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 61.6 m -104.37 108.85 20.45 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 121.099 -1.001 . . . . 0.0 110.029 -172.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -111.05 94.71 5.13 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.5 mt -74.96 78.32 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 135.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.34 178.6 47.12 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 116.517 1.367 . . . . 0.0 116.517 -169.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -110.25 74.82 0.87 Allowed Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.919 1.288 . . . . 0.0 114.196 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -70.52 105.38 1.6 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.769 2.979 . . . . 0.0 112.27 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.85 -21.67 30.91 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -73.09 -20.23 61.0 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.862 1.665 . . . . 0.0 112.93 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.34 -21.18 22.78 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.14 2.176 . . . . 0.0 114.135 171.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.13 -38.82 54.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.14 0.976 . . . . 0.0 111.515 167.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -125.45 -17.15 5.66 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 118.119 2.637 . . . . 0.0 118.119 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.406 HD22 ' HB1' ' A' ' 113' ' ' ALA 0.26 3.9 pp -70.31 167.49 17.93 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 123.174 2.716 . . . . 0.0 112.83 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -89.5 -163.94 1.08 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.811 1.244 . . . . 0.0 113.659 -157.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.27 170.32 8.03 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 126.673 1.989 . . . . 0.0 112.787 163.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.426 HG21 HG23 ' A' ' 116' ' ' VAL . 19.2 m -73.47 151.13 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.423 -0.798 . . . . 0.0 112.721 155.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 27.2 p -152.4 -178.57 6.91 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 128.054 2.542 . . . . 0.0 108.796 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -56.84 -141.88 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.848 1 C-N-CA 133.302 4.641 . . . . 0.0 107.767 161.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -86.49 127.05 34.83 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 118.089 -1.444 . . . . 0.0 114.068 -149.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -154.08 145.33 22.93 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.759 1.224 . . . . 0.0 112.409 -172.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -105.46 131.56 52.72 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.327 1.451 . . . . 0.0 110.358 169.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.4 pp -141.83 150.32 41.48 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.119 1.368 . . . . 0.0 114.537 -167.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.1 m -96.2 174.19 7.02 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 -166.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.25 -10.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 128.772 2.829 . . . . 0.0 114.8 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -134.84 35.63 3.11 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.212 -0.93 . . . . 0.0 111.412 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -110.07 147.5 33.49 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -175.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.406 ' HB1' HD22 ' A' ' 99' ' ' LEU . . . -152.75 135.26 15.18 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.255 1.022 . . . . 0.0 108.406 -148.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.01 157.9 38.33 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.067 1.347 . . . . 0.0 112.287 -175.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.8 t -97.35 143.67 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.859 1.264 . . . . 0.0 110.491 169.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.426 HG23 HG21 ' A' ' 102' ' ' VAL . 9.9 p -124.76 106.07 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 122.991 1.377 . . . . 0.0 109.749 157.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.5 p -123.46 163.93 19.91 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.077 1.751 . . . . 0.0 108.773 165.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -59.57 -21.32 60.15 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.571 -0.705 . . . . 0.0 112.414 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.17 -32.85 65.09 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.66 1.184 . . . . 0.0 113.566 173.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -69.96 -29.36 66.46 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 120.496 -1.378 . . . . 0.0 111.636 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.3 mp -72.25 -40.8 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.096 0.958 . . . . 0.0 109.924 167.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -55.26 -27.36 45.92 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.694 0.798 . . . . 0.0 112.414 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -79.71 -20.19 47.1 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.368 -1.458 . . . . 0.0 114.918 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 88.7 mt -84.13 -41.63 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 120.001 1.273 . . . . 0.0 110.01 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -153.17 139.89 12.71 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 127.25 2.22 . . . . 0.0 109.444 165.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.12 119.75 7.22 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.409 2.073 . . . . 0.0 112.201 174.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 71.2 m -68.98 162.03 27.65 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.707 0.803 . . . . 0.0 112.421 -172.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.38 149.46 28.64 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.168 2.187 . . . . 0.0 106.509 169.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -50.62 114.51 1.16 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 169.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.91 11.11 13.01 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 117.937 -1.479 . . . . 0.0 116.357 -166.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.8 t -59.63 147.76 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 120.938 2.369 . . . . 0.0 111.045 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.25 86.49 2.37 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.566 1.546 . . . . 0.0 109.345 160.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.8 m -78.32 137.96 38.33 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 168.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -123.12 130.1 52.33 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -174.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 21.7 p -116.8 136.22 53.13 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.029 -0.419 . . . . 0.0 110.771 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.0 t -113.1 130.26 67.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 125.454 1.502 . . . . 0.0 106.972 165.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.8 m -119.98 145.2 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.633 0.73 . . . . 0.0 109.933 160.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 45.5 ttm180 -146.14 154.82 42.23 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.797 1.639 . . . . 0.0 108.092 -169.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.311 0.0 OUTLIER -144.51 148.19 34.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.108 -0.995 . . . . 0.0 110.042 164.234 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.1 t -153.97 -171.28 3.83 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.233 1.013 . . . . 0.0 112.2 -155.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.3 m120 48.73 80.53 0.06 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.07 2.548 . . . . 0.0 111.664 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 63.2 p 53.55 -1.2 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -165.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.15 34.68 8.6 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.653 1.12 . . . . 0.0 113.003 -165.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 36.5 tpp -124.36 5.15 8.4 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.109 1.764 . . . . 0.0 113.203 -175.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.2 t -143.68 155.37 44.2 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.295 1.438 . . . . 0.0 111.05 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -134.57 144.37 47.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.852 1.261 . . . . 0.0 109.085 -164.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -151.45 147.44 26.86 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.658 -1.276 . . . . 0.0 111.333 -151.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.5 tt -145.78 147.01 18.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -170.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -139.82 122.97 16.86 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.757 0.823 . . . . 0.0 109.599 163.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.99 127.23 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 122.816 1.293 . . . . 0.0 112.777 172.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.5 m -132.61 150.51 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.819 2.048 . . . . 0.0 110.394 -164.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -126.77 138.17 53.33 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -173.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -139.92 157.0 46.4 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.236 1.415 . . . . 0.0 110.196 167.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.23 -153.11 29.59 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 124.548 1.071 . . . . 0.0 113.451 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.32 -16.12 16.86 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 124.908 3.738 . . . . 0.0 115.07 177.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -71.79 -12.47 61.31 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.438 2.695 . . . . 0.0 115.965 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -81.87 41.31 0.65 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 122.861 1.315 . . . . 0.0 112.916 -174.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -64.12 -20.58 66.08 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.528 1.531 . . . . 0.0 113.78 -168.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.83 -52.58 12.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.52 1.054 . . . . 0.0 110.921 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -60.19 -41.98 94.09 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.176 0.99 . . . . 0.0 112.121 171.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -61.16 -52.96 62.66 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 122.564 0.345 . . . . 0.0 110.908 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -65.21 -34.51 78.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.452 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.72 -33.07 74.83 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 119.386 0.994 . . . . 0.0 113.135 175.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.54 -50.13 34.17 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.463 0.705 . . . . 0.0 112.36 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.7 mt -55.26 -37.86 67.81 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.643 0.656 . . . . 0.0 111.582 175.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -69.91 -29.69 66.94 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.392 1.877 . . . . 0.0 112.267 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -88.03 -52.26 5.35 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . 0.287 1.3 pp -104.87 -7.15 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 -165.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -116.82 8.5 13.64 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.88 1.218 . . . . 0.0 111.927 163.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -137.29 27.76 2.83 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.877 1.271 . . . . 0.0 113.825 172.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.261 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 168.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 121.214 0.53 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.99 -4.53 24.18 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 125.12 1.343 . . . . 0.0 114.381 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -127.41 160.74 30.52 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.094 1.758 . . . . 0.0 112.015 -172.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -89.12 129.18 35.77 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 154.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -136.95 111.95 8.96 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.848 0.749 . . . . 0.0 112.08 -165.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.9 tp -76.66 99.22 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 122.929 1.347 . . . . 0.0 111.423 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -47.6 129.05 13.42 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 111.432 -2.622 . . . . 0.0 112.776 -162.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -56.43 -46.08 80.45 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -139.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -92.37 -28.05 17.15 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.152 0.981 . . . . 0.0 111.985 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.1 t -67.33 -55.04 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 124.47 1.108 . . . . 0.0 111.386 -169.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.66 -55.13 31.52 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 168.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.7 -41.65 70.53 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.735 1.268 . . . . 0.0 113.898 -174.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -73.16 -40.99 64.4 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.894 1.278 . . . . 0.0 112.425 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 mp -70.62 -37.63 73.85 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.099 -1.001 . . . . 0.0 112.523 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.62 -43.57 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.087 1.355 . . . . 0.0 109.491 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.2 p -66.19 -40.63 90.55 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.109 0.413 . . . . 0.0 111.643 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -63.6 -41.86 98.3 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 118.838 0.744 . . . . 0.0 112.263 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.3 m -60.44 -49.15 78.7 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.205 -0.935 . . . . 0.0 110.64 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.2 ptt85 -69.35 -32.9 72.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 118.241 -0.885 . . . . 0.0 113.251 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.1 ttt-85 -62.18 -48.4 80.24 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.29 1.436 . . . . 0.0 111.349 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.19 -33.03 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.978 0.911 . . . . 0.0 111.828 -174.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -90.51 -0.6 57.73 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 172.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 58.23 30.8 19.97 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.637 1.975 . . . . 0.0 114.874 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 pp -100.9 162.64 12.76 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.374 0.988 . . . . 0.0 112.311 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.75 155.37 33.25 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.12 0.968 . . . . 0.0 111.302 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.35 -21.24 66.67 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.073 -1.642 . . . . 0.0 113.542 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -96.2 10.5 37.6 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.294 1.438 . . . . 0.0 113.614 168.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -113.28 14.82 19.38 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.477 1.511 . . . . 0.0 110.215 168.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.9 tp -112.42 120.84 43.04 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 165.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -85.33 125.34 32.86 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 118.462 -1.295 . . . . 0.0 107.589 162.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.489 HD12 ' H ' ' A' ' 31' ' ' ILE 0.255 0.7 OUTLIER -117.08 144.24 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.602 1.961 . . . . 0.0 114.463 167.715 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -154.93 144.51 21.38 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.123 1.369 . . . . 0.0 109.346 -160.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -167.72 62.22 0.07 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.429 1.492 . . . . 0.0 112.298 -167.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.3 t -91.78 -58.35 2.44 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.742 -1.224 . . . . 0.0 112.888 154.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.24 -59.15 2.32 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.02 -152.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.542 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -54.42 -38.95 66.84 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.886 1.674 . . . . 0.0 112.979 177.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.544 ' HA ' ' H ' ' A' ' 44' ' ' SER . 1.4 mp -55.6 -25.98 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.156 1.382 . . . . 0.0 111.289 174.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 63.5 m -110.05 3.19 20.09 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.386 2.274 . . . . 0.0 115.38 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -94.49 20.39 8.46 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 120.378 1.444 . . . . 0.0 112.699 169.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -144.46 170.17 8.76 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 128.574 2.75 . . . . 0.0 107.412 173.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -58.74 -45.35 29.8 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.292 1.995 . . . . 0.0 114.861 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -119.44 -52.91 2.25 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 -171.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -170.31 133.47 1.09 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.201 2.2 . . . . 0.0 106.945 -166.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.544 ' H ' ' HA ' ' A' ' 37' ' ' ILE . 5.9 t -93.07 -156.69 0.49 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 117.695 -1.145 . . . . 0.0 108.146 173.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -88.84 -81.91 0.26 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 118.046 -1.462 . . . . 0.0 112.04 165.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 t 179.63 -176.41 0.3 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.235 1.016 . . . . 0.0 109.055 -170.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 17.6 t70 -136.68 115.88 12.54 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.52 132.81 48.32 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.725 1.61 . . . . 0.0 111.099 -158.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.1 ttm -128.73 123.47 33.1 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.705 -1.247 . . . . 0.0 112.785 -156.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.3 mt -120.77 141.73 50.23 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 127.129 2.172 . . . . 0.0 113.351 -144.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.6 p -96.96 160.0 14.59 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.559 1.544 . . . . 0.0 110.334 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 69.2 p -124.98 177.9 5.8 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -153.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.476 ' H ' ' HA ' ' A' ' 138' ' ' ARG . 10.7 t70 59.47 50.77 7.17 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.69 1.996 . . . . 0.0 110.394 -162.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.5 tp -142.75 145.32 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.647 1.579 . . . . 0.0 110.955 -167.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.8 p -109.18 140.56 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.964 1.306 . . . . 0.0 111.772 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -133.72 138.59 31.33 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 119.361 0.982 . . . . 0.0 111.896 170.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.99 71.4 2.15 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 125.142 3.895 . . . . 0.0 109.356 171.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 p -52.32 -38.55 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.326 1.45 . . . . 0.0 114.254 -157.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -70.19 -21.97 62.99 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.552 1.141 . . . . 0.0 112.472 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -66.29 -29.79 70.08 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.379 -0.826 . . . . 0.0 112.204 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 36.6 tp -76.52 -47.01 24.14 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.598 1.09 . . . . 0.0 110.572 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.2 mp -53.68 -49.4 68.08 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.022 0.529 . . . . 0.0 110.99 174.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.2 p -71.67 -29.37 64.52 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -65.76 -33.35 75.66 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.963 0.905 . . . . 0.0 112.086 174.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -75.7 -58.35 3.33 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 160.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.61 -34.46 77.05 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.251 -0.906 . . . . 0.0 112.365 -156.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 71.7 m -78.76 -11.51 59.99 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 ttt85 -69.49 -37.47 77.25 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.011 1.325 . . . . 0.0 114.019 -163.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.9 p -152.39 15.99 0.61 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.349 1.46 . . . . 0.0 112.46 171.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.31 81.8 0.14 Allowed Glycine 0 C--N 1.341 0.835 0 C-N-CA 125.705 1.622 . . . . 0.0 113.237 173.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -151.44 113.64 4.54 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.131 0.967 . . . . 0.0 111.809 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.0 m -66.19 133.59 50.97 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.152 1.381 . . . . 0.0 112.695 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -131.93 159.35 38.93 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.555 1.542 . . . . 0.0 114.439 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 81.8 m -96.76 108.03 20.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.069 2.547 . . . . 0.0 108.543 164.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -91.13 96.39 10.57 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.216 -0.927 . . . . 0.0 108.784 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.53 114.86 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.856 0.862 . . . . 0.0 110.852 -164.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -91.35 117.28 29.53 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 120.323 -1.486 . . . . 0.0 107.704 176.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.06 126.74 54.32 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.685 1.594 . . . . 0.0 111.094 174.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -95.4 128.61 42.4 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.527 1.131 . . . . 0.0 109.147 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.5 p -144.56 165.31 28.37 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 130.512 3.525 . . . . 0.0 105.711 -165.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.35 -121.54 0.0 OUTLIER Glycine 0 N--CA 1.491 2.314 0 C-N-CA 129.868 3.604 . . . . 0.0 115.935 -174.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.9 p -93.51 104.81 16.91 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 114.649 -2.82 . . . . 0.0 109.854 150.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.8 mtt85 -178.54 145.39 0.32 Allowed 'General case' 0 CA--C 1.555 1.138 1 C-N-CA 134.376 5.07 . . . . 0.0 106.753 131.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.14 135.52 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 121.839 2.109 . . . . 0.0 109.731 149.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.5 t -107.05 147.12 30.35 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.427 -1.421 . . . . 0.0 110.77 170.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 18.2 tp -110.98 106.32 15.37 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 159.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.5 m -78.64 111.33 14.61 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.126 164.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.7 t -103.88 110.75 23.0 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 119.613 -1.929 . . . . 0.0 110.733 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -111.13 113.35 25.8 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -173.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.9 mp -77.33 88.73 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 133.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.3 172.38 42.64 Favored Glycine 0 N--CA 1.475 1.299 0 N-CA-C 121.219 3.248 . . . . 0.0 121.219 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -110.91 49.61 0.27 Allowed Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 127.181 2.193 . . . . 0.0 116.457 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -63.25 166.94 13.65 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 CA-C-N 122.607 1.967 . . . . 0.0 115.514 173.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -77.52 -28.43 52.02 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -84.02 -16.73 42.85 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -172.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -50.74 -28.07 8.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 128.02 2.528 . . . . 0.0 112.908 172.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -61.88 -39.62 92.59 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.788 -0.625 . . . . 0.0 112.302 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -112.19 -17.3 12.82 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -173.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 pp -80.62 157.97 25.82 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 120.675 1.58 . . . . 0.0 111.894 168.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -168.45 138.17 2.42 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -172.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.669 ' CD ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -112.18 -179.14 3.6 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.851 1.66 . . . . 0.0 112.502 177.042 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.669 ' H ' ' CD ' ' A' ' 101' ' ' ARG . 3.1 p -162.6 173.91 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 125.764 1.626 . . . . 0.0 112.732 -142.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.483 ' HA ' HG13 ' A' ' 150' ' ' VAL . 46.3 t -121.56 122.21 39.18 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.716 0.806 . . . . 0.0 108.949 144.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -175.14 170.2 3.19 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.646 1.578 . . . . 0.0 108.823 -172.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -109.78 104.11 13.02 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.597 2.359 . . . . 0.0 110.436 165.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -129.93 165.93 21.08 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -171.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -137.22 137.01 38.64 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.632 1.173 . . . . 0.0 113.31 167.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.6 tt -149.82 144.04 25.74 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.277 1.031 . . . . 0.0 112.192 -135.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 m -71.5 156.0 39.94 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -6.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 129.364 3.065 . . . . 0.0 114.066 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -138.1 60.1 1.63 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.624 2.37 . . . . 0.0 108.587 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -142.36 150.42 40.71 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 121.014 -1.054 . . . . 0.0 113.091 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.722 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -150.9 155.27 38.81 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.08 -1.637 . . . . 0.0 112.976 -155.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.722 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -150.68 145.76 26.04 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.166 1.386 . . . . 0.0 111.038 -165.658 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.99 134.9 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 120.987 1.722 . . . . 0.0 112.885 162.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.83 157.68 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.47 1.108 . . . . 0.0 109.811 171.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.9 t -157.82 161.97 38.4 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.608 1.963 . . . . 0.0 108.288 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.43 -25.38 24.58 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.37 -37.33 28.41 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 120.302 1.41 . . . . 0.0 113.552 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.41 -31.62 63.97 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.67 -1.269 . . . . 0.0 111.319 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.1 tp -70.97 -32.92 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 121.645 -0.66 . . . . 0.0 111.764 167.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -65.51 -12.99 57.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.274 1.03 . . . . 0.0 112.882 171.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.33 -30.38 68.41 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.421 -1.425 . . . . 0.0 113.656 163.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 14.3 mt -87.2 -40.73 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.711 1.204 . . . . 0.0 111.223 -169.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -155.49 155.44 29.75 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 128.382 2.673 . . . . 0.0 107.597 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -53.8 130.22 38.0 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 121.915 1.744 . . . . 0.0 112.32 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 25.7 t -99.54 153.16 19.26 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.9 1.68 . . . . 0.0 111.046 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -156.8 162.71 39.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.502 1.521 . . . . 0.0 109.476 -170.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -58.44 126.9 29.51 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 127.055 2.142 . . . . 0.0 109.999 170.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.77 15.22 65.98 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-O 118.419 -1.212 . . . . 0.0 115.032 -173.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.77 138.94 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.253 1.526 . . . . 0.0 110.34 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 tp -132.7 82.48 2.01 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 123.781 1.753 . . . . 0.0 109.458 173.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 16.8 m -77.31 142.44 39.41 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 155.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -131.63 133.44 44.95 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 121.408 -0.808 . . . . 0.0 109.506 -167.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 46.1 t -127.04 130.54 50.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.215 0.461 . . . . 0.0 110.602 -166.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.78 113.4 40.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.584 1.554 . . . . 0.0 107.735 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.1 m -111.12 135.59 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 122.189 0.995 . . . . 0.0 111.152 173.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.476 ' HA ' ' H ' ' A' ' 53' ' ' ASP . 54.6 ttt85 -131.12 160.45 34.68 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.23 2.612 . . . . 0.0 106.901 170.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.274 0.0 OUTLIER -143.6 147.67 34.73 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.364 -0.835 . . . . 0.0 109.29 167.725 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.5 m -97.99 137.34 36.94 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.62 0.645 . . . . 0.0 109.548 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -61.09 168.54 2.44 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -169.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.7 m 53.08 28.26 6.64 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.613 1.165 . . . . 0.0 114.062 -170.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 69.48 25.37 75.56 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.416 1.008 . . . . 0.0 114.706 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 86.1 mtp -83.2 -22.1 33.27 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -166.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 t -165.99 156.32 12.74 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 174.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -104.66 137.27 42.74 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.075 0.95 . . . . 0.0 111.14 149.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -126.07 108.29 11.22 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -175.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.3 tp -140.64 103.14 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 122.659 1.219 . . . . 0.0 108.895 -142.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -136.48 141.54 43.51 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.67 -158.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.483 HG13 ' HA ' ' A' ' 103' ' ' CYS . 2.5 p -154.15 146.02 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.717 0.807 . . . . 0.0 111.083 177.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.2 m -132.14 134.39 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 127.189 2.196 . . . . 0.0 110.464 -174.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.85 116.18 31.56 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -168.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -137.61 158.15 44.99 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.876 0.845 . . . . 0.0 112.201 172.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -86.32 -160.6 34.43 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 125.568 1.556 . . . . 0.0 113.31 172.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.23 -16.27 27.27 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.67 2.913 . . . . 0.0 115.787 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -90.19 16.97 7.6 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.905 1.682 . . . . 0.0 114.273 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -70.43 56.24 0.16 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.565 1.546 . . . . 0.0 111.309 165.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.81 -26.15 65.54 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.304 1.042 . . . . 0.0 112.347 -173.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.51 -53.69 13.04 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -76.64 -26.34 54.77 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.662 0.665 . . . . 0.0 112.518 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -63.24 -56.25 18.16 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.268 0.94 . . . . 0.0 109.871 172.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -55.83 -33.48 64.51 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.115 -0.991 . . . . 0.0 112.949 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.86 -34.11 76.04 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.78 -48.13 64.46 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 120.687 -1.258 . . . . 0.0 112.537 171.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -59.49 -25.96 64.87 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 121.423 1.919 . . . . 0.0 114.484 172.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.0 ttp85 -68.49 -39.62 81.26 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.715 1.206 . . . . 0.0 111.975 169.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -72.21 -29.98 64.48 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.402 1.081 . . . . 0.0 113.486 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.69 -47.34 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.156 1.382 . . . . 0.0 109.589 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -62.6 -3.46 1.49 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 166.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -124.72 26.91 7.01 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 . . . . . 0 C--O 1.254 1.317 0 O-C-N 121.112 -0.993 . . . . 0.0 111.561 168.229 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.56 -150.78 45.48 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 118.913 0.779 . . . . 0.0 113.618 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -80.03 38.74 0.41 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -168.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.3 mtt -67.57 96.58 0.54 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.68 -1.263 . . . . 0.0 112.251 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -140.85 121.71 14.46 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.054 0.942 . . . . 0.0 112.787 169.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.4 mm -103.59 118.98 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 122.697 1.236 . . . . 0.0 107.79 145.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -85.3 149.48 25.43 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.421 -1.718 . . . . 0.0 111.051 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -52.95 -28.27 22.85 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -78.71 -25.53 44.67 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.497 -0.752 . . . . 0.0 111.564 -174.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.4 t -70.5 -46.25 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.613 1.165 . . . . 0.0 110.243 173.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.32 -52.58 52.37 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 169.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.6 -28.71 70.08 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.37 -1.076 . . . . 0.0 113.428 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -75.08 -43.71 51.61 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.232 1.378 . . . . 0.0 114.097 169.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.95 -40.14 83.28 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.321 0.964 . . . . 0.0 111.378 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -66.63 -41.9 88.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 O-C-N 121.256 -0.902 . . . . 0.0 110.238 172.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.3 t -57.7 -47.43 82.4 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.248 0.931 . . . . 0.0 112.506 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -72.38 -29.06 63.42 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.602 -0.686 . . . . 0.0 111.666 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.9 m -63.42 -47.66 81.02 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.701 1.137 . . . . 0.0 110.456 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -51.55 -50.54 59.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.61 1.164 . . . . 0.0 111.283 171.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -77.05 -38.71 52.14 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -168.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -78.97 -42.87 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.191 0.905 . . . . 0.0 110.755 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.04 -8.2 59.72 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 118.815 0.734 . . . . 0.0 112.695 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.4 mmt85 56.57 41.21 28.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.432 1.893 . . . . 0.0 113.034 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 pp -114.59 150.44 35.03 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.454 1.502 . . . . 0.0 110.255 168.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -66.85 153.3 43.78 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.807 -0.558 . . . . 0.0 111.151 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.53 -19.04 63.71 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.518 -1.364 . . . . 0.0 113.2 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -92.17 7.43 42.59 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.305 1.442 . . . . 0.0 113.258 166.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -119.33 10.55 11.98 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.948 1.699 . . . . 0.0 111.7 168.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.8 tp -99.63 130.58 45.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.225 2.21 . . . . 0.0 105.311 161.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -95.48 112.59 24.28 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.168 170.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.409 HD12 ' H ' ' A' ' 31' ' ' ILE . 0.9 OUTLIER -108.16 143.74 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 126.073 1.749 . . . . 0.0 112.411 173.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 m -155.55 131.0 9.65 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -139.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -171.27 57.73 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.774 0.797 . . . . 0.0 111.695 -161.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.5 p -87.55 -54.97 4.0 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.937 -1.102 . . . . 0.0 110.249 153.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.17 -45.37 16.47 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -158.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.485 ' CD1' ' H ' ' A' ' 36' ' ' LEU . 3.0 mp -60.02 -41.64 92.63 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.379 1.072 . . . . 0.0 109.557 176.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mp -75.92 -20.99 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 127.626 2.37 . . . . 0.0 111.107 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 15.4 t -74.09 -39.44 63.41 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.561 -1.337 . . . . 0.0 111.82 172.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.9 mmpt? -72.0 -46.27 57.85 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.96 0.8 . . . . 0.0 110.663 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -148.77 95.53 3.93 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 124.709 1.203 . . . . 0.0 109.59 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -66.33 -56.85 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 121.885 1.724 . . . . 0.0 112.596 -173.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -92.77 29.24 1.83 Allowed 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.516 1.126 . . . . 0.0 110.548 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -160.42 99.53 1.31 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 155.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.5 p -178.66 -178.55 0.58 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.778 1.631 . . . . 0.0 110.0 -173.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.5 tp -127.35 -87.03 0.58 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 168.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 p -178.67 176.04 1.02 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.815 1.293 . . . . 0.0 112.451 -159.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -148.91 120.16 7.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.334 1.454 . . . . 0.0 107.989 -177.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.5 144.05 45.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.199 2.2 . . . . 0.0 110.05 -157.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.5 mtt -132.83 131.68 41.3 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.369 1.44 . . . . 0.0 112.532 -162.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.3 mt -128.96 145.42 51.24 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 127.706 3.128 . . . . 0.0 112.15 -144.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.2 p -123.09 163.24 20.9 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 128.062 2.545 . . . . 0.0 111.558 -170.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.6 p -51.98 127.99 22.95 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.59 1.556 . . . . 0.0 113.489 -164.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.37 151.88 32.58 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 118.081 2.623 . . . . 0.0 118.081 -135.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.83 118.37 54.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 165.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.419 HG12 HG22 ' A' ' 136' ' ' VAL . 3.1 m -79.04 130.49 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.858 -154.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -136.29 148.81 65.79 Favored Pre-proline 0 C--O 1.236 0.367 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -166.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.55 76.67 2.3 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.061 3.174 . . . . 0.0 110.807 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.36 -45.44 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 126.526 1.93 . . . . 0.0 113.261 -167.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -78.26 -13.29 59.91 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -70.91 -35.98 72.52 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.409 -1.432 . . . . 0.0 110.146 162.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.0 tp -61.7 -43.95 97.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.745 0.818 . . . . 0.0 111.099 170.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp -56.29 -43.2 78.63 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.326 0.966 . . . . 0.0 112.6 170.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.1 t -61.83 -45.38 94.05 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.401 0.546 . . . . 0.0 111.575 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -66.5 -38.75 87.94 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.19 0.596 . . . . 0.0 112.511 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -57.49 12.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.406 1.483 . . . . 0.0 110.733 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.9 -35.81 81.3 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.198 0.599 . . . . 0.0 111.687 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.2 t -76.1 -23.45 54.93 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.54 -28.64 60.56 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 120.847 1.658 . . . . 0.0 115.163 -165.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.8 p -139.01 14.48 2.65 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.838 1.255 . . . . 0.0 113.415 157.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.47 79.73 0.2 Allowed Glycine 0 N--CA 1.472 1.051 0 C-N-CA 126.454 1.978 . . . . 0.0 113.305 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 74.5 mtt85 -157.58 115.91 3.16 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.033 1.733 . . . . 0.0 110.877 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.67 145.16 29.78 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -152.39 159.15 43.45 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.786 1.634 . . . . 0.0 113.373 -165.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.6 m -76.39 113.81 14.39 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.756 1.222 . . . . 0.0 109.725 162.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -96.2 98.38 10.27 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 122.559 1.171 . . . . 0.0 108.352 173.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.6 t -101.45 150.63 5.86 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 C-N-CA 127.206 2.202 . . . . 0.0 109.419 -164.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -121.76 129.71 52.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.073 -1.017 . . . . 0.0 108.837 164.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -123.04 116.32 23.31 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.805 1.642 . . . . 0.0 110.086 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -95.09 115.94 28.07 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.398 1.479 . . . . 0.0 109.13 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.6 t -147.79 159.7 43.54 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 -170.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -6.75 -126.2 0.0 OUTLIER Glycine 0 N--CA 1.48 1.574 0 O-C-N 119.021 -2.3 . . . . 0.0 112.959 -133.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.465 ' HB3' ' HE3' ' A' ' 139' ' ' LYS . 57.3 m -94.45 111.32 23.06 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 113.642 -3.223 . . . . 0.0 110.17 149.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -169.58 146.22 3.3 Favored 'General case' 0 N--CA 1.475 0.824 1 C-N-CA 132.111 4.164 . . . . 0.0 107.581 133.228 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.9 t -72.23 139.5 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.068 -1.645 . . . . 0.0 110.294 165.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.58 148.5 29.2 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.616 0.766 . . . . 0.0 111.636 165.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.3 tp -108.84 110.37 21.7 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 157.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.4 m -97.83 114.26 26.27 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.868 1.667 . . . . 0.0 108.723 -174.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 99.0 m -103.93 108.36 19.66 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.063 -1.648 . . . . 0.0 109.449 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -103.49 94.2 5.35 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.643 0.735 . . . . 0.0 111.74 -172.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.2 mp -72.99 94.67 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 126.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.36 149.73 10.02 Favored Glycine 0 N--CA 1.468 0.79 0 N-CA-C 119.113 2.405 . . . . 0.0 119.113 -169.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -114.46 58.05 0.93 Allowed Pre-proline 0 CA--C 1.556 1.178 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 170.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -67.77 174.09 8.14 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.993 2.462 . . . . 0.0 114.281 166.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -82.66 -39.08 22.56 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -75.31 -13.05 60.39 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -158.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.416 HD22 ' H ' ' A' ' 96' ' ' LEU . 3.3 mm? -51.57 -30.56 21.33 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 128.046 2.539 . . . . 0.0 112.994 170.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -52.95 -42.07 65.12 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.705 0.802 . . . . 0.0 111.206 170.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -100.77 -34.39 9.86 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -171.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.2 pp -85.61 155.99 20.91 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -167.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -151.47 122.74 7.76 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -159.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.469 ' HB3' HG23 ' A' ' 116' ' ' VAL . 0.8 OUTLIER -106.38 179.5 4.25 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 126.992 2.117 . . . . 0.0 110.104 171.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 p -165.07 173.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -149.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.465 ' HA ' HG13 ' A' ' 150' ' ' VAL . 97.7 m -128.32 120.63 27.44 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.723 1.147 . . . . 0.0 111.258 137.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -176.49 179.52 1.16 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 129.507 3.123 . . . . 0.0 105.237 -172.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -111.42 127.58 55.72 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.456 1.502 . . . . 0.0 110.875 162.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -148.45 159.36 44.12 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.455 1.102 . . . . 0.0 113.658 -161.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -109.13 151.47 26.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.447 2.299 . . . . 0.0 111.162 174.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 mt -142.48 146.8 35.13 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.836 1.255 . . . . 0.0 111.925 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.9 m -106.69 178.49 4.55 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.747 1.219 . . . . 0.0 114.001 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.82 -5.13 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 128.809 2.844 . . . . 0.0 116.113 -161.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -138.3 47.9 1.97 Allowed 'General case' 0 CA--C 1.551 1.015 0 O-C-N 120.608 -1.308 . . . . 0.0 112.794 168.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -111.18 146.76 36.32 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.911 1.284 . . . . 0.0 112.064 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.689 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -150.02 147.06 27.38 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 119.687 -1.883 . . . . 0.0 111.296 -154.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.689 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -142.17 147.5 36.72 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.999 1.32 . . . . 0.0 112.73 -169.252 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.47 141.75 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-N 121.396 1.907 . . . . 0.0 114.065 162.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 101' ' ' ARG . 1.0 OUTLIER -133.91 148.86 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.179 1.392 . . . . 0.0 109.831 173.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.9 t -140.42 159.83 41.33 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.738 2.015 . . . . 0.0 106.542 161.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -49.74 -30.66 9.82 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -171.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.36 -33.35 75.04 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 121.145 1.793 . . . . 0.0 113.734 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.49 -26.36 63.58 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.225 -0.922 . . . . 0.0 112.027 172.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 37.0 mm -77.95 -30.18 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.755 0.822 . . . . 0.0 111.48 167.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.96 -13.98 62.6 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.252 -0.905 . . . . 0.0 113.196 170.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -70.0 -36.25 74.99 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 120.107 -1.621 . . . . 0.0 113.3 158.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.83 -37.67 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.852 1.261 . . . . 0.0 110.593 -176.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.5 135.37 15.82 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 125.112 1.365 . . . . 0.0 111.323 169.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.54 -24.73 63.02 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.893 3.062 . . . . 0.0 116.39 -157.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.7 t -147.65 130.1 15.79 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.393 1.077 . . . . 0.0 110.436 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -168.5 158.5 9.58 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.951 2.1 . . . . 0.0 108.206 169.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -136.07 -31.95 0.89 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.903 1.681 . . . . 0.0 113.64 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -101.76 21.73 41.16 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.949 1.738 . . . . 0.0 114.982 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.87 146.25 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.017 1.408 . . . . 0.0 113.527 -159.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.7 mp -113.63 81.58 1.54 Allowed 'General case' 0 C--O 1.24 0.554 0 CA-C-O 123.431 1.586 . . . . 0.0 108.531 169.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.0 m -75.44 146.27 40.83 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 162.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -124.07 132.56 53.68 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 44.5 t -124.34 133.64 53.39 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.005 0.82 . . . . 0.0 111.168 -169.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.419 HG22 HG12 ' A' ' 55' ' ' VAL . 10.1 t -144.79 108.89 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.398 0.679 . . . . 0.0 111.027 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.1 m -99.59 141.4 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.996 1.319 . . . . 0.0 113.33 173.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -122.98 162.0 23.16 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.63 1.172 . . . . 0.0 109.456 155.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.465 ' HE3' ' HB3' ' A' ' 82' ' ' CYS 0.273 0.1 OUTLIER -147.61 154.49 40.73 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.006 1.722 . . . . 0.0 108.019 169.589 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.8 t -132.88 121.03 22.29 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -73.14 -43.52 61.45 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 118.068 0.394 . . . . 0.0 110.337 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.9 m -45.76 -46.19 15.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.782 1.633 . . . . 0.0 112.762 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -91.18 5.44 81.32 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.449 1.499 . . . . 0.0 115.692 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 43.9 tpp 41.89 50.11 4.09 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.201 1.8 . . . . 0.0 113.63 -173.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.3 t -138.69 140.18 38.69 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.309 -0.869 . . . . 0.0 111.652 -162.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -109.08 139.49 43.89 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.265 1.026 . . . . 0.0 109.603 162.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -143.15 106.44 4.57 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.9 pt -136.32 152.22 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.577 0.751 . . . . 0.0 112.936 -160.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -136.77 149.15 47.64 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.311 0.577 . . . . 0.0 112.245 165.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 103' ' ' CYS . 7.2 p -141.18 132.9 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.137 0.975 . . . . 0.0 109.169 169.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.9 m -138.17 122.98 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.33 1.052 . . . . 0.0 111.668 -156.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -103.95 122.78 45.91 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -164.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -141.24 148.19 39.48 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.256 1.423 . . . . 0.0 110.186 165.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -74.61 -162.43 9.17 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.322 1.439 . . . . 0.0 115.164 169.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -56.15 -13.49 9.64 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 124.401 3.401 . . . . 0.0 117.04 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -63.33 -4.87 2.89 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.746 1.618 . . . . 0.0 113.882 166.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -73.55 43.59 0.15 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 126.075 1.75 . . . . 0.0 112.86 172.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -50.32 -30.44 12.07 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.617 2.767 . . . . 0.0 113.673 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.75 -42.89 57.38 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.377 1.471 . . . . 0.0 114.415 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -71.21 -32.44 68.81 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.404 -1.435 . . . . 0.0 111.629 170.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -58.16 -54.0 51.96 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.478 1.035 . . . . 0.0 111.364 169.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -54.63 -49.31 70.82 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.493 0.588 . . . . 0.0 111.527 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -57.24 -44.45 83.82 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.032 0.833 . . . . 0.0 112.837 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.01 -60.95 2.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.1 mp -53.15 -35.86 60.2 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.269 1.427 . . . . 0.0 112.924 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -68.07 -35.74 78.7 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.148 1.379 . . . . 0.0 111.852 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.65 -26.1 24.52 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.8 pt -104.74 -44.85 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -171.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -90.2 -32.62 16.52 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.247 1.385 . . . . 0.0 109.93 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -97.45 24.11 6.93 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.084 0.954 . . . . 0.0 112.982 171.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.492 -1.242 . . . . 0.0 112.637 163.009 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.66 -36.02 67.25 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 119.575 1.08 . . . . 0.0 112.91 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -102.69 164.22 11.77 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.651 1.18 . . . . 0.0 110.589 158.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.26 132.79 54.76 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 122.829 0.452 . . . . 0.0 111.367 -170.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -72.77 97.21 2.17 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 123.112 1.434 . . . . 0.0 111.656 -164.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 tp -145.85 145.82 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 1 C-N-CA 134.554 5.141 . . . . 0.0 106.483 172.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -75.56 129.6 37.48 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.603 163.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -65.09 -4.23 4.59 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -155.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -93.7 -22.33 18.8 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.482 1.113 . . . . 0.0 113.511 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.73 -42.82 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.664 1.186 . . . . 0.0 113.539 -168.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.88 -47.33 89.75 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 168.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.77 -37.29 70.89 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.966 1.383 . . . . 0.0 112.493 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.43 -35.19 63.38 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.591 1.556 . . . . 0.0 114.129 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.4 tp -75.39 -37.07 60.75 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.136 1.374 . . . . 0.0 112.22 176.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -67.76 -44.32 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.604 1.562 . . . . 0.0 109.368 170.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.5 t -53.87 -44.85 70.74 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.234 1.014 . . . . 0.0 111.742 168.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -60.41 -37.05 79.6 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.495 -0.753 . . . . 0.0 111.451 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.5 m -67.01 -49.04 66.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.834 0.854 . . . . 0.0 111.501 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -64.79 -38.75 92.04 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 119.926 1.239 . . . . 0.0 112.77 173.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -78.79 -35.59 44.09 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -172.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.91 -23.7 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.965 1.257 . . . . 0.0 111.509 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.0 mp -86.75 -11.96 49.54 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 167.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 53.55 43.29 31.43 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.835 1.654 . . . . 0.0 112.08 -177.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 pp -107.18 162.63 13.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.545 0.738 . . . . 0.0 110.555 171.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.36 148.81 43.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.758 0.423 . . . . 0.0 111.777 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -25.41 67.94 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.447 -1.408 . . . . 0.0 112.881 173.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -79.11 2.38 20.97 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.945 1.698 . . . . 0.0 113.696 168.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -130.18 -5.93 4.36 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.522 1.529 . . . . 0.0 110.772 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.499 HD11 ' HB1' ' A' ' 48' ' ' ALA . 26.0 tp -87.78 138.49 31.42 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.306 1.842 . . . . 0.0 106.774 154.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.73 138.9 51.72 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 164.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.0 mm -98.79 141.11 16.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 O-C-N 125.8 1.938 . . . . 0.0 111.796 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.61 149.22 37.01 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.691 0.397 . . . . 0.0 110.808 174.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -158.26 56.29 0.46 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 166.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.7 p -87.43 -56.78 3.21 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.024 -1.672 . . . . 0.0 112.294 162.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.64 -55.99 3.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.808 0.813 . . . . 0.0 113.041 -158.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -64.39 -42.11 96.31 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.951 1.701 . . . . 0.0 112.482 -175.114 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.87 -27.17 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.393 1.077 . . . . 0.0 110.278 174.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.8 m -92.81 4.14 54.38 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.246 1.418 . . . . 0.0 114.272 174.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.24 -41.75 9.3 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.23 1.377 . . . . 0.0 110.737 172.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -100.38 77.64 0.17 Allowed Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 162.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -72.63 -0.09 8.34 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 N-CA-C 118.833 2.59 . . . . 0.0 118.833 -121.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -119.82 3.97 11.04 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 126.072 1.749 . . . . 0.0 113.234 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -133.02 170.6 15.14 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.735 1.607 . . . . 0.0 113.636 -148.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.5 m -67.58 158.71 31.41 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.162 1.385 . . . . 0.0 113.991 -169.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.78 -77.88 0.57 Allowed 'General case' 0 CA--C 1.541 0.629 0 O-C-N 117.738 -3.101 . . . . 0.0 115.722 14.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.48 -171.84 0.85 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.944 1.247 . . . . 0.0 112.736 -172.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -132.29 149.96 52.26 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.499 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -130.81 141.73 50.36 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 129.784 3.234 . . . . 0.0 108.326 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.3 ttp -124.89 128.25 48.35 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.888 -1.132 . . . . 0.0 108.331 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.5 mt -133.79 147.63 51.28 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.468 1.907 . . . . 0.0 114.73 -147.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.5 t -124.22 169.13 12.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.833 2.853 . . . . 0.0 112.999 -169.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.9 p -96.77 176.25 6.06 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.323 2.649 . . . . 0.0 115.419 -159.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 66.66 21.98 10.52 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 116.995 2.22 . . . . 0.0 116.995 166.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.52 161.38 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.86 1.264 . . . . 0.0 111.077 165.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.461 HG12 HG22 ' A' ' 136' ' ' VAL . 1.5 m -101.3 139.73 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.996 1.318 . . . . 0.0 109.235 171.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -133.28 125.25 18.72 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 118.995 0.816 . . . . 0.0 110.022 171.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -63.4 65.53 0.18 Allowed 'Trans proline' 0 C--N 1.357 1.005 1 C-N-CA 125.508 4.138 . . . . 0.0 113.129 170.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.12 -38.67 39.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 127.78 2.432 . . . . 0.0 114.292 -156.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -75.0 -10.47 59.5 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.33 -0.856 . . . . 0.0 113.032 -177.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -59.38 -31.49 69.27 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.616 -1.303 . . . . 0.0 112.058 161.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.8 tp -72.38 -42.98 64.61 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.268 0.94 . . . . 0.0 111.246 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mp -57.83 -43.73 86.01 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 122.128 -0.358 . . . . 0.0 111.062 169.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.9 m -62.63 -38.76 91.51 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.948 0.899 . . . . 0.0 111.52 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -65.73 -36.13 82.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 118.618 -0.706 . . . . 0.0 112.041 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -69.39 -53.66 18.3 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 168.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -63.04 -36.5 83.79 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.315 -0.865 . . . . 0.0 111.865 -172.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 73.6 m -73.57 -9.94 59.2 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.0 tpt85 -75.5 -32.56 60.58 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.395 0.998 . . . . 0.0 112.426 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.9 p -148.61 -36.91 0.18 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.401 1.08 . . . . 0.0 112.749 173.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.35 81.94 1.63 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 126.755 2.121 . . . . 0.0 110.816 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 72.6 mtt85 -148.44 114.15 5.69 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.321 1.848 . . . . 0.0 110.071 170.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.9 m -65.29 140.37 58.69 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.589 1.156 . . . . 0.0 113.099 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.8 147.86 33.39 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -170.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 64.4 m -76.39 108.79 9.59 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.896 2.878 . . . . 0.0 111.694 165.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -91.62 99.63 12.51 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.555 -1.341 . . . . 0.0 108.323 167.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.7 t -99.7 115.79 41.45 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 C-N-CA 125.906 1.682 . . . . 0.0 109.348 -168.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -96.8 124.97 40.93 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 120.351 -1.468 . . . . 0.0 108.365 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -118.06 122.57 43.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.858 1.263 . . . . 0.0 111.832 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -95.89 114.85 26.61 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.546 1.538 . . . . 0.0 109.692 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 p -144.17 160.16 41.42 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 -173.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -7.92 -130.56 0.0 OUTLIER Glycine 0 N--CA 1.483 1.801 0 O-C-N 118.642 -2.537 . . . . 0.0 113.492 -137.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.2 p -96.41 101.86 13.56 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 121.798 2.799 . . . . 0.0 110.124 158.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 mtt85 -173.84 141.63 0.83 Allowed 'General case' 0 N--CA 1.471 0.607 1 C-N-CA 132.982 4.513 . . . . 0.0 107.92 144.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.6 t -68.35 137.43 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 120.244 1.384 . . . . 0.0 110.405 165.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.9 m -104.49 145.7 29.91 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.101 -0.999 . . . . 0.0 110.374 158.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.8 tp -109.62 109.7 20.53 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 160.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.2 m -88.84 96.64 10.78 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.398 1.079 . . . . 0.0 109.19 170.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 7.9 p -101.9 111.16 23.33 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 119.396 -2.065 . . . . 0.0 109.927 -172.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -146.64 150.5 35.57 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 116.828 2.159 . . . . 0.0 116.828 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.17 109.04 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 168.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.41 139.9 14.74 Favored Glycine 0 CA--C 1.536 1.357 0 N-CA-C 117.864 1.906 . . . . 0.0 117.864 -138.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.3 62.93 46.93 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 152.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.49 106.35 1.6 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.688 2.926 . . . . 0.0 114.604 -170.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.49 -30.74 61.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.687 1.195 . . . . 0.0 113.85 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.3 tpt85 -92.68 3.13 56.17 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.2 tp -70.89 1.0 6.09 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.728 -1.232 . . . . 0.0 114.287 166.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -51.81 -37.8 53.17 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.656 -0.652 . . . . 0.0 111.099 150.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -123.78 -35.3 2.9 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 -169.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 pp -82.81 167.4 18.14 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 121.999 2.181 . . . . 0.0 114.862 -167.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -168.2 126.22 1.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 -165.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.458 ' NE ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -105.21 178.22 4.62 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.547 1.539 . . . . 0.0 110.261 170.147 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.458 ' H ' ' NE ' ' A' ' 101' ' ' ARG . 1.1 p -162.38 169.81 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -147.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.448 ' HA ' HG13 ' A' ' 150' ' ' VAL . 99.4 m -123.82 122.42 37.96 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.029 -1.044 . . . . 0.0 111.125 136.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -176.15 175.17 1.93 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 129.083 2.953 . . . . 0.0 106.838 -174.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -122.36 121.72 37.35 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.296 2.239 . . . . 0.0 111.476 164.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -159.09 171.43 19.98 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -100.14 137.53 38.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.485 2.314 . . . . 0.0 110.376 175.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.8 tp -146.2 142.97 28.93 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.139 1.376 . . . . 0.0 111.039 -158.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 p -92.38 177.16 6.22 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 118.161 2.652 . . . . 0.0 118.161 -172.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.6 t -76.54 -6.87 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 129.486 3.114 . . . . 0.0 114.551 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -122.43 32.65 5.7 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.233 1.413 . . . . 0.0 111.746 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -136.01 159.9 40.27 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.25 -1.531 . . . . 0.0 113.079 -162.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.666 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -155.17 148.71 25.21 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.667 -1.271 . . . . 0.0 110.356 -151.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.666 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -143.4 148.0 35.5 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.767 1.227 . . . . 0.0 110.971 -169.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.46 138.42 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 120.639 1.563 . . . . 0.0 113.229 160.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.92 156.37 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.659 1.184 . . . . 0.0 109.5 169.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.6 t -145.01 167.25 23.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.654 1.582 . . . . 0.0 108.27 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.53 -33.53 71.51 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.14 0.882 . . . . 0.0 113.324 -172.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.05 -30.74 70.89 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 172.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -73.19 -35.48 66.39 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.298 -0.876 . . . . 0.0 111.045 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.1 mm -77.53 -33.43 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.359 1.064 . . . . 0.0 111.647 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -57.98 -34.5 70.03 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.059 -1.025 . . . . 0.0 111.015 168.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -70.97 -25.47 62.73 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.618 171.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 54.0 mt -72.61 -44.85 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.394 1.452 . . . . 0.0 110.157 171.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.6 tptp 168.39 -49.62 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 128.291 2.636 . . . . 0.0 110.15 168.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -62.96 112.64 1.72 Allowed 'Trans proline' 0 C--N 1.357 0.985 0 CA-C-N 121.653 1.626 . . . . 0.0 114.604 -167.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 87.8 m -66.36 154.44 40.04 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.328 1.851 . . . . 0.0 112.933 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -80.36 -5.96 57.24 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 117.311 2.337 . . . . 0.0 117.311 -149.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -93.72 9.28 37.66 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.48 1.912 . . . . 0.0 115.413 -176.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -166.49 14.31 0.08 OUTLIER Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.506 1.363 . . . . 0.0 116.506 -166.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 63.9 t -70.1 122.73 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 118.724 1.262 . . . . 0.0 111.683 -171.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.9 mp -127.76 80.05 1.93 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 123.777 1.751 . . . . 0.0 108.344 153.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.6 m -85.09 129.91 34.71 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 160.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -125.86 132.64 52.16 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.146 0.979 . . . . 0.0 110.796 -158.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 49.3 t -124.4 141.45 52.07 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.546 1.138 . . . . 0.0 111.334 -167.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 55' ' ' VAL . 10.9 t -137.21 125.33 32.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.547 1.539 . . . . 0.0 108.87 -173.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.23 143.87 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 28.4 mtt-85 -133.12 159.14 41.0 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 128.087 2.555 . . . . 0.0 107.987 164.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.301 0.0 OUTLIER -145.67 100.89 3.49 Favored 'General case' 0 CA--C 1.558 1.258 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 173.085 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.1 t -58.44 125.18 22.22 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.044 -1.66 . . . . 0.0 112.642 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -81.34 -53.85 5.98 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.904 0.882 . . . . 0.0 112.141 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.0 m -57.12 -22.41 39.63 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -119.2 22.39 9.0 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 117.333 -1.815 . . . . 0.0 114.216 174.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 91.7 mmm 22.77 71.49 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 128.454 2.702 . . . . 0.0 114.876 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.7 p -164.35 170.43 16.13 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.373 -0.829 . . . . 0.0 112.312 -169.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -113.24 149.39 33.85 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.783 1.633 . . . . 0.0 112.055 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -123.85 115.76 21.84 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 166.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.8 tt -122.05 142.5 38.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.703 -170.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -140.03 145.96 38.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.198 0.523 . . . . 0.0 110.628 159.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.448 HG13 ' HA ' ' A' ' 103' ' ' CYS . 4.4 p -145.27 136.68 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 122.394 1.092 . . . . 0.0 111.179 167.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.4 m -130.54 129.67 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 126.38 1.872 . . . . 0.0 110.065 -163.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -100.12 120.68 40.23 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -164.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -140.3 153.21 46.38 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.953 0.883 . . . . 0.0 112.742 171.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -87.28 -143.78 8.39 Favored Glycine 0 CA--C 1.543 1.784 0 C-N-CA 125.267 1.413 . . . . 0.0 111.718 162.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.58 -13.88 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.712 3.608 . . . . 0.0 116.048 174.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -58.81 -14.58 9.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.487 1.915 . . . . 0.0 113.977 171.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -95.67 18.6 12.63 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -54.72 -30.3 55.68 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.22 -36.04 82.01 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.626 -1.296 . . . . 0.0 113.277 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -73.06 -37.6 66.76 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.593 -1.317 . . . . 0.0 111.113 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -56.17 -47.23 78.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.413 0.685 . . . . 0.0 111.048 171.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -60.48 -37.25 80.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.55 1.14 . . . . 0.0 112.461 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.92 -38.2 79.41 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.312 0.96 . . . . 0.0 113.518 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.04 -57.31 12.12 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.979 0.911 . . . . 0.0 113.017 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.7 mp -43.99 -39.88 4.36 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.847 1.659 . . . . 0.0 112.517 166.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 53.3 tpt85 -73.02 -21.5 60.81 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -92.46 -37.38 12.57 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.824 1.193 . . . . 0.0 113.103 171.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.4 pt -81.86 -34.61 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.028 0.931 . . . . 0.0 113.185 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -74.55 6.44 3.8 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.456 -0.778 . . . . 0.0 111.481 161.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -124.85 23.14 7.98 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 167.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 . . . . . 0 C--O 1.254 1.305 0 C-N-CA 126.054 1.742 . . . . 0.0 109.963 162.06 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.3 -10.52 59.96 Favored Glycine 0 CA--C 1.543 1.815 0 N-CA-C 117.61 1.804 . . . . 0.0 117.61 -171.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -137.4 174.99 10.01 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.088 2.155 . . . . 0.0 110.455 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.2 ptm -65.14 144.74 57.01 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.62 -1.3 . . . . 0.0 113.177 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -127.42 104.14 7.75 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.298 1.039 . . . . 0.0 111.995 -172.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 51.0 mm -114.62 117.23 54.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 127.676 2.391 . . . . 0.0 107.23 166.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.37 154.98 22.62 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 126.918 2.087 . . . . 0.0 112.188 176.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -53.75 -10.5 0.3 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.859 2.064 . . . . 0.0 115.104 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -113.14 -28.97 7.46 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.49 1.516 . . . . 0.0 114.551 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.1 t -72.0 -46.98 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.646 1.112 . . . . 0.0 112.433 -169.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.41 -45.02 95.89 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 171.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.28 -44.35 71.83 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 117.843 0.822 . . . . 0.0 112.539 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -74.89 -41.09 60.43 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.822 1.249 . . . . 0.0 114.25 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.63 -47.87 74.12 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.062 1.301 . . . . 0.0 111.012 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.12 -40.53 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.274 0.63 . . . . 0.0 109.567 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.9 t -56.56 -44.7 81.22 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.741 0.817 . . . . 0.0 112.337 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -64.43 -37.94 89.27 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.284 -0.885 . . . . 0.0 112.303 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.03 -49.25 78.39 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 120.57 1.532 . . . . 0.0 112.427 171.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 ptt85 -64.1 -39.59 94.39 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 120.328 1.422 . . . . 0.0 113.298 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -58.78 -44.17 90.64 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.809 2.044 . . . . 0.0 113.453 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.49 -30.77 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.307 1.043 . . . . 0.0 112.318 -175.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.411 HD21 HD23 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -87.4 -7.48 57.66 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.001 1.32 . . . . 0.0 112.455 174.819 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 64.31 9.35 4.8 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.488 2.715 . . . . 0.0 115.61 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . 0.262 4.3 pp -94.1 178.64 5.58 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.726 -1.234 . . . . 0.0 112.8 -173.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -95.96 154.32 17.3 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.275 1.03 . . . . 0.0 111.765 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -64.23 -24.18 67.57 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 119.488 -2.007 . . . . 0.0 112.81 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -78.36 0.26 26.26 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.811 1.644 . . . . 0.0 112.648 169.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -109.86 -18.8 13.32 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.149 1.38 . . . . 0.0 111.202 170.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.9 tp -88.23 111.81 22.07 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.629 1.572 . . . . 0.0 106.9 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.497 ' H ' ' HB3' ' A' ' 49' ' ' MET . 12.3 tpp180 -84.65 97.79 9.83 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 118.424 -1.31 . . . . 0.0 107.777 175.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.255 1.1 pp -92.46 148.63 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 126.646 1.978 . . . . 0.0 111.752 172.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.2 m -147.65 150.03 33.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.863 0.865 . . . . 0.0 108.921 -170.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -123.05 -158.68 0.8 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.829 1.252 . . . . 0.0 112.453 -161.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.8 t -41.49 -42.83 2.47 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 126.185 1.794 . . . . 0.0 115.252 -160.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.01 -30.08 65.82 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -171.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.23 -9.66 20.25 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 pt -110.14 -19.9 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.1 t -60.72 10.99 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 127.187 2.195 . . . . 0.0 116.781 -169.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -72.95 -20.12 61.11 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.714 2.006 . . . . 0.0 112.385 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -60.2 177.27 0.3 Allowed Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 127.433 2.293 . . . . 0.0 112.532 163.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -63.44 -86.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.936 2.424 . . . . 0.0 112.67 163.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -129.69 25.57 5.35 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 117.349 2.352 . . . . 0.0 117.349 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -162.68 142.13 9.14 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 118.811 -2.431 . . . . 0.0 110.717 -153.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m 176.54 -174.66 0.11 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.895 2.078 . . . . 0.0 108.895 -175.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.454 ' H ' ' HB3' ' A' ' 89' ' ' TYR . 30.1 tp -122.5 -75.41 0.6 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 119.174 -0.441 . . . . 0.0 111.306 150.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 15.0 p -163.35 -170.3 2.22 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.479 1.133 . . . . 0.0 113.223 -163.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 87' ' ' SER . 42.0 t0 -146.3 115.08 6.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.057 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.7 144.14 47.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.941 2.897 . . . . 0.0 109.287 -153.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.497 ' HB3' ' H ' ' A' ' 30' ' ' ARG . 29.5 ttp -122.3 128.1 50.66 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.904 1.684 . . . . 0.0 110.854 -165.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.411 HD23 HD21 ' A' ' 22' ' ' LEU . 0.6 OUTLIER -145.0 162.09 37.78 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 127.001 2.688 . . . . 0.0 115.439 -159.206 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.26 148.49 25.06 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 111.887 -2.415 . . . . 0.0 111.887 -142.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 t -66.03 156.37 33.93 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.072 0.949 . . . . 0.0 112.483 166.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 69.62 -0.85 2.47 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.109 2.164 . . . . 0.0 115.525 168.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.5 mp -103.98 147.01 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 126.08 1.752 . . . . 0.0 111.011 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.9 p -87.52 136.66 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.023 1.329 . . . . 0.0 111.714 170.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -107.54 110.25 62.78 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.56 1.144 . . . . 0.0 108.663 172.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -60.43 66.65 0.08 OUTLIER 'Trans proline' 0 CA--C 1.542 0.884 1 C-N-CA 126.521 4.814 . . . . 0.0 113.726 164.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.422 ' CG1' HG23 ' A' ' 133' ' ' THR . 3.6 p -68.75 -27.02 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.098 1.359 . . . . 0.0 114.424 -157.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -46.86 -45.19 20.15 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 126.46 1.904 . . . . 0.0 112.716 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -69.72 -30.67 68.34 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.996 -0.44 . . . . 0.0 112.164 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.1 mt -75.74 -45.26 37.52 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.824 0.85 . . . . 0.0 111.737 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 mp -53.58 -49.47 67.67 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.722 0.692 . . . . 0.0 109.813 171.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.8 m -64.97 -39.42 93.46 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -74.7 -33.75 62.48 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.444 -0.785 . . . . 0.0 112.408 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -63.89 -53.03 56.8 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.91 0.777 . . . . 0.0 111.375 171.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -73.67 -33.49 64.49 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -168.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.6 t -79.78 -19.15 49.28 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.904 1.282 . . . . 0.0 114.316 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -86.22 -26.1 25.24 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -166.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.2 m -138.79 -2.81 1.69 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -174.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.22 80.47 0.17 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.042 1.306 . . . . 0.0 111.384 -174.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.0 mtp85 -162.11 141.77 9.8 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 128.09 2.556 . . . . 0.0 105.642 169.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.2 m -65.61 140.98 58.56 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 125.064 1.346 . . . . 0.0 111.396 170.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.49 117.09 31.42 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 80.8 m -75.4 102.06 5.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.069 1.748 . . . . 0.0 108.333 157.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -85.12 96.15 9.36 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 167.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.9 t -99.75 141.3 17.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 C-N-CA 125.876 1.671 . . . . 0.0 108.165 -170.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -127.91 123.5 35.09 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 120.264 -1.523 . . . . 0.0 107.748 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -113.02 117.0 30.81 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.737 1.615 . . . . 0.0 108.842 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.75 115.79 31.12 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.309 1.844 . . . . 0.0 109.451 -172.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.3 p -143.25 165.09 28.41 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.409 2.684 . . . . 0.0 104.699 -160.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -13.66 -125.08 0.0 OUTLIER Glycine 0 N--CA 1.485 1.958 0 C-N-CA 129.58 3.466 . . . . 0.0 114.827 -152.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.7 p -92.89 99.78 12.37 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 113.862 -3.135 . . . . 0.0 110.151 152.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -170.75 162.49 7.71 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 130.605 3.562 . . . . 0.0 109.729 157.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.3 t -105.91 138.45 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 121.24 1.836 . . . . 0.0 112.443 148.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.7 t -104.42 138.91 40.13 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.932 0.893 . . . . 0.0 109.842 163.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tp -107.82 108.46 19.66 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 168.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 12.1 m -82.5 93.54 7.28 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 172.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.7 p -106.38 104.79 14.56 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 119.995 -1.691 . . . . 0.0 108.43 -169.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.454 ' HB3' ' H ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -142.9 149.92 39.12 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 117.022 2.231 . . . . 0.0 117.022 -177.026 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.7 pt -78.58 72.49 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 113.026 -1.897 . . . . 0.0 107.856 154.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -174.34 178.13 46.28 Favored Glycine 0 N--CA 1.478 1.471 0 N-CA-C 120.088 2.795 . . . . 0.0 120.088 -160.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -140.77 136.16 16.13 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.996 1.318 . . . . 0.0 114.499 -172.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -93.56 -166.71 0.15 Allowed 'Trans proline' 0 CA--C 1.549 1.241 1 C-N-CA 125.797 4.332 . . . . 0.0 112.492 172.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -79.26 -36.66 39.5 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 164.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -96.87 0.18 48.75 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 119.339 3.088 . . . . 0.0 119.339 -167.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.463 ' HA ' ' HG ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -54.1 -27.97 36.36 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 122.395 2.361 . . . . 0.0 114.383 -177.326 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.6 pttm -57.98 -30.41 66.01 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.275 1.03 . . . . 0.0 113.251 170.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -111.49 -29.97 7.56 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 99' ' ' LEU . 1.9 pp -74.31 165.31 25.39 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 121.753 2.07 . . . . 0.0 112.07 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -155.01 107.33 2.72 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 118.415 2.746 . . . . 0.0 118.415 -156.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.501 ' HE ' ' H ' ' A' ' 102' ' ' VAL . 0.1 OUTLIER -103.11 177.53 4.81 Favored 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 126.437 1.895 . . . . 0.0 111.533 169.586 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.501 ' H ' ' HE ' ' A' ' 101' ' ' ARG . 0.5 OUTLIER -165.82 170.64 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 -142.692 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 37.1 t -121.08 124.7 45.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.901 1.28 . . . . 0.0 109.918 141.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -172.86 167.91 5.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.4 1.88 . . . . 0.0 108.807 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -107.81 126.83 53.11 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.402 1.481 . . . . 0.0 109.522 150.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -152.12 165.65 34.11 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -165.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -101.0 145.43 28.71 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.023 1.729 . . . . 0.0 111.245 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.7 tp -140.89 143.04 34.43 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.133 0.973 . . . . 0.0 110.897 -158.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.9 p -111.43 -171.69 1.89 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.525 1.93 . . . . 0.0 114.639 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 65.9 t -73.32 -8.46 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 127.24 2.216 . . . . 0.0 113.58 172.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 -99.89 -3.41 32.51 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -165.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -96.98 148.95 22.45 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.503 1.501 . . . . 0.0 113.273 -147.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.633 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -144.73 143.76 30.86 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.144 -1.597 . . . . 0.0 109.061 -175.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -145.94 149.75 34.79 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-O 117.512 -1.232 . . . . 0.0 112.434 -168.089 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.41 141.94 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-N 121.338 1.881 . . . . 0.0 114.809 157.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.82 149.63 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.714 0.806 . . . . 0.0 111.123 169.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 39.8 m -146.29 154.43 41.68 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.844 2.057 . . . . 0.0 108.376 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -56.65 -36.9 70.05 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -163.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.02 -32.86 69.75 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.594 -1.316 . . . . 0.0 113.028 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -78.18 -29.37 48.49 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.373 1.069 . . . . 0.0 112.222 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.8 tp -76.97 -35.02 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 123.093 0.557 . . . . 0.0 111.889 168.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -61.14 -27.53 68.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.466 0.706 . . . . 0.0 112.27 171.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 22.3 ttm105 -77.44 -3.99 43.14 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.293 1.437 . . . . 0.0 114.622 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.8 mt -78.54 -25.22 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 O-C-N 120.955 -1.091 . . . . 0.0 110.616 168.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -91.09 179.5 1.42 Allowed Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.324 1.45 . . . . 0.0 108.855 153.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.6 -43.07 2.12 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 121.39 1.393 . . . . 0.0 111.435 160.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 38.2 t -158.53 148.72 19.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.925 2.49 . . . . 0.0 107.632 170.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -160.19 91.98 0.97 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.688 1.131 . . . . 0.0 111.732 171.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.7 63.34 0.19 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.56 1.944 . . . . 0.0 110.516 174.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 162.44 28.37 0.02 OUTLIER Glycine 0 CA--C 1.539 1.541 0 C-N-CA 125.195 1.378 . . . . 0.0 115.735 -171.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.7 t -61.58 128.0 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 120.132 1.966 . . . . 0.0 111.539 -174.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.18 89.05 2.98 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.459 1.904 . . . . 0.0 107.848 168.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.422 HG23 ' CG1' ' A' ' 58' ' ' VAL . 6.0 t -98.83 145.29 27.12 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.763 1.225 . . . . 0.0 111.488 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -138.72 132.78 31.33 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.267 1.027 . . . . 0.0 109.007 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 31.3 t -117.33 136.02 53.43 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.201 1.0 . . . . 0.0 111.038 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.4 t -136.71 138.14 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.457 1.903 . . . . 0.0 109.301 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.81 142.72 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.907 0.883 . . . . 0.0 110.943 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 31.5 mmm-85 -111.21 113.57 26.16 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.02 0.928 . . . . 0.0 108.734 163.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.608 ' HE2' ' CG ' ' A' ' 146' ' ' TYR . 0.0 OUTLIER -89.79 118.08 29.12 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 155.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.7 t -147.98 -167.94 2.94 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.027 0.831 . . . . 0.0 111.987 -169.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.2 m120 50.07 72.36 0.33 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.429 2.292 . . . . 0.0 112.321 168.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.9 m 54.01 3.45 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 -173.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.03 38.16 8.75 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.791 0.71 . . . . 0.0 112.288 -168.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 61.6 mtt -133.77 -13.23 2.56 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.73 142.33 24.48 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.875 0.845 . . . . 0.0 112.789 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.608 ' CG ' ' HE2' ' A' ' 139' ' ' LYS . 7.3 m-85 -140.82 173.63 11.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.666 -155.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -151.95 151.51 31.31 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.9 tt -141.19 136.5 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.405 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -137.53 125.7 23.05 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.386 1.074 . . . . 0.0 109.493 177.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.8 133.13 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.01 -1.056 . . . . 0.0 111.073 170.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.5 m -116.39 147.81 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.894 1.678 . . . . 0.0 110.966 -166.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.18 100.54 4.43 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.358 1.063 . . . . 0.0 111.609 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -119.85 161.77 20.25 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.718 1.607 . . . . 0.0 109.843 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -78.72 -147.35 3.58 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 118.639 0.654 . . . . 0.0 112.034 166.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.29 -11.99 7.11 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.625 2.883 . . . . 0.0 113.624 164.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -22.54 51.1 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.82 2.048 . . . . 0.0 113.012 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -87.36 57.09 4.25 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.946 1.355 . . . . 0.0 111.344 172.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -31.91 65.47 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.326 1.05 . . . . 0.0 111.531 171.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.78 -53.23 57.46 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -76.85 -25.52 53.23 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.186 0.903 . . . . 0.0 112.494 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -62.35 -54.02 46.57 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.986 1.267 . . . . 0.0 111.844 169.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -64.55 -28.67 69.8 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.458 -1.402 . . . . 0.0 112.352 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.19 -36.13 83.06 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.392 0.677 . . . . 0.0 112.484 168.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -70.59 -47.9 57.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.308 -0.853 . . . . 0.0 113.234 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.6 mp -48.41 -39.56 22.98 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 120.021 1.282 . . . . 0.0 112.858 166.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -71.33 -29.56 65.15 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -77.85 -32.58 52.16 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.637 1.575 . . . . 0.0 112.419 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.7 mt -86.4 -47.65 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.713 1.605 . . . . 0.0 112.149 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -68.04 1.74 2.54 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.066 0.848 . . . . 0.0 112.015 166.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -124.23 24.35 8.11 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 164.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . 0.277 9.6 mmm180 . . . . . 0 N--CA 1.48 1.025 0 C-N-CA 128.722 2.809 . . . . 0.0 116.344 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 120.399 0.143 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.67 152.57 52.44 Favored Glycine 0 CA--C 1.535 1.305 0 N-CA-C 115.894 1.118 . . . . 0.0 115.894 -172.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -79.53 -15.63 57.38 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.223 1.409 . . . . 0.0 112.135 167.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.88 152.32 34.74 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.499 1.52 . . . . 0.0 111.037 156.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -133.46 99.24 4.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.441 0.696 . . . . 0.0 109.601 167.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.1 tp -80.24 106.24 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -170.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -51.2 128.43 22.02 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 112.681 -2.054 . . . . 0.0 109.316 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -63.51 -23.74 67.52 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -160.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -94.41 -28.91 15.25 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.378 0.99 . . . . 0.0 112.773 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.23 -54.49 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 118.778 0.717 . . . . 0.0 112.23 -171.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.08 -43.08 99.64 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 119.186 0.903 . . . . 0.0 112.16 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.12 74.85 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 117.749 0.775 . . . . 0.0 111.77 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -75.58 -31.76 60.09 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.92 -48.5 53.23 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.244 1.383 . . . . 0.0 111.654 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.18 -36.34 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 119.026 -0.511 . . . . 0.0 109.718 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 m -69.92 -43.53 71.5 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.549 1.068 . . . . 0.0 112.329 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -65.51 -39.08 91.43 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.222 -0.924 . . . . 0.0 111.29 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.73 -34.64 69.72 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.038 1.29 . . . . 0.0 112.297 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -52.88 -43.92 66.48 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 120.589 -1.319 . . . . 0.0 111.611 169.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -76.85 -43.34 36.58 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.597 1.159 . . . . 0.0 113.25 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.75 -31.99 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.035 1.334 . . . . 0.0 112.266 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.1 mt -89.85 -12.12 39.97 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.676 1.191 . . . . 0.0 113.065 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 60.21 25.7 15.1 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.783 2.033 . . . . 0.0 113.808 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 pp -117.91 155.55 29.99 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.87 1.268 . . . . 0.0 111.422 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -80.69 161.04 24.8 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -168.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -69.19 -19.28 63.98 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 119.771 -1.831 . . . . 0.0 115.381 -166.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -94.91 -5.76 44.13 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.609 1.563 . . . . 0.0 113.612 168.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -110.99 2.51 18.06 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.099 2.16 . . . . 0.0 110.801 -176.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 13.6 tp -90.54 124.11 34.74 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 128.692 2.797 . . . . 0.0 105.385 154.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.8 ttt-85 -85.39 119.82 26.18 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 117.951 -1.5 . . . . 0.0 107.766 166.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.497 HD12 ' H ' ' A' ' 31' ' ' ILE 0.276 0.8 OUTLIER -112.26 141.77 26.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.193 0.997 . . . . 0.0 112.393 170.269 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.6 m -157.74 141.24 15.51 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.07 1.348 . . . . 0.0 108.138 -159.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -163.3 60.76 0.18 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.521 1.153 . . . . 0.0 112.702 -172.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.9 t -93.55 -56.62 2.85 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.908 -1.12 . . . . 0.0 113.274 150.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.82 -54.3 4.99 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.308 1.051 . . . . 0.0 113.108 -146.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.542 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -63.9 -9.82 17.41 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.326 1.85 . . . . 0.0 113.188 171.692 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mm -90.2 6.31 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.105 1.362 . . . . 0.0 110.731 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.4 p -69.01 -17.66 63.95 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -173.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.416 ' O ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -62.65 -53.78 49.29 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.917 1.235 . . . . 0.0 110.111 169.31 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -168.85 155.89 6.9 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 125.675 1.59 . . . . 0.0 109.038 169.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.51 -27.3 18.58 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 122.933 2.422 . . . . 0.0 114.961 166.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -110.15 18.77 19.63 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.147 2.979 . . . . 0.0 113.143 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -153.13 92.06 1.58 Allowed 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t 165.85 -169.19 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 130.073 3.349 . . . . 0.0 107.743 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.264 1.2 tm? -132.08 -79.77 0.51 Allowed 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 151.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 5.7 t -175.9 -178.33 1.03 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.917 1.687 . . . . 0.0 109.96 -168.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 6.1 t70 -143.3 126.65 16.68 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 120.676 -1.265 . . . . 0.0 109.882 -170.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.22 154.46 17.38 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.548 1.939 . . . . 0.0 110.538 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -124.58 129.39 50.5 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.413 1.006 . . . . 0.0 108.786 168.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.59 162.39 38.5 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 126.709 2.506 . . . . 0.0 114.826 -156.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 p -102.5 156.53 17.55 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.736 2.014 . . . . 0.0 114.734 -147.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 t -71.79 149.19 45.55 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.572 1.149 . . . . 0.0 113.565 173.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 t70 68.72 16.67 8.95 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 163.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.61 146.88 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.743 1.617 . . . . 0.0 109.542 168.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.6 p -97.48 139.47 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.559 1.544 . . . . 0.0 111.272 166.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -122.21 128.74 25.38 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.9 1.28 . . . . 0.0 110.472 -169.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.94 70.13 5.32 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 124.598 3.532 . . . . 0.0 110.782 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 p -65.48 -26.47 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.25 1.42 . . . . 0.0 113.956 -161.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -48.22 -45.99 34.71 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.531 1.533 . . . . 0.0 112.62 171.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -62.35 -39.68 93.89 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.591 0.632 . . . . 0.0 111.186 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.5 tp -69.63 -53.51 18.38 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.021 0.528 . . . . 0.0 110.814 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.18 -53.31 58.7 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.441 0.696 . . . . 0.0 111.479 177.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 72.7 m -76.72 -40.46 48.56 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -168.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -69.95 -33.48 72.17 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.596 1.089 . . . . 0.0 112.246 173.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -63.67 -48.22 78.08 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.106 0.866 . . . . 0.0 112.331 172.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -55.71 -41.9 74.47 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.434 0.694 . . . . 0.0 111.343 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.8 t -69.22 -17.92 63.84 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -175.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -63.28 -35.84 81.69 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.277 1.031 . . . . 0.0 113.414 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.9 m -115.99 -28.06 6.76 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.139 0.976 . . . . 0.0 112.223 167.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.88 77.35 0.95 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.956 2.217 . . . . 0.0 109.813 -169.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -160.63 117.98 2.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.517 2.327 . . . . 0.0 108.779 -174.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.4 m -61.78 130.15 44.38 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.517 0.727 . . . . 0.0 111.204 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.74 160.43 25.94 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.833 1.653 . . . . 0.0 114.502 -163.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 89.9 m -103.34 116.01 31.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.322 1.449 . . . . 0.0 112.49 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -91.14 114.51 27.05 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.639 1.575 . . . . 0.0 107.632 167.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.869 HG22 HG22 ' A' ' 115' ' ' VAL . 50.9 t -129.85 123.92 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 O-C-N 121.514 -0.742 . . . . 0.0 111.055 -162.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -96.39 129.78 43.67 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 119.963 -1.71 . . . . 0.0 109.609 174.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.66 98.12 8.72 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 162.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -106.95 111.61 24.18 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 125.093 1.357 . . . . 0.0 114.438 -164.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.3 p -144.76 165.61 27.58 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 129.661 3.184 . . . . 0.0 105.206 -149.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.08 -123.2 0.0 OUTLIER Glycine 0 N--CA 1.49 2.289 0 C-N-CA 130.524 3.916 . . . . 0.0 115.6 -163.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.6 p -91.66 104.95 17.37 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 113.182 -3.407 . . . . 0.0 110.443 152.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -169.1 153.29 5.45 Favored 'General case' 0 N--CA 1.474 0.75 1 C-N-CA 134.638 5.175 . . . . 0.0 106.236 159.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.6 t -106.29 136.29 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 119.748 -1.845 . . . . 0.0 109.716 129.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.9 m -106.56 140.79 38.89 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 160.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.0 tp -110.82 107.67 17.24 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.5 1.52 . . . . 0.0 107.234 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.6 m -78.03 128.81 34.43 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.252 1.021 . . . . 0.0 108.904 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 77.3 m -120.49 116.51 25.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -140.33 141.09 35.73 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 173.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.468 HD13 ' H ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -83.48 99.97 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 149.376 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 175.32 178.3 45.06 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 118.108 2.003 . . . . 0.0 118.108 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -125.86 56.35 15.19 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.973 1.309 . . . . 0.0 112.802 164.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -59.8 142.28 98.35 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.736 2.291 . . . . 0.0 111.197 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -55.09 -17.11 3.58 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 -158.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -21.18 63.19 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.77 -1.206 . . . . 0.0 113.301 171.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -52.55 -33.2 44.54 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.297 1.839 . . . . 0.0 113.565 168.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -79.57 4.63 15.3 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.815 1.246 . . . . 0.0 112.648 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -130.09 -35.82 1.58 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.002 1.321 . . . . 0.0 114.142 177.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.511 HD11 HG23 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -84.04 165.86 18.21 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 117.991 2.589 . . . . 0.0 117.991 -168.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -104.21 -172.62 2.14 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 126.784 2.033 . . . . 0.0 115.248 -161.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.65 158.95 16.83 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 126.823 2.049 . . . . 0.0 110.749 170.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.3 p -123.83 125.56 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 159.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 41.5 t -142.27 119.4 11.41 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 142.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -171.2 140.03 1.43 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.259 0.552 . . . . 0.0 110.335 -164.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -114.67 95.74 5.39 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.695 1.198 . . . . 0.0 108.997 141.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -160.96 177.51 10.29 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.983 -1.073 . . . . 0.0 113.636 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.19 157.32 37.85 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 121.331 -0.856 . . . . 0.0 111.828 161.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.7 tp -145.13 143.79 30.56 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.865 1.666 . . . . 0.0 108.994 -170.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.9 m -104.04 -174.03 2.45 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.217 1.007 . . . . 0.0 112.881 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.356 89.1 t -66.65 1.92 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 128.371 2.668 . . . . 0.0 115.08 -173.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -50.5 -4.75 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 118.244 2.683 . . . . 0.0 118.244 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.373 4.7 pt-20 54.57 3.54 0.05 Allowed 'General case' 0 N--CA 1.466 0.364 1 N-CA-C 124.319 4.933 . . . . 0.0 124.319 153.705 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -163.13 123.83 2.35 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 123.139 2.7 . . . . 0.0 108.448 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.4 pp -155.88 150.01 25.53 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.595 1.558 . . . . 0.0 111.459 -174.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.869 HG22 HG22 ' A' ' 76' ' ' VAL . 11.6 t -115.3 144.86 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 127.349 2.26 . . . . 0.0 113.062 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.6 138.81 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 123.844 0.857 . . . . 0.0 110.853 146.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.4 p -114.82 167.27 10.93 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.338 1.055 . . . . 0.0 112.403 172.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -35.38 74.65 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 120.721 -1.237 . . . . 0.0 111.667 174.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.91 -36.04 82.63 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.334 0.653 . . . . 0.0 112.518 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -64.36 -47.57 78.81 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 118.693 -0.67 . . . . 0.0 111.256 172.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.93 -50.01 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 119.026 0.83 . . . . 0.0 110.846 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -57.51 -36.11 71.13 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.069 0.947 . . . . 0.0 113.067 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -78.88 -31.6 45.52 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.982 -1.074 . . . . 0.0 112.738 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.4 mt -71.04 -37.62 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.727 1.611 . . . . 0.0 111.238 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -158.75 -54.54 0.02 OUTLIER Pre-proline 0 N--CA 1.48 1.061 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 164.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -120.2 109.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.66 0 CA-C-N 121.349 1.517 . . . . 0.0 112.818 -159.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 82.8 m -73.66 128.18 34.79 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 145.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -179.99 135.33 0.11 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.272 1.829 . . . . 0.0 111.07 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -74.47 56.84 0.69 Allowed 'General case' 0 N--CA 1.482 1.134 0 O-C-N 120.586 -1.321 . . . . 0.0 110.71 159.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.11 19.1 0.04 OUTLIER Glycine 0 CA--C 1.544 1.886 0 C-N-CA 127.253 2.359 . . . . 0.0 114.571 -169.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.0 t -63.97 136.91 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.903 1.281 . . . . 0.0 111.551 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.3 85.04 2.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 122.68 1.228 . . . . 0.0 109.191 160.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.8 m -78.07 144.85 36.22 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 166.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -146.03 132.5 19.72 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -165.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 42.0 t -136.55 140.79 43.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.533 0.606 . . . . 0.0 112.48 -167.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.1 t -136.09 138.99 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 127.199 2.2 . . . . 0.0 108.369 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.2 m -130.84 140.9 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.992 -0.442 . . . . 0.0 109.845 166.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -114.6 143.42 45.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 122.281 1.039 . . . . 0.0 110.686 157.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.96 137.52 49.84 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.732 2.013 . . . . 0.0 107.699 163.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 53.0 m -140.45 131.23 25.82 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 123.711 0.632 . . . . 0.0 110.489 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 17.4 m120 45.82 65.09 1.23 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.847 2.059 . . . . 0.0 114.437 168.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 37.1 m 59.5 12.63 2.85 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 101.71 7.04 48.87 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.494 1.045 . . . . 0.0 114.945 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 23.3 mmt -64.88 -13.88 57.87 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.728 1.264 . . . . 0.0 113.258 171.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.3 t -139.68 141.01 37.0 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.8 1.24 . . . . 0.0 110.242 158.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -115.59 152.24 33.45 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 157.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -134.53 146.42 49.68 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.161 -0.962 . . . . 0.0 109.689 170.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.3 tt -143.39 143.76 24.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.547 0.689 . . . . 0.0 112.327 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -134.57 130.94 37.29 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 161.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.22 131.07 35.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 122.907 1.337 . . . . 0.0 109.688 150.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.7 m -137.27 142.99 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 111.365 -2.652 . . . . 0.0 108.35 -162.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -123.47 132.96 54.08 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -142.91 162.23 36.03 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.431 1.892 . . . . 0.0 110.21 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -70.14 -144.82 0.24 Allowed Glycine 0 CA--C 1.543 1.828 0 O-C-N 120.632 -1.293 . . . . 0.0 110.928 149.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.64 17.36 0.46 Allowed 'Trans proline' 0 CA--C 1.553 1.45 0 C-N-CA 123.126 2.551 . . . . 0.0 114.17 174.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -85.63 -17.37 36.33 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -164.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -77.67 54.48 1.22 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 123.28 1.514 . . . . 0.0 109.802 163.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.88 -21.28 65.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.995 1.718 . . . . 0.0 114.144 -161.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.24 -43.62 66.9 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.925 0.784 . . . . 0.0 111.985 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -73.0 -31.65 64.63 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.579 0.752 . . . . 0.0 111.424 175.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -64.05 -49.99 70.17 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.309 -0.869 . . . . 0.0 110.609 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -54.95 -36.54 65.42 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.004 -1.06 . . . . 0.0 113.668 172.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.89 85.62 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.432 0.56 . . . . 0.0 112.185 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -71.81 -48.2 48.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.29 1.036 . . . . 0.0 113.192 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 98.1 mt -54.74 -35.95 64.28 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.621 1.101 . . . . 0.0 112.539 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -70.89 -40.93 71.92 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 125.723 1.609 . . . . 0.0 112.902 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -77.34 -35.56 54.57 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.8 pt -75.07 -38.32 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.142 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -65.6 -10.41 35.34 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 120.259 1.39 . . . . 0.0 112.885 164.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -110.64 28.14 8.97 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.257 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 110.728 -0.101 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.56 -10.37 63.44 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 124.674 1.13 . . . . 0.0 115.419 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -139.31 177.85 7.62 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.321 2.649 . . . . 0.0 108.982 167.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.42 123.37 22.22 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.736 0.814 . . . . 0.0 112.902 172.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -138.26 136.52 36.58 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.12 1.768 . . . . 0.0 112.057 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.7 tp -73.97 107.36 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-O 123.069 1.414 . . . . 0.0 114.603 -157.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -43.65 121.61 2.39 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 112.126 -2.307 . . . . 0.0 110.679 -174.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -63.84 -30.55 71.63 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 -139.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.85 -15.56 15.64 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.38 0.991 . . . . 0.0 113.663 172.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.3 t -69.96 -62.26 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.841 1.256 . . . . 0.0 111.662 -173.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.0 -53.46 14.45 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.63 1.109 . . . . 0.0 112.248 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.36 -45.94 72.87 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 118.958 1.379 . . . . 0.0 113.504 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.89 -39.02 76.51 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.085 -1.009 . . . . 0.0 112.805 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -70.39 -42.89 71.12 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.236 0.925 . . . . 0.0 112.219 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.36 -42.71 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.285 1.034 . . . . 0.0 109.851 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.7 p -68.51 -40.36 80.86 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.74 0.7 . . . . 0.0 112.227 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -69.08 -36.89 78.11 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.223 -0.923 . . . . 0.0 112.466 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 87.7 m -66.92 -48.09 69.73 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.193 -0.942 . . . . 0.0 110.715 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.2 ptt-85 -59.32 -41.58 89.4 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.284 0.947 . . . . 0.0 111.26 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -62.24 -56.74 15.64 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.19 1.396 . . . . 0.0 112.286 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.82 -30.18 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 119.369 0.986 . . . . 0.0 112.202 -172.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.75 -8.33 59.18 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.22 0.918 . . . . 0.0 113.249 169.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 52.76 46.36 26.89 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.387 1.875 . . . . 0.0 111.921 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 pp -129.37 159.44 36.2 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.851 1.261 . . . . 0.0 111.051 172.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -73.5 160.54 31.56 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -60.52 -27.89 67.98 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.166 -1.583 . . . . 0.0 111.983 168.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -84.4 6.12 24.5 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 119.775 1.171 . . . . 0.0 113.056 171.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -116.1 -12.95 11.2 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.605 -1.309 . . . . 0.0 110.996 174.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.589 HD11 ' HB1' ' A' ' 48' ' ' ALA . 26.9 tp -89.68 113.16 24.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.494 1.918 . . . . 0.0 109.348 171.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -94.67 130.72 41.05 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 119.584 -0.846 . . . . 0.0 112.849 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 47' ' ' ASP . 37.4 mm -95.87 138.01 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 127.442 2.297 . . . . 0.0 113.308 -176.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 m -147.29 148.44 31.42 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.818 1.19 . . . . 0.0 109.476 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.7 p30 -150.76 56.43 0.91 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 122.886 1.327 . . . . 0.0 114.394 171.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.0 p -91.45 -56.15 3.24 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.112 1.365 . . . . 0.0 114.352 157.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.92 -52.2 5.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 122.744 1.259 . . . . 0.0 114.193 -152.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.606 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -64.88 -27.54 68.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.112 1.765 . . . . 0.0 112.448 173.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.5 mp -71.43 -16.18 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.565 1.946 . . . . 0.0 112.6 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 54.7 m -61.04 -0.14 0.29 Allowed 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 118.069 2.618 . . . . 0.0 118.069 -166.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -90.07 -30.9 17.41 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 121.42 1.918 . . . . 0.0 113.298 169.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -134.41 84.3 41.13 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 165.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -69.98 21.95 0.18 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.535 3.49 . . . . 0.0 114.721 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -113.75 4.27 15.9 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.44 1.896 . . . . 0.0 111.587 169.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -130.14 164.27 24.8 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 120.302 1.41 . . . . 0.0 108.284 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 p -150.16 150.67 31.96 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.242 -0.911 . . . . 0.0 111.49 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.12 -82.77 0.64 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 117.036 -1.459 . . . . 0.0 110.692 147.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 30.5 p -170.88 163.5 7.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 121.681 2.037 . . . . 0.0 114.507 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 16.2 t70 -115.47 152.82 32.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 153.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -121.23 135.79 55.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 129.129 2.972 . . . . 0.0 108.743 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 55.7 mtm -112.04 134.05 53.83 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.9 1.227 . . . . 0.0 108.145 168.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.269 0.6 OUTLIER -147.79 131.93 17.34 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 118.493 2.775 . . . . 0.0 118.493 -155.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.25 160.22 18.53 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 110.539 -3.028 . . . . 0.0 114.395 -174.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.6 p -96.02 179.75 4.97 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.627 1.971 . . . . 0.0 115.464 -158.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . 0.268 28.9 t70 63.16 46.0 4.84 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.482 2.313 . . . . 0.0 115.349 177.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.36 164.28 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 127.065 2.146 . . . . 0.0 109.22 163.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 m -101.11 141.07 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.228 1.011 . . . . 0.0 108.548 161.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.65 110.52 44.49 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 119.829 1.195 . . . . 0.0 108.219 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -67.67 74.71 0.61 Allowed 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 125.159 3.906 . . . . 0.0 111.072 173.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.6 -24.65 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.644 1.978 . . . . 0.0 114.294 -152.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.11 -26.72 50.97 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.652 0.66 . . . . 0.0 112.26 172.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -57.26 -38.49 73.94 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.641 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.7 -43.09 63.49 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.434 1.015 . . . . 0.0 111.257 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -56.09 -48.72 75.58 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.166 0.986 . . . . 0.0 110.325 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.0 m -71.92 -42.89 66.17 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.391 1.476 . . . . 0.0 113.166 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -67.38 -33.96 76.29 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.909 1.231 . . . . 0.0 111.784 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -66.54 -46.99 74.29 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.524 0.602 . . . . 0.0 112.491 165.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -60.6 -30.06 69.59 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.786 -1.196 . . . . 0.0 112.717 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 79.2 m -76.66 -6.31 51.57 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.755 1.622 . . . . 0.0 114.234 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -82.38 -35.17 27.99 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 120.089 1.313 . . . . 0.0 112.971 -175.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.6 p -154.87 -23.98 0.12 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.534 1.134 . . . . 0.0 113.121 167.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.86 82.04 1.35 Allowed Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.761 2.124 . . . . 0.0 112.028 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.9 tpt85 -153.26 118.77 5.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 128.828 2.851 . . . . 0.0 104.957 169.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.6 m -62.03 150.99 36.54 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.705 0.802 . . . . 0.0 111.89 -175.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -141.04 149.91 42.3 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.146 1.378 . . . . 0.0 113.229 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 29.5 p -83.02 138.19 33.84 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.736 1.214 . . . . 0.0 111.484 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -110.59 115.7 30.07 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 172.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 1.072 HG22 HG22 ' A' ' 115' ' ' VAL . 95.1 t -130.04 111.26 21.01 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.549 0 C-N-CA 123.76 0.824 . . . . 0.0 109.56 -154.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -96.07 115.67 27.78 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 120.338 -1.476 . . . . 0.0 107.499 -170.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -108.49 107.87 18.57 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.89 1.276 . . . . 0.0 108.772 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -84.06 137.41 33.6 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.276 -0.89 . . . . 0.0 111.184 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.1 p -144.28 167.87 21.41 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 129.591 3.156 . . . . 0.0 104.626 -167.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -16.42 -123.32 0.0 OUTLIER Glycine 0 N--CA 1.489 2.169 1 C-N-CA 130.831 4.063 . . . . 0.0 116.636 -176.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 55.8 m -97.99 101.96 13.58 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 113.029 -3.468 . . . . 0.0 111.254 152.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.68 164.29 12.16 Favored 'General case' 0 CA--C 1.542 0.671 1 C-N-CA 133.465 4.706 . . . . 0.0 106.419 136.793 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.6 156.96 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 O-C-N 119.468 -2.02 . . . . 0.0 108.714 147.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -127.74 146.67 50.5 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.621 0.768 . . . . 0.0 110.242 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.0 tp -117.17 109.37 16.82 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.068 0.947 . . . . 0.0 108.657 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.2 m -76.69 132.02 39.13 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.103 1.361 . . . . 0.0 110.139 167.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.1 m -128.69 115.34 17.86 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.624 -1.298 . . . . 0.0 110.011 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -137.15 134.77 36.72 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.29 85.28 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 161.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 174.63 -176.61 46.89 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 117.694 1.837 . . . . 0.0 117.694 -174.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -111.15 79.97 2.23 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.734 1.214 . . . . 0.0 112.407 168.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -53.4 153.62 17.08 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 124.528 3.485 . . . . 0.0 116.479 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -72.56 -32.46 66.06 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -172.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -76.33 -10.02 59.08 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.943 1.247 . . . . 0.0 113.634 172.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.607 HD11 HG21 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -68.51 -2.71 9.38 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.524 1.93 . . . . 0.0 114.815 167.314 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 9.8 mmpt? -50.55 -41.02 53.59 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.489 -0.757 . . . . 0.0 110.753 151.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -118.98 -34.5 3.88 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -167.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.661 HD11 HG23 ' A' ' 115' ' ' VAL . 3.7 pp -83.87 160.6 21.11 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 120.69 1.586 . . . . 0.0 113.187 -163.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.3 pttt -164.08 129.08 2.83 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 -165.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.339 11.5 ttt180 -108.89 -173.59 2.31 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 125.472 1.509 . . . . 0.0 113.172 167.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.4 p 179.9 166.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 128.105 2.562 . . . . 0.0 109.353 -133.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 57.3 m -118.12 122.3 42.75 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.155 0.889 . . . . 0.0 109.286 151.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -170.97 163.32 7.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.652 2.381 . . . . 0.0 106.756 -171.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -139.27 115.36 10.3 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 126.077 1.751 . . . . 0.0 112.903 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -159.88 -172.92 3.84 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.339 1.456 . . . . 0.0 111.904 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -66.94 160.78 25.58 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.124 0.97 . . . . 0.0 112.58 160.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.6 tp -135.22 145.96 48.18 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 129.142 2.977 . . . . 0.0 108.777 -172.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.7 t -109.27 155.51 21.04 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.932 2.093 . . . . 0.0 110.543 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.01 -15.81 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -157.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -130.35 46.72 2.61 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.34 1.056 . . . . 0.0 110.643 -170.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -104.69 150.66 24.53 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.505 1.522 . . . . 0.0 112.589 -167.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.446 ' HB1' HD22 ' A' ' 99' ' ' LEU . . . -144.13 136.09 26.28 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.166 -1.584 . . . . 0.0 110.042 -172.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.32 139.25 15.32 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 120.632 -1.292 . . . . 0.0 113.63 -170.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 1.072 HG22 HG22 ' A' ' 76' ' ' VAL . 6.6 t -108.87 132.77 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 125.745 1.618 . . . . 0.0 111.012 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . 0.254 0.8 OUTLIER -129.79 123.53 57.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 122.64 1.209 . . . . 0.0 110.065 157.086 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.9 t -124.73 158.53 33.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.596 2.358 . . . . 0.0 107.846 173.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -36.12 64.41 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.968 0.803 . . . . 0.0 112.006 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.11 -31.95 68.41 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -76.2 -28.96 57.44 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.611 -1.306 . . . . 0.0 112.258 174.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 41.3 mm -67.81 -40.65 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 121.556 -0.715 . . . . 0.0 110.562 164.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.23 -11.9 52.89 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.26 1.024 . . . . 0.0 113.191 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -79.29 -45.39 19.8 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 119.77 -1.831 . . . . 0.0 112.214 164.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.9 pt -92.04 -12.94 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -170.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -122.87 161.32 44.95 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 125.287 1.435 . . . . 0.0 112.422 174.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -68.32 -31.4 28.5 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.906 1.737 . . . . 0.0 115.694 -168.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.428 ' SG ' ' HE2' ' A' ' 129' ' ' LYS . 5.6 t -153.29 162.39 41.34 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -172.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -99.99 -137.32 0.31 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.148 2.579 . . . . 0.0 111.482 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.428 ' HE2' ' SG ' ' A' ' 127' ' ' CYS . 63.4 pttt 44.84 22.03 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 119.278 3.066 . . . . 0.0 119.278 165.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.46 21.66 0.04 OUTLIER Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.124 1.345 . . . . 0.0 115.946 168.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.1 t -65.89 132.9 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 118.698 1.249 . . . . 0.0 111.946 -169.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 20.7 mt -124.18 108.84 12.72 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 122.4 1.095 . . . . 0.0 109.138 151.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.2 t -101.69 147.25 26.67 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.855 1.662 . . . . 0.0 109.725 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -124.7 133.74 53.09 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.661 1.184 . . . . 0.0 108.394 -174.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 72.3 m -109.67 143.09 39.92 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.625 0.77 . . . . 0.0 111.057 171.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.71 129.33 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.727 1.611 . . . . 0.0 108.863 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.1 m -136.85 147.81 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -132.0 145.9 51.74 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.08 1.752 . . . . 0.0 112.699 172.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.663 ' HE2' ' CD1' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -129.12 93.14 3.52 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.565 2.346 . . . . 0.0 114.211 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 18.1 t -83.79 123.1 29.54 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.679 -0.638 . . . . 0.0 112.211 170.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -96.38 -41.13 8.77 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.591 1.557 . . . . 0.0 110.963 167.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 98.0 p -64.63 -18.38 64.88 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -131.73 23.33 4.22 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 125.824 1.678 . . . . 0.0 114.919 168.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.9 mmt 31.1 59.83 0.25 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 128.352 2.661 . . . . 0.0 116.326 172.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.9 t -164.62 146.55 8.36 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.174 0.99 . . . . 0.0 110.55 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.663 ' CD1' ' HE2' ' A' ' 139' ' ' LYS . 4.5 m-85 -129.21 158.11 39.95 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -158.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -144.07 144.98 31.87 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 120.946 -1.096 . . . . 0.0 108.847 -171.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.0 tt -144.94 142.67 22.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.843 -168.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -141.02 136.21 31.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.361 1.465 . . . . 0.0 107.46 174.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.52 136.52 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 122.051 0.929 . . . . 0.0 110.946 155.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.3 m -129.23 149.64 33.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 126.218 1.807 . . . . 0.0 109.734 -172.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.93 127.63 23.35 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -133.47 157.62 45.17 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.457 1.903 . . . . 0.0 110.867 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -90.61 -159.35 35.53 Favored Glycine 0 CA--C 1.541 1.702 0 C-N-CA 124.404 1.002 . . . . 0.0 113.519 174.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.25 -7.75 21.73 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.339 2.693 . . . . 0.0 115.522 -172.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -75.58 -2.91 31.38 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 171.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -76.73 57.27 1.25 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.347 1.859 . . . . 0.0 111.683 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.18 -23.14 61.97 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.334 1.454 . . . . 0.0 113.696 -174.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.57 -51.24 37.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.141 0.882 . . . . 0.0 111.591 178.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -71.21 -34.97 71.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.881 0.872 . . . . 0.0 112.729 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -58.9 -53.71 55.33 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.854 0.752 . . . . 0.0 110.689 171.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -57.02 -39.02 73.95 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.884 0.765 . . . . 0.0 112.07 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.82 -42.99 98.78 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.295 0.952 . . . . 0.0 112.926 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.21 -46.98 72.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.569 -0.707 . . . . 0.0 112.586 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 86.9 mt -57.31 -34.64 68.94 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.837 0.455 . . . . 0.0 111.497 175.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -75.63 -17.59 59.95 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.586 1.955 . . . . 0.0 113.549 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -101.9 -31.17 10.83 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.0 pt -86.54 -36.63 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 120.415 1.461 . . . . 0.0 113.547 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -76.32 12.62 1.15 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.381 1.446 . . . . 0.0 111.508 161.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.85 25.61 4.31 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 170.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 125.224 1.409 . . . . 0.0 112.495 168.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.28 32.11 83.11 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 119.213 -0.771 . . . . 0.0 114.092 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -127.98 -10.31 5.41 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.032 1.333 . . . . 0.0 113.71 -167.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.1 ptp -150.73 64.33 0.93 Allowed 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.923 -1.111 . . . . 0.0 110.787 158.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.12 115.2 9.73 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -168.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 6' ' ' ILE . 7.5 tp -76.14 105.38 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 122.422 1.106 . . . . 0.0 111.248 169.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -44.38 127.16 5.68 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 112.251 -2.25 . . . . 0.0 112.122 -163.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -55.76 -20.95 16.68 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -162.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -97.17 -31.17 12.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.278 1.031 . . . . 0.0 112.603 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.9 -59.49 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.93 0.892 . . . . 0.0 112.079 -168.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.37 -42.38 97.42 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.534 -0.592 . . . . 0.0 111.845 171.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.61 -51.15 69.75 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.542 1.171 . . . . 0.0 112.757 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -64.45 -43.03 95.57 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.317 1.047 . . . . 0.0 112.445 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.44 -47.36 61.09 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.896 0.878 . . . . 0.0 111.893 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.16 -41.55 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.547 0.739 . . . . 0.0 109.646 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.5 m -59.29 -38.37 80.02 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.769 0.713 . . . . 0.0 112.387 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -76.0 -32.32 59.37 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.645 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -71.99 -43.66 64.74 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 120.454 1.479 . . . . 0.0 111.646 170.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -49.72 -43.64 47.78 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.456 1.502 . . . . 0.0 111.791 172.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -73.46 -59.57 2.65 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.245 1.418 . . . . 0.0 113.651 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.02 -31.81 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 120.699 1.59 . . . . 0.0 112.718 -168.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.0 mp -84.0 -13.43 53.31 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.152 -0.967 . . . . 0.0 112.543 173.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 54.44 60.1 3.76 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.82 1.648 . . . . 0.0 112.514 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 pp -130.89 148.66 52.69 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.89 0.876 . . . . 0.0 109.385 167.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -69.99 159.51 33.65 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.991 0.424 . . . . 0.0 110.585 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -65.42 -27.38 68.49 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.376 -1.452 . . . . 0.0 111.757 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -68.57 -9.01 46.8 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.97 1.308 . . . . 0.0 113.848 166.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -125.49 3.05 7.66 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.471 1.508 . . . . 0.0 111.639 -176.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.472 HD11 ' HB1' ' A' ' 48' ' ' ALA . 24.2 tp -93.34 128.68 39.47 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 156.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 131.91 50.17 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.906 0.775 . . . . 0.0 111.134 167.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.8 mm -93.71 143.44 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 127.236 2.215 . . . . 0.0 110.723 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.5 m -149.77 154.1 37.92 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 121.394 -0.816 . . . . 0.0 110.674 168.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.2 p30 -155.75 58.81 0.61 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.678 1.228 . . . . 0.0 112.999 -176.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 30.1 p -86.93 -60.2 2.05 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.626 -1.296 . . . . 0.0 111.341 169.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.16 -38.09 15.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 113.919 -1.491 . . . . 0.0 112.474 -158.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.528 HD12 HD12 ' A' ' 37' ' ' ILE . 2.4 pp -99.63 -1.94 36.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.054 2.142 . . . . 0.0 113.718 -171.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.528 HD12 HD12 ' A' ' 36' ' ' LEU . 1.7 mp -97.5 5.53 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 126.53 1.932 . . . . 0.0 110.354 166.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.3 t -59.49 -29.71 68.03 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.354 1.462 . . . . 0.0 114.117 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.463 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -81.22 26.75 0.43 Allowed 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.059 -1.651 . . . . 0.0 112.913 169.354 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 m120 71.69 165.13 0.14 Allowed Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 128.646 2.779 . . . . 0.0 112.758 -168.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.12 -3.69 3.22 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.749 2.966 . . . . 0.0 114.896 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -97.82 5.71 48.75 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.409 2.284 . . . . 0.0 112.454 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -157.36 94.54 1.39 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 171.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.4 p -175.24 168.76 3.34 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.501 -159.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -131.61 -81.51 0.52 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 116.78 -1.968 . . . . 0.0 115.345 132.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.38 -176.98 2.31 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.343 1.057 . . . . 0.0 111.408 -174.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -116.72 146.18 42.96 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 168.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.472 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -131.54 130.24 42.05 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.628 2.371 . . . . 0.0 107.682 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 18.4 mtt -123.6 134.16 53.85 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.018 -1.051 . . . . 0.0 110.61 -170.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.5 mt -130.77 142.26 50.4 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 126.154 2.159 . . . . 0.0 112.748 -147.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.6 p -110.7 161.58 15.61 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.058 2.543 . . . . 0.0 111.584 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.658 HG22 HG23 ' A' ' 137' ' ' VAL . 28.4 p -126.77 108.6 11.19 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -163.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -158.92 2.26 0.09 Allowed 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 125.584 1.554 . . . . 0.0 114.84 165.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.65 173.08 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 126.578 1.951 . . . . 0.0 113.196 -162.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.457 HG21 HD21 ' A' ' 134' ' ' ASN . 1.4 m -96.78 142.54 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.894 1.678 . . . . 0.0 112.178 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -109.2 106.41 58.65 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -73.51 71.53 3.85 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.668 3.579 . . . . 0.0 110.397 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.48 -28.58 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 114.088 -1.414 . . . . 0.0 114.653 -149.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -56.99 -35.01 68.7 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -67.13 -32.94 74.4 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.384 0.538 . . . . 0.0 111.722 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.0 mt -75.01 -45.0 44.82 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.748 0.704 . . . . 0.0 111.458 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 mp -55.27 -44.21 75.4 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.8 0.727 . . . . 0.0 111.261 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -63.62 -45.37 90.62 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.606 0.762 . . . . 0.0 112.501 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -63.69 -32.44 73.93 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.63 0.772 . . . . 0.0 112.593 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -69.1 -45.25 70.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.575 1.15 . . . . 0.0 111.823 171.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.09 -37.79 77.95 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 119.583 1.083 . . . . 0.0 112.095 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.1 t -62.97 -1.48 0.93 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.438 1.895 . . . . 0.0 115.706 -168.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -70.88 -18.22 62.69 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 120.287 -1.508 . . . . 0.0 113.58 172.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.7 p -164.21 -16.4 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.628 1.571 . . . . 0.0 113.813 166.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.5 83.55 1.12 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 126.941 2.21 . . . . 0.0 109.62 -165.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -161.76 114.87 1.84 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.469 2.308 . . . . 0.0 106.555 -168.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.4 m -71.93 126.28 29.34 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -167.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.11 143.52 36.75 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.858 1.663 . . . . 0.0 111.667 172.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 60.3 m -98.4 127.77 44.49 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.143 0.977 . . . . 0.0 109.389 176.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -93.89 104.2 16.27 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.909 1.684 . . . . 0.0 109.311 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.453 HG22 ' CG2' ' A' ' 115' ' ' VAL . 44.4 t -99.06 117.92 44.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 C-N-CA 124.787 1.235 . . . . 0.0 109.225 -171.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -94.37 109.03 20.91 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.57 ' HE3' ' HB2' ' A' ' 113' ' ' ALA . 14.2 mmmm -111.14 101.83 10.32 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.727 2.011 . . . . 0.0 108.743 172.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -98.28 135.84 39.32 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.797 -1.19 . . . . 0.0 111.366 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.31 165.05 36.97 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 130.173 3.389 . . . . 0.0 104.407 -161.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -9.68 -123.01 0.0 OUTLIER Glycine 0 N--CA 1.486 1.996 0 C-N-CA 128.7 3.047 . . . . 0.0 115.286 -153.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 9.1 p -95.48 106.61 18.69 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 113.405 -3.318 . . . . 0.0 111.57 150.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.96 139.95 2.42 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 131.529 3.932 . . . . 0.0 107.276 131.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.1 t -63.38 133.41 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 117.104 -1.838 . . . . 0.0 108.482 152.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.68 140.44 39.54 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.7 0.682 . . . . 0.0 109.432 163.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.8 tp -110.64 106.15 15.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 163.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.9 m -86.93 118.64 26.45 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.88 1.672 . . . . 0.0 109.019 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 82.2 m -102.92 110.32 22.19 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.296 -1.502 . . . . 0.0 109.169 -172.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -99.92 109.8 22.15 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.658 -175.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mp -82.33 98.08 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 129.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.47 178.89 47.44 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 118.621 2.208 . . . . 0.0 118.621 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -126.21 45.79 1.62 Allowed Pre-proline 0 CA--C 1.56 1.331 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 160.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -52.18 155.36 9.23 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.826 3.017 . . . . 0.0 117.689 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -49.86 -33.42 16.93 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.841 2.456 . . . . 0.0 116.249 -162.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -92.99 -17.32 24.06 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.14 -35.61 59.91 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.622 2.769 . . . . 0.0 113.653 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -57.24 -43.03 82.57 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 118.486 -0.768 . . . . 0.0 111.845 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -98.26 -34.34 10.74 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.982 1.264 . . . . 0.0 114.105 -174.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.92 157.8 35.92 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 121.113 1.778 . . . . 0.0 112.166 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -164.12 134.38 4.17 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 -163.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.511 ' HD3' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -120.2 -178.03 3.57 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.638 1.575 . . . . 0.0 114.332 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.511 ' H ' ' HD3' ' A' ' 101' ' ' ARG . 8.9 p -163.37 174.67 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 127.733 2.413 . . . . 0.0 112.278 -140.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.425 ' HA ' HG13 ' A' ' 150' ' ' VAL . 75.0 m -129.72 135.51 48.56 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.081 -1.012 . . . . 0.0 111.333 144.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.3 t0 178.57 166.76 0.85 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 127.865 2.466 . . . . 0.0 107.249 -168.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -128.76 121.39 28.3 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.166 1.386 . . . . 0.0 113.959 162.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -160.38 -176.68 5.75 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 126.027 1.731 . . . . 0.0 110.923 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -80.67 165.67 21.78 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.442 -1.411 . . . . 0.0 111.481 164.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.7 tp -144.67 141.2 29.16 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.555 1.142 . . . . 0.0 111.149 -170.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.3 m -77.98 151.67 33.5 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.09 1.756 . . . . 0.0 115.293 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.65 -8.62 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 127.094 2.158 . . . . 0.0 116.131 -161.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -137.6 38.65 2.43 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.769 1.228 . . . . 0.0 112.787 -170.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -106.05 165.95 10.85 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.257 1.423 . . . . 0.0 113.753 -164.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.57 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . . . -146.95 133.73 20.06 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 125.537 1.535 . . . . 0.0 110.157 -170.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.8 144.28 20.2 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.823 1.249 . . . . 0.0 111.38 -174.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.453 ' CG2' HG22 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -129.77 141.76 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 121.472 1.942 . . . . 0.0 113.965 174.628 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.99 149.87 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.648 1.179 . . . . 0.0 110.784 175.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 t -146.6 172.59 13.34 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.013 0.925 . . . . 0.0 112.091 168.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.37 -34.17 66.4 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.71 -41.92 67.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.712 0.687 . . . . 0.0 112.385 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -75.4 -26.51 58.46 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.884 0.874 . . . . 0.0 112.734 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.2 tp -75.51 -38.96 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.212 1.005 . . . . 0.0 111.452 170.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -55.11 -39.96 69.96 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.23 1.012 . . . . 0.0 111.315 168.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -66.97 -20.22 65.85 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.344 1.058 . . . . 0.0 112.794 -173.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 66.9 mt -69.74 -41.43 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 118.67 0.668 . . . . 0.0 110.463 -177.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.499 ' H ' ' HD2' ' A' ' 126' ' ' PRO . 33.5 ttpt -167.39 -47.73 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.765 0 CA-C-O 116.559 -1.686 . . . . 0.0 112.301 175.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.499 ' HD2' ' H ' ' A' ' 125' ' ' LYS . 41.2 Cg_endo -82.58 -132.84 0.01 OUTLIER 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 122.606 2.204 . . . . 0.0 112.949 -170.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 20.9 t -166.7 133.94 2.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.2 1.8 . . . . 0.0 111.209 -164.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . 0.253 25.4 p30 -70.69 3.76 2.94 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 -161.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -104.67 10.4 34.8 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.61 1.964 . . . . 0.0 113.208 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.07 29.17 0.16 Allowed Glycine 0 CA--C 1.534 1.271 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.6 t -83.58 135.61 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 119.139 1.469 . . . . 0.0 112.349 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.49 105.67 11.9 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.992 0.917 . . . . 0.0 108.691 153.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.34 144.62 31.39 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.699 0.8 . . . . 0.0 110.086 166.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.457 HD21 HG21 ' A' ' 55' ' ' VAL . 48.0 t30 -137.05 136.93 38.83 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.692 0.797 . . . . 0.0 109.411 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 43.2 t -128.11 133.81 49.05 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.846 0.859 . . . . 0.0 111.42 -169.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.5 t -132.55 111.35 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.119 0.968 . . . . 0.0 109.483 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.658 HG23 HG22 ' A' ' 52' ' ' THR . 29.7 m -105.22 151.61 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.573 1.549 . . . . 0.0 110.595 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -124.7 135.63 53.2 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.152 1.381 . . . . 0.0 111.256 157.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.457 ' HE3' ' CE2' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -77.32 144.52 38.0 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.278 1.031 . . . . 0.0 112.166 135.516 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.0 m -147.31 76.57 1.41 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.735 2.014 . . . . 0.0 109.061 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -65.66 -48.48 71.99 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.539 -1.351 . . . . 0.0 113.617 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.1 m -57.75 -39.66 77.89 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.072 -1.017 . . . . 0.0 111.715 174.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.05 -0.16 68.95 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 126.304 1.907 . . . . 0.0 115.938 173.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 75.9 mtm 43.37 53.14 5.68 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.078 2.551 . . . . 0.0 115.241 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 99.5 p -148.66 163.39 37.42 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.457 ' CE2' ' HE3' ' A' ' 139' ' ' LYS . 41.8 m-85 -100.2 151.84 20.97 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.684 147.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -134.95 141.85 46.36 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.04 137.31 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.81 0.814 . . . . 0.0 110.647 -161.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -135.79 139.26 43.38 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.498 1.519 . . . . 0.0 108.587 169.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 103' ' ' CYS . 2.2 p -140.9 134.39 32.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 122.363 1.077 . . . . 0.0 109.196 149.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 30.2 m -116.65 143.18 27.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 127.95 2.5 . . . . 0.0 109.033 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.82 129.95 39.19 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -165.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -134.43 156.05 49.24 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.576 1.551 . . . . 0.0 110.799 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.552 ' H ' ' CD ' ' A' ' 155' ' ' PRO . . . -171.78 33.33 0.14 Allowed Glycine 0 CA--C 1.546 1.97 0 CA-C-O 116.364 -2.354 . . . . 0.0 117.28 161.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.552 ' CD ' ' H ' ' A' ' 154' ' ' GLY . 59.5 Cg_endo -105.62 -49.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.037 0 CA-C-N 121.812 2.806 . . . . 0.0 113.353 160.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -117.74 -26.96 6.38 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 53.79 1.28 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 118.289 2.7 . . . . 0.0 118.289 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.97 -45.31 94.23 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -155.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.91 -53.07 29.25 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -169.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -69.04 -31.56 70.43 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.889 0.876 . . . . 0.0 112.241 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -60.63 -55.31 34.79 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.048 0.84 . . . . 0.0 110.84 172.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -64.5 -34.16 77.56 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.385 -0.822 . . . . 0.0 112.721 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.21 -33.19 74.96 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.99 1.268 . . . . 0.0 112.654 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -50.97 51.29 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.425 1.49 . . . . 0.0 108.868 173.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 76.7 mt -60.59 -38.09 83.51 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.231 1.012 . . . . 0.0 111.439 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -70.0 -32.16 70.2 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 127.059 2.143 . . . . 0.0 112.939 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -86.72 -37.96 17.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.31 1.044 . . . . 0.0 113.359 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.6 pt -77.55 -34.2 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 119.33 0.968 . . . . 0.0 111.629 -178.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -63.45 -19.83 65.05 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.826 -0.546 . . . . 0.0 111.256 166.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -117.01 26.49 9.76 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 . . . . . 0 C--O 1.252 1.186 0 C-N-CA 128.42 2.688 . . . . 0.0 114.886 168.874 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.91 -8.18 0.03 OUTLIER Glycine 0 CA--C 1.539 1.554 0 N-CA-C 116.759 1.464 . . . . 0.0 116.759 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -135.45 -13.84 2.0 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.758 1.623 . . . . 0.0 113.715 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.3 ptm -147.2 167.74 23.43 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.964 1.706 . . . . 0.0 112.373 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -129.77 110.9 12.12 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.996 0.918 . . . . 0.0 111.075 166.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 6' ' ' ILE . 8.5 tp -75.15 103.06 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 123.328 1.537 . . . . 0.0 111.413 -176.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -45.68 128.14 8.29 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 111.12 -2.764 . . . . 0.0 111.443 -168.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -64.21 -6.27 6.44 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 118.379 2.733 . . . . 0.0 118.379 -139.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.6 -4.24 15.54 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 120.37 1.441 . . . . 0.0 114.033 172.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 78.6 t -69.51 -56.17 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.825 1.25 . . . . 0.0 111.649 -172.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.34 -43.18 98.88 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.6 -54.31 43.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 117.925 0.862 . . . . 0.0 112.147 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -67.11 -37.85 84.59 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.088 -1.007 . . . . 0.0 113.602 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -69.18 -45.91 68.8 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.848 1.204 . . . . 0.0 111.845 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.85 -43.09 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.299 0.64 . . . . 0.0 109.745 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -68.88 -37.15 78.84 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.588 0.631 . . . . 0.0 112.609 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -76.02 -30.63 58.55 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.061 -1.024 . . . . 0.0 111.695 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.4 m -62.98 -46.52 87.32 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.799 1.636 . . . . 0.0 110.397 169.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.5 ttt-85 -52.84 -34.73 55.48 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.086 1.754 . . . . 0.0 112.396 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -83.03 -49.1 9.9 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.741 -1.224 . . . . 0.0 113.258 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.03 -28.86 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.41 1.084 . . . . 0.0 111.878 -174.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -91.71 -8.71 46.18 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.809 1.243 . . . . 0.0 112.633 171.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.5 mtp-105 58.09 17.98 4.89 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.925 2.09 . . . . 0.0 115.07 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 pp -94.31 159.04 15.3 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.331 1.452 . . . . 0.0 111.734 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -81.89 163.16 22.45 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 119.641 1.109 . . . . 0.0 112.467 176.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -64.8 -34.74 79.06 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 119.512 -1.993 . . . . 0.0 111.393 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -60.42 -16.85 39.96 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.429 2.291 . . . . 0.0 113.382 166.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -105.6 -9.83 17.17 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.958 1.254 . . . . 0.0 111.708 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.462 HD11 ' HB1' ' A' ' 48' ' ' ALA . 26.5 tp -91.47 135.57 33.74 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.265 1.826 . . . . 0.0 108.868 176.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -106.39 128.36 53.98 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 118.363 0.529 . . . . 0.0 112.395 170.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.4 mm -97.26 142.0 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.919 2.087 . . . . 0.0 112.829 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.2 m -124.92 146.34 49.4 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.371 0.987 . . . . 0.0 108.836 167.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -123.56 -153.42 0.55 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.336 2.254 . . . . 0.0 110.642 -163.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 t -36.8 -36.04 0.1 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 128.306 2.643 . . . . 0.0 116.241 -167.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.1 -43.56 70.5 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 174.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.72 -22.83 25.78 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 121.164 1.802 . . . . 0.0 112.419 175.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.8 mm -58.29 -39.7 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.144 0.977 . . . . 0.0 109.45 173.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 57.0 m -55.65 6.73 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -117.59 13.92 14.4 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 121.518 1.963 . . . . 0.0 112.034 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.9 170.2 5.68 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 126.511 1.924 . . . . 0.0 109.145 146.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -66.92 -51.14 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 121.721 1.614 . . . . 0.0 114.693 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -124.82 -34.32 2.83 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 117.562 2.43 . . . . 0.0 117.562 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -161.12 100.24 1.22 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 122.893 1.33 . . . . 0.0 109.458 -137.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.9 m -140.44 165.62 26.92 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.261 2.224 . . . . 0.0 107.507 173.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.46 HD13 ' HB2' ' A' ' 46' ' ' CYS 0.29 1.1 tm? -87.47 -77.2 0.35 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 117.288 -1.339 . . . . 0.0 113.058 -164.088 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.46 ' HB2' HD13 ' A' ' 45' ' ' LEU . 12.7 m -163.94 -175.56 4.12 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.954 1.706 . . . . 0.0 111.86 -172.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -119.82 156.98 29.62 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.301 1.44 . . . . 0.0 107.398 157.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -137.39 131.62 32.32 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.738 2.815 . . . . 0.0 108.07 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.5 ttp -121.93 134.47 54.85 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.232 1.378 . . . . 0.0 110.661 -169.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 mt -131.7 146.44 52.17 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 128.473 2.709 . . . . 0.0 113.385 -148.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.6 t -98.62 159.12 15.17 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.066 1.346 . . . . 0.0 113.581 -171.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -71.38 170.84 12.34 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.229 1.811 . . . . 0.0 112.66 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.7 t70 57.89 36.23 26.09 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 170.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.58 134.66 60.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.993 1.717 . . . . 0.0 110.079 -176.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.9 p -91.24 139.17 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.966 0.907 . . . . 0.0 109.456 159.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -134.28 136.93 26.88 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 118.862 0.756 . . . . 0.0 111.701 169.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.45 69.75 5.79 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.905 3.737 . . . . 0.0 111.105 177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.4 p -62.29 -43.53 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -152.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.97 -9.31 58.18 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.037 -1.039 . . . . 0.0 113.093 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -65.54 -33.37 75.77 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.775 1.171 . . . . 0.0 111.598 165.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.9 tp -70.18 -37.45 75.15 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.656 0.662 . . . . 0.0 111.32 173.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.92 -49.87 76.01 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.375 0.534 . . . . 0.0 111.911 173.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.3 p -67.45 -31.97 72.5 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 119.175 -0.44 . . . . 0.0 112.119 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -63.6 -39.15 93.63 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.947 0.794 . . . . 0.0 112.512 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -66.26 -51.71 54.85 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.492 1.042 . . . . 0.0 112.299 169.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.26 -41.07 83.45 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.662 0.385 . . . . 0.0 111.514 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 83.1 m -77.43 -2.57 35.96 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.95 -34.66 13.68 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.379 1.472 . . . . 0.0 114.046 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.2 m -137.29 -8.73 1.73 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.32 74.49 0.43 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 126.006 1.765 . . . . 0.0 112.523 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -166.9 136.44 2.94 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.304 1.442 . . . . 0.0 109.775 161.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.4 m -64.47 142.81 58.29 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.031 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.74 151.08 47.82 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 m -75.29 103.94 5.65 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.326 1.851 . . . . 0.0 109.768 167.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -87.74 99.83 12.38 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 166.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.07 147.4 6.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 C-N-CA 126.585 1.954 . . . . 0.0 108.254 -171.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -130.72 121.42 25.43 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 120.513 -1.367 . . . . 0.0 107.583 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -121.7 121.01 36.35 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.303 1.841 . . . . 0.0 109.412 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -95.84 125.41 40.38 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.895 1.678 . . . . 0.0 108.892 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.4 p -143.71 155.31 44.16 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -174.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.94 80.61 0.1 OUTLIER Glycine 0 N--CA 1.476 1.339 0 C-N-CA 130.39 3.852 . . . . 0.0 112.175 -172.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.3 t 168.95 -128.15 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 -136.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -129.28 178.7 6.25 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 130.379 3.472 . . . . 0.0 109.336 -176.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.8 t -75.96 136.66 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.574 -1.329 . . . . 0.0 109.203 164.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.3 m -114.78 152.62 31.78 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.858 0.754 . . . . 0.0 112.28 170.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 tp -108.81 108.68 19.58 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.084 2.154 . . . . 0.0 105.705 164.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.2 m -80.93 102.63 10.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 167.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 44.1 t -102.49 111.28 23.51 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 119.778 -1.826 . . . . 0.0 108.556 -173.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -150.93 151.0 31.52 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 118.628 2.825 . . . . 0.0 118.628 174.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.631 HD13 ' H ' ' A' ' 90' ' ' ILE . 0.1 OUTLIER -70.94 84.17 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 112.632 -2.077 . . . . 0.0 108.503 143.768 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.22 166.21 38.61 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 118.7 2.24 . . . . 0.0 118.7 -163.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -156.27 49.35 0.4 Allowed Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -170.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -47.4 121.25 5.22 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.241 1.961 . . . . 0.0 113.112 166.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -44.17 -13.69 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 118.615 2.82 . . . . 0.0 118.615 -169.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 95' ' ' ARG . 3.7 mmp_? -59.89 -23.59 63.59 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.283 1.401 . . . . 0.0 113.856 163.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -50.93 -28.58 10.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.831 2.052 . . . . 0.0 112.72 166.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -62.28 -34.8 77.26 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.661 175.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -115.75 -22.39 9.16 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -174.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.502 ' C ' HD12 ' A' ' 99' ' ' LEU . 2.4 pp -75.67 165.59 24.83 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 121.346 1.885 . . . . 0.0 114.1 -176.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -152.16 118.08 5.47 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -163.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.471 ' HD2' ' H ' ' A' ' 102' ' ' VAL . 0.1 OUTLIER -107.43 178.15 4.62 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 120.495 1.498 . . . . 0.0 111.926 161.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.471 ' H ' ' HD2' ' A' ' 101' ' ' ARG . 3.0 p -172.35 173.62 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.587 -140.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.421 ' HA ' HG13 ' A' ' 150' ' ' VAL . 64.8 m -120.86 124.82 45.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.33 0.652 . . . . 0.0 109.501 137.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -172.31 171.41 4.79 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.71 2.404 . . . . 0.0 107.514 -166.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -122.72 99.85 6.61 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.006 2.522 . . . . 0.0 110.061 172.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -140.51 148.4 41.02 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 -173.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -82.19 142.04 32.52 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.914 1.286 . . . . 0.0 110.578 165.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 37.9 tp -148.23 141.59 25.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.076 0.95 . . . . 0.0 110.087 -150.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 p -93.09 168.9 10.81 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 116.941 2.201 . . . . 0.0 116.941 -169.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.6 t -69.76 -6.92 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 128.145 2.578 . . . . 0.0 113.083 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -134.74 45.84 2.51 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.469 1.108 . . . . 0.0 110.25 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -125.59 152.26 45.35 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 116.064 1.875 . . . . 0.0 116.064 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.696 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -149.3 142.46 25.0 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.632 -146.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.696 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -144.38 147.95 34.06 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.183 1.393 . . . . 0.0 111.521 -168.485 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -136.31 141.64 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 121.404 1.911 . . . . 0.0 113.166 158.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.59 153.28 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.88 0.872 . . . . 0.0 110.538 167.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.0 t -143.01 167.34 22.29 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.696 0.798 . . . . 0.0 109.979 162.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.93 -36.09 76.3 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -160.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.7 73.03 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.791 -1.193 . . . . 0.0 113.791 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -70.7 -30.83 67.51 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.394 -0.816 . . . . 0.0 111.627 175.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.0 mm -73.37 -35.51 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.012 0.925 . . . . 0.0 111.076 169.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -59.9 -25.48 65.14 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.448 -0.783 . . . . 0.0 111.931 170.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -83.2 -7.64 59.59 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 168.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.9 mt -89.21 -40.05 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.803 1.183 . . . . 0.0 109.987 167.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -143.31 124.36 8.16 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.603 1.161 . . . . 0.0 110.413 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -82.5 60.1 7.16 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 123.943 3.095 . . . . 0.0 114.355 -163.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 45.6 t -155.84 134.59 11.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.56 1.544 . . . . 0.0 110.201 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -122.85 -4.01 8.63 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -85.2 12.85 7.16 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.85 50.83 0.06 OUTLIER Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.71 1.148 . . . . 0.0 113.516 -176.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.83 125.12 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 117.947 0.873 . . . . 0.0 110.701 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.83 88.04 2.52 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.518 1.527 . . . . 0.0 108.229 169.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.608 HG22 ' HA ' ' A' ' 152' ' ' ALA . 17.6 p -83.83 146.39 28.14 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.908 0.883 . . . . 0.0 109.316 164.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.46 125.77 52.15 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 18.8 t -118.43 127.8 54.0 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.39 0.996 . . . . 0.0 109.131 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.4 t -138.43 116.91 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.411 1.084 . . . . 0.0 109.149 -167.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 148' ' ' ILE . 20.1 m -112.3 140.59 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.268 -0.895 . . . . 0.0 111.421 -175.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 29.0 ttm105 -129.57 98.23 4.77 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 122.162 0.982 . . . . 0.0 110.343 171.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.473 ' HG3' ' CD2' ' A' ' 146' ' ' TYR 0.251 9.0 tmtt? -120.13 134.98 55.11 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.767 1.227 . . . . 0.0 109.047 -178.202 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.1 m -161.45 133.33 5.67 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.026 1.33 . . . . 0.0 110.585 -164.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -85.68 -35.55 20.81 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.766 -0.584 . . . . 0.0 112.496 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.1 p -48.45 -50.12 32.65 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.201 1.401 . . . . 0.0 113.398 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -96.29 11.25 67.28 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.258 1.885 . . . . 0.0 115.074 171.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 41.1 ttm 44.61 57.35 4.53 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.114 2.166 . . . . 0.0 115.397 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 97.9 p -147.82 142.86 27.02 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.473 ' CD2' ' HG3' ' A' ' 139' ' ' LYS . 1.0 OUTLIER -106.65 144.54 33.17 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 163.489 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -150.87 147.26 27.01 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.445 -1.409 . . . . 0.0 109.492 -173.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . 0.428 HG13 HG12 ' A' ' 137' ' ' VAL . 6.8 tt -141.62 140.31 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 122.213 1.006 . . . . 0.0 113.4 -176.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -135.31 115.44 13.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.033 1.333 . . . . 0.0 109.941 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.421 HG13 ' HA ' ' A' ' 103' ' ' CYS 0.28 7.3 p -139.27 145.14 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 121.129 -0.982 . . . . 0.0 112.981 174.385 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.3 m -141.31 151.55 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 128.109 2.564 . . . . 0.0 109.643 -167.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.608 ' HA ' HG22 ' A' ' 133' ' ' THR . . . -125.59 125.73 43.65 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -168.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -142.18 156.88 45.36 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.686 1.194 . . . . 0.0 111.926 175.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -91.51 -148.92 22.87 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 124.519 1.057 . . . . 0.0 112.177 165.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.94 -22.72 10.69 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 124.53 3.487 . . . . 0.0 117.041 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.13 1.46 2.79 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 126.423 1.889 . . . . 0.0 115.595 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -90.86 38.84 0.97 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.192 1.797 . . . . 0.0 112.163 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -62.36 -28.85 70.05 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -167.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.32 -51.49 51.83 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.918 0.781 . . . . 0.0 112.099 -176.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -65.18 -34.21 77.84 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.934 0.894 . . . . 0.0 112.468 170.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -62.02 -49.31 76.53 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.427 1.012 . . . . 0.0 111.457 175.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -65.83 -29.67 70.17 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.81 -1.182 . . . . 0.0 112.701 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.42 83.91 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 119.189 0.904 . . . . 0.0 112.671 171.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.92 -54.29 19.84 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.523 1.129 . . . . 0.0 112.763 174.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.7 mp -46.79 -34.92 5.68 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.752 1.221 . . . . 0.0 113.983 167.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -74.67 -25.78 59.41 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.46 1.504 . . . . 0.0 113.357 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -89.71 -36.63 15.09 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.537 1.062 . . . . 0.0 113.664 170.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.2 pt -88.42 -42.37 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.063 -1.023 . . . . 0.0 112.724 -169.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -71.33 -6.15 37.78 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.622 1.555 . . . . 0.0 111.355 171.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -119.62 23.18 11.3 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 172.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 . . . . . 0 C--O 1.252 1.207 0 C-N-CA 126.472 1.909 . . . . 0.0 112.503 169.967 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.666 0 CA-C-O 120.19 0.043 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.4 170.82 53.4 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 123.941 0.782 . . . . 0.0 113.382 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -51.79 142.74 14.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.776 1.231 . . . . 0.0 113.391 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 12.4 ptm -102.64 150.53 23.34 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.443 1.497 . . . . 0.0 113.928 -161.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -83.11 94.96 7.93 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 124.078 1.894 . . . . 0.0 112.148 -170.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 tp -145.64 144.15 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 1 C-N-CA 132.541 4.336 . . . . 0.0 106.658 173.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.23 134.47 37.58 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.026 -1.443 . . . . 0.0 108.644 170.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -19.03 64.53 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -163.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -85.21 -24.0 28.05 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.798 0.839 . . . . 0.0 112.283 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.4 t -73.38 -53.68 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.682 1.193 . . . . 0.0 112.565 -165.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.12 -52.04 53.78 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 168.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.8 -39.93 59.53 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 118.443 1.121 . . . . 0.0 113.323 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -74.74 -39.24 61.96 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.867 -1.146 . . . . 0.0 113.972 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.12 -40.74 98.5 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.614 1.166 . . . . 0.0 111.7 173.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.52 -43.05 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.053 1.341 . . . . 0.0 109.721 174.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.4 m -66.64 -31.21 71.75 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.296 -0.878 . . . . 0.0 112.918 175.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -67.37 -44.19 79.57 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.318 -0.864 . . . . 0.0 109.345 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.3 m -60.55 -43.61 97.04 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.168 -1.582 . . . . 0.0 111.753 175.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -54.24 -32.09 55.11 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.27 1.828 . . . . 0.0 112.8 171.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.22 -46.79 10.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.053 1.341 . . . . 0.0 113.449 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.6 mm -66.63 -49.21 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 119.691 1.132 . . . . 0.0 110.889 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.66 -2.88 57.11 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.036 1.334 . . . . 0.0 112.528 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 59.33 11.52 2.21 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 127.629 2.372 . . . . 0.0 115.43 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.458 HD11 HD13 ' A' ' 29' ' ' LEU . 2.7 pp -94.45 154.97 17.17 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.112 0.965 . . . . 0.0 111.172 -176.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.81 155.93 38.21 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.441 -0.787 . . . . 0.0 112.917 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.79 -24.13 63.87 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.83 -1.169 . . . . 0.0 112.546 171.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -97.04 8.74 43.85 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.489 1.516 . . . . 0.0 113.316 172.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -118.73 8.52 11.88 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.963 1.705 . . . . 0.0 111.478 167.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.458 HD13 HD11 ' A' ' 24' ' ' LEU . 21.3 tp -107.74 127.7 53.92 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.859 2.463 . . . . 0.0 107.521 166.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -94.34 115.39 27.61 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 120.076 1.307 . . . . 0.0 111.305 171.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.451 HD11 HD23 ' A' ' 29' ' ' LEU . 32.8 mm -91.02 143.06 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.292 1.437 . . . . 0.0 112.58 170.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.4 m -126.71 147.75 49.93 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 162.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.57 -148.29 0.26 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.309 1.444 . . . . 0.0 112.265 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.9 t -58.51 -29.17 66.08 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -162.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.77 -33.36 34.9 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -169.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.62 -4.84 27.66 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.45 14.42 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 124.806 1.242 . . . . 0.0 111.974 167.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.4 t -57.89 12.06 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 128.64 2.776 . . . . 0.0 117.985 -163.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.407 ' HE2' ' CD1' ' A' ' 92' ' ' PHE . 48.9 tptt -57.4 -40.37 78.12 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 119.798 -1.814 . . . . 0.0 113.033 -172.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -127.02 139.19 34.4 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 132.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -58.54 -31.06 93.61 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 CA-C-N 121.663 1.63 . . . . 0.0 112.571 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -96.46 30.97 2.37 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.237 1.815 . . . . 0.0 110.403 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -147.86 101.12 3.28 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.472 1.487 . . . . 0.0 107.299 159.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 p 179.91 151.24 0.4 Allowed 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.985 -1.072 . . . . 0.0 111.986 -139.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.36 -81.17 0.52 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 164.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.1 p -166.51 -174.48 2.85 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -174.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -122.82 154.98 37.51 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.403 1.881 . . . . 0.0 107.891 163.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.95 122.81 10.64 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.797 1.635 . . . . 0.0 109.094 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.3 ttm -117.94 129.28 55.52 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.748 -1.22 . . . . 0.0 111.564 -160.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.27 0.3 OUTLIER -138.4 156.6 47.44 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 124.677 2.18 . . . . 0.0 115.979 -159.019 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 t -99.24 167.96 10.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 130.446 3.498 . . . . 0.0 108.515 -172.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -50.95 114.0 1.06 Allowed 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.574 1.079 . . . . 0.0 109.334 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.471 ' C ' HD13 ' A' ' 54' ' ' ILE . 1.3 t70 -151.69 156.8 41.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.754 1.264 . . . . 0.0 109.865 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.471 HD13 ' C ' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -119.51 -176.8 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 113.243 -1.799 . . . . 0.0 109.044 -146.414 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.5 p -70.16 121.65 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 121.485 -0.759 . . . . 0.0 111.598 -132.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -130.34 151.5 78.63 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -166.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -80.22 80.98 2.88 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 124.425 3.417 . . . . 0.0 111.031 -166.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 p -69.42 -39.17 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -164.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.2 -33.36 75.21 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 119.688 1.131 . . . . 0.0 113.26 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -57.7 -37.86 74.22 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 119.105 -0.474 . . . . 0.0 110.621 167.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.51 -44.88 61.6 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.917 1.287 . . . . 0.0 112.083 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.405 ' HA ' ' CE1' ' A' ' 75' ' ' PHE . 5.1 mp -52.5 -46.73 66.77 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 122.147 0.975 . . . . 0.0 110.621 169.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.1 m -72.23 -39.81 68.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.616 0.766 . . . . 0.0 112.168 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -63.94 -41.78 97.51 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.736 0.698 . . . . 0.0 110.837 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.15 -55.65 29.86 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.272 1.029 . . . . 0.0 110.993 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.38 -29.36 68.05 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -176.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.1 t -76.35 -32.09 58.46 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -61.25 -25.68 67.24 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 -161.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.7 t -141.66 4.97 1.76 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.661 1.184 . . . . 0.0 113.289 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.52 78.4 0.2 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.895 1.712 . . . . 0.0 111.34 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -166.64 134.18 2.62 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.007 1.723 . . . . 0.0 107.555 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.3 m -76.64 149.73 36.47 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 128.19 2.596 . . . . 0.0 112.973 -173.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -152.05 165.43 34.74 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.628 1.171 . . . . 0.0 113.839 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 27.4 p -108.81 142.37 39.48 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.432 0.693 . . . . 0.0 111.551 156.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.405 ' CE1' ' HA ' ' A' ' 62' ' ' LEU . 3.0 m-85 -82.6 132.58 35.19 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.442 1.097 . . . . 0.0 108.887 165.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.852 HG22 HG22 ' A' ' 115' ' ' VAL . 61.8 t -130.47 151.34 35.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 124.734 1.214 . . . . 0.0 109.348 -172.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -131.05 122.59 27.03 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -124.62 108.77 12.4 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.906 2.083 . . . . 0.0 108.538 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -90.74 123.37 34.27 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.381 -0.824 . . . . 0.0 109.447 173.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.8 p -148.07 150.52 34.05 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 130.132 3.373 . . . . 0.0 104.147 -166.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -11.5 -133.53 0.0 OUTLIER Glycine 0 N--CA 1.481 1.648 0 O-C-N 117.802 -3.061 . . . . 0.0 114.841 -121.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 13.2 p -90.69 88.22 7.01 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 120.145 1.972 . . . . 0.0 108.434 169.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.0 ttt85 -169.61 144.02 2.85 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 128.605 2.762 . . . . 0.0 109.044 166.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.1 t -83.32 140.02 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 119.995 1.271 . . . . 0.0 109.675 171.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.45 143.8 40.23 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 121.007 -1.058 . . . . 0.0 111.328 157.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tp -107.95 107.0 17.52 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 171.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.436 ' HB3' ' CE1' ' A' ' 89' ' ' TYR . 7.5 m -98.1 130.26 44.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.383 -172.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 76.1 m -117.57 108.38 15.4 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.11 -1.619 . . . . 0.0 109.007 -170.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CE1' ' HB3' ' A' ' 87' ' ' SER . 14.4 m-30 -121.92 98.43 5.94 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.414 0.626 . . . . 0.0 110.619 -157.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.3 mt -59.88 -38.36 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.46 -177.54 16.37 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.802 1.668 . . . . 0.0 110.634 166.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.407 ' CD1' ' HE2' ' A' ' 39' ' ' LYS . 26.4 p90 -107.46 96.05 15.29 Favored Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -163.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.38 -177.76 3.23 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 124.126 3.217 . . . . 0.0 115.973 -173.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -50.37 -39.58 46.97 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 117.284 2.328 . . . . 0.0 117.284 -160.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.265 17.1 mmt180 -98.85 -3.67 34.86 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 175.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.55 -33.86 47.58 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.556 2.343 . . . . 0.0 114.052 175.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -50.82 -35.9 34.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.398 1.079 . . . . 0.0 111.45 169.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.01 -27.8 8.27 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -169.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.439 HD12 HG23 ' A' ' 115' ' ' VAL . 3.9 pp -87.37 144.54 26.72 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 121.042 1.746 . . . . 0.0 112.231 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -157.07 126.43 6.04 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -153.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -115.57 -172.3 2.13 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 128.369 2.668 . . . . 0.0 112.529 173.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -166.22 168.55 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 129.094 2.957 . . . . 0.0 108.842 -135.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -123.45 122.48 38.34 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.142 0.883 . . . . 0.0 110.695 138.542 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -176.88 175.53 1.6 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 129.029 2.931 . . . . 0.0 106.144 -165.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -105.93 117.91 35.23 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 128.28 2.632 . . . . 0.0 109.04 171.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -151.18 160.05 44.07 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -92.55 162.7 14.09 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.892 1.677 . . . . 0.0 112.613 170.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.8 mt -141.06 152.05 44.51 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 129.441 3.096 . . . . 0.0 111.026 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 m -128.12 167.3 16.97 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.822 2.449 . . . . 0.0 110.224 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.283 0.9 OUTLIER -69.92 -4.88 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -173.536 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -122.25 32.9 5.63 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.556 1.143 . . . . 0.0 113.012 167.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -104.01 132.66 50.05 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.095 -1.003 . . . . 0.0 110.303 -173.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.728 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -140.25 138.08 34.77 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.122 0.969 . . . . 0.0 112.846 -166.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.728 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -144.22 141.15 29.71 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.974 1.31 . . . . 0.0 112.712 -165.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.852 HG22 HG22 ' A' ' 76' ' ' VAL . 17.0 t -118.42 137.9 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 126.603 1.961 . . . . 0.0 111.919 168.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.1 t -125.66 121.36 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.744 0.783 . . . . 0.0 109.711 157.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 73.3 p -90.02 163.95 14.71 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.075 0.95 . . . . 0.0 110.575 165.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.47 -35.23 73.68 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.332 -0.855 . . . . 0.0 111.08 174.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.38 -34.88 78.2 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -63.12 -33.52 75.63 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.953 1.251 . . . . 0.0 112.175 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.8 mm -77.18 -36.07 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.087 0.955 . . . . 0.0 111.433 172.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -54.88 -38.65 67.8 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.802 0.841 . . . . 0.0 111.294 174.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.3 mmt-85 -74.16 -12.77 60.68 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.427 ' C ' ' HE2' ' A' ' 125' ' ' LYS . 20.3 mt -73.25 -26.54 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 119.973 1.26 . . . . 0.0 110.192 175.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.427 ' HE2' ' C ' ' A' ' 124' ' ' ILE . 0.5 OUTLIER -105.12 161.5 22.56 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 125.127 1.371 . . . . 0.0 111.634 175.211 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -74.35 -39.69 1.45 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.623 2.215 . . . . 0.0 113.131 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 42.2 t -152.41 134.34 14.84 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.58 1.952 . . . . 0.0 108.439 174.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -73.8 -53.29 10.6 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 -154.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? 51.74 10.31 0.1 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 128.66 2.784 . . . . 0.0 116.823 166.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 132.75 67.45 0.08 OUTLIER Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.337 1.446 . . . . 0.0 112.536 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 76.8 t -72.85 130.48 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.216 0.607 . . . . 0.0 111.289 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 50.4 tp -119.37 157.59 27.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 123.147 1.451 . . . . 0.0 109.169 145.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 49.8 m -149.48 146.56 27.47 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 119.392 -2.068 . . . . 0.0 106.426 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -123.99 127.93 48.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -166.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 38.2 t -126.65 138.37 53.41 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.213 0.605 . . . . 0.0 109.945 -171.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.8 t -142.84 139.53 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.31 1.444 . . . . 0.0 108.966 -174.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.5 m -129.5 139.04 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.849 0.833 . . . . 0.0 112.152 174.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 43.2 mtm105 -126.0 150.58 47.97 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 127.985 2.514 . . . . 0.0 108.685 172.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.27 1.9 tmtt? -153.24 151.72 30.38 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.434 1.094 . . . . 0.0 109.07 172.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.6 t -134.22 127.83 32.71 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.787 1.176 . . . . 0.0 107.84 170.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -73.23 -55.61 6.21 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.084 0.402 . . . . 0.0 111.069 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.1 p -65.07 -31.87 73.3 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.176 1.391 . . . . 0.0 113.077 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.05 2.22 76.48 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.874 1.226 . . . . 0.0 115.222 170.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.8 mmt 48.12 40.74 14.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.095 1.758 . . . . 0.0 114.96 173.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.3 m -147.91 137.74 22.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.397 0.679 . . . . 0.0 111.58 -170.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -125.35 131.42 53.0 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -152.46 112.27 3.97 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 120.468 1.486 . . . . 0.0 112.89 -147.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 4.8 pt -137.12 151.57 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 O-C-N 120.932 -1.105 . . . . 0.0 113.351 -163.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.34 144.15 36.16 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.938 0.875 . . . . 0.0 111.507 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.8 p -146.18 136.93 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 121.07 -1.019 . . . . 0.0 109.927 169.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.5 m -131.7 125.79 56.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.723 1.609 . . . . 0.0 108.843 -165.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -113.98 135.7 53.71 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.955 0.902 . . . . 0.0 112.409 -167.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -144.38 159.13 43.25 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.175 0.988 . . . . 0.0 113.614 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -89.74 -140.97 8.29 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 160.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.04 83.89 0.26 Allowed 'Trans proline' 0 CA--C 1.548 1.22 0 CA-C-N 119.344 1.572 . . . . 0.0 110.421 153.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -123.02 -25.29 4.57 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 172.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.11 74.91 1.42 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -172.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -51.05 -35.4 34.41 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.136 -1.393 . . . . 0.0 112.396 175.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.54 -35.1 75.18 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.464 1.029 . . . . 0.0 113.311 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.13 -44.04 55.22 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.345 1.058 . . . . 0.0 111.637 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -54.75 -49.27 71.25 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.51 1.05 . . . . 0.0 111.36 175.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -63.98 -41.02 97.66 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.843 1.657 . . . . 0.0 112.261 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.23 -31.65 72.22 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.473 -0.767 . . . . 0.0 112.554 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.63 -47.24 61.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.226 -0.921 . . . . 0.0 112.982 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 96.6 mt -53.72 -37.69 63.56 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.011 0.525 . . . . 0.0 111.772 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 88.1 mtm-85 -75.54 -32.9 60.61 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -73.93 -39.18 63.97 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.353 1.061 . . . . 0.0 112.646 173.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.9 pt -90.91 -38.62 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.144 -0.972 . . . . 0.0 112.639 -168.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -85.81 4.41 37.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.657 0.662 . . . . 0.0 111.44 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.75 29.52 5.0 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 165.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 . . . . . 0 C--O 1.258 1.542 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 -179.512 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 119.75 -0.167 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 158.55 -178.62 34.69 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.479 1.038 . . . . 0.0 113.076 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -64.65 -17.69 64.27 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 -171.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.9 mmt -121.78 126.63 49.29 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.892 1.277 . . . . 0.0 110.153 160.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -141.54 153.54 44.93 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.126 1.37 . . . . 0.0 111.353 166.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 6' ' ' ILE . 5.9 tp -136.41 107.82 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 126.818 2.047 . . . . 0.0 112.081 166.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -99.81 153.36 19.19 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -157.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -48.18 -32.51 7.15 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.246 2.218 . . . . 0.0 114.746 174.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -93.46 -25.09 17.79 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.084 0.856 . . . . 0.0 112.04 -177.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.3 t -62.55 -51.02 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.064 0.946 . . . . 0.0 109.762 170.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.36 -50.49 59.63 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.233 -0.759 . . . . 0.0 112.291 168.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.42 -47.25 79.45 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.805 1.303 . . . . 0.0 113.055 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -74.07 -40.86 62.49 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.092 0.957 . . . . 0.0 112.615 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.51 -33.33 62.77 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.552 1.524 . . . . 0.0 113.074 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.1 mp -68.92 -38.92 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 119.06 0.845 . . . . 0.0 109.555 169.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.6 m -59.9 -45.44 92.51 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.054 -1.029 . . . . 0.0 112.483 171.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -77.55 -28.07 51.74 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -173.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 p -66.79 -53.2 35.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.135 1.334 . . . . 0.0 110.252 168.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -49.16 -46.65 45.66 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.611 1.564 . . . . 0.0 112.786 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -70.22 -49.21 52.5 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.014 1.726 . . . . 0.0 114.463 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.93 -26.49 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.687 1.131 . . . . 0.0 111.198 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.6 mt -82.07 -17.21 47.42 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 171.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 46.32 56.45 6.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.959 1.704 . . . . 0.0 112.343 -167.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 pp -125.99 166.53 16.76 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.886 1.274 . . . . 0.0 111.122 167.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -75.92 158.31 32.18 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.755 1.222 . . . . 0.0 112.503 176.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -61.94 -21.74 65.03 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 119.994 -1.692 . . . . 0.0 114.175 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -95.56 3.05 54.47 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.215 1.006 . . . . 0.0 112.932 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -101.54 -12.62 18.36 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.477 1.111 . . . . 0.0 111.487 169.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.48 HD23 HD11 ' A' ' 31' ' ' ILE . 18.2 tp -88.84 137.71 32.07 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.538 1.935 . . . . 0.0 105.863 165.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.477 ' H ' ' HB3' ' A' ' 49' ' ' MET . 39.9 ttt-85 -102.48 124.77 48.63 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.938 160.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.48 HD11 HD23 ' A' ' 29' ' ' LEU . 41.3 mm -90.42 142.75 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 125.469 1.508 . . . . 0.0 110.815 168.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.3 m -117.62 136.51 53.25 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 149.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -87.0 -151.09 0.16 Allowed 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 t -59.79 -21.21 60.5 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -166.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.37 -32.07 24.55 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.267 0.9 OUTLIER -96.03 -8.67 32.95 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 176.531 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.3 11.52 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.323 1.449 . . . . 0.0 111.732 166.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.9 t -64.15 6.43 0.18 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.627 2.371 . . . . 0.0 115.352 -167.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -61.37 -21.49 64.09 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 121.042 -1.036 . . . . 0.0 111.167 174.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -142.54 124.84 8.95 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 140.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.86 -15.98 53.07 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 121.842 1.695 . . . . 0.0 114.119 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -105.96 23.29 14.22 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.369 2.267 . . . . 0.0 111.97 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -154.92 94.44 1.65 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 170.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.1 p 175.57 154.78 0.17 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.727 -1.579 . . . . 0.0 108.083 -142.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.92 -82.22 0.48 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.367 1.44 . . . . 0.0 114.446 151.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 9.2 m -163.99 177.72 8.28 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.734 1.214 . . . . 0.0 112.966 -172.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -115.95 155.87 27.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.06 1.744 . . . . 0.0 108.59 165.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -131.9 138.86 48.56 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.208 2.603 . . . . 0.0 107.481 175.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.477 ' HB3' ' H ' ' A' ' 30' ' ' ARG . 11.1 tmm? -126.5 131.64 51.57 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.092 1.315 . . . . 0.0 109.329 -169.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 mt -123.27 142.36 51.02 Favored 'General case' 0 C--O 1.245 0.847 0 O-C-N 127.074 2.734 . . . . 0.0 111.736 -153.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.3 p -97.07 161.62 13.74 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.262 2.225 . . . . 0.0 112.673 -172.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.8 t -67.58 143.37 56.11 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . 0.271 12.7 t70 66.21 33.09 7.54 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.795 2.438 . . . . 0.0 114.646 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 tp -109.83 137.33 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.721 1.209 . . . . 0.0 111.858 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 p -110.4 141.12 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 125.701 1.6 . . . . 0.0 112.655 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -136.48 120.24 12.39 Favored Pre-proline 0 CA--C 1.548 0.9 0 O-C-N 120.803 -1.186 . . . . 0.0 111.64 166.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -65.29 80.23 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 125.03 3.82 . . . . 0.0 112.003 168.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.3 p -67.15 -30.75 50.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -151.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -55.2 -39.28 69.43 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 119.036 0.835 . . . . 0.0 112.538 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -62.38 -27.19 68.91 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.69 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.2 tp -81.3 -48.96 11.31 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.922 1.289 . . . . 0.0 112.511 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 mp -53.65 -49.2 68.45 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.461 0.704 . . . . 0.0 110.189 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.0 m -74.8 -27.54 60.35 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.254 1.022 . . . . 0.0 113.1 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -61.44 -34.69 75.84 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.294 1.406 . . . . 0.0 112.456 169.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.421 ' CZ2' HD11 ' A' ' 90' ' ' ILE . 41.6 t-105 -70.63 -57.75 4.39 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.461 0.573 . . . . 0.0 112.05 167.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.54 -36.35 83.48 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -169.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 45.7 t -59.01 -17.49 25.54 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.686 1.594 . . . . 0.0 113.355 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.1 ttt85 -70.21 -43.64 70.26 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.199 -0.938 . . . . 0.0 112.768 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.5 m -159.22 3.35 0.09 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -169.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.93 82.72 0.11 Allowed Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.205 0.907 . . . . 0.0 111.481 -171.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -146.65 124.51 11.96 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 126.862 2.065 . . . . 0.0 106.833 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.3 m -78.42 117.09 19.31 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 126.25 1.82 . . . . 0.0 112.482 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.24 139.26 35.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.889 1.675 . . . . 0.0 110.828 168.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 39.1 m -102.24 145.48 29.36 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.887 0.851 . . . . 0.0 111.256 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.82 105.09 10.85 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.711 1.604 . . . . 0.0 108.923 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.7 t -96.32 154.04 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 126.677 1.991 . . . . 0.0 108.815 176.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -142.11 110.82 6.17 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.874 2.07 . . . . 0.0 106.856 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -111.15 115.35 29.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.021 2.128 . . . . 0.0 110.161 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -93.12 134.85 34.87 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.691 -0.671 . . . . 0.0 112.046 174.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.1 p -153.65 167.44 29.57 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 130.892 3.677 . . . . 0.0 107.088 -156.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -9.81 -124.99 0.0 OUTLIER Glycine 0 N--CA 1.49 2.294 0 C-N-CA 130.063 3.697 . . . . 0.0 116.296 -167.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 17.1 m -96.45 104.39 16.36 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 111.774 -3.97 . . . . 0.0 107.97 146.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.42 139.29 0.44 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 129.753 3.221 . . . . 0.0 109.272 151.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.9 t -74.73 134.77 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.97 1.259 . . . . 0.0 110.05 154.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.46 138.93 45.09 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.59 0.756 . . . . 0.0 110.288 163.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.2 tt -111.16 112.48 24.3 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.089 1.755 . . . . 0.0 106.452 170.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.421 ' HB3' ' CE1' ' A' ' 89' ' ' TYR . 2.3 m -95.87 126.88 41.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.256 -178.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 49.0 t -108.5 111.03 22.68 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 119.976 -1.703 . . . . 0.0 107.9 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 87' ' ' SER . 21.9 m-30 -116.44 100.38 7.83 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.971 0.415 . . . . 0.0 111.507 -169.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.421 HD11 ' CZ2' ' A' ' 65' ' ' TRP . 42.9 mt -62.32 115.28 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 130.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -178.83 167.46 37.8 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 122.445 3.738 . . . . 0.0 122.445 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -126.47 49.66 4.11 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 126.748 2.019 . . . . 0.0 113.895 155.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.04 172.73 14.91 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.595 2.863 . . . . 0.0 114.38 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.1 -40.78 59.7 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -156.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.268 11.7 tpt180 -95.68 -7.33 37.77 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 116.299 1.962 . . . . 0.0 116.299 -177.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -51.09 -42.29 60.52 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 128.774 2.829 . . . . 0.0 113.708 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -64.5 -27.4 68.95 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 117.434 -1.27 . . . . 0.0 112.52 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -106.15 -24.78 12.26 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.411 HD22 ' HB1' ' A' ' 113' ' ' ALA . 3.8 pp -75.41 161.06 29.56 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-N 121.358 1.89 . . . . 0.0 113.647 169.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -168.24 137.02 2.35 Favored 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 117.746 2.499 . . . . 0.0 117.746 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.401 ' CG ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -105.83 179.72 4.19 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 127.639 2.376 . . . . 0.0 111.453 178.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.401 ' H ' ' CG ' ' A' ' 101' ' ' ARG . 2.5 p -165.82 174.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.465 1.906 . . . . 0.0 112.172 -142.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.449 ' HA ' HG13 ' A' ' 150' ' ' VAL . 11.1 t -117.22 121.88 42.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.822 1.249 . . . . 0.0 109.354 151.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -171.55 153.7 3.54 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.369 1.868 . . . . 0.0 108.082 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -120.76 112.16 18.49 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.35 1.86 . . . . 0.0 110.724 172.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -160.06 -172.8 3.76 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.82 1.248 . . . . 0.0 112.04 -157.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -102.43 160.52 14.48 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.094 0.957 . . . . 0.0 111.84 164.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.4 tp -134.59 151.37 51.03 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 128.661 2.784 . . . . 0.0 108.668 -168.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 m -124.21 158.51 32.25 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.004 1.722 . . . . 0.0 111.818 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -5.17 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 126.143 1.777 . . . . 0.0 115.543 -166.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -127.14 55.13 1.59 Allowed 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.946 -1.096 . . . . 0.0 112.186 170.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.25 152.73 23.72 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 177.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.411 ' HB1' HD22 ' A' ' 99' ' ' LEU . . . -149.34 128.44 12.76 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 126.218 1.807 . . . . 0.0 107.402 -172.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.84 143.95 21.03 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 121.054 -1.029 . . . . 0.0 110.891 -172.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.73 140.69 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 125.285 1.434 . . . . 0.0 114.423 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.2 t -134.79 154.12 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.07 1.748 . . . . 0.0 111.442 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.6 t -143.07 170.34 15.9 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.27 1.828 . . . . 0.0 110.152 171.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.19 -31.47 63.49 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.873 -1.142 . . . . 0.0 113.875 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.14 -32.54 67.01 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 118.623 0.647 . . . . 0.0 112.579 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -67.92 -44.8 76.06 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.641 1.177 . . . . 0.0 110.249 176.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 37.5 mm -67.33 -33.67 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.705 -0.622 . . . . 0.0 111.252 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -62.65 -24.65 67.72 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.245 -0.909 . . . . 0.0 113.285 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -80.85 -15.67 55.74 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 120.741 1.61 . . . . 0.0 113.701 168.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.7 mt -73.81 -44.34 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 120.309 1.413 . . . . 0.0 111.392 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -173.24 -38.55 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.181 0 CA-C-O 116.687 -1.625 . . . . 0.0 112.092 168.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -73.21 -147.04 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.259 0 C-N-CA 123.068 2.512 . . . . 0.0 115.753 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 5.3 t -152.63 138.95 18.45 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 129.967 3.307 . . . . 0.0 108.844 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.04 -0.9 17.82 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 119.816 3.265 . . . . 0.0 119.816 -151.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.34 19.29 20.04 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -173.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.59 12.38 0.76 Allowed Glycine 0 N--CA 1.473 1.144 0 C-N-CA 124.322 0.963 . . . . 0.0 114.735 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.44 125.5 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 118.15 0.975 . . . . 0.0 111.907 -167.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.81 85.81 2.45 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.644 1.212 . . . . 0.0 108.097 162.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.1 t -90.83 148.35 22.57 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.978 0.911 . . . . 0.0 109.914 166.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -141.58 137.61 32.05 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.966 0.906 . . . . 0.0 110.203 -169.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 35.9 t -135.05 130.32 35.44 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.188 0.449 . . . . 0.0 110.11 -160.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.1 t -135.54 126.91 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.076 1.351 . . . . 0.0 109.655 -169.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.7 m -121.9 143.5 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.691 0.757 . . . . 0.0 111.907 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -127.56 159.86 33.34 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.136 2.174 . . . . 0.0 109.05 165.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.305 0.1 OUTLIER -148.44 155.51 41.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.104 1.361 . . . . 0.0 110.099 166.769 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.6 t -134.65 115.38 13.74 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.31 0.959 . . . . 0.0 109.437 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -71.03 -52.69 18.1 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.999 0.818 . . . . 0.0 110.886 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.1 p -56.8 -36.26 69.68 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.68 -4.3 90.26 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.648 1.118 . . . . 0.0 115.542 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 58.5 mtm 47.67 38.87 9.03 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.21 1.804 . . . . 0.0 114.986 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.8 t -149.55 166.04 30.4 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -130.27 137.26 49.91 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.61 1.564 . . . . 0.0 107.901 -173.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -130.47 132.25 45.58 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.596 0.634 . . . . 0.0 109.969 -166.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.15 132.69 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -153.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -140.03 132.31 28.28 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.304 1.842 . . . . 0.0 109.257 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.449 HG13 ' HA ' ' A' ' 103' ' ' CYS . 3.3 p -145.5 139.12 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 120.684 -1.26 . . . . 0.0 109.275 159.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.68 147.38 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.77 2.028 . . . . 0.0 109.542 -172.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.56 112.41 9.54 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.378 -0.826 . . . . 0.0 113.212 -170.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -126.37 161.0 28.86 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.042 2.137 . . . . 0.0 110.661 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -75.94 -146.05 1.68 Allowed Glycine 0 CA--C 1.546 2.029 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 154.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.81 0.08 8.2 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.553 2.835 . . . . 0.0 114.728 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.01 -20.51 65.96 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.107 -1.621 . . . . 0.0 114.107 -177.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -83.37 61.58 6.25 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.842 1.306 . . . . 0.0 112.04 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -52.7 -32.87 44.92 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.489 1.515 . . . . 0.0 111.846 171.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.74 -51.71 66.1 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.908 0.883 . . . . 0.0 113.099 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.94 -36.12 79.59 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.791 1.178 . . . . 0.0 113.077 171.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -64.51 -52.86 55.65 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.95 1.25 . . . . 0.0 110.792 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -63.08 -32.38 73.75 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.836 -1.165 . . . . 0.0 113.192 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.89 -38.22 84.93 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.219 0.918 . . . . 0.0 112.277 171.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -76.02 -43.03 46.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.119 0.968 . . . . 0.0 113.547 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 93.8 mt -56.0 -36.03 67.46 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.212 0.914 . . . . 0.0 112.254 172.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -66.89 -51.08 59.67 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.467 1.107 . . . . 0.0 110.83 172.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.53 -26.81 64.69 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.2 pt -85.22 -34.95 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.681 0.793 . . . . 0.0 112.028 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -67.64 -0.96 4.43 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.684 1.129 . . . . 0.0 112.819 158.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -127.77 25.56 5.98 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 125.629 1.572 . . . . 0.0 112.293 179.852 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -101.83 -165.92 27.09 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.107 1.336 . . . . 0.0 114.767 -175.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -144.1 154.22 42.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.912 1.685 . . . . 0.0 111.179 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.94 73.76 0.6 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.564 1.546 . . . . 0.0 113.134 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -134.69 149.12 50.46 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.424 2.29 . . . . 0.0 109.246 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 6' ' ' ILE . 6.7 tp -85.47 128.66 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 124.103 1.906 . . . . 0.0 113.568 -164.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -114.72 148.1 38.77 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 111.097 -2.774 . . . . 0.0 111.745 172.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -55.14 -17.8 4.75 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -75.08 -21.96 58.61 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.865 -1.147 . . . . 0.0 112.111 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 t -72.05 -44.0 66.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.483 1.513 . . . . 0.0 110.093 171.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.88 -51.83 56.57 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 169.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.07 -45.12 64.63 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.295 1.047 . . . . 0.0 112.709 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -74.54 -35.13 63.1 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.47 -33.67 60.84 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.572 -1.33 . . . . 0.0 112.668 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -70.41 -41.25 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.839 0.745 . . . . 0.0 109.78 170.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.0 m -55.54 -46.78 77.04 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.207 -0.933 . . . . 0.0 111.858 171.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -64.41 -43.91 92.91 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.513 -0.742 . . . . 0.0 112.453 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -71.5 -24.65 62.01 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . 0.274 22.9 ptt-85 -74.8 -55.78 5.47 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 120.606 1.548 . . . . 0.0 113.88 158.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.0 -42.28 15.03 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -158.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.41 -25.89 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-N 119.654 1.115 . . . . 0.0 110.871 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.06 -12.1 60.25 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.699 1.6 . . . . 0.0 112.58 169.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 52.23 46.32 26.85 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 128.057 2.543 . . . . 0.0 115.199 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.564 HD11 HD13 ' A' ' 29' ' ' LEU . 4.7 pp -121.12 161.03 22.5 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.995 1.718 . . . . 0.0 112.703 174.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.31 149.48 26.04 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.659 -0.651 . . . . 0.0 111.49 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -64.96 -25.17 67.76 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.614 -1.304 . . . . 0.0 113.295 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -69.24 -21.46 63.92 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.995 -1.066 . . . . 0.0 112.417 168.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -104.25 -3.96 23.63 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.425 1.89 . . . . 0.0 112.297 -172.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.803 HD11 ' HB1' ' A' ' 48' ' ' ALA . 15.2 tp -94.61 133.49 38.19 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.528 2.731 . . . . 0.0 108.462 163.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.89 122.66 44.43 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.573 0.624 . . . . 0.0 109.724 166.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.2 mm -94.62 138.61 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.388 1.075 . . . . 0.0 110.746 170.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 36' ' ' LEU . 3.5 m -139.21 144.66 38.6 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -117.02 -146.13 0.4 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.632 1.573 . . . . 0.0 110.608 -161.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 t -42.53 -32.31 0.54 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 128.122 2.569 . . . . 0.0 115.884 -171.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.52 -26.99 67.27 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 120.201 1.364 . . . . 0.0 113.989 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' A' ' 32' ' ' THR . 40.8 mt -76.79 -43.69 35.74 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.817 1.19 . . . . 0.0 112.824 174.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -96.61 16.09 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.505 1.922 . . . . 0.0 111.415 -170.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.2 t -57.37 5.6 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.93 2.892 . . . . 0.0 116.845 -165.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.57 -39.04 11.06 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.851 1.26 . . . . 0.0 110.99 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -121.96 67.62 24.01 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.215 1.406 . . . . 0.0 107.393 160.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.89 -44.42 49.38 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 123.323 2.682 . . . . 0.0 113.241 -165.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -93.3 6.57 47.64 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.617 -1.182 . . . . 0.0 110.784 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -128.58 100.2 5.66 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 121.172 1.805 . . . . 0.0 107.516 171.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.1 p 176.67 170.51 0.48 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.447 -0.783 . . . . 0.0 111.147 -141.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.7 tp -128.05 -83.93 0.59 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 118.576 -1.25 . . . . 0.0 112.967 145.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 77.3 m -170.58 -161.98 0.26 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.348 1.459 . . . . 0.0 109.175 -160.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -148.0 157.37 43.48 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.348 2.259 . . . . 0.0 107.838 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.803 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -131.68 134.49 46.0 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.075 2.55 . . . . 0.0 107.571 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.8 ttm -122.51 130.94 53.57 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.428 -1.42 . . . . 0.0 111.273 -166.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.0 147.86 52.48 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.368 1.467 . . . . 0.0 114.685 -158.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.9 t -99.95 154.93 17.98 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.411 1.884 . . . . 0.0 109.315 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.2 t -46.89 113.15 0.61 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.538 1.535 . . . . 0.0 110.992 -153.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.78 157.86 26.71 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.356 1.074 . . . . 0.0 113.21 -143.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.419 HG22 ' H ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -110.71 178.5 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 113.499 -1.682 . . . . 0.0 109.575 -160.197 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.419 ' H ' HG22 ' A' ' 54' ' ' ILE . 7.6 p -80.15 116.87 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.854 -168.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -125.58 139.3 33.69 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 118.612 -0.708 . . . . 0.0 109.736 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -66.38 78.19 0.34 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.148 3.232 . . . . 0.0 113.688 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.2 p -56.39 -30.28 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 127.554 2.341 . . . . 0.0 113.745 -170.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.555 ' HB2' ' H ' ' A' ' 133' ' ' THR . 22.7 tp10 -62.52 -22.49 66.33 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -177.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -55.59 -44.32 76.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.119 0.872 . . . . 0.0 111.117 169.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.1 mp -74.25 -44.5 52.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.941 1.296 . . . . 0.0 111.884 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mp -54.0 -50.04 67.48 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 172.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.1 m -63.72 -50.39 69.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.126 0.97 . . . . 0.0 112.056 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -60.02 -29.56 68.58 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 118.264 -0.874 . . . . 0.0 113.008 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -76.29 -57.63 3.75 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.107 1.321 . . . . 0.0 114.204 169.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -76.53 -40.43 50.01 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -167.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 6.5 p -75.95 -1.81 27.38 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.85 -1.156 . . . . 0.0 113.625 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -60.83 -37.0 80.52 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.173 1.789 . . . . 0.0 113.333 -172.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.7 p -165.76 27.1 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.576 1.55 . . . . 0.0 113.483 169.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.03 86.08 0.16 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.686 1.612 . . . . 0.0 113.936 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -150.08 118.88 6.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 128.85 2.86 . . . . 0.0 104.656 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.6 m -65.6 117.93 8.78 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 122.909 0.484 . . . . 0.0 110.02 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.12 144.91 50.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.476 1.51 . . . . 0.0 111.372 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 26.8 p -115.73 141.0 48.67 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.663 1.185 . . . . 0.0 111.43 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -90.11 151.45 21.6 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 157.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 t -137.67 156.37 32.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 126.534 1.933 . . . . 0.0 108.284 -173.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.555 ' HB2' HD11 ' A' ' 114' ' ' LEU . 86.6 m-85 -123.85 138.52 54.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.044 0.926 . . . . 0.0 109.865 159.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -116.92 103.12 9.96 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.997 2.119 . . . . 0.0 108.246 172.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -87.84 127.36 35.34 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.036 1.334 . . . . 0.0 110.166 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.6 t -148.41 166.76 27.13 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 130.318 3.447 . . . . 0.0 105.405 -151.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -18.02 -122.81 0.0 OUTLIER Glycine 0 N--CA 1.486 1.986 1 C-N-CA 131.241 4.258 . . . . 0.0 116.327 -176.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 45.9 t -96.23 101.03 12.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 113.897 -3.121 . . . . 0.0 109.651 150.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.7 mtt180 -171.64 -177.16 1.95 Allowed 'General case' 0 CA--C 1.549 0.934 1 C-N-CA 133.496 4.718 . . . . 0.0 107.05 123.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.5 t -95.26 146.34 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 120.265 -1.522 . . . . 0.0 111.5 145.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.11 136.91 43.73 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.09 1.356 . . . . 0.0 110.359 162.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -110.94 109.35 19.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.032 2.133 . . . . 0.0 106.175 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 m -104.3 144.78 31.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.332 1.053 . . . . 0.0 110.82 -164.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 74.1 m -127.53 114.32 17.28 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 120.908 -1.12 . . . . 0.0 110.79 -171.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -128.31 117.02 20.73 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.7 pt -88.45 62.54 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 122.792 1.282 . . . . 0.0 109.082 144.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.36 -179.38 43.99 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 121.618 3.407 . . . . 0.0 121.618 -145.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -144.46 116.22 5.43 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 126.162 1.785 . . . . 0.0 111.702 177.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -82.97 163.65 15.65 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.556 2.837 . . . . 0.0 111.706 153.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.72 -18.73 56.11 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.546 1.138 . . . . 0.0 114.061 175.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 -25.64 36.21 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.42 1.488 . . . . 0.0 114.966 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.4 -44.08 65.16 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.45 2.7 . . . . 0.0 114.289 -169.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -36.84 76.29 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.001 0.52 . . . . 0.0 110.907 175.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -98.04 -23.63 15.69 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -170.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 pp -76.68 175.42 9.36 Favored 'General case' 0 CA--C 1.556 1.173 0 CA-C-N 119.926 1.239 . . . . 0.0 112.375 172.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -119.62 -162.51 0.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.878 -1.139 . . . . 0.0 113.917 -162.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -121.88 149.07 43.91 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.451 1.501 . . . . 0.0 111.693 172.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.4 p -127.89 136.7 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.155 0.982 . . . . 0.0 111.607 164.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.439 ' HA ' HG13 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -151.96 123.81 8.0 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 123.131 1.443 . . . . 0.0 108.793 116.213 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 170.89 -179.47 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 130.088 3.355 . . . . 0.0 105.156 -153.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -124.96 133.25 53.09 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.244 1.018 . . . . 0.0 112.331 159.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -150.85 149.89 30.25 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.63 1.172 . . . . 0.0 112.666 -164.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -73.29 132.62 43.33 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.131 0.972 . . . . 0.0 110.801 170.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.1 tp -119.13 148.7 42.78 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.049 1.739 . . . . 0.0 111.233 -163.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.7 t -117.26 168.56 10.21 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.07 2.148 . . . . 0.0 110.979 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -77.24 -8.9 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.331 1.452 . . . . 0.0 113.931 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -130.57 70.51 1.45 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.488 1.915 . . . . 0.0 109.175 172.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -133.44 142.06 48.12 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.295 -0.878 . . . . 0.0 111.115 173.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -149.79 129.26 13.02 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.183 1.393 . . . . 0.0 108.077 -163.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 77' ' ' PHE . 4.4 pp -157.94 156.14 30.75 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -159.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.4 t -105.03 145.37 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 127.33 2.252 . . . . 0.0 111.644 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.41 123.39 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 122.489 1.138 . . . . 0.0 111.156 152.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.0 t -146.65 153.55 40.43 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.043 1.337 . . . . 0.0 111.191 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.87 -27.22 67.96 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.469 1.107 . . . . 0.0 113.393 -173.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.19 83.2 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 120.805 1.639 . . . . 0.0 112.628 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.18 -33.97 59.32 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.742 0.817 . . . . 0.0 112.672 172.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.52 -37.09 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.851 1.205 . . . . 0.0 110.714 168.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.33 -19.52 65.46 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.937 1.695 . . . . 0.0 112.761 171.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.2 mtm-85 -80.07 -30.33 39.3 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 121.935 2.152 . . . . 0.0 113.365 161.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 73.1 mt -82.63 -34.51 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.417 1.487 . . . . 0.0 113.461 -172.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -120.5 150.95 53.18 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 125.254 1.422 . . . . 0.0 110.845 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.31 -7.87 21.71 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.149 2.566 . . . . 0.0 113.522 173.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 35.3 m -121.31 131.17 54.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.74 1.616 . . . . 0.0 109.569 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -103.61 -137.43 0.35 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.143 1.377 . . . . 0.0 111.124 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -36.57 125.62 0.84 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.721 1.608 . . . . 0.0 111.701 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 116.69 -30.28 6.48 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.243 1.402 . . . . 0.0 112.293 -149.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 t -60.52 147.84 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.943 1.297 . . . . 0.0 113.153 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 26.4 tp -122.28 92.64 3.77 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.548 1.539 . . . . 0.0 109.481 159.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.555 ' H ' ' HB2' ' A' ' 59' ' ' GLU . 17.9 m -75.29 154.78 37.22 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.201 2.201 . . . . 0.0 109.933 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -142.11 134.57 28.03 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.773 1.229 . . . . 0.0 108.208 -168.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 34.7 t -139.28 142.04 37.76 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.252 0.933 . . . . 0.0 112.136 -163.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.7 t -147.2 141.44 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.976 2.11 . . . . 0.0 109.888 -168.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.91 138.21 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 O-C-N 121.208 -0.933 . . . . 0.0 111.068 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.02 113.2 26.57 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.472 1.109 . . . . 0.0 108.981 166.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.665 ' HE2' ' CD1' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -88.79 128.83 35.65 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 143.573 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.8 m -149.74 175.31 11.7 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -167.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 69.89 160.39 0.2 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 128.244 2.618 . . . . 0.0 115.154 167.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 84.4 p -89.82 -47.71 7.72 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.568 1.547 . . . . 0.0 110.526 171.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -65.88 -1.28 8.71 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 125.629 1.585 . . . . 0.0 115.082 165.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.4 mmt 64.78 128.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 129.032 2.933 . . . . 0.0 114.754 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.4 p -172.31 155.67 3.61 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.877 2.071 . . . . 0.0 108.476 169.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.665 ' CD1' ' HE2' ' A' ' 139' ' ' LYS . 2.5 m-85 -136.08 163.95 29.14 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -166.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -151.46 155.7 39.11 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.35 -1.469 . . . . 0.0 107.55 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.1 tt -136.59 138.94 45.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.092 -0.38 . . . . 0.0 110.516 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -141.69 123.61 15.34 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.321 0.648 . . . . 0.0 110.389 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' A' ' 103' ' ' CYS . 2.1 p -140.61 133.07 31.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-O 122.356 1.074 . . . . 0.0 110.201 168.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.4 m -135.6 130.88 50.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 127.102 2.161 . . . . 0.0 110.735 -163.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -107.65 111.13 23.2 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.094 0.957 . . . . 0.0 111.62 -171.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -109.95 159.47 17.23 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.25 1.42 . . . . 0.0 110.719 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -74.79 -170.79 26.32 Favored Glycine 0 CA--C 1.542 1.735 0 O-C-N 121.314 -0.866 . . . . 0.0 113.728 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.27 -25.8 64.4 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.37 2.047 . . . . 0.0 112.085 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.52 9.0 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 129.349 3.06 . . . . 0.0 114.963 171.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -82.51 46.86 1.1 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.085 2.154 . . . . 0.0 108.605 169.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -58.2 -39.6 79.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.289 2.236 . . . . 0.0 111.824 -165.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.57 -44.42 78.27 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.832 -0.604 . . . . 0.0 112.585 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.91 -40.87 75.34 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.657 0.783 . . . . 0.0 111.783 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -53.69 -59.08 5.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.224 1.01 . . . . 0.0 110.433 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -60.55 -43.11 97.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.962 0.905 . . . . 0.0 112.91 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.43 -38.01 88.07 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.293 0.951 . . . . 0.0 113.058 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.7 -42.7 70.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.314 -0.866 . . . . 0.0 111.962 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.05 -35.12 74.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.33 0.513 . . . . 0.0 111.7 173.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -63.06 -31.66 72.85 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.597 1.559 . . . . 0.0 111.803 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -88.37 -45.11 10.27 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -106.7 -24.82 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 118.013 2.597 . . . . 0.0 118.013 -167.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -103.47 -11.49 17.78 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.707 1.203 . . . . 0.0 110.05 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -125.21 25.8 7.08 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.482 1.513 . . . . 0.0 114.134 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 160.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 111.144 0.053 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -48.2 -38.14 17.57 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -165.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -94.68 -22.24 18.26 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.281 0.946 . . . . 0.0 112.151 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.6 t -72.44 -51.12 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.697 1.599 . . . . 0.0 113.164 -168.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.94 -46.66 94.11 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.27 -35.91 67.98 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.222 1.011 . . . . 0.0 112.584 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -68.43 -47.47 67.11 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.405 1.482 . . . . 0.0 112.534 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.48 -38.31 77.64 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.209 -0.932 . . . . 0.0 111.977 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.58 -39.83 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.505 1.522 . . . . 0.0 110.497 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.2 t -58.97 -48.27 82.16 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.197 0.999 . . . . 0.0 111.51 172.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -60.36 -43.01 96.92 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.66 -0.65 . . . . 0.0 111.156 173.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.9 m -62.75 -45.97 90.21 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.621 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.7 ptt-85 -65.81 -36.65 84.09 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.587 1.54 . . . . 0.0 112.592 174.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -68.66 -42.85 77.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.408 1.883 . . . . 0.0 114.375 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . 0.3 0.8 OUTLIER -88.24 -17.34 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 173.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.13 -5.72 58.64 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 121.022 1.737 . . . . 0.0 112.309 163.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 48.86 41.67 18.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 128.05 2.54 . . . . 0.0 114.468 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 pp -120.48 169.82 9.97 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.458 2.303 . . . . 0.0 110.804 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -92.74 168.41 11.22 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -66.95 -18.24 65.29 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.698 1.599 . . . . 0.0 114.427 -173.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -102.97 12.14 36.46 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.043 1.337 . . . . 0.0 112.314 171.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -127.48 -14.02 5.34 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.101 1.76 . . . . 0.0 110.953 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.462 HD11 ' HB1' ' A' ' 48' ' ' ALA . 35.6 tp -83.93 122.35 28.62 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 155.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.439 ' H ' ' HB3' ' A' ' 49' ' ' MET . 8.9 ttp-105 -92.19 126.43 37.26 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 118.932 -1.107 . . . . 0.0 110.839 172.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.8 mm -98.99 142.42 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.946 1.699 . . . . 0.0 112.007 173.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.9 m -140.8 143.14 34.68 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.318 0.508 . . . . 0.0 110.116 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -96.85 -142.38 0.29 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.386 1.474 . . . . 0.0 111.656 176.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.9 p -46.92 -38.55 10.71 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.16 2.184 . . . . 0.0 115.706 -156.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.45 -29.61 64.33 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -165.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.39 -15.2 16.6 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 115.961 1.838 . . . . 0.0 115.961 173.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 pt -112.62 -14.0 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 -175.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.5 t -61.53 9.33 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 -166.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -83.79 -15.7 47.4 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 119.657 -1.902 . . . . 0.0 113.075 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -91.49 113.44 58.56 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 141.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.99 -11.1 11.29 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.125 1.883 . . . . 0.0 115.871 -160.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -121.9 -10.97 8.6 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 120.806 1.639 . . . . 0.0 115.164 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -162.1 160.19 27.04 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.078 1.351 . . . . 0.0 108.325 -169.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.7 p 164.61 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.273 1.829 . . . . 0.0 106.426 -155.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.0 tp -122.33 -78.16 0.6 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 119.16 -1.016 . . . . 0.0 112.42 147.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.5 m -177.34 -160.04 0.05 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.794 2.038 . . . . 0.0 108.004 -165.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -131.78 157.83 42.84 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.921 2.088 . . . . 0.0 107.937 169.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -135.17 130.97 36.19 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 128.815 2.846 . . . . 0.0 108.951 -177.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.439 ' HB3' ' H ' ' A' ' 30' ' ' ARG . 35.8 ttp -118.22 131.67 56.36 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.096 -1.003 . . . . 0.0 110.844 -166.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 mt -127.51 149.03 50.31 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.348 2.659 . . . . 0.0 112.711 -151.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.1 p -96.93 159.02 15.15 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.063 2.145 . . . . 0.0 113.176 -169.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.5 t -72.07 158.61 35.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.903 1.281 . . . . 0.0 112.537 173.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.3 t70 57.11 43.69 23.73 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.113 1.765 . . . . 0.0 113.7 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 tp -132.74 139.73 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.546 1.139 . . . . 0.0 111.266 -171.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.2 p -123.37 140.92 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.424 1.49 . . . . 0.0 111.769 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -138.35 153.1 72.57 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 157.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.82 78.09 1.78 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.847 3.032 . . . . 0.0 109.949 167.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -47.73 -36.7 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 127.547 2.339 . . . . 0.0 115.047 -167.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.98 -18.61 60.35 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -59.55 -34.23 72.4 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.268 -0.895 . . . . 0.0 111.011 167.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.6 tp -78.87 -44.57 22.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.523 1.129 . . . . 0.0 112.409 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.7 mp -54.25 -45.93 72.51 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.733 1.151 . . . . 0.0 110.627 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.4 t -57.57 -50.36 73.35 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.924 1.29 . . . . 0.0 111.864 175.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -61.87 -37.69 85.46 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -59.55 -54.92 41.01 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.711 1.604 . . . . 0.0 111.95 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -72.1 -31.38 66.0 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 9.9 t -72.27 -18.26 61.82 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 -69.59 -35.14 75.06 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -168.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.1 m -147.17 8.04 0.92 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.84 71.76 0.79 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.986 1.279 . . . . 0.0 111.784 -170.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -168.0 135.31 2.18 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 128.425 2.69 . . . . 0.0 105.76 172.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -100.79 154.99 18.18 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 127.832 2.453 . . . . 0.0 111.734 -170.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.74 147.27 44.6 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.599 1.16 . . . . 0.0 112.566 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.49 ' HA ' HG23 ' A' ' 117' ' ' THR . 26.9 p -86.9 142.29 28.13 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.661 0.743 . . . . 0.0 110.517 160.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -92.06 108.61 20.06 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 167.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.518 HG22 HG22 ' A' ' 115' ' ' VAL . 59.3 t -101.48 109.02 24.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -92.36 113.12 25.31 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 120.712 -1.243 . . . . 0.0 107.677 -173.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -107.52 101.68 11.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.383 1.473 . . . . 0.0 108.851 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -79.62 129.02 34.1 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.801 1.64 . . . . 0.0 109.511 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.8 p -145.18 168.71 19.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.075 2.55 . . . . 0.0 104.57 -170.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -12.75 -119.44 0.0 OUTLIER Glycine 0 N--CA 1.487 2.051 0 C-N-CA 129.542 3.449 . . . . 0.0 116.098 -171.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.8 p -95.45 105.84 17.85 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 113.96 -3.096 . . . . 0.0 111.082 153.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -178.75 145.88 0.31 Allowed 'General case' 0 N--CA 1.474 0.728 1 C-N-CA 132.179 4.192 . . . . 0.0 108.477 146.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 t -78.73 142.27 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 119.246 -2.159 . . . . 0.0 110.431 145.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.0 p -125.23 161.95 25.77 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.77 -1.207 . . . . 0.0 112.69 154.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 pp -112.44 116.11 29.77 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 122.11 0.957 . . . . 0.0 109.034 158.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.4 m -80.23 121.26 25.4 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.389 1.476 . . . . 0.0 108.006 169.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 42.4 t -104.91 113.68 27.43 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.028 -1.045 . . . . 0.0 110.98 -172.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -105.11 108.84 20.57 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.75 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.7 mt -76.67 72.09 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 140.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.77 -179.11 48.43 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 121.445 3.338 . . . . 0.0 121.445 -155.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -115.57 105.49 51.88 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-N 111.134 -2.533 . . . . 0.0 110.035 -171.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.444 ' HG2' HD23 ' A' ' 96' ' ' LEU . 20.4 Cg_exo -86.12 152.68 9.58 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.639 2.226 . . . . 0.0 114.636 -173.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -42.93 62.52 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -177.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 ttt85 -88.76 3.63 50.28 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.444 HD23 ' HG2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -49.88 -29.36 8.0 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.339 2.256 . . . . 0.0 113.612 178.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -53.49 -45.03 69.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.413 1.885 . . . . 0.0 113.543 168.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -122.08 -20.18 6.35 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -166.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.427 ' C ' HD12 ' A' ' 99' ' ' LEU . 2.7 pp -60.93 168.92 2.15 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 121.578 1.99 . . . . 0.0 114.711 165.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -117.25 172.88 7.01 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -160.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.595 ' CZ ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -131.0 155.14 47.33 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.984 1.313 . . . . 0.0 113.992 157.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.595 ' H ' ' CZ ' ' A' ' 101' ' ' ARG . 1.5 p -136.67 137.61 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.327 1.451 . . . . 0.0 113.432 174.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 28.1 p -123.38 112.66 17.83 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.448 133.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 t0 176.49 -167.23 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 128.521 2.729 . . . . 0.0 107.601 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -113.59 138.83 49.62 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.064 1.346 . . . . 0.0 111.396 150.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -158.09 159.66 36.52 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -60.77 142.59 55.81 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.306 1.042 . . . . 0.0 111.034 160.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 20.9 tp -142.4 133.39 25.84 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.848 1.659 . . . . 0.0 110.172 -173.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 m -71.68 156.57 39.21 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -174.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.47 -10.43 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -169.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.99 41.73 3.12 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.052 1.341 . . . . 0.0 112.201 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.41 ' HG3' ' H ' ' A' ' 113' ' ' ALA . 8.3 tp10 -105.04 172.42 6.8 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.058 2.143 . . . . 0.0 113.481 -169.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.41 ' H ' ' HG3' ' A' ' 112' ' ' GLU . . . -149.8 139.07 21.31 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 126.579 1.952 . . . . 0.0 106.315 -167.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.54 133.21 9.19 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.263 0.938 . . . . 0.0 113.445 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.518 HG22 HG22 ' A' ' 76' ' ' VAL . 3.6 t -95.88 136.43 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 117.252 -1.356 . . . . 0.0 109.315 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.491 ' HB ' ' CZ ' ' A' ' 101' ' ' ARG . 11.4 p -138.23 115.39 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 120.322 1.419 . . . . 0.0 109.354 164.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.49 HG23 ' HA ' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -138.01 171.29 14.63 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.002 1.721 . . . . 0.0 111.282 -175.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 79.4 mt -59.71 -29.99 68.49 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.534 0.734 . . . . 0.0 112.913 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.98 -33.32 65.75 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 119.712 1.142 . . . . 0.0 113.043 173.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -74.39 -45.64 45.46 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.802 1.241 . . . . 0.0 111.862 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 28.4 mm -60.34 -40.98 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.493 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -61.44 -29.99 70.3 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 172.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -70.1 -41.05 74.54 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 121.692 2.042 . . . . 0.0 111.864 172.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.5 pt -96.72 -11.9 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -168.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -154.15 150.67 22.89 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 126.539 1.936 . . . . 0.0 110.748 166.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -61.34 113.2 1.67 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 121.775 1.65 . . . . 0.0 110.926 168.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 19.7 p -83.32 161.64 21.36 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.608 0.718 . . . . 0.0 112.672 -176.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -151.19 147.96 27.66 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.264 1.826 . . . . 0.0 108.233 -171.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.257 0.1 OUTLIER -67.14 54.23 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 127.859 2.464 . . . . 0.0 112.635 170.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 179.6 -0.58 0.02 OUTLIER Glycine 0 CA--C 1.539 1.562 0 C-N-CA 127.516 2.484 . . . . 0.0 114.215 -167.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.1 t -65.42 131.15 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.011 1.405 . . . . 0.0 111.28 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 90.5 mt -118.44 89.21 3.08 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.982 1.713 . . . . 0.0 108.281 159.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.0 m -72.95 148.36 44.35 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 170.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -133.28 134.29 43.71 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.427 1.491 . . . . 0.0 108.661 -165.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 41.9 t -140.89 135.97 31.84 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.525 1.057 . . . . 0.0 112.027 -169.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.5 124.17 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.374 1.869 . . . . 0.0 110.175 -167.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.0 m -121.65 145.86 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.213 -0.93 . . . . 0.0 112.831 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -130.22 138.6 50.65 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.389 1.076 . . . . 0.0 112.12 158.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.51 ' HD2' ' CE1' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -77.58 146.08 36.45 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 129.034 2.934 . . . . 0.0 112.423 152.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.5 t -139.51 143.49 37.47 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.518 1.127 . . . . 0.0 110.217 162.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -101.29 -41.18 6.79 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.453 1.501 . . . . 0.0 110.755 169.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.9 t -54.76 -33.75 61.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.832 0.853 . . . . 0.0 112.808 174.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -102.49 1.2 49.65 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 117.71 -1.605 . . . . 0.0 115.849 172.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.3 mmt 39.44 57.85 2.04 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.837 1.819 . . . . 0.0 113.455 -173.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.0 m -149.46 163.52 37.55 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.002 0.921 . . . . 0.0 113.13 -163.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.51 ' CE1' ' HD2' ' A' ' 139' ' ' LYS . 76.7 m-85 -107.29 154.34 21.4 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.098 0.959 . . . . 0.0 111.098 154.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -130.83 106.19 8.28 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.61 139.19 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 123.972 0.909 . . . . 0.0 109.683 -163.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -141.46 134.3 28.82 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.689 0.796 . . . . 0.0 109.45 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.5 p -150.44 132.58 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 122.42 1.105 . . . . 0.0 110.642 164.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.4 m -137.28 145.69 29.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 126.505 1.922 . . . . 0.0 109.013 -162.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -112.36 118.11 34.32 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.689 -0.632 . . . . 0.0 112.392 -169.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -121.59 157.21 31.28 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.384 1.074 . . . . 0.0 111.338 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -85.6 -146.97 9.25 Favored Glycine 0 CA--C 1.54 1.626 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 159.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -63.39 -3.44 5.22 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.564 2.843 . . . . 0.0 115.973 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -63.76 -18.7 64.32 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.133 1.373 . . . . 0.0 114.01 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -77.37 30.24 0.15 Allowed 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.478 1.111 . . . . 0.0 112.172 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -61.54 -26.79 68.17 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.433 1.893 . . . . 0.0 114.177 -171.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.88 -52.57 12.54 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.404 1.082 . . . . 0.0 112.051 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -61.38 -39.78 91.93 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.375 1.07 . . . . 0.0 112.188 171.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -52.44 -54.68 29.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.611 0.764 . . . . 0.0 110.873 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -59.04 -45.29 91.11 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.565 -0.71 . . . . 0.0 112.852 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.36 -34.81 75.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.319 0.648 . . . . 0.0 112.309 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.43 -45.33 60.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.434 -0.791 . . . . 0.0 111.942 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 88.9 mt -56.85 -34.38 67.74 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.824 0.738 . . . . 0.0 111.683 171.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -79.38 -7.93 58.72 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.229 1.812 . . . . 0.0 114.231 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -99.78 -57.23 2.19 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.987 1.315 . . . . 0.0 113.053 160.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.8 pt -83.8 -32.12 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -160.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -90.69 10.98 23.66 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.017 0.927 . . . . 0.0 109.449 168.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.91 24.87 5.31 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.399 1.48 . . . . 0.0 114.638 174.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 16.7 mmt85 . . . . . 0 C--O 1.252 1.233 0 CA-C-O 117.628 -1.177 . . . . 0.0 111.319 157.46 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.4 t0 . . . . . 0 N--CA 1.482 1.149 0 CA-C-O 121.608 0.718 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -68.5 -23.48 64.56 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 -135.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -112.8 -17.17 12.6 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.039 1.336 . . . . 0.0 113.425 172.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 80.1 t -67.18 -60.64 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.298 1.039 . . . . 0.0 111.532 -173.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.28 -37.35 80.48 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.282 -0.732 . . . . 0.0 113.472 175.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.71 -59.2 5.79 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.245 1.023 . . . . 0.0 110.916 175.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -65.77 -46.95 76.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.616 1.166 . . . . 0.0 111.668 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.0 mp -70.46 -43.7 69.28 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.643 -0.66 . . . . 0.0 111.637 -173.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.29 -34.56 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 119.203 0.91 . . . . 0.0 110.231 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.2 t -59.49 -52.33 66.02 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.41 1.005 . . . . 0.0 111.761 174.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -64.73 -31.51 72.76 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.416 -0.803 . . . . 0.0 111.581 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 m -68.72 -50.09 53.57 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.196 -0.94 . . . . 0.0 111.685 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.1 ptt85 -61.87 -22.06 65.22 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.002 1.274 . . . . 0.0 113.577 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -85.1 -52.56 5.86 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.446 1.099 . . . . 0.0 112.953 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.85 -30.48 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 118.635 0.652 . . . . 0.0 112.201 -175.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -84.38 -7.66 59.23 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.912 1.233 . . . . 0.0 111.633 171.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 65.65 5.13 3.14 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 128.243 2.617 . . . . 0.0 115.249 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 pp -97.37 147.1 24.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.153 1.381 . . . . 0.0 111.497 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -76.01 165.23 25.26 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -168.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -58.77 -39.77 81.97 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.196 -1.565 . . . . 0.0 112.51 -174.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -88.27 6.92 34.64 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.84 0.856 . . . . 0.0 112.784 176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -108.87 -5.59 16.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.321 1.448 . . . . 0.0 111.769 172.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.6 tp -89.06 112.61 23.61 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 166.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.59 93.17 8.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 118.701 -1.199 . . . . 0.0 109.193 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -87.69 146.69 5.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 125.609 1.563 . . . . 0.0 112.541 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 m -145.86 153.3 40.71 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.925 1.29 . . . . 0.0 110.425 -171.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -117.72 -165.69 1.12 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.368 1.467 . . . . 0.0 112.609 -163.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.4 t -41.34 -41.15 1.88 Allowed 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 118.081 2.622 . . . . 0.0 118.081 -147.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.7 -17.24 61.15 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 -160.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.42 -14.25 17.64 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.3 pt -102.85 -6.65 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 126.703 2.001 . . . . 0.0 113.583 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -41.53 8.14 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.055 1 C-N-CA 133.641 4.776 . . . . 0.0 121.397 -169.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -65.48 -21.39 66.63 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 122.468 2.395 . . . . 0.0 113.391 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -92.65 117.51 67.62 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 144.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -73.26 -8.31 21.77 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.052 2.501 . . . . 0.0 114.561 -171.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -108.69 -43.43 4.27 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 120.099 1.318 . . . . 0.0 112.007 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -165.51 126.69 1.93 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.539 1.535 . . . . 0.0 110.062 159.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 t -92.94 -162.03 0.9 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 147.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.96 -82.48 0.17 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -168.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 2.4 t -164.9 175.99 9.08 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 120.803 1.638 . . . . 0.0 113.562 -170.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -147.61 106.88 3.88 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.83 158.54 15.46 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.91 2.884 . . . . 0.0 112.059 -168.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 12.8 tmm? -125.57 137.2 53.9 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.895 1.225 . . . . 0.0 110.944 172.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.1 mt -129.86 128.99 43.38 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 129.204 3.002 . . . . 0.0 111.095 -157.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.7 t -128.95 162.7 26.96 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 128.021 2.528 . . . . 0.0 110.383 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.6 p -39.11 113.03 0.28 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.744 1.618 . . . . 0.0 113.515 -149.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.544 ' C ' HD13 ' A' ' 54' ' ' ILE . 1.4 p30 -106.81 159.05 16.53 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.939 172.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.544 HD13 ' C ' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -121.78 177.44 3.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 113.69 -1.596 . . . . 0.0 106.721 -173.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.471 ' H ' HG22 ' A' ' 54' ' ' ILE . 11.7 p -77.15 103.38 4.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.912 -155.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -137.72 158.22 72.08 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.433 1.093 . . . . 0.0 111.913 -166.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.46 ' HD3' HD13 ' A' ' 164' ' ' LEU . 58.7 Cg_endo -66.53 88.27 0.27 Allowed 'Trans proline' 0 C--N 1.357 0.999 1 C-N-CA 125.741 4.294 . . . . 0.0 112.187 -178.218 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.64 -40.83 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.451 0.7 . . . . 0.0 112.541 -172.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -12.52 60.39 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -55.39 -27.72 49.43 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.192 0.905 . . . . 0.0 112.687 167.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.3 mp -77.97 -44.32 27.12 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.885 0.874 . . . . 0.0 111.554 171.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mp -56.71 -43.57 80.71 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 118.138 0.426 . . . . 0.0 111.37 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.3 p -72.31 -30.74 65.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.801 0.84 . . . . 0.0 112.515 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -37.6 80.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.381 0.991 . . . . 0.0 112.865 171.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -50.63 16.2 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.105 0.866 . . . . 0.0 111.866 172.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -61.24 -33.62 73.81 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.775 -1.203 . . . . 0.0 113.325 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 69.5 m -79.17 -20.56 48.15 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 172.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -38.36 79.34 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.641 1.11 . . . . 0.0 113.269 -169.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.6 m -150.81 0.23 0.41 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.97 82.3 0.16 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.19 1.376 . . . . 0.0 110.952 -165.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -153.71 115.91 4.34 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 125.665 1.586 . . . . 0.0 107.841 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 79.4 m -91.89 113.12 25.3 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.942 1.297 . . . . 0.0 109.792 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.47 148.38 40.81 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.056 1.342 . . . . 0.0 113.285 -168.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 74.4 m -89.21 127.14 35.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.702 0.801 . . . . 0.0 109.535 165.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -91.91 103.48 16.01 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 164.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.6 t -105.46 141.62 20.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 C-N-CA 125.07 1.348 . . . . 0.0 109.204 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -124.93 123.28 39.56 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.245 -0.909 . . . . 0.0 110.08 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.1 112.86 25.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.054 1.741 . . . . 0.0 109.262 172.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -86.26 126.68 34.47 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.074 -1.016 . . . . 0.0 111.281 165.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.8 p -143.69 157.11 44.64 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.732 3.213 . . . . 0.0 103.369 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -7.07 -129.85 0.0 OUTLIER Glycine 0 N--CA 1.486 1.993 0 O-C-N 117.707 -3.121 . . . . 0.0 112.83 -116.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 82.4 m -97.58 107.5 20.02 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 113.666 -3.213 . . . . 0.0 108.601 149.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -169.66 125.14 0.83 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 130.754 3.622 . . . . 0.0 106.203 161.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.431 HG23 ' CZ ' ' A' ' 146' ' ' TYR . 2.6 t -78.03 135.45 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 117.978 -1.489 . . . . 0.0 110.938 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.8 m -110.22 146.19 36.02 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.21 0.604 . . . . 0.0 110.477 163.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.1 tp -110.73 108.79 18.78 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 126.208 1.803 . . . . 0.0 107.082 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.6 m -80.12 101.47 8.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 167.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 45.3 t -103.81 108.12 19.29 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 120.73 -1.231 . . . . 0.0 108.23 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.4 151.17 48.26 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -175.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.59 96.1 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 141.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.91 142.75 6.67 Favored Glycine 0 N--CA 1.471 1.015 0 N-CA-C 118.332 2.093 . . . . 0.0 118.332 -167.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -133.28 64.81 71.02 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.626 1.571 . . . . 0.0 112.267 175.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.58 158.12 32.24 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.369 2.713 . . . . 0.0 115.495 -172.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -50.52 -19.89 1.01 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.252 2.621 . . . . 0.0 115.752 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -69.83 -11.62 61.0 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.182 -1.574 . . . . 0.0 113.242 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.71 -4.7 16.76 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 164.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 1.67 32.76 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 120.051 1.296 . . . . 0.0 112.241 160.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -131.16 -34.2 1.45 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.533 1.933 . . . . 0.0 114.154 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 pp -100.49 160.0 14.7 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 120.196 1.362 . . . . 0.0 114.628 -172.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -108.69 -160.97 0.74 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 125.714 1.606 . . . . 0.0 113.069 -166.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.45 166.11 13.08 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.711 1.205 . . . . 0.0 111.833 162.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.1 p -125.13 130.97 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 170.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.514 ' HB2' HD13 ' A' ' 124' ' ' ILE . 10.8 t -147.58 112.1 5.3 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 127.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -176.91 175.29 1.62 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.507 1.923 . . . . 0.0 107.886 -170.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -115.82 121.06 41.27 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.384 1.873 . . . . 0.0 110.667 161.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -159.0 165.95 32.88 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -74.09 149.42 41.11 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.517 -0.74 . . . . 0.0 111.71 164.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.8 tp -135.87 143.09 44.86 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.596 1.958 . . . . 0.0 108.87 -171.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.8 p -117.44 173.21 6.83 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -166.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.9 t -67.11 -9.77 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 128.433 2.693 . . . . 0.0 115.422 -163.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -135.21 25.11 3.54 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.996 -1.065 . . . . 0.0 112.803 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -116.2 151.75 35.1 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.141 -0.974 . . . . 0.0 111.803 -163.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.61 166.15 31.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.077 -1.014 . . . . 0.0 112.549 -165.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.69 164.1 37.67 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.276 1.03 . . . . 0.0 113.46 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.402 ' CG1' HG23 ' A' ' 117' ' ' THR . 6.8 t -99.76 145.45 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 127.788 2.435 . . . . 0.0 109.275 163.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.6 128.7 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.565 0.698 . . . . 0.0 109.287 151.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.402 HG23 ' CG1' ' A' ' 115' ' ' VAL . 4.7 p -128.97 159.13 36.87 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.444 1.498 . . . . 0.0 111.001 174.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -59.44 -38.46 80.73 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.383 0.673 . . . . 0.0 111.672 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.18 -32.53 74.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.046 0.938 . . . . 0.0 112.58 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -71.47 -33.14 69.06 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 117.575 -1.202 . . . . 0.0 111.996 173.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 31.9 mm -66.7 -41.39 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 119.742 1.156 . . . . 0.0 110.786 170.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.54 -27.89 66.6 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 171.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -86.52 -21.84 26.72 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.97 1.708 . . . . 0.0 115.178 171.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.514 HD13 ' HB2' ' A' ' 103' ' ' CYS . 6.3 mt -77.2 -38.54 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.056 1.342 . . . . 0.0 111.007 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -145.06 172.31 5.52 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 125.715 1.606 . . . . 0.0 111.858 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -57.43 20.97 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.335 1 C-N-CA 126.262 4.641 . . . . 0.0 117.086 164.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 77.9 m -74.75 160.38 30.81 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.676 1.99 . . . . 0.0 112.097 176.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -125.02 -166.42 1.53 Allowed 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 128.002 2.521 . . . . 0.0 108.7 173.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.26 -24.69 67.75 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -173.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -85.86 15.24 48.92 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 118.155 -1.358 . . . . 0.0 115.98 -175.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.73 158.61 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.219 1.509 . . . . 0.0 113.801 -165.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.7 tt -116.43 126.71 53.8 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 122.352 1.072 . . . . 0.0 110.618 154.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 2.4 p -123.26 148.38 45.96 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 127.496 2.318 . . . . 0.0 109.711 -173.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -130.98 128.47 40.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -164.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 46.3 t -136.38 138.92 42.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.467 0.707 . . . . 0.0 110.728 -165.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.5 t -146.23 114.76 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.892 0.877 . . . . 0.0 110.98 -167.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 m -109.01 129.95 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -115.51 140.92 48.72 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.46 2.304 . . . . 0.0 107.261 168.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.451 ' HB2' ' CD2' ' A' ' 146' ' ' TYR 0.304 0.2 OUTLIER -149.69 152.84 36.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.504 0.722 . . . . 0.0 110.664 169.845 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.7 t -136.8 123.34 20.92 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.846 0.748 . . . . 0.0 109.16 171.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -76.0 -57.08 4.09 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.213 1.405 . . . . 0.0 110.67 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.6 t -61.09 -36.32 79.35 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.04 0.936 . . . . 0.0 112.591 169.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.66 14.16 48.7 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.361 -1.244 . . . . 0.0 114.896 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 28.0 ptm 42.63 49.46 4.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.268 2.227 . . . . 0.0 116.985 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.5 t -157.82 148.74 21.09 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.451 ' CD2' ' HB2' ' A' ' 139' ' ' LYS . 1.4 t80 -108.93 140.08 42.9 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.706 1.202 . . . . 0.0 111.267 163.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -140.79 121.32 14.16 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 122.17 0.986 . . . . 0.0 111.447 -173.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -133.5 134.58 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.097 -1.002 . . . . 0.0 110.828 -151.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -142.66 131.76 23.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.675 1.19 . . . . 0.0 111.064 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.8 p -145.19 139.37 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.545 -0.722 . . . . 0.0 110.588 161.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.9 m -136.04 151.43 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 127.772 2.429 . . . . 0.0 109.821 -165.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.12 128.85 23.12 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -166.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -148.12 133.25 18.3 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 170.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.54 -162.21 0.27 Allowed Glycine 0 CA--C 1.549 2.185 0 C-N-CA 127.558 2.504 . . . . 0.0 116.344 166.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.6 -20.77 12.92 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.892 3.728 . . . . 0.0 119.521 -160.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -75.58 -2.39 28.95 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 120.58 1.537 . . . . 0.0 114.03 173.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 45.7 p30 -58.82 13.03 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 129.304 3.042 . . . . 0.0 117.861 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -49.4 -40.02 34.67 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.389 1.876 . . . . 0.0 112.623 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.43 -51.44 65.72 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -74.2 -26.7 60.42 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.086 -1.009 . . . . 0.0 112.427 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -64.98 -48.56 73.56 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.709 0.804 . . . . 0.0 111.74 168.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -62.61 -38.11 88.91 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.332 -0.855 . . . . 0.0 112.087 174.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.55 -30.85 70.03 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.46 HD13 ' HD3' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -79.09 -51.72 9.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.724 1.21 . . . . 0.0 110.887 -179.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.5 pp -66.43 -27.55 67.91 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.316 -0.865 . . . . 0.0 110.972 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -77.21 -24.42 51.29 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 117.895 -1.05 . . . . 0.0 112.828 172.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.64 -30.86 64.67 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 167.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.1 mt -76.03 -36.8 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 120.708 -1.245 . . . . 0.0 110.977 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -64.83 -4.9 4.9 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 158.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -108.56 25.17 12.02 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 170.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.171 0 C-N-CA 128.539 2.736 . . . . 0.0 116.52 162.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.6 t0 . . . . . 0 CA--C 1.552 1.05 0 CA-C-O 121.147 0.499 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -57.86 -35.58 71.16 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 -143.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -102.92 -19.73 14.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.211 1.404 . . . . 0.0 112.349 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.27 -52.41 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.986 0.915 . . . . 0.0 112.388 -168.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.73 -49.92 73.33 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 119.179 0.9 . . . . 0.0 111.885 174.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.51 76.84 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.278 1.039 . . . . 0.0 112.156 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.76 -42.41 73.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.334 1.054 . . . . 0.0 113.303 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.4 tp -76.58 -31.44 57.5 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.271 1.029 . . . . 0.0 112.914 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.9 -40.41 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 121.487 -0.758 . . . . 0.0 109.344 168.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.1 m -59.58 -35.24 73.9 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 119.688 1.131 . . . . 0.0 112.495 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -72.0 -40.09 68.75 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.675 1.19 . . . . 0.0 111.452 177.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.7 m -64.87 -42.51 94.78 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.989 -1.069 . . . . 0.0 110.514 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -54.33 -37.21 64.61 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.977 1.711 . . . . 0.0 112.353 171.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -83.84 -49.28 9.2 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.519 1.528 . . . . 0.0 113.473 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.8 -42.49 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 118.989 0.813 . . . . 0.0 111.093 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.01 -2.52 58.38 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.471 0.708 . . . . 0.0 112.785 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . 0.273 32.8 ptt180 51.88 22.99 1.92 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.07 2.548 . . . . 0.0 116.179 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.411 HD11 HD23 ' A' ' 29' ' ' LEU . 3.6 pp -92.36 153.41 19.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.145 1.778 . . . . 0.0 112.139 175.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -80.41 160.12 25.45 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.006 0.922 . . . . 0.0 113.454 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -69.76 -24.37 63.52 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 119.903 -1.748 . . . . 0.0 115.586 -168.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -96.14 8.06 44.8 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.673 1.124 . . . . 0.0 112.517 167.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -110.62 -1.35 16.86 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.842 1.657 . . . . 0.0 111.013 172.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.411 HD23 HD11 ' A' ' 24' ' ' LEU . 2.0 tm? -94.8 117.67 30.52 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 127.839 2.456 . . . . 0.0 105.804 165.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -89.09 134.18 34.1 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.537 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.656 ' H ' HD12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -125.83 142.95 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 124.71 1.204 . . . . 0.0 112.21 173.025 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.4 p -154.3 145.12 22.52 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.974 1.31 . . . . 0.0 110.123 -166.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -166.94 59.89 0.09 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 122.935 1.35 . . . . 0.0 112.329 -170.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 76.1 p -89.89 -58.3 2.56 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.38 -0.825 . . . . 0.0 111.836 153.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.95 -55.95 4.09 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.959 0.885 . . . . 0.0 113.016 -151.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -61.25 -30.15 70.28 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.801 1.241 . . . . 0.0 112.344 172.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.661 ' HA ' ' H ' ' A' ' 44' ' ' SER . 1.5 mp -66.03 -29.87 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.922 0.889 . . . . 0.0 111.174 175.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.8 m -84.71 4.89 30.54 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.394 1.478 . . . . 0.0 114.612 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -84.47 -14.42 49.22 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.531 1.514 . . . . 0.0 112.346 170.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -120.66 161.96 37.02 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 127.045 2.138 . . . . 0.0 110.389 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -58.83 -38.26 89.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.52 2.147 . . . . 0.0 114.26 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -121.57 -35.78 3.17 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 116.852 2.168 . . . . 0.0 116.852 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -166.31 143.68 5.23 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 120.705 1.593 . . . . 0.0 109.387 -171.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.661 ' H ' ' HA ' ' A' ' 37' ' ' ILE . 96.8 p -106.57 -168.09 1.37 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 135.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -75.62 -75.45 0.18 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.768 1.622 . . . . 0.0 112.195 -166.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -178.13 -174.65 0.43 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.926 0.89 . . . . 0.0 109.541 -173.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 11.5 t0 -139.13 136.38 35.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.74 140.87 49.24 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.527 1.531 . . . . 0.0 112.154 -169.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.8 mtt -114.48 130.53 56.74 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 120.56 1.527 . . . . 0.0 111.857 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.0 mt -131.55 161.24 33.08 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 128.536 2.734 . . . . 0.0 112.936 -153.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.5 p -93.93 179.81 5.22 Favored 'General case' 0 N--CA 1.48 1.062 1 C-N-CA 132.876 4.47 . . . . 0.0 114.573 -153.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 t -120.34 109.01 14.85 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.52 -1.362 . . . . 0.0 108.082 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.468 ' HB3' ' H ' ' A' ' 54' ' ' ILE . 6.0 m-20 -161.01 -154.97 0.39 Allowed 'General case' 0 CA--C 1.561 1.367 0 O-C-N 120.88 -1.138 . . . . 0.0 112.898 -136.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.468 ' H ' ' HB3' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -145.35 178.85 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 1 C-N-CA 132.359 4.264 . . . . 0.0 109.09 -157.066 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.7 p -76.22 123.44 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.973 1.309 . . . . 0.0 112.294 -164.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -122.56 148.08 52.06 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.84 1.256 . . . . 0.0 112.315 -173.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.62 72.74 5.92 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 125.234 3.956 . . . . 0.0 111.986 -172.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.3 p -66.12 -24.09 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.075 0.95 . . . . 0.0 113.3 -169.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.61 -40.08 51.79 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.514 1.126 . . . . 0.0 113.765 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -60.82 -38.5 85.62 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.032 0.533 . . . . 0.0 111.784 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.7 -46.7 62.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.294 1.038 . . . . 0.0 111.037 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -58.35 -44.72 88.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.206 1.002 . . . . 0.0 111.673 173.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.5 m -73.59 -48.09 35.42 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.977 0.911 . . . . 0.0 112.307 -172.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -59.43 -45.2 92.23 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.215 174.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -58.64 -48.42 81.1 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.106 0.866 . . . . 0.0 112.497 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -58.98 -43.67 91.46 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 70.9 m -74.17 -23.46 59.24 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -74.14 -17.16 60.96 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -167.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.7 p -144.2 2.84 1.16 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 175.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.34 71.27 0.86 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 127.062 2.267 . . . . 0.0 110.342 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -165.5 128.85 2.2 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 127.882 2.473 . . . . 0.0 105.677 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.0 m -84.55 141.73 30.5 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 126.412 1.885 . . . . 0.0 110.496 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.93 151.04 31.58 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -170.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 24.9 p -101.06 133.86 44.94 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.819 0.848 . . . . 0.0 111.427 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -89.35 117.61 28.42 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 168.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 115' ' ' VAL . 42.1 t -121.86 113.85 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 123.464 0.706 . . . . 0.0 109.284 -169.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -89.86 125.12 35.21 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.518 -1.364 . . . . 0.0 107.581 -176.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.8 97.82 6.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 123.293 1.52 . . . . 0.0 107.55 168.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -73.7 116.77 14.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.545 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.0 p -147.41 158.27 43.91 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 128.521 2.728 . . . . 0.0 104.674 -161.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -11.42 -131.09 0.0 OUTLIER Glycine 0 N--CA 1.483 1.783 0 O-C-N 119.304 -2.122 . . . . 0.0 114.442 -127.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 30.3 p -94.03 101.01 13.03 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 115.058 -2.657 . . . . 0.0 108.308 161.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -172.67 165.87 5.43 Favored 'General case' 0 N--CA 1.469 0.516 1 C-N-CA 131.76 4.024 . . . . 0.0 106.835 158.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.4 t -87.98 124.77 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.02 -1.05 . . . . 0.0 110.218 159.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.78 141.55 37.84 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.991 0.814 . . . . 0.0 108.861 164.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 31.4 tp -119.72 106.1 11.81 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.416 1.086 . . . . 0.0 108.617 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.4 m -80.17 125.62 30.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.122 0.569 . . . . 0.0 110.916 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 10.8 m -111.38 107.04 16.15 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 120.893 -1.129 . . . . 0.0 109.751 -173.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -103.73 97.65 7.63 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.028 0.531 . . . . 0.0 112.32 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.3 mt -75.7 82.81 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 139.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -178.03 179.87 48.29 Favored Glycine 0 N--CA 1.468 0.791 0 N-CA-C 122.413 3.725 . . . . 0.0 122.413 -161.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -108.88 66.73 0.32 Allowed Pre-proline 0 CA--C 1.551 1.002 0 CA-C-N 112.886 -1.657 . . . . 0.0 113.346 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.67 134.78 45.69 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.192 2.594 . . . . 0.0 113.428 -176.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -76.33 -41.74 47.39 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.3 1.04 . . . . 0.0 111.77 171.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -69.84 -11.67 61.03 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -172.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.11 -18.29 5.36 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.478 1.911 . . . . 0.0 114.017 163.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -78.37 -2.22 37.19 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.879 1.272 . . . . 0.0 114.063 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -134.35 -35.7 0.91 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.12 0.873 . . . . 0.0 113.188 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 pp -77.0 166.26 23.56 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -164.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -92.13 -175.17 3.99 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.515 1.126 . . . . 0.0 112.808 -162.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -122.07 168.63 11.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.566 1.546 . . . . 0.0 109.541 159.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.5 p -122.69 124.9 71.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 167.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 47.3 t -125.14 114.39 18.96 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 122.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -178.23 168.16 1.93 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 123.126 1.441 . . . . 0.0 109.126 -165.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -141.99 109.16 5.52 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 127.045 2.138 . . . . 0.0 109.591 164.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -151.04 162.8 40.15 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -168.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -73.69 149.71 41.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.17 0.988 . . . . 0.0 111.946 164.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.4 tp -142.45 147.54 36.29 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 128.125 2.57 . . . . 0.0 109.696 -157.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.7 p -114.75 176.0 5.25 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.919 2.088 . . . . 0.0 114.013 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.83 -13.19 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 126.166 1.787 . . . . 0.0 114.548 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -115.02 33.07 5.63 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.672 -1.268 . . . . 0.0 112.46 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.07 153.13 19.82 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.733 -1.229 . . . . 0.0 114.114 -172.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -156.92 128.15 6.89 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.491 1.516 . . . . 0.0 108.854 -174.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.4 pp -158.18 152.26 24.1 Favored 'General case' 0 CA--C 1.554 1.096 0 O-C-N 121.062 -1.024 . . . . 0.0 113.194 -168.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 76' ' ' VAL . 29.8 t -99.91 146.46 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 126.585 1.954 . . . . 0.0 111.981 175.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.41 133.51 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.317 0.579 . . . . 0.0 110.841 145.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.2 t -154.42 153.83 32.23 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.027 1.331 . . . . 0.0 111.839 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -27.67 68.24 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.157 1.383 . . . . 0.0 114.34 -166.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.7 -30.72 46.21 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.524 -1.36 . . . . 0.0 113.307 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.29 -33.65 65.33 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.129 -0.982 . . . . 0.0 111.39 168.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.6 mm -60.95 -38.67 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 118.626 0.648 . . . . 0.0 111.004 166.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -65.79 -23.7 66.76 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 173.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -70.4 -29.69 66.39 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 120.243 -1.535 . . . . 0.0 112.269 167.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 27.4 mt -78.58 -38.31 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.715 0.806 . . . . 0.0 110.717 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.482 ' HE3' ' HA ' ' A' ' 153' ' ' PHE . 54.9 mmtt -136.08 109.78 9.88 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 126.549 1.94 . . . . 0.0 111.82 -174.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -62.33 -12.59 28.05 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 N-CA-C 120.083 3.07 . . . . 0.0 120.083 -166.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 9.5 m -133.95 130.96 38.45 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.824 1.647 . . . . 0.0 112.303 173.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -96.59 12.57 31.2 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 -167.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -77.71 14.16 1.12 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -171.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.49 41.16 0.08 OUTLIER Glycine 0 N--CA 1.47 0.951 0 O-C-N 120.918 -1.113 . . . . 0.0 112.856 -172.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.8 115.65 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.383 0.673 . . . . 0.0 111.65 -172.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.42 88.21 3.6 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 158.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 88.7 m -88.3 133.67 34.01 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 163.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -131.78 128.79 39.53 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.655 1.182 . . . . 0.0 108.431 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 51.7 t -136.6 136.04 38.88 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.938 -1.101 . . . . 0.0 111.786 -162.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -142.87 129.83 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.489 1.116 . . . . 0.0 109.855 -167.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.404 HG12 HD12 ' A' ' 148' ' ' ILE . 14.0 m -131.94 144.6 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 121.454 -0.778 . . . . 0.0 110.68 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -132.51 152.08 51.69 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 125.256 1.423 . . . . 0.0 108.384 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.29 0.9 OUTLIER -148.43 152.68 37.37 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.938 1.295 . . . . 0.0 108.507 167.126 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.0 t -128.33 139.77 52.23 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -93.43 -53.26 4.15 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.989 0.916 . . . . 0.0 109.614 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.3 m -50.3 -41.44 50.85 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.253 1.421 . . . . 0.0 113.18 172.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -100.5 13.32 59.75 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.589 1.566 . . . . 0.0 115.007 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 92.7 mtp 28.96 63.53 0.12 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 127.961 2.504 . . . . 0.0 114.754 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.8 t -159.68 139.76 11.77 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.292 -0.88 . . . . 0.0 110.279 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -130.92 156.92 44.26 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 122.129 -0.357 . . . . 0.0 110.262 -162.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -149.85 136.93 19.6 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.038 0.835 . . . . 0.0 113.139 -163.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.404 HD12 HG12 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -146.56 115.27 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.184 0.516 . . . . 0.0 110.519 -159.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -142.86 137.42 29.56 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.178 -0.951 . . . . 0.0 112.311 -169.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.1 p -150.43 140.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 120.912 -1.118 . . . . 0.0 110.563 162.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.7 m -118.84 149.29 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 128.281 2.633 . . . . 0.0 109.552 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -134.34 135.25 42.6 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.482 ' HA ' ' HE3' ' A' ' 125' ' ' LYS . 64.8 m-85 -135.81 158.54 44.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.901 2.081 . . . . 0.0 110.537 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -104.1 -143.3 12.34 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 164.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -45.41 -35.47 11.94 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.931 3.087 . . . . 0.0 114.653 169.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -62.68 -10.02 11.1 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -172.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -107.77 70.21 0.77 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 123.17 1.462 . . . . 0.0 111.195 167.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.1 -25.25 58.45 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.726 1.611 . . . . 0.0 112.096 165.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.44 -53.89 8.65 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -74.61 -20.44 59.91 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 120.598 1.545 . . . . 0.0 113.107 170.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.84 -57.45 12.6 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.488 1.495 . . . . 0.0 110.978 165.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -63.4 -29.64 70.91 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.981 -1.074 . . . . 0.0 112.995 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.16 -33.79 76.84 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.364 0.984 . . . . 0.0 113.088 172.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -75.13 -52.45 10.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.255 -0.903 . . . . 0.0 112.091 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 10.0 mp -50.93 -34.82 30.23 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.627 1.103 . . . . 0.0 113.963 170.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -60.41 -50.97 71.49 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.989 1.716 . . . . 0.0 110.689 171.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -72.88 -18.2 61.45 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.2 mm -83.29 -38.38 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 120.288 1.403 . . . . 0.0 110.707 171.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -62.21 -22.63 66.09 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.512 -1.367 . . . . 0.0 112.558 166.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -101.33 28.68 5.25 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.589 1.556 . . . . 0.0 114.362 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 C-N-CA 126.205 1.802 . . . . 0.0 115.831 170.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.541 0.598 0 CA-C-O 121.564 0.697 . . . . 0.0 111.309 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -59.99 -24.34 64.36 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 116.618 2.081 . . . . 0.0 116.618 -155.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -106.08 -27.05 11.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.127 0.971 . . . . 0.0 112.436 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.9 t -74.35 -61.0 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.754 1.221 . . . . 0.0 111.687 -172.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.8 -45.93 92.91 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.471 -0.627 . . . . 0.0 111.829 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.15 -53.04 30.37 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.936 0.894 . . . . 0.0 112.741 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -68.29 -41.08 81.48 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 mp -75.98 -40.08 54.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.987 1.267 . . . . 0.0 111.92 -172.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.56 -46.31 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.424 -0.797 . . . . 0.0 109.863 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.4 m -70.16 -41.29 74.0 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.536 -0.727 . . . . 0.0 111.666 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -69.35 -22.27 63.76 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.685 -1.26 . . . . 0.0 112.833 172.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.3 m -63.83 -48.15 77.93 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.772 1.624 . . . . 0.0 109.804 168.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -43.09 92.04 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.996 0.816 . . . . 0.0 112.105 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.8 ttt85 -71.22 -42.08 69.38 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.228 1.811 . . . . 0.0 113.54 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.7 -40.26 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 119.44 1.018 . . . . 0.0 110.036 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -79.46 -8.12 58.9 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 55.57 37.11 28.45 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.978 1.711 . . . . 0.0 114.247 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 pp -112.46 160.07 18.12 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.821 1.248 . . . . 0.0 110.878 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.9 156.08 39.61 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.239 0.542 . . . . 0.0 112.282 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -60.23 -26.97 66.83 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.308 -1.495 . . . . 0.0 112.033 170.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -91.88 12.48 21.45 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.314 1.845 . . . . 0.0 113.27 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -119.38 -10.41 9.7 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.511 1.124 . . . . 0.0 111.945 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.52 HD11 ' HB1' ' A' ' 48' ' ' ALA . 26.8 tp -88.54 111.32 21.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 171.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -85.46 124.78 32.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.258 175.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.0 mm -89.7 141.33 14.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 125.581 1.553 . . . . 0.0 109.875 172.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 54.6 m -118.68 141.77 48.3 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 164.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.71 -152.62 0.32 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.392 2.277 . . . . 0.0 112.513 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.0 t -51.41 -32.13 25.34 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -158.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.4 -42.3 61.33 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -167.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.99 -8.17 24.2 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.0 pt -110.3 -2.85 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 127.186 2.194 . . . . 0.0 115.051 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.3 m -42.08 11.17 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 130.256 3.422 . . . . 0.0 117.468 160.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -67.58 -48.9 65.56 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.106 -1.621 . . . . 0.0 109.282 171.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -69.91 160.15 81.35 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.949 162.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -52.73 -35.03 67.25 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.264 2.643 . . . . 0.0 114.817 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -118.71 -52.9 2.33 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.243 0.929 . . . . 0.0 112.852 161.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -145.51 123.85 12.31 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.312 1.968 . . . . 0.0 116.312 -163.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.4 m -73.89 -159.27 0.07 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.834 1.253 . . . . 0.0 109.83 144.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.4 tp -70.15 -76.43 0.1 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 121.272 1.851 . . . . 0.0 112.528 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 11.8 p -174.96 -161.69 0.1 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.974 0.91 . . . . 0.0 111.735 -167.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -127.25 158.31 37.51 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.635 1.574 . . . . 0.0 108.676 161.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -131.31 133.69 45.61 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.909 2.884 . . . . 0.0 108.93 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.1 ttp -124.89 132.61 53.28 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.161 -0.962 . . . . 0.0 111.32 -168.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.6 mt -137.22 163.86 29.9 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.37 1.868 . . . . 0.0 114.296 -139.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.2 t -92.76 179.51 5.46 Favored 'General case' 0 N--CA 1.475 0.811 1 C-N-CA 132.596 4.358 . . . . 0.0 114.303 -145.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.2 t -134.15 112.96 11.55 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 170.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.605 ' C ' HD13 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -164.54 -151.89 0.17 Allowed 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -141.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.605 HD13 ' C ' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -125.8 -176.03 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 131.391 3.876 . . . . 0.0 109.546 -165.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 54' ' ' ILE . 32.9 m -76.04 133.7 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.499 0.719 . . . . 0.0 111.563 -177.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -132.2 145.3 56.75 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.044 0.938 . . . . 0.0 113.255 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -76.45 71.42 5.91 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 125.175 3.917 . . . . 0.0 111.784 -173.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.8 p -58.88 -29.38 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.307 1.843 . . . . 0.0 113.221 -169.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -52.48 -37.42 57.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.073 1.749 . . . . 0.0 113.817 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -66.15 -35.2 79.86 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.241 -0.912 . . . . 0.0 110.697 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 37.4 tp -74.97 -42.49 57.51 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.623 0.769 . . . . 0.0 112.207 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 mp -57.62 -32.15 66.95 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.973 0.806 . . . . 0.0 112.122 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.7 m -73.77 -50.95 18.14 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.823 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -58.29 -34.97 71.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.258 0.935 . . . . 0.0 112.894 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 47.8 t-105 -66.64 -58.71 4.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.749 1.22 . . . . 0.0 112.825 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -75.85 -36.96 59.41 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -174.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.5 t -69.08 -13.81 62.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.012 0.925 . . . . 0.0 113.352 -175.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.4 tpt85 -68.45 -16.13 63.79 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 119.537 1.062 . . . . 0.0 113.151 -172.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.2 p -140.46 -28.79 0.71 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.401 1.48 . . . . 0.0 112.259 165.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.18 79.99 0.67 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 125.796 1.665 . . . . 0.0 108.983 -164.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -158.17 119.95 3.6 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 127.871 2.469 . . . . 0.0 107.168 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.0 m -64.89 116.29 6.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 122.111 0.958 . . . . 0.0 111.268 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.52 143.46 31.56 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.189 1.795 . . . . 0.0 111.857 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 79.3 m -96.25 128.86 43.54 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.748 -0.595 . . . . 0.0 111.791 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -80.31 129.31 34.42 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 149.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.8 t -123.81 114.37 41.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -174.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -87.43 110.97 20.66 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -173.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -112.56 102.17 10.27 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -74.33 125.92 29.54 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.394 -0.817 . . . . 0.0 109.92 170.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.3 p -145.48 160.19 41.97 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 128.285 2.634 . . . . 0.0 104.772 -165.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -11.09 -128.39 0.0 OUTLIER Glycine 0 N--CA 1.486 1.967 0 C-N-CA 126.809 2.147 . . . . 0.0 116.267 -146.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 53.5 t -92.95 98.08 11.13 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 116.27 -2.172 . . . . 0.0 108.588 162.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.68 154.91 2.58 Favored 'General case' 0 CA--C 1.538 0.519 1 C-N-CA 132.412 4.285 . . . . 0.0 106.628 159.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.07 148.85 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 119.714 -1.866 . . . . 0.0 109.429 149.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.2 p -139.61 163.62 32.09 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 119.597 -1.939 . . . . 0.0 110.764 162.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 pp -128.93 130.14 46.37 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.696 0.76 . . . . 0.0 110.467 164.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.3 m -83.78 133.6 34.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.99 1.316 . . . . 0.0 109.845 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 61.6 m -104.37 108.85 20.45 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 121.099 -1.001 . . . . 0.0 110.029 -172.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -111.05 94.71 5.13 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.5 mt -74.96 78.32 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 135.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.34 178.6 47.12 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 116.517 1.367 . . . . 0.0 116.517 -169.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -110.25 74.82 0.87 Allowed Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.919 1.288 . . . . 0.0 114.196 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -70.52 105.38 1.6 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.769 2.979 . . . . 0.0 112.27 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.85 -21.67 30.91 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -73.09 -20.23 61.0 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.862 1.665 . . . . 0.0 112.93 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.34 -21.18 22.78 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.14 2.176 . . . . 0.0 114.135 171.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.13 -38.82 54.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.14 0.976 . . . . 0.0 111.515 167.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -125.45 -17.15 5.66 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 118.119 2.637 . . . . 0.0 118.119 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.406 HD22 ' HB1' ' A' ' 113' ' ' ALA 0.26 3.9 pp -70.31 167.49 17.93 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 123.174 2.716 . . . . 0.0 112.83 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -89.5 -163.94 1.08 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.811 1.244 . . . . 0.0 113.659 -157.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.27 170.32 8.03 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 126.673 1.989 . . . . 0.0 112.787 163.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.426 HG21 HG23 ' A' ' 116' ' ' VAL . 19.2 m -73.47 151.13 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.423 -0.798 . . . . 0.0 112.721 155.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 27.2 p -152.4 -178.57 6.91 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 128.054 2.542 . . . . 0.0 108.796 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -56.84 -141.88 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.848 1 C-N-CA 133.302 4.641 . . . . 0.0 107.767 161.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -86.49 127.05 34.83 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 118.089 -1.444 . . . . 0.0 114.068 -149.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -154.08 145.33 22.93 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.759 1.224 . . . . 0.0 112.409 -172.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -105.46 131.56 52.72 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.327 1.451 . . . . 0.0 110.358 169.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.4 pp -141.83 150.32 41.48 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.119 1.368 . . . . 0.0 114.537 -167.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.1 m -96.2 174.19 7.02 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 -166.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.25 -10.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 128.772 2.829 . . . . 0.0 114.8 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -134.84 35.63 3.11 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.212 -0.93 . . . . 0.0 111.412 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -110.07 147.5 33.49 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -175.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.406 ' HB1' HD22 ' A' ' 99' ' ' LEU . . . -152.75 135.26 15.18 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.255 1.022 . . . . 0.0 108.406 -148.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.01 157.9 38.33 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.067 1.347 . . . . 0.0 112.287 -175.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.8 t -97.35 143.67 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.859 1.264 . . . . 0.0 110.491 169.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.426 HG23 HG21 ' A' ' 102' ' ' VAL . 9.9 p -124.76 106.07 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 122.991 1.377 . . . . 0.0 109.749 157.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.5 p -123.46 163.93 19.91 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.077 1.751 . . . . 0.0 108.773 165.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -59.57 -21.32 60.15 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.571 -0.705 . . . . 0.0 112.414 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.17 -32.85 65.09 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.66 1.184 . . . . 0.0 113.566 173.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -69.96 -29.36 66.46 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 120.496 -1.378 . . . . 0.0 111.636 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.3 mp -72.25 -40.8 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.096 0.958 . . . . 0.0 109.924 167.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -55.26 -27.36 45.92 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.694 0.798 . . . . 0.0 112.414 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -79.71 -20.19 47.1 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.368 -1.458 . . . . 0.0 114.918 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 88.7 mt -84.13 -41.63 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 120.001 1.273 . . . . 0.0 110.01 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -153.17 139.89 12.71 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 127.25 2.22 . . . . 0.0 109.444 165.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.12 119.75 7.22 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.409 2.073 . . . . 0.0 112.201 174.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 71.2 m -68.98 162.03 27.65 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.707 0.803 . . . . 0.0 112.421 -172.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.38 149.46 28.64 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.168 2.187 . . . . 0.0 106.509 169.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -50.62 114.51 1.16 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 169.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.91 11.11 13.01 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 117.937 -1.479 . . . . 0.0 116.357 -166.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.8 t -59.63 147.76 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 120.938 2.369 . . . . 0.0 111.045 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.25 86.49 2.37 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.566 1.546 . . . . 0.0 109.345 160.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.8 m -78.32 137.96 38.33 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 168.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -123.12 130.1 52.33 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -174.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 21.7 p -116.8 136.22 53.13 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.029 -0.419 . . . . 0.0 110.771 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.0 t -113.1 130.26 67.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 125.454 1.502 . . . . 0.0 106.972 165.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.8 m -119.98 145.2 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.633 0.73 . . . . 0.0 109.933 160.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 45.5 ttm180 -146.14 154.82 42.23 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.797 1.639 . . . . 0.0 108.092 -169.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.311 0.0 OUTLIER -144.51 148.19 34.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.108 -0.995 . . . . 0.0 110.042 164.234 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.1 t -153.97 -171.28 3.83 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.233 1.013 . . . . 0.0 112.2 -155.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.3 m120 48.73 80.53 0.06 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.07 2.548 . . . . 0.0 111.664 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 63.2 p 53.55 -1.2 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -165.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.15 34.68 8.6 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.653 1.12 . . . . 0.0 113.003 -165.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 36.5 tpp -124.36 5.15 8.4 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.109 1.764 . . . . 0.0 113.203 -175.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.2 t -143.68 155.37 44.2 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.295 1.438 . . . . 0.0 111.05 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -134.57 144.37 47.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.852 1.261 . . . . 0.0 109.085 -164.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -151.45 147.44 26.86 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.658 -1.276 . . . . 0.0 111.333 -151.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.5 tt -145.78 147.01 18.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -170.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -139.82 122.97 16.86 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.757 0.823 . . . . 0.0 109.599 163.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.99 127.23 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 122.816 1.293 . . . . 0.0 112.777 172.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.5 m -132.61 150.51 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.819 2.048 . . . . 0.0 110.394 -164.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -126.77 138.17 53.33 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -173.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -139.92 157.0 46.4 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.236 1.415 . . . . 0.0 110.196 167.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.23 -153.11 29.59 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 124.548 1.071 . . . . 0.0 113.451 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.32 -16.12 16.86 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 124.908 3.738 . . . . 0.0 115.07 177.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -71.79 -12.47 61.31 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.438 2.695 . . . . 0.0 115.965 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -81.87 41.31 0.65 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 122.861 1.315 . . . . 0.0 112.916 -174.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -64.12 -20.58 66.08 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.528 1.531 . . . . 0.0 113.78 -168.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.83 -52.58 12.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.52 1.054 . . . . 0.0 110.921 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -60.19 -41.98 94.09 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.176 0.99 . . . . 0.0 112.121 171.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -61.16 -52.96 62.66 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 122.564 0.345 . . . . 0.0 110.908 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -65.21 -34.51 78.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.452 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.72 -33.07 74.83 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 119.386 0.994 . . . . 0.0 113.135 175.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.54 -50.13 34.17 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.463 0.705 . . . . 0.0 112.36 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.7 mt -55.26 -37.86 67.81 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.643 0.656 . . . . 0.0 111.582 175.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -69.91 -29.69 66.94 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.392 1.877 . . . . 0.0 112.267 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -88.03 -52.26 5.35 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . 0.287 1.3 pp -104.87 -7.15 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 -165.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -116.82 8.5 13.64 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.88 1.218 . . . . 0.0 111.927 163.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -137.29 27.76 2.83 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.877 1.271 . . . . 0.0 113.825 172.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.261 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 168.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 t70 . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -56.43 -46.08 80.45 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -139.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -92.37 -28.05 17.15 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.152 0.981 . . . . 0.0 111.985 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.1 t -67.33 -55.04 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 124.47 1.108 . . . . 0.0 111.386 -169.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.66 -55.13 31.52 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 168.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.7 -41.65 70.53 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.735 1.268 . . . . 0.0 113.898 -174.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -73.16 -40.99 64.4 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.894 1.278 . . . . 0.0 112.425 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 mp -70.62 -37.63 73.85 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.099 -1.001 . . . . 0.0 112.523 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.62 -43.57 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.087 1.355 . . . . 0.0 109.491 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.2 p -66.19 -40.63 90.55 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.109 0.413 . . . . 0.0 111.643 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -63.6 -41.86 98.3 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 118.838 0.744 . . . . 0.0 112.263 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.3 m -60.44 -49.15 78.7 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.205 -0.935 . . . . 0.0 110.64 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.2 ptt85 -69.35 -32.9 72.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 118.241 -0.885 . . . . 0.0 113.251 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.1 ttt-85 -62.18 -48.4 80.24 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.29 1.436 . . . . 0.0 111.349 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.19 -33.03 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.978 0.911 . . . . 0.0 111.828 -174.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -90.51 -0.6 57.73 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 172.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 58.23 30.8 19.97 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.637 1.975 . . . . 0.0 114.874 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 pp -100.9 162.64 12.76 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.374 0.988 . . . . 0.0 112.311 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.75 155.37 33.25 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.12 0.968 . . . . 0.0 111.302 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.35 -21.24 66.67 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.073 -1.642 . . . . 0.0 113.542 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -96.2 10.5 37.6 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.294 1.438 . . . . 0.0 113.614 168.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -113.28 14.82 19.38 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.477 1.511 . . . . 0.0 110.215 168.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.9 tp -112.42 120.84 43.04 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 165.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -85.33 125.34 32.86 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 118.462 -1.295 . . . . 0.0 107.589 162.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 31' ' ' ILE 0.255 0.7 OUTLIER -117.08 144.24 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.602 1.961 . . . . 0.0 114.463 167.715 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -154.93 144.51 21.38 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.123 1.369 . . . . 0.0 109.346 -160.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -167.72 62.22 0.07 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.429 1.492 . . . . 0.0 112.298 -167.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.3 t -91.78 -58.35 2.44 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.742 -1.224 . . . . 0.0 112.888 154.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.24 -59.15 2.32 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.02 -152.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.542 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -54.42 -38.95 66.84 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.886 1.674 . . . . 0.0 112.979 177.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.544 ' HA ' ' H ' ' A' ' 44' ' ' SER . 1.4 mp -55.6 -25.98 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.156 1.382 . . . . 0.0 111.289 174.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 63.5 m -110.05 3.19 20.09 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.386 2.274 . . . . 0.0 115.38 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -94.49 20.39 8.46 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 120.378 1.444 . . . . 0.0 112.699 169.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -144.46 170.17 8.76 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 128.574 2.75 . . . . 0.0 107.412 173.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -58.74 -45.35 29.8 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.292 1.995 . . . . 0.0 114.861 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -119.44 -52.91 2.25 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 -171.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -170.31 133.47 1.09 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.201 2.2 . . . . 0.0 106.945 -166.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.544 ' H ' ' HA ' ' A' ' 37' ' ' ILE . 5.9 t -93.07 -156.69 0.49 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 117.695 -1.145 . . . . 0.0 108.146 173.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -88.84 -81.91 0.26 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 118.046 -1.462 . . . . 0.0 112.04 165.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 t 179.63 -176.41 0.3 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.235 1.016 . . . . 0.0 109.055 -170.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 17.6 t70 -136.68 115.88 12.54 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.52 132.81 48.32 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.725 1.61 . . . . 0.0 111.099 -158.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.1 ttm -128.73 123.47 33.1 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.705 -1.247 . . . . 0.0 112.785 -156.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.3 mt -120.77 141.73 50.23 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 127.129 2.172 . . . . 0.0 113.351 -144.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.6 p -96.96 160.0 14.59 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.559 1.544 . . . . 0.0 110.334 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 69.2 p -124.98 177.9 5.8 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -153.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.476 ' H ' ' HA ' ' A' ' 138' ' ' ARG . 10.7 t70 59.47 50.77 7.17 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.69 1.996 . . . . 0.0 110.394 -162.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.5 tp -142.75 145.32 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.647 1.579 . . . . 0.0 110.955 -167.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.8 p -109.18 140.56 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.964 1.306 . . . . 0.0 111.772 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -133.72 138.59 31.33 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 119.361 0.982 . . . . 0.0 111.896 170.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.99 71.4 2.15 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 125.142 3.895 . . . . 0.0 109.356 171.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 p -52.32 -38.55 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.326 1.45 . . . . 0.0 114.254 -157.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -70.19 -21.97 62.99 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.552 1.141 . . . . 0.0 112.472 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -66.29 -29.79 70.08 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.379 -0.826 . . . . 0.0 112.204 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 36.6 tp -76.52 -47.01 24.14 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.598 1.09 . . . . 0.0 110.572 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.2 mp -53.68 -49.4 68.08 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.022 0.529 . . . . 0.0 110.99 174.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.2 p -71.67 -29.37 64.52 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -65.76 -33.35 75.66 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.963 0.905 . . . . 0.0 112.086 174.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -75.7 -58.35 3.33 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 160.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.61 -34.46 77.05 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.251 -0.906 . . . . 0.0 112.365 -156.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 71.7 m -78.76 -11.51 59.99 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 ttt85 -69.49 -37.47 77.25 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.011 1.325 . . . . 0.0 114.019 -163.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.9 p -152.39 15.99 0.61 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.349 1.46 . . . . 0.0 112.46 171.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.31 81.8 0.14 Allowed Glycine 0 C--N 1.341 0.835 0 C-N-CA 125.705 1.622 . . . . 0.0 113.237 173.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -151.44 113.64 4.54 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.131 0.967 . . . . 0.0 111.809 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.0 m -66.19 133.59 50.97 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.152 1.381 . . . . 0.0 112.695 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -131.93 159.35 38.93 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.555 1.542 . . . . 0.0 114.439 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 81.8 m -96.76 108.03 20.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.069 2.547 . . . . 0.0 108.543 164.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -91.13 96.39 10.57 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.216 -0.927 . . . . 0.0 108.784 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.53 114.86 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.856 0.862 . . . . 0.0 110.852 -164.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -91.35 117.28 29.53 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 120.323 -1.486 . . . . 0.0 107.704 176.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.06 126.74 54.32 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.685 1.594 . . . . 0.0 111.094 174.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -95.4 128.61 42.4 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.527 1.131 . . . . 0.0 109.147 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.5 p -144.56 165.31 28.37 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 130.512 3.525 . . . . 0.0 105.711 -165.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.35 -121.54 0.0 OUTLIER Glycine 0 N--CA 1.491 2.314 0 C-N-CA 129.868 3.604 . . . . 0.0 115.935 -174.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.9 p -93.51 104.81 16.91 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 114.649 -2.82 . . . . 0.0 109.854 150.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.8 mtt85 -178.54 145.39 0.32 Allowed 'General case' 0 CA--C 1.555 1.138 1 C-N-CA 134.376 5.07 . . . . 0.0 106.753 131.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.14 135.52 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 121.839 2.109 . . . . 0.0 109.731 149.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.5 t -107.05 147.12 30.35 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.427 -1.421 . . . . 0.0 110.77 170.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 18.2 tp -110.98 106.32 15.37 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 159.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.5 m -78.64 111.33 14.61 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.126 164.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.7 t -103.88 110.75 23.0 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 119.613 -1.929 . . . . 0.0 110.733 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -111.13 113.35 25.8 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -173.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.9 mp -77.33 88.73 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 133.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.3 172.38 42.64 Favored Glycine 0 N--CA 1.475 1.299 0 N-CA-C 121.219 3.248 . . . . 0.0 121.219 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -110.91 49.61 0.27 Allowed Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 127.181 2.193 . . . . 0.0 116.457 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -63.25 166.94 13.65 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 CA-C-N 122.607 1.967 . . . . 0.0 115.514 173.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -77.52 -28.43 52.02 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -84.02 -16.73 42.85 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -172.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -50.74 -28.07 8.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 128.02 2.528 . . . . 0.0 112.908 172.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -61.88 -39.62 92.59 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.788 -0.625 . . . . 0.0 112.302 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -112.19 -17.3 12.82 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -173.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 pp -80.62 157.97 25.82 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 120.675 1.58 . . . . 0.0 111.894 168.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -168.45 138.17 2.42 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -172.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.669 ' CD ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -112.18 -179.14 3.6 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.851 1.66 . . . . 0.0 112.502 177.042 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.669 ' H ' ' CD ' ' A' ' 101' ' ' ARG . 3.1 p -162.6 173.91 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 125.764 1.626 . . . . 0.0 112.732 -142.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.483 ' HA ' HG13 ' A' ' 150' ' ' VAL . 46.3 t -121.56 122.21 39.18 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.716 0.806 . . . . 0.0 108.949 144.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -175.14 170.2 3.19 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.646 1.578 . . . . 0.0 108.823 -172.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -109.78 104.11 13.02 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.597 2.359 . . . . 0.0 110.436 165.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -129.93 165.93 21.08 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -171.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -137.22 137.01 38.64 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.632 1.173 . . . . 0.0 113.31 167.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.6 tt -149.82 144.04 25.74 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.277 1.031 . . . . 0.0 112.192 -135.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 m -71.5 156.0 39.94 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -6.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 129.364 3.065 . . . . 0.0 114.066 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -138.1 60.1 1.63 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.624 2.37 . . . . 0.0 108.587 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -142.36 150.42 40.71 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 121.014 -1.054 . . . . 0.0 113.091 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.722 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -150.9 155.27 38.81 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.08 -1.637 . . . . 0.0 112.976 -155.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.722 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -150.68 145.76 26.04 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.166 1.386 . . . . 0.0 111.038 -165.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.99 134.9 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 120.987 1.722 . . . . 0.0 112.885 162.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.83 157.68 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.47 1.108 . . . . 0.0 109.811 171.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.9 t -157.82 161.97 38.4 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.608 1.963 . . . . 0.0 108.288 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.43 -25.38 24.58 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.37 -37.33 28.41 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 120.302 1.41 . . . . 0.0 113.552 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.41 -31.62 63.97 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.67 -1.269 . . . . 0.0 111.319 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.1 tp -70.97 -32.92 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 121.645 -0.66 . . . . 0.0 111.764 167.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -65.51 -12.99 57.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.274 1.03 . . . . 0.0 112.882 171.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.33 -30.38 68.41 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.421 -1.425 . . . . 0.0 113.656 163.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 14.3 mt -87.2 -40.73 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.711 1.204 . . . . 0.0 111.223 -169.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -155.49 155.44 29.75 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 128.382 2.673 . . . . 0.0 107.597 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -53.8 130.22 38.0 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 121.915 1.744 . . . . 0.0 112.32 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 25.7 t -99.54 153.16 19.26 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.9 1.68 . . . . 0.0 111.046 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -156.8 162.71 39.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.502 1.521 . . . . 0.0 109.476 -170.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -58.44 126.9 29.51 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 127.055 2.142 . . . . 0.0 109.999 170.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.77 15.22 65.98 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-O 118.419 -1.212 . . . . 0.0 115.032 -173.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.77 138.94 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.253 1.526 . . . . 0.0 110.34 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 tp -132.7 82.48 2.01 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 123.781 1.753 . . . . 0.0 109.458 173.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 16.8 m -77.31 142.44 39.41 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 155.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -131.63 133.44 44.95 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 121.408 -0.808 . . . . 0.0 109.506 -167.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 46.1 t -127.04 130.54 50.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.215 0.461 . . . . 0.0 110.602 -166.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.78 113.4 40.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.584 1.554 . . . . 0.0 107.735 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.1 m -111.12 135.59 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 122.189 0.995 . . . . 0.0 111.152 173.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.476 ' HA ' ' H ' ' A' ' 53' ' ' ASP . 54.6 ttt85 -131.12 160.45 34.68 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.23 2.612 . . . . 0.0 106.901 170.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.274 0.0 OUTLIER -143.6 147.67 34.73 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.364 -0.835 . . . . 0.0 109.29 167.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.5 m -97.99 137.34 36.94 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.62 0.645 . . . . 0.0 109.548 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -61.09 168.54 2.44 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -169.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.7 m 53.08 28.26 6.64 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.613 1.165 . . . . 0.0 114.062 -170.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 69.48 25.37 75.56 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.416 1.008 . . . . 0.0 114.706 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 86.1 mtp -83.2 -22.1 33.27 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -166.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 t -165.99 156.32 12.74 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 174.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -104.66 137.27 42.74 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.075 0.95 . . . . 0.0 111.14 149.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -126.07 108.29 11.22 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -175.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.3 tp -140.64 103.14 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 122.659 1.219 . . . . 0.0 108.895 -142.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -136.48 141.54 43.51 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.67 -158.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.483 HG13 ' HA ' ' A' ' 103' ' ' CYS . 2.5 p -154.15 146.02 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.717 0.807 . . . . 0.0 111.083 177.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.2 m -132.14 134.39 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 127.189 2.196 . . . . 0.0 110.464 -174.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.85 116.18 31.56 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -168.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -137.61 158.15 44.99 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.876 0.845 . . . . 0.0 112.201 172.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -86.32 -160.6 34.43 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 125.568 1.556 . . . . 0.0 113.31 172.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.23 -16.27 27.27 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.67 2.913 . . . . 0.0 115.787 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -90.19 16.97 7.6 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.905 1.682 . . . . 0.0 114.273 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -70.43 56.24 0.16 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.565 1.546 . . . . 0.0 111.309 165.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.81 -26.15 65.54 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.304 1.042 . . . . 0.0 112.347 -173.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.51 -53.69 13.04 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -76.64 -26.34 54.77 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.662 0.665 . . . . 0.0 112.518 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -63.24 -56.25 18.16 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.268 0.94 . . . . 0.0 109.871 172.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -55.83 -33.48 64.51 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.115 -0.991 . . . . 0.0 112.949 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.86 -34.11 76.04 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.78 -48.13 64.46 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 120.687 -1.258 . . . . 0.0 112.537 171.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -59.49 -25.96 64.87 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 121.423 1.919 . . . . 0.0 114.484 172.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.0 ttp85 -68.49 -39.62 81.26 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.715 1.206 . . . . 0.0 111.975 169.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -72.21 -29.98 64.48 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.402 1.081 . . . . 0.0 113.486 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.69 -47.34 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.156 1.382 . . . . 0.0 109.589 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -62.6 -3.46 1.49 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 166.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -124.72 26.91 7.01 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 . . . . . 0 C--O 1.254 1.317 0 O-C-N 121.112 -0.993 . . . . 0.0 111.561 168.229 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.3 t70 . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 120.546 0.212 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -52.95 -28.27 22.85 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -78.71 -25.53 44.67 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.497 -0.752 . . . . 0.0 111.564 -174.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.4 t -70.5 -46.25 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.613 1.165 . . . . 0.0 110.243 173.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.32 -52.58 52.37 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 169.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.6 -28.71 70.08 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.37 -1.076 . . . . 0.0 113.428 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -75.08 -43.71 51.61 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.232 1.378 . . . . 0.0 114.097 169.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.95 -40.14 83.28 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.321 0.964 . . . . 0.0 111.378 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -66.63 -41.9 88.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 O-C-N 121.256 -0.902 . . . . 0.0 110.238 172.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.3 t -57.7 -47.43 82.4 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.248 0.931 . . . . 0.0 112.506 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -72.38 -29.06 63.42 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.602 -0.686 . . . . 0.0 111.666 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.9 m -63.42 -47.66 81.02 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.701 1.137 . . . . 0.0 110.456 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -51.55 -50.54 59.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.61 1.164 . . . . 0.0 111.283 171.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -77.05 -38.71 52.14 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -168.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -78.97 -42.87 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.191 0.905 . . . . 0.0 110.755 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.04 -8.2 59.72 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 118.815 0.734 . . . . 0.0 112.695 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.4 mmt85 56.57 41.21 28.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.432 1.893 . . . . 0.0 113.034 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 pp -114.59 150.44 35.03 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.454 1.502 . . . . 0.0 110.255 168.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -66.85 153.3 43.78 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.807 -0.558 . . . . 0.0 111.151 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.53 -19.04 63.71 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.518 -1.364 . . . . 0.0 113.2 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -92.17 7.43 42.59 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.305 1.442 . . . . 0.0 113.258 166.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -119.33 10.55 11.98 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.948 1.699 . . . . 0.0 111.7 168.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.8 tp -99.63 130.58 45.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.225 2.21 . . . . 0.0 105.311 161.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -95.48 112.59 24.28 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.168 170.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.409 ' H ' HD12 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -108.16 143.74 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 126.073 1.749 . . . . 0.0 112.411 173.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 m -155.55 131.0 9.65 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -139.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -171.27 57.73 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.774 0.797 . . . . 0.0 111.695 -161.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.5 p -87.55 -54.97 4.0 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.937 -1.102 . . . . 0.0 110.249 153.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.17 -45.37 16.47 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -158.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.485 ' H ' ' CD1' ' A' ' 36' ' ' LEU . 3.0 mp -60.02 -41.64 92.63 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.379 1.072 . . . . 0.0 109.557 176.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mp -75.92 -20.99 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 127.626 2.37 . . . . 0.0 111.107 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 15.4 t -74.09 -39.44 63.41 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.561 -1.337 . . . . 0.0 111.82 172.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.9 mmpt? -72.0 -46.27 57.85 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.96 0.8 . . . . 0.0 110.663 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -148.77 95.53 3.93 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 124.709 1.203 . . . . 0.0 109.59 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -66.33 -56.85 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 121.885 1.724 . . . . 0.0 112.596 -173.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -92.77 29.24 1.83 Allowed 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.516 1.126 . . . . 0.0 110.548 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -160.42 99.53 1.31 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 155.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.5 p -178.66 -178.55 0.58 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.778 1.631 . . . . 0.0 110.0 -173.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.5 tp -127.35 -87.03 0.58 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 168.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 p -178.67 176.04 1.02 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.815 1.293 . . . . 0.0 112.451 -159.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -148.91 120.16 7.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.334 1.454 . . . . 0.0 107.989 -177.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.5 144.05 45.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.199 2.2 . . . . 0.0 110.05 -157.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.5 mtt -132.83 131.68 41.3 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.369 1.44 . . . . 0.0 112.532 -162.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.3 mt -128.96 145.42 51.24 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 127.706 3.128 . . . . 0.0 112.15 -144.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.2 p -123.09 163.24 20.9 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 128.062 2.545 . . . . 0.0 111.558 -170.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.6 p -51.98 127.99 22.95 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.59 1.556 . . . . 0.0 113.489 -164.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.37 151.88 32.58 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 118.081 2.623 . . . . 0.0 118.081 -135.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.83 118.37 54.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 165.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.419 HG12 HG22 ' A' ' 136' ' ' VAL . 3.1 m -79.04 130.49 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.858 -154.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -136.29 148.81 65.79 Favored Pre-proline 0 C--O 1.236 0.367 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -166.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.55 76.67 2.3 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.061 3.174 . . . . 0.0 110.807 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.36 -45.44 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 126.526 1.93 . . . . 0.0 113.261 -167.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -78.26 -13.29 59.91 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -70.91 -35.98 72.52 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.409 -1.432 . . . . 0.0 110.146 162.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.0 tp -61.7 -43.95 97.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.745 0.818 . . . . 0.0 111.099 170.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp -56.29 -43.2 78.63 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.326 0.966 . . . . 0.0 112.6 170.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.1 t -61.83 -45.38 94.05 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.401 0.546 . . . . 0.0 111.575 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -66.5 -38.75 87.94 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.19 0.596 . . . . 0.0 112.511 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -57.49 12.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.406 1.483 . . . . 0.0 110.733 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.9 -35.81 81.3 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.198 0.599 . . . . 0.0 111.687 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.2 t -76.1 -23.45 54.93 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.54 -28.64 60.56 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 120.847 1.658 . . . . 0.0 115.163 -165.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.8 p -139.01 14.48 2.65 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.838 1.255 . . . . 0.0 113.415 157.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.47 79.73 0.2 Allowed Glycine 0 N--CA 1.472 1.051 0 C-N-CA 126.454 1.978 . . . . 0.0 113.305 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 74.5 mtt85 -157.58 115.91 3.16 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.033 1.733 . . . . 0.0 110.877 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.67 145.16 29.78 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -152.39 159.15 43.45 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.786 1.634 . . . . 0.0 113.373 -165.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.6 m -76.39 113.81 14.39 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.756 1.222 . . . . 0.0 109.725 162.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -96.2 98.38 10.27 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 122.559 1.171 . . . . 0.0 108.352 173.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.6 t -101.45 150.63 5.86 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 C-N-CA 127.206 2.202 . . . . 0.0 109.419 -164.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -121.76 129.71 52.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.073 -1.017 . . . . 0.0 108.837 164.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -123.04 116.32 23.31 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.805 1.642 . . . . 0.0 110.086 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -95.09 115.94 28.07 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.398 1.479 . . . . 0.0 109.13 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.6 t -147.79 159.7 43.54 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 -170.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -6.75 -126.2 0.0 OUTLIER Glycine 0 N--CA 1.48 1.574 0 O-C-N 119.021 -2.3 . . . . 0.0 112.959 -133.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.465 ' HB3' ' HE3' ' A' ' 139' ' ' LYS . 57.3 m -94.45 111.32 23.06 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 113.642 -3.223 . . . . 0.0 110.17 149.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -169.58 146.22 3.3 Favored 'General case' 0 N--CA 1.475 0.824 1 C-N-CA 132.111 4.164 . . . . 0.0 107.581 133.228 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.9 t -72.23 139.5 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.068 -1.645 . . . . 0.0 110.294 165.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.58 148.5 29.2 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.616 0.766 . . . . 0.0 111.636 165.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.3 tp -108.84 110.37 21.7 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 157.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.4 m -97.83 114.26 26.27 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.868 1.667 . . . . 0.0 108.723 -174.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 99.0 m -103.93 108.36 19.66 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.063 -1.648 . . . . 0.0 109.449 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -103.49 94.2 5.35 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.643 0.735 . . . . 0.0 111.74 -172.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.2 mp -72.99 94.67 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 126.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.36 149.73 10.02 Favored Glycine 0 N--CA 1.468 0.79 0 N-CA-C 119.113 2.405 . . . . 0.0 119.113 -169.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -114.46 58.05 0.93 Allowed Pre-proline 0 CA--C 1.556 1.178 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 170.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -67.77 174.09 8.14 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.993 2.462 . . . . 0.0 114.281 166.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -82.66 -39.08 22.56 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -75.31 -13.05 60.39 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -158.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.416 HD22 ' H ' ' A' ' 96' ' ' LEU . 3.3 mm? -51.57 -30.56 21.33 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 128.046 2.539 . . . . 0.0 112.994 170.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -52.95 -42.07 65.12 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.705 0.802 . . . . 0.0 111.206 170.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -100.77 -34.39 9.86 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -171.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.2 pp -85.61 155.99 20.91 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -167.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -151.47 122.74 7.76 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -159.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.469 ' HB3' HG23 ' A' ' 116' ' ' VAL . 0.8 OUTLIER -106.38 179.5 4.25 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 126.992 2.117 . . . . 0.0 110.104 171.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 p -165.07 173.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -149.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.465 ' HA ' HG13 ' A' ' 150' ' ' VAL . 97.7 m -128.32 120.63 27.44 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.723 1.147 . . . . 0.0 111.258 137.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -176.49 179.52 1.16 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 129.507 3.123 . . . . 0.0 105.237 -172.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -111.42 127.58 55.72 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.456 1.502 . . . . 0.0 110.875 162.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -148.45 159.36 44.12 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.455 1.102 . . . . 0.0 113.658 -161.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -109.13 151.47 26.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.447 2.299 . . . . 0.0 111.162 174.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 mt -142.48 146.8 35.13 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.836 1.255 . . . . 0.0 111.925 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.9 m -106.69 178.49 4.55 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.747 1.219 . . . . 0.0 114.001 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.82 -5.13 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 128.809 2.844 . . . . 0.0 116.113 -161.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -138.3 47.9 1.97 Allowed 'General case' 0 CA--C 1.551 1.015 0 O-C-N 120.608 -1.308 . . . . 0.0 112.794 168.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -111.18 146.76 36.32 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.911 1.284 . . . . 0.0 112.064 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.689 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -150.02 147.06 27.38 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 119.687 -1.883 . . . . 0.0 111.296 -154.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.689 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -142.17 147.5 36.72 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.999 1.32 . . . . 0.0 112.73 -169.252 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.47 141.75 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-N 121.396 1.907 . . . . 0.0 114.065 162.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 101' ' ' ARG . 1.0 OUTLIER -133.91 148.86 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.179 1.392 . . . . 0.0 109.831 173.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.9 t -140.42 159.83 41.33 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.738 2.015 . . . . 0.0 106.542 161.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -49.74 -30.66 9.82 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -171.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.36 -33.35 75.04 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 121.145 1.793 . . . . 0.0 113.734 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.49 -26.36 63.58 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.225 -0.922 . . . . 0.0 112.027 172.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 37.0 mm -77.95 -30.18 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.755 0.822 . . . . 0.0 111.48 167.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.96 -13.98 62.6 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.252 -0.905 . . . . 0.0 113.196 170.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -70.0 -36.25 74.99 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 120.107 -1.621 . . . . 0.0 113.3 158.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.83 -37.67 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.852 1.261 . . . . 0.0 110.593 -176.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.5 135.37 15.82 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 125.112 1.365 . . . . 0.0 111.323 169.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.54 -24.73 63.02 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.893 3.062 . . . . 0.0 116.39 -157.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.7 t -147.65 130.1 15.79 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.393 1.077 . . . . 0.0 110.436 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -168.5 158.5 9.58 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.951 2.1 . . . . 0.0 108.206 169.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -136.07 -31.95 0.89 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.903 1.681 . . . . 0.0 113.64 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -101.76 21.73 41.16 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.949 1.738 . . . . 0.0 114.982 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.87 146.25 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.017 1.408 . . . . 0.0 113.527 -159.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.7 mp -113.63 81.58 1.54 Allowed 'General case' 0 C--O 1.24 0.554 0 CA-C-O 123.431 1.586 . . . . 0.0 108.531 169.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.0 m -75.44 146.27 40.83 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 162.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -124.07 132.56 53.68 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 44.5 t -124.34 133.64 53.39 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.005 0.82 . . . . 0.0 111.168 -169.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.419 HG22 HG12 ' A' ' 55' ' ' VAL . 10.1 t -144.79 108.89 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.398 0.679 . . . . 0.0 111.027 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.1 m -99.59 141.4 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.996 1.319 . . . . 0.0 113.33 173.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -122.98 162.0 23.16 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.63 1.172 . . . . 0.0 109.456 155.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.465 ' HE3' ' HB3' ' A' ' 82' ' ' CYS 0.273 0.1 OUTLIER -147.61 154.49 40.73 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.006 1.722 . . . . 0.0 108.019 169.589 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.8 t -132.88 121.03 22.29 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -73.14 -43.52 61.45 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 118.068 0.394 . . . . 0.0 110.337 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.9 m -45.76 -46.19 15.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.782 1.633 . . . . 0.0 112.762 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -91.18 5.44 81.32 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.449 1.499 . . . . 0.0 115.692 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 43.9 tpp 41.89 50.11 4.09 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.201 1.8 . . . . 0.0 113.63 -173.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.3 t -138.69 140.18 38.69 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.309 -0.869 . . . . 0.0 111.652 -162.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -109.08 139.49 43.89 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.265 1.026 . . . . 0.0 109.603 162.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -143.15 106.44 4.57 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.9 pt -136.32 152.22 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.577 0.751 . . . . 0.0 112.936 -160.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -136.77 149.15 47.64 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.311 0.577 . . . . 0.0 112.245 165.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 103' ' ' CYS . 7.2 p -141.18 132.9 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.137 0.975 . . . . 0.0 109.169 169.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.9 m -138.17 122.98 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.33 1.052 . . . . 0.0 111.668 -156.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -103.95 122.78 45.91 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -164.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -141.24 148.19 39.48 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.256 1.423 . . . . 0.0 110.186 165.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -74.61 -162.43 9.17 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.322 1.439 . . . . 0.0 115.164 169.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -56.15 -13.49 9.64 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 124.401 3.401 . . . . 0.0 117.04 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -63.33 -4.87 2.89 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.746 1.618 . . . . 0.0 113.882 166.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -73.55 43.59 0.15 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 126.075 1.75 . . . . 0.0 112.86 172.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -50.32 -30.44 12.07 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.617 2.767 . . . . 0.0 113.673 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.75 -42.89 57.38 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.377 1.471 . . . . 0.0 114.415 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -71.21 -32.44 68.81 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.404 -1.435 . . . . 0.0 111.629 170.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -58.16 -54.0 51.96 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.478 1.035 . . . . 0.0 111.364 169.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -54.63 -49.31 70.82 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.493 0.588 . . . . 0.0 111.527 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -57.24 -44.45 83.82 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.032 0.833 . . . . 0.0 112.837 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.01 -60.95 2.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.1 mp -53.15 -35.86 60.2 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.269 1.427 . . . . 0.0 112.924 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -68.07 -35.74 78.7 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.148 1.379 . . . . 0.0 111.852 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.65 -26.1 24.52 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.8 pt -104.74 -44.85 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -171.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -90.2 -32.62 16.52 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.247 1.385 . . . . 0.0 109.93 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -97.45 24.11 6.93 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.084 0.954 . . . . 0.0 112.982 171.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.492 -1.242 . . . . 0.0 112.637 163.009 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 CA--C 1.543 0.692 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -65.09 -4.23 4.59 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -155.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -93.7 -22.33 18.8 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.482 1.113 . . . . 0.0 113.511 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.73 -42.82 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.664 1.186 . . . . 0.0 113.539 -168.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.88 -47.33 89.75 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 168.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.77 -37.29 70.89 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.966 1.383 . . . . 0.0 112.493 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.43 -35.19 63.38 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.591 1.556 . . . . 0.0 114.129 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.4 tp -75.39 -37.07 60.75 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.136 1.374 . . . . 0.0 112.22 176.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -67.76 -44.32 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.604 1.562 . . . . 0.0 109.368 170.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.5 t -53.87 -44.85 70.74 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.234 1.014 . . . . 0.0 111.742 168.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -60.41 -37.05 79.6 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.495 -0.753 . . . . 0.0 111.451 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.5 m -67.01 -49.04 66.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.834 0.854 . . . . 0.0 111.501 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -64.79 -38.75 92.04 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 119.926 1.239 . . . . 0.0 112.77 173.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -78.79 -35.59 44.09 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -172.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.91 -23.7 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.965 1.257 . . . . 0.0 111.509 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.0 mp -86.75 -11.96 49.54 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 167.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 53.55 43.29 31.43 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.835 1.654 . . . . 0.0 112.08 -177.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 pp -107.18 162.63 13.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.545 0.738 . . . . 0.0 110.555 171.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.36 148.81 43.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.758 0.423 . . . . 0.0 111.777 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -25.41 67.94 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.447 -1.408 . . . . 0.0 112.881 173.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -79.11 2.38 20.97 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.945 1.698 . . . . 0.0 113.696 168.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -130.18 -5.93 4.36 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.522 1.529 . . . . 0.0 110.772 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.499 HD11 ' HB1' ' A' ' 48' ' ' ALA . 26.0 tp -87.78 138.49 31.42 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.306 1.842 . . . . 0.0 106.774 154.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.73 138.9 51.72 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 164.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.0 mm -98.79 141.11 16.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 O-C-N 125.8 1.938 . . . . 0.0 111.796 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.61 149.22 37.01 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.691 0.397 . . . . 0.0 110.808 174.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -158.26 56.29 0.46 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 166.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.7 p -87.43 -56.78 3.21 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.024 -1.672 . . . . 0.0 112.294 162.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.64 -55.99 3.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.808 0.813 . . . . 0.0 113.041 -158.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -64.39 -42.11 96.31 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.951 1.701 . . . . 0.0 112.482 -175.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.87 -27.17 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.393 1.077 . . . . 0.0 110.278 174.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.8 m -92.81 4.14 54.38 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.246 1.418 . . . . 0.0 114.272 174.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.24 -41.75 9.3 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.23 1.377 . . . . 0.0 110.737 172.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -100.38 77.64 0.17 Allowed Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 162.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -72.63 -0.09 8.34 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 N-CA-C 118.833 2.59 . . . . 0.0 118.833 -121.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -119.82 3.97 11.04 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 126.072 1.749 . . . . 0.0 113.234 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -133.02 170.6 15.14 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.735 1.607 . . . . 0.0 113.636 -148.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.5 m -67.58 158.71 31.41 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.162 1.385 . . . . 0.0 113.991 -169.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.78 -77.88 0.57 Allowed 'General case' 0 CA--C 1.541 0.629 0 O-C-N 117.738 -3.101 . . . . 0.0 115.722 14.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.48 -171.84 0.85 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.944 1.247 . . . . 0.0 112.736 -172.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -132.29 149.96 52.26 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.499 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -130.81 141.73 50.36 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 129.784 3.234 . . . . 0.0 108.326 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.3 ttp -124.89 128.25 48.35 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.888 -1.132 . . . . 0.0 108.331 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.5 mt -133.79 147.63 51.28 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.468 1.907 . . . . 0.0 114.73 -147.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.5 t -124.22 169.13 12.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.833 2.853 . . . . 0.0 112.999 -169.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.9 p -96.77 176.25 6.06 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.323 2.649 . . . . 0.0 115.419 -159.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 66.66 21.98 10.52 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 116.995 2.22 . . . . 0.0 116.995 166.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.52 161.38 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.86 1.264 . . . . 0.0 111.077 165.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.461 HG12 HG22 ' A' ' 136' ' ' VAL . 1.5 m -101.3 139.73 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.996 1.318 . . . . 0.0 109.235 171.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -133.28 125.25 18.72 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 118.995 0.816 . . . . 0.0 110.022 171.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -63.4 65.53 0.18 Allowed 'Trans proline' 0 C--N 1.357 1.005 1 C-N-CA 125.508 4.138 . . . . 0.0 113.129 170.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.12 -38.67 39.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 127.78 2.432 . . . . 0.0 114.292 -156.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -75.0 -10.47 59.5 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.33 -0.856 . . . . 0.0 113.032 -177.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -59.38 -31.49 69.27 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.616 -1.303 . . . . 0.0 112.058 161.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.8 tp -72.38 -42.98 64.61 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.268 0.94 . . . . 0.0 111.246 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mp -57.83 -43.73 86.01 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 122.128 -0.358 . . . . 0.0 111.062 169.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.9 m -62.63 -38.76 91.51 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.948 0.899 . . . . 0.0 111.52 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -65.73 -36.13 82.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 118.618 -0.706 . . . . 0.0 112.041 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -69.39 -53.66 18.3 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 168.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -63.04 -36.5 83.79 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.315 -0.865 . . . . 0.0 111.865 -172.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 73.6 m -73.57 -9.94 59.2 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.0 tpt85 -75.5 -32.56 60.58 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.395 0.998 . . . . 0.0 112.426 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.9 p -148.61 -36.91 0.18 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.401 1.08 . . . . 0.0 112.749 173.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.35 81.94 1.63 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 126.755 2.121 . . . . 0.0 110.816 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 72.6 mtt85 -148.44 114.15 5.69 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.321 1.848 . . . . 0.0 110.071 170.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.9 m -65.29 140.37 58.69 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.589 1.156 . . . . 0.0 113.099 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.8 147.86 33.39 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -170.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 64.4 m -76.39 108.79 9.59 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.896 2.878 . . . . 0.0 111.694 165.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -91.62 99.63 12.51 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.555 -1.341 . . . . 0.0 108.323 167.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.7 t -99.7 115.79 41.45 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 C-N-CA 125.906 1.682 . . . . 0.0 109.348 -168.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -96.8 124.97 40.93 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 120.351 -1.468 . . . . 0.0 108.365 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -118.06 122.57 43.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.858 1.263 . . . . 0.0 111.832 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -95.89 114.85 26.61 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.546 1.538 . . . . 0.0 109.692 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 p -144.17 160.16 41.42 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 -173.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -7.92 -130.56 0.0 OUTLIER Glycine 0 N--CA 1.483 1.801 0 O-C-N 118.642 -2.537 . . . . 0.0 113.492 -137.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.2 p -96.41 101.86 13.56 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 121.798 2.799 . . . . 0.0 110.124 158.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 mtt85 -173.84 141.63 0.83 Allowed 'General case' 0 N--CA 1.471 0.607 1 C-N-CA 132.982 4.513 . . . . 0.0 107.92 144.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.6 t -68.35 137.43 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 120.244 1.384 . . . . 0.0 110.405 165.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.9 m -104.49 145.7 29.91 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.101 -0.999 . . . . 0.0 110.374 158.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.8 tp -109.62 109.7 20.53 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 160.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.2 m -88.84 96.64 10.78 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.398 1.079 . . . . 0.0 109.19 170.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 7.9 p -101.9 111.16 23.33 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 119.396 -2.065 . . . . 0.0 109.927 -172.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -146.64 150.5 35.57 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 116.828 2.159 . . . . 0.0 116.828 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.17 109.04 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 168.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.41 139.9 14.74 Favored Glycine 0 CA--C 1.536 1.357 0 N-CA-C 117.864 1.906 . . . . 0.0 117.864 -138.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.3 62.93 46.93 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 152.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.49 106.35 1.6 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.688 2.926 . . . . 0.0 114.604 -170.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.49 -30.74 61.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.687 1.195 . . . . 0.0 113.85 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.3 tpt85 -92.68 3.13 56.17 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.2 tp -70.89 1.0 6.09 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.728 -1.232 . . . . 0.0 114.287 166.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -51.81 -37.8 53.17 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.656 -0.652 . . . . 0.0 111.099 150.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -123.78 -35.3 2.9 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 -169.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 pp -82.81 167.4 18.14 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 121.999 2.181 . . . . 0.0 114.862 -167.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -168.2 126.22 1.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 -165.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.458 ' NE ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -105.21 178.22 4.62 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.547 1.539 . . . . 0.0 110.261 170.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.458 ' H ' ' NE ' ' A' ' 101' ' ' ARG . 1.1 p -162.38 169.81 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -147.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.448 ' HA ' HG13 ' A' ' 150' ' ' VAL . 99.4 m -123.82 122.42 37.96 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.029 -1.044 . . . . 0.0 111.125 136.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -176.15 175.17 1.93 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 129.083 2.953 . . . . 0.0 106.838 -174.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -122.36 121.72 37.35 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.296 2.239 . . . . 0.0 111.476 164.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -159.09 171.43 19.98 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -100.14 137.53 38.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.485 2.314 . . . . 0.0 110.376 175.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.8 tp -146.2 142.97 28.93 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.139 1.376 . . . . 0.0 111.039 -158.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 p -92.38 177.16 6.22 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 118.161 2.652 . . . . 0.0 118.161 -172.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.6 t -76.54 -6.87 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 129.486 3.114 . . . . 0.0 114.551 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -122.43 32.65 5.7 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.233 1.413 . . . . 0.0 111.746 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -136.01 159.9 40.27 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.25 -1.531 . . . . 0.0 113.079 -162.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.666 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -155.17 148.71 25.21 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.667 -1.271 . . . . 0.0 110.356 -151.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.666 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -143.4 148.0 35.5 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.767 1.227 . . . . 0.0 110.971 -169.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.46 138.42 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 120.639 1.563 . . . . 0.0 113.229 160.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.92 156.37 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.659 1.184 . . . . 0.0 109.5 169.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.6 t -145.01 167.25 23.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.654 1.582 . . . . 0.0 108.27 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.53 -33.53 71.51 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.14 0.882 . . . . 0.0 113.324 -172.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.05 -30.74 70.89 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 172.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -73.19 -35.48 66.39 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.298 -0.876 . . . . 0.0 111.045 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.1 mm -77.53 -33.43 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.359 1.064 . . . . 0.0 111.647 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -57.98 -34.5 70.03 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.059 -1.025 . . . . 0.0 111.015 168.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -70.97 -25.47 62.73 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.618 171.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 54.0 mt -72.61 -44.85 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.394 1.452 . . . . 0.0 110.157 171.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.6 tptp 168.39 -49.62 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 128.291 2.636 . . . . 0.0 110.15 168.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -62.96 112.64 1.72 Allowed 'Trans proline' 0 C--N 1.357 0.985 0 CA-C-N 121.653 1.626 . . . . 0.0 114.604 -167.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 87.8 m -66.36 154.44 40.04 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.328 1.851 . . . . 0.0 112.933 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -80.36 -5.96 57.24 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 117.311 2.337 . . . . 0.0 117.311 -149.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -93.72 9.28 37.66 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.48 1.912 . . . . 0.0 115.413 -176.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -166.49 14.31 0.08 OUTLIER Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.506 1.363 . . . . 0.0 116.506 -166.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 63.9 t -70.1 122.73 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 118.724 1.262 . . . . 0.0 111.683 -171.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.9 mp -127.76 80.05 1.93 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 123.777 1.751 . . . . 0.0 108.344 153.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.6 m -85.09 129.91 34.71 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 160.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -125.86 132.64 52.16 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.146 0.979 . . . . 0.0 110.796 -158.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 49.3 t -124.4 141.45 52.07 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.546 1.138 . . . . 0.0 111.334 -167.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 55' ' ' VAL . 10.9 t -137.21 125.33 32.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.547 1.539 . . . . 0.0 108.87 -173.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.23 143.87 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 28.4 mtt-85 -133.12 159.14 41.0 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 128.087 2.555 . . . . 0.0 107.987 164.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.301 0.0 OUTLIER -145.67 100.89 3.49 Favored 'General case' 0 CA--C 1.558 1.258 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 173.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.1 t -58.44 125.18 22.22 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.044 -1.66 . . . . 0.0 112.642 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -81.34 -53.85 5.98 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.904 0.882 . . . . 0.0 112.141 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.0 m -57.12 -22.41 39.63 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -119.2 22.39 9.0 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 117.333 -1.815 . . . . 0.0 114.216 174.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 91.7 mmm 22.77 71.49 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 128.454 2.702 . . . . 0.0 114.876 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.7 p -164.35 170.43 16.13 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.373 -0.829 . . . . 0.0 112.312 -169.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -113.24 149.39 33.85 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.783 1.633 . . . . 0.0 112.055 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -123.85 115.76 21.84 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 166.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.8 tt -122.05 142.5 38.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.703 -170.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -140.03 145.96 38.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.198 0.523 . . . . 0.0 110.628 159.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.448 HG13 ' HA ' ' A' ' 103' ' ' CYS . 4.4 p -145.27 136.68 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 122.394 1.092 . . . . 0.0 111.179 167.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.4 m -130.54 129.67 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 126.38 1.872 . . . . 0.0 110.065 -163.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -100.12 120.68 40.23 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -164.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -140.3 153.21 46.38 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.953 0.883 . . . . 0.0 112.742 171.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -87.28 -143.78 8.39 Favored Glycine 0 CA--C 1.543 1.784 0 C-N-CA 125.267 1.413 . . . . 0.0 111.718 162.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.58 -13.88 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.712 3.608 . . . . 0.0 116.048 174.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -58.81 -14.58 9.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.487 1.915 . . . . 0.0 113.977 171.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -95.67 18.6 12.63 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -54.72 -30.3 55.68 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.22 -36.04 82.01 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.626 -1.296 . . . . 0.0 113.277 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -73.06 -37.6 66.76 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.593 -1.317 . . . . 0.0 111.113 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -56.17 -47.23 78.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.413 0.685 . . . . 0.0 111.048 171.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -60.48 -37.25 80.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.55 1.14 . . . . 0.0 112.461 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.92 -38.2 79.41 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.312 0.96 . . . . 0.0 113.518 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.04 -57.31 12.12 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.979 0.911 . . . . 0.0 113.017 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.7 mp -43.99 -39.88 4.36 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.847 1.659 . . . . 0.0 112.517 166.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 53.3 tpt85 -73.02 -21.5 60.81 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -92.46 -37.38 12.57 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.824 1.193 . . . . 0.0 113.103 171.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.4 pt -81.86 -34.61 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.028 0.931 . . . . 0.0 113.185 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -74.55 6.44 3.8 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.456 -0.778 . . . . 0.0 111.481 161.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -124.85 23.14 7.98 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 167.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 . . . . . 0 C--O 1.254 1.305 0 C-N-CA 126.054 1.742 . . . . 0.0 109.963 162.06 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.8 t70 . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -53.75 -10.5 0.3 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.859 2.064 . . . . 0.0 115.104 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -113.14 -28.97 7.46 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.49 1.516 . . . . 0.0 114.551 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.1 t -72.0 -46.98 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.646 1.112 . . . . 0.0 112.433 -169.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.41 -45.02 95.89 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 171.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.28 -44.35 71.83 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 117.843 0.822 . . . . 0.0 112.539 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -74.89 -41.09 60.43 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.822 1.249 . . . . 0.0 114.25 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.63 -47.87 74.12 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.062 1.301 . . . . 0.0 111.012 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.12 -40.53 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.274 0.63 . . . . 0.0 109.567 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.9 t -56.56 -44.7 81.22 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.741 0.817 . . . . 0.0 112.337 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -64.43 -37.94 89.27 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.284 -0.885 . . . . 0.0 112.303 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.03 -49.25 78.39 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 120.57 1.532 . . . . 0.0 112.427 171.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 ptt85 -64.1 -39.59 94.39 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 120.328 1.422 . . . . 0.0 113.298 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -58.78 -44.17 90.64 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.809 2.044 . . . . 0.0 113.453 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.49 -30.77 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.307 1.043 . . . . 0.0 112.318 -175.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.411 HD21 HD23 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -87.4 -7.48 57.66 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.001 1.32 . . . . 0.0 112.455 174.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 64.31 9.35 4.8 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.488 2.715 . . . . 0.0 115.61 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . 0.262 4.3 pp -94.1 178.64 5.58 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.726 -1.234 . . . . 0.0 112.8 -173.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -95.96 154.32 17.3 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.275 1.03 . . . . 0.0 111.765 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -64.23 -24.18 67.57 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 119.488 -2.007 . . . . 0.0 112.81 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -78.36 0.26 26.26 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.811 1.644 . . . . 0.0 112.648 169.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -109.86 -18.8 13.32 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.149 1.38 . . . . 0.0 111.202 170.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.9 tp -88.23 111.81 22.07 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.629 1.572 . . . . 0.0 106.9 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.497 ' H ' ' HB3' ' A' ' 49' ' ' MET . 12.3 tpp180 -84.65 97.79 9.83 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 118.424 -1.31 . . . . 0.0 107.777 175.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.255 1.1 pp -92.46 148.63 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 126.646 1.978 . . . . 0.0 111.752 172.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.2 m -147.65 150.03 33.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.863 0.865 . . . . 0.0 108.921 -170.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -123.05 -158.68 0.8 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.829 1.252 . . . . 0.0 112.453 -161.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.8 t -41.49 -42.83 2.47 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 126.185 1.794 . . . . 0.0 115.252 -160.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.01 -30.08 65.82 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -171.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.23 -9.66 20.25 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 pt -110.14 -19.9 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.1 t -60.72 10.99 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 127.187 2.195 . . . . 0.0 116.781 -169.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -72.95 -20.12 61.11 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.714 2.006 . . . . 0.0 112.385 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -60.2 177.27 0.3 Allowed Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 127.433 2.293 . . . . 0.0 112.532 163.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -63.44 -86.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.936 2.424 . . . . 0.0 112.67 163.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -129.69 25.57 5.35 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 117.349 2.352 . . . . 0.0 117.349 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -162.68 142.13 9.14 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 118.811 -2.431 . . . . 0.0 110.717 -153.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m 176.54 -174.66 0.11 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.895 2.078 . . . . 0.0 108.895 -175.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.454 ' H ' ' HB3' ' A' ' 89' ' ' TYR . 30.1 tp -122.5 -75.41 0.6 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 119.174 -0.441 . . . . 0.0 111.306 150.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 15.0 p -163.35 -170.3 2.22 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.479 1.133 . . . . 0.0 113.223 -163.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 87' ' ' SER . 42.0 t0 -146.3 115.08 6.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.057 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.7 144.14 47.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.941 2.897 . . . . 0.0 109.287 -153.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.497 ' HB3' ' H ' ' A' ' 30' ' ' ARG . 29.5 ttp -122.3 128.1 50.66 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.904 1.684 . . . . 0.0 110.854 -165.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.411 HD23 HD21 ' A' ' 22' ' ' LEU . 0.6 OUTLIER -145.0 162.09 37.78 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 127.001 2.688 . . . . 0.0 115.439 -159.206 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.26 148.49 25.06 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 111.887 -2.415 . . . . 0.0 111.887 -142.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 t -66.03 156.37 33.93 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.072 0.949 . . . . 0.0 112.483 166.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 69.62 -0.85 2.47 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.109 2.164 . . . . 0.0 115.525 168.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.5 mp -103.98 147.01 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 126.08 1.752 . . . . 0.0 111.011 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.9 p -87.52 136.66 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.023 1.329 . . . . 0.0 111.714 170.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -107.54 110.25 62.78 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.56 1.144 . . . . 0.0 108.663 172.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -60.43 66.65 0.08 OUTLIER 'Trans proline' 0 CA--C 1.542 0.884 1 C-N-CA 126.521 4.814 . . . . 0.0 113.726 164.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.422 ' CG1' HG23 ' A' ' 133' ' ' THR . 3.6 p -68.75 -27.02 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.098 1.359 . . . . 0.0 114.424 -157.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -46.86 -45.19 20.15 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 126.46 1.904 . . . . 0.0 112.716 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -69.72 -30.67 68.34 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.996 -0.44 . . . . 0.0 112.164 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.1 mt -75.74 -45.26 37.52 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.824 0.85 . . . . 0.0 111.737 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 mp -53.58 -49.47 67.67 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.722 0.692 . . . . 0.0 109.813 171.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.8 m -64.97 -39.42 93.46 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -74.7 -33.75 62.48 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.444 -0.785 . . . . 0.0 112.408 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -63.89 -53.03 56.8 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.91 0.777 . . . . 0.0 111.375 171.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -73.67 -33.49 64.49 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -168.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.6 t -79.78 -19.15 49.28 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.904 1.282 . . . . 0.0 114.316 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -86.22 -26.1 25.24 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -166.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.2 m -138.79 -2.81 1.69 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -174.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.22 80.47 0.17 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.042 1.306 . . . . 0.0 111.384 -174.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.0 mtp85 -162.11 141.77 9.8 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 128.09 2.556 . . . . 0.0 105.642 169.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.2 m -65.61 140.98 58.56 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 125.064 1.346 . . . . 0.0 111.396 170.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.49 117.09 31.42 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 80.8 m -75.4 102.06 5.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.069 1.748 . . . . 0.0 108.333 157.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -85.12 96.15 9.36 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 167.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.9 t -99.75 141.3 17.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 C-N-CA 125.876 1.671 . . . . 0.0 108.165 -170.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -127.91 123.5 35.09 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 120.264 -1.523 . . . . 0.0 107.748 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -113.02 117.0 30.81 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.737 1.615 . . . . 0.0 108.842 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.75 115.79 31.12 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.309 1.844 . . . . 0.0 109.451 -172.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.3 p -143.25 165.09 28.41 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.409 2.684 . . . . 0.0 104.699 -160.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -13.66 -125.08 0.0 OUTLIER Glycine 0 N--CA 1.485 1.958 0 C-N-CA 129.58 3.466 . . . . 0.0 114.827 -152.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.7 p -92.89 99.78 12.37 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 113.862 -3.135 . . . . 0.0 110.151 152.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -170.75 162.49 7.71 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 130.605 3.562 . . . . 0.0 109.729 157.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.3 t -105.91 138.45 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 121.24 1.836 . . . . 0.0 112.443 148.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.7 t -104.42 138.91 40.13 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.932 0.893 . . . . 0.0 109.842 163.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tp -107.82 108.46 19.66 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 168.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 12.1 m -82.5 93.54 7.28 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 172.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.7 p -106.38 104.79 14.56 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 119.995 -1.691 . . . . 0.0 108.43 -169.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.454 ' HB3' ' H ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -142.9 149.92 39.12 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 117.022 2.231 . . . . 0.0 117.022 -177.026 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.7 pt -78.58 72.49 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 113.026 -1.897 . . . . 0.0 107.856 154.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -174.34 178.13 46.28 Favored Glycine 0 N--CA 1.478 1.471 0 N-CA-C 120.088 2.795 . . . . 0.0 120.088 -160.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -140.77 136.16 16.13 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.996 1.318 . . . . 0.0 114.499 -172.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -93.56 -166.71 0.15 Allowed 'Trans proline' 0 CA--C 1.549 1.241 1 C-N-CA 125.797 4.332 . . . . 0.0 112.492 172.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -79.26 -36.66 39.5 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 164.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -96.87 0.18 48.75 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 119.339 3.088 . . . . 0.0 119.339 -167.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.463 ' HA ' ' HG ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -54.1 -27.97 36.36 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 122.395 2.361 . . . . 0.0 114.383 -177.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.6 pttm -57.98 -30.41 66.01 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.275 1.03 . . . . 0.0 113.251 170.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -111.49 -29.97 7.56 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 99' ' ' LEU . 1.9 pp -74.31 165.31 25.39 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 121.753 2.07 . . . . 0.0 112.07 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -155.01 107.33 2.72 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 118.415 2.746 . . . . 0.0 118.415 -156.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.501 ' HE ' ' H ' ' A' ' 102' ' ' VAL . 0.1 OUTLIER -103.11 177.53 4.81 Favored 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 126.437 1.895 . . . . 0.0 111.533 169.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.501 ' H ' ' HE ' ' A' ' 101' ' ' ARG . 0.5 OUTLIER -165.82 170.64 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 -142.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 37.1 t -121.08 124.7 45.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.901 1.28 . . . . 0.0 109.918 141.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -172.86 167.91 5.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.4 1.88 . . . . 0.0 108.807 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -107.81 126.83 53.11 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.402 1.481 . . . . 0.0 109.522 150.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -152.12 165.65 34.11 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -165.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -101.0 145.43 28.71 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.023 1.729 . . . . 0.0 111.245 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.7 tp -140.89 143.04 34.43 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.133 0.973 . . . . 0.0 110.897 -158.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.9 p -111.43 -171.69 1.89 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.525 1.93 . . . . 0.0 114.639 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 65.9 t -73.32 -8.46 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 127.24 2.216 . . . . 0.0 113.58 172.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 -99.89 -3.41 32.51 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -165.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -96.98 148.95 22.45 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.503 1.501 . . . . 0.0 113.273 -147.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.633 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -144.73 143.76 30.86 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.144 -1.597 . . . . 0.0 109.061 -175.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -145.94 149.75 34.79 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-O 117.512 -1.232 . . . . 0.0 112.434 -168.089 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.41 141.94 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-N 121.338 1.881 . . . . 0.0 114.809 157.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.82 149.63 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.714 0.806 . . . . 0.0 111.123 169.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 39.8 m -146.29 154.43 41.68 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.844 2.057 . . . . 0.0 108.376 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -56.65 -36.9 70.05 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -163.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.02 -32.86 69.75 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.594 -1.316 . . . . 0.0 113.028 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -78.18 -29.37 48.49 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.373 1.069 . . . . 0.0 112.222 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.8 tp -76.97 -35.02 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 123.093 0.557 . . . . 0.0 111.889 168.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -61.14 -27.53 68.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.466 0.706 . . . . 0.0 112.27 171.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 22.3 ttm105 -77.44 -3.99 43.14 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.293 1.437 . . . . 0.0 114.622 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.8 mt -78.54 -25.22 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 O-C-N 120.955 -1.091 . . . . 0.0 110.616 168.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -91.09 179.5 1.42 Allowed Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.324 1.45 . . . . 0.0 108.855 153.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.6 -43.07 2.12 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 121.39 1.393 . . . . 0.0 111.435 160.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 38.2 t -158.53 148.72 19.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.925 2.49 . . . . 0.0 107.632 170.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -160.19 91.98 0.97 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.688 1.131 . . . . 0.0 111.732 171.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.7 63.34 0.19 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.56 1.944 . . . . 0.0 110.516 174.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 162.44 28.37 0.02 OUTLIER Glycine 0 CA--C 1.539 1.541 0 C-N-CA 125.195 1.378 . . . . 0.0 115.735 -171.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.7 t -61.58 128.0 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 120.132 1.966 . . . . 0.0 111.539 -174.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.18 89.05 2.98 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.459 1.904 . . . . 0.0 107.848 168.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.422 HG23 ' CG1' ' A' ' 58' ' ' VAL . 6.0 t -98.83 145.29 27.12 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.763 1.225 . . . . 0.0 111.488 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -138.72 132.78 31.33 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.267 1.027 . . . . 0.0 109.007 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 31.3 t -117.33 136.02 53.43 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.201 1.0 . . . . 0.0 111.038 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.4 t -136.71 138.14 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.457 1.903 . . . . 0.0 109.301 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.81 142.72 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.907 0.883 . . . . 0.0 110.943 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 31.5 mmm-85 -111.21 113.57 26.16 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.02 0.928 . . . . 0.0 108.734 163.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.608 ' HE2' ' CG ' ' A' ' 146' ' ' TYR . 0.0 OUTLIER -89.79 118.08 29.12 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 155.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.7 t -147.98 -167.94 2.94 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.027 0.831 . . . . 0.0 111.987 -169.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.2 m120 50.07 72.36 0.33 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.429 2.292 . . . . 0.0 112.321 168.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.9 m 54.01 3.45 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 -173.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.03 38.16 8.75 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.791 0.71 . . . . 0.0 112.288 -168.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 61.6 mtt -133.77 -13.23 2.56 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.73 142.33 24.48 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.875 0.845 . . . . 0.0 112.789 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.608 ' CG ' ' HE2' ' A' ' 139' ' ' LYS . 7.3 m-85 -140.82 173.63 11.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.666 -155.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -151.95 151.51 31.31 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.9 tt -141.19 136.5 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.405 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -137.53 125.7 23.05 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.386 1.074 . . . . 0.0 109.493 177.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.8 133.13 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.01 -1.056 . . . . 0.0 111.073 170.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.5 m -116.39 147.81 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.894 1.678 . . . . 0.0 110.966 -166.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.18 100.54 4.43 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.358 1.063 . . . . 0.0 111.609 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -119.85 161.77 20.25 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.718 1.607 . . . . 0.0 109.843 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -78.72 -147.35 3.58 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 118.639 0.654 . . . . 0.0 112.034 166.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.29 -11.99 7.11 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.625 2.883 . . . . 0.0 113.624 164.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -22.54 51.1 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.82 2.048 . . . . 0.0 113.012 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -87.36 57.09 4.25 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.946 1.355 . . . . 0.0 111.344 172.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -31.91 65.47 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.326 1.05 . . . . 0.0 111.531 171.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.78 -53.23 57.46 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -76.85 -25.52 53.23 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.186 0.903 . . . . 0.0 112.494 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -62.35 -54.02 46.57 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.986 1.267 . . . . 0.0 111.844 169.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -64.55 -28.67 69.8 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.458 -1.402 . . . . 0.0 112.352 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.19 -36.13 83.06 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.392 0.677 . . . . 0.0 112.484 168.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -70.59 -47.9 57.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.308 -0.853 . . . . 0.0 113.234 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.6 mp -48.41 -39.56 22.98 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 120.021 1.282 . . . . 0.0 112.858 166.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -71.33 -29.56 65.15 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -77.85 -32.58 52.16 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.637 1.575 . . . . 0.0 112.419 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.7 mt -86.4 -47.65 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.713 1.605 . . . . 0.0 112.149 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -68.04 1.74 2.54 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.066 0.848 . . . . 0.0 112.015 166.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -124.23 24.35 8.11 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 164.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . 0.277 9.6 mmm180 . . . . . 0 N--CA 1.48 1.025 0 C-N-CA 128.722 2.809 . . . . 0.0 116.344 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.3 t70 . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 121.678 0.751 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -63.51 -23.74 67.52 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -160.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -94.41 -28.91 15.25 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.378 0.99 . . . . 0.0 112.773 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.23 -54.49 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 118.778 0.717 . . . . 0.0 112.23 -171.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.08 -43.08 99.64 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 119.186 0.903 . . . . 0.0 112.16 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.12 74.85 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 117.749 0.775 . . . . 0.0 111.77 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -75.58 -31.76 60.09 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.92 -48.5 53.23 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.244 1.383 . . . . 0.0 111.654 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.18 -36.34 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 119.026 -0.511 . . . . 0.0 109.718 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 m -69.92 -43.53 71.5 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.549 1.068 . . . . 0.0 112.329 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -65.51 -39.08 91.43 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.222 -0.924 . . . . 0.0 111.29 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.73 -34.64 69.72 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.038 1.29 . . . . 0.0 112.297 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -52.88 -43.92 66.48 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 120.589 -1.319 . . . . 0.0 111.611 169.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -76.85 -43.34 36.58 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.597 1.159 . . . . 0.0 113.25 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.75 -31.99 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.035 1.334 . . . . 0.0 112.266 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.1 mt -89.85 -12.12 39.97 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.676 1.191 . . . . 0.0 113.065 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 60.21 25.7 15.1 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.783 2.033 . . . . 0.0 113.808 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 pp -117.91 155.55 29.99 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.87 1.268 . . . . 0.0 111.422 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -80.69 161.04 24.8 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -168.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -69.19 -19.28 63.98 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 119.771 -1.831 . . . . 0.0 115.381 -166.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -94.91 -5.76 44.13 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.609 1.563 . . . . 0.0 113.612 168.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -110.99 2.51 18.06 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.099 2.16 . . . . 0.0 110.801 -176.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 13.6 tp -90.54 124.11 34.74 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 128.692 2.797 . . . . 0.0 105.385 154.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.8 ttt-85 -85.39 119.82 26.18 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 117.951 -1.5 . . . . 0.0 107.766 166.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.497 ' H ' HD12 ' A' ' 31' ' ' ILE 0.276 0.8 OUTLIER -112.26 141.77 26.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.193 0.997 . . . . 0.0 112.393 170.269 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.6 m -157.74 141.24 15.51 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.07 1.348 . . . . 0.0 108.138 -159.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -163.3 60.76 0.18 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.521 1.153 . . . . 0.0 112.702 -172.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.9 t -93.55 -56.62 2.85 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.908 -1.12 . . . . 0.0 113.274 150.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.82 -54.3 4.99 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.308 1.051 . . . . 0.0 113.108 -146.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.542 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -63.9 -9.82 17.41 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.326 1.85 . . . . 0.0 113.188 171.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mm -90.2 6.31 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.105 1.362 . . . . 0.0 110.731 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.4 p -69.01 -17.66 63.95 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -173.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.416 ' HE3' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -62.65 -53.78 49.29 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.917 1.235 . . . . 0.0 110.111 169.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -168.85 155.89 6.9 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 125.675 1.59 . . . . 0.0 109.038 169.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.51 -27.3 18.58 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 122.933 2.422 . . . . 0.0 114.961 166.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -110.15 18.77 19.63 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.147 2.979 . . . . 0.0 113.143 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -153.13 92.06 1.58 Allowed 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t 165.85 -169.19 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 130.073 3.349 . . . . 0.0 107.743 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.264 1.2 tm? -132.08 -79.77 0.51 Allowed 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 151.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 5.7 t -175.9 -178.33 1.03 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.917 1.687 . . . . 0.0 109.96 -168.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 6.1 t70 -143.3 126.65 16.68 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 120.676 -1.265 . . . . 0.0 109.882 -170.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.22 154.46 17.38 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.548 1.939 . . . . 0.0 110.538 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -124.58 129.39 50.5 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.413 1.006 . . . . 0.0 108.786 168.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.59 162.39 38.5 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 126.709 2.506 . . . . 0.0 114.826 -156.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 p -102.5 156.53 17.55 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.736 2.014 . . . . 0.0 114.734 -147.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 t -71.79 149.19 45.55 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.572 1.149 . . . . 0.0 113.565 173.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 t70 68.72 16.67 8.95 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 163.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.61 146.88 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.743 1.617 . . . . 0.0 109.542 168.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.6 p -97.48 139.47 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.559 1.544 . . . . 0.0 111.272 166.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -122.21 128.74 25.38 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.9 1.28 . . . . 0.0 110.472 -169.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.94 70.13 5.32 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 124.598 3.532 . . . . 0.0 110.782 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 p -65.48 -26.47 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.25 1.42 . . . . 0.0 113.956 -161.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -48.22 -45.99 34.71 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.531 1.533 . . . . 0.0 112.62 171.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -62.35 -39.68 93.89 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.591 0.632 . . . . 0.0 111.186 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.5 tp -69.63 -53.51 18.38 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.021 0.528 . . . . 0.0 110.814 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.18 -53.31 58.7 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.441 0.696 . . . . 0.0 111.479 177.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 72.7 m -76.72 -40.46 48.56 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -168.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -69.95 -33.48 72.17 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.596 1.089 . . . . 0.0 112.246 173.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -63.67 -48.22 78.08 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.106 0.866 . . . . 0.0 112.331 172.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -55.71 -41.9 74.47 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.434 0.694 . . . . 0.0 111.343 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.8 t -69.22 -17.92 63.84 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -175.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -63.28 -35.84 81.69 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.277 1.031 . . . . 0.0 113.414 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.9 m -115.99 -28.06 6.76 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.139 0.976 . . . . 0.0 112.223 167.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.88 77.35 0.95 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.956 2.217 . . . . 0.0 109.813 -169.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -160.63 117.98 2.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.517 2.327 . . . . 0.0 108.779 -174.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.4 m -61.78 130.15 44.38 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.517 0.727 . . . . 0.0 111.204 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.74 160.43 25.94 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.833 1.653 . . . . 0.0 114.502 -163.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 89.9 m -103.34 116.01 31.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.322 1.449 . . . . 0.0 112.49 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -91.14 114.51 27.05 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.639 1.575 . . . . 0.0 107.632 167.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.869 HG22 HG22 ' A' ' 115' ' ' VAL . 50.9 t -129.85 123.92 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 O-C-N 121.514 -0.742 . . . . 0.0 111.055 -162.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -96.39 129.78 43.67 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 119.963 -1.71 . . . . 0.0 109.609 174.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.66 98.12 8.72 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 162.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -106.95 111.61 24.18 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 125.093 1.357 . . . . 0.0 114.438 -164.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.3 p -144.76 165.61 27.58 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 129.661 3.184 . . . . 0.0 105.206 -149.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.08 -123.2 0.0 OUTLIER Glycine 0 N--CA 1.49 2.289 0 C-N-CA 130.524 3.916 . . . . 0.0 115.6 -163.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.6 p -91.66 104.95 17.37 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 113.182 -3.407 . . . . 0.0 110.443 152.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -169.1 153.29 5.45 Favored 'General case' 0 N--CA 1.474 0.75 1 C-N-CA 134.638 5.175 . . . . 0.0 106.236 159.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.6 t -106.29 136.29 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 119.748 -1.845 . . . . 0.0 109.716 129.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.9 m -106.56 140.79 38.89 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 160.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.0 tp -110.82 107.67 17.24 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.5 1.52 . . . . 0.0 107.234 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.6 m -78.03 128.81 34.43 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.252 1.021 . . . . 0.0 108.904 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 77.3 m -120.49 116.51 25.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -140.33 141.09 35.73 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 173.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.468 ' H ' HD13 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -83.48 99.97 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 149.376 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 175.32 178.3 45.06 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 118.108 2.003 . . . . 0.0 118.108 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -125.86 56.35 15.19 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.973 1.309 . . . . 0.0 112.802 164.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -59.8 142.28 98.35 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.736 2.291 . . . . 0.0 111.197 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -55.09 -17.11 3.58 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 -158.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -21.18 63.19 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.77 -1.206 . . . . 0.0 113.301 171.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -52.55 -33.2 44.54 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.297 1.839 . . . . 0.0 113.565 168.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -79.57 4.63 15.3 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.815 1.246 . . . . 0.0 112.648 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -130.09 -35.82 1.58 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.002 1.321 . . . . 0.0 114.142 177.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.511 HD11 HG23 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -84.04 165.86 18.21 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 117.991 2.589 . . . . 0.0 117.991 -168.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -104.21 -172.62 2.14 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 126.784 2.033 . . . . 0.0 115.248 -161.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.65 158.95 16.83 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 126.823 2.049 . . . . 0.0 110.749 170.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.3 p -123.83 125.56 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 159.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 41.5 t -142.27 119.4 11.41 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 142.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -171.2 140.03 1.43 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.259 0.552 . . . . 0.0 110.335 -164.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -114.67 95.74 5.39 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.695 1.198 . . . . 0.0 108.997 141.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -160.96 177.51 10.29 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.983 -1.073 . . . . 0.0 113.636 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.19 157.32 37.85 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 121.331 -0.856 . . . . 0.0 111.828 161.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.7 tp -145.13 143.79 30.56 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.865 1.666 . . . . 0.0 108.994 -170.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.9 m -104.04 -174.03 2.45 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.217 1.007 . . . . 0.0 112.881 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.356 89.1 t -66.65 1.92 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 128.371 2.668 . . . . 0.0 115.08 -173.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -50.5 -4.75 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 118.244 2.683 . . . . 0.0 118.244 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.373 4.7 pt-20 54.57 3.54 0.05 Allowed 'General case' 0 N--CA 1.466 0.364 1 N-CA-C 124.319 4.933 . . . . 0.0 124.319 153.705 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -163.13 123.83 2.35 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 123.139 2.7 . . . . 0.0 108.448 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.4 pp -155.88 150.01 25.53 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.595 1.558 . . . . 0.0 111.459 -174.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.869 HG22 HG22 ' A' ' 76' ' ' VAL . 11.6 t -115.3 144.86 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 127.349 2.26 . . . . 0.0 113.062 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.6 138.81 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 123.844 0.857 . . . . 0.0 110.853 146.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.4 p -114.82 167.27 10.93 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.338 1.055 . . . . 0.0 112.403 172.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -35.38 74.65 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 120.721 -1.237 . . . . 0.0 111.667 174.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.91 -36.04 82.63 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.334 0.653 . . . . 0.0 112.518 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -64.36 -47.57 78.81 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 118.693 -0.67 . . . . 0.0 111.256 172.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.93 -50.01 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 119.026 0.83 . . . . 0.0 110.846 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -57.51 -36.11 71.13 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.069 0.947 . . . . 0.0 113.067 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -78.88 -31.6 45.52 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.982 -1.074 . . . . 0.0 112.738 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.4 mt -71.04 -37.62 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.727 1.611 . . . . 0.0 111.238 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -158.75 -54.54 0.02 OUTLIER Pre-proline 0 N--CA 1.48 1.061 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 164.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -120.2 109.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.66 0 CA-C-N 121.349 1.517 . . . . 0.0 112.818 -159.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 82.8 m -73.66 128.18 34.79 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 145.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -179.99 135.33 0.11 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.272 1.829 . . . . 0.0 111.07 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -74.47 56.84 0.69 Allowed 'General case' 0 N--CA 1.482 1.134 0 O-C-N 120.586 -1.321 . . . . 0.0 110.71 159.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.11 19.1 0.04 OUTLIER Glycine 0 CA--C 1.544 1.886 0 C-N-CA 127.253 2.359 . . . . 0.0 114.571 -169.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.0 t -63.97 136.91 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.903 1.281 . . . . 0.0 111.551 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.3 85.04 2.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 122.68 1.228 . . . . 0.0 109.191 160.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.8 m -78.07 144.85 36.22 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 166.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -146.03 132.5 19.72 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -165.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 42.0 t -136.55 140.79 43.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.533 0.606 . . . . 0.0 112.48 -167.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.1 t -136.09 138.99 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 127.199 2.2 . . . . 0.0 108.369 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.2 m -130.84 140.9 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.992 -0.442 . . . . 0.0 109.845 166.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -114.6 143.42 45.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 122.281 1.039 . . . . 0.0 110.686 157.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.96 137.52 49.84 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.732 2.013 . . . . 0.0 107.699 163.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 53.0 m -140.45 131.23 25.82 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 123.711 0.632 . . . . 0.0 110.489 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 17.4 m120 45.82 65.09 1.23 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.847 2.059 . . . . 0.0 114.437 168.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 37.1 m 59.5 12.63 2.85 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 101.71 7.04 48.87 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.494 1.045 . . . . 0.0 114.945 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 23.3 mmt -64.88 -13.88 57.87 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.728 1.264 . . . . 0.0 113.258 171.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.3 t -139.68 141.01 37.0 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.8 1.24 . . . . 0.0 110.242 158.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -115.59 152.24 33.45 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 157.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -134.53 146.42 49.68 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.161 -0.962 . . . . 0.0 109.689 170.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.3 tt -143.39 143.76 24.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.547 0.689 . . . . 0.0 112.327 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -134.57 130.94 37.29 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 161.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.22 131.07 35.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 122.907 1.337 . . . . 0.0 109.688 150.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.7 m -137.27 142.99 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 111.365 -2.652 . . . . 0.0 108.35 -162.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -123.47 132.96 54.08 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -142.91 162.23 36.03 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.431 1.892 . . . . 0.0 110.21 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -70.14 -144.82 0.24 Allowed Glycine 0 CA--C 1.543 1.828 0 O-C-N 120.632 -1.293 . . . . 0.0 110.928 149.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.64 17.36 0.46 Allowed 'Trans proline' 0 CA--C 1.553 1.45 0 C-N-CA 123.126 2.551 . . . . 0.0 114.17 174.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -85.63 -17.37 36.33 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -164.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -77.67 54.48 1.22 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 123.28 1.514 . . . . 0.0 109.802 163.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.88 -21.28 65.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.995 1.718 . . . . 0.0 114.144 -161.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.24 -43.62 66.9 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.925 0.784 . . . . 0.0 111.985 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -73.0 -31.65 64.63 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.579 0.752 . . . . 0.0 111.424 175.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -64.05 -49.99 70.17 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.309 -0.869 . . . . 0.0 110.609 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -54.95 -36.54 65.42 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.004 -1.06 . . . . 0.0 113.668 172.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.89 85.62 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.432 0.56 . . . . 0.0 112.185 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -71.81 -48.2 48.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.29 1.036 . . . . 0.0 113.192 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 98.1 mt -54.74 -35.95 64.28 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.621 1.101 . . . . 0.0 112.539 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -70.89 -40.93 71.92 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 125.723 1.609 . . . . 0.0 112.902 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -77.34 -35.56 54.57 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.8 pt -75.07 -38.32 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.142 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -65.6 -10.41 35.34 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 120.259 1.39 . . . . 0.0 112.885 164.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -110.64 28.14 8.97 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.257 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.8 t0 . . . . . 0 CA--C 1.551 1.008 0 CA-C-O 121.232 0.539 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -63.84 -30.55 71.63 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 -139.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.85 -15.56 15.64 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.38 0.991 . . . . 0.0 113.663 172.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.3 t -69.96 -62.26 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.841 1.256 . . . . 0.0 111.662 -173.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.0 -53.46 14.45 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.63 1.109 . . . . 0.0 112.248 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.36 -45.94 72.87 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 118.958 1.379 . . . . 0.0 113.504 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.89 -39.02 76.51 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.085 -1.009 . . . . 0.0 112.805 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -70.39 -42.89 71.12 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.236 0.925 . . . . 0.0 112.219 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.36 -42.71 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.285 1.034 . . . . 0.0 109.851 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.7 p -68.51 -40.36 80.86 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.74 0.7 . . . . 0.0 112.227 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -69.08 -36.89 78.11 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.223 -0.923 . . . . 0.0 112.466 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 87.7 m -66.92 -48.09 69.73 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.193 -0.942 . . . . 0.0 110.715 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.2 ptt-85 -59.32 -41.58 89.4 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.284 0.947 . . . . 0.0 111.26 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -62.24 -56.74 15.64 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.19 1.396 . . . . 0.0 112.286 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.82 -30.18 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 119.369 0.986 . . . . 0.0 112.202 -172.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.75 -8.33 59.18 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.22 0.918 . . . . 0.0 113.249 169.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 52.76 46.36 26.89 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.387 1.875 . . . . 0.0 111.921 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 pp -129.37 159.44 36.2 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.851 1.261 . . . . 0.0 111.051 172.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -73.5 160.54 31.56 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -60.52 -27.89 67.98 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.166 -1.583 . . . . 0.0 111.983 168.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -84.4 6.12 24.5 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 119.775 1.171 . . . . 0.0 113.056 171.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -116.1 -12.95 11.2 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.605 -1.309 . . . . 0.0 110.996 174.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.589 HD11 ' HB1' ' A' ' 48' ' ' ALA . 26.9 tp -89.68 113.16 24.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.494 1.918 . . . . 0.0 109.348 171.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -94.67 130.72 41.05 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 119.584 -0.846 . . . . 0.0 112.849 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 47' ' ' ASP . 37.4 mm -95.87 138.01 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 127.442 2.297 . . . . 0.0 113.308 -176.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 m -147.29 148.44 31.42 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.818 1.19 . . . . 0.0 109.476 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.7 p30 -150.76 56.43 0.91 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 122.886 1.327 . . . . 0.0 114.394 171.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.0 p -91.45 -56.15 3.24 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.112 1.365 . . . . 0.0 114.352 157.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.92 -52.2 5.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 122.744 1.259 . . . . 0.0 114.193 -152.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.606 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -64.88 -27.54 68.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.112 1.765 . . . . 0.0 112.448 173.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.5 mp -71.43 -16.18 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.565 1.946 . . . . 0.0 112.6 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 54.7 m -61.04 -0.14 0.29 Allowed 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 118.069 2.618 . . . . 0.0 118.069 -166.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -90.07 -30.9 17.41 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 121.42 1.918 . . . . 0.0 113.298 169.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -134.41 84.3 41.13 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 165.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -69.98 21.95 0.18 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.535 3.49 . . . . 0.0 114.721 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -113.75 4.27 15.9 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.44 1.896 . . . . 0.0 111.587 169.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -130.14 164.27 24.8 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 120.302 1.41 . . . . 0.0 108.284 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 p -150.16 150.67 31.96 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.242 -0.911 . . . . 0.0 111.49 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.12 -82.77 0.64 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 117.036 -1.459 . . . . 0.0 110.692 147.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 30.5 p -170.88 163.5 7.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 121.681 2.037 . . . . 0.0 114.507 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 16.2 t70 -115.47 152.82 32.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 153.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -121.23 135.79 55.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 129.129 2.972 . . . . 0.0 108.743 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 55.7 mtm -112.04 134.05 53.83 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.9 1.227 . . . . 0.0 108.145 168.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.269 0.6 OUTLIER -147.79 131.93 17.34 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 118.493 2.775 . . . . 0.0 118.493 -155.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.25 160.22 18.53 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 110.539 -3.028 . . . . 0.0 114.395 -174.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.6 p -96.02 179.75 4.97 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.627 1.971 . . . . 0.0 115.464 -158.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . 0.268 28.9 t70 63.16 46.0 4.84 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.482 2.313 . . . . 0.0 115.349 177.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.36 164.28 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 127.065 2.146 . . . . 0.0 109.22 163.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 m -101.11 141.07 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.228 1.011 . . . . 0.0 108.548 161.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.65 110.52 44.49 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 119.829 1.195 . . . . 0.0 108.219 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -67.67 74.71 0.61 Allowed 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 125.159 3.906 . . . . 0.0 111.072 173.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.6 -24.65 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.644 1.978 . . . . 0.0 114.294 -152.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.11 -26.72 50.97 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.652 0.66 . . . . 0.0 112.26 172.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -57.26 -38.49 73.94 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.641 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.7 -43.09 63.49 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.434 1.015 . . . . 0.0 111.257 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -56.09 -48.72 75.58 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.166 0.986 . . . . 0.0 110.325 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.0 m -71.92 -42.89 66.17 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.391 1.476 . . . . 0.0 113.166 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -67.38 -33.96 76.29 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.909 1.231 . . . . 0.0 111.784 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -66.54 -46.99 74.29 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.524 0.602 . . . . 0.0 112.491 165.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -60.6 -30.06 69.59 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.786 -1.196 . . . . 0.0 112.717 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 79.2 m -76.66 -6.31 51.57 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.755 1.622 . . . . 0.0 114.234 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -82.38 -35.17 27.99 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 120.089 1.313 . . . . 0.0 112.971 -175.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.6 p -154.87 -23.98 0.12 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.534 1.134 . . . . 0.0 113.121 167.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.86 82.04 1.35 Allowed Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.761 2.124 . . . . 0.0 112.028 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.9 tpt85 -153.26 118.77 5.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 128.828 2.851 . . . . 0.0 104.957 169.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.6 m -62.03 150.99 36.54 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.705 0.802 . . . . 0.0 111.89 -175.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -141.04 149.91 42.3 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.146 1.378 . . . . 0.0 113.229 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 29.5 p -83.02 138.19 33.84 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.736 1.214 . . . . 0.0 111.484 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -110.59 115.7 30.07 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 172.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 1.072 HG22 HG22 ' A' ' 115' ' ' VAL . 95.1 t -130.04 111.26 21.01 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.549 0 C-N-CA 123.76 0.824 . . . . 0.0 109.56 -154.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -96.07 115.67 27.78 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 120.338 -1.476 . . . . 0.0 107.499 -170.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -108.49 107.87 18.57 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.89 1.276 . . . . 0.0 108.772 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -84.06 137.41 33.6 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.276 -0.89 . . . . 0.0 111.184 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.1 p -144.28 167.87 21.41 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 129.591 3.156 . . . . 0.0 104.626 -167.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -16.42 -123.32 0.0 OUTLIER Glycine 0 N--CA 1.489 2.169 1 C-N-CA 130.831 4.063 . . . . 0.0 116.636 -176.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 55.8 m -97.99 101.96 13.58 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 113.029 -3.468 . . . . 0.0 111.254 152.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.68 164.29 12.16 Favored 'General case' 0 CA--C 1.542 0.671 1 C-N-CA 133.465 4.706 . . . . 0.0 106.419 136.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.6 156.96 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 O-C-N 119.468 -2.02 . . . . 0.0 108.714 147.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -127.74 146.67 50.5 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.621 0.768 . . . . 0.0 110.242 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.0 tp -117.17 109.37 16.82 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.068 0.947 . . . . 0.0 108.657 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.2 m -76.69 132.02 39.13 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.103 1.361 . . . . 0.0 110.139 167.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.1 m -128.69 115.34 17.86 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.624 -1.298 . . . . 0.0 110.011 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -137.15 134.77 36.72 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.29 85.28 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 161.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 174.63 -176.61 46.89 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 117.694 1.837 . . . . 0.0 117.694 -174.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -111.15 79.97 2.23 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.734 1.214 . . . . 0.0 112.407 168.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -53.4 153.62 17.08 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 124.528 3.485 . . . . 0.0 116.479 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -72.56 -32.46 66.06 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -172.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -76.33 -10.02 59.08 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.943 1.247 . . . . 0.0 113.634 172.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.607 HD11 HG21 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -68.51 -2.71 9.38 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.524 1.93 . . . . 0.0 114.815 167.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 9.8 mmpt? -50.55 -41.02 53.59 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.489 -0.757 . . . . 0.0 110.753 151.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -118.98 -34.5 3.88 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -167.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.661 HD11 HG23 ' A' ' 115' ' ' VAL . 3.7 pp -83.87 160.6 21.11 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 120.69 1.586 . . . . 0.0 113.187 -163.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.3 pttt -164.08 129.08 2.83 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 -165.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.339 11.5 ttt180 -108.89 -173.59 2.31 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 125.472 1.509 . . . . 0.0 113.172 167.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.4 p 179.9 166.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 128.105 2.562 . . . . 0.0 109.353 -133.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 57.3 m -118.12 122.3 42.75 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.155 0.889 . . . . 0.0 109.286 151.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -170.97 163.32 7.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.652 2.381 . . . . 0.0 106.756 -171.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -139.27 115.36 10.3 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 126.077 1.751 . . . . 0.0 112.903 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -159.88 -172.92 3.84 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.339 1.456 . . . . 0.0 111.904 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -66.94 160.78 25.58 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.124 0.97 . . . . 0.0 112.58 160.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.6 tp -135.22 145.96 48.18 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 129.142 2.977 . . . . 0.0 108.777 -172.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.7 t -109.27 155.51 21.04 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.932 2.093 . . . . 0.0 110.543 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.01 -15.81 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -157.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -130.35 46.72 2.61 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.34 1.056 . . . . 0.0 110.643 -170.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -104.69 150.66 24.53 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.505 1.522 . . . . 0.0 112.589 -167.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.446 ' HB1' HD22 ' A' ' 99' ' ' LEU . . . -144.13 136.09 26.28 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.166 -1.584 . . . . 0.0 110.042 -172.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.32 139.25 15.32 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 120.632 -1.292 . . . . 0.0 113.63 -170.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 1.072 HG22 HG22 ' A' ' 76' ' ' VAL . 6.6 t -108.87 132.77 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 125.745 1.618 . . . . 0.0 111.012 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . 0.254 0.8 OUTLIER -129.79 123.53 57.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 122.64 1.209 . . . . 0.0 110.065 157.086 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.9 t -124.73 158.53 33.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.596 2.358 . . . . 0.0 107.846 173.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -36.12 64.41 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.968 0.803 . . . . 0.0 112.006 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.11 -31.95 68.41 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -76.2 -28.96 57.44 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.611 -1.306 . . . . 0.0 112.258 174.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 41.3 mm -67.81 -40.65 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 121.556 -0.715 . . . . 0.0 110.562 164.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.23 -11.9 52.89 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.26 1.024 . . . . 0.0 113.191 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -79.29 -45.39 19.8 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 119.77 -1.831 . . . . 0.0 112.214 164.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.9 pt -92.04 -12.94 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -170.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -122.87 161.32 44.95 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 125.287 1.435 . . . . 0.0 112.422 174.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -68.32 -31.4 28.5 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.906 1.737 . . . . 0.0 115.694 -168.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.428 ' SG ' ' HE2' ' A' ' 129' ' ' LYS . 5.6 t -153.29 162.39 41.34 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -172.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -99.99 -137.32 0.31 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.148 2.579 . . . . 0.0 111.482 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.428 ' HE2' ' SG ' ' A' ' 127' ' ' CYS . 63.4 pttt 44.84 22.03 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 119.278 3.066 . . . . 0.0 119.278 165.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.46 21.66 0.04 OUTLIER Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.124 1.345 . . . . 0.0 115.946 168.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.1 t -65.89 132.9 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 118.698 1.249 . . . . 0.0 111.946 -169.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 20.7 mt -124.18 108.84 12.72 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 122.4 1.095 . . . . 0.0 109.138 151.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.2 t -101.69 147.25 26.67 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.855 1.662 . . . . 0.0 109.725 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -124.7 133.74 53.09 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.661 1.184 . . . . 0.0 108.394 -174.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 72.3 m -109.67 143.09 39.92 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.625 0.77 . . . . 0.0 111.057 171.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.71 129.33 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.727 1.611 . . . . 0.0 108.863 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.1 m -136.85 147.81 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -132.0 145.9 51.74 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.08 1.752 . . . . 0.0 112.699 172.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.663 ' HE2' ' CD1' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -129.12 93.14 3.52 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.565 2.346 . . . . 0.0 114.211 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 18.1 t -83.79 123.1 29.54 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.679 -0.638 . . . . 0.0 112.211 170.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -96.38 -41.13 8.77 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.591 1.557 . . . . 0.0 110.963 167.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 98.0 p -64.63 -18.38 64.88 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -131.73 23.33 4.22 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 125.824 1.678 . . . . 0.0 114.919 168.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.9 mmt 31.1 59.83 0.25 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 128.352 2.661 . . . . 0.0 116.326 172.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.9 t -164.62 146.55 8.36 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.174 0.99 . . . . 0.0 110.55 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.663 ' CD1' ' HE2' ' A' ' 139' ' ' LYS . 4.5 m-85 -129.21 158.11 39.95 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -158.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -144.07 144.98 31.87 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 120.946 -1.096 . . . . 0.0 108.847 -171.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.0 tt -144.94 142.67 22.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.843 -168.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -141.02 136.21 31.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.361 1.465 . . . . 0.0 107.46 174.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.52 136.52 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 122.051 0.929 . . . . 0.0 110.946 155.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.3 m -129.23 149.64 33.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 126.218 1.807 . . . . 0.0 109.734 -172.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.93 127.63 23.35 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -133.47 157.62 45.17 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.457 1.903 . . . . 0.0 110.867 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -90.61 -159.35 35.53 Favored Glycine 0 CA--C 1.541 1.702 0 C-N-CA 124.404 1.002 . . . . 0.0 113.519 174.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.25 -7.75 21.73 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.339 2.693 . . . . 0.0 115.522 -172.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -75.58 -2.91 31.38 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 171.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -76.73 57.27 1.25 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.347 1.859 . . . . 0.0 111.683 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.18 -23.14 61.97 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.334 1.454 . . . . 0.0 113.696 -174.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.57 -51.24 37.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.141 0.882 . . . . 0.0 111.591 178.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -71.21 -34.97 71.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.881 0.872 . . . . 0.0 112.729 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -58.9 -53.71 55.33 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.854 0.752 . . . . 0.0 110.689 171.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -57.02 -39.02 73.95 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.884 0.765 . . . . 0.0 112.07 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.82 -42.99 98.78 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.295 0.952 . . . . 0.0 112.926 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.21 -46.98 72.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.569 -0.707 . . . . 0.0 112.586 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 86.9 mt -57.31 -34.64 68.94 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.837 0.455 . . . . 0.0 111.497 175.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -75.63 -17.59 59.95 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.586 1.955 . . . . 0.0 113.549 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -101.9 -31.17 10.83 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.0 pt -86.54 -36.63 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 120.415 1.461 . . . . 0.0 113.547 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -76.32 12.62 1.15 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.381 1.446 . . . . 0.0 111.508 161.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.85 25.61 4.31 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 170.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 125.224 1.409 . . . . 0.0 112.495 168.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.6 t70 . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 120.984 0.421 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -55.76 -20.95 16.68 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -162.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -97.17 -31.17 12.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.278 1.031 . . . . 0.0 112.603 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.9 -59.49 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.93 0.892 . . . . 0.0 112.079 -168.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.37 -42.38 97.42 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.534 -0.592 . . . . 0.0 111.845 171.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.61 -51.15 69.75 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.542 1.171 . . . . 0.0 112.757 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -64.45 -43.03 95.57 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.317 1.047 . . . . 0.0 112.445 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.44 -47.36 61.09 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.896 0.878 . . . . 0.0 111.893 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.16 -41.55 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.547 0.739 . . . . 0.0 109.646 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.5 m -59.29 -38.37 80.02 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.769 0.713 . . . . 0.0 112.387 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -76.0 -32.32 59.37 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.645 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -71.99 -43.66 64.74 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 120.454 1.479 . . . . 0.0 111.646 170.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -49.72 -43.64 47.78 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.456 1.502 . . . . 0.0 111.791 172.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -73.46 -59.57 2.65 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.245 1.418 . . . . 0.0 113.651 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.02 -31.81 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 120.699 1.59 . . . . 0.0 112.718 -168.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.0 mp -84.0 -13.43 53.31 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.152 -0.967 . . . . 0.0 112.543 173.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 54.44 60.1 3.76 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.82 1.648 . . . . 0.0 112.514 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 pp -130.89 148.66 52.69 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.89 0.876 . . . . 0.0 109.385 167.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -69.99 159.51 33.65 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.991 0.424 . . . . 0.0 110.585 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -65.42 -27.38 68.49 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.376 -1.452 . . . . 0.0 111.757 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -68.57 -9.01 46.8 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.97 1.308 . . . . 0.0 113.848 166.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -125.49 3.05 7.66 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.471 1.508 . . . . 0.0 111.639 -176.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.472 HD11 ' HB1' ' A' ' 48' ' ' ALA . 24.2 tp -93.34 128.68 39.47 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 156.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 131.91 50.17 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.906 0.775 . . . . 0.0 111.134 167.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.8 mm -93.71 143.44 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 127.236 2.215 . . . . 0.0 110.723 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.5 m -149.77 154.1 37.92 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 121.394 -0.816 . . . . 0.0 110.674 168.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.2 p30 -155.75 58.81 0.61 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.678 1.228 . . . . 0.0 112.999 -176.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 30.1 p -86.93 -60.2 2.05 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.626 -1.296 . . . . 0.0 111.341 169.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.16 -38.09 15.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 113.919 -1.491 . . . . 0.0 112.474 -158.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.528 HD12 HD12 ' A' ' 37' ' ' ILE . 2.4 pp -99.63 -1.94 36.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.054 2.142 . . . . 0.0 113.718 -171.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.528 HD12 HD12 ' A' ' 36' ' ' LEU . 1.7 mp -97.5 5.53 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 126.53 1.932 . . . . 0.0 110.354 166.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.3 t -59.49 -29.71 68.03 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.354 1.462 . . . . 0.0 114.117 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.463 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -81.22 26.75 0.43 Allowed 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.059 -1.651 . . . . 0.0 112.913 169.354 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 m120 71.69 165.13 0.14 Allowed Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 128.646 2.779 . . . . 0.0 112.758 -168.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.12 -3.69 3.22 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.749 2.966 . . . . 0.0 114.896 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -97.82 5.71 48.75 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.409 2.284 . . . . 0.0 112.454 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -157.36 94.54 1.39 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 171.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.4 p -175.24 168.76 3.34 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.501 -159.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -131.61 -81.51 0.52 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 116.78 -1.968 . . . . 0.0 115.345 132.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.38 -176.98 2.31 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.343 1.057 . . . . 0.0 111.408 -174.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -116.72 146.18 42.96 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 168.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.472 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -131.54 130.24 42.05 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.628 2.371 . . . . 0.0 107.682 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 18.4 mtt -123.6 134.16 53.85 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.018 -1.051 . . . . 0.0 110.61 -170.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.5 mt -130.77 142.26 50.4 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 126.154 2.159 . . . . 0.0 112.748 -147.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.6 p -110.7 161.58 15.61 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.058 2.543 . . . . 0.0 111.584 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.658 HG22 HG23 ' A' ' 137' ' ' VAL . 28.4 p -126.77 108.6 11.19 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -163.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -158.92 2.26 0.09 Allowed 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 125.584 1.554 . . . . 0.0 114.84 165.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.65 173.08 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 126.578 1.951 . . . . 0.0 113.196 -162.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.457 HG21 HD21 ' A' ' 134' ' ' ASN . 1.4 m -96.78 142.54 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.894 1.678 . . . . 0.0 112.178 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -109.2 106.41 58.65 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -73.51 71.53 3.85 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.668 3.579 . . . . 0.0 110.397 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.48 -28.58 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 114.088 -1.414 . . . . 0.0 114.653 -149.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -56.99 -35.01 68.7 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -67.13 -32.94 74.4 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.384 0.538 . . . . 0.0 111.722 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.0 mt -75.01 -45.0 44.82 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.748 0.704 . . . . 0.0 111.458 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 mp -55.27 -44.21 75.4 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.8 0.727 . . . . 0.0 111.261 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -63.62 -45.37 90.62 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.606 0.762 . . . . 0.0 112.501 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -63.69 -32.44 73.93 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.63 0.772 . . . . 0.0 112.593 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -69.1 -45.25 70.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.575 1.15 . . . . 0.0 111.823 171.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.09 -37.79 77.95 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 119.583 1.083 . . . . 0.0 112.095 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.1 t -62.97 -1.48 0.93 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.438 1.895 . . . . 0.0 115.706 -168.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -70.88 -18.22 62.69 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 120.287 -1.508 . . . . 0.0 113.58 172.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.7 p -164.21 -16.4 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.628 1.571 . . . . 0.0 113.813 166.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.5 83.55 1.12 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 126.941 2.21 . . . . 0.0 109.62 -165.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -161.76 114.87 1.84 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.469 2.308 . . . . 0.0 106.555 -168.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.4 m -71.93 126.28 29.34 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -167.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.11 143.52 36.75 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.858 1.663 . . . . 0.0 111.667 172.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 60.3 m -98.4 127.77 44.49 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.143 0.977 . . . . 0.0 109.389 176.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -93.89 104.2 16.27 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.909 1.684 . . . . 0.0 109.311 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.453 HG22 ' CG2' ' A' ' 115' ' ' VAL . 44.4 t -99.06 117.92 44.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 C-N-CA 124.787 1.235 . . . . 0.0 109.225 -171.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -94.37 109.03 20.91 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.57 ' HE3' ' HB2' ' A' ' 113' ' ' ALA . 14.2 mmmm -111.14 101.83 10.32 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.727 2.011 . . . . 0.0 108.743 172.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -98.28 135.84 39.32 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.797 -1.19 . . . . 0.0 111.366 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.31 165.05 36.97 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 130.173 3.389 . . . . 0.0 104.407 -161.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -9.68 -123.01 0.0 OUTLIER Glycine 0 N--CA 1.486 1.996 0 C-N-CA 128.7 3.047 . . . . 0.0 115.286 -153.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 9.1 p -95.48 106.61 18.69 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 113.405 -3.318 . . . . 0.0 111.57 150.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.96 139.95 2.42 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 131.529 3.932 . . . . 0.0 107.276 131.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.1 t -63.38 133.41 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 117.104 -1.838 . . . . 0.0 108.482 152.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.68 140.44 39.54 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.7 0.682 . . . . 0.0 109.432 163.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.8 tp -110.64 106.15 15.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 163.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.9 m -86.93 118.64 26.45 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.88 1.672 . . . . 0.0 109.019 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 82.2 m -102.92 110.32 22.19 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.296 -1.502 . . . . 0.0 109.169 -172.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -99.92 109.8 22.15 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.658 -175.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mp -82.33 98.08 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 129.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.47 178.89 47.44 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 118.621 2.208 . . . . 0.0 118.621 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -126.21 45.79 1.62 Allowed Pre-proline 0 CA--C 1.56 1.331 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 160.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -52.18 155.36 9.23 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.826 3.017 . . . . 0.0 117.689 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -49.86 -33.42 16.93 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.841 2.456 . . . . 0.0 116.249 -162.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -92.99 -17.32 24.06 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.14 -35.61 59.91 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.622 2.769 . . . . 0.0 113.653 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -57.24 -43.03 82.57 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 118.486 -0.768 . . . . 0.0 111.845 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -98.26 -34.34 10.74 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.982 1.264 . . . . 0.0 114.105 -174.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.92 157.8 35.92 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 121.113 1.778 . . . . 0.0 112.166 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -164.12 134.38 4.17 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 -163.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.511 ' HD3' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -120.2 -178.03 3.57 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.638 1.575 . . . . 0.0 114.332 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.511 ' H ' ' HD3' ' A' ' 101' ' ' ARG . 8.9 p -163.37 174.67 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 127.733 2.413 . . . . 0.0 112.278 -140.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.425 ' HA ' HG13 ' A' ' 150' ' ' VAL . 75.0 m -129.72 135.51 48.56 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.081 -1.012 . . . . 0.0 111.333 144.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.3 t0 178.57 166.76 0.85 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 127.865 2.466 . . . . 0.0 107.249 -168.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -128.76 121.39 28.3 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.166 1.386 . . . . 0.0 113.959 162.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -160.38 -176.68 5.75 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 126.027 1.731 . . . . 0.0 110.923 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -80.67 165.67 21.78 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.442 -1.411 . . . . 0.0 111.481 164.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.7 tp -144.67 141.2 29.16 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.555 1.142 . . . . 0.0 111.149 -170.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.3 m -77.98 151.67 33.5 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.09 1.756 . . . . 0.0 115.293 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.65 -8.62 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 127.094 2.158 . . . . 0.0 116.131 -161.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -137.6 38.65 2.43 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.769 1.228 . . . . 0.0 112.787 -170.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -106.05 165.95 10.85 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.257 1.423 . . . . 0.0 113.753 -164.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.57 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . . . -146.95 133.73 20.06 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 125.537 1.535 . . . . 0.0 110.157 -170.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.8 144.28 20.2 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.823 1.249 . . . . 0.0 111.38 -174.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.453 ' CG2' HG22 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -129.77 141.76 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 121.472 1.942 . . . . 0.0 113.965 174.628 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.99 149.87 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.648 1.179 . . . . 0.0 110.784 175.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 t -146.6 172.59 13.34 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.013 0.925 . . . . 0.0 112.091 168.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.37 -34.17 66.4 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.71 -41.92 67.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.712 0.687 . . . . 0.0 112.385 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -75.4 -26.51 58.46 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.884 0.874 . . . . 0.0 112.734 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.2 tp -75.51 -38.96 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.212 1.005 . . . . 0.0 111.452 170.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -55.11 -39.96 69.96 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.23 1.012 . . . . 0.0 111.315 168.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -66.97 -20.22 65.85 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.344 1.058 . . . . 0.0 112.794 -173.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 66.9 mt -69.74 -41.43 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 118.67 0.668 . . . . 0.0 110.463 -177.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.499 ' H ' ' HD2' ' A' ' 126' ' ' PRO . 33.5 ttpt -167.39 -47.73 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.765 0 CA-C-O 116.559 -1.686 . . . . 0.0 112.301 175.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.499 ' HD2' ' H ' ' A' ' 125' ' ' LYS . 41.2 Cg_endo -82.58 -132.84 0.01 OUTLIER 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 122.606 2.204 . . . . 0.0 112.949 -170.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 20.9 t -166.7 133.94 2.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.2 1.8 . . . . 0.0 111.209 -164.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . 0.253 25.4 p30 -70.69 3.76 2.94 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 -161.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -104.67 10.4 34.8 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.61 1.964 . . . . 0.0 113.208 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.07 29.17 0.16 Allowed Glycine 0 CA--C 1.534 1.271 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.6 t -83.58 135.61 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 119.139 1.469 . . . . 0.0 112.349 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.49 105.67 11.9 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.992 0.917 . . . . 0.0 108.691 153.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.34 144.62 31.39 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.699 0.8 . . . . 0.0 110.086 166.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.457 HD21 HG21 ' A' ' 55' ' ' VAL . 48.0 t30 -137.05 136.93 38.83 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.692 0.797 . . . . 0.0 109.411 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 43.2 t -128.11 133.81 49.05 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.846 0.859 . . . . 0.0 111.42 -169.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.5 t -132.55 111.35 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.119 0.968 . . . . 0.0 109.483 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.658 HG23 HG22 ' A' ' 52' ' ' THR . 29.7 m -105.22 151.61 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.573 1.549 . . . . 0.0 110.595 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -124.7 135.63 53.2 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.152 1.381 . . . . 0.0 111.256 157.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.457 ' HE3' ' CE2' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -77.32 144.52 38.0 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.278 1.031 . . . . 0.0 112.166 135.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.0 m -147.31 76.57 1.41 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.735 2.014 . . . . 0.0 109.061 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -65.66 -48.48 71.99 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.539 -1.351 . . . . 0.0 113.617 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.1 m -57.75 -39.66 77.89 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.072 -1.017 . . . . 0.0 111.715 174.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.05 -0.16 68.95 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 126.304 1.907 . . . . 0.0 115.938 173.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 75.9 mtm 43.37 53.14 5.68 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.078 2.551 . . . . 0.0 115.241 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 99.5 p -148.66 163.39 37.42 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.457 ' CE2' ' HE3' ' A' ' 139' ' ' LYS . 41.8 m-85 -100.2 151.84 20.97 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.684 147.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -134.95 141.85 46.36 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.04 137.31 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.81 0.814 . . . . 0.0 110.647 -161.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -135.79 139.26 43.38 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.498 1.519 . . . . 0.0 108.587 169.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 103' ' ' CYS . 2.2 p -140.9 134.39 32.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 122.363 1.077 . . . . 0.0 109.196 149.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 30.2 m -116.65 143.18 27.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 127.95 2.5 . . . . 0.0 109.033 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.82 129.95 39.19 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -165.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -134.43 156.05 49.24 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.576 1.551 . . . . 0.0 110.799 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.552 ' H ' ' CD ' ' A' ' 155' ' ' PRO . . . -171.78 33.33 0.14 Allowed Glycine 0 CA--C 1.546 1.97 0 CA-C-O 116.364 -2.354 . . . . 0.0 117.28 161.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.552 ' CD ' ' H ' ' A' ' 154' ' ' GLY . 59.5 Cg_endo -105.62 -49.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.037 0 CA-C-N 121.812 2.806 . . . . 0.0 113.353 160.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -117.74 -26.96 6.38 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 53.79 1.28 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 118.289 2.7 . . . . 0.0 118.289 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.97 -45.31 94.23 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -155.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.91 -53.07 29.25 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -169.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -69.04 -31.56 70.43 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.889 0.876 . . . . 0.0 112.241 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -60.63 -55.31 34.79 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.048 0.84 . . . . 0.0 110.84 172.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -64.5 -34.16 77.56 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.385 -0.822 . . . . 0.0 112.721 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.21 -33.19 74.96 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.99 1.268 . . . . 0.0 112.654 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -50.97 51.29 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.425 1.49 . . . . 0.0 108.868 173.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 76.7 mt -60.59 -38.09 83.51 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.231 1.012 . . . . 0.0 111.439 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -70.0 -32.16 70.2 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 127.059 2.143 . . . . 0.0 112.939 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -86.72 -37.96 17.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.31 1.044 . . . . 0.0 113.359 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.6 pt -77.55 -34.2 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 119.33 0.968 . . . . 0.0 111.629 -178.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -63.45 -19.83 65.05 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.826 -0.546 . . . . 0.0 111.256 166.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -117.01 26.49 9.76 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 . . . . . 0 C--O 1.252 1.186 0 C-N-CA 128.42 2.688 . . . . 0.0 114.886 168.874 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 121.16 0.505 . . . . 0.0 111.443 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -64.21 -6.27 6.44 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 118.379 2.733 . . . . 0.0 118.379 -139.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.6 -4.24 15.54 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 120.37 1.441 . . . . 0.0 114.033 172.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 78.6 t -69.51 -56.17 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.825 1.25 . . . . 0.0 111.649 -172.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.34 -43.18 98.88 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.6 -54.31 43.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 117.925 0.862 . . . . 0.0 112.147 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -67.11 -37.85 84.59 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.088 -1.007 . . . . 0.0 113.602 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -69.18 -45.91 68.8 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.848 1.204 . . . . 0.0 111.845 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.85 -43.09 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.299 0.64 . . . . 0.0 109.745 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -68.88 -37.15 78.84 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.588 0.631 . . . . 0.0 112.609 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -76.02 -30.63 58.55 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.061 -1.024 . . . . 0.0 111.695 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.4 m -62.98 -46.52 87.32 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.799 1.636 . . . . 0.0 110.397 169.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.5 ttt-85 -52.84 -34.73 55.48 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.086 1.754 . . . . 0.0 112.396 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -83.03 -49.1 9.9 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.741 -1.224 . . . . 0.0 113.258 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.03 -28.86 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.41 1.084 . . . . 0.0 111.878 -174.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -91.71 -8.71 46.18 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.809 1.243 . . . . 0.0 112.633 171.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.5 mtp-105 58.09 17.98 4.89 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.925 2.09 . . . . 0.0 115.07 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 pp -94.31 159.04 15.3 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.331 1.452 . . . . 0.0 111.734 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -81.89 163.16 22.45 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 119.641 1.109 . . . . 0.0 112.467 176.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -64.8 -34.74 79.06 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 119.512 -1.993 . . . . 0.0 111.393 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -60.42 -16.85 39.96 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.429 2.291 . . . . 0.0 113.382 166.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -105.6 -9.83 17.17 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.958 1.254 . . . . 0.0 111.708 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.462 HD11 ' HB1' ' A' ' 48' ' ' ALA . 26.5 tp -91.47 135.57 33.74 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.265 1.826 . . . . 0.0 108.868 176.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -106.39 128.36 53.98 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 118.363 0.529 . . . . 0.0 112.395 170.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.4 mm -97.26 142.0 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.919 2.087 . . . . 0.0 112.829 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.2 m -124.92 146.34 49.4 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.371 0.987 . . . . 0.0 108.836 167.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -123.56 -153.42 0.55 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.336 2.254 . . . . 0.0 110.642 -163.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 t -36.8 -36.04 0.1 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 128.306 2.643 . . . . 0.0 116.241 -167.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.1 -43.56 70.5 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 174.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.72 -22.83 25.78 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 121.164 1.802 . . . . 0.0 112.419 175.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.8 mm -58.29 -39.7 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.144 0.977 . . . . 0.0 109.45 173.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 57.0 m -55.65 6.73 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -117.59 13.92 14.4 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 121.518 1.963 . . . . 0.0 112.034 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.9 170.2 5.68 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 126.511 1.924 . . . . 0.0 109.145 146.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -66.92 -51.14 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 121.721 1.614 . . . . 0.0 114.693 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -124.82 -34.32 2.83 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 117.562 2.43 . . . . 0.0 117.562 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -161.12 100.24 1.22 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 122.893 1.33 . . . . 0.0 109.458 -137.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.9 m -140.44 165.62 26.92 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.261 2.224 . . . . 0.0 107.507 173.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.46 HD13 ' HB2' ' A' ' 46' ' ' CYS 0.29 1.1 tm? -87.47 -77.2 0.35 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 117.288 -1.339 . . . . 0.0 113.058 -164.088 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.46 ' HB2' HD13 ' A' ' 45' ' ' LEU . 12.7 m -163.94 -175.56 4.12 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.954 1.706 . . . . 0.0 111.86 -172.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -119.82 156.98 29.62 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.301 1.44 . . . . 0.0 107.398 157.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -137.39 131.62 32.32 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.738 2.815 . . . . 0.0 108.07 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.5 ttp -121.93 134.47 54.85 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.232 1.378 . . . . 0.0 110.661 -169.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 mt -131.7 146.44 52.17 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 128.473 2.709 . . . . 0.0 113.385 -148.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.6 t -98.62 159.12 15.17 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.066 1.346 . . . . 0.0 113.581 -171.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -71.38 170.84 12.34 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.229 1.811 . . . . 0.0 112.66 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.7 t70 57.89 36.23 26.09 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 170.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.58 134.66 60.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.993 1.717 . . . . 0.0 110.079 -176.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.9 p -91.24 139.17 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.966 0.907 . . . . 0.0 109.456 159.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -134.28 136.93 26.88 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 118.862 0.756 . . . . 0.0 111.701 169.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.45 69.75 5.79 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.905 3.737 . . . . 0.0 111.105 177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.4 p -62.29 -43.53 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -152.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.97 -9.31 58.18 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.037 -1.039 . . . . 0.0 113.093 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -65.54 -33.37 75.77 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.775 1.171 . . . . 0.0 111.598 165.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.9 tp -70.18 -37.45 75.15 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.656 0.662 . . . . 0.0 111.32 173.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.92 -49.87 76.01 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.375 0.534 . . . . 0.0 111.911 173.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.3 p -67.45 -31.97 72.5 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 119.175 -0.44 . . . . 0.0 112.119 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -63.6 -39.15 93.63 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.947 0.794 . . . . 0.0 112.512 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -66.26 -51.71 54.85 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.492 1.042 . . . . 0.0 112.299 169.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.26 -41.07 83.45 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.662 0.385 . . . . 0.0 111.514 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 83.1 m -77.43 -2.57 35.96 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.95 -34.66 13.68 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.379 1.472 . . . . 0.0 114.046 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.2 m -137.29 -8.73 1.73 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.32 74.49 0.43 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 126.006 1.765 . . . . 0.0 112.523 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -166.9 136.44 2.94 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.304 1.442 . . . . 0.0 109.775 161.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.4 m -64.47 142.81 58.29 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.031 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.74 151.08 47.82 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 m -75.29 103.94 5.65 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.326 1.851 . . . . 0.0 109.768 167.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -87.74 99.83 12.38 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 166.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.07 147.4 6.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 C-N-CA 126.585 1.954 . . . . 0.0 108.254 -171.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -130.72 121.42 25.43 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 120.513 -1.367 . . . . 0.0 107.583 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -121.7 121.01 36.35 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.303 1.841 . . . . 0.0 109.412 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -95.84 125.41 40.38 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.895 1.678 . . . . 0.0 108.892 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.4 p -143.71 155.31 44.16 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -174.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.94 80.61 0.1 OUTLIER Glycine 0 N--CA 1.476 1.339 0 C-N-CA 130.39 3.852 . . . . 0.0 112.175 -172.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.3 t 168.95 -128.15 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 -136.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -129.28 178.7 6.25 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 130.379 3.472 . . . . 0.0 109.336 -176.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.8 t -75.96 136.66 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.574 -1.329 . . . . 0.0 109.203 164.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.3 m -114.78 152.62 31.78 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.858 0.754 . . . . 0.0 112.28 170.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 tp -108.81 108.68 19.58 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.084 2.154 . . . . 0.0 105.705 164.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.2 m -80.93 102.63 10.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 167.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 44.1 t -102.49 111.28 23.51 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 119.778 -1.826 . . . . 0.0 108.556 -173.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -150.93 151.0 31.52 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 118.628 2.825 . . . . 0.0 118.628 174.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.631 ' H ' HD13 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -70.94 84.17 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 112.632 -2.077 . . . . 0.0 108.503 143.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.22 166.21 38.61 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 118.7 2.24 . . . . 0.0 118.7 -163.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -156.27 49.35 0.4 Allowed Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -170.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -47.4 121.25 5.22 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.241 1.961 . . . . 0.0 113.112 166.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -44.17 -13.69 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 118.615 2.82 . . . . 0.0 118.615 -169.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 95' ' ' ARG . 3.7 mmp_? -59.89 -23.59 63.59 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.283 1.401 . . . . 0.0 113.856 163.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -50.93 -28.58 10.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.831 2.052 . . . . 0.0 112.72 166.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -62.28 -34.8 77.26 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.661 175.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -115.75 -22.39 9.16 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -174.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.502 ' C ' HD12 ' A' ' 99' ' ' LEU . 2.4 pp -75.67 165.59 24.83 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 121.346 1.885 . . . . 0.0 114.1 -176.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -152.16 118.08 5.47 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -163.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.471 ' HD2' ' H ' ' A' ' 102' ' ' VAL . 0.1 OUTLIER -107.43 178.15 4.62 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 120.495 1.498 . . . . 0.0 111.926 161.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.471 ' H ' ' HD2' ' A' ' 101' ' ' ARG . 3.0 p -172.35 173.62 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.587 -140.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.421 ' HA ' HG13 ' A' ' 150' ' ' VAL . 64.8 m -120.86 124.82 45.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.33 0.652 . . . . 0.0 109.501 137.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -172.31 171.41 4.79 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.71 2.404 . . . . 0.0 107.514 -166.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -122.72 99.85 6.61 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.006 2.522 . . . . 0.0 110.061 172.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -140.51 148.4 41.02 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 -173.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -82.19 142.04 32.52 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.914 1.286 . . . . 0.0 110.578 165.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 37.9 tp -148.23 141.59 25.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.076 0.95 . . . . 0.0 110.087 -150.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 p -93.09 168.9 10.81 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 116.941 2.201 . . . . 0.0 116.941 -169.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.6 t -69.76 -6.92 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 128.145 2.578 . . . . 0.0 113.083 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -134.74 45.84 2.51 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.469 1.108 . . . . 0.0 110.25 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -125.59 152.26 45.35 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 116.064 1.875 . . . . 0.0 116.064 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.696 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -149.3 142.46 25.0 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.632 -146.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.696 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -144.38 147.95 34.06 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.183 1.393 . . . . 0.0 111.521 -168.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -136.31 141.64 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 121.404 1.911 . . . . 0.0 113.166 158.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.59 153.28 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.88 0.872 . . . . 0.0 110.538 167.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.0 t -143.01 167.34 22.29 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.696 0.798 . . . . 0.0 109.979 162.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.93 -36.09 76.3 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -160.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.7 73.03 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.791 -1.193 . . . . 0.0 113.791 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -70.7 -30.83 67.51 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.394 -0.816 . . . . 0.0 111.627 175.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.0 mm -73.37 -35.51 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.012 0.925 . . . . 0.0 111.076 169.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -59.9 -25.48 65.14 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.448 -0.783 . . . . 0.0 111.931 170.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -83.2 -7.64 59.59 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 168.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.9 mt -89.21 -40.05 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.803 1.183 . . . . 0.0 109.987 167.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -143.31 124.36 8.16 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.603 1.161 . . . . 0.0 110.413 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -82.5 60.1 7.16 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 123.943 3.095 . . . . 0.0 114.355 -163.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 45.6 t -155.84 134.59 11.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.56 1.544 . . . . 0.0 110.201 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -122.85 -4.01 8.63 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -85.2 12.85 7.16 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.85 50.83 0.06 OUTLIER Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.71 1.148 . . . . 0.0 113.516 -176.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.83 125.12 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 117.947 0.873 . . . . 0.0 110.701 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.83 88.04 2.52 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.518 1.527 . . . . 0.0 108.229 169.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.608 HG22 ' HA ' ' A' ' 152' ' ' ALA . 17.6 p -83.83 146.39 28.14 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.908 0.883 . . . . 0.0 109.316 164.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.46 125.77 52.15 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 18.8 t -118.43 127.8 54.0 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.39 0.996 . . . . 0.0 109.131 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.4 t -138.43 116.91 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.411 1.084 . . . . 0.0 109.149 -167.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 148' ' ' ILE . 20.1 m -112.3 140.59 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.268 -0.895 . . . . 0.0 111.421 -175.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 29.0 ttm105 -129.57 98.23 4.77 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 122.162 0.982 . . . . 0.0 110.343 171.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.473 ' HG3' ' CD2' ' A' ' 146' ' ' TYR 0.251 9.0 tmtt? -120.13 134.98 55.11 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.767 1.227 . . . . 0.0 109.047 -178.202 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.1 m -161.45 133.33 5.67 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.026 1.33 . . . . 0.0 110.585 -164.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -85.68 -35.55 20.81 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.766 -0.584 . . . . 0.0 112.496 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.1 p -48.45 -50.12 32.65 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.201 1.401 . . . . 0.0 113.398 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -96.29 11.25 67.28 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.258 1.885 . . . . 0.0 115.074 171.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 41.1 ttm 44.61 57.35 4.53 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.114 2.166 . . . . 0.0 115.397 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 97.9 p -147.82 142.86 27.02 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.473 ' CD2' ' HG3' ' A' ' 139' ' ' LYS . 1.0 OUTLIER -106.65 144.54 33.17 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 163.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -150.87 147.26 27.01 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.445 -1.409 . . . . 0.0 109.492 -173.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . 0.428 HG13 HG12 ' A' ' 137' ' ' VAL . 6.8 tt -141.62 140.31 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 122.213 1.006 . . . . 0.0 113.4 -176.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -135.31 115.44 13.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.033 1.333 . . . . 0.0 109.941 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.421 HG13 ' HA ' ' A' ' 103' ' ' CYS 0.28 7.3 p -139.27 145.14 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 121.129 -0.982 . . . . 0.0 112.981 174.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.3 m -141.31 151.55 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 128.109 2.564 . . . . 0.0 109.643 -167.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.608 ' HA ' HG22 ' A' ' 133' ' ' THR . . . -125.59 125.73 43.65 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -168.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -142.18 156.88 45.36 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.686 1.194 . . . . 0.0 111.926 175.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -91.51 -148.92 22.87 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 124.519 1.057 . . . . 0.0 112.177 165.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.94 -22.72 10.69 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 124.53 3.487 . . . . 0.0 117.041 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.13 1.46 2.79 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 126.423 1.889 . . . . 0.0 115.595 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -90.86 38.84 0.97 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.192 1.797 . . . . 0.0 112.163 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -62.36 -28.85 70.05 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -167.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.32 -51.49 51.83 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.918 0.781 . . . . 0.0 112.099 -176.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -65.18 -34.21 77.84 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.934 0.894 . . . . 0.0 112.468 170.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -62.02 -49.31 76.53 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.427 1.012 . . . . 0.0 111.457 175.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -65.83 -29.67 70.17 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.81 -1.182 . . . . 0.0 112.701 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.42 83.91 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 119.189 0.904 . . . . 0.0 112.671 171.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.92 -54.29 19.84 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.523 1.129 . . . . 0.0 112.763 174.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.7 mp -46.79 -34.92 5.68 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.752 1.221 . . . . 0.0 113.983 167.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -74.67 -25.78 59.41 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.46 1.504 . . . . 0.0 113.357 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -89.71 -36.63 15.09 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.537 1.062 . . . . 0.0 113.664 170.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.2 pt -88.42 -42.37 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.063 -1.023 . . . . 0.0 112.724 -169.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -71.33 -6.15 37.78 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.622 1.555 . . . . 0.0 111.355 171.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -119.62 23.18 11.3 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 172.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 . . . . . 0 C--O 1.252 1.207 0 C-N-CA 126.472 1.909 . . . . 0.0 112.503 169.967 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -19.03 64.53 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -163.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -85.21 -24.0 28.05 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.798 0.839 . . . . 0.0 112.283 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.4 t -73.38 -53.68 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.682 1.193 . . . . 0.0 112.565 -165.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.12 -52.04 53.78 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 168.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.8 -39.93 59.53 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 118.443 1.121 . . . . 0.0 113.323 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -74.74 -39.24 61.96 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.867 -1.146 . . . . 0.0 113.972 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.12 -40.74 98.5 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.614 1.166 . . . . 0.0 111.7 173.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.52 -43.05 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.053 1.341 . . . . 0.0 109.721 174.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.4 m -66.64 -31.21 71.75 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.296 -0.878 . . . . 0.0 112.918 175.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -67.37 -44.19 79.57 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.318 -0.864 . . . . 0.0 109.345 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.3 m -60.55 -43.61 97.04 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.168 -1.582 . . . . 0.0 111.753 175.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -54.24 -32.09 55.11 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.27 1.828 . . . . 0.0 112.8 171.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.22 -46.79 10.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.053 1.341 . . . . 0.0 113.449 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.6 mm -66.63 -49.21 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 119.691 1.132 . . . . 0.0 110.889 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.66 -2.88 57.11 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.036 1.334 . . . . 0.0 112.528 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 59.33 11.52 2.21 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 127.629 2.372 . . . . 0.0 115.43 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.458 HD11 HD13 ' A' ' 29' ' ' LEU . 2.7 pp -94.45 154.97 17.17 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.112 0.965 . . . . 0.0 111.172 -176.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.81 155.93 38.21 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.441 -0.787 . . . . 0.0 112.917 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.79 -24.13 63.87 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.83 -1.169 . . . . 0.0 112.546 171.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -97.04 8.74 43.85 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.489 1.516 . . . . 0.0 113.316 172.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -118.73 8.52 11.88 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.963 1.705 . . . . 0.0 111.478 167.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.458 HD13 HD11 ' A' ' 24' ' ' LEU . 21.3 tp -107.74 127.7 53.92 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.859 2.463 . . . . 0.0 107.521 166.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -94.34 115.39 27.61 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 120.076 1.307 . . . . 0.0 111.305 171.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.451 HD11 HD23 ' A' ' 29' ' ' LEU . 32.8 mm -91.02 143.06 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.292 1.437 . . . . 0.0 112.58 170.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.4 m -126.71 147.75 49.93 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 162.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.57 -148.29 0.26 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.309 1.444 . . . . 0.0 112.265 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.9 t -58.51 -29.17 66.08 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -162.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.77 -33.36 34.9 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -169.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.62 -4.84 27.66 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.45 14.42 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 124.806 1.242 . . . . 0.0 111.974 167.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.4 t -57.89 12.06 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 128.64 2.776 . . . . 0.0 117.985 -163.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.407 ' HE2' ' CD1' ' A' ' 92' ' ' PHE . 48.9 tptt -57.4 -40.37 78.12 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 119.798 -1.814 . . . . 0.0 113.033 -172.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -127.02 139.19 34.4 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 132.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -58.54 -31.06 93.61 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 CA-C-N 121.663 1.63 . . . . 0.0 112.571 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -96.46 30.97 2.37 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.237 1.815 . . . . 0.0 110.403 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -147.86 101.12 3.28 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.472 1.487 . . . . 0.0 107.299 159.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 p 179.91 151.24 0.4 Allowed 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.985 -1.072 . . . . 0.0 111.986 -139.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.36 -81.17 0.52 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 164.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.1 p -166.51 -174.48 2.85 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -174.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -122.82 154.98 37.51 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.403 1.881 . . . . 0.0 107.891 163.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.95 122.81 10.64 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.797 1.635 . . . . 0.0 109.094 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.3 ttm -117.94 129.28 55.52 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.748 -1.22 . . . . 0.0 111.564 -160.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.27 0.3 OUTLIER -138.4 156.6 47.44 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 124.677 2.18 . . . . 0.0 115.979 -159.019 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 t -99.24 167.96 10.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 130.446 3.498 . . . . 0.0 108.515 -172.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -50.95 114.0 1.06 Allowed 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.574 1.079 . . . . 0.0 109.334 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.471 ' C ' HD13 ' A' ' 54' ' ' ILE . 1.3 t70 -151.69 156.8 41.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.754 1.264 . . . . 0.0 109.865 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.471 HD13 ' C ' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -119.51 -176.8 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 113.243 -1.799 . . . . 0.0 109.044 -146.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.5 p -70.16 121.65 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 121.485 -0.759 . . . . 0.0 111.598 -132.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -130.34 151.5 78.63 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -166.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -80.22 80.98 2.88 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 124.425 3.417 . . . . 0.0 111.031 -166.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 p -69.42 -39.17 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -164.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.2 -33.36 75.21 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 119.688 1.131 . . . . 0.0 113.26 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -57.7 -37.86 74.22 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 119.105 -0.474 . . . . 0.0 110.621 167.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.51 -44.88 61.6 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.917 1.287 . . . . 0.0 112.083 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.405 ' HA ' ' CE1' ' A' ' 75' ' ' PHE . 5.1 mp -52.5 -46.73 66.77 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 122.147 0.975 . . . . 0.0 110.621 169.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.1 m -72.23 -39.81 68.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.616 0.766 . . . . 0.0 112.168 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -63.94 -41.78 97.51 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.736 0.698 . . . . 0.0 110.837 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.15 -55.65 29.86 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.272 1.029 . . . . 0.0 110.993 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.38 -29.36 68.05 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -176.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.1 t -76.35 -32.09 58.46 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -61.25 -25.68 67.24 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 -161.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.7 t -141.66 4.97 1.76 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.661 1.184 . . . . 0.0 113.289 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.52 78.4 0.2 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.895 1.712 . . . . 0.0 111.34 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -166.64 134.18 2.62 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.007 1.723 . . . . 0.0 107.555 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.3 m -76.64 149.73 36.47 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 128.19 2.596 . . . . 0.0 112.973 -173.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -152.05 165.43 34.74 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.628 1.171 . . . . 0.0 113.839 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 27.4 p -108.81 142.37 39.48 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.432 0.693 . . . . 0.0 111.551 156.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.405 ' CE1' ' HA ' ' A' ' 62' ' ' LEU . 3.0 m-85 -82.6 132.58 35.19 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.442 1.097 . . . . 0.0 108.887 165.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.852 HG22 HG22 ' A' ' 115' ' ' VAL . 61.8 t -130.47 151.34 35.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 124.734 1.214 . . . . 0.0 109.348 -172.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -131.05 122.59 27.03 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -124.62 108.77 12.4 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.906 2.083 . . . . 0.0 108.538 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -90.74 123.37 34.27 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.381 -0.824 . . . . 0.0 109.447 173.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.8 p -148.07 150.52 34.05 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 130.132 3.373 . . . . 0.0 104.147 -166.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -11.5 -133.53 0.0 OUTLIER Glycine 0 N--CA 1.481 1.648 0 O-C-N 117.802 -3.061 . . . . 0.0 114.841 -121.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 13.2 p -90.69 88.22 7.01 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 120.145 1.972 . . . . 0.0 108.434 169.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.0 ttt85 -169.61 144.02 2.85 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 128.605 2.762 . . . . 0.0 109.044 166.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.1 t -83.32 140.02 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 119.995 1.271 . . . . 0.0 109.675 171.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.45 143.8 40.23 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 121.007 -1.058 . . . . 0.0 111.328 157.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tp -107.95 107.0 17.52 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 171.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.436 ' HB3' ' CE1' ' A' ' 89' ' ' TYR . 7.5 m -98.1 130.26 44.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.383 -172.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 76.1 m -117.57 108.38 15.4 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.11 -1.619 . . . . 0.0 109.007 -170.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CE1' ' HB3' ' A' ' 87' ' ' SER . 14.4 m-30 -121.92 98.43 5.94 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.414 0.626 . . . . 0.0 110.619 -157.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.3 mt -59.88 -38.36 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.46 -177.54 16.37 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.802 1.668 . . . . 0.0 110.634 166.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.407 ' CD1' ' HE2' ' A' ' 39' ' ' LYS . 26.4 p90 -107.46 96.05 15.29 Favored Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -163.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.38 -177.76 3.23 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 124.126 3.217 . . . . 0.0 115.973 -173.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -50.37 -39.58 46.97 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 117.284 2.328 . . . . 0.0 117.284 -160.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.265 17.1 mmt180 -98.85 -3.67 34.86 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 175.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.55 -33.86 47.58 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.556 2.343 . . . . 0.0 114.052 175.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -50.82 -35.9 34.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.398 1.079 . . . . 0.0 111.45 169.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.01 -27.8 8.27 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -169.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.439 HD12 HG23 ' A' ' 115' ' ' VAL . 3.9 pp -87.37 144.54 26.72 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 121.042 1.746 . . . . 0.0 112.231 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -157.07 126.43 6.04 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -153.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -115.57 -172.3 2.13 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 128.369 2.668 . . . . 0.0 112.529 173.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -166.22 168.55 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 129.094 2.957 . . . . 0.0 108.842 -135.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -123.45 122.48 38.34 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.142 0.883 . . . . 0.0 110.695 138.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -176.88 175.53 1.6 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 129.029 2.931 . . . . 0.0 106.144 -165.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -105.93 117.91 35.23 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 128.28 2.632 . . . . 0.0 109.04 171.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -151.18 160.05 44.07 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -92.55 162.7 14.09 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.892 1.677 . . . . 0.0 112.613 170.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.8 mt -141.06 152.05 44.51 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 129.441 3.096 . . . . 0.0 111.026 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 m -128.12 167.3 16.97 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.822 2.449 . . . . 0.0 110.224 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.283 0.9 OUTLIER -69.92 -4.88 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -173.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -122.25 32.9 5.63 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.556 1.143 . . . . 0.0 113.012 167.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -104.01 132.66 50.05 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.095 -1.003 . . . . 0.0 110.303 -173.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.728 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -140.25 138.08 34.77 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.122 0.969 . . . . 0.0 112.846 -166.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.728 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -144.22 141.15 29.71 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.974 1.31 . . . . 0.0 112.712 -165.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.852 HG22 HG22 ' A' ' 76' ' ' VAL . 17.0 t -118.42 137.9 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 126.603 1.961 . . . . 0.0 111.919 168.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.1 t -125.66 121.36 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.744 0.783 . . . . 0.0 109.711 157.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 73.3 p -90.02 163.95 14.71 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.075 0.95 . . . . 0.0 110.575 165.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.47 -35.23 73.68 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.332 -0.855 . . . . 0.0 111.08 174.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.38 -34.88 78.2 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -63.12 -33.52 75.63 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.953 1.251 . . . . 0.0 112.175 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.8 mm -77.18 -36.07 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.087 0.955 . . . . 0.0 111.433 172.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -54.88 -38.65 67.8 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.802 0.841 . . . . 0.0 111.294 174.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.3 mmt-85 -74.16 -12.77 60.68 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.427 ' C ' ' HE2' ' A' ' 125' ' ' LYS . 20.3 mt -73.25 -26.54 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 119.973 1.26 . . . . 0.0 110.192 175.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.427 ' HE2' ' C ' ' A' ' 124' ' ' ILE . 0.5 OUTLIER -105.12 161.5 22.56 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 125.127 1.371 . . . . 0.0 111.634 175.211 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -74.35 -39.69 1.45 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.623 2.215 . . . . 0.0 113.131 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 42.2 t -152.41 134.34 14.84 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.58 1.952 . . . . 0.0 108.439 174.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -73.8 -53.29 10.6 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 -154.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? 51.74 10.31 0.1 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 128.66 2.784 . . . . 0.0 116.823 166.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 132.75 67.45 0.08 OUTLIER Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.337 1.446 . . . . 0.0 112.536 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 76.8 t -72.85 130.48 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.216 0.607 . . . . 0.0 111.289 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 50.4 tp -119.37 157.59 27.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 123.147 1.451 . . . . 0.0 109.169 145.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 49.8 m -149.48 146.56 27.47 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 119.392 -2.068 . . . . 0.0 106.426 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -123.99 127.93 48.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -166.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 38.2 t -126.65 138.37 53.41 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.213 0.605 . . . . 0.0 109.945 -171.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.8 t -142.84 139.53 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.31 1.444 . . . . 0.0 108.966 -174.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.5 m -129.5 139.04 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.849 0.833 . . . . 0.0 112.152 174.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 43.2 mtm105 -126.0 150.58 47.97 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 127.985 2.514 . . . . 0.0 108.685 172.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.27 1.9 tmtt? -153.24 151.72 30.38 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.434 1.094 . . . . 0.0 109.07 172.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.6 t -134.22 127.83 32.71 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.787 1.176 . . . . 0.0 107.84 170.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -73.23 -55.61 6.21 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.084 0.402 . . . . 0.0 111.069 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.1 p -65.07 -31.87 73.3 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.176 1.391 . . . . 0.0 113.077 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.05 2.22 76.48 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.874 1.226 . . . . 0.0 115.222 170.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.8 mmt 48.12 40.74 14.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.095 1.758 . . . . 0.0 114.96 173.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.3 m -147.91 137.74 22.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.397 0.679 . . . . 0.0 111.58 -170.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -125.35 131.42 53.0 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -152.46 112.27 3.97 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 120.468 1.486 . . . . 0.0 112.89 -147.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 4.8 pt -137.12 151.57 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 O-C-N 120.932 -1.105 . . . . 0.0 113.351 -163.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.34 144.15 36.16 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.938 0.875 . . . . 0.0 111.507 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.8 p -146.18 136.93 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 121.07 -1.019 . . . . 0.0 109.927 169.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.5 m -131.7 125.79 56.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.723 1.609 . . . . 0.0 108.843 -165.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -113.98 135.7 53.71 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.955 0.902 . . . . 0.0 112.409 -167.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -144.38 159.13 43.25 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.175 0.988 . . . . 0.0 113.614 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -89.74 -140.97 8.29 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 160.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.04 83.89 0.26 Allowed 'Trans proline' 0 CA--C 1.548 1.22 0 CA-C-N 119.344 1.572 . . . . 0.0 110.421 153.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -123.02 -25.29 4.57 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 172.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.11 74.91 1.42 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -172.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -51.05 -35.4 34.41 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.136 -1.393 . . . . 0.0 112.396 175.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.54 -35.1 75.18 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.464 1.029 . . . . 0.0 113.311 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.13 -44.04 55.22 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.345 1.058 . . . . 0.0 111.637 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -54.75 -49.27 71.25 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.51 1.05 . . . . 0.0 111.36 175.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -63.98 -41.02 97.66 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.843 1.657 . . . . 0.0 112.261 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.23 -31.65 72.22 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.473 -0.767 . . . . 0.0 112.554 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.63 -47.24 61.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.226 -0.921 . . . . 0.0 112.982 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 96.6 mt -53.72 -37.69 63.56 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.011 0.525 . . . . 0.0 111.772 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 88.1 mtm-85 -75.54 -32.9 60.61 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -73.93 -39.18 63.97 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.353 1.061 . . . . 0.0 112.646 173.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.9 pt -90.91 -38.62 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.144 -0.972 . . . . 0.0 112.639 -168.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -85.81 4.41 37.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.657 0.662 . . . . 0.0 111.44 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.75 29.52 5.0 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 165.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 . . . . . 0 C--O 1.258 1.542 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 -179.512 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -48.18 -32.51 7.15 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.246 2.218 . . . . 0.0 114.746 174.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -93.46 -25.09 17.79 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.084 0.856 . . . . 0.0 112.04 -177.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.3 t -62.55 -51.02 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.064 0.946 . . . . 0.0 109.762 170.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.36 -50.49 59.63 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.233 -0.759 . . . . 0.0 112.291 168.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.42 -47.25 79.45 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.805 1.303 . . . . 0.0 113.055 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -74.07 -40.86 62.49 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.092 0.957 . . . . 0.0 112.615 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.51 -33.33 62.77 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.552 1.524 . . . . 0.0 113.074 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.1 mp -68.92 -38.92 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 119.06 0.845 . . . . 0.0 109.555 169.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.6 m -59.9 -45.44 92.51 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.054 -1.029 . . . . 0.0 112.483 171.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -77.55 -28.07 51.74 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -173.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 p -66.79 -53.2 35.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.135 1.334 . . . . 0.0 110.252 168.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -49.16 -46.65 45.66 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.611 1.564 . . . . 0.0 112.786 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -70.22 -49.21 52.5 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.014 1.726 . . . . 0.0 114.463 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.93 -26.49 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.687 1.131 . . . . 0.0 111.198 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.6 mt -82.07 -17.21 47.42 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 171.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 46.32 56.45 6.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.959 1.704 . . . . 0.0 112.343 -167.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 pp -125.99 166.53 16.76 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.886 1.274 . . . . 0.0 111.122 167.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -75.92 158.31 32.18 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.755 1.222 . . . . 0.0 112.503 176.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -61.94 -21.74 65.03 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 119.994 -1.692 . . . . 0.0 114.175 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -95.56 3.05 54.47 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.215 1.006 . . . . 0.0 112.932 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -101.54 -12.62 18.36 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.477 1.111 . . . . 0.0 111.487 169.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.48 HD23 HD11 ' A' ' 31' ' ' ILE . 18.2 tp -88.84 137.71 32.07 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.538 1.935 . . . . 0.0 105.863 165.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.477 ' H ' ' HB3' ' A' ' 49' ' ' MET . 39.9 ttt-85 -102.48 124.77 48.63 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.938 160.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.48 HD11 HD23 ' A' ' 29' ' ' LEU . 41.3 mm -90.42 142.75 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 125.469 1.508 . . . . 0.0 110.815 168.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.3 m -117.62 136.51 53.25 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 149.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -87.0 -151.09 0.16 Allowed 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 t -59.79 -21.21 60.5 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -166.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.37 -32.07 24.55 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.267 0.9 OUTLIER -96.03 -8.67 32.95 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 176.531 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.3 11.52 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.323 1.449 . . . . 0.0 111.732 166.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.9 t -64.15 6.43 0.18 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.627 2.371 . . . . 0.0 115.352 -167.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -61.37 -21.49 64.09 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 121.042 -1.036 . . . . 0.0 111.167 174.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -142.54 124.84 8.95 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 140.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.86 -15.98 53.07 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 121.842 1.695 . . . . 0.0 114.119 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -105.96 23.29 14.22 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.369 2.267 . . . . 0.0 111.97 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -154.92 94.44 1.65 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 170.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.1 p 175.57 154.78 0.17 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.727 -1.579 . . . . 0.0 108.083 -142.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.92 -82.22 0.48 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.367 1.44 . . . . 0.0 114.446 151.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 9.2 m -163.99 177.72 8.28 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.734 1.214 . . . . 0.0 112.966 -172.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -115.95 155.87 27.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.06 1.744 . . . . 0.0 108.59 165.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -131.9 138.86 48.56 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.208 2.603 . . . . 0.0 107.481 175.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.477 ' HB3' ' H ' ' A' ' 30' ' ' ARG . 11.1 tmm? -126.5 131.64 51.57 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.092 1.315 . . . . 0.0 109.329 -169.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 mt -123.27 142.36 51.02 Favored 'General case' 0 C--O 1.245 0.847 0 O-C-N 127.074 2.734 . . . . 0.0 111.736 -153.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.3 p -97.07 161.62 13.74 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.262 2.225 . . . . 0.0 112.673 -172.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.8 t -67.58 143.37 56.11 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . 0.271 12.7 t70 66.21 33.09 7.54 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.795 2.438 . . . . 0.0 114.646 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 tp -109.83 137.33 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.721 1.209 . . . . 0.0 111.858 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 p -110.4 141.12 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 125.701 1.6 . . . . 0.0 112.655 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -136.48 120.24 12.39 Favored Pre-proline 0 CA--C 1.548 0.9 0 O-C-N 120.803 -1.186 . . . . 0.0 111.64 166.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -65.29 80.23 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 125.03 3.82 . . . . 0.0 112.003 168.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.3 p -67.15 -30.75 50.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -151.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -55.2 -39.28 69.43 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 119.036 0.835 . . . . 0.0 112.538 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -62.38 -27.19 68.91 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.69 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.2 tp -81.3 -48.96 11.31 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.922 1.289 . . . . 0.0 112.511 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 mp -53.65 -49.2 68.45 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.461 0.704 . . . . 0.0 110.189 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.0 m -74.8 -27.54 60.35 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.254 1.022 . . . . 0.0 113.1 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -61.44 -34.69 75.84 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.294 1.406 . . . . 0.0 112.456 169.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . 0.421 ' CZ2' HD11 ' A' ' 90' ' ' ILE . 41.6 t-105 -70.63 -57.75 4.39 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.461 0.573 . . . . 0.0 112.05 167.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.54 -36.35 83.48 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -169.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 45.7 t -59.01 -17.49 25.54 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.686 1.594 . . . . 0.0 113.355 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.1 ttt85 -70.21 -43.64 70.26 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.199 -0.938 . . . . 0.0 112.768 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.5 m -159.22 3.35 0.09 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -169.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.93 82.72 0.11 Allowed Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.205 0.907 . . . . 0.0 111.481 -171.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -146.65 124.51 11.96 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 126.862 2.065 . . . . 0.0 106.833 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.3 m -78.42 117.09 19.31 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 126.25 1.82 . . . . 0.0 112.482 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.24 139.26 35.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.889 1.675 . . . . 0.0 110.828 168.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 39.1 m -102.24 145.48 29.36 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.887 0.851 . . . . 0.0 111.256 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.82 105.09 10.85 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.711 1.604 . . . . 0.0 108.923 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.7 t -96.32 154.04 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 126.677 1.991 . . . . 0.0 108.815 176.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -142.11 110.82 6.17 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.874 2.07 . . . . 0.0 106.856 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -111.15 115.35 29.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.021 2.128 . . . . 0.0 110.161 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -93.12 134.85 34.87 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.691 -0.671 . . . . 0.0 112.046 174.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.1 p -153.65 167.44 29.57 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 130.892 3.677 . . . . 0.0 107.088 -156.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -9.81 -124.99 0.0 OUTLIER Glycine 0 N--CA 1.49 2.294 0 C-N-CA 130.063 3.697 . . . . 0.0 116.296 -167.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 17.1 m -96.45 104.39 16.36 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 111.774 -3.97 . . . . 0.0 107.97 146.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.42 139.29 0.44 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 129.753 3.221 . . . . 0.0 109.272 151.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.9 t -74.73 134.77 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.97 1.259 . . . . 0.0 110.05 154.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.46 138.93 45.09 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.59 0.756 . . . . 0.0 110.288 163.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.2 tt -111.16 112.48 24.3 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.089 1.755 . . . . 0.0 106.452 170.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.421 ' HB3' ' CE1' ' A' ' 89' ' ' TYR . 2.3 m -95.87 126.88 41.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.256 -178.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 49.0 t -108.5 111.03 22.68 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 119.976 -1.703 . . . . 0.0 107.9 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 87' ' ' SER . 21.9 m-30 -116.44 100.38 7.83 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.971 0.415 . . . . 0.0 111.507 -169.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.421 HD11 ' CZ2' ' A' ' 65' ' ' TRP . 42.9 mt -62.32 115.28 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 130.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -178.83 167.46 37.8 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 122.445 3.738 . . . . 0.0 122.445 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -126.47 49.66 4.11 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 126.748 2.019 . . . . 0.0 113.895 155.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.04 172.73 14.91 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.595 2.863 . . . . 0.0 114.38 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.1 -40.78 59.7 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -156.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.268 11.7 tpt180 -95.68 -7.33 37.77 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 116.299 1.962 . . . . 0.0 116.299 -177.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -51.09 -42.29 60.52 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 128.774 2.829 . . . . 0.0 113.708 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -64.5 -27.4 68.95 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 117.434 -1.27 . . . . 0.0 112.52 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -106.15 -24.78 12.26 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.411 HD22 ' HB1' ' A' ' 113' ' ' ALA . 3.8 pp -75.41 161.06 29.56 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-N 121.358 1.89 . . . . 0.0 113.647 169.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -168.24 137.02 2.35 Favored 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 117.746 2.499 . . . . 0.0 117.746 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.401 ' CG ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -105.83 179.72 4.19 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 127.639 2.376 . . . . 0.0 111.453 178.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.401 ' H ' ' CG ' ' A' ' 101' ' ' ARG . 2.5 p -165.82 174.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.465 1.906 . . . . 0.0 112.172 -142.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.449 ' HA ' HG13 ' A' ' 150' ' ' VAL . 11.1 t -117.22 121.88 42.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.822 1.249 . . . . 0.0 109.354 151.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -171.55 153.7 3.54 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.369 1.868 . . . . 0.0 108.082 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -120.76 112.16 18.49 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.35 1.86 . . . . 0.0 110.724 172.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -160.06 -172.8 3.76 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.82 1.248 . . . . 0.0 112.04 -157.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -102.43 160.52 14.48 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.094 0.957 . . . . 0.0 111.84 164.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.4 tp -134.59 151.37 51.03 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 128.661 2.784 . . . . 0.0 108.668 -168.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 m -124.21 158.51 32.25 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.004 1.722 . . . . 0.0 111.818 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -5.17 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 126.143 1.777 . . . . 0.0 115.543 -166.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -127.14 55.13 1.59 Allowed 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.946 -1.096 . . . . 0.0 112.186 170.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.25 152.73 23.72 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 177.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.411 ' HB1' HD22 ' A' ' 99' ' ' LEU . . . -149.34 128.44 12.76 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 126.218 1.807 . . . . 0.0 107.402 -172.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.84 143.95 21.03 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 121.054 -1.029 . . . . 0.0 110.891 -172.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.73 140.69 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 125.285 1.434 . . . . 0.0 114.423 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.2 t -134.79 154.12 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.07 1.748 . . . . 0.0 111.442 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.6 t -143.07 170.34 15.9 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.27 1.828 . . . . 0.0 110.152 171.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.19 -31.47 63.49 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.873 -1.142 . . . . 0.0 113.875 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.14 -32.54 67.01 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 118.623 0.647 . . . . 0.0 112.579 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -67.92 -44.8 76.06 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.641 1.177 . . . . 0.0 110.249 176.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 37.5 mm -67.33 -33.67 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.705 -0.622 . . . . 0.0 111.252 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -62.65 -24.65 67.72 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.245 -0.909 . . . . 0.0 113.285 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -80.85 -15.67 55.74 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 120.741 1.61 . . . . 0.0 113.701 168.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.7 mt -73.81 -44.34 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 120.309 1.413 . . . . 0.0 111.392 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -173.24 -38.55 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.181 0 CA-C-O 116.687 -1.625 . . . . 0.0 112.092 168.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -73.21 -147.04 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.259 0 C-N-CA 123.068 2.512 . . . . 0.0 115.753 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 5.3 t -152.63 138.95 18.45 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 129.967 3.307 . . . . 0.0 108.844 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.04 -0.9 17.82 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 119.816 3.265 . . . . 0.0 119.816 -151.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.34 19.29 20.04 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -173.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.59 12.38 0.76 Allowed Glycine 0 N--CA 1.473 1.144 0 C-N-CA 124.322 0.963 . . . . 0.0 114.735 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.44 125.5 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 118.15 0.975 . . . . 0.0 111.907 -167.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.81 85.81 2.45 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.644 1.212 . . . . 0.0 108.097 162.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.1 t -90.83 148.35 22.57 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.978 0.911 . . . . 0.0 109.914 166.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -141.58 137.61 32.05 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.966 0.906 . . . . 0.0 110.203 -169.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 35.9 t -135.05 130.32 35.44 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.188 0.449 . . . . 0.0 110.11 -160.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.1 t -135.54 126.91 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.076 1.351 . . . . 0.0 109.655 -169.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.7 m -121.9 143.5 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.691 0.757 . . . . 0.0 111.907 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -127.56 159.86 33.34 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.136 2.174 . . . . 0.0 109.05 165.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.305 0.1 OUTLIER -148.44 155.51 41.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.104 1.361 . . . . 0.0 110.099 166.769 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.6 t -134.65 115.38 13.74 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.31 0.959 . . . . 0.0 109.437 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -71.03 -52.69 18.1 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.999 0.818 . . . . 0.0 110.886 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.1 p -56.8 -36.26 69.68 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.68 -4.3 90.26 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.648 1.118 . . . . 0.0 115.542 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 58.5 mtm 47.67 38.87 9.03 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.21 1.804 . . . . 0.0 114.986 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.8 t -149.55 166.04 30.4 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -130.27 137.26 49.91 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.61 1.564 . . . . 0.0 107.901 -173.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -130.47 132.25 45.58 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.596 0.634 . . . . 0.0 109.969 -166.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.15 132.69 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -153.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -140.03 132.31 28.28 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.304 1.842 . . . . 0.0 109.257 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.449 HG13 ' HA ' ' A' ' 103' ' ' CYS . 3.3 p -145.5 139.12 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 120.684 -1.26 . . . . 0.0 109.275 159.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.68 147.38 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.77 2.028 . . . . 0.0 109.542 -172.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.56 112.41 9.54 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.378 -0.826 . . . . 0.0 113.212 -170.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -126.37 161.0 28.86 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.042 2.137 . . . . 0.0 110.661 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -75.94 -146.05 1.68 Allowed Glycine 0 CA--C 1.546 2.029 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 154.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.81 0.08 8.2 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.553 2.835 . . . . 0.0 114.728 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.01 -20.51 65.96 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.107 -1.621 . . . . 0.0 114.107 -177.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -83.37 61.58 6.25 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.842 1.306 . . . . 0.0 112.04 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -52.7 -32.87 44.92 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.489 1.515 . . . . 0.0 111.846 171.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.74 -51.71 66.1 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.908 0.883 . . . . 0.0 113.099 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.94 -36.12 79.59 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.791 1.178 . . . . 0.0 113.077 171.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -64.51 -52.86 55.65 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.95 1.25 . . . . 0.0 110.792 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -63.08 -32.38 73.75 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.836 -1.165 . . . . 0.0 113.192 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.89 -38.22 84.93 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.219 0.918 . . . . 0.0 112.277 171.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -76.02 -43.03 46.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.119 0.968 . . . . 0.0 113.547 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 93.8 mt -56.0 -36.03 67.46 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.212 0.914 . . . . 0.0 112.254 172.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -66.89 -51.08 59.67 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.467 1.107 . . . . 0.0 110.83 172.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.53 -26.81 64.69 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.2 pt -85.22 -34.95 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.681 0.793 . . . . 0.0 112.028 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -67.64 -0.96 4.43 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.684 1.129 . . . . 0.0 112.819 158.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -127.77 25.56 5.98 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 125.629 1.572 . . . . 0.0 112.293 179.852 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.3 t70 . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -55.14 -17.8 4.75 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -75.08 -21.96 58.61 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.865 -1.147 . . . . 0.0 112.111 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 t -72.05 -44.0 66.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.483 1.513 . . . . 0.0 110.093 171.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.88 -51.83 56.57 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 169.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.07 -45.12 64.63 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.295 1.047 . . . . 0.0 112.709 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -74.54 -35.13 63.1 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.47 -33.67 60.84 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.572 -1.33 . . . . 0.0 112.668 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -70.41 -41.25 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.839 0.745 . . . . 0.0 109.78 170.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.0 m -55.54 -46.78 77.04 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.207 -0.933 . . . . 0.0 111.858 171.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -64.41 -43.91 92.91 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.513 -0.742 . . . . 0.0 112.453 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -71.5 -24.65 62.01 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . 0.274 22.9 ptt-85 -74.8 -55.78 5.47 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 120.606 1.548 . . . . 0.0 113.88 158.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.0 -42.28 15.03 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -158.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.41 -25.89 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-N 119.654 1.115 . . . . 0.0 110.871 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.06 -12.1 60.25 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.699 1.6 . . . . 0.0 112.58 169.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 52.23 46.32 26.85 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 128.057 2.543 . . . . 0.0 115.199 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.564 HD11 HD13 ' A' ' 29' ' ' LEU . 4.7 pp -121.12 161.03 22.5 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.995 1.718 . . . . 0.0 112.703 174.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.31 149.48 26.04 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.659 -0.651 . . . . 0.0 111.49 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -64.96 -25.17 67.76 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.614 -1.304 . . . . 0.0 113.295 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -69.24 -21.46 63.92 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.995 -1.066 . . . . 0.0 112.417 168.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -104.25 -3.96 23.63 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.425 1.89 . . . . 0.0 112.297 -172.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.803 HD11 ' HB1' ' A' ' 48' ' ' ALA . 15.2 tp -94.61 133.49 38.19 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.528 2.731 . . . . 0.0 108.462 163.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.89 122.66 44.43 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.573 0.624 . . . . 0.0 109.724 166.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.2 mm -94.62 138.61 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.388 1.075 . . . . 0.0 110.746 170.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 36' ' ' LEU . 3.5 m -139.21 144.66 38.6 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -117.02 -146.13 0.4 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.632 1.573 . . . . 0.0 110.608 -161.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 t -42.53 -32.31 0.54 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 128.122 2.569 . . . . 0.0 115.884 -171.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.52 -26.99 67.27 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 120.201 1.364 . . . . 0.0 113.989 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' A' ' 32' ' ' THR . 40.8 mt -76.79 -43.69 35.74 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.817 1.19 . . . . 0.0 112.824 174.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -96.61 16.09 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.505 1.922 . . . . 0.0 111.415 -170.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.2 t -57.37 5.6 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.93 2.892 . . . . 0.0 116.845 -165.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.57 -39.04 11.06 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.851 1.26 . . . . 0.0 110.99 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -121.96 67.62 24.01 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.215 1.406 . . . . 0.0 107.393 160.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.89 -44.42 49.38 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 123.323 2.682 . . . . 0.0 113.241 -165.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -93.3 6.57 47.64 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.617 -1.182 . . . . 0.0 110.784 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -128.58 100.2 5.66 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 121.172 1.805 . . . . 0.0 107.516 171.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.1 p 176.67 170.51 0.48 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.447 -0.783 . . . . 0.0 111.147 -141.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.7 tp -128.05 -83.93 0.59 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 118.576 -1.25 . . . . 0.0 112.967 145.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 77.3 m -170.58 -161.98 0.26 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.348 1.459 . . . . 0.0 109.175 -160.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -148.0 157.37 43.48 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.348 2.259 . . . . 0.0 107.838 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.803 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -131.68 134.49 46.0 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.075 2.55 . . . . 0.0 107.571 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.8 ttm -122.51 130.94 53.57 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.428 -1.42 . . . . 0.0 111.273 -166.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.0 147.86 52.48 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.368 1.467 . . . . 0.0 114.685 -158.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.9 t -99.95 154.93 17.98 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.411 1.884 . . . . 0.0 109.315 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.2 t -46.89 113.15 0.61 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.538 1.535 . . . . 0.0 110.992 -153.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.78 157.86 26.71 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.356 1.074 . . . . 0.0 113.21 -143.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.419 HG22 ' H ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -110.71 178.5 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 113.499 -1.682 . . . . 0.0 109.575 -160.197 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.419 ' H ' HG22 ' A' ' 54' ' ' ILE . 7.6 p -80.15 116.87 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.854 -168.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -125.58 139.3 33.69 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 118.612 -0.708 . . . . 0.0 109.736 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -66.38 78.19 0.34 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.148 3.232 . . . . 0.0 113.688 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.2 p -56.39 -30.28 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 127.554 2.341 . . . . 0.0 113.745 -170.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.555 ' HB2' ' H ' ' A' ' 133' ' ' THR . 22.7 tp10 -62.52 -22.49 66.33 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -177.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -55.59 -44.32 76.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.119 0.872 . . . . 0.0 111.117 169.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.1 mp -74.25 -44.5 52.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.941 1.296 . . . . 0.0 111.884 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mp -54.0 -50.04 67.48 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 172.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.1 m -63.72 -50.39 69.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.126 0.97 . . . . 0.0 112.056 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -60.02 -29.56 68.58 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 118.264 -0.874 . . . . 0.0 113.008 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -76.29 -57.63 3.75 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.107 1.321 . . . . 0.0 114.204 169.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -76.53 -40.43 50.01 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -167.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 6.5 p -75.95 -1.81 27.38 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.85 -1.156 . . . . 0.0 113.625 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -60.83 -37.0 80.52 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.173 1.789 . . . . 0.0 113.333 -172.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.7 p -165.76 27.1 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.576 1.55 . . . . 0.0 113.483 169.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.03 86.08 0.16 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.686 1.612 . . . . 0.0 113.936 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -150.08 118.88 6.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 128.85 2.86 . . . . 0.0 104.656 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.6 m -65.6 117.93 8.78 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 122.909 0.484 . . . . 0.0 110.02 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.12 144.91 50.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.476 1.51 . . . . 0.0 111.372 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 26.8 p -115.73 141.0 48.67 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.663 1.185 . . . . 0.0 111.43 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -90.11 151.45 21.6 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 157.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 t -137.67 156.37 32.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 126.534 1.933 . . . . 0.0 108.284 -173.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.555 ' HB2' HD11 ' A' ' 114' ' ' LEU . 86.6 m-85 -123.85 138.52 54.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.044 0.926 . . . . 0.0 109.865 159.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -116.92 103.12 9.96 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.997 2.119 . . . . 0.0 108.246 172.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -87.84 127.36 35.34 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.036 1.334 . . . . 0.0 110.166 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.6 t -148.41 166.76 27.13 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 130.318 3.447 . . . . 0.0 105.405 -151.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -18.02 -122.81 0.0 OUTLIER Glycine 0 N--CA 1.486 1.986 1 C-N-CA 131.241 4.258 . . . . 0.0 116.327 -176.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 45.9 t -96.23 101.03 12.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 113.897 -3.121 . . . . 0.0 109.651 150.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.7 mtt180 -171.64 -177.16 1.95 Allowed 'General case' 0 CA--C 1.549 0.934 1 C-N-CA 133.496 4.718 . . . . 0.0 107.05 123.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.5 t -95.26 146.34 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 120.265 -1.522 . . . . 0.0 111.5 145.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.11 136.91 43.73 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.09 1.356 . . . . 0.0 110.359 162.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -110.94 109.35 19.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.032 2.133 . . . . 0.0 106.175 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 m -104.3 144.78 31.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.332 1.053 . . . . 0.0 110.82 -164.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 74.1 m -127.53 114.32 17.28 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 120.908 -1.12 . . . . 0.0 110.79 -171.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -128.31 117.02 20.73 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.7 pt -88.45 62.54 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 122.792 1.282 . . . . 0.0 109.082 144.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.36 -179.38 43.99 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 121.618 3.407 . . . . 0.0 121.618 -145.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -144.46 116.22 5.43 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 126.162 1.785 . . . . 0.0 111.702 177.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -82.97 163.65 15.65 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.556 2.837 . . . . 0.0 111.706 153.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.72 -18.73 56.11 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.546 1.138 . . . . 0.0 114.061 175.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 -25.64 36.21 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.42 1.488 . . . . 0.0 114.966 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.4 -44.08 65.16 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.45 2.7 . . . . 0.0 114.289 -169.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -36.84 76.29 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.001 0.52 . . . . 0.0 110.907 175.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -98.04 -23.63 15.69 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -170.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 pp -76.68 175.42 9.36 Favored 'General case' 0 CA--C 1.556 1.173 0 CA-C-N 119.926 1.239 . . . . 0.0 112.375 172.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -119.62 -162.51 0.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.878 -1.139 . . . . 0.0 113.917 -162.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -121.88 149.07 43.91 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.451 1.501 . . . . 0.0 111.693 172.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.4 p -127.89 136.7 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.155 0.982 . . . . 0.0 111.607 164.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.439 ' HA ' HG13 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -151.96 123.81 8.0 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 123.131 1.443 . . . . 0.0 108.793 116.213 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 170.89 -179.47 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 130.088 3.355 . . . . 0.0 105.156 -153.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -124.96 133.25 53.09 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.244 1.018 . . . . 0.0 112.331 159.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -150.85 149.89 30.25 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.63 1.172 . . . . 0.0 112.666 -164.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -73.29 132.62 43.33 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.131 0.972 . . . . 0.0 110.801 170.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.1 tp -119.13 148.7 42.78 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.049 1.739 . . . . 0.0 111.233 -163.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.7 t -117.26 168.56 10.21 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.07 2.148 . . . . 0.0 110.979 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -77.24 -8.9 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.331 1.452 . . . . 0.0 113.931 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -130.57 70.51 1.45 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.488 1.915 . . . . 0.0 109.175 172.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -133.44 142.06 48.12 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.295 -0.878 . . . . 0.0 111.115 173.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -149.79 129.26 13.02 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.183 1.393 . . . . 0.0 108.077 -163.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 77' ' ' PHE . 4.4 pp -157.94 156.14 30.75 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -159.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.4 t -105.03 145.37 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 127.33 2.252 . . . . 0.0 111.644 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.41 123.39 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 122.489 1.138 . . . . 0.0 111.156 152.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.0 t -146.65 153.55 40.43 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.043 1.337 . . . . 0.0 111.191 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.87 -27.22 67.96 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.469 1.107 . . . . 0.0 113.393 -173.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.19 83.2 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 120.805 1.639 . . . . 0.0 112.628 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.18 -33.97 59.32 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.742 0.817 . . . . 0.0 112.672 172.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.52 -37.09 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.851 1.205 . . . . 0.0 110.714 168.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.33 -19.52 65.46 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.937 1.695 . . . . 0.0 112.761 171.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.2 mtm-85 -80.07 -30.33 39.3 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 121.935 2.152 . . . . 0.0 113.365 161.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 73.1 mt -82.63 -34.51 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.417 1.487 . . . . 0.0 113.461 -172.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -120.5 150.95 53.18 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 125.254 1.422 . . . . 0.0 110.845 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.31 -7.87 21.71 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.149 2.566 . . . . 0.0 113.522 173.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 35.3 m -121.31 131.17 54.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.74 1.616 . . . . 0.0 109.569 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -103.61 -137.43 0.35 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.143 1.377 . . . . 0.0 111.124 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -36.57 125.62 0.84 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.721 1.608 . . . . 0.0 111.701 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 116.69 -30.28 6.48 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.243 1.402 . . . . 0.0 112.293 -149.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 t -60.52 147.84 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.943 1.297 . . . . 0.0 113.153 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 26.4 tp -122.28 92.64 3.77 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.548 1.539 . . . . 0.0 109.481 159.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.555 ' H ' ' HB2' ' A' ' 59' ' ' GLU . 17.9 m -75.29 154.78 37.22 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.201 2.201 . . . . 0.0 109.933 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -142.11 134.57 28.03 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.773 1.229 . . . . 0.0 108.208 -168.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 34.7 t -139.28 142.04 37.76 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.252 0.933 . . . . 0.0 112.136 -163.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.7 t -147.2 141.44 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.976 2.11 . . . . 0.0 109.888 -168.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.91 138.21 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 O-C-N 121.208 -0.933 . . . . 0.0 111.068 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.02 113.2 26.57 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.472 1.109 . . . . 0.0 108.981 166.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.665 ' HE2' ' CD1' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -88.79 128.83 35.65 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 143.573 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.8 m -149.74 175.31 11.7 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -167.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 69.89 160.39 0.2 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 128.244 2.618 . . . . 0.0 115.154 167.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 84.4 p -89.82 -47.71 7.72 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.568 1.547 . . . . 0.0 110.526 171.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -65.88 -1.28 8.71 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 125.629 1.585 . . . . 0.0 115.082 165.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.4 mmt 64.78 128.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 129.032 2.933 . . . . 0.0 114.754 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.4 p -172.31 155.67 3.61 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.877 2.071 . . . . 0.0 108.476 169.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.665 ' CD1' ' HE2' ' A' ' 139' ' ' LYS . 2.5 m-85 -136.08 163.95 29.14 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -166.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -151.46 155.7 39.11 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.35 -1.469 . . . . 0.0 107.55 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.1 tt -136.59 138.94 45.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.092 -0.38 . . . . 0.0 110.516 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -141.69 123.61 15.34 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.321 0.648 . . . . 0.0 110.389 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' A' ' 103' ' ' CYS . 2.1 p -140.61 133.07 31.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-O 122.356 1.074 . . . . 0.0 110.201 168.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.4 m -135.6 130.88 50.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 127.102 2.161 . . . . 0.0 110.735 -163.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -107.65 111.13 23.2 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.094 0.957 . . . . 0.0 111.62 -171.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -109.95 159.47 17.23 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.25 1.42 . . . . 0.0 110.719 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -74.79 -170.79 26.32 Favored Glycine 0 CA--C 1.542 1.735 0 O-C-N 121.314 -0.866 . . . . 0.0 113.728 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.27 -25.8 64.4 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.37 2.047 . . . . 0.0 112.085 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.52 9.0 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 129.349 3.06 . . . . 0.0 114.963 171.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -82.51 46.86 1.1 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.085 2.154 . . . . 0.0 108.605 169.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -58.2 -39.6 79.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.289 2.236 . . . . 0.0 111.824 -165.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.57 -44.42 78.27 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.832 -0.604 . . . . 0.0 112.585 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.91 -40.87 75.34 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.657 0.783 . . . . 0.0 111.783 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -53.69 -59.08 5.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.224 1.01 . . . . 0.0 110.433 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -60.55 -43.11 97.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.962 0.905 . . . . 0.0 112.91 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.43 -38.01 88.07 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.293 0.951 . . . . 0.0 113.058 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.7 -42.7 70.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.314 -0.866 . . . . 0.0 111.962 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.05 -35.12 74.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.33 0.513 . . . . 0.0 111.7 173.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -63.06 -31.66 72.85 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.597 1.559 . . . . 0.0 111.803 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -88.37 -45.11 10.27 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -106.7 -24.82 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 118.013 2.597 . . . . 0.0 118.013 -167.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -103.47 -11.49 17.78 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.707 1.203 . . . . 0.0 110.05 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -125.21 25.8 7.08 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.482 1.513 . . . . 0.0 114.134 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 160.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 120.691 0.282 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.44 -142.27 5.64 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.739 0.685 . . . . 0.0 114.342 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -89.86 0.6 56.95 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.63 151.27 26.37 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.668 1.187 . . . . 0.0 110.182 156.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -138.24 109.46 6.86 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.468 -0.77 . . . . 0.0 111.586 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.434 ' HA ' HD12 ' A' ' 6' ' ' ILE . 2.4 tp -126.81 143.72 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.872 0 C-N-CA 130.113 3.365 . . . . 0.0 108.509 163.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -74.31 148.39 41.42 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 126.356 1.862 . . . . 0.0 111.144 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -48.2 -38.14 17.57 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -165.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -94.68 -22.24 18.26 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.281 0.946 . . . . 0.0 112.151 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.6 t -72.44 -51.12 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.697 1.599 . . . . 0.0 113.164 -168.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.94 -46.66 94.11 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.27 -35.91 67.98 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 118.222 1.011 . . . . 0.0 112.584 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -68.43 -47.47 67.11 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.405 1.482 . . . . 0.0 112.534 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -69.48 -38.31 77.64 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.209 -0.932 . . . . 0.0 111.977 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.58 -39.83 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 125.505 1.522 . . . . 0.0 110.497 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.2 t -58.97 -48.27 82.16 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.197 0.999 . . . . 0.0 111.51 172.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -60.36 -43.01 96.92 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.66 -0.65 . . . . 0.0 111.156 173.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.9 m -62.75 -45.97 90.21 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.621 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.7 ptt-85 -65.81 -36.65 84.09 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.587 1.54 . . . . 0.0 112.592 174.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -68.66 -42.85 77.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.408 1.883 . . . . 0.0 114.375 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . 0.3 0.8 OUTLIER -88.24 -17.34 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 173.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.13 -5.72 58.64 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 121.022 1.737 . . . . 0.0 112.309 163.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 22.6 ptt180 48.86 41.67 18.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 128.05 2.54 . . . . 0.0 114.468 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.9 pp -120.48 169.82 9.97 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.458 2.303 . . . . 0.0 110.804 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -92.74 168.41 11.22 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -66.95 -18.24 65.29 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.698 1.599 . . . . 0.0 114.427 -173.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -102.97 12.14 36.46 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.043 1.337 . . . . 0.0 112.314 171.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -127.48 -14.02 5.34 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.101 1.76 . . . . 0.0 110.953 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.462 HD11 ' HB1' ' A' ' 48' ' ' ALA . 35.6 tp -83.93 122.35 28.62 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 155.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.439 ' H ' ' HB3' ' A' ' 49' ' ' MET . 8.9 ttp-105 -92.19 126.43 37.26 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 118.932 -1.107 . . . . 0.0 110.839 172.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.8 mm -98.99 142.42 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.946 1.699 . . . . 0.0 112.007 173.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.9 m -140.8 143.14 34.68 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.318 0.508 . . . . 0.0 110.116 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -96.85 -142.38 0.29 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.386 1.474 . . . . 0.0 111.656 176.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.9 p -46.92 -38.55 10.71 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.16 2.184 . . . . 0.0 115.706 -156.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.45 -29.61 64.33 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -165.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.39 -15.2 16.6 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 115.961 1.838 . . . . 0.0 115.961 173.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 pt -112.62 -14.0 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 117.453 2.39 . . . . 0.0 117.453 -175.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.5 t -61.53 9.33 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 -166.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -83.79 -15.7 47.4 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 119.657 -1.902 . . . . 0.0 113.075 -176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -91.49 113.44 58.56 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 141.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.99 -11.1 11.29 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.125 1.883 . . . . 0.0 115.871 -160.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -121.9 -10.97 8.6 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 120.806 1.639 . . . . 0.0 115.164 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -162.1 160.19 27.04 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.078 1.351 . . . . 0.0 108.325 -169.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.7 p 164.61 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.273 1.829 . . . . 0.0 106.426 -155.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.0 tp -122.33 -78.16 0.6 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 119.16 -1.016 . . . . 0.0 112.42 147.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.5 m -177.34 -160.04 0.05 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.794 2.038 . . . . 0.0 108.004 -165.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -131.78 157.83 42.84 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.921 2.088 . . . . 0.0 107.937 169.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -135.17 130.97 36.19 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 128.815 2.846 . . . . 0.0 108.951 -177.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.439 ' HB3' ' H ' ' A' ' 30' ' ' ARG . 35.8 ttp -118.22 131.67 56.36 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.096 -1.003 . . . . 0.0 110.844 -166.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 mt -127.51 149.03 50.31 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.348 2.659 . . . . 0.0 112.711 -151.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.1 p -96.93 159.02 15.15 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.063 2.145 . . . . 0.0 113.176 -169.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.5 t -72.07 158.61 35.64 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.903 1.281 . . . . 0.0 112.537 173.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 27.3 t70 57.11 43.69 23.73 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.113 1.765 . . . . 0.0 113.7 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 tp -132.74 139.73 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.546 1.139 . . . . 0.0 111.266 -171.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.2 p -123.37 140.92 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.424 1.49 . . . . 0.0 111.769 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -138.35 153.1 72.57 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 157.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.82 78.09 1.78 Allowed 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 123.847 3.032 . . . . 0.0 109.949 167.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -47.73 -36.7 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 127.547 2.339 . . . . 0.0 115.047 -167.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.98 -18.61 60.35 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -176.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -59.55 -34.23 72.4 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.268 -0.895 . . . . 0.0 111.011 167.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.6 tp -78.87 -44.57 22.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.523 1.129 . . . . 0.0 112.409 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.7 mp -54.25 -45.93 72.51 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.733 1.151 . . . . 0.0 110.627 172.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.4 t -57.57 -50.36 73.35 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.924 1.29 . . . . 0.0 111.864 175.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -61.87 -37.69 85.46 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -59.55 -54.92 41.01 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.711 1.604 . . . . 0.0 111.95 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -72.1 -31.38 66.0 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 9.9 t -72.27 -18.26 61.82 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.3 tpt85 -69.59 -35.14 75.06 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -168.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.1 m -147.17 8.04 0.92 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.84 71.76 0.79 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.986 1.279 . . . . 0.0 111.784 -170.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -168.0 135.31 2.18 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 128.425 2.69 . . . . 0.0 105.76 172.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -100.79 154.99 18.18 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 127.832 2.453 . . . . 0.0 111.734 -170.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.74 147.27 44.6 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.599 1.16 . . . . 0.0 112.566 174.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.49 ' HA ' HG23 ' A' ' 117' ' ' THR . 26.9 p -86.9 142.29 28.13 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.661 0.743 . . . . 0.0 110.517 160.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -92.06 108.61 20.06 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 167.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.518 HG22 HG22 ' A' ' 115' ' ' VAL . 59.3 t -101.48 109.02 24.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.296 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -92.36 113.12 25.31 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 120.712 -1.243 . . . . 0.0 107.677 -173.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -107.52 101.68 11.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.383 1.473 . . . . 0.0 108.851 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -79.62 129.02 34.1 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.801 1.64 . . . . 0.0 109.511 174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 66.8 p -145.18 168.71 19.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.075 2.55 . . . . 0.0 104.57 -170.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -12.75 -119.44 0.0 OUTLIER Glycine 0 N--CA 1.487 2.051 0 C-N-CA 129.542 3.449 . . . . 0.0 116.098 -171.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.8 p -95.45 105.84 17.85 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 113.96 -3.096 . . . . 0.0 111.082 153.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -178.75 145.88 0.31 Allowed 'General case' 0 N--CA 1.474 0.728 1 C-N-CA 132.179 4.192 . . . . 0.0 108.477 146.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 t -78.73 142.27 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 119.246 -2.159 . . . . 0.0 110.431 145.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.0 p -125.23 161.95 25.77 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.77 -1.207 . . . . 0.0 112.69 154.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.1 pp -112.44 116.11 29.77 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 122.11 0.957 . . . . 0.0 109.034 158.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.4 m -80.23 121.26 25.4 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.389 1.476 . . . . 0.0 108.006 169.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 42.4 t -104.91 113.68 27.43 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.028 -1.045 . . . . 0.0 110.98 -172.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -105.11 108.84 20.57 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.75 177.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.7 mt -76.67 72.09 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 140.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.77 -179.11 48.43 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 121.445 3.338 . . . . 0.0 121.445 -155.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -115.57 105.49 51.88 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-N 111.134 -2.533 . . . . 0.0 110.035 -171.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.444 ' HG2' HD23 ' A' ' 96' ' ' LEU . 20.4 Cg_exo -86.12 152.68 9.58 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.639 2.226 . . . . 0.0 114.636 -173.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -42.93 62.52 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -177.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.0 ttt85 -88.76 3.63 50.28 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 -175.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.444 HD23 ' HG2' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -49.88 -29.36 8.0 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.339 2.256 . . . . 0.0 113.612 178.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -53.49 -45.03 69.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.413 1.885 . . . . 0.0 113.543 168.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -122.08 -20.18 6.35 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -166.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.427 ' C ' HD12 ' A' ' 99' ' ' LEU . 2.7 pp -60.93 168.92 2.15 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 121.578 1.99 . . . . 0.0 114.711 165.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -117.25 172.88 7.01 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -160.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.595 ' CZ ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -131.0 155.14 47.33 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.984 1.313 . . . . 0.0 113.992 157.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.595 ' H ' ' CZ ' ' A' ' 101' ' ' ARG . 1.5 p -136.67 137.61 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 125.327 1.451 . . . . 0.0 113.432 174.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 28.1 p -123.38 112.66 17.83 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 118.373 -1.331 . . . . 0.0 110.448 133.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 t0 176.49 -167.23 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 128.521 2.729 . . . . 0.0 107.601 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -113.59 138.83 49.62 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.064 1.346 . . . . 0.0 111.396 150.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -158.09 159.66 36.52 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -60.77 142.59 55.81 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.306 1.042 . . . . 0.0 111.034 160.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 20.9 tp -142.4 133.39 25.84 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.848 1.659 . . . . 0.0 110.172 -173.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.6 m -71.68 156.57 39.21 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 -174.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.47 -10.43 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -169.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.99 41.73 3.12 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.052 1.341 . . . . 0.0 112.201 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.41 ' HG3' ' H ' ' A' ' 113' ' ' ALA . 8.3 tp10 -105.04 172.42 6.8 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.058 2.143 . . . . 0.0 113.481 -169.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.41 ' H ' ' HG3' ' A' ' 112' ' ' GLU . . . -149.8 139.07 21.31 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 126.579 1.952 . . . . 0.0 106.315 -167.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.54 133.21 9.19 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.263 0.938 . . . . 0.0 113.445 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.518 HG22 HG22 ' A' ' 76' ' ' VAL . 3.6 t -95.88 136.43 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 117.252 -1.356 . . . . 0.0 109.315 -179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.491 ' HB ' ' CZ ' ' A' ' 101' ' ' ARG . 11.4 p -138.23 115.39 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 120.322 1.419 . . . . 0.0 109.354 164.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.49 HG23 ' HA ' ' A' ' 74' ' ' CYS . 0.2 OUTLIER -138.01 171.29 14.63 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.002 1.721 . . . . 0.0 111.282 -175.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 79.4 mt -59.71 -29.99 68.49 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.534 0.734 . . . . 0.0 112.913 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.98 -33.32 65.75 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 119.712 1.142 . . . . 0.0 113.043 173.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -74.39 -45.64 45.46 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.802 1.241 . . . . 0.0 111.862 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 28.4 mm -60.34 -40.98 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.493 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -61.44 -29.99 70.3 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 172.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -70.1 -41.05 74.54 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 121.692 2.042 . . . . 0.0 111.864 172.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.5 pt -96.72 -11.9 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -168.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -154.15 150.67 22.89 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 126.539 1.936 . . . . 0.0 110.748 166.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -61.34 113.2 1.67 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 121.775 1.65 . . . . 0.0 110.926 168.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 19.7 p -83.32 161.64 21.36 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.608 0.718 . . . . 0.0 112.672 -176.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -151.19 147.96 27.66 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.264 1.826 . . . . 0.0 108.233 -171.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . 0.257 0.1 OUTLIER -67.14 54.23 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 127.859 2.464 . . . . 0.0 112.635 170.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 179.6 -0.58 0.02 OUTLIER Glycine 0 CA--C 1.539 1.562 0 C-N-CA 127.516 2.484 . . . . 0.0 114.215 -167.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.1 t -65.42 131.15 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.011 1.405 . . . . 0.0 111.28 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 90.5 mt -118.44 89.21 3.08 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.982 1.713 . . . . 0.0 108.281 159.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.0 m -72.95 148.36 44.35 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 170.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -133.28 134.29 43.71 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.427 1.491 . . . . 0.0 108.661 -165.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 41.9 t -140.89 135.97 31.84 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.525 1.057 . . . . 0.0 112.027 -169.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.5 124.17 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 126.374 1.869 . . . . 0.0 110.175 -167.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.0 m -121.65 145.86 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.213 -0.93 . . . . 0.0 112.831 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -130.22 138.6 50.65 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.389 1.076 . . . . 0.0 112.12 158.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.51 ' HD2' ' CE1' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -77.58 146.08 36.45 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 129.034 2.934 . . . . 0.0 112.423 152.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.5 t -139.51 143.49 37.47 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.518 1.127 . . . . 0.0 110.217 162.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -101.29 -41.18 6.79 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.453 1.501 . . . . 0.0 110.755 169.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 30.9 t -54.76 -33.75 61.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.832 0.853 . . . . 0.0 112.808 174.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -102.49 1.2 49.65 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 117.71 -1.605 . . . . 0.0 115.849 172.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.3 mmt 39.44 57.85 2.04 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.837 1.819 . . . . 0.0 113.455 -173.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.0 m -149.46 163.52 37.55 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.002 0.921 . . . . 0.0 113.13 -163.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.51 ' CE1' ' HD2' ' A' ' 139' ' ' LYS . 76.7 m-85 -107.29 154.34 21.4 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.098 0.959 . . . . 0.0 111.098 154.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -130.83 106.19 8.28 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -115.61 139.19 43.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 123.972 0.909 . . . . 0.0 109.683 -163.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -141.46 134.3 28.82 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.689 0.796 . . . . 0.0 109.45 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.5 p -150.44 132.58 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 122.42 1.105 . . . . 0.0 110.642 164.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.4 m -137.28 145.69 29.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 126.505 1.922 . . . . 0.0 109.013 -162.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -112.36 118.11 34.32 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.689 -0.632 . . . . 0.0 112.392 -169.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -121.59 157.21 31.28 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.384 1.074 . . . . 0.0 111.338 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -85.6 -146.97 9.25 Favored Glycine 0 CA--C 1.54 1.626 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 159.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -63.39 -3.44 5.22 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.564 2.843 . . . . 0.0 115.973 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -63.76 -18.7 64.32 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.133 1.373 . . . . 0.0 114.01 174.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -77.37 30.24 0.15 Allowed 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 124.478 1.111 . . . . 0.0 112.172 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -61.54 -26.79 68.17 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.433 1.893 . . . . 0.0 114.177 -171.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.88 -52.57 12.54 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.404 1.082 . . . . 0.0 112.051 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -61.38 -39.78 91.93 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.375 1.07 . . . . 0.0 112.188 171.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -52.44 -54.68 29.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.611 0.764 . . . . 0.0 110.873 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -59.04 -45.29 91.11 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.565 -0.71 . . . . 0.0 112.852 175.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.36 -34.81 75.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.319 0.648 . . . . 0.0 112.309 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.43 -45.33 60.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.434 -0.791 . . . . 0.0 111.942 177.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 88.9 mt -56.85 -34.38 67.74 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.824 0.738 . . . . 0.0 111.683 171.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -79.38 -7.93 58.72 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 126.229 1.812 . . . . 0.0 114.231 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -99.78 -57.23 2.19 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.987 1.315 . . . . 0.0 113.053 160.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.8 pt -83.8 -32.12 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -160.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -90.69 10.98 23.66 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.017 0.927 . . . . 0.0 109.449 168.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.91 24.87 5.31 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.399 1.48 . . . . 0.0 114.638 174.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 16.7 mmt85 . . . . . 0 C--O 1.252 1.233 0 CA-C-O 117.628 -1.177 . . . . 0.0 111.319 157.46 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.04 -175.24 47.15 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.822 0.725 . . . . 0.0 113.311 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -82.9 -33.7 26.83 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.847 0.859 . . . . 0.0 111.029 173.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -125.78 131.01 52.57 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.286 1.434 . . . . 0.0 110.235 169.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -136.63 152.51 50.51 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.449 1.499 . . . . 0.0 110.357 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.5 tp -140.04 145.7 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 128.899 2.88 . . . . 0.0 111.617 -169.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -44.12 131.09 6.07 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.46 1.504 . . . . 0.0 111.673 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -68.5 -23.48 64.56 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 -135.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -112.8 -17.17 12.6 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.039 1.336 . . . . 0.0 113.425 172.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 80.1 t -67.18 -60.64 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.298 1.039 . . . . 0.0 111.532 -173.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.28 -37.35 80.48 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.282 -0.732 . . . . 0.0 113.472 175.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.71 -59.2 5.79 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.245 1.023 . . . . 0.0 110.916 175.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -65.77 -46.95 76.83 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.616 1.166 . . . . 0.0 111.668 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.0 mp -70.46 -43.7 69.28 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.643 -0.66 . . . . 0.0 111.637 -173.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.29 -34.56 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 119.203 0.91 . . . . 0.0 110.231 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.2 t -59.49 -52.33 66.02 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 119.41 1.005 . . . . 0.0 111.761 174.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -64.73 -31.51 72.76 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.416 -0.803 . . . . 0.0 111.581 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 m -68.72 -50.09 53.57 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.196 -0.94 . . . . 0.0 111.685 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.1 ptt85 -61.87 -22.06 65.22 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.002 1.274 . . . . 0.0 113.577 177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -85.1 -52.56 5.86 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.446 1.099 . . . . 0.0 112.953 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.85 -30.48 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 118.635 0.652 . . . . 0.0 112.201 -175.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -84.38 -7.66 59.23 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.912 1.233 . . . . 0.0 111.633 171.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 65.65 5.13 3.14 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 128.243 2.617 . . . . 0.0 115.249 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 pp -97.37 147.1 24.53 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.153 1.381 . . . . 0.0 111.497 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -76.01 165.23 25.26 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -168.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -58.77 -39.77 81.97 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.196 -1.565 . . . . 0.0 112.51 -174.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -88.27 6.92 34.64 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.84 0.856 . . . . 0.0 112.784 176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -108.87 -5.59 16.13 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.321 1.448 . . . . 0.0 111.769 172.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.6 tp -89.06 112.61 23.61 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 166.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.59 93.17 8.32 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 118.701 -1.199 . . . . 0.0 109.193 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -87.69 146.69 5.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 125.609 1.563 . . . . 0.0 112.541 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 m -145.86 153.3 40.71 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.925 1.29 . . . . 0.0 110.425 -171.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -117.72 -165.69 1.12 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.368 1.467 . . . . 0.0 112.609 -163.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.4 t -41.34 -41.15 1.88 Allowed 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 118.081 2.622 . . . . 0.0 118.081 -147.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.7 -17.24 61.15 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 -160.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.42 -14.25 17.64 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 174.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.3 pt -102.85 -6.65 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 126.703 2.001 . . . . 0.0 113.583 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -41.53 8.14 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.055 1 C-N-CA 133.641 4.776 . . . . 0.0 121.397 -169.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -65.48 -21.39 66.63 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 122.468 2.395 . . . . 0.0 113.391 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -92.65 117.51 67.62 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 144.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -73.26 -8.31 21.77 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.052 2.501 . . . . 0.0 114.561 -171.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -108.69 -43.43 4.27 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 120.099 1.318 . . . . 0.0 112.007 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -165.51 126.69 1.93 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.539 1.535 . . . . 0.0 110.062 159.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 t -92.94 -162.03 0.9 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 147.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.96 -82.48 0.17 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -168.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 2.4 t -164.9 175.99 9.08 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 120.803 1.638 . . . . 0.0 113.562 -170.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -147.61 106.88 3.88 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.83 158.54 15.46 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.91 2.884 . . . . 0.0 112.059 -168.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 12.8 tmm? -125.57 137.2 53.9 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.895 1.225 . . . . 0.0 110.944 172.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.1 mt -129.86 128.99 43.38 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 129.204 3.002 . . . . 0.0 111.095 -157.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.7 t -128.95 162.7 26.96 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 128.021 2.528 . . . . 0.0 110.383 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.6 p -39.11 113.03 0.28 Allowed 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.744 1.618 . . . . 0.0 113.515 -149.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.544 ' C ' HD13 ' A' ' 54' ' ' ILE . 1.4 p30 -106.81 159.05 16.53 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.939 172.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.544 HD13 ' C ' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -121.78 177.44 3.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 113.69 -1.596 . . . . 0.0 106.721 -173.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.471 ' H ' HG22 ' A' ' 54' ' ' ILE . 11.7 p -77.15 103.38 4.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.912 -155.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -137.72 158.22 72.08 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.433 1.093 . . . . 0.0 111.913 -166.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.46 ' HD3' HD13 ' A' ' 164' ' ' LEU . 58.7 Cg_endo -66.53 88.27 0.27 Allowed 'Trans proline' 0 C--N 1.357 0.999 1 C-N-CA 125.741 4.294 . . . . 0.0 112.187 -178.218 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.64 -40.83 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.451 0.7 . . . . 0.0 112.541 -172.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.35 -12.52 60.39 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -55.39 -27.72 49.43 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.192 0.905 . . . . 0.0 112.687 167.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.3 mp -77.97 -44.32 27.12 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.885 0.874 . . . . 0.0 111.554 171.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.6 mp -56.71 -43.57 80.71 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 118.138 0.426 . . . . 0.0 111.37 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.3 p -72.31 -30.74 65.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.801 0.84 . . . . 0.0 112.515 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.07 -37.6 80.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.381 0.991 . . . . 0.0 112.865 171.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.9 -50.63 16.2 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.105 0.866 . . . . 0.0 111.866 172.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -61.24 -33.62 73.81 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.775 -1.203 . . . . 0.0 113.325 -175.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 69.5 m -79.17 -20.56 48.15 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 172.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -38.36 79.34 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 119.641 1.11 . . . . 0.0 113.269 -169.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.6 m -150.81 0.23 0.41 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -174.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.97 82.3 0.16 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.19 1.376 . . . . 0.0 110.952 -165.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -153.71 115.91 4.34 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 125.665 1.586 . . . . 0.0 107.841 -173.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 79.4 m -91.89 113.12 25.3 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.942 1.297 . . . . 0.0 109.792 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.47 148.38 40.81 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.056 1.342 . . . . 0.0 113.285 -168.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 74.4 m -89.21 127.14 35.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.702 0.801 . . . . 0.0 109.535 165.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -91.91 103.48 16.01 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 164.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.6 t -105.46 141.62 20.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.53 0 C-N-CA 125.07 1.348 . . . . 0.0 109.204 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -124.93 123.28 39.56 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.245 -0.909 . . . . 0.0 110.08 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.1 112.86 25.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.054 1.741 . . . . 0.0 109.262 172.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -86.26 126.68 34.47 Favored 'General case' 0 C--O 1.24 0.601 0 O-C-N 121.074 -1.016 . . . . 0.0 111.281 165.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.8 p -143.69 157.11 44.64 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.732 3.213 . . . . 0.0 103.369 -176.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -7.07 -129.85 0.0 OUTLIER Glycine 0 N--CA 1.486 1.993 0 O-C-N 117.707 -3.121 . . . . 0.0 112.83 -116.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 82.4 m -97.58 107.5 20.02 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 113.666 -3.213 . . . . 0.0 108.601 149.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -169.66 125.14 0.83 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 130.754 3.622 . . . . 0.0 106.203 161.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.431 HG23 ' CZ ' ' A' ' 146' ' ' TYR . 2.6 t -78.03 135.45 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 117.978 -1.489 . . . . 0.0 110.938 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.8 m -110.22 146.19 36.02 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.21 0.604 . . . . 0.0 110.477 163.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.1 tp -110.73 108.79 18.78 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 126.208 1.803 . . . . 0.0 107.082 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.6 m -80.12 101.47 8.78 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 167.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 45.3 t -103.81 108.12 19.29 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 120.73 -1.231 . . . . 0.0 108.23 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.4 151.17 48.26 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -175.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.59 96.1 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 141.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.91 142.75 6.67 Favored Glycine 0 N--CA 1.471 1.015 0 N-CA-C 118.332 2.093 . . . . 0.0 118.332 -167.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -133.28 64.81 71.02 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.626 1.571 . . . . 0.0 112.267 175.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.58 158.12 32.24 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.369 2.713 . . . . 0.0 115.495 -172.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -50.52 -19.89 1.01 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 128.252 2.621 . . . . 0.0 115.752 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -69.83 -11.62 61.0 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.182 -1.574 . . . . 0.0 113.242 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.71 -4.7 16.76 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 164.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 1.67 32.76 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 120.051 1.296 . . . . 0.0 112.241 160.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -131.16 -34.2 1.45 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.533 1.933 . . . . 0.0 114.154 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 pp -100.49 160.0 14.7 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 120.196 1.362 . . . . 0.0 114.628 -172.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -108.69 -160.97 0.74 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 125.714 1.606 . . . . 0.0 113.069 -166.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.45 166.11 13.08 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.711 1.205 . . . . 0.0 111.833 162.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 13.1 p -125.13 130.97 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 170.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.514 ' HB2' HD13 ' A' ' 124' ' ' ILE . 10.8 t -147.58 112.1 5.3 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 127.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -176.91 175.29 1.62 Allowed 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 126.507 1.923 . . . . 0.0 107.886 -170.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -115.82 121.06 41.27 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.384 1.873 . . . . 0.0 110.667 161.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -159.0 165.95 32.88 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -74.09 149.42 41.11 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.517 -0.74 . . . . 0.0 111.71 164.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.8 tp -135.87 143.09 44.86 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.596 1.958 . . . . 0.0 108.87 -171.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.8 p -117.44 173.21 6.83 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -166.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.9 t -67.11 -9.77 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 128.433 2.693 . . . . 0.0 115.422 -163.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -135.21 25.11 3.54 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.996 -1.065 . . . . 0.0 112.803 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -116.2 151.75 35.1 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.141 -0.974 . . . . 0.0 111.803 -163.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -159.61 166.15 31.29 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 121.077 -1.014 . . . . 0.0 112.549 -165.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.69 164.1 37.67 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.276 1.03 . . . . 0.0 113.46 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.402 ' CG1' HG23 ' A' ' 117' ' ' THR . 6.8 t -99.76 145.45 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 127.788 2.435 . . . . 0.0 109.275 163.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.6 128.7 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.565 0.698 . . . . 0.0 109.287 151.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.402 HG23 ' CG1' ' A' ' 115' ' ' VAL . 4.7 p -128.97 159.13 36.87 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.444 1.498 . . . . 0.0 111.001 174.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -59.44 -38.46 80.73 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.383 0.673 . . . . 0.0 111.672 174.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.18 -32.53 74.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.046 0.938 . . . . 0.0 112.58 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -71.47 -33.14 69.06 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 117.575 -1.202 . . . . 0.0 111.996 173.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 31.9 mm -66.7 -41.39 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 119.742 1.156 . . . . 0.0 110.786 170.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.54 -27.89 66.6 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 171.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -86.52 -21.84 26.72 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.97 1.708 . . . . 0.0 115.178 171.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.514 HD13 ' HB2' ' A' ' 103' ' ' CYS . 6.3 mt -77.2 -38.54 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.056 1.342 . . . . 0.0 111.007 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -145.06 172.31 5.52 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 125.715 1.606 . . . . 0.0 111.858 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -57.43 20.97 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.335 1 C-N-CA 126.262 4.641 . . . . 0.0 117.086 164.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 77.9 m -74.75 160.38 30.81 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.676 1.99 . . . . 0.0 112.097 176.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -125.02 -166.42 1.53 Allowed 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 128.002 2.521 . . . . 0.0 108.7 173.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.26 -24.69 67.75 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -173.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -85.86 15.24 48.92 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-O 118.155 -1.358 . . . . 0.0 115.98 -175.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.73 158.61 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-N 119.219 1.509 . . . . 0.0 113.801 -165.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.7 tt -116.43 126.71 53.8 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 122.352 1.072 . . . . 0.0 110.618 154.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 2.4 p -123.26 148.38 45.96 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 127.496 2.318 . . . . 0.0 109.711 -173.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -130.98 128.47 40.48 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -164.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 46.3 t -136.38 138.92 42.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.467 0.707 . . . . 0.0 110.728 -165.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.5 t -146.23 114.76 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.892 0.877 . . . . 0.0 110.98 -167.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 m -109.01 129.95 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -115.51 140.92 48.72 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.46 2.304 . . . . 0.0 107.261 168.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.451 ' HB2' ' CD2' ' A' ' 146' ' ' TYR 0.304 0.2 OUTLIER -149.69 152.84 36.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.504 0.722 . . . . 0.0 110.664 169.845 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 24.7 t -136.8 123.34 20.92 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.846 0.748 . . . . 0.0 109.16 171.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -76.0 -57.08 4.09 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.213 1.405 . . . . 0.0 110.67 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 38.6 t -61.09 -36.32 79.35 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.04 0.936 . . . . 0.0 112.591 169.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.66 14.16 48.7 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.361 -1.244 . . . . 0.0 114.896 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 28.0 ptm 42.63 49.46 4.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.268 2.227 . . . . 0.0 116.985 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.5 t -157.82 148.74 21.09 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.451 ' CD2' ' HB2' ' A' ' 139' ' ' LYS . 1.4 t80 -108.93 140.08 42.9 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.706 1.202 . . . . 0.0 111.267 163.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -140.79 121.32 14.16 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 122.17 0.986 . . . . 0.0 111.447 -173.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -133.5 134.58 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.097 -1.002 . . . . 0.0 110.828 -151.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -142.66 131.76 23.19 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.675 1.19 . . . . 0.0 111.064 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.8 p -145.19 139.37 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.545 -0.722 . . . . 0.0 110.588 161.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.9 m -136.04 151.43 29.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 C-N-CA 127.772 2.429 . . . . 0.0 109.821 -165.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.12 128.85 23.12 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -166.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -148.12 133.25 18.3 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 170.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.54 -162.21 0.27 Allowed Glycine 0 CA--C 1.549 2.185 0 C-N-CA 127.558 2.504 . . . . 0.0 116.344 166.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.6 -20.77 12.92 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.892 3.728 . . . . 0.0 119.521 -160.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -75.58 -2.39 28.95 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 120.58 1.537 . . . . 0.0 114.03 173.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 45.7 p30 -58.82 13.03 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 129.304 3.042 . . . . 0.0 117.861 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -49.4 -40.02 34.67 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.389 1.876 . . . . 0.0 112.623 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.43 -51.44 65.72 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -74.2 -26.7 60.42 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.086 -1.009 . . . . 0.0 112.427 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -64.98 -48.56 73.56 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.709 0.804 . . . . 0.0 111.74 168.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -62.61 -38.11 88.91 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.332 -0.855 . . . . 0.0 112.087 174.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.55 -30.85 70.03 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.46 HD13 ' HD3' ' A' ' 57' ' ' PRO . 0.2 OUTLIER -79.09 -51.72 9.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.724 1.21 . . . . 0.0 110.887 -179.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.5 pp -66.43 -27.55 67.91 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.316 -0.865 . . . . 0.0 110.972 -177.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -77.21 -24.42 51.29 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 117.895 -1.05 . . . . 0.0 112.828 172.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.64 -30.86 64.67 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 167.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.1 mt -76.03 -36.8 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 120.708 -1.245 . . . . 0.0 110.977 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -64.83 -4.9 4.9 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 158.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -108.56 25.17 12.02 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 170.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.171 0 C-N-CA 128.539 2.736 . . . . 0.0 116.52 162.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.675 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.23 -17.6 9.66 Favored Glycine 0 CA--C 1.542 1.752 0 N-CA-C 116.548 1.379 . . . . 0.0 116.548 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -132.31 -157.01 0.79 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 126.173 1.789 . . . . 0.0 112.144 -177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.46 159.41 15.64 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 119.873 -1.767 . . . . 0.0 113.175 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -126.82 97.97 5.18 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.355 -0.841 . . . . 0.0 112.497 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 6' ' ' ILE . 7.6 tp -76.32 106.07 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 123.1 1.428 . . . . 0.0 112.442 -176.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -45.19 123.85 4.26 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 111.831 -2.441 . . . . 0.0 110.613 -173.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -57.86 -35.58 71.16 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 -143.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -102.92 -19.73 14.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.211 1.404 . . . . 0.0 112.349 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.27 -52.41 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.986 0.915 . . . . 0.0 112.388 -168.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.73 -49.92 73.33 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 119.179 0.9 . . . . 0.0 111.885 174.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.51 76.84 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.278 1.039 . . . . 0.0 112.156 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.76 -42.41 73.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.334 1.054 . . . . 0.0 113.303 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.4 tp -76.58 -31.44 57.5 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.271 1.029 . . . . 0.0 112.914 -176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.9 -40.41 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 O-C-N 121.487 -0.758 . . . . 0.0 109.344 168.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.1 m -59.58 -35.24 73.9 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 119.688 1.131 . . . . 0.0 112.495 170.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -72.0 -40.09 68.75 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.675 1.19 . . . . 0.0 111.452 177.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.7 m -64.87 -42.51 94.78 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.989 -1.069 . . . . 0.0 110.514 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.5 ttp180 -54.33 -37.21 64.61 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.977 1.711 . . . . 0.0 112.353 171.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -83.84 -49.28 9.2 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.519 1.528 . . . . 0.0 113.473 -175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -69.8 -42.49 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 118.989 0.813 . . . . 0.0 111.093 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.01 -2.52 58.38 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.471 0.708 . . . . 0.0 112.785 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . 0.273 32.8 ptt180 51.88 22.99 1.92 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.07 2.548 . . . . 0.0 116.179 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.411 HD11 HD23 ' A' ' 29' ' ' LEU . 3.6 pp -92.36 153.41 19.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.145 1.778 . . . . 0.0 112.139 175.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -80.41 160.12 25.45 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.006 0.922 . . . . 0.0 113.454 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -69.76 -24.37 63.52 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 119.903 -1.748 . . . . 0.0 115.586 -168.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -96.14 8.06 44.8 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.673 1.124 . . . . 0.0 112.517 167.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -110.62 -1.35 16.86 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.842 1.657 . . . . 0.0 111.013 172.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.411 HD23 HD11 ' A' ' 24' ' ' LEU . 2.0 tm? -94.8 117.67 30.52 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 127.839 2.456 . . . . 0.0 105.804 165.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -89.09 134.18 34.1 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.537 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.656 ' H ' HD12 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -125.83 142.95 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 124.71 1.204 . . . . 0.0 112.21 173.025 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.4 p -154.3 145.12 22.52 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.974 1.31 . . . . 0.0 110.123 -166.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -166.94 59.89 0.09 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 122.935 1.35 . . . . 0.0 112.329 -170.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 76.1 p -89.89 -58.3 2.56 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.38 -0.825 . . . . 0.0 111.836 153.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.95 -55.95 4.09 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.959 0.885 . . . . 0.0 113.016 -151.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -61.25 -30.15 70.28 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.801 1.241 . . . . 0.0 112.344 172.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.661 ' HA ' ' H ' ' A' ' 44' ' ' SER . 1.5 mp -66.03 -29.87 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.922 0.889 . . . . 0.0 111.174 175.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.8 m -84.71 4.89 30.54 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.394 1.478 . . . . 0.0 114.612 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -84.47 -14.42 49.22 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.531 1.514 . . . . 0.0 112.346 170.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -120.66 161.96 37.02 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 127.045 2.138 . . . . 0.0 110.389 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -58.83 -38.26 89.55 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.52 2.147 . . . . 0.0 114.26 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -121.57 -35.78 3.17 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 116.852 2.168 . . . . 0.0 116.852 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -166.31 143.68 5.23 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 120.705 1.593 . . . . 0.0 109.387 -171.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.661 ' H ' ' HA ' ' A' ' 37' ' ' ILE . 96.8 p -106.57 -168.09 1.37 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 135.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -75.62 -75.45 0.18 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.768 1.622 . . . . 0.0 112.195 -166.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -178.13 -174.65 0.43 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.926 0.89 . . . . 0.0 109.541 -173.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 11.5 t0 -139.13 136.38 35.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 177.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -118.74 140.87 49.24 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.527 1.531 . . . . 0.0 112.154 -169.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 29.8 mtt -114.48 130.53 56.74 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 120.56 1.527 . . . . 0.0 111.857 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.0 mt -131.55 161.24 33.08 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 128.536 2.734 . . . . 0.0 112.936 -153.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.5 p -93.93 179.81 5.22 Favored 'General case' 0 N--CA 1.48 1.062 1 C-N-CA 132.876 4.47 . . . . 0.0 114.573 -153.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 t -120.34 109.01 14.85 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.52 -1.362 . . . . 0.0 108.082 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.468 ' HB3' ' H ' ' A' ' 54' ' ' ILE . 6.0 m-20 -161.01 -154.97 0.39 Allowed 'General case' 0 CA--C 1.561 1.367 0 O-C-N 120.88 -1.138 . . . . 0.0 112.898 -136.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.468 ' H ' ' HB3' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -145.35 178.85 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 1 C-N-CA 132.359 4.264 . . . . 0.0 109.09 -157.066 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.7 p -76.22 123.44 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.973 1.309 . . . . 0.0 112.294 -164.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -122.56 148.08 52.06 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.84 1.256 . . . . 0.0 112.315 -173.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -77.62 72.74 5.92 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 125.234 3.956 . . . . 0.0 111.986 -172.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.3 p -66.12 -24.09 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.075 0.95 . . . . 0.0 113.3 -169.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.61 -40.08 51.79 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.514 1.126 . . . . 0.0 113.765 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -60.82 -38.5 85.62 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.032 0.533 . . . . 0.0 111.784 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.7 -46.7 62.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.294 1.038 . . . . 0.0 111.037 -175.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -58.35 -44.72 88.91 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.206 1.002 . . . . 0.0 111.673 173.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.5 m -73.59 -48.09 35.42 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.977 0.911 . . . . 0.0 112.307 -172.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -59.43 -45.2 92.23 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 118.991 -0.528 . . . . 0.0 110.215 174.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -58.64 -48.42 81.1 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.106 0.866 . . . . 0.0 112.497 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -58.98 -43.67 91.46 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 176.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 70.9 m -74.17 -23.46 59.24 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -177.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -74.14 -17.16 60.96 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 -167.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.7 p -144.2 2.84 1.16 Allowed 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 175.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.34 71.27 0.86 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 127.062 2.267 . . . . 0.0 110.342 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -165.5 128.85 2.2 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 127.882 2.473 . . . . 0.0 105.677 -174.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.0 m -84.55 141.73 30.5 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 126.412 1.885 . . . . 0.0 110.496 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.93 151.04 31.58 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -170.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 24.9 p -101.06 133.86 44.94 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.819 0.848 . . . . 0.0 111.427 174.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -89.35 117.61 28.42 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 168.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 115' ' ' VAL . 42.1 t -121.86 113.85 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 123.464 0.706 . . . . 0.0 109.284 -169.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -89.86 125.12 35.21 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.518 -1.364 . . . . 0.0 107.581 -176.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.8 97.82 6.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 123.293 1.52 . . . . 0.0 107.55 168.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -73.7 116.77 14.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.545 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 17.0 p -147.41 158.27 43.91 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 128.521 2.728 . . . . 0.0 104.674 -161.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -11.42 -131.09 0.0 OUTLIER Glycine 0 N--CA 1.483 1.783 0 O-C-N 119.304 -2.122 . . . . 0.0 114.442 -127.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 30.3 p -94.03 101.01 13.03 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 115.058 -2.657 . . . . 0.0 108.308 161.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -172.67 165.87 5.43 Favored 'General case' 0 N--CA 1.469 0.516 1 C-N-CA 131.76 4.024 . . . . 0.0 106.835 158.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.4 t -87.98 124.77 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.02 -1.05 . . . . 0.0 110.218 159.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.78 141.55 37.84 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 118.991 0.814 . . . . 0.0 108.861 164.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 31.4 tp -119.72 106.1 11.81 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.416 1.086 . . . . 0.0 108.617 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.4 m -80.17 125.62 30.06 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.122 0.569 . . . . 0.0 110.916 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 10.8 m -111.38 107.04 16.15 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 120.893 -1.129 . . . . 0.0 109.751 -173.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -103.73 97.65 7.63 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.028 0.531 . . . . 0.0 112.32 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.3 mt -75.7 82.81 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 139.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -178.03 179.87 48.29 Favored Glycine 0 N--CA 1.468 0.791 0 N-CA-C 122.413 3.725 . . . . 0.0 122.413 -161.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -108.88 66.73 0.32 Allowed Pre-proline 0 CA--C 1.551 1.002 0 CA-C-N 112.886 -1.657 . . . . 0.0 113.346 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.67 134.78 45.69 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.192 2.594 . . . . 0.0 113.428 -176.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -76.33 -41.74 47.39 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.3 1.04 . . . . 0.0 111.77 171.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -69.84 -11.67 61.03 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -172.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.11 -18.29 5.36 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.478 1.911 . . . . 0.0 114.017 163.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -78.37 -2.22 37.19 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.879 1.272 . . . . 0.0 114.063 170.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -134.35 -35.7 0.91 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.12 0.873 . . . . 0.0 113.188 171.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 pp -77.0 166.26 23.56 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 -164.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -92.13 -175.17 3.99 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.515 1.126 . . . . 0.0 112.808 -162.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -122.07 168.63 11.73 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.566 1.546 . . . . 0.0 109.541 159.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.5 p -122.69 124.9 71.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 167.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 47.3 t -125.14 114.39 18.96 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 122.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -178.23 168.16 1.93 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 123.126 1.441 . . . . 0.0 109.126 -165.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -141.99 109.16 5.52 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 127.045 2.138 . . . . 0.0 109.591 164.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -151.04 162.8 40.15 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -168.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -73.69 149.71 41.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.17 0.988 . . . . 0.0 111.946 164.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.4 tp -142.45 147.54 36.29 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 128.125 2.57 . . . . 0.0 109.696 -157.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.7 p -114.75 176.0 5.25 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.919 2.088 . . . . 0.0 114.013 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.83 -13.19 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 126.166 1.787 . . . . 0.0 114.548 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -115.02 33.07 5.63 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 120.672 -1.268 . . . . 0.0 112.46 -173.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.07 153.13 19.82 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.733 -1.229 . . . . 0.0 114.114 -172.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -156.92 128.15 6.89 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.491 1.516 . . . . 0.0 108.854 -174.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.4 pp -158.18 152.26 24.1 Favored 'General case' 0 CA--C 1.554 1.096 0 O-C-N 121.062 -1.024 . . . . 0.0 113.194 -168.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 76' ' ' VAL . 29.8 t -99.91 146.46 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 126.585 1.954 . . . . 0.0 111.981 175.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.6 p -130.41 133.51 63.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.317 0.579 . . . . 0.0 110.841 145.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.2 t -154.42 153.83 32.23 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.027 1.331 . . . . 0.0 111.839 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.83 -27.67 68.24 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.157 1.383 . . . . 0.0 114.34 -166.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.7 -30.72 46.21 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 120.524 -1.36 . . . . 0.0 113.307 175.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -73.29 -33.65 65.33 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.129 -0.982 . . . . 0.0 111.39 168.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.6 mm -60.95 -38.67 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 118.626 0.648 . . . . 0.0 111.004 166.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -65.79 -23.7 66.76 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 173.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -70.4 -29.69 66.39 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 120.243 -1.535 . . . . 0.0 112.269 167.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 27.4 mt -78.58 -38.31 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.715 0.806 . . . . 0.0 110.717 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.482 ' HE3' ' HA ' ' A' ' 153' ' ' PHE . 54.9 mmtt -136.08 109.78 9.88 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 126.549 1.94 . . . . 0.0 111.82 -174.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -62.33 -12.59 28.05 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 N-CA-C 120.083 3.07 . . . . 0.0 120.083 -166.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 9.5 m -133.95 130.96 38.45 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.824 1.647 . . . . 0.0 112.303 173.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -96.59 12.57 31.2 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 -167.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -77.71 14.16 1.12 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -171.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.49 41.16 0.08 OUTLIER Glycine 0 N--CA 1.47 0.951 0 O-C-N 120.918 -1.113 . . . . 0.0 112.856 -172.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.8 115.65 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.383 0.673 . . . . 0.0 111.65 -172.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.42 88.21 3.6 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 158.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 88.7 m -88.3 133.67 34.01 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 163.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -131.78 128.79 39.53 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.655 1.182 . . . . 0.0 108.431 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 51.7 t -136.6 136.04 38.88 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 120.938 -1.101 . . . . 0.0 111.786 -162.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -142.87 129.83 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.489 1.116 . . . . 0.0 109.855 -167.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.404 HG12 HD12 ' A' ' 148' ' ' ILE . 14.0 m -131.94 144.6 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 121.454 -0.778 . . . . 0.0 110.68 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -132.51 152.08 51.69 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 125.256 1.423 . . . . 0.0 108.384 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.29 0.9 OUTLIER -148.43 152.68 37.37 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 124.938 1.295 . . . . 0.0 108.507 167.126 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.0 t -128.33 139.77 52.23 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 170.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -93.43 -53.26 4.15 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.989 0.916 . . . . 0.0 109.614 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 20.3 m -50.3 -41.44 50.85 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.253 1.421 . . . . 0.0 113.18 172.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -100.5 13.32 59.75 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.589 1.566 . . . . 0.0 115.007 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 92.7 mtp 28.96 63.53 0.12 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 127.961 2.504 . . . . 0.0 114.754 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.8 t -159.68 139.76 11.77 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.292 -0.88 . . . . 0.0 110.279 -175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -130.92 156.92 44.26 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 122.129 -0.357 . . . . 0.0 110.262 -162.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -149.85 136.93 19.6 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.038 0.835 . . . . 0.0 113.139 -163.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.404 HD12 HG12 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -146.56 115.27 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.184 0.516 . . . . 0.0 110.519 -159.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -142.86 137.42 29.56 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.178 -0.951 . . . . 0.0 112.311 -169.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.1 p -150.43 140.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 O-C-N 120.912 -1.118 . . . . 0.0 110.563 162.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.7 m -118.84 149.29 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 128.281 2.633 . . . . 0.0 109.552 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -134.34 135.25 42.6 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.482 ' HA ' ' HE3' ' A' ' 125' ' ' LYS . 64.8 m-85 -135.81 158.54 44.15 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.901 2.081 . . . . 0.0 110.537 178.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -104.1 -143.3 12.34 Favored Glycine 0 CA--C 1.538 1.506 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 164.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -45.41 -35.47 11.94 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.931 3.087 . . . . 0.0 114.653 169.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -62.68 -10.02 11.1 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 117.558 2.429 . . . . 0.0 117.558 -172.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -107.77 70.21 0.77 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 123.17 1.462 . . . . 0.0 111.195 167.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.1 -25.25 58.45 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.726 1.611 . . . . 0.0 112.096 165.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.44 -53.89 8.65 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -174.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -74.61 -20.44 59.91 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 120.598 1.545 . . . . 0.0 113.107 170.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.84 -57.45 12.6 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.488 1.495 . . . . 0.0 110.978 165.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -63.4 -29.64 70.91 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.981 -1.074 . . . . 0.0 112.995 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.16 -33.79 76.84 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.364 0.984 . . . . 0.0 113.088 172.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -75.13 -52.45 10.94 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.255 -0.903 . . . . 0.0 112.091 176.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 10.0 mp -50.93 -34.82 30.23 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.627 1.103 . . . . 0.0 113.963 170.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -60.41 -50.97 71.49 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.989 1.716 . . . . 0.0 110.689 171.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -72.88 -18.2 61.45 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.2 mm -83.29 -38.38 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 CA-C-N 120.288 1.403 . . . . 0.0 110.707 171.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -62.21 -22.63 66.09 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.512 -1.367 . . . . 0.0 112.558 166.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -101.33 28.68 5.25 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.589 1.556 . . . . 0.0 114.362 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.275 0 C-N-CA 126.205 1.802 . . . . 0.0 115.831 170.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 120.773 0.321 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.69 -0.73 85.4 Favored Glycine 0 CA--C 1.537 1.446 0 N-CA-C 117.252 1.661 . . . . 0.0 117.252 168.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -56.8 143.72 35.83 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 120.157 1.979 . . . . 0.0 111.821 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 94.0 mtp -72.05 96.54 1.76 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.727 1.211 . . . . 0.0 112.599 -171.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -83.78 92.85 7.83 Favored 'General case' 0 C--O 1.24 0.579 0 O-C-N 121.478 -0.764 . . . . 0.0 109.377 177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 6' ' ' ILE . 9.2 tp -80.67 104.93 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-O 123.137 1.446 . . . . 0.0 113.073 -172.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -48.2 125.92 10.14 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 111.786 -2.461 . . . . 0.0 111.309 -173.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -59.99 -24.34 64.36 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 116.618 2.081 . . . . 0.0 116.618 -155.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -106.08 -27.05 11.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.127 0.971 . . . . 0.0 112.436 178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.9 t -74.35 -61.0 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.754 1.221 . . . . 0.0 111.687 -172.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.8 -45.93 92.91 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 119.471 -0.627 . . . . 0.0 111.829 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.15 -53.04 30.37 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.936 0.894 . . . . 0.0 112.741 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -68.29 -41.08 81.48 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 mp -75.98 -40.08 54.54 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.987 1.267 . . . . 0.0 111.92 -172.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.56 -46.31 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.424 -0.797 . . . . 0.0 109.863 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.4 m -70.16 -41.29 74.0 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.536 -0.727 . . . . 0.0 111.666 -176.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -69.35 -22.27 63.76 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.685 -1.26 . . . . 0.0 112.833 172.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 93.3 m -63.83 -48.15 77.93 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.772 1.624 . . . . 0.0 109.804 168.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.15 -43.09 92.04 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 118.996 0.816 . . . . 0.0 112.105 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.8 ttt85 -71.22 -42.08 69.38 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.228 1.811 . . . . 0.0 113.54 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.7 -40.26 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 119.44 1.018 . . . . 0.0 110.036 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -79.46 -8.12 58.9 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 55.57 37.11 28.45 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.978 1.711 . . . . 0.0 114.247 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 pp -112.46 160.07 18.12 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.821 1.248 . . . . 0.0 110.878 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.9 156.08 39.61 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.239 0.542 . . . . 0.0 112.282 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -60.23 -26.97 66.83 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.308 -1.495 . . . . 0.0 112.033 170.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -91.88 12.48 21.45 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.314 1.845 . . . . 0.0 113.27 173.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -119.38 -10.41 9.7 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.511 1.124 . . . . 0.0 111.945 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.52 HD11 ' HB1' ' A' ' 48' ' ' ALA . 26.8 tp -88.54 111.32 21.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 171.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -85.46 124.78 32.43 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 118.762 -1.175 . . . . 0.0 110.258 175.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 38.0 mm -89.7 141.33 14.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 125.581 1.553 . . . . 0.0 109.875 172.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 54.6 m -118.68 141.77 48.3 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 164.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.71 -152.62 0.32 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.392 2.277 . . . . 0.0 112.513 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.0 t -51.41 -32.13 25.34 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 -158.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.4 -42.3 61.33 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -167.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.99 -8.17 24.2 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.0 pt -110.3 -2.85 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 127.186 2.194 . . . . 0.0 115.051 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.3 m -42.08 11.17 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.376 0 C-N-CA 130.256 3.422 . . . . 0.0 117.468 160.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -67.58 -48.9 65.56 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 120.106 -1.621 . . . . 0.0 109.282 171.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -69.91 160.15 81.35 Favored Pre-proline 0 CA--C 1.552 1.04 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.949 162.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -52.73 -35.03 67.25 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.264 2.643 . . . . 0.0 114.817 -176.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -118.71 -52.9 2.33 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.243 0.929 . . . . 0.0 112.852 161.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -145.51 123.85 12.31 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 116.312 1.968 . . . . 0.0 116.312 -163.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.4 m -73.89 -159.27 0.07 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.834 1.253 . . . . 0.0 109.83 144.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 35.4 tp -70.15 -76.43 0.1 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 121.272 1.851 . . . . 0.0 112.528 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 11.8 p -174.96 -161.69 0.1 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.974 0.91 . . . . 0.0 111.735 -167.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -127.25 158.31 37.51 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.635 1.574 . . . . 0.0 108.676 161.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -131.31 133.69 45.61 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.909 2.884 . . . . 0.0 108.93 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.1 ttp -124.89 132.61 53.28 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.161 -0.962 . . . . 0.0 111.32 -168.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.6 mt -137.22 163.86 29.9 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.37 1.868 . . . . 0.0 114.296 -139.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.2 t -92.76 179.51 5.46 Favored 'General case' 0 N--CA 1.475 0.811 1 C-N-CA 132.596 4.358 . . . . 0.0 114.303 -145.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.2 t -134.15 112.96 11.55 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 170.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.605 ' C ' HD13 ' A' ' 54' ' ' ILE . 0.4 OUTLIER -164.54 -151.89 0.17 Allowed 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 -141.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.605 HD13 ' C ' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -125.8 -176.03 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 131.391 3.876 . . . . 0.0 109.546 -165.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 54' ' ' ILE . 32.9 m -76.04 133.7 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.499 0.719 . . . . 0.0 111.563 -177.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -132.2 145.3 56.75 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 124.044 0.938 . . . . 0.0 113.255 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -76.45 71.42 5.91 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 125.175 3.917 . . . . 0.0 111.784 -173.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.8 p -58.88 -29.38 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.307 1.843 . . . . 0.0 113.221 -169.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -52.48 -37.42 57.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.073 1.749 . . . . 0.0 113.817 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.1 m-30 -66.15 -35.2 79.86 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.241 -0.912 . . . . 0.0 110.697 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 37.4 tp -74.97 -42.49 57.51 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.623 0.769 . . . . 0.0 112.207 177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 mp -57.62 -32.15 66.95 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 118.973 0.806 . . . . 0.0 112.122 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.7 m -73.77 -50.95 18.14 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.823 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -58.29 -34.97 71.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.258 0.935 . . . . 0.0 112.894 174.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 47.8 t-105 -66.64 -58.71 4.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.749 1.22 . . . . 0.0 112.825 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -75.85 -36.96 59.41 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -174.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 34.5 t -69.08 -13.81 62.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.012 0.925 . . . . 0.0 113.352 -175.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.4 tpt85 -68.45 -16.13 63.79 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 119.537 1.062 . . . . 0.0 113.151 -172.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 89.2 p -140.46 -28.79 0.71 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.401 1.48 . . . . 0.0 112.259 165.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.18 79.99 0.67 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 125.796 1.665 . . . . 0.0 108.983 -164.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -158.17 119.95 3.6 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 127.871 2.469 . . . . 0.0 107.168 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.0 m -64.89 116.29 6.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 122.111 0.958 . . . . 0.0 111.268 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.52 143.46 31.56 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.189 1.795 . . . . 0.0 111.857 -173.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 79.3 m -96.25 128.86 43.54 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.748 -0.595 . . . . 0.0 111.791 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -80.31 129.31 34.42 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 149.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 83.8 t -123.81 114.37 41.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -174.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -87.43 110.97 20.66 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -173.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -112.56 102.17 10.27 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -74.33 125.92 29.54 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.394 -0.817 . . . . 0.0 109.92 170.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.3 p -145.48 160.19 41.97 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 128.285 2.634 . . . . 0.0 104.772 -165.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -11.09 -128.39 0.0 OUTLIER Glycine 0 N--CA 1.486 1.967 0 C-N-CA 126.809 2.147 . . . . 0.0 116.267 -146.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 53.5 t -92.95 98.08 11.13 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 116.27 -2.172 . . . . 0.0 108.588 162.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.68 154.91 2.58 Favored 'General case' 0 CA--C 1.538 0.519 1 C-N-CA 132.412 4.285 . . . . 0.0 106.628 159.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.07 148.85 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 119.714 -1.866 . . . . 0.0 109.429 149.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.2 p -139.61 163.62 32.09 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 119.597 -1.939 . . . . 0.0 110.764 162.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 pp -128.93 130.14 46.37 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.696 0.76 . . . . 0.0 110.467 164.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.3 m -83.78 133.6 34.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.99 1.316 . . . . 0.0 109.845 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 61.6 m -104.37 108.85 20.45 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 121.099 -1.001 . . . . 0.0 110.029 -172.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -111.05 94.71 5.13 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.5 mt -74.96 78.32 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 135.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.34 178.6 47.12 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 116.517 1.367 . . . . 0.0 116.517 -169.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -110.25 74.82 0.87 Allowed Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 124.919 1.288 . . . . 0.0 114.196 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -70.52 105.38 1.6 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.769 2.979 . . . . 0.0 112.27 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.85 -21.67 30.91 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -73.09 -20.23 61.0 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.862 1.665 . . . . 0.0 112.93 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.34 -21.18 22.78 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 127.14 2.176 . . . . 0.0 114.135 171.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.13 -38.82 54.21 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.14 0.976 . . . . 0.0 111.515 167.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -125.45 -17.15 5.66 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 118.119 2.637 . . . . 0.0 118.119 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.406 HD22 ' HB1' ' A' ' 113' ' ' ALA 0.26 3.9 pp -70.31 167.49 17.93 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 123.174 2.716 . . . . 0.0 112.83 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -89.5 -163.94 1.08 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.811 1.244 . . . . 0.0 113.659 -157.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.27 170.32 8.03 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 126.673 1.989 . . . . 0.0 112.787 163.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.426 HG21 HG23 ' A' ' 116' ' ' VAL . 19.2 m -73.47 151.13 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 121.423 -0.798 . . . . 0.0 112.721 155.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 27.2 p -152.4 -178.57 6.91 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 128.054 2.542 . . . . 0.0 108.796 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -56.84 -141.88 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.848 1 C-N-CA 133.302 4.641 . . . . 0.0 107.767 161.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -86.49 127.05 34.83 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 118.089 -1.444 . . . . 0.0 114.068 -149.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -154.08 145.33 22.93 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 124.759 1.224 . . . . 0.0 112.409 -172.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -105.46 131.56 52.72 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.327 1.451 . . . . 0.0 110.358 169.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.4 pp -141.83 150.32 41.48 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.119 1.368 . . . . 0.0 114.537 -167.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.1 m -96.2 174.19 7.02 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 -166.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.0 t -58.25 -10.25 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 128.772 2.829 . . . . 0.0 114.8 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -134.84 35.63 3.11 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.212 -0.93 . . . . 0.0 111.412 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -110.07 147.5 33.49 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -175.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.406 ' HB1' HD22 ' A' ' 99' ' ' LEU . . . -152.75 135.26 15.18 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.255 1.022 . . . . 0.0 108.406 -148.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.01 157.9 38.33 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.067 1.347 . . . . 0.0 112.287 -175.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.8 t -97.35 143.67 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.859 1.264 . . . . 0.0 110.491 169.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.426 HG23 HG21 ' A' ' 102' ' ' VAL . 9.9 p -124.76 106.07 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 122.991 1.377 . . . . 0.0 109.749 157.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 80.5 p -123.46 163.93 19.91 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.077 1.751 . . . . 0.0 108.773 165.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -59.57 -21.32 60.15 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.571 -0.705 . . . . 0.0 112.414 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.17 -32.85 65.09 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.66 1.184 . . . . 0.0 113.566 173.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -69.96 -29.36 66.46 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 120.496 -1.378 . . . . 0.0 111.636 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.3 mp -72.25 -40.8 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.096 0.958 . . . . 0.0 109.924 167.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -55.26 -27.36 45.92 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.694 0.798 . . . . 0.0 112.414 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -79.71 -20.19 47.1 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.368 -1.458 . . . . 0.0 114.918 170.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 88.7 mt -84.13 -41.63 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 120.001 1.273 . . . . 0.0 110.01 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -153.17 139.89 12.71 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 127.25 2.22 . . . . 0.0 109.444 165.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.12 119.75 7.22 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.409 2.073 . . . . 0.0 112.201 174.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 71.2 m -68.98 162.03 27.65 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.707 0.803 . . . . 0.0 112.421 -172.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.38 149.46 28.64 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.168 2.187 . . . . 0.0 106.509 169.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -50.62 114.51 1.16 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 169.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 113.91 11.11 13.01 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 117.937 -1.479 . . . . 0.0 116.357 -166.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.8 t -59.63 147.76 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 120.938 2.369 . . . . 0.0 111.045 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.25 86.49 2.37 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.566 1.546 . . . . 0.0 109.345 160.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.8 m -78.32 137.96 38.33 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 168.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -123.12 130.1 52.33 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -174.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 21.7 p -116.8 136.22 53.13 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.029 -0.419 . . . . 0.0 110.771 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.0 t -113.1 130.26 67.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 125.454 1.502 . . . . 0.0 106.972 165.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.8 m -119.98 145.2 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 121.633 0.73 . . . . 0.0 109.933 160.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 45.5 ttm180 -146.14 154.82 42.23 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.797 1.639 . . . . 0.0 108.092 -169.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.311 0.0 OUTLIER -144.51 148.19 34.17 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.108 -0.995 . . . . 0.0 110.042 164.234 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.1 t -153.97 -171.28 3.83 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.233 1.013 . . . . 0.0 112.2 -155.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.3 m120 48.73 80.53 0.06 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.07 2.548 . . . . 0.0 111.664 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 63.2 p 53.55 -1.2 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -165.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.15 34.68 8.6 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.653 1.12 . . . . 0.0 113.003 -165.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 36.5 tpp -124.36 5.15 8.4 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.109 1.764 . . . . 0.0 113.203 -175.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.2 t -143.68 155.37 44.2 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.295 1.438 . . . . 0.0 111.05 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -134.57 144.37 47.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.852 1.261 . . . . 0.0 109.085 -164.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -151.45 147.44 26.86 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 120.658 -1.276 . . . . 0.0 111.333 -151.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 6.5 tt -145.78 147.01 18.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -170.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -139.82 122.97 16.86 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.757 0.823 . . . . 0.0 109.599 163.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.99 127.23 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 122.816 1.293 . . . . 0.0 112.777 172.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.5 m -132.61 150.51 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.819 2.048 . . . . 0.0 110.394 -164.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -126.77 138.17 53.33 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -173.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -139.92 157.0 46.4 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.236 1.415 . . . . 0.0 110.196 167.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.23 -153.11 29.59 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 124.548 1.071 . . . . 0.0 113.451 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.32 -16.12 16.86 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 124.908 3.738 . . . . 0.0 115.07 177.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -71.79 -12.47 61.31 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.438 2.695 . . . . 0.0 115.965 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -81.87 41.31 0.65 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 122.861 1.315 . . . . 0.0 112.916 -174.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -64.12 -20.58 66.08 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.528 1.531 . . . . 0.0 113.78 -168.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.83 -52.58 12.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.52 1.054 . . . . 0.0 110.921 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -60.19 -41.98 94.09 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.176 0.99 . . . . 0.0 112.121 171.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -61.16 -52.96 62.66 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 122.564 0.345 . . . . 0.0 110.908 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -65.21 -34.51 78.54 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.452 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.72 -33.07 74.83 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 119.386 0.994 . . . . 0.0 113.135 175.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -71.54 -50.13 34.17 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.463 0.705 . . . . 0.0 112.36 174.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 89.7 mt -55.26 -37.86 67.81 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.643 0.656 . . . . 0.0 111.582 175.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -69.91 -29.69 66.94 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.392 1.877 . . . . 0.0 112.267 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -88.03 -52.26 5.35 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . 0.287 1.3 pp -104.87 -7.15 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 -165.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -116.82 8.5 13.64 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.88 1.218 . . . . 0.0 111.927 163.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -137.29 27.76 2.83 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.877 1.271 . . . . 0.0 113.825 172.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.261 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 168.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 121.214 0.53 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.99 -4.53 24.18 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 125.12 1.343 . . . . 0.0 114.381 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -127.41 160.74 30.52 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.094 1.758 . . . . 0.0 112.015 -172.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -89.12 129.18 35.77 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 154.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -136.95 111.95 8.96 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.848 0.749 . . . . 0.0 112.08 -165.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.9 tp -76.66 99.22 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 122.929 1.347 . . . . 0.0 111.423 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -47.6 129.05 13.42 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 111.432 -2.622 . . . . 0.0 112.776 -162.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -56.43 -46.08 80.45 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -139.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -92.37 -28.05 17.15 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.152 0.981 . . . . 0.0 111.985 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.1 t -67.33 -55.04 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 124.47 1.108 . . . . 0.0 111.386 -169.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.66 -55.13 31.52 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 168.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.7 -41.65 70.53 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.735 1.268 . . . . 0.0 113.898 -174.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -73.16 -40.99 64.4 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.894 1.278 . . . . 0.0 112.425 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 mp -70.62 -37.63 73.85 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.099 -1.001 . . . . 0.0 112.523 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.62 -43.57 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.087 1.355 . . . . 0.0 109.491 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.2 p -66.19 -40.63 90.55 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.109 0.413 . . . . 0.0 111.643 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -63.6 -41.86 98.3 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 118.838 0.744 . . . . 0.0 112.263 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 88.3 m -60.44 -49.15 78.7 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.205 -0.935 . . . . 0.0 110.64 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.2 ptt85 -69.35 -32.9 72.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 118.241 -0.885 . . . . 0.0 113.251 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.1 ttt-85 -62.18 -48.4 80.24 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.29 1.436 . . . . 0.0 111.349 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.19 -33.03 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.978 0.911 . . . . 0.0 111.828 -174.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 mp -90.51 -0.6 57.73 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 172.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 58.23 30.8 19.97 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.637 1.975 . . . . 0.0 114.874 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 pp -100.9 162.64 12.76 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 119.374 0.988 . . . . 0.0 112.311 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.75 155.37 33.25 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.12 0.968 . . . . 0.0 111.302 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.35 -21.24 66.67 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.073 -1.642 . . . . 0.0 113.542 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -96.2 10.5 37.6 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.294 1.438 . . . . 0.0 113.614 168.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -113.28 14.82 19.38 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.477 1.511 . . . . 0.0 110.215 168.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.9 tp -112.42 120.84 43.04 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 165.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -85.33 125.34 32.86 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 118.462 -1.295 . . . . 0.0 107.589 162.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 31' ' ' ILE 0.255 0.7 OUTLIER -117.08 144.24 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.602 1.961 . . . . 0.0 114.463 167.715 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -154.93 144.51 21.38 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.123 1.369 . . . . 0.0 109.346 -160.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -167.72 62.22 0.07 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.429 1.492 . . . . 0.0 112.298 -167.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.3 t -91.78 -58.35 2.44 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.742 -1.224 . . . . 0.0 112.888 154.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.24 -59.15 2.32 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.02 -152.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.542 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -54.42 -38.95 66.84 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.886 1.674 . . . . 0.0 112.979 177.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.544 ' HA ' ' H ' ' A' ' 44' ' ' SER . 1.4 mp -55.6 -25.98 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.156 1.382 . . . . 0.0 111.289 174.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 63.5 m -110.05 3.19 20.09 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.386 2.274 . . . . 0.0 115.38 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -94.49 20.39 8.46 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 120.378 1.444 . . . . 0.0 112.699 169.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -144.46 170.17 8.76 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 128.574 2.75 . . . . 0.0 107.412 173.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -58.74 -45.35 29.8 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.292 1.995 . . . . 0.0 114.861 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -119.44 -52.91 2.25 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 -171.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -170.31 133.47 1.09 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.201 2.2 . . . . 0.0 106.945 -166.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.544 ' H ' ' HA ' ' A' ' 37' ' ' ILE . 5.9 t -93.07 -156.69 0.49 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 117.695 -1.145 . . . . 0.0 108.146 173.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -88.84 -81.91 0.26 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 118.046 -1.462 . . . . 0.0 112.04 165.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 t 179.63 -176.41 0.3 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.235 1.016 . . . . 0.0 109.055 -170.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 17.6 t70 -136.68 115.88 12.54 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -128.52 132.81 48.32 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.725 1.61 . . . . 0.0 111.099 -158.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.1 ttm -128.73 123.47 33.1 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.705 -1.247 . . . . 0.0 112.785 -156.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.3 mt -120.77 141.73 50.23 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 127.129 2.172 . . . . 0.0 113.351 -144.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.6 p -96.96 160.0 14.59 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.559 1.544 . . . . 0.0 110.334 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 69.2 p -124.98 177.9 5.8 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -153.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.476 ' H ' ' HA ' ' A' ' 138' ' ' ARG . 10.7 t70 59.47 50.77 7.17 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.69 1.996 . . . . 0.0 110.394 -162.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.5 tp -142.75 145.32 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.647 1.579 . . . . 0.0 110.955 -167.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.8 p -109.18 140.56 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.964 1.306 . . . . 0.0 111.772 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -133.72 138.59 31.33 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-N 119.361 0.982 . . . . 0.0 111.896 170.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.99 71.4 2.15 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 125.142 3.895 . . . . 0.0 109.356 171.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 p -52.32 -38.55 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.326 1.45 . . . . 0.0 114.254 -157.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -70.19 -21.97 62.99 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.552 1.141 . . . . 0.0 112.472 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.1 m-30 -66.29 -29.79 70.08 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.379 -0.826 . . . . 0.0 112.204 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 36.6 tp -76.52 -47.01 24.14 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.598 1.09 . . . . 0.0 110.572 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.2 mp -53.68 -49.4 68.08 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.022 0.529 . . . . 0.0 110.99 174.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.2 p -71.67 -29.37 64.52 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -65.76 -33.35 75.66 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.963 0.905 . . . . 0.0 112.086 174.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -75.7 -58.35 3.33 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 160.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -67.61 -34.46 77.05 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.251 -0.906 . . . . 0.0 112.365 -156.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 71.7 m -78.76 -11.51 59.99 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 ttt85 -69.49 -37.47 77.25 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.011 1.325 . . . . 0.0 114.019 -163.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.9 p -152.39 15.99 0.61 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.349 1.46 . . . . 0.0 112.46 171.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.31 81.8 0.14 Allowed Glycine 0 C--N 1.341 0.835 0 C-N-CA 125.705 1.622 . . . . 0.0 113.237 173.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -151.44 113.64 4.54 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 122.131 0.967 . . . . 0.0 111.809 174.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.0 m -66.19 133.59 50.97 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.152 1.381 . . . . 0.0 112.695 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -131.93 159.35 38.93 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.555 1.542 . . . . 0.0 114.439 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 81.8 m -96.76 108.03 20.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 128.069 2.547 . . . . 0.0 108.543 164.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -91.13 96.39 10.57 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.216 -0.927 . . . . 0.0 108.784 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.3 t -101.53 114.86 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.856 0.862 . . . . 0.0 110.852 -164.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -91.35 117.28 29.53 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 120.323 -1.486 . . . . 0.0 107.704 176.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.06 126.74 54.32 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.685 1.594 . . . . 0.0 111.094 174.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -95.4 128.61 42.4 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.527 1.131 . . . . 0.0 109.147 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.5 p -144.56 165.31 28.37 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 130.512 3.525 . . . . 0.0 105.711 -165.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.35 -121.54 0.0 OUTLIER Glycine 0 N--CA 1.491 2.314 0 C-N-CA 129.868 3.604 . . . . 0.0 115.935 -174.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.9 p -93.51 104.81 16.91 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 114.649 -2.82 . . . . 0.0 109.854 150.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.8 mtt85 -178.54 145.39 0.32 Allowed 'General case' 0 CA--C 1.555 1.138 1 C-N-CA 134.376 5.07 . . . . 0.0 106.753 131.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.2 t -64.14 135.52 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 121.839 2.109 . . . . 0.0 109.731 149.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.5 t -107.05 147.12 30.35 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 120.427 -1.421 . . . . 0.0 110.77 170.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 18.2 tp -110.98 106.32 15.37 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 159.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.5 m -78.64 111.33 14.61 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.126 164.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 37.7 t -103.88 110.75 23.0 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 119.613 -1.929 . . . . 0.0 110.733 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -111.13 113.35 25.8 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -173.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.9 mp -77.33 88.73 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 133.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.3 172.38 42.64 Favored Glycine 0 N--CA 1.475 1.299 0 N-CA-C 121.219 3.248 . . . . 0.0 121.219 -179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -110.91 49.61 0.27 Allowed Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 127.181 2.193 . . . . 0.0 116.457 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -63.25 166.94 13.65 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 CA-C-N 122.607 1.967 . . . . 0.0 115.514 173.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -77.52 -28.43 52.02 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 -173.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -84.02 -16.73 42.85 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 -172.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -50.74 -28.07 8.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 128.02 2.528 . . . . 0.0 112.908 172.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -61.88 -39.62 92.59 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.788 -0.625 . . . . 0.0 112.302 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -112.19 -17.3 12.82 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -173.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 pp -80.62 157.97 25.82 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 120.675 1.58 . . . . 0.0 111.894 168.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? -168.45 138.17 2.42 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -172.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.669 ' CD ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -112.18 -179.14 3.6 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.851 1.66 . . . . 0.0 112.502 177.042 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.669 ' H ' ' CD ' ' A' ' 101' ' ' ARG . 3.1 p -162.6 173.91 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 C-N-CA 125.764 1.626 . . . . 0.0 112.732 -142.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.483 ' HA ' HG13 ' A' ' 150' ' ' VAL . 46.3 t -121.56 122.21 39.18 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.716 0.806 . . . . 0.0 108.949 144.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -175.14 170.2 3.19 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.646 1.578 . . . . 0.0 108.823 -172.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -109.78 104.11 13.02 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.597 2.359 . . . . 0.0 110.436 165.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -129.93 165.93 21.08 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -171.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -137.22 137.01 38.64 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.632 1.173 . . . . 0.0 113.31 167.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.6 tt -149.82 144.04 25.74 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.277 1.031 . . . . 0.0 112.192 -135.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 m -71.5 156.0 39.94 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -176.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -6.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 129.364 3.065 . . . . 0.0 114.066 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -138.1 60.1 1.63 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.624 2.37 . . . . 0.0 108.587 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -142.36 150.42 40.71 Favored 'General case' 0 CA--C 1.551 0.984 0 O-C-N 121.014 -1.054 . . . . 0.0 113.091 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.722 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -150.9 155.27 38.81 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.08 -1.637 . . . . 0.0 112.976 -155.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.722 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -150.68 145.76 26.04 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.166 1.386 . . . . 0.0 111.038 -165.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.99 134.9 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 120.987 1.722 . . . . 0.0 112.885 162.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -129.83 157.68 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.47 1.108 . . . . 0.0 109.811 171.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.9 t -157.82 161.97 38.4 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.608 1.963 . . . . 0.0 108.288 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.43 -25.38 24.58 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.37 -37.33 28.41 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 120.302 1.41 . . . . 0.0 113.552 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.41 -31.62 63.97 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.67 -1.269 . . . . 0.0 111.319 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.1 tp -70.97 -32.92 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 121.645 -0.66 . . . . 0.0 111.764 167.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -65.51 -12.99 57.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.274 1.03 . . . . 0.0 112.882 171.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.33 -30.38 68.41 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 120.421 -1.425 . . . . 0.0 113.656 163.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 14.3 mt -87.2 -40.73 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 124.711 1.204 . . . . 0.0 111.223 -169.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -155.49 155.44 29.75 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 128.382 2.673 . . . . 0.0 107.597 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -53.8 130.22 38.0 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 121.915 1.744 . . . . 0.0 112.32 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 25.7 t -99.54 153.16 19.26 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.9 1.68 . . . . 0.0 111.046 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -156.8 162.71 39.72 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.502 1.521 . . . . 0.0 109.476 -170.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -58.44 126.9 29.51 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 127.055 2.142 . . . . 0.0 109.999 170.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.77 15.22 65.98 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-O 118.419 -1.212 . . . . 0.0 115.032 -173.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -60.77 138.94 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.253 1.526 . . . . 0.0 110.34 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 tp -132.7 82.48 2.01 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 123.781 1.753 . . . . 0.0 109.458 173.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 16.8 m -77.31 142.44 39.41 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 155.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -131.63 133.44 44.95 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 121.408 -0.808 . . . . 0.0 109.506 -167.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 46.1 t -127.04 130.54 50.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.215 0.461 . . . . 0.0 110.602 -166.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.78 113.4 40.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.584 1.554 . . . . 0.0 107.735 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.1 m -111.12 135.59 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 122.189 0.995 . . . . 0.0 111.152 173.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.476 ' HA ' ' H ' ' A' ' 53' ' ' ASP . 54.6 ttt85 -131.12 160.45 34.68 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.23 2.612 . . . . 0.0 106.901 170.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.274 0.0 OUTLIER -143.6 147.67 34.73 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.364 -0.835 . . . . 0.0 109.29 167.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.5 m -97.99 137.34 36.94 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.62 0.645 . . . . 0.0 109.548 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -61.09 168.54 2.44 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -169.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.7 m 53.08 28.26 6.64 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.613 1.165 . . . . 0.0 114.062 -170.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 69.48 25.37 75.56 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.416 1.008 . . . . 0.0 114.706 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 86.1 mtp -83.2 -22.1 33.27 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -166.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 t -165.99 156.32 12.74 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 174.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -104.66 137.27 42.74 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.075 0.95 . . . . 0.0 111.14 149.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -126.07 108.29 11.22 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -175.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.3 tp -140.64 103.14 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 122.659 1.219 . . . . 0.0 108.895 -142.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -136.48 141.54 43.51 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.67 -158.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.483 HG13 ' HA ' ' A' ' 103' ' ' CYS . 2.5 p -154.15 146.02 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 123.717 0.807 . . . . 0.0 111.083 177.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.2 m -132.14 134.39 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 127.189 2.196 . . . . 0.0 110.464 -174.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.85 116.18 31.56 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -168.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -137.61 158.15 44.99 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.876 0.845 . . . . 0.0 112.201 172.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -86.32 -160.6 34.43 Favored Glycine 0 CA--C 1.541 1.686 0 C-N-CA 125.568 1.556 . . . . 0.0 113.31 172.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.23 -16.27 27.27 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.67 2.913 . . . . 0.0 115.787 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -90.19 16.97 7.6 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.905 1.682 . . . . 0.0 114.273 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -70.43 56.24 0.16 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.565 1.546 . . . . 0.0 111.309 165.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -59.81 -26.15 65.54 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.304 1.042 . . . . 0.0 112.347 -173.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.51 -53.69 13.04 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -76.64 -26.34 54.77 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 118.662 0.665 . . . . 0.0 112.518 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -63.24 -56.25 18.16 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.268 0.94 . . . . 0.0 109.871 172.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -55.83 -33.48 64.51 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.115 -0.991 . . . . 0.0 112.949 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -67.86 -34.11 76.04 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 174.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.78 -48.13 64.46 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 120.687 -1.258 . . . . 0.0 112.537 171.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -59.49 -25.96 64.87 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 121.423 1.919 . . . . 0.0 114.484 172.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 27.0 ttp85 -68.49 -39.62 81.26 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.715 1.206 . . . . 0.0 111.975 169.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -72.21 -29.98 64.48 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.402 1.081 . . . . 0.0 113.486 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.69 -47.34 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.156 1.382 . . . . 0.0 109.589 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 22.9 m-30 -62.6 -3.46 1.49 Allowed 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.807 1.039 . . . . 0.0 113.807 166.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -124.72 26.91 7.01 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 . . . . . 0 C--O 1.254 1.317 0 O-C-N 121.112 -0.993 . . . . 0.0 111.561 168.229 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.56 -150.78 45.48 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 118.913 0.779 . . . . 0.0 113.618 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -80.03 38.74 0.41 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -168.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.3 mtt -67.57 96.58 0.54 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.68 -1.263 . . . . 0.0 112.251 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -140.85 121.71 14.46 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.054 0.942 . . . . 0.0 112.787 169.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.4 mm -103.59 118.98 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-O 122.697 1.236 . . . . 0.0 107.79 145.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -85.3 149.48 25.43 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 113.421 -1.718 . . . . 0.0 111.051 173.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -52.95 -28.27 22.85 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -78.71 -25.53 44.67 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.497 -0.752 . . . . 0.0 111.564 -174.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.4 t -70.5 -46.25 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.613 1.165 . . . . 0.0 110.243 173.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.32 -52.58 52.37 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 169.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.6 -28.71 70.08 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.37 -1.076 . . . . 0.0 113.428 -176.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -75.08 -43.71 51.61 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.232 1.378 . . . . 0.0 114.097 169.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.95 -40.14 83.28 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.321 0.964 . . . . 0.0 111.378 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -66.63 -41.9 88.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 O-C-N 121.256 -0.902 . . . . 0.0 110.238 172.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.3 t -57.7 -47.43 82.4 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.248 0.931 . . . . 0.0 112.506 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -72.38 -29.06 63.42 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.602 -0.686 . . . . 0.0 111.666 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.9 m -63.42 -47.66 81.02 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.701 1.137 . . . . 0.0 110.456 169.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -51.55 -50.54 59.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.61 1.164 . . . . 0.0 111.283 171.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -77.05 -38.71 52.14 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -168.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -78.97 -42.87 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.191 0.905 . . . . 0.0 110.755 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.04 -8.2 59.72 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 118.815 0.734 . . . . 0.0 112.695 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.4 mmt85 56.57 41.21 28.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.432 1.893 . . . . 0.0 113.034 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 pp -114.59 150.44 35.03 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.454 1.502 . . . . 0.0 110.255 168.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -66.85 153.3 43.78 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.807 -0.558 . . . . 0.0 111.151 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.53 -19.04 63.71 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.518 -1.364 . . . . 0.0 113.2 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -92.17 7.43 42.59 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.305 1.442 . . . . 0.0 113.258 166.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -119.33 10.55 11.98 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.948 1.699 . . . . 0.0 111.7 168.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.8 tp -99.63 130.58 45.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.225 2.21 . . . . 0.0 105.311 161.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -95.48 112.59 24.28 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 119.377 -0.929 . . . . 0.0 109.168 170.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.409 ' H ' HD12 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -108.16 143.74 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 126.073 1.749 . . . . 0.0 112.411 173.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 m -155.55 131.0 9.65 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -139.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 p30 -171.27 57.73 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.774 0.797 . . . . 0.0 111.695 -161.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.5 p -87.55 -54.97 4.0 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.937 -1.102 . . . . 0.0 110.249 153.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.17 -45.37 16.47 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -158.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.485 ' H ' ' CD1' ' A' ' 36' ' ' LEU . 3.0 mp -60.02 -41.64 92.63 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.379 1.072 . . . . 0.0 109.557 176.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mp -75.92 -20.99 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 127.626 2.37 . . . . 0.0 111.107 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 15.4 t -74.09 -39.44 63.41 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.561 -1.337 . . . . 0.0 111.82 172.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.9 mmpt? -72.0 -46.27 57.85 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.96 0.8 . . . . 0.0 110.663 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -148.77 95.53 3.93 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 124.709 1.203 . . . . 0.0 109.59 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -66.33 -56.85 0.25 Allowed 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 121.885 1.724 . . . . 0.0 112.596 -173.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.7 m-20 -92.77 29.24 1.83 Allowed 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.516 1.126 . . . . 0.0 110.548 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -160.42 99.53 1.31 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 155.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.5 p -178.66 -178.55 0.58 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.778 1.631 . . . . 0.0 110.0 -173.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.5 tp -127.35 -87.03 0.58 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 168.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 p -178.67 176.04 1.02 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 122.815 1.293 . . . . 0.0 112.451 -159.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -148.91 120.16 7.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.334 1.454 . . . . 0.0 107.989 -177.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -117.5 144.05 45.45 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.199 2.2 . . . . 0.0 110.05 -157.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.5 mtt -132.83 131.68 41.3 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.369 1.44 . . . . 0.0 112.532 -162.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.3 mt -128.96 145.42 51.24 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 127.706 3.128 . . . . 0.0 112.15 -144.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.2 p -123.09 163.24 20.9 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 128.062 2.545 . . . . 0.0 111.558 -170.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.6 p -51.98 127.99 22.95 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.59 1.556 . . . . 0.0 113.489 -164.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.37 151.88 32.58 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 118.081 2.623 . . . . 0.0 118.081 -135.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.83 118.37 54.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 165.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.419 HG12 HG22 ' A' ' 136' ' ' VAL . 3.1 m -79.04 130.49 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.858 -154.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -136.29 148.81 65.79 Favored Pre-proline 0 C--O 1.236 0.367 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -166.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -72.55 76.67 2.3 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 124.061 3.174 . . . . 0.0 110.807 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.36 -45.44 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 126.526 1.93 . . . . 0.0 113.261 -167.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -78.26 -13.29 59.91 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -70.91 -35.98 72.52 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.409 -1.432 . . . . 0.0 110.146 162.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.0 tp -61.7 -43.95 97.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.745 0.818 . . . . 0.0 111.099 170.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.6 mp -56.29 -43.2 78.63 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.326 0.966 . . . . 0.0 112.6 170.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.1 t -61.83 -45.38 94.05 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.401 0.546 . . . . 0.0 111.575 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -66.5 -38.75 87.94 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.19 0.596 . . . . 0.0 112.511 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -57.49 12.76 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.406 1.483 . . . . 0.0 110.733 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.9 -35.81 81.3 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.198 0.599 . . . . 0.0 111.687 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.2 t -76.1 -23.45 54.93 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -175.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.54 -28.64 60.56 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 120.847 1.658 . . . . 0.0 115.163 -165.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.8 p -139.01 14.48 2.65 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.838 1.255 . . . . 0.0 113.415 157.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.47 79.73 0.2 Allowed Glycine 0 N--CA 1.472 1.051 0 C-N-CA 126.454 1.978 . . . . 0.0 113.305 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 74.5 mtt85 -157.58 115.91 3.16 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.033 1.733 . . . . 0.0 110.877 -175.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.67 145.16 29.78 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -152.39 159.15 43.45 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.786 1.634 . . . . 0.0 113.373 -165.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 1.6 m -76.39 113.81 14.39 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.756 1.222 . . . . 0.0 109.725 162.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -96.2 98.38 10.27 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 122.559 1.171 . . . . 0.0 108.352 173.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.6 t -101.45 150.63 5.86 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 C-N-CA 127.206 2.202 . . . . 0.0 109.419 -164.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -121.76 129.71 52.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.073 -1.017 . . . . 0.0 108.837 164.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -123.04 116.32 23.31 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.805 1.642 . . . . 0.0 110.086 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -95.09 115.94 28.07 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.398 1.479 . . . . 0.0 109.13 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.6 t -147.79 159.7 43.54 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 -170.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -6.75 -126.2 0.0 OUTLIER Glycine 0 N--CA 1.48 1.574 0 O-C-N 119.021 -2.3 . . . . 0.0 112.959 -133.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.465 ' HB3' ' HE3' ' A' ' 139' ' ' LYS . 57.3 m -94.45 111.32 23.06 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 113.642 -3.223 . . . . 0.0 110.17 149.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -169.58 146.22 3.3 Favored 'General case' 0 N--CA 1.475 0.824 1 C-N-CA 132.111 4.164 . . . . 0.0 107.581 133.228 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.9 t -72.23 139.5 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.068 -1.645 . . . . 0.0 110.294 165.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.58 148.5 29.2 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.616 0.766 . . . . 0.0 111.636 165.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.3 tp -108.84 110.37 21.7 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 157.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.4 m -97.83 114.26 26.27 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.868 1.667 . . . . 0.0 108.723 -174.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 99.0 m -103.93 108.36 19.66 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.063 -1.648 . . . . 0.0 109.449 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 19.0 m-30 -103.49 94.2 5.35 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.643 0.735 . . . . 0.0 111.74 -172.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.2 mp -72.99 94.67 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 126.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -176.36 149.73 10.02 Favored Glycine 0 N--CA 1.468 0.79 0 N-CA-C 119.113 2.405 . . . . 0.0 119.113 -169.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -114.46 58.05 0.93 Allowed Pre-proline 0 CA--C 1.556 1.178 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 170.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -67.77 174.09 8.14 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.993 2.462 . . . . 0.0 114.281 166.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -82.66 -39.08 22.56 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.5 tpp85 -75.31 -13.05 60.39 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -158.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.416 HD22 ' H ' ' A' ' 96' ' ' LEU . 3.3 mm? -51.57 -30.56 21.33 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 128.046 2.539 . . . . 0.0 112.994 170.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -52.95 -42.07 65.12 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.705 0.802 . . . . 0.0 111.206 170.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -100.77 -34.39 9.86 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -171.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.2 pp -85.61 155.99 20.91 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -167.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -151.47 122.74 7.76 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 -159.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.469 ' HB3' HG23 ' A' ' 116' ' ' VAL . 0.8 OUTLIER -106.38 179.5 4.25 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 126.992 2.117 . . . . 0.0 110.104 171.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 p -165.07 173.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -149.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.465 ' HA ' HG13 ' A' ' 150' ' ' VAL . 97.7 m -128.32 120.63 27.44 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 119.723 1.147 . . . . 0.0 111.258 137.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -176.49 179.52 1.16 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 129.507 3.123 . . . . 0.0 105.237 -172.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -111.42 127.58 55.72 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.456 1.502 . . . . 0.0 110.875 162.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -148.45 159.36 44.12 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.455 1.102 . . . . 0.0 113.658 -161.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -109.13 151.47 26.4 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.447 2.299 . . . . 0.0 111.162 174.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 mt -142.48 146.8 35.13 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.836 1.255 . . . . 0.0 111.925 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 51.9 m -106.69 178.49 4.55 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.747 1.219 . . . . 0.0 114.001 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 48.7 t -67.82 -5.13 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 128.809 2.844 . . . . 0.0 116.113 -161.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -138.3 47.9 1.97 Allowed 'General case' 0 CA--C 1.551 1.015 0 O-C-N 120.608 -1.308 . . . . 0.0 112.794 168.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -111.18 146.76 36.32 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.911 1.284 . . . . 0.0 112.064 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.689 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -150.02 147.06 27.38 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 119.687 -1.883 . . . . 0.0 111.296 -154.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.689 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -142.17 147.5 36.72 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.999 1.32 . . . . 0.0 112.73 -169.252 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.47 141.75 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-N 121.396 1.907 . . . . 0.0 114.065 162.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 101' ' ' ARG . 1.0 OUTLIER -133.91 148.86 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.179 1.392 . . . . 0.0 109.831 173.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.9 t -140.42 159.83 41.33 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.738 2.015 . . . . 0.0 106.542 161.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -49.74 -30.66 9.82 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -171.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.36 -33.35 75.04 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 121.145 1.793 . . . . 0.0 113.734 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.49 -26.36 63.58 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.225 -0.922 . . . . 0.0 112.027 172.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 37.0 mm -77.95 -30.18 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.755 0.822 . . . . 0.0 111.48 167.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.96 -13.98 62.6 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.252 -0.905 . . . . 0.0 113.196 170.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -70.0 -36.25 74.99 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 120.107 -1.621 . . . . 0.0 113.3 158.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.83 -37.67 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.852 1.261 . . . . 0.0 110.593 -176.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.5 135.37 15.82 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 125.112 1.365 . . . . 0.0 111.323 169.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.54 -24.73 63.02 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.893 3.062 . . . . 0.0 116.39 -157.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.7 t -147.65 130.1 15.79 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.393 1.077 . . . . 0.0 110.436 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -168.5 158.5 9.58 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.951 2.1 . . . . 0.0 108.206 169.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -136.07 -31.95 0.89 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.903 1.681 . . . . 0.0 113.64 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -101.76 21.73 41.16 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.949 1.738 . . . . 0.0 114.982 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.87 146.25 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.017 1.408 . . . . 0.0 113.527 -159.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.7 mp -113.63 81.58 1.54 Allowed 'General case' 0 C--O 1.24 0.554 0 CA-C-O 123.431 1.586 . . . . 0.0 108.531 169.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.0 m -75.44 146.27 40.83 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 162.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -124.07 132.56 53.68 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -172.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 44.5 t -124.34 133.64 53.39 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.005 0.82 . . . . 0.0 111.168 -169.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.419 HG22 HG12 ' A' ' 55' ' ' VAL . 10.1 t -144.79 108.89 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.398 0.679 . . . . 0.0 111.027 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.1 m -99.59 141.4 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.996 1.319 . . . . 0.0 113.33 173.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -122.98 162.0 23.16 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.63 1.172 . . . . 0.0 109.456 155.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.465 ' HE3' ' HB3' ' A' ' 82' ' ' CYS 0.273 0.1 OUTLIER -147.61 154.49 40.73 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.006 1.722 . . . . 0.0 108.019 169.589 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.8 t -132.88 121.03 22.29 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 170.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -73.14 -43.52 61.45 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 118.068 0.394 . . . . 0.0 110.337 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 44.9 m -45.76 -46.19 15.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.782 1.633 . . . . 0.0 112.762 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -91.18 5.44 81.32 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.449 1.499 . . . . 0.0 115.692 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 43.9 tpp 41.89 50.11 4.09 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.201 1.8 . . . . 0.0 113.63 -173.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.3 t -138.69 140.18 38.69 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.309 -0.869 . . . . 0.0 111.652 -162.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -109.08 139.49 43.89 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.265 1.026 . . . . 0.0 109.603 162.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -143.15 106.44 4.57 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 3.9 pt -136.32 152.22 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.577 0.751 . . . . 0.0 112.936 -160.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -136.77 149.15 47.64 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.311 0.577 . . . . 0.0 112.245 165.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 103' ' ' CYS . 7.2 p -141.18 132.9 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.137 0.975 . . . . 0.0 109.169 169.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.9 m -138.17 122.98 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.33 1.052 . . . . 0.0 111.668 -156.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -103.95 122.78 45.91 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -164.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -141.24 148.19 39.48 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.256 1.423 . . . . 0.0 110.186 165.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -74.61 -162.43 9.17 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.322 1.439 . . . . 0.0 115.164 169.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -56.15 -13.49 9.64 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 124.401 3.401 . . . . 0.0 117.04 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -63.33 -4.87 2.89 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.746 1.618 . . . . 0.0 113.882 166.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -73.55 43.59 0.15 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 126.075 1.75 . . . . 0.0 112.86 172.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -50.32 -30.44 12.07 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.617 2.767 . . . . 0.0 113.673 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.75 -42.89 57.38 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.377 1.471 . . . . 0.0 114.415 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -71.21 -32.44 68.81 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.404 -1.435 . . . . 0.0 111.629 170.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -58.16 -54.0 51.96 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.478 1.035 . . . . 0.0 111.364 169.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -54.63 -49.31 70.82 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.493 0.588 . . . . 0.0 111.527 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -57.24 -44.45 83.82 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 119.032 0.833 . . . . 0.0 112.837 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -64.01 -60.95 2.61 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.1 mp -53.15 -35.86 60.2 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.269 1.427 . . . . 0.0 112.924 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -68.07 -35.74 78.7 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.148 1.379 . . . . 0.0 111.852 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.65 -26.1 24.52 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.8 pt -104.74 -44.85 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -171.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -90.2 -32.62 16.52 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.247 1.385 . . . . 0.0 109.93 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -97.45 24.11 6.93 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.084 0.954 . . . . 0.0 112.982 171.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 73.6 ttt-85 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.492 -1.242 . . . . 0.0 112.637 163.009 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.66 -36.02 67.25 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 119.575 1.08 . . . . 0.0 112.91 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -102.69 164.22 11.77 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.651 1.18 . . . . 0.0 110.589 158.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.26 132.79 54.76 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 122.829 0.452 . . . . 0.0 111.367 -170.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -72.77 97.21 2.17 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 123.112 1.434 . . . . 0.0 111.656 -164.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 tp -145.85 145.82 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 1 C-N-CA 134.554 5.141 . . . . 0.0 106.483 172.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -75.56 129.6 37.48 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.603 163.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -65.09 -4.23 4.59 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 117.496 2.406 . . . . 0.0 117.496 -155.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -93.7 -22.33 18.8 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.482 1.113 . . . . 0.0 113.511 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.73 -42.82 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.664 1.186 . . . . 0.0 113.539 -168.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.88 -47.33 89.75 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 168.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.77 -37.29 70.89 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 118.966 1.383 . . . . 0.0 112.493 179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -74.43 -35.19 63.38 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.591 1.556 . . . . 0.0 114.129 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.4 tp -75.39 -37.07 60.75 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.136 1.374 . . . . 0.0 112.22 176.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -67.76 -44.32 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.604 1.562 . . . . 0.0 109.368 170.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.5 t -53.87 -44.85 70.74 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.234 1.014 . . . . 0.0 111.742 168.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -60.41 -37.05 79.6 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.495 -0.753 . . . . 0.0 111.451 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.5 m -67.01 -49.04 66.57 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.834 0.854 . . . . 0.0 111.501 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -64.79 -38.75 92.04 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 119.926 1.239 . . . . 0.0 112.77 173.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -78.79 -35.59 44.09 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -172.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.91 -23.7 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.965 1.257 . . . . 0.0 111.509 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.0 mp -86.75 -11.96 49.54 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 167.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 53.55 43.29 31.43 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.835 1.654 . . . . 0.0 112.08 -177.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 pp -107.18 162.63 13.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.545 0.738 . . . . 0.0 110.555 171.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -73.36 148.81 43.08 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.758 0.423 . . . . 0.0 111.777 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -25.41 67.94 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.447 -1.408 . . . . 0.0 112.881 173.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -79.11 2.38 20.97 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.945 1.698 . . . . 0.0 113.696 168.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -130.18 -5.93 4.36 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.522 1.529 . . . . 0.0 110.772 -178.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.499 HD11 ' HB1' ' A' ' 48' ' ' ALA . 26.0 tp -87.78 138.49 31.42 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.306 1.842 . . . . 0.0 106.774 154.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.73 138.9 51.72 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 164.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.0 mm -98.79 141.11 16.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 O-C-N 125.8 1.938 . . . . 0.0 111.796 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.61 149.22 37.01 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.691 0.397 . . . . 0.0 110.808 174.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -158.26 56.29 0.46 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 166.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.7 p -87.43 -56.78 3.21 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.024 -1.672 . . . . 0.0 112.294 162.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.64 -55.99 3.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.808 0.813 . . . . 0.0 113.041 -158.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -64.39 -42.11 96.31 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.951 1.701 . . . . 0.0 112.482 -175.114 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.87 -27.17 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.393 1.077 . . . . 0.0 110.278 174.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.8 m -92.81 4.14 54.38 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.246 1.418 . . . . 0.0 114.272 174.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.24 -41.75 9.3 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 120.23 1.377 . . . . 0.0 110.737 172.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -100.38 77.64 0.17 Allowed Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 162.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -72.63 -0.09 8.34 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 N-CA-C 118.833 2.59 . . . . 0.0 118.833 -121.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -119.82 3.97 11.04 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 126.072 1.749 . . . . 0.0 113.234 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -133.02 170.6 15.14 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.735 1.607 . . . . 0.0 113.636 -148.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.5 m -67.58 158.71 31.41 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.162 1.385 . . . . 0.0 113.991 -169.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.78 -77.88 0.57 Allowed 'General case' 0 CA--C 1.541 0.629 0 O-C-N 117.738 -3.101 . . . . 0.0 115.722 14.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.48 -171.84 0.85 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.944 1.247 . . . . 0.0 112.736 -172.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -132.29 149.96 52.26 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -174.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.499 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -130.81 141.73 50.36 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 129.784 3.234 . . . . 0.0 108.326 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.3 ttp -124.89 128.25 48.35 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.888 -1.132 . . . . 0.0 108.331 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.5 mt -133.79 147.63 51.28 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.468 1.907 . . . . 0.0 114.73 -147.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.5 t -124.22 169.13 12.05 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.833 2.853 . . . . 0.0 112.999 -169.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.9 p -96.77 176.25 6.06 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.323 2.649 . . . . 0.0 115.419 -159.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 66.66 21.98 10.52 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 116.995 2.22 . . . . 0.0 116.995 166.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.52 161.38 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.86 1.264 . . . . 0.0 111.077 165.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.461 HG12 HG22 ' A' ' 136' ' ' VAL . 1.5 m -101.3 139.73 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.996 1.318 . . . . 0.0 109.235 171.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -133.28 125.25 18.72 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 118.995 0.816 . . . . 0.0 110.022 171.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -63.4 65.53 0.18 Allowed 'Trans proline' 0 C--N 1.357 1.005 1 C-N-CA 125.508 4.138 . . . . 0.0 113.129 170.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.12 -38.67 39.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 127.78 2.432 . . . . 0.0 114.292 -156.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -75.0 -10.47 59.5 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.33 -0.856 . . . . 0.0 113.032 -177.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -59.38 -31.49 69.27 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 120.616 -1.303 . . . . 0.0 112.058 161.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 32.8 tp -72.38 -42.98 64.61 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.268 0.94 . . . . 0.0 111.246 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.1 mp -57.83 -43.73 86.01 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 122.128 -0.358 . . . . 0.0 111.062 169.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.9 m -62.63 -38.76 91.51 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.948 0.899 . . . . 0.0 111.52 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -65.73 -36.13 82.72 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 118.618 -0.706 . . . . 0.0 112.041 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -69.39 -53.66 18.3 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 168.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -63.04 -36.5 83.79 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.315 -0.865 . . . . 0.0 111.865 -172.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 73.6 m -73.57 -9.94 59.2 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.0 tpt85 -75.5 -32.56 60.58 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.395 0.998 . . . . 0.0 112.426 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.9 p -148.61 -36.91 0.18 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.401 1.08 . . . . 0.0 112.749 173.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.35 81.94 1.63 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 126.755 2.121 . . . . 0.0 110.816 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 72.6 mtt85 -148.44 114.15 5.69 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.321 1.848 . . . . 0.0 110.071 170.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.9 m -65.29 140.37 58.69 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.589 1.156 . . . . 0.0 113.099 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.8 147.86 33.39 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -170.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 64.4 m -76.39 108.79 9.59 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.896 2.878 . . . . 0.0 111.694 165.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -91.62 99.63 12.51 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.555 -1.341 . . . . 0.0 108.323 167.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.7 t -99.7 115.79 41.45 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 C-N-CA 125.906 1.682 . . . . 0.0 109.348 -168.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -96.8 124.97 40.93 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 120.351 -1.468 . . . . 0.0 108.365 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -118.06 122.57 43.47 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.858 1.263 . . . . 0.0 111.832 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -95.89 114.85 26.61 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.546 1.538 . . . . 0.0 109.692 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 p -144.17 160.16 41.42 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 -173.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -7.92 -130.56 0.0 OUTLIER Glycine 0 N--CA 1.483 1.801 0 O-C-N 118.642 -2.537 . . . . 0.0 113.492 -137.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.2 p -96.41 101.86 13.56 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 121.798 2.799 . . . . 0.0 110.124 158.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.0 mtt85 -173.84 141.63 0.83 Allowed 'General case' 0 N--CA 1.471 0.607 1 C-N-CA 132.982 4.513 . . . . 0.0 107.92 144.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.6 t -68.35 137.43 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 CA-C-N 120.244 1.384 . . . . 0.0 110.405 165.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.9 m -104.49 145.7 29.91 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.101 -0.999 . . . . 0.0 110.374 158.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.8 tp -109.62 109.7 20.53 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 160.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.2 m -88.84 96.64 10.78 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.398 1.079 . . . . 0.0 109.19 170.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 7.9 p -101.9 111.16 23.33 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 119.396 -2.065 . . . . 0.0 109.927 -172.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -146.64 150.5 35.57 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 116.828 2.159 . . . . 0.0 116.828 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.17 109.04 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 168.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -97.41 139.9 14.74 Favored Glycine 0 CA--C 1.536 1.357 0 N-CA-C 117.864 1.906 . . . . 0.0 117.864 -138.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.3 62.93 46.93 Favored Pre-proline 0 CA--C 1.551 1.016 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 152.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -69.49 106.35 1.6 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.688 2.926 . . . . 0.0 114.604 -170.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -55.49 -30.74 61.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.687 1.195 . . . . 0.0 113.85 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 7.3 tpt85 -92.68 3.13 56.17 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.2 tp -70.89 1.0 6.09 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.728 -1.232 . . . . 0.0 114.287 166.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -51.81 -37.8 53.17 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.656 -0.652 . . . . 0.0 111.099 150.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -123.78 -35.3 2.9 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 -169.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 pp -82.81 167.4 18.14 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 121.999 2.181 . . . . 0.0 114.862 -167.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -168.2 126.22 1.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 -165.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.458 ' NE ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -105.21 178.22 4.62 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.547 1.539 . . . . 0.0 110.261 170.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.458 ' H ' ' NE ' ' A' ' 101' ' ' ARG . 1.1 p -162.38 169.81 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 -147.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.448 ' HA ' HG13 ' A' ' 150' ' ' VAL . 99.4 m -123.82 122.42 37.96 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.029 -1.044 . . . . 0.0 111.125 136.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -176.15 175.17 1.93 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 129.083 2.953 . . . . 0.0 106.838 -174.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -122.36 121.72 37.35 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.296 2.239 . . . . 0.0 111.476 164.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -159.09 171.43 19.98 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -100.14 137.53 38.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.485 2.314 . . . . 0.0 110.376 175.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.8 tp -146.2 142.97 28.93 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.139 1.376 . . . . 0.0 111.039 -158.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 p -92.38 177.16 6.22 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 118.161 2.652 . . . . 0.0 118.161 -172.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.6 t -76.54 -6.87 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 129.486 3.114 . . . . 0.0 114.551 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -122.43 32.65 5.7 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.233 1.413 . . . . 0.0 111.746 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -136.01 159.9 40.27 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.25 -1.531 . . . . 0.0 113.079 -162.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.666 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -155.17 148.71 25.21 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.667 -1.271 . . . . 0.0 110.356 -151.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.666 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -143.4 148.0 35.5 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.767 1.227 . . . . 0.0 110.971 -169.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.46 138.42 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 120.639 1.563 . . . . 0.0 113.229 160.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -132.92 156.37 42.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.659 1.184 . . . . 0.0 109.5 169.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.6 t -145.01 167.25 23.11 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.654 1.582 . . . . 0.0 108.27 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.53 -33.53 71.51 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.14 0.882 . . . . 0.0 113.324 -172.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.05 -30.74 70.89 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 172.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -73.19 -35.48 66.39 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.298 -0.876 . . . . 0.0 111.045 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.1 mm -77.53 -33.43 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.359 1.064 . . . . 0.0 111.647 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -57.98 -34.5 70.03 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.059 -1.025 . . . . 0.0 111.015 168.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -70.97 -25.47 62.73 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.618 171.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 54.0 mt -72.61 -44.85 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.394 1.452 . . . . 0.0 110.157 171.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.6 tptp 168.39 -49.62 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 128.291 2.636 . . . . 0.0 110.15 168.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -62.96 112.64 1.72 Allowed 'Trans proline' 0 C--N 1.357 0.985 0 CA-C-N 121.653 1.626 . . . . 0.0 114.604 -167.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 87.8 m -66.36 154.44 40.04 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.328 1.851 . . . . 0.0 112.933 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -80.36 -5.96 57.24 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 117.311 2.337 . . . . 0.0 117.311 -149.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -93.72 9.28 37.66 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.48 1.912 . . . . 0.0 115.413 -176.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -166.49 14.31 0.08 OUTLIER Glycine 0 CA--C 1.53 1.023 0 N-CA-C 116.506 1.363 . . . . 0.0 116.506 -166.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 63.9 t -70.1 122.73 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 118.724 1.262 . . . . 0.0 111.683 -171.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.9 mp -127.76 80.05 1.93 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 123.777 1.751 . . . . 0.0 108.344 153.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.6 m -85.09 129.91 34.71 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 160.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -125.86 132.64 52.16 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.146 0.979 . . . . 0.0 110.796 -158.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 49.3 t -124.4 141.45 52.07 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.546 1.138 . . . . 0.0 111.334 -167.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 55' ' ' VAL . 10.9 t -137.21 125.33 32.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.547 1.539 . . . . 0.0 108.87 -173.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.23 143.87 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -174.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 28.4 mtt-85 -133.12 159.14 41.0 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 128.087 2.555 . . . . 0.0 107.987 164.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.301 0.0 OUTLIER -145.67 100.89 3.49 Favored 'General case' 0 CA--C 1.558 1.258 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 173.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.1 t -58.44 125.18 22.22 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 120.044 -1.66 . . . . 0.0 112.642 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -81.34 -53.85 5.98 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.904 0.882 . . . . 0.0 112.141 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.0 m -57.12 -22.41 39.63 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 175.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -119.2 22.39 9.0 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 117.333 -1.815 . . . . 0.0 114.216 174.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 91.7 mmm 22.77 71.49 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 128.454 2.702 . . . . 0.0 114.876 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.7 p -164.35 170.43 16.13 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.373 -0.829 . . . . 0.0 112.312 -169.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -113.24 149.39 33.85 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.783 1.633 . . . . 0.0 112.055 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -123.85 115.76 21.84 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 166.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 8.8 tt -122.05 142.5 38.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.703 -170.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -140.03 145.96 38.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.198 0.523 . . . . 0.0 110.628 159.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.448 HG13 ' HA ' ' A' ' 103' ' ' CYS . 4.4 p -145.27 136.68 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 122.394 1.092 . . . . 0.0 111.179 167.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.4 m -130.54 129.67 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 126.38 1.872 . . . . 0.0 110.065 -163.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -100.12 120.68 40.23 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -164.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -140.3 153.21 46.38 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.953 0.883 . . . . 0.0 112.742 171.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -87.28 -143.78 8.39 Favored Glycine 0 CA--C 1.543 1.784 0 C-N-CA 125.267 1.413 . . . . 0.0 111.718 162.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.58 -13.88 2.73 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.712 3.608 . . . . 0.0 116.048 174.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -58.81 -14.58 9.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.487 1.915 . . . . 0.0 113.977 171.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -95.67 18.6 12.63 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -54.72 -30.3 55.68 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.22 -36.04 82.01 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.626 -1.296 . . . . 0.0 113.277 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -73.06 -37.6 66.76 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.593 -1.317 . . . . 0.0 111.113 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -56.17 -47.23 78.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.413 0.685 . . . . 0.0 111.048 171.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -60.48 -37.25 80.42 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.55 1.14 . . . . 0.0 112.461 174.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -68.92 -38.2 79.41 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.312 0.96 . . . . 0.0 113.518 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -62.04 -57.31 12.12 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.979 0.911 . . . . 0.0 113.017 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.7 mp -43.99 -39.88 4.36 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.847 1.659 . . . . 0.0 112.517 166.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 53.3 tpt85 -73.02 -21.5 60.81 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -92.46 -37.38 12.57 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.824 1.193 . . . . 0.0 113.103 171.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.4 pt -81.86 -34.61 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.028 0.931 . . . . 0.0 113.185 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -74.55 6.44 3.8 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.456 -0.778 . . . . 0.0 111.481 161.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -124.85 23.14 7.98 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 167.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 . . . . . 0 C--O 1.254 1.305 0 C-N-CA 126.054 1.742 . . . . 0.0 109.963 162.06 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.3 -10.52 59.96 Favored Glycine 0 CA--C 1.543 1.815 0 N-CA-C 117.61 1.804 . . . . 0.0 117.61 -171.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -137.4 174.99 10.01 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.088 2.155 . . . . 0.0 110.455 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.2 ptm -65.14 144.74 57.01 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 120.62 -1.3 . . . . 0.0 113.177 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -127.42 104.14 7.75 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.298 1.039 . . . . 0.0 111.995 -172.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 51.0 mm -114.62 117.23 54.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 127.676 2.391 . . . . 0.0 107.23 166.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -61.37 154.98 22.62 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 126.918 2.087 . . . . 0.0 112.188 176.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -53.75 -10.5 0.3 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 126.859 2.064 . . . . 0.0 115.104 177.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -113.14 -28.97 7.46 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.49 1.516 . . . . 0.0 114.551 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.1 t -72.0 -46.98 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.646 1.112 . . . . 0.0 112.433 -169.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.41 -45.02 95.89 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 171.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.28 -44.35 71.83 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 117.843 0.822 . . . . 0.0 112.539 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -74.89 -41.09 60.43 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.822 1.249 . . . . 0.0 114.25 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 mp -65.63 -47.87 74.12 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.062 1.301 . . . . 0.0 111.012 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.12 -40.53 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.274 0.63 . . . . 0.0 109.567 175.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.9 t -56.56 -44.7 81.22 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.741 0.817 . . . . 0.0 112.337 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -64.43 -37.94 89.27 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.284 -0.885 . . . . 0.0 112.303 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.03 -49.25 78.39 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 120.57 1.532 . . . . 0.0 112.427 171.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 ptt85 -64.1 -39.59 94.39 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 120.328 1.422 . . . . 0.0 113.298 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -58.78 -44.17 90.64 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.809 2.044 . . . . 0.0 113.453 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.49 -30.77 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.307 1.043 . . . . 0.0 112.318 -175.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.411 HD21 HD23 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -87.4 -7.48 57.66 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.001 1.32 . . . . 0.0 112.455 174.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 64.31 9.35 4.8 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.488 2.715 . . . . 0.0 115.61 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . 0.262 4.3 pp -94.1 178.64 5.58 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 120.726 -1.234 . . . . 0.0 112.8 -173.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -95.96 154.32 17.3 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.275 1.03 . . . . 0.0 111.765 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -64.23 -24.18 67.57 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 119.488 -2.007 . . . . 0.0 112.81 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -78.36 0.26 26.26 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.811 1.644 . . . . 0.0 112.648 169.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -109.86 -18.8 13.32 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.149 1.38 . . . . 0.0 111.202 170.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.9 tp -88.23 111.81 22.07 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.629 1.572 . . . . 0.0 106.9 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.497 ' H ' ' HB3' ' A' ' 49' ' ' MET . 12.3 tpp180 -84.65 97.79 9.83 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 118.424 -1.31 . . . . 0.0 107.777 175.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . 0.255 1.1 pp -92.46 148.63 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 126.646 1.978 . . . . 0.0 111.752 172.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.2 m -147.65 150.03 33.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.863 0.865 . . . . 0.0 108.921 -170.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -123.05 -158.68 0.8 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.829 1.252 . . . . 0.0 112.453 -161.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.8 t -41.49 -42.83 2.47 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 126.185 1.794 . . . . 0.0 115.252 -160.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.01 -30.08 65.82 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 -171.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.23 -9.66 20.25 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 pt -110.14 -19.9 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.1 t -60.72 10.99 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 127.187 2.195 . . . . 0.0 116.781 -169.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -72.95 -20.12 61.11 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.714 2.006 . . . . 0.0 112.385 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -60.2 177.27 0.3 Allowed Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 127.433 2.293 . . . . 0.0 112.532 163.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -63.44 -86.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.936 2.424 . . . . 0.0 112.67 163.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -129.69 25.57 5.35 Favored 'General case' 0 CA--C 1.555 1.155 0 N-CA-C 117.349 2.352 . . . . 0.0 117.349 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -162.68 142.13 9.14 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 118.811 -2.431 . . . . 0.0 110.717 -153.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m 176.54 -174.66 0.11 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.895 2.078 . . . . 0.0 108.895 -175.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.454 ' H ' ' HB3' ' A' ' 89' ' ' TYR . 30.1 tp -122.5 -75.41 0.6 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 119.174 -0.441 . . . . 0.0 111.306 150.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 15.0 p -163.35 -170.3 2.22 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.479 1.133 . . . . 0.0 113.223 -163.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 87' ' ' SER . 42.0 t0 -146.3 115.08 6.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.057 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -119.7 144.14 47.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.941 2.897 . . . . 0.0 109.287 -153.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.497 ' HB3' ' H ' ' A' ' 30' ' ' ARG . 29.5 ttp -122.3 128.1 50.66 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.904 1.684 . . . . 0.0 110.854 -165.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.411 HD23 HD21 ' A' ' 22' ' ' LEU . 0.6 OUTLIER -145.0 162.09 37.78 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 127.001 2.688 . . . . 0.0 115.439 -159.206 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.26 148.49 25.06 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 111.887 -2.415 . . . . 0.0 111.887 -142.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 t -66.03 156.37 33.93 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.072 0.949 . . . . 0.0 112.483 166.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 69.62 -0.85 2.47 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.109 2.164 . . . . 0.0 115.525 168.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.5 mp -103.98 147.01 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 126.08 1.752 . . . . 0.0 111.011 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.9 p -87.52 136.66 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.023 1.329 . . . . 0.0 111.714 170.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -107.54 110.25 62.78 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.56 1.144 . . . . 0.0 108.663 172.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -60.43 66.65 0.08 OUTLIER 'Trans proline' 0 CA--C 1.542 0.884 1 C-N-CA 126.521 4.814 . . . . 0.0 113.726 164.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.422 ' CG1' HG23 ' A' ' 133' ' ' THR . 3.6 p -68.75 -27.02 34.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 125.098 1.359 . . . . 0.0 114.424 -157.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -46.86 -45.19 20.15 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 126.46 1.904 . . . . 0.0 112.716 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -69.72 -30.67 68.34 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.996 -0.44 . . . . 0.0 112.164 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.1 mt -75.74 -45.26 37.52 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.824 0.85 . . . . 0.0 111.737 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 mp -53.58 -49.47 67.67 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.722 0.692 . . . . 0.0 109.813 171.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.8 m -64.97 -39.42 93.46 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -74.7 -33.75 62.48 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.444 -0.785 . . . . 0.0 112.408 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -63.89 -53.03 56.8 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.91 0.777 . . . . 0.0 111.375 171.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -73.67 -33.49 64.49 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -168.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 8.6 t -79.78 -19.15 49.28 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.904 1.282 . . . . 0.0 114.316 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -86.22 -26.1 25.24 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -166.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.2 m -138.79 -2.81 1.69 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -174.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.22 80.47 0.17 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.042 1.306 . . . . 0.0 111.384 -174.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.0 mtp85 -162.11 141.77 9.8 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 128.09 2.556 . . . . 0.0 105.642 169.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.2 m -65.61 140.98 58.56 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 125.064 1.346 . . . . 0.0 111.396 170.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.49 117.09 31.42 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 80.8 m -75.4 102.06 5.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.069 1.748 . . . . 0.0 108.333 157.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -85.12 96.15 9.36 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 167.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.9 t -99.75 141.3 17.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 C-N-CA 125.876 1.671 . . . . 0.0 108.165 -170.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -127.91 123.5 35.09 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 120.264 -1.523 . . . . 0.0 107.748 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -113.02 117.0 30.81 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.737 1.615 . . . . 0.0 108.842 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -103.75 115.79 31.12 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.309 1.844 . . . . 0.0 109.451 -172.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.3 p -143.25 165.09 28.41 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.409 2.684 . . . . 0.0 104.699 -160.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -13.66 -125.08 0.0 OUTLIER Glycine 0 N--CA 1.485 1.958 0 C-N-CA 129.58 3.466 . . . . 0.0 114.827 -152.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.7 p -92.89 99.78 12.37 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 113.862 -3.135 . . . . 0.0 110.151 152.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -170.75 162.49 7.71 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 130.605 3.562 . . . . 0.0 109.729 157.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.3 t -105.91 138.45 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 121.24 1.836 . . . . 0.0 112.443 148.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.7 t -104.42 138.91 40.13 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.932 0.893 . . . . 0.0 109.842 163.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 tp -107.82 108.46 19.66 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 168.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 47' ' ' ASP . 12.1 m -82.5 93.54 7.28 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 172.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 3.7 p -106.38 104.79 14.56 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 119.995 -1.691 . . . . 0.0 108.43 -169.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.454 ' HB3' ' H ' ' A' ' 45' ' ' LEU . 0.8 OUTLIER -142.9 149.92 39.12 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 117.022 2.231 . . . . 0.0 117.022 -177.026 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.7 pt -78.58 72.49 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 113.026 -1.897 . . . . 0.0 107.856 154.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -174.34 178.13 46.28 Favored Glycine 0 N--CA 1.478 1.471 0 N-CA-C 120.088 2.795 . . . . 0.0 120.088 -160.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -140.77 136.16 16.13 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.996 1.318 . . . . 0.0 114.499 -172.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -93.56 -166.71 0.15 Allowed 'Trans proline' 0 CA--C 1.549 1.241 1 C-N-CA 125.797 4.332 . . . . 0.0 112.492 172.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -79.26 -36.66 39.5 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 164.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -96.87 0.18 48.75 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 119.339 3.088 . . . . 0.0 119.339 -167.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.463 ' HA ' ' HG ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -54.1 -27.97 36.36 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 122.395 2.361 . . . . 0.0 114.383 -177.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.6 pttm -57.98 -30.41 66.01 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.275 1.03 . . . . 0.0 113.251 170.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -111.49 -29.97 7.56 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.466 ' C ' HD12 ' A' ' 99' ' ' LEU . 1.9 pp -74.31 165.31 25.39 Favored 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 121.753 2.07 . . . . 0.0 112.07 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -155.01 107.33 2.72 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 118.415 2.746 . . . . 0.0 118.415 -156.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.501 ' HE ' ' H ' ' A' ' 102' ' ' VAL . 0.1 OUTLIER -103.11 177.53 4.81 Favored 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 126.437 1.895 . . . . 0.0 111.533 169.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.501 ' H ' ' HE ' ' A' ' 101' ' ' ARG . 0.5 OUTLIER -165.82 170.64 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 -142.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 37.1 t -121.08 124.7 45.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.901 1.28 . . . . 0.0 109.918 141.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -172.86 167.91 5.07 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.4 1.88 . . . . 0.0 108.807 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -107.81 126.83 53.11 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.402 1.481 . . . . 0.0 109.522 150.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -152.12 165.65 34.11 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -165.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -101.0 145.43 28.71 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.023 1.729 . . . . 0.0 111.245 173.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.7 tp -140.89 143.04 34.43 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.133 0.973 . . . . 0.0 110.897 -158.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.9 p -111.43 -171.69 1.89 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.525 1.93 . . . . 0.0 114.639 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 65.9 t -73.32 -8.46 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 127.24 2.216 . . . . 0.0 113.58 172.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 -99.89 -3.41 32.51 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -165.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -96.98 148.95 22.45 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 120.503 1.501 . . . . 0.0 113.273 -147.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.633 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -144.73 143.76 30.86 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.144 -1.597 . . . . 0.0 109.061 -175.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.1 OUTLIER -145.94 149.75 34.79 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-O 117.512 -1.232 . . . . 0.0 112.434 -168.089 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.41 141.94 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-N 121.338 1.881 . . . . 0.0 114.809 157.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.82 149.63 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.714 0.806 . . . . 0.0 111.123 169.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 39.8 m -146.29 154.43 41.68 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.844 2.057 . . . . 0.0 108.376 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -56.65 -36.9 70.05 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -163.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.02 -32.86 69.75 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 120.594 -1.316 . . . . 0.0 113.028 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -78.18 -29.37 48.49 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.373 1.069 . . . . 0.0 112.222 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.8 tp -76.97 -35.02 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 123.093 0.557 . . . . 0.0 111.889 168.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -61.14 -27.53 68.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.466 0.706 . . . . 0.0 112.27 171.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 22.3 ttm105 -77.44 -3.99 43.14 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.293 1.437 . . . . 0.0 114.622 174.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.8 mt -78.54 -25.22 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 O-C-N 120.955 -1.091 . . . . 0.0 110.616 168.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -91.09 179.5 1.42 Allowed Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.324 1.45 . . . . 0.0 108.855 153.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.6 -43.07 2.12 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 121.39 1.393 . . . . 0.0 111.435 160.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 38.2 t -158.53 148.72 19.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.925 2.49 . . . . 0.0 107.632 170.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -160.19 91.98 0.97 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 119.688 1.131 . . . . 0.0 111.732 171.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.7 63.34 0.19 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.56 1.944 . . . . 0.0 110.516 174.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 162.44 28.37 0.02 OUTLIER Glycine 0 CA--C 1.539 1.541 0 C-N-CA 125.195 1.378 . . . . 0.0 115.735 -171.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.7 t -61.58 128.0 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 120.132 1.966 . . . . 0.0 111.539 -174.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.18 89.05 2.98 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.459 1.904 . . . . 0.0 107.848 168.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.422 HG23 ' CG1' ' A' ' 58' ' ' VAL . 6.0 t -98.83 145.29 27.12 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.763 1.225 . . . . 0.0 111.488 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -138.72 132.78 31.33 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.267 1.027 . . . . 0.0 109.007 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 31.3 t -117.33 136.02 53.43 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.201 1.0 . . . . 0.0 111.038 -174.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.4 t -136.71 138.14 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 126.457 1.903 . . . . 0.0 109.301 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.81 142.72 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.907 0.883 . . . . 0.0 110.943 177.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 31.5 mmm-85 -111.21 113.57 26.16 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.02 0.928 . . . . 0.0 108.734 163.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.608 ' HE2' ' CG ' ' A' ' 146' ' ' TYR . 0.0 OUTLIER -89.79 118.08 29.12 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 155.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.7 t -147.98 -167.94 2.94 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.027 0.831 . . . . 0.0 111.987 -169.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.2 m120 50.07 72.36 0.33 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.429 2.292 . . . . 0.0 112.321 168.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.9 m 54.01 3.45 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 -173.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.03 38.16 8.75 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.791 0.71 . . . . 0.0 112.288 -168.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 61.6 mtt -133.77 -13.23 2.56 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.73 142.33 24.48 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.875 0.845 . . . . 0.0 112.789 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.608 ' CG ' ' HE2' ' A' ' 139' ' ' LYS . 7.3 m-85 -140.82 173.63 11.3 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.666 -155.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -151.95 151.51 31.31 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 10.9 tt -141.19 136.5 33.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 111.405 -176.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -137.53 125.7 23.05 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.386 1.074 . . . . 0.0 109.493 177.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.8 133.13 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 O-C-N 121.01 -1.056 . . . . 0.0 111.073 170.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 28.5 m -116.39 147.81 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.894 1.678 . . . . 0.0 110.966 -166.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.18 100.54 4.43 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.358 1.063 . . . . 0.0 111.609 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -119.85 161.77 20.25 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.718 1.607 . . . . 0.0 109.843 176.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -78.72 -147.35 3.58 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 118.639 0.654 . . . . 0.0 112.034 166.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.29 -11.99 7.11 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.625 2.883 . . . . 0.0 113.624 164.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -22.54 51.1 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.82 2.048 . . . . 0.0 113.012 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -87.36 57.09 4.25 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.946 1.355 . . . . 0.0 111.344 172.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -31.91 65.47 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.326 1.05 . . . . 0.0 111.531 171.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.78 -53.23 57.46 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -76.85 -25.52 53.23 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.186 0.903 . . . . 0.0 112.494 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -62.35 -54.02 46.57 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.986 1.267 . . . . 0.0 111.844 169.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -64.55 -28.67 69.8 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.458 -1.402 . . . . 0.0 112.352 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.19 -36.13 83.06 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.392 0.677 . . . . 0.0 112.484 168.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -70.59 -47.9 57.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 118.308 -0.853 . . . . 0.0 113.234 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.6 mp -48.41 -39.56 22.98 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 120.021 1.282 . . . . 0.0 112.858 166.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -71.33 -29.56 65.15 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -77.85 -32.58 52.16 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.637 1.575 . . . . 0.0 112.419 175.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.7 mt -86.4 -47.65 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.713 1.605 . . . . 0.0 112.149 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -68.04 1.74 2.54 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.066 0.848 . . . . 0.0 112.015 166.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -124.23 24.35 8.11 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 164.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . 0.277 9.6 mmm180 . . . . . 0 N--CA 1.48 1.025 0 C-N-CA 128.722 2.809 . . . . 0.0 116.344 173.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 120.399 0.143 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.67 152.57 52.44 Favored Glycine 0 CA--C 1.535 1.305 0 N-CA-C 115.894 1.118 . . . . 0.0 115.894 -172.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -79.53 -15.63 57.38 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.223 1.409 . . . . 0.0 112.135 167.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.88 152.32 34.74 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.499 1.52 . . . . 0.0 111.037 156.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -133.46 99.24 4.45 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.441 0.696 . . . . 0.0 109.601 167.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.1 tp -80.24 106.24 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -170.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -51.2 128.43 22.02 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 112.681 -2.054 . . . . 0.0 109.316 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -63.51 -23.74 67.52 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 -160.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -94.41 -28.91 15.25 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.378 0.99 . . . . 0.0 112.773 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -68.23 -54.49 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 118.778 0.717 . . . . 0.0 112.23 -171.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.08 -43.08 99.64 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 119.186 0.903 . . . . 0.0 112.16 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.45 -50.12 74.85 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 117.749 0.775 . . . . 0.0 111.77 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -75.58 -31.76 60.09 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.92 -48.5 53.23 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.244 1.383 . . . . 0.0 111.654 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.18 -36.34 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 119.026 -0.511 . . . . 0.0 109.718 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 m -69.92 -43.53 71.5 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.549 1.068 . . . . 0.0 112.329 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -65.51 -39.08 91.43 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.222 -0.924 . . . . 0.0 111.29 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.73 -34.64 69.72 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.038 1.29 . . . . 0.0 112.297 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -52.88 -43.92 66.48 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 120.589 -1.319 . . . . 0.0 111.611 169.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -76.85 -43.34 36.58 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.597 1.159 . . . . 0.0 113.25 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -71.75 -31.99 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.035 1.334 . . . . 0.0 112.266 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.1 mt -89.85 -12.12 39.97 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.676 1.191 . . . . 0.0 113.065 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 60.21 25.7 15.1 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.783 2.033 . . . . 0.0 113.808 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 pp -117.91 155.55 29.99 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.87 1.268 . . . . 0.0 111.422 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -80.69 161.04 24.8 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -168.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -69.19 -19.28 63.98 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 119.771 -1.831 . . . . 0.0 115.381 -166.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -94.91 -5.76 44.13 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.609 1.563 . . . . 0.0 113.612 168.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -110.99 2.51 18.06 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.099 2.16 . . . . 0.0 110.801 -176.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 13.6 tp -90.54 124.11 34.74 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 128.692 2.797 . . . . 0.0 105.385 154.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 41.8 ttt-85 -85.39 119.82 26.18 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 117.951 -1.5 . . . . 0.0 107.766 166.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.497 ' H ' HD12 ' A' ' 31' ' ' ILE 0.276 0.8 OUTLIER -112.26 141.77 26.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.193 0.997 . . . . 0.0 112.393 170.269 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.6 m -157.74 141.24 15.51 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.07 1.348 . . . . 0.0 108.138 -159.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -163.3 60.76 0.18 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 122.521 1.153 . . . . 0.0 112.702 -172.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.9 t -93.55 -56.62 2.85 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.908 -1.12 . . . . 0.0 113.274 150.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.82 -54.3 4.99 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 122.308 1.051 . . . . 0.0 113.108 -146.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.542 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -63.9 -9.82 17.41 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.326 1.85 . . . . 0.0 113.188 171.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mm -90.2 6.31 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.105 1.362 . . . . 0.0 110.731 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.4 p -69.01 -17.66 63.95 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -173.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.416 ' HE3' ' O ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -62.65 -53.78 49.29 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.917 1.235 . . . . 0.0 110.111 169.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -168.85 155.89 6.9 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 125.675 1.59 . . . . 0.0 109.038 169.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.51 -27.3 18.58 Favored 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 122.933 2.422 . . . . 0.0 114.961 166.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -110.15 18.77 19.63 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 129.147 2.979 . . . . 0.0 113.143 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -153.13 92.06 1.58 Allowed 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t 165.85 -169.19 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 130.073 3.349 . . . . 0.0 107.743 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.264 1.2 tm? -132.08 -79.77 0.51 Allowed 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 151.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 5.7 t -175.9 -178.33 1.03 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.917 1.687 . . . . 0.0 109.96 -168.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 6.1 t70 -143.3 126.65 16.68 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 120.676 -1.265 . . . . 0.0 109.882 -170.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.22 154.46 17.38 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.548 1.939 . . . . 0.0 110.538 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -124.58 129.39 50.5 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.413 1.006 . . . . 0.0 108.786 168.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.59 162.39 38.5 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 126.709 2.506 . . . . 0.0 114.826 -156.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 p -102.5 156.53 17.55 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.736 2.014 . . . . 0.0 114.734 -147.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 t -71.79 149.19 45.55 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.572 1.149 . . . . 0.0 113.565 173.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 t70 68.72 16.67 8.95 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 163.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.61 146.88 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.743 1.617 . . . . 0.0 109.542 168.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.6 p -97.48 139.47 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.559 1.544 . . . . 0.0 111.272 166.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -122.21 128.74 25.38 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 124.9 1.28 . . . . 0.0 110.472 -169.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.94 70.13 5.32 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 124.598 3.532 . . . . 0.0 110.782 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.5 p -65.48 -26.47 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.25 1.42 . . . . 0.0 113.956 -161.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -48.22 -45.99 34.71 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.531 1.533 . . . . 0.0 112.62 171.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -62.35 -39.68 93.89 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.591 0.632 . . . . 0.0 111.186 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.5 tp -69.63 -53.51 18.38 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.021 0.528 . . . . 0.0 110.814 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.18 -53.31 58.7 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.441 0.696 . . . . 0.0 111.479 177.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 72.7 m -76.72 -40.46 48.56 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -168.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -69.95 -33.48 72.17 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.596 1.089 . . . . 0.0 112.246 173.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -63.67 -48.22 78.08 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.106 0.866 . . . . 0.0 112.331 172.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -55.71 -41.9 74.47 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.434 0.694 . . . . 0.0 111.343 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 4.8 t -69.22 -17.92 63.84 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -175.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -63.28 -35.84 81.69 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.277 1.031 . . . . 0.0 113.414 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.9 m -115.99 -28.06 6.76 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.139 0.976 . . . . 0.0 112.223 167.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.88 77.35 0.95 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.956 2.217 . . . . 0.0 109.813 -169.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -160.63 117.98 2.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.517 2.327 . . . . 0.0 108.779 -174.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 48.4 m -61.78 130.15 44.38 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.517 0.727 . . . . 0.0 111.204 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.74 160.43 25.94 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.833 1.653 . . . . 0.0 114.502 -163.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 89.9 m -103.34 116.01 31.64 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.322 1.449 . . . . 0.0 112.49 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -91.14 114.51 27.05 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.639 1.575 . . . . 0.0 107.632 167.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.869 HG22 HG22 ' A' ' 115' ' ' VAL . 50.9 t -129.85 123.92 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 O-C-N 121.514 -0.742 . . . . 0.0 111.055 -162.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -96.39 129.78 43.67 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 119.963 -1.71 . . . . 0.0 109.609 174.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.66 98.12 8.72 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 162.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -106.95 111.61 24.18 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 125.093 1.357 . . . . 0.0 114.438 -164.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.3 p -144.76 165.61 27.58 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 129.661 3.184 . . . . 0.0 105.206 -149.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -14.08 -123.2 0.0 OUTLIER Glycine 0 N--CA 1.49 2.289 0 C-N-CA 130.524 3.916 . . . . 0.0 115.6 -163.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.6 p -91.66 104.95 17.37 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 113.182 -3.407 . . . . 0.0 110.443 152.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -169.1 153.29 5.45 Favored 'General case' 0 N--CA 1.474 0.75 1 C-N-CA 134.638 5.175 . . . . 0.0 106.236 159.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.6 t -106.29 136.29 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 119.748 -1.845 . . . . 0.0 109.716 129.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.9 m -106.56 140.79 38.89 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 160.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.0 tp -110.82 107.67 17.24 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.5 1.52 . . . . 0.0 107.234 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.6 m -78.03 128.81 34.43 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.252 1.021 . . . . 0.0 108.904 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 77.3 m -120.49 116.51 25.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 172.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -140.33 141.09 35.73 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 173.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.468 ' H ' HD13 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -83.48 99.97 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 149.376 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 175.32 178.3 45.06 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 118.108 2.003 . . . . 0.0 118.108 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -125.86 56.35 15.19 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.973 1.309 . . . . 0.0 112.802 164.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -59.8 142.28 98.35 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.736 2.291 . . . . 0.0 111.197 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -55.09 -17.11 3.58 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 -158.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -21.18 63.19 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 120.77 -1.206 . . . . 0.0 113.301 171.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -52.55 -33.2 44.54 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.297 1.839 . . . . 0.0 113.565 168.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -79.57 4.63 15.3 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.815 1.246 . . . . 0.0 112.648 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -130.09 -35.82 1.58 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.002 1.321 . . . . 0.0 114.142 177.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.511 HD11 HG23 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -84.04 165.86 18.21 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 117.991 2.589 . . . . 0.0 117.991 -168.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.2 mmmt -104.21 -172.62 2.14 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 126.784 2.033 . . . . 0.0 115.248 -161.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.65 158.95 16.83 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 126.823 2.049 . . . . 0.0 110.749 170.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.3 p -123.83 125.56 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 159.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 41.5 t -142.27 119.4 11.41 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 142.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -171.2 140.03 1.43 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.259 0.552 . . . . 0.0 110.335 -164.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -114.67 95.74 5.39 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.695 1.198 . . . . 0.0 108.997 141.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -160.96 177.51 10.29 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.983 -1.073 . . . . 0.0 113.636 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.19 157.32 37.85 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 121.331 -0.856 . . . . 0.0 111.828 161.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.7 tp -145.13 143.79 30.56 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.865 1.666 . . . . 0.0 108.994 -170.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.9 m -104.04 -174.03 2.45 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.217 1.007 . . . . 0.0 112.881 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.356 89.1 t -66.65 1.92 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 128.371 2.668 . . . . 0.0 115.08 -173.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -50.5 -4.75 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.252 0 N-CA-C 118.244 2.683 . . . . 0.0 118.244 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.373 4.7 pt-20 54.57 3.54 0.05 Allowed 'General case' 0 N--CA 1.466 0.364 1 N-CA-C 124.319 4.933 . . . . 0.0 124.319 153.705 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -163.13 123.83 2.35 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 123.139 2.7 . . . . 0.0 108.448 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.4 pp -155.88 150.01 25.53 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.595 1.558 . . . . 0.0 111.459 -174.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.869 HG22 HG22 ' A' ' 76' ' ' VAL . 11.6 t -115.3 144.86 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 127.349 2.26 . . . . 0.0 113.062 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.6 138.81 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 123.844 0.857 . . . . 0.0 110.853 146.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.4 p -114.82 167.27 10.93 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.338 1.055 . . . . 0.0 112.403 172.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -35.38 74.65 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 120.721 -1.237 . . . . 0.0 111.667 174.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.91 -36.04 82.63 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.334 0.653 . . . . 0.0 112.518 175.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -64.36 -47.57 78.81 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 118.693 -0.67 . . . . 0.0 111.256 172.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.93 -50.01 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 119.026 0.83 . . . . 0.0 110.846 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -57.51 -36.11 71.13 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.069 0.947 . . . . 0.0 113.067 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -78.88 -31.6 45.52 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 120.982 -1.074 . . . . 0.0 112.738 176.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.4 mt -71.04 -37.62 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.727 1.611 . . . . 0.0 111.238 -177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -158.75 -54.54 0.02 OUTLIER Pre-proline 0 N--CA 1.48 1.061 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 164.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -120.2 109.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.66 0 CA-C-N 121.349 1.517 . . . . 0.0 112.818 -159.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 82.8 m -73.66 128.18 34.79 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 145.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -179.99 135.33 0.11 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.272 1.829 . . . . 0.0 111.07 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -74.47 56.84 0.69 Allowed 'General case' 0 N--CA 1.482 1.134 0 O-C-N 120.586 -1.321 . . . . 0.0 110.71 159.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.11 19.1 0.04 OUTLIER Glycine 0 CA--C 1.544 1.886 0 C-N-CA 127.253 2.359 . . . . 0.0 114.571 -169.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.0 t -63.97 136.91 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.903 1.281 . . . . 0.0 111.551 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.3 85.04 2.32 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 122.68 1.228 . . . . 0.0 109.191 160.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.8 m -78.07 144.85 36.22 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 166.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -146.03 132.5 19.72 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -165.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 42.0 t -136.55 140.79 43.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.533 0.606 . . . . 0.0 112.48 -167.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 85.1 t -136.09 138.99 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 127.199 2.2 . . . . 0.0 108.369 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.2 m -130.84 140.9 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.992 -0.442 . . . . 0.0 109.845 166.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -114.6 143.42 45.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 122.281 1.039 . . . . 0.0 110.686 157.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.96 137.52 49.84 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.732 2.013 . . . . 0.0 107.699 163.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 53.0 m -140.45 131.23 25.82 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 123.711 0.632 . . . . 0.0 110.489 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 17.4 m120 45.82 65.09 1.23 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.847 2.059 . . . . 0.0 114.437 168.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 37.1 m 59.5 12.63 2.85 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 101.71 7.04 48.87 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.494 1.045 . . . . 0.0 114.945 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 23.3 mmt -64.88 -13.88 57.87 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.728 1.264 . . . . 0.0 113.258 171.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.3 t -139.68 141.01 37.0 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.8 1.24 . . . . 0.0 110.242 158.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -115.59 152.24 33.45 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 157.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -134.53 146.42 49.68 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.161 -0.962 . . . . 0.0 109.689 170.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.3 tt -143.39 143.76 24.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.547 0.689 . . . . 0.0 112.327 -172.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -134.57 130.94 37.29 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 161.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.22 131.07 35.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-O 122.907 1.337 . . . . 0.0 109.688 150.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.7 m -137.27 142.99 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 111.365 -2.652 . . . . 0.0 108.35 -162.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -123.47 132.96 54.08 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -142.91 162.23 36.03 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.431 1.892 . . . . 0.0 110.21 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -70.14 -144.82 0.24 Allowed Glycine 0 CA--C 1.543 1.828 0 O-C-N 120.632 -1.293 . . . . 0.0 110.928 149.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.64 17.36 0.46 Allowed 'Trans proline' 0 CA--C 1.553 1.45 0 C-N-CA 123.126 2.551 . . . . 0.0 114.17 174.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -85.63 -17.37 36.33 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -164.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -77.67 54.48 1.22 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 123.28 1.514 . . . . 0.0 109.802 163.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.88 -21.28 65.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.995 1.718 . . . . 0.0 114.144 -161.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.24 -43.62 66.9 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 118.925 0.784 . . . . 0.0 111.985 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -73.0 -31.65 64.63 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.579 0.752 . . . . 0.0 111.424 175.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -64.05 -49.99 70.17 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.309 -0.869 . . . . 0.0 110.609 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -54.95 -36.54 65.42 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.004 -1.06 . . . . 0.0 113.668 172.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.89 85.62 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 118.432 0.56 . . . . 0.0 112.185 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -71.81 -48.2 48.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.29 1.036 . . . . 0.0 113.192 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 98.1 mt -54.74 -35.95 64.28 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.621 1.101 . . . . 0.0 112.539 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -70.89 -40.93 71.92 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 125.723 1.609 . . . . 0.0 112.902 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -77.34 -35.56 54.57 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.8 pt -75.07 -38.32 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.142 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -65.6 -10.41 35.34 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 120.259 1.39 . . . . 0.0 112.885 164.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -110.64 28.14 8.97 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.257 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 174.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 110.728 -0.101 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.56 -10.37 63.44 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 124.674 1.13 . . . . 0.0 115.419 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -139.31 177.85 7.62 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.321 2.649 . . . . 0.0 108.982 167.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -71.42 123.37 22.22 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.736 0.814 . . . . 0.0 112.902 172.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -138.26 136.52 36.58 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.12 1.768 . . . . 0.0 112.057 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.7 tp -73.97 107.36 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-O 123.069 1.414 . . . . 0.0 114.603 -157.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -43.65 121.61 2.39 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 112.126 -2.307 . . . . 0.0 110.679 -174.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -63.84 -30.55 71.63 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 -139.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.85 -15.56 15.64 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 119.38 0.991 . . . . 0.0 113.663 172.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.3 t -69.96 -62.26 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.841 1.256 . . . . 0.0 111.662 -173.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -48.0 -53.46 14.45 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.63 1.109 . . . . 0.0 112.248 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.36 -45.94 72.87 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 118.958 1.379 . . . . 0.0 113.504 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.89 -39.02 76.51 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.085 -1.009 . . . . 0.0 112.805 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -70.39 -42.89 71.12 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.236 0.925 . . . . 0.0 112.219 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.36 -42.71 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.285 1.034 . . . . 0.0 109.851 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.7 p -68.51 -40.36 80.86 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.74 0.7 . . . . 0.0 112.227 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -69.08 -36.89 78.11 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.223 -0.923 . . . . 0.0 112.466 175.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 87.7 m -66.92 -48.09 69.73 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.193 -0.942 . . . . 0.0 110.715 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.2 ptt-85 -59.32 -41.58 89.4 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 119.284 0.947 . . . . 0.0 111.26 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -62.24 -56.74 15.64 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.19 1.396 . . . . 0.0 112.286 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.82 -30.18 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 119.369 0.986 . . . . 0.0 112.202 -172.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -79.75 -8.33 59.18 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.22 0.918 . . . . 0.0 113.249 169.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 52.76 46.36 26.89 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.387 1.875 . . . . 0.0 111.921 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 pp -129.37 159.44 36.2 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.851 1.261 . . . . 0.0 111.051 172.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -73.5 160.54 31.56 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -60.52 -27.89 67.98 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.166 -1.583 . . . . 0.0 111.983 168.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -84.4 6.12 24.5 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 119.775 1.171 . . . . 0.0 113.056 171.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -116.1 -12.95 11.2 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.605 -1.309 . . . . 0.0 110.996 174.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.589 HD11 ' HB1' ' A' ' 48' ' ' ALA . 26.9 tp -89.68 113.16 24.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.494 1.918 . . . . 0.0 109.348 171.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -94.67 130.72 41.05 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 119.584 -0.846 . . . . 0.0 112.849 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 47' ' ' ASP . 37.4 mm -95.87 138.01 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 127.442 2.297 . . . . 0.0 113.308 -176.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 m -147.29 148.44 31.42 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.818 1.19 . . . . 0.0 109.476 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.7 p30 -150.76 56.43 0.91 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 122.886 1.327 . . . . 0.0 114.394 171.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.0 p -91.45 -56.15 3.24 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.112 1.365 . . . . 0.0 114.352 157.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.92 -52.2 5.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 122.744 1.259 . . . . 0.0 114.193 -152.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.606 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -64.88 -27.54 68.93 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.112 1.765 . . . . 0.0 112.448 173.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.5 mp -71.43 -16.18 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.565 1.946 . . . . 0.0 112.6 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 54.7 m -61.04 -0.14 0.29 Allowed 'General case' 0 CA--C 1.552 1.05 0 N-CA-C 118.069 2.618 . . . . 0.0 118.069 -166.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -90.07 -30.9 17.41 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 121.42 1.918 . . . . 0.0 113.298 169.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -134.41 84.3 41.13 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 165.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -69.98 21.95 0.18 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.535 3.49 . . . . 0.0 114.721 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -113.75 4.27 15.9 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.44 1.896 . . . . 0.0 111.587 169.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -130.14 164.27 24.8 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 120.302 1.41 . . . . 0.0 108.284 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 p -150.16 150.67 31.96 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.242 -0.911 . . . . 0.0 111.49 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.12 -82.77 0.64 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 117.036 -1.459 . . . . 0.0 110.692 147.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 30.5 p -170.88 163.5 7.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 121.681 2.037 . . . . 0.0 114.507 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 31' ' ' ILE . 16.2 t70 -115.47 152.82 32.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 153.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -121.23 135.79 55.08 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 129.129 2.972 . . . . 0.0 108.743 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 55.7 mtm -112.04 134.05 53.83 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.9 1.227 . . . . 0.0 108.145 168.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.269 0.6 OUTLIER -147.79 131.93 17.34 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 118.493 2.775 . . . . 0.0 118.493 -155.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.25 160.22 18.53 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 110.539 -3.028 . . . . 0.0 114.395 -174.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.6 p -96.02 179.75 4.97 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.627 1.971 . . . . 0.0 115.464 -158.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . 0.268 28.9 t70 63.16 46.0 4.84 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.482 2.313 . . . . 0.0 115.349 177.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.36 164.28 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 127.065 2.146 . . . . 0.0 109.22 163.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 m -101.11 141.07 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.228 1.011 . . . . 0.0 108.548 161.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.65 110.52 44.49 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 119.829 1.195 . . . . 0.0 108.219 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -67.67 74.71 0.61 Allowed 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 125.159 3.906 . . . . 0.0 111.072 173.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.6 p -66.6 -24.65 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 126.644 1.978 . . . . 0.0 114.294 -152.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.11 -26.72 50.97 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 118.652 0.66 . . . . 0.0 112.26 172.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -57.26 -38.49 73.94 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.363 -0.827 . . . . 0.0 112.641 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.3 mp -72.7 -43.09 63.49 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.434 1.015 . . . . 0.0 111.257 176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -56.09 -48.72 75.58 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.166 0.986 . . . . 0.0 110.325 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.0 m -71.92 -42.89 66.17 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.391 1.476 . . . . 0.0 113.166 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -67.38 -33.96 76.29 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.909 1.231 . . . . 0.0 111.784 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -66.54 -46.99 74.29 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.524 0.602 . . . . 0.0 112.491 165.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -60.6 -30.06 69.59 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.786 -1.196 . . . . 0.0 112.717 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 79.2 m -76.66 -6.31 51.57 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.755 1.622 . . . . 0.0 114.234 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.7 tpm_? -82.38 -35.17 27.99 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 120.089 1.313 . . . . 0.0 112.971 -175.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.6 p -154.87 -23.98 0.12 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.534 1.134 . . . . 0.0 113.121 167.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.86 82.04 1.35 Allowed Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.761 2.124 . . . . 0.0 112.028 -178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.9 tpt85 -153.26 118.77 5.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 128.828 2.851 . . . . 0.0 104.957 169.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.6 m -62.03 150.99 36.54 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.705 0.802 . . . . 0.0 111.89 -175.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -141.04 149.91 42.3 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.146 1.378 . . . . 0.0 113.229 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 29.5 p -83.02 138.19 33.84 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.736 1.214 . . . . 0.0 111.484 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -110.59 115.7 30.07 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 172.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 1.072 HG22 HG22 ' A' ' 115' ' ' VAL . 95.1 t -130.04 111.26 21.01 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.549 0 C-N-CA 123.76 0.824 . . . . 0.0 109.56 -154.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -96.07 115.67 27.78 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 120.338 -1.476 . . . . 0.0 107.499 -170.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -108.49 107.87 18.57 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.89 1.276 . . . . 0.0 108.772 177.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -84.06 137.41 33.6 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.276 -0.89 . . . . 0.0 111.184 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.1 p -144.28 167.87 21.41 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 129.591 3.156 . . . . 0.0 104.626 -167.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -16.42 -123.32 0.0 OUTLIER Glycine 0 N--CA 1.489 2.169 1 C-N-CA 130.831 4.063 . . . . 0.0 116.636 -176.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 55.8 m -97.99 101.96 13.58 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 113.029 -3.468 . . . . 0.0 111.254 152.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.68 164.29 12.16 Favored 'General case' 0 CA--C 1.542 0.671 1 C-N-CA 133.465 4.706 . . . . 0.0 106.419 136.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.6 156.96 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 O-C-N 119.468 -2.02 . . . . 0.0 108.714 147.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -127.74 146.67 50.5 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.621 0.768 . . . . 0.0 110.242 167.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.0 tp -117.17 109.37 16.82 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.068 0.947 . . . . 0.0 108.657 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.2 m -76.69 132.02 39.13 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.103 1.361 . . . . 0.0 110.139 167.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 87.1 m -128.69 115.34 17.86 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.624 -1.298 . . . . 0.0 110.011 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -137.15 134.77 36.72 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.29 85.28 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 161.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 174.63 -176.61 46.89 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 117.694 1.837 . . . . 0.0 117.694 -174.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -111.15 79.97 2.23 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.734 1.214 . . . . 0.0 112.407 168.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -53.4 153.62 17.08 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 124.528 3.485 . . . . 0.0 116.479 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -72.56 -32.46 66.06 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -172.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -76.33 -10.02 59.08 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.943 1.247 . . . . 0.0 113.634 172.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.607 HD11 HG21 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -68.51 -2.71 9.38 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.524 1.93 . . . . 0.0 114.815 167.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.471 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 9.8 mmpt? -50.55 -41.02 53.59 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.489 -0.757 . . . . 0.0 110.753 151.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -118.98 -34.5 3.88 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -167.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.661 HD11 HG23 ' A' ' 115' ' ' VAL . 3.7 pp -83.87 160.6 21.11 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 120.69 1.586 . . . . 0.0 113.187 -163.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.3 pttt -164.08 129.08 2.83 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 116.833 2.16 . . . . 0.0 116.833 -165.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . 0.339 11.5 ttt180 -108.89 -173.59 2.31 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 125.472 1.509 . . . . 0.0 113.172 167.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 7.4 p 179.9 166.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 128.105 2.562 . . . . 0.0 109.353 -133.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . . 57.3 m -118.12 122.3 42.75 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.155 0.889 . . . . 0.0 109.286 151.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -170.97 163.32 7.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.652 2.381 . . . . 0.0 106.756 -171.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -139.27 115.36 10.3 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 126.077 1.751 . . . . 0.0 112.903 174.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -159.88 -172.92 3.84 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.339 1.456 . . . . 0.0 111.904 -175.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -66.94 160.78 25.58 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.124 0.97 . . . . 0.0 112.58 160.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.6 tp -135.22 145.96 48.18 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 129.142 2.977 . . . . 0.0 108.777 -172.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.7 t -109.27 155.51 21.04 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.932 2.093 . . . . 0.0 110.543 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.01 -15.81 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -157.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -130.35 46.72 2.61 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.34 1.056 . . . . 0.0 110.643 -170.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -104.69 150.66 24.53 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.505 1.522 . . . . 0.0 112.589 -167.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.446 ' HB1' HD22 ' A' ' 99' ' ' LEU . . . -144.13 136.09 26.28 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.166 -1.584 . . . . 0.0 110.042 -172.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.32 139.25 15.32 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 120.632 -1.292 . . . . 0.0 113.63 -170.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 1.072 HG22 HG22 ' A' ' 76' ' ' VAL . 6.6 t -108.87 132.77 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 125.745 1.618 . . . . 0.0 111.012 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . 0.254 0.8 OUTLIER -129.79 123.53 57.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-O 122.64 1.209 . . . . 0.0 110.065 157.086 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.9 t -124.73 158.53 33.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.596 2.358 . . . . 0.0 107.846 173.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.73 -36.12 64.41 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.968 0.803 . . . . 0.0 112.006 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.11 -31.95 68.41 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 175.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -76.2 -28.96 57.44 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.611 -1.306 . . . . 0.0 112.258 174.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 41.3 mm -67.81 -40.65 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 121.556 -0.715 . . . . 0.0 110.562 164.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -66.23 -11.9 52.89 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.26 1.024 . . . . 0.0 113.191 174.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -79.29 -45.39 19.8 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 119.77 -1.831 . . . . 0.0 112.214 164.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.9 pt -92.04 -12.94 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -170.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -122.87 161.32 44.95 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 125.287 1.435 . . . . 0.0 112.422 174.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -68.32 -31.4 28.5 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.906 1.737 . . . . 0.0 115.694 -168.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.428 ' SG ' ' HE2' ' A' ' 129' ' ' LYS . 5.6 t -153.29 162.39 41.34 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -172.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -99.99 -137.32 0.31 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.148 2.579 . . . . 0.0 111.482 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.428 ' HE2' ' SG ' ' A' ' 127' ' ' CYS . 63.4 pttt 44.84 22.03 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 119.278 3.066 . . . . 0.0 119.278 165.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -178.46 21.66 0.04 OUTLIER Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.124 1.345 . . . . 0.0 115.946 168.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.1 t -65.89 132.9 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 118.698 1.249 . . . . 0.0 111.946 -169.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 20.7 mt -124.18 108.84 12.72 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 122.4 1.095 . . . . 0.0 109.138 151.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.2 t -101.69 147.25 26.67 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.855 1.662 . . . . 0.0 109.725 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -124.7 133.74 53.09 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.661 1.184 . . . . 0.0 108.394 -174.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 72.3 m -109.67 143.09 39.92 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.625 0.77 . . . . 0.0 111.057 171.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.71 129.33 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.727 1.611 . . . . 0.0 108.863 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.1 m -136.85 147.81 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -175.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -132.0 145.9 51.74 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.08 1.752 . . . . 0.0 112.699 172.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.663 ' HE2' ' CD1' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -129.12 93.14 3.52 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 127.565 2.346 . . . . 0.0 114.211 179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 18.1 t -83.79 123.1 29.54 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.679 -0.638 . . . . 0.0 112.211 170.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -96.38 -41.13 8.77 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.591 1.557 . . . . 0.0 110.963 167.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 98.0 p -64.63 -18.38 64.88 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -131.73 23.33 4.22 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 125.824 1.678 . . . . 0.0 114.919 168.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 25.9 mmt 31.1 59.83 0.25 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 128.352 2.661 . . . . 0.0 116.326 172.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.9 t -164.62 146.55 8.36 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.174 0.99 . . . . 0.0 110.55 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.663 ' CD1' ' HE2' ' A' ' 139' ' ' LYS . 4.5 m-85 -129.21 158.11 39.95 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -158.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -144.07 144.98 31.87 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 120.946 -1.096 . . . . 0.0 108.847 -171.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 11.0 tt -144.94 142.67 22.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.843 -168.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -141.02 136.21 31.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.361 1.465 . . . . 0.0 107.46 174.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.3 p -142.52 136.52 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 122.051 0.929 . . . . 0.0 110.946 155.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 15.3 m -129.23 149.64 33.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 126.218 1.807 . . . . 0.0 109.734 -172.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.93 127.63 23.35 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -133.47 157.62 45.17 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.457 1.903 . . . . 0.0 110.867 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -90.61 -159.35 35.53 Favored Glycine 0 CA--C 1.541 1.702 0 C-N-CA 124.404 1.002 . . . . 0.0 113.519 174.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.25 -7.75 21.73 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.339 2.693 . . . . 0.0 115.522 -172.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -75.58 -2.91 31.38 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 171.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -76.73 57.27 1.25 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.347 1.859 . . . . 0.0 111.683 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.18 -23.14 61.97 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.334 1.454 . . . . 0.0 113.696 -174.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.57 -51.24 37.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 119.141 0.882 . . . . 0.0 111.591 178.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -71.21 -34.97 71.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.881 0.872 . . . . 0.0 112.729 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -58.9 -53.71 55.33 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.854 0.752 . . . . 0.0 110.689 171.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -57.02 -39.02 73.95 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.884 0.765 . . . . 0.0 112.07 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.82 -42.99 98.78 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.295 0.952 . . . . 0.0 112.926 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.21 -46.98 72.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.569 -0.707 . . . . 0.0 112.586 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 86.9 mt -57.31 -34.64 68.94 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.837 0.455 . . . . 0.0 111.497 175.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -75.63 -17.59 59.95 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.586 1.955 . . . . 0.0 113.549 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -101.9 -31.17 10.83 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.0 pt -86.54 -36.63 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 120.415 1.461 . . . . 0.0 113.547 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -76.32 12.62 1.15 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.381 1.446 . . . . 0.0 111.508 161.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -132.85 25.61 4.31 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 170.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.1 0 C-N-CA 125.224 1.409 . . . . 0.0 112.495 168.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.28 32.11 83.11 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-O 119.213 -0.771 . . . . 0.0 114.092 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -127.98 -10.31 5.41 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.032 1.333 . . . . 0.0 113.71 -167.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.1 ptp -150.73 64.33 0.93 Allowed 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.923 -1.111 . . . . 0.0 110.787 158.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.12 115.2 9.73 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -168.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.411 ' HA ' HD12 ' A' ' 6' ' ' ILE . 7.5 tp -76.14 105.38 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 122.422 1.106 . . . . 0.0 111.248 169.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -44.38 127.16 5.68 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 112.251 -2.25 . . . . 0.0 112.122 -163.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -55.76 -20.95 16.68 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -162.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -97.17 -31.17 12.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.278 1.031 . . . . 0.0 112.603 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.9 -59.49 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 123.93 0.892 . . . . 0.0 112.079 -168.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.37 -42.38 97.42 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.534 -0.592 . . . . 0.0 111.845 171.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.61 -51.15 69.75 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.542 1.171 . . . . 0.0 112.757 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -64.45 -43.03 95.57 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.317 1.047 . . . . 0.0 112.445 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.44 -47.36 61.09 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.896 0.878 . . . . 0.0 111.893 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -62.16 -41.55 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.547 0.739 . . . . 0.0 109.646 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.5 m -59.29 -38.37 80.02 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.769 0.713 . . . . 0.0 112.387 174.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -76.0 -32.32 59.37 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 118.624 -0.703 . . . . 0.0 112.645 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -71.99 -43.66 64.74 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 120.454 1.479 . . . . 0.0 111.646 170.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 41.8 ttp180 -49.72 -43.64 47.78 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.456 1.502 . . . . 0.0 111.791 172.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -73.46 -59.57 2.65 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.245 1.418 . . . . 0.0 113.651 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.02 -31.81 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 120.699 1.59 . . . . 0.0 112.718 -168.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.0 mp -84.0 -13.43 53.31 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.152 -0.967 . . . . 0.0 112.543 173.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 54.44 60.1 3.76 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.82 1.648 . . . . 0.0 112.514 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 pp -130.89 148.66 52.69 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.89 0.876 . . . . 0.0 109.385 167.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -69.99 159.51 33.65 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.991 0.424 . . . . 0.0 110.585 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -65.42 -27.38 68.49 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 120.376 -1.452 . . . . 0.0 111.757 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -68.57 -9.01 46.8 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.97 1.308 . . . . 0.0 113.848 166.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -125.49 3.05 7.66 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.471 1.508 . . . . 0.0 111.639 -176.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.472 HD11 ' HB1' ' A' ' 48' ' ' ALA . 24.2 tp -93.34 128.68 39.47 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 156.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 131.91 50.17 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.906 0.775 . . . . 0.0 111.134 167.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.8 mm -93.71 143.44 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 127.236 2.215 . . . . 0.0 110.723 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.5 m -149.77 154.1 37.92 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 121.394 -0.816 . . . . 0.0 110.674 168.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.2 p30 -155.75 58.81 0.61 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.678 1.228 . . . . 0.0 112.999 -176.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 30.1 p -86.93 -60.2 2.05 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.626 -1.296 . . . . 0.0 111.341 169.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.16 -38.09 15.62 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 113.919 -1.491 . . . . 0.0 112.474 -158.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.528 HD12 HD12 ' A' ' 37' ' ' ILE . 2.4 pp -99.63 -1.94 36.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.054 2.142 . . . . 0.0 113.718 -171.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.528 HD12 HD12 ' A' ' 36' ' ' LEU . 1.7 mp -97.5 5.53 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 126.53 1.932 . . . . 0.0 110.354 166.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 52.3 t -59.49 -29.71 68.03 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.354 1.462 . . . . 0.0 114.117 -177.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.463 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -81.22 26.75 0.43 Allowed 'General case' 0 N--CA 1.485 1.305 0 O-C-N 120.059 -1.651 . . . . 0.0 112.913 169.354 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.3 m120 71.69 165.13 0.14 Allowed Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 128.646 2.779 . . . . 0.0 112.758 -168.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.12 -3.69 3.22 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.749 2.966 . . . . 0.0 114.896 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -97.82 5.71 48.75 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 127.409 2.284 . . . . 0.0 112.454 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -157.36 94.54 1.39 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 171.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.4 p -175.24 168.76 3.34 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.501 -159.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -131.61 -81.51 0.52 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 116.78 -1.968 . . . . 0.0 115.345 132.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.38 -176.98 2.31 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.343 1.057 . . . . 0.0 111.408 -174.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -116.72 146.18 42.96 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 168.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.472 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -131.54 130.24 42.05 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.628 2.371 . . . . 0.0 107.682 -177.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 18.4 mtt -123.6 134.16 53.85 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.018 -1.051 . . . . 0.0 110.61 -170.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.5 mt -130.77 142.26 50.4 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 126.154 2.159 . . . . 0.0 112.748 -147.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.6 p -110.7 161.58 15.61 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.058 2.543 . . . . 0.0 111.584 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.658 HG22 HG23 ' A' ' 137' ' ' VAL . 28.4 p -126.77 108.6 11.19 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -163.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -158.92 2.26 0.09 Allowed 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 125.584 1.554 . . . . 0.0 114.84 165.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.65 173.08 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 126.578 1.951 . . . . 0.0 113.196 -162.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.457 HG21 HD21 ' A' ' 134' ' ' ASN . 1.4 m -96.78 142.54 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 125.894 1.678 . . . . 0.0 112.178 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -109.2 106.41 58.65 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -73.51 71.53 3.85 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.668 3.579 . . . . 0.0 110.397 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.8 p -68.48 -28.58 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 114.088 -1.414 . . . . 0.0 114.653 -149.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -56.99 -35.01 68.7 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 175.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -67.13 -32.94 74.4 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.384 0.538 . . . . 0.0 111.722 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 69.0 mt -75.01 -45.0 44.82 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.748 0.704 . . . . 0.0 111.458 177.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.1 mp -55.27 -44.21 75.4 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 118.8 0.727 . . . . 0.0 111.261 171.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -63.62 -45.37 90.62 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.606 0.762 . . . . 0.0 112.501 178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -63.69 -32.44 73.93 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.63 0.772 . . . . 0.0 112.593 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -69.1 -45.25 70.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.575 1.15 . . . . 0.0 111.823 171.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.09 -37.79 77.95 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 119.583 1.083 . . . . 0.0 112.095 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.1 t -62.97 -1.48 0.93 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.438 1.895 . . . . 0.0 115.706 -168.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -70.88 -18.22 62.69 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 120.287 -1.508 . . . . 0.0 113.58 172.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 95.7 p -164.21 -16.4 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.628 1.571 . . . . 0.0 113.813 166.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.5 83.55 1.12 Allowed Glycine 0 CA--C 1.529 0.933 0 C-N-CA 126.941 2.21 . . . . 0.0 109.62 -165.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -161.76 114.87 1.84 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.469 2.308 . . . . 0.0 106.555 -168.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.4 m -71.93 126.28 29.34 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -167.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.11 143.52 36.75 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.858 1.663 . . . . 0.0 111.667 172.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 60.3 m -98.4 127.77 44.49 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.143 0.977 . . . . 0.0 109.389 176.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -93.89 104.2 16.27 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.909 1.684 . . . . 0.0 109.311 -175.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.453 HG22 ' CG2' ' A' ' 115' ' ' VAL . 44.4 t -99.06 117.92 44.88 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 C-N-CA 124.787 1.235 . . . . 0.0 109.225 -171.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -94.37 109.03 20.91 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 177.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.57 ' HE3' ' HB2' ' A' ' 113' ' ' ALA . 14.2 mmmm -111.14 101.83 10.32 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.727 2.011 . . . . 0.0 108.743 172.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -98.28 135.84 39.32 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 120.797 -1.19 . . . . 0.0 111.366 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.31 165.05 36.97 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 130.173 3.389 . . . . 0.0 104.407 -161.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -9.68 -123.01 0.0 OUTLIER Glycine 0 N--CA 1.486 1.996 0 C-N-CA 128.7 3.047 . . . . 0.0 115.286 -153.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 9.1 p -95.48 106.61 18.69 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 113.405 -3.318 . . . . 0.0 111.57 150.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.96 139.95 2.42 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 131.529 3.932 . . . . 0.0 107.276 131.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 92.1 t -63.38 133.41 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 117.104 -1.838 . . . . 0.0 108.482 152.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.68 140.44 39.54 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.7 0.682 . . . . 0.0 109.432 163.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.8 tp -110.64 106.15 15.3 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 163.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.9 m -86.93 118.64 26.45 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.88 1.672 . . . . 0.0 109.019 175.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 82.2 m -102.92 110.32 22.19 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.296 -1.502 . . . . 0.0 109.169 -172.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -99.92 109.8 22.15 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.658 -175.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.0 mp -82.33 98.08 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 129.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.47 178.89 47.44 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 118.621 2.208 . . . . 0.0 118.621 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -126.21 45.79 1.62 Allowed Pre-proline 0 CA--C 1.56 1.331 0 N-CA-C 117.548 2.425 . . . . 0.0 117.548 160.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -52.18 155.36 9.23 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.826 3.017 . . . . 0.0 117.689 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -49.86 -33.42 16.93 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.841 2.456 . . . . 0.0 116.249 -162.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 25.4 mmt85 -92.99 -17.32 24.06 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.14 -35.61 59.91 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 128.622 2.769 . . . . 0.0 113.653 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -57.24 -43.03 82.57 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 118.486 -0.768 . . . . 0.0 111.845 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -98.26 -34.34 10.74 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.982 1.264 . . . . 0.0 114.105 -174.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.7 pp -68.92 157.8 35.92 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 121.113 1.778 . . . . 0.0 112.166 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -164.12 134.38 4.17 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 -163.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.511 ' HD3' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -120.2 -178.03 3.57 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 125.638 1.575 . . . . 0.0 114.332 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.511 ' H ' ' HD3' ' A' ' 101' ' ' ARG . 8.9 p -163.37 174.67 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 127.733 2.413 . . . . 0.0 112.278 -140.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.425 ' HA ' HG13 ' A' ' 150' ' ' VAL . 75.0 m -129.72 135.51 48.56 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 121.081 -1.012 . . . . 0.0 111.333 144.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.3 t0 178.57 166.76 0.85 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 127.865 2.466 . . . . 0.0 107.249 -168.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -128.76 121.39 28.3 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.166 1.386 . . . . 0.0 113.959 162.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -160.38 -176.68 5.75 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 126.027 1.731 . . . . 0.0 110.923 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -80.67 165.67 21.78 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 120.442 -1.411 . . . . 0.0 111.481 164.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.7 tp -144.67 141.2 29.16 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.555 1.142 . . . . 0.0 111.149 -170.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.3 m -77.98 151.67 33.5 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.09 1.756 . . . . 0.0 115.293 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.65 -8.62 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 127.094 2.158 . . . . 0.0 116.131 -161.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -137.6 38.65 2.43 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.769 1.228 . . . . 0.0 112.787 -170.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -106.05 165.95 10.85 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.257 1.423 . . . . 0.0 113.753 -164.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.57 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . . . -146.95 133.73 20.06 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 125.537 1.535 . . . . 0.0 110.157 -170.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.8 144.28 20.2 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.823 1.249 . . . . 0.0 111.38 -174.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.453 ' CG2' HG22 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -129.77 141.76 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 121.472 1.942 . . . . 0.0 113.965 174.628 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.99 149.87 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.648 1.179 . . . . 0.0 110.784 175.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.3 t -146.6 172.59 13.34 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.013 0.925 . . . . 0.0 112.091 168.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.37 -34.17 66.4 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -171.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.71 -41.92 67.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.712 0.687 . . . . 0.0 112.385 177.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -75.4 -26.51 58.46 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.884 0.874 . . . . 0.0 112.734 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.2 tp -75.51 -38.96 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.212 1.005 . . . . 0.0 111.452 170.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -55.11 -39.96 69.96 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.23 1.012 . . . . 0.0 111.315 168.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -66.97 -20.22 65.85 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.344 1.058 . . . . 0.0 112.794 -173.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 66.9 mt -69.74 -41.43 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 118.67 0.668 . . . . 0.0 110.463 -177.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.499 ' H ' ' HD2' ' A' ' 126' ' ' PRO . 33.5 ttpt -167.39 -47.73 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.765 0 CA-C-O 116.559 -1.686 . . . . 0.0 112.301 175.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.499 ' HD2' ' H ' ' A' ' 125' ' ' LYS . 41.2 Cg_endo -82.58 -132.84 0.01 OUTLIER 'Trans proline' 0 CA--C 1.548 1.205 0 C-N-CA 122.606 2.204 . . . . 0.0 112.949 -170.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 20.9 t -166.7 133.94 2.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.2 1.8 . . . . 0.0 111.209 -164.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . 0.253 25.4 p30 -70.69 3.76 2.94 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 -161.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -104.67 10.4 34.8 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.61 1.964 . . . . 0.0 113.208 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.07 29.17 0.16 Allowed Glycine 0 CA--C 1.534 1.271 0 N-CA-C 116.229 1.251 . . . . 0.0 116.229 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 55.6 t -83.58 135.61 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 119.139 1.469 . . . . 0.0 112.349 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.49 105.67 11.9 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.992 0.917 . . . . 0.0 108.691 153.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.34 144.62 31.39 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.699 0.8 . . . . 0.0 110.086 166.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.457 HD21 HG21 ' A' ' 55' ' ' VAL . 48.0 t30 -137.05 136.93 38.83 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.692 0.797 . . . . 0.0 109.411 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 43.2 t -128.11 133.81 49.05 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.846 0.859 . . . . 0.0 111.42 -169.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.5 t -132.55 111.35 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.119 0.968 . . . . 0.0 109.483 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.658 HG23 HG22 ' A' ' 52' ' ' THR . 29.7 m -105.22 151.61 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.573 1.549 . . . . 0.0 110.595 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -124.7 135.63 53.2 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.152 1.381 . . . . 0.0 111.256 157.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.457 ' HE3' ' CE2' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -77.32 144.52 38.0 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.278 1.031 . . . . 0.0 112.166 135.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.0 m -147.31 76.57 1.41 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.735 2.014 . . . . 0.0 109.061 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -65.66 -48.48 71.99 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 120.539 -1.351 . . . . 0.0 113.617 -171.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.1 m -57.75 -39.66 77.89 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.072 -1.017 . . . . 0.0 111.715 174.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.05 -0.16 68.95 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 126.304 1.907 . . . . 0.0 115.938 173.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 75.9 mtm 43.37 53.14 5.68 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 128.078 2.551 . . . . 0.0 115.241 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 99.5 p -148.66 163.39 37.42 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 175.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.457 ' CE2' ' HE3' ' A' ' 139' ' ' LYS . 41.8 m-85 -100.2 151.84 20.97 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.684 147.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -134.95 141.85 46.36 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.04 137.31 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.81 0.814 . . . . 0.0 110.647 -161.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -135.79 139.26 43.38 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.498 1.519 . . . . 0.0 108.587 169.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.425 HG13 ' HA ' ' A' ' 103' ' ' CYS . 2.2 p -140.9 134.39 32.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 122.363 1.077 . . . . 0.0 109.196 149.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 30.2 m -116.65 143.18 27.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 127.95 2.5 . . . . 0.0 109.033 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.82 129.95 39.19 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -165.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -134.43 156.05 49.24 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.576 1.551 . . . . 0.0 110.799 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.552 ' H ' ' CD ' ' A' ' 155' ' ' PRO . . . -171.78 33.33 0.14 Allowed Glycine 0 CA--C 1.546 1.97 0 CA-C-O 116.364 -2.354 . . . . 0.0 117.28 161.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.552 ' CD ' ' H ' ' A' ' 154' ' ' GLY . 59.5 Cg_endo -105.62 -49.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.358 1.037 0 CA-C-N 121.812 2.806 . . . . 0.0 113.353 160.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -117.74 -26.96 6.38 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 53.79 1.28 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 118.289 2.7 . . . . 0.0 118.289 176.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -61.97 -45.31 94.23 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -155.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.91 -53.07 29.25 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -169.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -69.04 -31.56 70.43 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.889 0.876 . . . . 0.0 112.241 175.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -60.63 -55.31 34.79 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.048 0.84 . . . . 0.0 110.84 172.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -64.5 -34.16 77.56 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.385 -0.822 . . . . 0.0 112.721 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.21 -33.19 74.96 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.99 1.268 . . . . 0.0 112.654 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -50.97 51.29 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.425 1.49 . . . . 0.0 108.868 173.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 76.7 mt -60.59 -38.09 83.51 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.231 1.012 . . . . 0.0 111.439 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -70.0 -32.16 70.2 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 127.059 2.143 . . . . 0.0 112.939 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -86.72 -37.96 17.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.31 1.044 . . . . 0.0 113.359 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.6 pt -77.55 -34.2 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-N 119.33 0.968 . . . . 0.0 111.629 -178.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -63.45 -19.83 65.05 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.826 -0.546 . . . . 0.0 111.256 166.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -117.01 26.49 9.76 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 . . . . . 0 C--O 1.252 1.186 0 C-N-CA 128.42 2.688 . . . . 0.0 114.886 168.874 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.91 -8.18 0.03 OUTLIER Glycine 0 CA--C 1.539 1.554 0 N-CA-C 116.759 1.464 . . . . 0.0 116.759 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -135.45 -13.84 2.0 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.758 1.623 . . . . 0.0 113.715 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.3 ptm -147.2 167.74 23.43 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.964 1.706 . . . . 0.0 112.373 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -129.77 110.9 12.12 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.996 0.918 . . . . 0.0 111.075 166.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 6' ' ' ILE . 8.5 tp -75.15 103.06 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 123.328 1.537 . . . . 0.0 111.413 -176.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -45.68 128.14 8.29 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 111.12 -2.764 . . . . 0.0 111.443 -168.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -64.21 -6.27 6.44 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 118.379 2.733 . . . . 0.0 118.379 -139.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.6 -4.24 15.54 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 120.37 1.441 . . . . 0.0 114.033 172.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 78.6 t -69.51 -56.17 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.825 1.25 . . . . 0.0 111.649 -172.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.34 -43.18 98.88 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 173.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.6 -54.31 43.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 117.925 0.862 . . . . 0.0 112.147 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -67.11 -37.85 84.59 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.088 -1.007 . . . . 0.0 113.602 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -69.18 -45.91 68.8 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.848 1.204 . . . . 0.0 111.845 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.0 mp -70.85 -43.09 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.299 0.64 . . . . 0.0 109.745 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.2 t -68.88 -37.15 78.84 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.588 0.631 . . . . 0.0 112.609 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -76.02 -30.63 58.55 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.061 -1.024 . . . . 0.0 111.695 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.4 m -62.98 -46.52 87.32 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.799 1.636 . . . . 0.0 110.397 169.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.5 ttt-85 -52.84 -34.73 55.48 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 126.086 1.754 . . . . 0.0 112.396 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -83.03 -49.1 9.9 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.741 -1.224 . . . . 0.0 113.258 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 mp -73.03 -28.86 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.41 1.084 . . . . 0.0 111.878 -174.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -91.71 -8.71 46.18 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.809 1.243 . . . . 0.0 112.633 171.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 24.5 mtp-105 58.09 17.98 4.89 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.925 2.09 . . . . 0.0 115.07 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 pp -94.31 159.04 15.3 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.331 1.452 . . . . 0.0 111.734 176.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -81.89 163.16 22.45 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 119.641 1.109 . . . . 0.0 112.467 176.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -64.8 -34.74 79.06 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 119.512 -1.993 . . . . 0.0 111.393 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -60.42 -16.85 39.96 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.429 2.291 . . . . 0.0 113.382 166.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -105.6 -9.83 17.17 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.958 1.254 . . . . 0.0 111.708 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.462 HD11 ' HB1' ' A' ' 48' ' ' ALA . 26.5 tp -91.47 135.57 33.74 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.265 1.826 . . . . 0.0 108.868 176.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -106.39 128.36 53.98 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 118.363 0.529 . . . . 0.0 112.395 170.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.4 mm -97.26 142.0 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.919 2.087 . . . . 0.0 112.829 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 22.2 m -124.92 146.34 49.4 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.371 0.987 . . . . 0.0 108.836 167.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -123.56 -153.42 0.55 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.336 2.254 . . . . 0.0 110.642 -163.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.1 t -36.8 -36.04 0.1 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 128.306 2.643 . . . . 0.0 116.241 -167.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.1 -43.56 70.5 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 174.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.72 -22.83 25.78 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 121.164 1.802 . . . . 0.0 112.419 175.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.8 mm -58.29 -39.7 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.144 0.977 . . . . 0.0 109.45 173.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 57.0 m -55.65 6.73 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 117.699 2.481 . . . . 0.0 117.699 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -117.59 13.92 14.4 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 121.518 1.963 . . . . 0.0 112.034 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.9 170.2 5.68 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 126.511 1.924 . . . . 0.0 109.145 146.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -66.92 -51.14 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 121.721 1.614 . . . . 0.0 114.693 -176.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -124.82 -34.32 2.83 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 117.562 2.43 . . . . 0.0 117.562 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -161.12 100.24 1.22 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 122.893 1.33 . . . . 0.0 109.458 -137.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.9 m -140.44 165.62 26.92 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.261 2.224 . . . . 0.0 107.507 173.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.46 HD13 ' HB2' ' A' ' 46' ' ' CYS 0.29 1.1 tm? -87.47 -77.2 0.35 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 117.288 -1.339 . . . . 0.0 113.058 -164.088 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.46 ' HB2' HD13 ' A' ' 45' ' ' LEU . 12.7 m -163.94 -175.56 4.12 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.954 1.706 . . . . 0.0 111.86 -172.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -119.82 156.98 29.62 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.301 1.44 . . . . 0.0 107.398 157.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.462 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -137.39 131.62 32.32 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.738 2.815 . . . . 0.0 108.07 -177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 47.5 ttp -121.93 134.47 54.85 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.232 1.378 . . . . 0.0 110.661 -169.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 mt -131.7 146.44 52.17 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 128.473 2.709 . . . . 0.0 113.385 -148.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.6 t -98.62 159.12 15.17 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.066 1.346 . . . . 0.0 113.581 -171.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -71.38 170.84 12.34 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.229 1.811 . . . . 0.0 112.66 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.7 t70 57.89 36.23 26.09 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 170.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.58 134.66 60.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 125.993 1.717 . . . . 0.0 110.079 -176.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.9 p -91.24 139.17 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.966 0.907 . . . . 0.0 109.456 159.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -134.28 136.93 26.88 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 118.862 0.756 . . . . 0.0 111.701 169.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.45 69.75 5.79 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.905 3.737 . . . . 0.0 111.105 177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.4 p -62.29 -43.53 98.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -152.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.97 -9.31 58.18 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.037 -1.039 . . . . 0.0 113.093 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -65.54 -33.37 75.77 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.775 1.171 . . . . 0.0 111.598 165.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.9 tp -70.18 -37.45 75.15 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 118.656 0.662 . . . . 0.0 111.32 173.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.92 -49.87 76.01 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.375 0.534 . . . . 0.0 111.911 173.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.3 p -67.45 -31.97 72.5 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 119.175 -0.44 . . . . 0.0 112.119 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -63.6 -39.15 93.63 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.947 0.794 . . . . 0.0 112.512 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -66.26 -51.71 54.85 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.492 1.042 . . . . 0.0 112.299 169.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.26 -41.07 83.45 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.662 0.385 . . . . 0.0 111.514 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 83.1 m -77.43 -2.57 35.96 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.95 -34.66 13.68 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.379 1.472 . . . . 0.0 114.046 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.2 m -137.29 -8.73 1.73 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 63.32 74.49 0.43 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 126.006 1.765 . . . . 0.0 112.523 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -166.9 136.44 2.94 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.304 1.442 . . . . 0.0 109.775 161.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.4 m -64.47 142.81 58.29 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.031 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.74 151.08 47.82 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 m -75.29 103.94 5.65 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.326 1.851 . . . . 0.0 109.768 167.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -87.74 99.83 12.38 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 166.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.07 147.4 6.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 C-N-CA 126.585 1.954 . . . . 0.0 108.254 -171.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -130.72 121.42 25.43 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 120.513 -1.367 . . . . 0.0 107.583 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -121.7 121.01 36.35 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.303 1.841 . . . . 0.0 109.412 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -95.84 125.41 40.38 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.895 1.678 . . . . 0.0 108.892 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.4 p -143.71 155.31 44.16 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -174.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.94 80.61 0.1 OUTLIER Glycine 0 N--CA 1.476 1.339 0 C-N-CA 130.39 3.852 . . . . 0.0 112.175 -172.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.3 t 168.95 -128.15 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 103.543 -2.762 . . . . 0.0 103.543 -136.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -129.28 178.7 6.25 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 130.379 3.472 . . . . 0.0 109.336 -176.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 76.8 t -75.96 136.66 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 120.574 -1.329 . . . . 0.0 109.203 164.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.3 m -114.78 152.62 31.78 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.858 0.754 . . . . 0.0 112.28 170.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.6 tp -108.81 108.68 19.58 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.084 2.154 . . . . 0.0 105.705 164.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.2 m -80.93 102.63 10.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 167.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 44.1 t -102.49 111.28 23.51 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 119.778 -1.826 . . . . 0.0 108.556 -173.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -150.93 151.0 31.52 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 118.628 2.825 . . . . 0.0 118.628 174.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.631 ' H ' HD13 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -70.94 84.17 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-N 112.632 -2.077 . . . . 0.0 108.503 143.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.22 166.21 38.61 Favored Glycine 0 N--CA 1.472 1.083 0 N-CA-C 118.7 2.24 . . . . 0.0 118.7 -163.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -156.27 49.35 0.4 Allowed Pre-proline 0 CA--C 1.55 0.958 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -170.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -47.4 121.25 5.22 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.241 1.961 . . . . 0.0 113.112 166.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -44.17 -13.69 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 118.615 2.82 . . . . 0.0 118.615 -169.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 95' ' ' ARG . 3.7 mmp_? -59.89 -23.59 63.59 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.283 1.401 . . . . 0.0 113.856 163.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -50.93 -28.58 10.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.831 2.052 . . . . 0.0 112.72 166.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -62.28 -34.8 77.26 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.661 175.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -115.75 -22.39 9.16 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -174.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.502 ' C ' HD12 ' A' ' 99' ' ' LEU . 2.4 pp -75.67 165.59 24.83 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 121.346 1.885 . . . . 0.0 114.1 -176.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -152.16 118.08 5.47 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -163.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.471 ' HD2' ' H ' ' A' ' 102' ' ' VAL . 0.1 OUTLIER -107.43 178.15 4.62 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 120.495 1.498 . . . . 0.0 111.926 161.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.471 ' H ' ' HD2' ' A' ' 101' ' ' ARG . 3.0 p -172.35 173.62 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.587 -140.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.421 ' HA ' HG13 ' A' ' 150' ' ' VAL . 64.8 m -120.86 124.82 45.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.33 0.652 . . . . 0.0 109.501 137.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -172.31 171.41 4.79 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 127.71 2.404 . . . . 0.0 107.514 -166.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -122.72 99.85 6.61 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.006 2.522 . . . . 0.0 110.061 172.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -140.51 148.4 41.02 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 -173.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -82.19 142.04 32.52 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.914 1.286 . . . . 0.0 110.578 165.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 37.9 tp -148.23 141.59 25.24 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.076 0.95 . . . . 0.0 110.087 -150.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 p -93.09 168.9 10.81 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 116.941 2.201 . . . . 0.0 116.941 -169.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 63.6 t -69.76 -6.92 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 128.145 2.578 . . . . 0.0 113.083 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -134.74 45.84 2.51 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.469 1.108 . . . . 0.0 110.25 173.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -125.59 152.26 45.35 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 116.064 1.875 . . . . 0.0 116.064 -176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.696 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -149.3 142.46 25.0 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.632 -146.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.696 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -144.38 147.95 34.06 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.183 1.393 . . . . 0.0 111.521 -168.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -136.31 141.64 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 121.404 1.911 . . . . 0.0 113.166 158.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.59 153.28 38.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.88 0.872 . . . . 0.0 110.538 167.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.0 t -143.01 167.34 22.29 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.696 0.798 . . . . 0.0 109.979 162.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.93 -36.09 76.3 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -160.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.7 73.03 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.791 -1.193 . . . . 0.0 113.791 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -70.7 -30.83 67.51 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.394 -0.816 . . . . 0.0 111.627 175.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.0 mm -73.37 -35.51 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.012 0.925 . . . . 0.0 111.076 169.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -59.9 -25.48 65.14 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.448 -0.783 . . . . 0.0 111.931 170.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -83.2 -7.64 59.59 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 168.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.9 mt -89.21 -40.05 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 119.803 1.183 . . . . 0.0 109.987 167.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -143.31 124.36 8.16 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.603 1.161 . . . . 0.0 110.413 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -82.5 60.1 7.16 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 123.943 3.095 . . . . 0.0 114.355 -163.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 45.6 t -155.84 134.59 11.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.56 1.544 . . . . 0.0 110.201 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -122.85 -4.01 8.63 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -85.2 12.85 7.16 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -178.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 175.85 50.83 0.06 OUTLIER Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.71 1.148 . . . . 0.0 113.516 -176.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.83 125.12 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-N 117.947 0.873 . . . . 0.0 110.701 -179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.83 88.04 2.52 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.518 1.527 . . . . 0.0 108.229 169.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.608 HG22 ' HA ' ' A' ' 152' ' ' ALA . 17.6 p -83.83 146.39 28.14 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.908 0.883 . . . . 0.0 109.316 164.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -108.46 125.77 52.15 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 18.8 t -118.43 127.8 54.0 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.39 0.996 . . . . 0.0 109.131 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.4 t -138.43 116.91 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 124.411 1.084 . . . . 0.0 109.149 -167.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 148' ' ' ILE . 20.1 m -112.3 140.59 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.268 -0.895 . . . . 0.0 111.421 -175.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 29.0 ttm105 -129.57 98.23 4.77 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 122.162 0.982 . . . . 0.0 110.343 171.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.473 ' HG3' ' CD2' ' A' ' 146' ' ' TYR 0.251 9.0 tmtt? -120.13 134.98 55.11 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.767 1.227 . . . . 0.0 109.047 -178.202 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.1 m -161.45 133.33 5.67 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.026 1.33 . . . . 0.0 110.585 -164.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -85.68 -35.55 20.81 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.766 -0.584 . . . . 0.0 112.496 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.1 p -48.45 -50.12 32.65 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.201 1.401 . . . . 0.0 113.398 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -96.29 11.25 67.28 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.258 1.885 . . . . 0.0 115.074 171.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 41.1 ttm 44.61 57.35 4.53 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.114 2.166 . . . . 0.0 115.397 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 97.9 p -147.82 142.86 27.02 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.473 ' CD2' ' HG3' ' A' ' 139' ' ' LYS . 1.0 OUTLIER -106.65 144.54 33.17 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 163.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -150.87 147.26 27.01 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.445 -1.409 . . . . 0.0 109.492 -173.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . 0.428 HG13 HG12 ' A' ' 137' ' ' VAL . 6.8 tt -141.62 140.31 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 122.213 1.006 . . . . 0.0 113.4 -176.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -135.31 115.44 13.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.033 1.333 . . . . 0.0 109.941 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.421 HG13 ' HA ' ' A' ' 103' ' ' CYS 0.28 7.3 p -139.27 145.14 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 121.129 -0.982 . . . . 0.0 112.981 174.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.3 m -141.31 151.55 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 128.109 2.564 . . . . 0.0 109.643 -167.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.608 ' HA ' HG22 ' A' ' 133' ' ' THR . . . -125.59 125.73 43.65 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -168.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -142.18 156.88 45.36 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.686 1.194 . . . . 0.0 111.926 175.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -91.51 -148.92 22.87 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 124.519 1.057 . . . . 0.0 112.177 165.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.94 -22.72 10.69 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 124.53 3.487 . . . . 0.0 117.041 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.13 1.46 2.79 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 126.423 1.889 . . . . 0.0 115.595 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -90.86 38.84 0.97 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.192 1.797 . . . . 0.0 112.163 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -62.36 -28.85 70.05 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -167.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.32 -51.49 51.83 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.918 0.781 . . . . 0.0 112.099 -176.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -65.18 -34.21 77.84 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.934 0.894 . . . . 0.0 112.468 170.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -62.02 -49.31 76.53 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.427 1.012 . . . . 0.0 111.457 175.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -65.83 -29.67 70.17 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 120.81 -1.182 . . . . 0.0 112.701 176.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.42 83.91 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 119.189 0.904 . . . . 0.0 112.671 171.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.92 -54.29 19.84 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.523 1.129 . . . . 0.0 112.763 174.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.7 mp -46.79 -34.92 5.68 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.752 1.221 . . . . 0.0 113.983 167.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 25.5 ttt180 -74.67 -25.78 59.41 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.46 1.504 . . . . 0.0 113.357 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -89.71 -36.63 15.09 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.537 1.062 . . . . 0.0 113.664 170.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.2 pt -88.42 -42.37 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.063 -1.023 . . . . 0.0 112.724 -169.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -71.33 -6.15 37.78 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.622 1.555 . . . . 0.0 111.355 171.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -119.62 23.18 11.3 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 172.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 . . . . . 0 C--O 1.252 1.207 0 C-N-CA 126.472 1.909 . . . . 0.0 112.503 169.967 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.666 0 CA-C-O 120.19 0.043 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.4 170.82 53.4 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 123.941 0.782 . . . . 0.0 113.382 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -51.79 142.74 14.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.776 1.231 . . . . 0.0 113.391 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 12.4 ptm -102.64 150.53 23.34 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.443 1.497 . . . . 0.0 113.928 -161.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -83.11 94.96 7.93 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 124.078 1.894 . . . . 0.0 112.148 -170.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 tp -145.64 144.15 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 1 C-N-CA 132.541 4.336 . . . . 0.0 106.658 173.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.23 134.47 37.58 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.026 -1.443 . . . . 0.0 108.644 170.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -19.03 64.53 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -163.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -85.21 -24.0 28.05 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.798 0.839 . . . . 0.0 112.283 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.4 t -73.38 -53.68 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.682 1.193 . . . . 0.0 112.565 -165.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.12 -52.04 53.78 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 168.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.8 -39.93 59.53 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 118.443 1.121 . . . . 0.0 113.323 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -74.74 -39.24 61.96 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.867 -1.146 . . . . 0.0 113.972 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.12 -40.74 98.5 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.614 1.166 . . . . 0.0 111.7 173.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.52 -43.05 90.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.053 1.341 . . . . 0.0 109.721 174.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.4 m -66.64 -31.21 71.75 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.296 -0.878 . . . . 0.0 112.918 175.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -67.37 -44.19 79.57 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.318 -0.864 . . . . 0.0 109.345 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.3 m -60.55 -43.61 97.04 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.168 -1.582 . . . . 0.0 111.753 175.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -54.24 -32.09 55.11 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.27 1.828 . . . . 0.0 112.8 171.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.22 -46.79 10.04 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.053 1.341 . . . . 0.0 113.449 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.6 mm -66.63 -49.21 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 119.691 1.132 . . . . 0.0 110.889 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.66 -2.88 57.11 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.036 1.334 . . . . 0.0 112.528 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 59.33 11.52 2.21 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 127.629 2.372 . . . . 0.0 115.43 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.458 HD11 HD13 ' A' ' 29' ' ' LEU . 2.7 pp -94.45 154.97 17.17 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.112 0.965 . . . . 0.0 111.172 -176.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.81 155.93 38.21 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.441 -0.787 . . . . 0.0 112.917 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.79 -24.13 63.87 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 120.83 -1.169 . . . . 0.0 112.546 171.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -97.04 8.74 43.85 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.489 1.516 . . . . 0.0 113.316 172.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -118.73 8.52 11.88 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.963 1.705 . . . . 0.0 111.478 167.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.458 HD13 HD11 ' A' ' 24' ' ' LEU . 21.3 tp -107.74 127.7 53.92 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 127.859 2.463 . . . . 0.0 107.521 166.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -94.34 115.39 27.61 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 120.076 1.307 . . . . 0.0 111.305 171.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.451 HD11 HD23 ' A' ' 29' ' ' LEU . 32.8 mm -91.02 143.06 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.292 1.437 . . . . 0.0 112.58 170.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.4 m -126.71 147.75 49.93 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 162.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -93.57 -148.29 0.26 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.309 1.444 . . . . 0.0 112.265 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.9 t -58.51 -29.17 66.08 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -162.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.77 -33.36 34.9 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -169.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.62 -4.84 27.66 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.45 14.42 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 124.806 1.242 . . . . 0.0 111.974 167.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.4 t -57.89 12.06 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 128.64 2.776 . . . . 0.0 117.985 -163.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.407 ' HE2' ' CD1' ' A' ' 92' ' ' PHE . 48.9 tptt -57.4 -40.37 78.12 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 119.798 -1.814 . . . . 0.0 113.033 -172.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -127.02 139.19 34.4 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 132.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -58.54 -31.06 93.61 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 CA-C-N 121.663 1.63 . . . . 0.0 112.571 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -96.46 30.97 2.37 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.237 1.815 . . . . 0.0 110.403 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -147.86 101.12 3.28 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.472 1.487 . . . . 0.0 107.299 159.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.0 p 179.91 151.24 0.4 Allowed 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.985 -1.072 . . . . 0.0 111.986 -139.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.36 -81.17 0.52 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 164.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.1 p -166.51 -174.48 2.85 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -174.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -122.82 154.98 37.51 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.403 1.881 . . . . 0.0 107.891 163.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -146.95 122.81 10.64 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 120.797 1.635 . . . . 0.0 109.094 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 30.3 ttm -117.94 129.28 55.52 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.748 -1.22 . . . . 0.0 111.564 -160.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.27 0.3 OUTLIER -138.4 156.6 47.44 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 124.677 2.18 . . . . 0.0 115.979 -159.019 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 t -99.24 167.96 10.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 130.446 3.498 . . . . 0.0 108.515 -172.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.2 t -50.95 114.0 1.06 Allowed 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.574 1.079 . . . . 0.0 109.334 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.471 ' C ' HD13 ' A' ' 54' ' ' ILE . 1.3 t70 -151.69 156.8 41.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 122.754 1.264 . . . . 0.0 109.865 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.471 HD13 ' C ' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -119.51 -176.8 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 113.243 -1.799 . . . . 0.0 109.044 -146.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.5 p -70.16 121.65 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 121.485 -0.759 . . . . 0.0 111.598 -132.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -130.34 151.5 78.63 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -166.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -80.22 80.98 2.88 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 124.425 3.417 . . . . 0.0 111.031 -166.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 p -69.42 -39.17 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -164.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.2 -33.36 75.21 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 119.688 1.131 . . . . 0.0 113.26 176.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -57.7 -37.86 74.22 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 119.105 -0.474 . . . . 0.0 110.621 167.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.51 -44.88 61.6 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.917 1.287 . . . . 0.0 112.083 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.405 ' HA ' ' CE1' ' A' ' 75' ' ' PHE . 5.1 mp -52.5 -46.73 66.77 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 122.147 0.975 . . . . 0.0 110.621 169.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.1 m -72.23 -39.81 68.21 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 123.616 0.766 . . . . 0.0 112.168 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -63.94 -41.78 97.51 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.736 0.698 . . . . 0.0 110.837 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.15 -55.65 29.86 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.272 1.029 . . . . 0.0 110.993 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.38 -29.36 68.05 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -176.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.1 t -76.35 -32.09 58.46 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -61.25 -25.68 67.24 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 -161.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.7 t -141.66 4.97 1.76 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.661 1.184 . . . . 0.0 113.289 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.52 78.4 0.2 Allowed Glycine 0 CA--C 1.528 0.872 0 C-N-CA 125.895 1.712 . . . . 0.0 111.34 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -166.64 134.18 2.62 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.007 1.723 . . . . 0.0 107.555 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.3 m -76.64 149.73 36.47 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 128.19 2.596 . . . . 0.0 112.973 -173.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -152.05 165.43 34.74 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.628 1.171 . . . . 0.0 113.839 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 27.4 p -108.81 142.37 39.48 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.432 0.693 . . . . 0.0 111.551 156.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.405 ' CE1' ' HA ' ' A' ' 62' ' ' LEU . 3.0 m-85 -82.6 132.58 35.19 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.442 1.097 . . . . 0.0 108.887 165.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.852 HG22 HG22 ' A' ' 115' ' ' VAL . 61.8 t -130.47 151.34 35.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 124.734 1.214 . . . . 0.0 109.348 -172.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -131.05 122.59 27.03 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -124.62 108.77 12.4 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.906 2.083 . . . . 0.0 108.538 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -90.74 123.37 34.27 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.381 -0.824 . . . . 0.0 109.447 173.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.8 p -148.07 150.52 34.05 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 130.132 3.373 . . . . 0.0 104.147 -166.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -11.5 -133.53 0.0 OUTLIER Glycine 0 N--CA 1.481 1.648 0 O-C-N 117.802 -3.061 . . . . 0.0 114.841 -121.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 13.2 p -90.69 88.22 7.01 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 120.145 1.972 . . . . 0.0 108.434 169.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.0 ttt85 -169.61 144.02 2.85 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 128.605 2.762 . . . . 0.0 109.044 166.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.1 t -83.32 140.02 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 119.995 1.271 . . . . 0.0 109.675 171.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.45 143.8 40.23 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 121.007 -1.058 . . . . 0.0 111.328 157.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.7 tp -107.95 107.0 17.52 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 171.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.436 ' HB3' ' CE1' ' A' ' 89' ' ' TYR . 7.5 m -98.1 130.26 44.89 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.458 -1.246 . . . . 0.0 108.383 -172.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 76.1 m -117.57 108.38 15.4 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.11 -1.619 . . . . 0.0 109.007 -170.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CE1' ' HB3' ' A' ' 87' ' ' SER . 14.4 m-30 -121.92 98.43 5.94 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.414 0.626 . . . . 0.0 110.619 -157.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 7.3 mt -59.88 -38.36 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.46 -177.54 16.37 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.802 1.668 . . . . 0.0 110.634 166.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.407 ' CD1' ' HE2' ' A' ' 39' ' ' LYS . 26.4 p90 -107.46 96.05 15.29 Favored Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -163.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -73.38 -177.76 3.23 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 124.126 3.217 . . . . 0.0 115.973 -173.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -50.37 -39.58 46.97 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 117.284 2.328 . . . . 0.0 117.284 -160.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.265 17.1 mmt180 -98.85 -3.67 34.86 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 175.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.55 -33.86 47.58 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.556 2.343 . . . . 0.0 114.052 175.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -50.82 -35.9 34.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.398 1.079 . . . . 0.0 111.45 169.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.01 -27.8 8.27 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -169.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.439 HD12 HG23 ' A' ' 115' ' ' VAL . 3.9 pp -87.37 144.54 26.72 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 121.042 1.746 . . . . 0.0 112.231 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -157.07 126.43 6.04 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -153.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -115.57 -172.3 2.13 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 128.369 2.668 . . . . 0.0 112.529 173.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -166.22 168.55 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 129.094 2.957 . . . . 0.0 108.842 -135.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . . . . . . . . 0.257 0.0 OUTLIER -123.45 122.48 38.34 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.142 0.883 . . . . 0.0 110.695 138.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -176.88 175.53 1.6 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 129.029 2.931 . . . . 0.0 106.144 -165.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -105.93 117.91 35.23 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 128.28 2.632 . . . . 0.0 109.04 171.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -151.18 160.05 44.07 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -174.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -92.55 162.7 14.09 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.892 1.677 . . . . 0.0 112.613 170.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.8 mt -141.06 152.05 44.51 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 129.441 3.096 . . . . 0.0 111.026 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.1 m -128.12 167.3 16.97 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 127.822 2.449 . . . . 0.0 110.224 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.283 0.9 OUTLIER -69.92 -4.88 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 -173.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -122.25 32.9 5.63 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.556 1.143 . . . . 0.0 113.012 167.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -104.01 132.66 50.05 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.095 -1.003 . . . . 0.0 110.303 -173.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.728 ' C ' HD23 ' A' ' 114' ' ' LEU . . . -140.25 138.08 34.77 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.122 0.969 . . . . 0.0 112.846 -166.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.728 HD23 ' C ' ' A' ' 113' ' ' ALA . 0.0 OUTLIER -144.22 141.15 29.71 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.974 1.31 . . . . 0.0 112.712 -165.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.852 HG22 HG22 ' A' ' 76' ' ' VAL . 17.0 t -118.42 137.9 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 126.603 1.961 . . . . 0.0 111.919 168.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.1 t -125.66 121.36 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.744 0.783 . . . . 0.0 109.711 157.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 73.3 p -90.02 163.95 14.71 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.075 0.95 . . . . 0.0 110.575 165.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.47 -35.23 73.68 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.332 -0.855 . . . . 0.0 111.08 174.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.38 -34.88 78.2 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 173.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -63.12 -33.52 75.63 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.953 1.251 . . . . 0.0 112.175 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.8 mm -77.18 -36.07 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.087 0.955 . . . . 0.0 111.433 172.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -54.88 -38.65 67.8 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.802 0.841 . . . . 0.0 111.294 174.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.3 mmt-85 -74.16 -12.77 60.68 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.427 ' C ' ' HE2' ' A' ' 125' ' ' LYS . 20.3 mt -73.25 -26.54 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 119.973 1.26 . . . . 0.0 110.192 175.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.427 ' HE2' ' C ' ' A' ' 124' ' ' ILE . 0.5 OUTLIER -105.12 161.5 22.56 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 125.127 1.371 . . . . 0.0 111.634 175.211 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -74.35 -39.69 1.45 Allowed 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.623 2.215 . . . . 0.0 113.131 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 42.2 t -152.41 134.34 14.84 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.58 1.952 . . . . 0.0 108.439 174.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -73.8 -53.29 10.6 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 -154.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? 51.74 10.31 0.1 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 128.66 2.784 . . . . 0.0 116.823 166.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 132.75 67.45 0.08 OUTLIER Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.337 1.446 . . . . 0.0 112.536 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 76.8 t -72.85 130.48 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.216 0.607 . . . . 0.0 111.289 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 50.4 tp -119.37 157.59 27.85 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 123.147 1.451 . . . . 0.0 109.169 145.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 49.8 m -149.48 146.56 27.47 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 119.392 -2.068 . . . . 0.0 106.426 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -123.99 127.93 48.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -166.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 38.2 t -126.65 138.37 53.41 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.213 0.605 . . . . 0.0 109.945 -171.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.8 t -142.84 139.53 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 125.31 1.444 . . . . 0.0 108.966 -174.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.5 m -129.5 139.04 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.849 0.833 . . . . 0.0 112.152 174.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 43.2 mtm105 -126.0 150.58 47.97 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 127.985 2.514 . . . . 0.0 108.685 172.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.27 1.9 tmtt? -153.24 151.72 30.38 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.434 1.094 . . . . 0.0 109.07 172.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.6 t -134.22 127.83 32.71 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.787 1.176 . . . . 0.0 107.84 170.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -73.23 -55.61 6.21 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.084 0.402 . . . . 0.0 111.069 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 46.1 p -65.07 -31.87 73.3 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.176 1.391 . . . . 0.0 113.077 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.05 2.22 76.48 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.874 1.226 . . . . 0.0 115.222 170.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 24.8 mmt 48.12 40.74 14.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.095 1.758 . . . . 0.0 114.96 173.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.3 m -147.91 137.74 22.6 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.397 0.679 . . . . 0.0 111.58 -170.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -125.35 131.42 53.0 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -177.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -152.46 112.27 3.97 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 120.468 1.486 . . . . 0.0 112.89 -147.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 4.8 pt -137.12 151.57 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 O-C-N 120.932 -1.105 . . . . 0.0 113.351 -163.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.34 144.15 36.16 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.938 0.875 . . . . 0.0 111.507 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.8 p -146.18 136.93 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 121.07 -1.019 . . . . 0.0 109.927 169.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.5 m -131.7 125.79 56.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.723 1.609 . . . . 0.0 108.843 -165.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -113.98 135.7 53.71 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.955 0.902 . . . . 0.0 112.409 -167.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -144.38 159.13 43.25 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.175 0.988 . . . . 0.0 113.614 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -89.74 -140.97 8.29 Favored Glycine 0 CA--C 1.539 1.572 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 160.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.04 83.89 0.26 Allowed 'Trans proline' 0 CA--C 1.548 1.22 0 CA-C-N 119.344 1.572 . . . . 0.0 110.421 153.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -123.02 -25.29 4.57 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 172.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.11 74.91 1.42 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -172.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -51.05 -35.4 34.41 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.136 -1.393 . . . . 0.0 112.396 175.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.54 -35.1 75.18 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.464 1.029 . . . . 0.0 113.311 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -74.13 -44.04 55.22 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.345 1.058 . . . . 0.0 111.637 170.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -54.75 -49.27 71.25 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.51 1.05 . . . . 0.0 111.36 175.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -63.98 -41.02 97.66 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.843 1.657 . . . . 0.0 112.261 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.23 -31.65 72.22 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.473 -0.767 . . . . 0.0 112.554 174.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.63 -47.24 61.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 121.226 -0.921 . . . . 0.0 112.982 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 96.6 mt -53.72 -37.69 63.56 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.011 0.525 . . . . 0.0 111.772 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 88.1 mtm-85 -75.54 -32.9 60.61 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -73.93 -39.18 63.97 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.353 1.061 . . . . 0.0 112.646 173.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.9 pt -90.91 -38.62 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.144 -0.972 . . . . 0.0 112.639 -168.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -85.81 4.41 37.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.657 0.662 . . . . 0.0 111.44 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.75 29.52 5.0 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 165.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 44.5 ptt85 . . . . . 0 C--O 1.258 1.542 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 -179.512 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 119.75 -0.167 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 158.55 -178.62 34.69 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.479 1.038 . . . . 0.0 113.076 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -64.65 -17.69 64.27 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 -171.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.9 mmt -121.78 126.63 49.29 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.892 1.277 . . . . 0.0 110.153 160.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -141.54 153.54 44.93 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.126 1.37 . . . . 0.0 111.353 166.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.438 ' HA ' HD12 ' A' ' 6' ' ' ILE . 5.9 tp -136.41 107.82 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 C-N-CA 126.818 2.047 . . . . 0.0 112.081 166.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -99.81 153.36 19.19 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -157.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -48.18 -32.51 7.15 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 127.246 2.218 . . . . 0.0 114.746 174.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -93.46 -25.09 17.79 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.084 0.856 . . . . 0.0 112.04 -177.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.3 t -62.55 -51.02 77.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.064 0.946 . . . . 0.0 109.762 170.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.36 -50.49 59.63 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.233 -0.759 . . . . 0.0 112.291 168.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.42 -47.25 79.45 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.805 1.303 . . . . 0.0 113.055 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -74.07 -40.86 62.49 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.092 0.957 . . . . 0.0 112.615 -178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.51 -33.33 62.77 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 120.552 1.524 . . . . 0.0 113.074 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.1 mp -68.92 -38.92 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 119.06 0.845 . . . . 0.0 109.555 169.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.6 m -59.9 -45.44 92.51 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 121.054 -1.029 . . . . 0.0 112.483 171.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -77.55 -28.07 51.74 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -173.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 p -66.79 -53.2 35.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.135 1.334 . . . . 0.0 110.252 168.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -49.16 -46.65 45.66 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.611 1.564 . . . . 0.0 112.786 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -70.22 -49.21 52.5 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.014 1.726 . . . . 0.0 114.463 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.93 -26.49 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 119.687 1.131 . . . . 0.0 111.198 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.6 mt -82.07 -17.21 47.42 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 171.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? 46.32 56.45 6.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.959 1.704 . . . . 0.0 112.343 -167.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 pp -125.99 166.53 16.76 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.886 1.274 . . . . 0.0 111.122 167.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -75.92 158.31 32.18 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.755 1.222 . . . . 0.0 112.503 176.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -61.94 -21.74 65.03 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 119.994 -1.692 . . . . 0.0 114.175 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -95.56 3.05 54.47 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.215 1.006 . . . . 0.0 112.932 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -101.54 -12.62 18.36 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.477 1.111 . . . . 0.0 111.487 169.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.48 HD23 HD11 ' A' ' 31' ' ' ILE . 18.2 tp -88.84 137.71 32.07 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.538 1.935 . . . . 0.0 105.863 165.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.477 ' H ' ' HB3' ' A' ' 49' ' ' MET . 39.9 ttt-85 -102.48 124.77 48.63 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.938 160.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.48 HD11 HD23 ' A' ' 29' ' ' LEU . 41.3 mm -90.42 142.75 12.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 125.469 1.508 . . . . 0.0 110.815 168.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.3 m -117.62 136.51 53.25 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 149.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -87.0 -151.09 0.16 Allowed 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.9 t -59.79 -21.21 60.5 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -166.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.37 -32.07 24.55 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . 0.267 0.9 OUTLIER -96.03 -8.67 32.95 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 176.531 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.3 11.52 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.323 1.449 . . . . 0.0 111.732 166.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.9 t -64.15 6.43 0.18 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.627 2.371 . . . . 0.0 115.352 -167.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -61.37 -21.49 64.09 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 121.042 -1.036 . . . . 0.0 111.167 174.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 -142.54 124.84 8.95 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 140.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.86 -15.98 53.07 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 121.842 1.695 . . . . 0.0 114.119 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -105.96 23.29 14.22 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 127.369 2.267 . . . . 0.0 111.97 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -154.92 94.44 1.65 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 170.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.1 p 175.57 154.78 0.17 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.727 -1.579 . . . . 0.0 108.083 -142.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.92 -82.22 0.48 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.367 1.44 . . . . 0.0 114.446 151.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 9.2 m -163.99 177.72 8.28 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.734 1.214 . . . . 0.0 112.966 -172.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -115.95 155.87 27.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.06 1.744 . . . . 0.0 108.59 165.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -131.9 138.86 48.56 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.208 2.603 . . . . 0.0 107.481 175.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.477 ' HB3' ' H ' ' A' ' 30' ' ' ARG . 11.1 tmm? -126.5 131.64 51.57 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.092 1.315 . . . . 0.0 109.329 -169.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.2 mt -123.27 142.36 51.02 Favored 'General case' 0 C--O 1.245 0.847 0 O-C-N 127.074 2.734 . . . . 0.0 111.736 -153.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.3 p -97.07 161.62 13.74 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 127.262 2.225 . . . . 0.0 112.673 -172.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.8 t -67.58 143.37 56.11 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . 0.271 12.7 t70 66.21 33.09 7.54 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.795 2.438 . . . . 0.0 114.646 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.6 tp -109.83 137.33 42.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.721 1.209 . . . . 0.0 111.858 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 p -110.4 141.12 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 125.701 1.6 . . . . 0.0 112.655 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -136.48 120.24 12.39 Favored Pre-proline 0 CA--C 1.548 0.9 0 O-C-N 120.803 -1.186 . . . . 0.0 111.64 166.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -65.29 80.23 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 125.03 3.82 . . . . 0.0 112.003 168.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.3 p -67.15 -30.75 50.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -151.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -55.2 -39.28 69.43 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 119.036 0.835 . . . . 0.0 112.538 174.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -62.38 -27.19 68.91 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.69 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 45.2 tp -81.3 -48.96 11.31 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.922 1.289 . . . . 0.0 112.511 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 mp -53.65 -49.2 68.45 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.461 0.704 . . . . 0.0 110.189 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 69.0 m -74.8 -27.54 60.35 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.254 1.022 . . . . 0.0 113.1 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -61.44 -34.69 75.84 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.294 1.406 . . . . 0.0 112.456 169.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.421 ' CZ2' HD11 ' A' ' 90' ' ' ILE . 41.6 t-105 -70.63 -57.75 4.39 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.461 0.573 . . . . 0.0 112.05 167.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.54 -36.35 83.48 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -169.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 45.7 t -59.01 -17.49 25.54 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.686 1.594 . . . . 0.0 113.355 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.1 ttt85 -70.21 -43.64 70.26 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.199 -0.938 . . . . 0.0 112.768 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.5 m -159.22 3.35 0.09 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -169.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.93 82.72 0.11 Allowed Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.205 0.907 . . . . 0.0 111.481 -171.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 66.6 mtp180 -146.65 124.51 11.96 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 126.862 2.065 . . . . 0.0 106.833 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.3 m -78.42 117.09 19.31 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 126.25 1.82 . . . . 0.0 112.482 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.24 139.26 35.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.889 1.675 . . . . 0.0 110.828 168.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 39.1 m -102.24 145.48 29.36 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.887 0.851 . . . . 0.0 111.256 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.82 105.09 10.85 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.711 1.604 . . . . 0.0 108.923 177.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.7 t -96.32 154.04 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 126.677 1.991 . . . . 0.0 108.815 176.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -142.11 110.82 6.17 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.874 2.07 . . . . 0.0 106.856 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -111.15 115.35 29.26 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.021 2.128 . . . . 0.0 110.161 175.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -93.12 134.85 34.87 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.691 -0.671 . . . . 0.0 112.046 174.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.1 p -153.65 167.44 29.57 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 130.892 3.677 . . . . 0.0 107.088 -156.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -9.81 -124.99 0.0 OUTLIER Glycine 0 N--CA 1.49 2.294 0 C-N-CA 130.063 3.697 . . . . 0.0 116.296 -167.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 17.1 m -96.45 104.39 16.36 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 111.774 -3.97 . . . . 0.0 107.97 146.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.42 139.29 0.44 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 129.753 3.221 . . . . 0.0 109.272 151.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.9 t -74.73 134.77 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 119.97 1.259 . . . . 0.0 110.05 154.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.46 138.93 45.09 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.59 0.756 . . . . 0.0 110.288 163.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.2 tt -111.16 112.48 24.3 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.089 1.755 . . . . 0.0 106.452 170.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.421 ' HB3' ' CE1' ' A' ' 89' ' ' TYR . 2.3 m -95.87 126.88 41.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.256 -178.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 49.0 t -108.5 111.03 22.68 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 119.976 -1.703 . . . . 0.0 107.9 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 87' ' ' SER . 21.9 m-30 -116.44 100.38 7.83 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.971 0.415 . . . . 0.0 111.507 -169.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.421 HD11 ' CZ2' ' A' ' 65' ' ' TRP . 42.9 mt -62.32 115.28 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 130.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -178.83 167.46 37.8 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 122.445 3.738 . . . . 0.0 122.445 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -126.47 49.66 4.11 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 126.748 2.019 . . . . 0.0 113.895 155.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.04 172.73 14.91 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.595 2.863 . . . . 0.0 114.38 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.1 -40.78 59.7 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -156.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . 0.268 11.7 tpt180 -95.68 -7.33 37.77 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 116.299 1.962 . . . . 0.0 116.299 -177.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -51.09 -42.29 60.52 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 128.774 2.829 . . . . 0.0 113.708 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -64.5 -27.4 68.95 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 117.434 -1.27 . . . . 0.0 112.52 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -106.15 -24.78 12.26 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 -176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.411 HD22 ' HB1' ' A' ' 113' ' ' ALA . 3.8 pp -75.41 161.06 29.56 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-N 121.358 1.89 . . . . 0.0 113.647 169.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -168.24 137.02 2.35 Favored 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 117.746 2.499 . . . . 0.0 117.746 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.401 ' CG ' ' H ' ' A' ' 102' ' ' VAL . 0.0 OUTLIER -105.83 179.72 4.19 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 127.639 2.376 . . . . 0.0 111.453 178.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.401 ' H ' ' CG ' ' A' ' 101' ' ' ARG . 2.5 p -165.82 174.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 126.465 1.906 . . . . 0.0 112.172 -142.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.449 ' HA ' HG13 ' A' ' 150' ' ' VAL . 11.1 t -117.22 121.88 42.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.822 1.249 . . . . 0.0 109.354 151.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -171.55 153.7 3.54 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.369 1.868 . . . . 0.0 108.082 -176.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -120.76 112.16 18.49 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.35 1.86 . . . . 0.0 110.724 172.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -160.06 -172.8 3.76 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.82 1.248 . . . . 0.0 112.04 -157.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -102.43 160.52 14.48 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.094 0.957 . . . . 0.0 111.84 164.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.4 tp -134.59 151.37 51.03 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 128.661 2.784 . . . . 0.0 108.668 -168.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.5 m -124.21 158.51 32.25 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.004 1.722 . . . . 0.0 111.818 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.63 -5.17 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 126.143 1.777 . . . . 0.0 115.543 -166.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -127.14 55.13 1.59 Allowed 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.946 -1.096 . . . . 0.0 112.186 170.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.25 152.73 23.72 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 177.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.411 ' HB1' HD22 ' A' ' 99' ' ' LEU . . . -149.34 128.44 12.76 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 126.218 1.807 . . . . 0.0 107.402 -172.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.84 143.95 21.03 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 121.054 -1.029 . . . . 0.0 110.891 -172.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.73 140.69 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 125.285 1.434 . . . . 0.0 114.423 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.2 t -134.79 154.12 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.07 1.748 . . . . 0.0 111.442 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.6 t -143.07 170.34 15.9 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.27 1.828 . . . . 0.0 110.152 171.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.19 -31.47 63.49 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 120.873 -1.142 . . . . 0.0 113.875 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.14 -32.54 67.01 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 118.623 0.647 . . . . 0.0 112.579 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -67.92 -44.8 76.06 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.641 1.177 . . . . 0.0 110.249 176.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 37.5 mm -67.33 -33.67 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.705 -0.622 . . . . 0.0 111.252 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -62.65 -24.65 67.72 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.245 -0.909 . . . . 0.0 113.285 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -80.85 -15.67 55.74 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 120.741 1.61 . . . . 0.0 113.701 168.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.7 mt -73.81 -44.34 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 120.309 1.413 . . . . 0.0 111.392 -177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -173.24 -38.55 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.181 0 CA-C-O 116.687 -1.625 . . . . 0.0 112.092 168.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -73.21 -147.04 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.259 0 C-N-CA 123.068 2.512 . . . . 0.0 115.753 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 5.3 t -152.63 138.95 18.45 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 129.967 3.307 . . . . 0.0 108.844 -174.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.04 -0.9 17.82 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 119.816 3.265 . . . . 0.0 119.816 -151.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.34 19.29 20.04 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -173.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.59 12.38 0.76 Allowed Glycine 0 N--CA 1.473 1.144 0 C-N-CA 124.322 0.963 . . . . 0.0 114.735 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.44 125.5 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 118.15 0.975 . . . . 0.0 111.907 -167.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.81 85.81 2.45 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.644 1.212 . . . . 0.0 108.097 162.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.1 t -90.83 148.35 22.57 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.978 0.911 . . . . 0.0 109.914 166.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -141.58 137.61 32.05 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.966 0.906 . . . . 0.0 110.203 -169.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 35.9 t -135.05 130.32 35.44 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.188 0.449 . . . . 0.0 110.11 -160.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.1 t -135.54 126.91 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.076 1.351 . . . . 0.0 109.655 -169.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.7 m -121.9 143.5 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.691 0.757 . . . . 0.0 111.907 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -127.56 159.86 33.34 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.136 2.174 . . . . 0.0 109.05 165.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . 0.305 0.1 OUTLIER -148.44 155.51 41.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.104 1.361 . . . . 0.0 110.099 166.769 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.6 t -134.65 115.38 13.74 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.31 0.959 . . . . 0.0 109.437 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -71.03 -52.69 18.1 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 118.999 0.818 . . . . 0.0 110.886 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 60.1 p -56.8 -36.26 69.68 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.68 -4.3 90.26 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.648 1.118 . . . . 0.0 115.542 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 58.5 mtm 47.67 38.87 9.03 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.21 1.804 . . . . 0.0 114.986 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.8 t -149.55 166.04 30.4 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -130.27 137.26 49.91 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.61 1.564 . . . . 0.0 107.901 -173.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -130.47 132.25 45.58 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.596 0.634 . . . . 0.0 109.969 -166.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -142.15 132.69 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -153.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -140.03 132.31 28.28 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.304 1.842 . . . . 0.0 109.257 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.449 HG13 ' HA ' ' A' ' 103' ' ' CYS . 3.3 p -145.5 139.12 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 120.684 -1.26 . . . . 0.0 109.275 159.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.68 147.38 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.77 2.028 . . . . 0.0 109.542 -172.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.56 112.41 9.54 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.378 -0.826 . . . . 0.0 113.212 -170.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -126.37 161.0 28.86 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.042 2.137 . . . . 0.0 110.661 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -75.94 -146.05 1.68 Allowed Glycine 0 CA--C 1.546 2.029 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 154.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.81 0.08 8.2 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 123.553 2.835 . . . . 0.0 114.728 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.01 -20.51 65.96 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.107 -1.621 . . . . 0.0 114.107 -177.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -83.37 61.58 6.25 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.842 1.306 . . . . 0.0 112.04 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -52.7 -32.87 44.92 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.489 1.515 . . . . 0.0 111.846 171.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.74 -51.71 66.1 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.908 0.883 . . . . 0.0 113.099 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.94 -36.12 79.59 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.791 1.178 . . . . 0.0 113.077 171.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -64.51 -52.86 55.65 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.95 1.25 . . . . 0.0 110.792 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -63.08 -32.38 73.75 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 120.836 -1.165 . . . . 0.0 113.192 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.89 -38.22 84.93 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.219 0.918 . . . . 0.0 112.277 171.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -76.02 -43.03 46.03 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.119 0.968 . . . . 0.0 113.547 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 93.8 mt -56.0 -36.03 67.46 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.212 0.914 . . . . 0.0 112.254 172.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -66.89 -51.08 59.67 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.467 1.107 . . . . 0.0 110.83 172.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.53 -26.81 64.69 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -175.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.2 pt -85.22 -34.95 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.681 0.793 . . . . 0.0 112.028 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -67.64 -0.96 4.43 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.684 1.129 . . . . 0.0 112.819 158.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -127.77 25.56 5.98 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 125.629 1.572 . . . . 0.0 112.293 179.852 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -101.83 -165.92 27.09 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.107 1.336 . . . . 0.0 114.767 -175.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -144.1 154.22 42.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.912 1.685 . . . . 0.0 111.179 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.94 73.76 0.6 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.564 1.546 . . . . 0.0 113.134 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -134.69 149.12 50.46 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.424 2.29 . . . . 0.0 109.246 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 6' ' ' ILE . 6.7 tp -85.47 128.66 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-O 124.103 1.906 . . . . 0.0 113.568 -164.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -114.72 148.1 38.77 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 111.097 -2.774 . . . . 0.0 111.745 172.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -55.14 -17.8 4.75 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.2 p30 -75.08 -21.96 58.61 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.865 -1.147 . . . . 0.0 112.111 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.8 t -72.05 -44.0 66.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.483 1.513 . . . . 0.0 110.093 171.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.88 -51.83 56.57 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 169.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.07 -45.12 64.63 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.295 1.047 . . . . 0.0 112.709 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -74.54 -35.13 63.1 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.47 -33.67 60.84 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 120.572 -1.33 . . . . 0.0 112.668 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -70.41 -41.25 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.839 0.745 . . . . 0.0 109.78 170.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.0 m -55.54 -46.78 77.04 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.207 -0.933 . . . . 0.0 111.858 171.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -64.41 -43.91 92.91 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.513 -0.742 . . . . 0.0 112.453 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.7 p -71.5 -24.65 62.01 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -177.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . 0.274 22.9 ptt-85 -74.8 -55.78 5.47 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 120.606 1.548 . . . . 0.0 113.88 158.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.0 -42.28 15.03 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -158.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.41 -25.89 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 CA-C-N 119.654 1.115 . . . . 0.0 110.871 177.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.06 -12.1 60.25 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.699 1.6 . . . . 0.0 112.58 169.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 52.23 46.32 26.85 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 128.057 2.543 . . . . 0.0 115.199 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.564 HD11 HD13 ' A' ' 29' ' ' LEU . 4.7 pp -121.12 161.03 22.5 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.995 1.718 . . . . 0.0 112.703 174.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.31 149.48 26.04 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.659 -0.651 . . . . 0.0 111.49 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -64.96 -25.17 67.76 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.614 -1.304 . . . . 0.0 113.295 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -69.24 -21.46 63.92 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.995 -1.066 . . . . 0.0 112.417 168.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -104.25 -3.96 23.63 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.425 1.89 . . . . 0.0 112.297 -172.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.803 HD11 ' HB1' ' A' ' 48' ' ' ALA . 15.2 tp -94.61 133.49 38.19 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.528 2.731 . . . . 0.0 108.462 163.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.89 122.66 44.43 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.573 0.624 . . . . 0.0 109.724 166.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.2 mm -94.62 138.61 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 124.388 1.075 . . . . 0.0 110.746 170.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.527 ' HB ' HD11 ' A' ' 36' ' ' LEU . 3.5 m -139.21 144.66 38.6 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -117.02 -146.13 0.4 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.632 1.573 . . . . 0.0 110.608 -161.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.7 t -42.53 -32.31 0.54 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 128.122 2.569 . . . . 0.0 115.884 -171.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.52 -26.99 67.27 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 120.201 1.364 . . . . 0.0 113.989 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' A' ' 32' ' ' THR . 40.8 mt -76.79 -43.69 35.74 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 119.817 1.19 . . . . 0.0 112.824 174.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -96.61 16.09 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.505 1.922 . . . . 0.0 111.415 -170.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 3.2 t -57.37 5.6 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.93 2.892 . . . . 0.0 116.845 -165.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.57 -39.04 11.06 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.851 1.26 . . . . 0.0 110.99 175.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -121.96 67.62 24.01 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.215 1.406 . . . . 0.0 107.393 160.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.89 -44.42 49.38 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 123.323 2.682 . . . . 0.0 113.241 -165.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -93.3 6.57 47.64 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.617 -1.182 . . . . 0.0 110.784 -174.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -128.58 100.2 5.66 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 121.172 1.805 . . . . 0.0 107.516 171.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.1 p 176.67 170.51 0.48 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.447 -0.783 . . . . 0.0 111.147 -141.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.7 tp -128.05 -83.93 0.59 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 118.576 -1.25 . . . . 0.0 112.967 145.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 77.3 m -170.58 -161.98 0.26 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.348 1.459 . . . . 0.0 109.175 -160.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -148.0 157.37 43.48 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.348 2.259 . . . . 0.0 107.838 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.803 ' HB1' HD11 ' A' ' 29' ' ' LEU . . . -131.68 134.49 46.0 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.075 2.55 . . . . 0.0 107.571 177.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 42.8 ttm -122.51 130.94 53.57 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.428 -1.42 . . . . 0.0 111.273 -166.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.0 147.86 52.48 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.368 1.467 . . . . 0.0 114.685 -158.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.9 t -99.95 154.93 17.98 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.411 1.884 . . . . 0.0 109.315 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.2 t -46.89 113.15 0.61 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.538 1.535 . . . . 0.0 110.992 -153.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.78 157.86 26.71 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.356 1.074 . . . . 0.0 113.21 -143.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.419 HG22 ' H ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -110.71 178.5 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 113.499 -1.682 . . . . 0.0 109.575 -160.197 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.419 ' H ' HG22 ' A' ' 54' ' ' ILE . 7.6 p -80.15 116.87 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.854 -168.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -125.58 139.3 33.69 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 118.612 -0.708 . . . . 0.0 109.736 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -66.38 78.19 0.34 Allowed 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.148 3.232 . . . . 0.0 113.688 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.2 p -56.39 -30.28 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 127.554 2.341 . . . . 0.0 113.745 -170.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.555 ' HB2' ' H ' ' A' ' 133' ' ' THR . 22.7 tp10 -62.52 -22.49 66.33 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -177.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -55.59 -44.32 76.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.119 0.872 . . . . 0.0 111.117 169.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.1 mp -74.25 -44.5 52.77 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.941 1.296 . . . . 0.0 111.884 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.4 mp -54.0 -50.04 67.48 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 172.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.1 m -63.72 -50.39 69.31 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.126 0.97 . . . . 0.0 112.056 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -60.02 -29.56 68.58 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 118.264 -0.874 . . . . 0.0 113.008 -178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -76.29 -57.63 3.75 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.107 1.321 . . . . 0.0 114.204 169.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -76.53 -40.43 50.01 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -167.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 6.5 p -75.95 -1.81 27.38 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.85 -1.156 . . . . 0.0 113.625 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -60.83 -37.0 80.52 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.173 1.789 . . . . 0.0 113.333 -172.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.7 p -165.76 27.1 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.576 1.55 . . . . 0.0 113.483 169.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.03 86.08 0.16 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.686 1.612 . . . . 0.0 113.936 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -150.08 118.88 6.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 128.85 2.86 . . . . 0.0 104.656 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.6 m -65.6 117.93 8.78 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 122.909 0.484 . . . . 0.0 110.02 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.12 144.91 50.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.476 1.51 . . . . 0.0 111.372 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 26.8 p -115.73 141.0 48.67 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.663 1.185 . . . . 0.0 111.43 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -90.11 151.45 21.6 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 157.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 t -137.67 156.37 32.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 126.534 1.933 . . . . 0.0 108.284 -173.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.555 ' HB2' HD11 ' A' ' 114' ' ' LEU . 86.6 m-85 -123.85 138.52 54.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.044 0.926 . . . . 0.0 109.865 159.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -116.92 103.12 9.96 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 126.997 2.119 . . . . 0.0 108.246 172.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -87.84 127.36 35.34 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.036 1.334 . . . . 0.0 110.166 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.6 t -148.41 166.76 27.13 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 130.318 3.447 . . . . 0.0 105.405 -151.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -18.02 -122.81 0.0 OUTLIER Glycine 0 N--CA 1.486 1.986 1 C-N-CA 131.241 4.258 . . . . 0.0 116.327 -176.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 45.9 t -96.23 101.03 12.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 113.897 -3.121 . . . . 0.0 109.651 150.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.7 mtt180 -171.64 -177.16 1.95 Allowed 'General case' 0 CA--C 1.549 0.934 1 C-N-CA 133.496 4.718 . . . . 0.0 107.05 123.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.5 t -95.26 146.34 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 120.265 -1.522 . . . . 0.0 111.5 145.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.11 136.91 43.73 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.09 1.356 . . . . 0.0 110.359 162.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -110.94 109.35 19.45 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.032 2.133 . . . . 0.0 106.175 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.6 m -104.3 144.78 31.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.332 1.053 . . . . 0.0 110.82 -164.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 74.1 m -127.53 114.32 17.28 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 120.908 -1.12 . . . . 0.0 110.79 -171.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -128.31 117.02 20.73 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.7 pt -88.45 62.54 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 122.792 1.282 . . . . 0.0 109.082 144.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.36 -179.38 43.99 Favored Glycine 0 N--CA 1.47 0.959 0 N-CA-C 121.618 3.407 . . . . 0.0 121.618 -145.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -144.46 116.22 5.43 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 126.162 1.785 . . . . 0.0 111.702 177.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -82.97 163.65 15.65 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.556 2.837 . . . . 0.0 111.706 153.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -60.72 -18.73 56.11 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.546 1.138 . . . . 0.0 114.061 175.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 -25.64 36.21 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.42 1.488 . . . . 0.0 114.966 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.4 -44.08 65.16 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 128.45 2.7 . . . . 0.0 114.289 -169.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -36.84 76.29 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.001 0.52 . . . . 0.0 110.907 175.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -98.04 -23.63 15.69 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -170.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 pp -76.68 175.42 9.36 Favored 'General case' 0 CA--C 1.556 1.173 0 CA-C-N 119.926 1.239 . . . . 0.0 112.375 172.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -119.62 -162.51 0.92 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.878 -1.139 . . . . 0.0 113.917 -162.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -121.88 149.07 43.91 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.451 1.501 . . . . 0.0 111.693 172.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.4 p -127.89 136.7 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.155 0.982 . . . . 0.0 111.607 164.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.439 ' HA ' HG13 ' A' ' 150' ' ' VAL . 0.0 OUTLIER -151.96 123.81 8.0 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 123.131 1.443 . . . . 0.0 108.793 116.213 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 170.89 -179.47 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 130.088 3.355 . . . . 0.0 105.156 -153.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -124.96 133.25 53.09 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.244 1.018 . . . . 0.0 112.331 159.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -150.85 149.89 30.25 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.63 1.172 . . . . 0.0 112.666 -164.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -73.29 132.62 43.33 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.131 0.972 . . . . 0.0 110.801 170.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 21.1 tp -119.13 148.7 42.78 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.049 1.739 . . . . 0.0 111.233 -163.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.7 t -117.26 168.56 10.21 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.07 2.148 . . . . 0.0 110.979 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -77.24 -8.9 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.331 1.452 . . . . 0.0 113.931 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -130.57 70.51 1.45 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.488 1.915 . . . . 0.0 109.175 172.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -133.44 142.06 48.12 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.295 -0.878 . . . . 0.0 111.115 173.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -149.79 129.26 13.02 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.183 1.393 . . . . 0.0 108.077 -163.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 77' ' ' PHE . 4.4 pp -157.94 156.14 30.75 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -159.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.4 t -105.03 145.37 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 C-N-CA 127.33 2.252 . . . . 0.0 111.644 173.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.4 p -126.41 123.39 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 122.489 1.138 . . . . 0.0 111.156 152.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.0 t -146.65 153.55 40.43 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.043 1.337 . . . . 0.0 111.191 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.87 -27.22 67.96 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.469 1.107 . . . . 0.0 113.393 -173.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.19 83.2 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 120.805 1.639 . . . . 0.0 112.628 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.18 -33.97 59.32 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.742 0.817 . . . . 0.0 112.672 172.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 38.2 mm -62.52 -37.09 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.851 1.205 . . . . 0.0 110.714 168.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.33 -19.52 65.46 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.937 1.695 . . . . 0.0 112.761 171.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.2 mtm-85 -80.07 -30.33 39.3 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 121.935 2.152 . . . . 0.0 113.365 161.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 73.1 mt -82.63 -34.51 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.417 1.487 . . . . 0.0 113.461 -172.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -120.5 150.95 53.18 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 125.254 1.422 . . . . 0.0 110.845 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.31 -7.87 21.71 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.149 2.566 . . . . 0.0 113.522 173.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 35.3 m -121.31 131.17 54.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.74 1.616 . . . . 0.0 109.569 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -103.61 -137.43 0.35 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.143 1.377 . . . . 0.0 111.124 -176.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -36.57 125.62 0.84 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.721 1.608 . . . . 0.0 111.701 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 116.69 -30.28 6.48 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.243 1.402 . . . . 0.0 112.293 -149.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 t -60.52 147.84 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.943 1.297 . . . . 0.0 113.153 177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 26.4 tp -122.28 92.64 3.77 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.548 1.539 . . . . 0.0 109.481 159.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.555 ' H ' ' HB2' ' A' ' 59' ' ' GLU . 17.9 m -75.29 154.78 37.22 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.201 2.201 . . . . 0.0 109.933 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -142.11 134.57 28.03 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.773 1.229 . . . . 0.0 108.208 -168.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 34.7 t -139.28 142.04 37.76 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 119.252 0.933 . . . . 0.0 112.136 -163.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.7 t -147.2 141.44 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.976 2.11 . . . . 0.0 109.888 -168.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.91 138.21 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 O-C-N 121.208 -0.933 . . . . 0.0 111.068 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.02 113.2 26.57 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.472 1.109 . . . . 0.0 108.981 166.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.665 ' HE2' ' CD1' ' A' ' 146' ' ' TYR . 0.2 OUTLIER -88.79 128.83 35.65 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 143.573 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.8 m -149.74 175.31 11.7 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -167.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 69.89 160.39 0.2 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 128.244 2.618 . . . . 0.0 115.154 167.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 84.4 p -89.82 -47.71 7.72 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.568 1.547 . . . . 0.0 110.526 171.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -65.88 -1.28 8.71 Favored Glycine 0 CA--C 1.541 1.675 0 C-N-CA 125.629 1.585 . . . . 0.0 115.082 165.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.4 mmt 64.78 128.6 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 129.032 2.933 . . . . 0.0 114.754 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 19.4 p -172.31 155.67 3.61 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.877 2.071 . . . . 0.0 108.476 169.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.665 ' CD1' ' HE2' ' A' ' 139' ' ' LYS . 2.5 m-85 -136.08 163.95 29.14 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -166.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -151.46 155.7 39.11 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.35 -1.469 . . . . 0.0 107.55 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 7.1 tt -136.59 138.94 45.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.092 -0.38 . . . . 0.0 110.516 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -141.69 123.61 15.34 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.321 0.648 . . . . 0.0 110.389 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' A' ' 103' ' ' CYS . 2.1 p -140.61 133.07 31.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-O 122.356 1.074 . . . . 0.0 110.201 168.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.4 m -135.6 130.88 50.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 127.102 2.161 . . . . 0.0 110.735 -163.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -107.65 111.13 23.2 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.094 0.957 . . . . 0.0 111.62 -171.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -109.95 159.47 17.23 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.25 1.42 . . . . 0.0 110.719 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -74.79 -170.79 26.32 Favored Glycine 0 CA--C 1.542 1.735 0 O-C-N 121.314 -0.866 . . . . 0.0 113.728 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.27 -25.8 64.4 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.37 2.047 . . . . 0.0 112.085 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.52 9.0 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 129.349 3.06 . . . . 0.0 114.963 171.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -82.51 46.86 1.1 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.085 2.154 . . . . 0.0 108.605 169.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -58.2 -39.6 79.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.289 2.236 . . . . 0.0 111.824 -165.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -67.57 -44.42 78.27 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.832 -0.604 . . . . 0.0 112.585 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -69.91 -40.87 75.34 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.657 0.783 . . . . 0.0 111.783 174.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -53.69 -59.08 5.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.224 1.01 . . . . 0.0 110.433 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -60.55 -43.11 97.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.962 0.905 . . . . 0.0 112.91 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.43 -38.01 88.07 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.293 0.951 . . . . 0.0 113.058 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.7 -42.7 70.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.314 -0.866 . . . . 0.0 111.962 176.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.05 -35.12 74.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.33 0.513 . . . . 0.0 111.7 173.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -63.06 -31.66 72.85 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.597 1.559 . . . . 0.0 111.803 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -88.37 -45.11 10.27 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -106.7 -24.82 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 118.013 2.597 . . . . 0.0 118.013 -167.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -103.47 -11.49 17.78 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.707 1.203 . . . . 0.0 110.05 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -125.21 25.8 7.08 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.482 1.513 . . . . 0.0 114.134 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 160.012 . . . . . . . . 1 1 . 1 stop_ save_